{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e73614f6-4103-4a89-b078-6f962afc6e73",
     "showTitle": false,
     "title": ""
    }
   },
   "source": [
    "Considering I have downloaded the zip files, i.e., clinicaltrial_2023 and pharma from the assignment brief and uploaded both of them on the definite path location. Now, in order to copy files from one location to another, lets use the databricks utilities to inetract with it: "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "cbb61759-cfe3-40f0-8bb1-fd62bfbffe68",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[1]: True"
     ]
    }
   ],
   "source": [
    "dbutils.fs.cp(\"/FileStore/tables/pharma.zip\", \"file:/tmp/\")\n",
    "dbutils.fs.cp(\"/FileStore/tables/clinicaltrial_2023.zip\", \"file:/tmp/\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0b895212-fb15-4212-93f9-55f715b5fc43",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rserv\nRtmp0Yanez\nchauffeur-daemon-params\nchauffeur-daemon.pid\nchauffeur-env.sh\nclinicaltrial_2023.zip\ncustom-spark.conf\ndriver-daemon-params\ndriver-daemon.pid\ndriver-env.sh\nhsperfdata_root\npharma.zip\npython_lsp_logs\nsystemd-private-0badb3befbea4e99839512e184fef401-apache2.service-dJgYRi\nsystemd-private-0badb3befbea4e99839512e184fef401-ntp.service-T2nQ0e\nsystemd-private-0badb3befbea4e99839512e184fef401-systemd-logind.service-7st3Ei\nsystemd-private-0badb3befbea4e99839512e184fef401-systemd-resolved.service-xEVmof\ntmp.r0ik4R20cr\n"
     ]
    }
   ],
   "source": [
    "\n",
    "%sh\n",
    "ls /tmp/\n",
    "#Run a shell script so as to lists the contents of the /tmp/ directory to check the presence of the tables we just uploaded.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "81028875-7bd8-41bb-b2ba-58f88a89244f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Archive:  /tmp/pharma.zip\n  inflating: /tmp/pharma.csv         \nArchive:  /tmp/clinicaltrial_2023.zip\n  inflating: /tmp/clinicaltrial_2023.csv  \n"
     ]
    }
   ],
   "source": [
    "%sh\n",
    "unzip -d /tmp/ /tmp/pharma.zip\n",
    "unzip -d /tmp/ /tmp/clinicaltrial_2023.zip\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "11e77451-b649-4497-9bb4-b944da1252e6",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "/tmp/pharma.csv\n/tmp/clinicaltrial_2023.csv\n"
     ]
    }
   ],
   "source": [
    "\n",
    "%sh\n",
    "ls /tmp/pharma.csv\n",
    "ls /tmp/clinicaltrial_2023.csv\n",
    "\n",
    "#check whether the files are present in the /tmp/ path or not\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0fccc225-0295-463f-96b6-3e615decf923",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[5]: True"
     ]
    }
   ],
   "source": [
    "#create a directory on the name pharma.csv\n",
    "\n",
    "dbutils.fs.mkdirs(\"FileStore/tables/pharma.csv\")\n",
    "# \"dbutils.fs.mkdirs(\"FileStore/tables/clinicaltrial_2023.csv\") -- not using this command since there is already the file present in the path because by mistake have already stored in it at initial stage of doing the assignment. Since, can't change the file name. keeping the stored file path as it is! Hence, we dont have to create the directory.\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "edfcf42a-0e92-4aa3-82ff-faaa5691dabe",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[6]: True"
     ]
    }
   ],
   "source": [
    "# Now, we can move the file from temp folder to the needed one\n",
    "dbutils.fs.mv(\"file:/tmp/pharma.csv\", \"/FileStore/tables/pharma.csv\", True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "1d2c58fe-7a86-43e1-9ba6-1fb96ff7d172",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[7]: [FileInfo(path='dbfs:/FileStore/tables/pharma.csv/pharma.csv', name='pharma.csv', size=678999, modificationTime=1714595146000)]"
     ]
    }
   ],
   "source": [
    "#check the existence of the file in the path location\n",
    "\n",
    "dbutils.fs.ls(\"FileStore/tables/pharma.csv/\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "8833b329-fb87-4b7c-b2b3-72491eefb45b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": [
    "# to list the contents of the directory"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e63dbd5a-75a9-47f8-a953-3da1ac40b15f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "display_data",
     "data": {
      "text/html": [
       "<style scoped>\n",
       "  .table-result-container {\n",
       "    max-height: 300px;\n",
       "    overflow: auto;\n",
       "  }\n",
       "  table, th, td {\n",
       "    border: 1px solid black;\n",
       "    border-collapse: collapse;\n",
       "  }\n",
       "  th, td {\n",
       "    padding: 5px;\n",
       "  }\n",
       "  th {\n",
       "    text-align: left;\n",
       "  }\n",
       "</style><div class='table-result-container'><table class='table-result'><thead style='background-color: white'><tr><th>path</th><th>name</th><th>size</th><th>modificationTime</th></tr></thead><tbody><tr><td>dbfs:/FileStore/tables/pharma.csv/pharma.csv</td><td>pharma.csv</td><td>678999</td><td>1714595146000</td></tr></tbody></table></div>"
      ]
     },
     "metadata": {
      "application/vnd.databricks.v1+output": {
       "addedWidgets": {},
       "aggData": [],
       "aggError": "",
       "aggOverflow": false,
       "aggSchema": [],
       "aggSeriesLimitReached": false,
       "aggType": "",
       "arguments": {},
       "columnCustomDisplayInfos": {},
       "data": [
        [
         "dbfs:/FileStore/tables/pharma.csv/pharma.csv",
         "pharma.csv",
         678999,
         1714595146000
        ]
       ],
       "datasetInfos": [],
       "dbfsResultPath": null,
       "isJsonSchema": true,
       "metadata": {
        "isDbfsCommandResult": false
       },
       "overflow": false,
       "plotOptions": {
        "customPlotOptions": {},
        "displayType": "table",
        "pivotAggregation": null,
        "pivotColumns": null,
        "xColumns": null,
        "yColumns": null
       },
       "removedWidgets": [],
       "schema": [
        {
         "metadata": "{}",
         "name": "path",
         "type": "\"string\""
        },
        {
         "metadata": "{}",
         "name": "name",
         "type": "\"string\""
        },
        {
         "metadata": "{}",
         "name": "size",
         "type": "\"long\""
        },
        {
         "metadata": "{}",
         "name": "modificationTime",
         "type": "\"long\""
        }
       ],
       "type": "table"
      }
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "%fs ls /FileStore/tables/pharma.csv "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "78190870-56a3-40a0-83f8-bc2e40a5518b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[9]: ['\"Company\",\"Parent_Company\",\"Penalty_Amount\",\"Subtraction_From_Penalty\",\"Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting\",\"Penalty_Year\",\"Penalty_Date\",\"Offense_Group\",\"Primary_Offense\",\"Secondary_Offense\",\"Description\",\"Level_of_Government\",\"Action_Type\",\"Agency\",\"Civil/Criminal\",\"Prosecution_Agreement\",\"Court\",\"Case_ID\",\"Private_Litigation_Case_Title\",\"Lawsuit_Resolution\",\"Facility_State\",\"City\",\"Address\",\"Zip\",\"NAICS_Code\",\"NAICS_Translation\",\"HQ_Country_of_Parent\",\"HQ_State_of_Parent\",\"Ownership_Structure\",\"Parent_Company_Stock_Ticker\",\"Major_Industry_of_Parent\",\"Specific_Industry_of_Parent\",\"Info_Source\",\"Notes\"',\n '\"Abbott Laboratories\",\"Abbott Laboratories\",\"$5,475,000\",\"$0\",\"$5,475,000\",\"2013\",\"20131227\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"kickbacks and bribery\",\"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company\\'s carotid, biliary and peripheral vascular products.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$1,500,000,000\",\"$0\",\"$1,500,000,000\",\"2012\",\"20120507\",\"healthcare-related offenses\",\"off-label or unapproved promotion of medical products\",\"\",\"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company\\'s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\",\"federal\",\"agency action\",\"Food and Drug Administration referral to the Justice Department\",\"civil and criminal\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote\",\"\"',\n '\"Abbott Laboratories Inc.\",\"AbbVie\",\"$126,500,000\",\"$0\",\"$126,500,000\",\"2010\",\"20101207\",\"government-contracting-related offenses\",\"False Claims Act and related\",\"\",\"Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.\",\"federal\",\"agency action\",\"Justice Department Civil Division\",\"civil\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"USA\",\"Illinois\",\"publicly traded\",\"ABBV\",\"pharmaceuticals\",\"pharmaceuticals\",\"https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases\",\"\"',\n '\"Abbott Laboratories Puerto Rico, Inc.\",\"Abbott Laboratories\",\"$49,045\",\"$0\",\"$49,045\",\"2009\",\"20090305\",\"employment-related offenses\",\"wage and hour violation\",\"Fair Labor Standards Act\",\"\",\"federal\",\"agency action\",\"Labor Department Wage and Hour Division\",\"civil\",\"\",\"\",\"1527129\",\"\",\"\",\"Puerto Rico\",\"San Juan\",\"\",\"\",\"423450\",\"423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers\",\"USA\",\"Illinois\",\"publicly traded\",\"ABT\",\"pharmaceuticals\",\"pharmaceuticals\",\"March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\",\"Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\"']"
     ]
    }
   ],
   "source": [
    "# let's name the RDD as \"pharma_rdd\"\n",
    "pharma_rdd = sc.textFile(\"FileStore/tables/pharma.csv/\")\n",
    "\n",
    "# Display the first few rows of the pharma_rdd\n",
    "pharma_rdd.take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "a11ab79e-2db2-490a-9cd0-d01640f813d5",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[10]: ['\"Id\\tStudy Title\\tAcronym\\tStatus\\tConditions\\tInterventions\\tSponsor\\tCollaborators\\tEnrollment\\tFunder Type\\tType\\tStudy Design\\tStart\\tCompletion\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,',\n '\"NCT03630471\\tEffectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India\\tPRIDE\\tCOMPLETED\\tMental Health Issue (E.G.\", Depression, Psychosis, Personality Disorder,\" Substance Abuse)\\tBEHAVIORAL: PRIDE \\'Step 1\\' problem-solving intervention|BEHAVIORAL: Enhanced usual care\\tSangath\\tHarvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine\\t250.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR\",\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\\t2018-08-20\\t2019-02-28\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,',\n '\"NCT05992571\\tOral Ketone Monoester Supplementation and Resting-state Brain Connectivity\\t\\tRECRUITING\\tCerebrovascular Function|Cognition\\tOTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB\\tMcMaster University\\tAlzheimer\\'s Society of Brant\", Haldimand Norfolk,\" Hamilton Halton\\t30.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT\", INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\\t2023-10-25\\t2024-08\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,',\n '\"NCT00237471\\tImpact of Tight Glycaemic Control in Acute Myocardial Infarction\\t\\tTERMINATED\\tMyocardial Infarct|Hyperglycemia\\tDRUG: Insulin (tight blood glucose control)\\tMelbourne Health\\tNational Health and Medical Research Council\",\" Australia|Bristol-Myers Squibb\\t40.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\\t2005-10\\t2006-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,',\n '\"NCT03820271\\tNew Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation\\tSUPERMELD\\tRECRUITING\\tDecompensated Cirrhosis|Liver Transplantation\\tOTHER: SuperMELD\\tAssistance Publique - Hôpitaux de Paris\\t\\t500.0\\tOTHER\\tINTERVENTIONAL\\tAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\\t2020-10-01\\t2023-10-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,']"
     ]
    }
   ],
   "source": [
    "# let's name the RDD as \"clinicaltrial_2023_rdd\"\n",
    "clinicaltrial_2023_rdd = sc.textFile(\"FileStore/tables/clinicaltrial_2023.csv/\")\n",
    "\n",
    "# Display the first few rows of the clinicaltrial_2023_rdd\n",
    "clinicaltrial_2023_rdd.take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "047e32c7-d7b8-40a8-a682-f94cb4832e03",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "column names values - pharma_rdd : \"Company\",\"Parent_Company\",\"Penalty_Amount\",\"Subtraction_From_Penalty\",\"Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting\",\"Penalty_Year\",\"Penalty_Date\",\"Offense_Group\",\"Primary_Offense\",\"Secondary_Offense\",\"Description\",\"Level_of_Government\",\"Action_Type\",\"Agency\",\"Civil/Criminal\",\"Prosecution_Agreement\",\"Court\",\"Case_ID\",\"Private_Litigation_Case_Title\",\"Lawsuit_Resolution\",\"Facility_State\",\"City\",\"Address\",\"Zip\",\"NAICS_Code\",\"NAICS_Translation\",\"HQ_Country_of_Parent\",\"HQ_State_of_Parent\",\"Ownership_Structure\",\"Parent_Company_Stock_Ticker\",\"Major_Industry_of_Parent\",\"Specific_Industry_of_Parent\",\"Info_Source\",\"Notes\"\n"
     ]
    }
   ],
   "source": [
    "# Check the first row of pharma_Rdd and print its values\n",
    "column_names_pharma = pharma_rdd.first()\n",
    "print(\"column names values - pharma_rdd :\", column_names_pharma)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "7c75c2f0-1a48-4194-ae0f-d7011b5c3fd1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Row count of pharma_with_none_notes RDD: 969\n"
     ]
    }
   ],
   "source": [
    "# Assuming pharma_rdd is your RDD\n",
    "row_count = pharma_rdd.count()\n",
    "\n",
    "print(\"Row count of pharma_with_none_notes RDD:\", row_count)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "58245fd0-8a68-4eec-833c-929b39c17aa2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [],
   "source": [
    "# Read the data into the name \"clinicaltrial_2023_rdd\"\n",
    "\n",
    "clinicaltrial_2023_rdd = sc.textFile(\"/FileStore/tables/clinicaltrial_2023.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0bd6cd3e-145e-4351-93e3-68ea55b0e385",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "First row values: \"Id\tStudy Title\tAcronym\tStatus\tConditions\tInterventions\tSponsor\tCollaborators\tEnrollment\tFunder Type\tType\tStudy Design\tStart\tCompletion\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,\n"
     ]
    }
   ],
   "source": [
    "# Check the first row and print its values\n",
    "column_names_clinicaltrial = clinicaltrial_2023_rdd.first()\n",
    "print(\"First row values:\", column_names_clinicaltrial)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "6eceba56-628d-4180-b9bc-9a410741be99",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[15]: [(['\"Id'],\n  'Study Title',\n  'Acronym',\n  'Status',\n  'Conditions',\n  'Interventions',\n  'Sponsor',\n  'Collaborators',\n  'Enrollment',\n  'Funder Type',\n  'Type',\n  'Study Design',\n  'Start',\n  'Completion\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,'),\n (['\"NCT03630471'],\n  'Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India',\n  'PRIDE',\n  'COMPLETED',\n  'Mental Health Issue (E.G.\", Depression, Psychosis, Personality Disorder,\" Substance Abuse)',\n  \"BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care\",\n  'Sangath',\n  'Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine',\n  '250.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR\",\" OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT',\n  '2018-08-20',\n  '2019-02-28\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,'),\n (['\"NCT05992571'],\n  'Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity',\n  '',\n  'RECRUITING',\n  'Cerebrovascular Function|Cognition',\n  'OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB',\n  'McMaster University',\n  'Alzheimer\\'s Society of Brant\", Haldimand Norfolk,\" Hamilton Halton',\n  '30.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT\", INVESTIGATOR,\" OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE',\n  '2023-10-25',\n  '2024-08\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,'),\n (['\"NCT00237471'],\n  'Impact of Tight Glycaemic Control in Acute Myocardial Infarction',\n  '',\n  'TERMINATED',\n  'Myocardial Infarct|Hyperglycemia',\n  'DRUG: Insulin (tight blood glucose control)',\n  'Melbourne Health',\n  'National Health and Medical Research Council\",\" Australia|Bristol-Myers Squibb',\n  '40.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT',\n  '2005-10',\n  '2006-05\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,'),\n (['\"NCT03820271'],\n  'New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation',\n  'SUPERMELD',\n  'RECRUITING',\n  'Decompensated Cirrhosis|Liver Transplantation',\n  'OTHER: SuperMELD',\n  'Assistance Publique - Hôpitaux de Paris',\n  '',\n  '500.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER',\n  '2020-10-01',\n  '2023-10-01\",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,')]"
     ]
    }
   ],
   "source": [
    "# lets do the data preparation and cleansing on the table clinicaltrial_2023 to make it ready for the tasks\n",
    "\n",
    "# Each line in the RDD is a string containing tab-separated values, and the lambda function splits each line into a list of values.\n",
    "clinicaltrial_2023_parsed_data_rdd = clinicaltrial_2023_rdd.map(lambda line: line.split(\"\\t\"))\n",
    "\n",
    "# define a function for extracting the variables from the first column\n",
    "def parse_first_column(row):\n",
    "    columns = row[0].split(\"|\")\n",
    "    return (columns,) + tuple(row[1:]) #-- this returns a tuple containing all the column values with the extracted first column along with it\n",
    "\n",
    "# Now, in order to apply the parsing function to each row\n",
    "clinicaltrial_2023_structured_data_rdd = clinicaltrial_2023_parsed_data_rdd.map(parse_first_column)\n",
    "\n",
    "#Printing first few rows in order to check whether the pasing have been successfully done or not.\n",
    "clinicaltrial_2023_structured_data_rdd.take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "fae590bf-18c4-4787-9639-b9227a32ce0b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[16]: [['Id',\n  'Study Title',\n  'Acronym',\n  'Status',\n  'Conditions',\n  'Interventions',\n  'Sponsor',\n  'Collaborators',\n  'Enrollment',\n  'Funder Type',\n  'Type',\n  'Study Design',\n  'Start',\n  'Completion'],\n ['NCT03630471',\n  'Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India',\n  'PRIDE',\n  'COMPLETED',\n  'Mental Health Issue (E.G. Depression Psychosis Personality Disorder Substance Abuse)',\n  \"BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care\",\n  'Sangath',\n  'Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine',\n  '250.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT',\n  '2018-08-20',\n  '2019-02-28'],\n ['NCT05992571',\n  'Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity',\n  '',\n  'RECRUITING',\n  'Cerebrovascular Function|Cognition',\n  'OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB',\n  'McMaster University',\n  \"Alzheimer's Society of Brant Haldimand Norfolk Hamilton Halton\",\n  '30.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE',\n  '2023-10-25',\n  '2024-08'],\n ['NCT00237471',\n  'Impact of Tight Glycaemic Control in Acute Myocardial Infarction',\n  '',\n  'TERMINATED',\n  'Myocardial Infarct|Hyperglycemia',\n  'DRUG: Insulin (tight blood glucose control)',\n  'Melbourne Health',\n  'National Health and Medical Research Council Australia|Bristol-Myers Squibb',\n  '40.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT',\n  '2005-10',\n  '2006-05'],\n ['NCT03820271',\n  'New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation',\n  'SUPERMELD',\n  'RECRUITING',\n  'Decompensated Cirrhosis|Liver Transplantation',\n  'OTHER: SuperMELD',\n  'Assistance Publique - Hôpitaux de Paris',\n  '',\n  '500.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER',\n  '2020-10-01',\n  '2023-10-01']]"
     ]
    }
   ],
   "source": [
    "# Since, there are extra unwanted commas and quotes present in our parsed dataset, we need to remove it from each row\n",
    "\n",
    "clinicaltrial_2023_cleaned_data_rdd = clinicaltrial_2023_parsed_data_rdd.map(lambda row: [field.replace(',', '').replace('\"', '') for field in row])\n",
    "\n",
    "# view first few rows to check and confirm the data cleansing have successfully implemented\n",
    "clinicaltrial_2023_cleaned_data_rdd.take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c1795004-dbec-47a0-96cf-ed5c51556902",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Yes\n['NCT05992571', 'Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity', '', 'RECRUITING', 'Cerebrovascular Function|Cognition', 'OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB', 'McMaster University', \"Alzheimer's Society of Brant Haldimand Norfolk Hamilton Halton\", '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE', '2023-10-25', '2024-08']\n['NCT00237471', 'Impact of Tight Glycaemic Control in Acute Myocardial Infarction', '', 'TERMINATED', 'Myocardial Infarct|Hyperglycemia', 'DRUG: Insulin (tight blood glucose control)', 'Melbourne Health', 'National Health and Medical Research Council Australia|Bristol-Myers Squibb', '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2005-10', '2006-05']\n['NCT03820271', 'New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation', 'SUPERMELD', 'RECRUITING', 'Decompensated Cirrhosis|Liver Transplantation', 'OTHER: SuperMELD', 'Assistance Publique - Hôpitaux de Paris', '', '500.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER', '2020-10-01', '2023-10-01']\n['NCT02945371', 'Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life', 'REV', 'COMPLETED', 'Smoking|Alcohol Drinking|Prescription Drug Abuse|Substance-Related Disorders|Oral Intake Reduced', 'BEHAVIORAL: Person-centered inhibitory control training|BEHAVIORAL: Active behavioral response training', 'University of Oregon', '', '103.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION', '2014-09', '2016-05']\n['NCT01055171', 'Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence', '', 'COMPLETED', 'Alcohol Dependence|PTSD', 'DRUG: Propranolol|DRUG: Placebo', 'Medical University of South Carolina', 'National Institute on Alcohol Abuse and Alcoholism (NIAAA)', '44.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2010-01', '2012-08']\n['NCT01125371', 'Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women', '', 'COMPLETED', 'Alcohol; Harmful Use|Binge Drinking|Risk Behavior|HIV Infection', 'BEHAVIORAL: Computerized brief alcohol intervention + IVR booster calls|BEHAVIORAL: Computerized brief alcohol intervention|BEHAVIORAL: Attention Control', 'Johns Hopkins University', 'National Institute on Alcohol Abuse and Alcoholism (NIAAA)', '439.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2011-10', '2016-06-07']\n['NCT02554071', 'Manitoba Pharmacist Initiated Smoking Cessation Pilot Project', '', 'COMPLETED', 'Smoking Cessation', 'OTHER: Pharmacist - Smoking Cessation Support', 'University of Manitoba', 'Govenment of Manitoba|Canadian Foundation for Pharmacy|Neighbourhood Pharmacy Association of Canada', '119.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2014-01', '2014-11']\n['NCT01772771', 'Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program', '', 'RECRUITING', 'Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Melanoma|Sarcoma', 'PROCEDURE: Biospecimen Collection|OTHER: Genetic Testing|OTHER: Medical Chart Review', 'M.D. Anderson Cancer Center', 'National Cancer Institute (NCI)', '12000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-03-01', '2033-03-01']\n['NCT02633371', 'A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults', '', 'COMPLETED', 'Hyperhidrosis', 'DRUG: Oxybutynin 3% gel', 'University of Colorado Denver', 'Society for Pediatric Dermatology', '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-02', '2017-05']\n['NCT00120471', 'Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies', '', 'COMPLETED', 'HIV Infections', 'DRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute on Drug Abuse (NIDA)|National Institute of Mental Health (NIMH)', '122.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2006-11', '2011-12']\n['NCT04765371', 'Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy With CoViD-19', 'COPreDex', 'COMPLETED', 'Coronavirus Infection', 'DRUG: DEXAMETHASONE|DRUG: PREDNISOLONE', 'Hôpital NOVO', '', '89.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2021-03-03', '2022-05-13']\n['NCT02830971', 'Developing a Standardized Learning Curve', '', 'COMPLETED', 'Registered Nurses|Nursing Personnel|Motor Skills', 'PROCEDURE: Doing Different ICU techniques and skills', 'Baqiyatallah Medical Sciences University', 'Shahid Beheshti University|Tehran University of Medical Sciences', '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2016-07', '2021-04-12']\n['NCT00416871', 'Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer', '', 'COMPLETED', 'Kidney Cancer', 'BIOLOGICAL: aldesleukin|BIOLOGICAL: recombinant interferon alfa', 'Centre Leon Berard', '', '220.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', '', '2006-02']\n['NCT02469571', 'Modulation of Gut Microbiota in Early Sepsis: A Pilot Study', 'MGM-sepsis', 'COMPLETED', 'Sepsis', 'DIETARY_SUPPLEMENT: Winclove 607|DIETARY_SUPPLEMENT: Placebo', 'Medical University of Graz', '', '15.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2015-09-01', '2018-03-01']\n['NCT05807971', 'Assessment of Safety Tolerability Pharmacokinetics and Pharmacodynamics of ATH-063 in Healthy Subjects', '', 'RECRUITING', 'Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Autoimmune Diseases', 'DRUG: ATH-063|DRUG: Placebo', 'Athos Therapeutics Inc', 'Syneos Health|Athos Therapeutics Australia Pty Ltd', '76.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2023-04-06', '2024-02-08']\n['NCT02083471', \"Cow's Milk and Hen's Egg Hyposensitization in Adults\", '', 'UNKNOWN', \"Egg Allergy|Cow's Milk Allergy\", \"DIETARY_SUPPLEMENT: Specific Oral Tolerance Induction with Egg or Cow's milk\", 'Turku University Hospital', '', '40.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2015-04', '2017-05']\n['NCT01062971', 'Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide', '', 'COMPLETED', 'Primary Open Angle Glaucoma|Ocular Hypertension', 'DRUG: dorzolamide-timolol-brimonidine', 'Laboratorios Sophia S.A de C.V.', '', '124.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2006-02', '2008-06']\n['NCT03928171', 'The Effect of Intra-abdominal Pressure on Peritoneal Perfusion During Laparoscopic Colorectal Surgery', 'PERFUSION', 'COMPLETED', 'Laparoscopic Surgery|Pneumoperitoneum', 'OTHER: Intra-abdominal pressure during laparoscopy', 'Radboud University Medical Center', '', '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2018-06-13', '2018-12-24']\n['NCT00897871', 'Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer', '', 'UNKNOWN', 'Unspecified Childhood Solid Tumor Protocol Specific', 'DRUG: carboplatin|DRUG: cyclophosphamide|DRUG: etoposide phosphate|GENETIC: gene expression analysis|GENETIC: polymorphism analysis|OTHER: pharmacological study', \"Children's Cancer and Leukaemia Group\", '', '60.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2007-02', '']\n['NCT06135571', 'Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer', '', 'RECRUITING', 'Colorectal Cancer|Lymph Node Metastasis', 'PROCEDURE: Laparoscopic colorectal surgery', 'Cancer Institute and Hospital Chinese Academy of Medical Sciences', 'Peking Union Medical College Hospital|Peking University Cancer Hospital & Institute|China-Japan Friendship Hospital|Chinese PLA General Hospital', '3000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-09-01', '2026-09-01']\n['NCT01189071', 'Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain', '', 'TERMINATED', 'Overactive Bladder|Renal Colic|Pain Postoperative', 'DRUG: Darifenacin', 'University of Missouri-Columbia', '', '3.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2009-08', '2011-07']\n['NCT00728871', 'The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis', '', 'UNKNOWN', 'Cervical Cancer|Cervical Intraepithelial Neoplasia', 'PROCEDURE: peripheral blood isolation', 'National Taiwan University Hospital', '', '600.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2005-12', '2011-12']\n['NCT00520871', 'The Water-Blueberry Study', '', 'COMPLETED', 'Cardiovascular Disease', 'DRUG: Blueberry juice', 'University of Oslo', 'Ullevaal University Hospital', '62.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: PREVENTION', '2003-03', '2004-04']\n['NCT05913271', 'Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure', '', 'RECRUITING', 'Heart Failure|Levosimendan|Efficacy|Safety', '', 'Yi Han', 'Qianfoshan Hospital', '352.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-05-30', '2025-05-30']\n['NCT04006171', 'Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women', 'CNP', 'COMPLETED', 'Polycystic Ovary Syndrome|c Type Natriuretic Peptide|Menstrual Irregularity|Hyperandrogenism', 'DIAGNOSTIC_TEST: C type natriuretic peptide', 'Near East University Turkey', '', '90.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2019-07-15', '2020-09-01']\n['NCT04370171', 'Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic', 'TeleCoviDiab', 'COMPLETED', 'Diabetes|Covid-19', 'OTHER: care modalities|OTHER: Teleconsultation either by phone or by computer consultation', 'University Hospital Strasbourg France', '', '610.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2020-05-04', '2020-05-29']\n['NCT04340271', 'The Clinical Utility of Extracorporeal Shock Wave Therapy on Burns', '', 'COMPLETED', 'Burn Scar', 'OTHER: Extracorporeal shock wave therapy|OTHER: conventional occupational therapy', 'Hangang Sacred Heart Hospital', '', '48.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2020-04-15', '2020-05-31']\n['NCT03075371', 'Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa', '', 'COMPLETED', 'Anorexia Nervosa|Healthy', 'OTHER: Glucose|OTHER: Placebo', 'University of Heidelberg Medical Center', 'German Research Foundation', '85.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE', '2014-09', '2019-02']\n['NCT05966571', 'Ovarian Innervation Study in Patients With Polycystic Ovary Syndrome (PCOS)', '', 'RECRUITING', 'Polycystic Ovary Syndrome', 'PROCEDURE: Ovary Biopsie', 'Albanian University', '', '50.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-07-01', '2024-12-01']\n['NCT03313271', 'China Lymphoma Patient Registry Study', 'CLAP', 'RECRUITING', 'Lymphoma', '', 'Jun Zhu', 'Peking University First Hospital|Tianjin Medical University Cancer Hospital|Zhejiang Cancer Hospital|Heilongjiang Cancer Hospital|Sipai(Beijing)Network Technology Co Ltd', '5000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2017-05-17', '2027-08-30']\n['NCT03490071', 'Long-term Follow up of Patients With Longstanding Hip and Groin Pain', 'Lund LHGP', 'RECRUITING', 'Hip Pain Chronic', '', 'Lund University', '', '81.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2018-01-01', '2024-12-31']\n['NCT05801471', 'Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression', '', 'RECRUITING', 'Glaucoma', '', 'Centervue SpA', '', '200.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2022-05-06', '2025-11-06']\n['NCT00266071', 'Study of the Cutaneous Microcirculation in Elderly People', '', 'UNKNOWN', 'Elderly People', 'BEHAVIORAL: Cutaneous response', 'University Hospital Angers', '', '', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2005-12', '']\n['NCT04405271', 'TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)', '', 'UNKNOWN', 'Healthcare Workers|COVID-19|SARS-CoV 2', 'DRUG: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|DRUG: Placebo', 'Hospital Italiano de Buenos Aires', 'Sociedad Argentina de Infectología (SADI) (Argentine Society of Infectious Diseases)', '1378.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2020-07-31', '2020-11-15']\n['NCT02121171', 'Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma', '', 'UNKNOWN', 'Congenital Glaucoma', 'DEVICE: Ologen Collagen Matrix|PROCEDURE: Combined trabeculotomy-trabeculectomy', 'National Centre of Ophthalmology named after academician Zarifa Aliyeva', 'Aeon Astron Europe B.V.', '40.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2010-09', '2015-09']\n['NCT01068171', 'Developing a Diabetic Foot Ulcer Protocol', '', 'WITHDRAWN', 'Diabetic Foot Ulcers', 'OTHER: type of footwear|OTHER: collagen dressing with and without silver', 'The University of Texas Health Science Center Houston', 'Harris County Hospital District|Baylor College of Medicine', '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2010-05', '2012-06']\n['NCT00553371', 'Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer', '', 'UNKNOWN', 'Testicular Germ Cell Tumor', 'OTHER: biomarker analysis|PROCEDURE: computed tomography', 'Royal Marsden NHS Foundation Trust', '', '300.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2006-04', '']\n['NCT04674371', 'German Point Prevalence Study on CVC', '', 'COMPLETED', 'Data Collection', 'OTHER: central venous catheter insertion', 'Wolfram Schummer MD PhD', '', '537.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2022-05-17', '2022-05-20']\n['NCT02321371', 'Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.', '', 'COMPLETED', 'Acute-On-Chronic Liver Failure', 'DRUG: Lactulose + Rifaximin|DRUG: Lactulose', 'Institute of Liver and Biliary Sciences India', '', '73.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2014-10-19', '2016-01-31']\n['NCT02344771', 'Perioperative Endothelial Dysfunction', '', 'COMPLETED', 'Myocardial Injury', 'PROCEDURE: Elective colon cancer surgery', 'Zealand University Hospital', '', '31.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-03', '2015-06']\n['NCT03354871', 'Developing Models for Fatigue Monitoring in Obstetrics and Gyne- Cology Residents Using Wearables', 'IoT4Resident', 'UNKNOWN', 'Fatigue', '', 'Hillel Yaffe Medical Center', 'International Business Machines (IBM)', '6.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2017-11', '2018-02-28']\n['NCT02804971', 'Cardiovascular Comorbidities and Bronchiectasis', 'BRONCOCA', 'ACTIVE_NOT_RECRUITING', 'Bronchiectasis', '', 'Centre Hospitalier Intercommunal Creteil', '', '200.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2016-10-25', '2023-12']\n['NCT04591171', 'Assessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney Disease', '', 'COMPLETED', 'Hypertension|Chronic Kidney Diseases', 'PROCEDURE: n-of-1 trial guided clinical decision making', 'The University of Texas Health Science Center Houston', \"Children's Hospital of Philadelphia|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\", '9.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2021-01-25', '2022-02-18']\n['NCT04814771', 'Mass Balance Study of TS-142 in Healthy Adult Subjects.', '', 'COMPLETED', 'Healthy Male Subjects', 'DRUG: [14C] TS-142', 'Taisho Pharmaceutical Co. Ltd.', '', '6.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2021-04-19', '2021-05-19']\n['NCT00991471', 'The Effect of an Physician-Nurse Supplementary Triage Assistance Team on Emergency Department Patient Wait Times', 'MDRNSTAT', 'COMPLETED', 'Emergencies', 'BEHAVIORAL: Interaction with MDRN STAT|BEHAVIORAL: No MDRNSTAT', 'Sunnybrook Health Sciences Centre', '', '6300.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2009-09', '2010-02']\n['NCT05702671', 'Kenota 1 CWS Method Comparison Validation Study', '', 'COMPLETED', 'Allergy|Immunoglobulin E-Mediated Allergic Disorder', 'DIAGNOSTIC_TEST: Total Immunoglobulin E Obtained From Fingerstick Sample', 'Kenota Inc.', '', '411.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-01-27', '2023-04-07']\n['NCT02069171', 'Cross-sectional and Questionnaire Study for Leg Lymphedema', '', 'COMPLETED', 'Gynecologic Cancer', '', 'National Cancer Center Korea', '', '333.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-06', '2012-11']\n['NCT00474071', 'Optimum Dose of Remifentanil for Intubation in Small Children', '', 'COMPLETED', 'Endotracheal Intubation', 'DRUG: Remifentanil', 'University of British Columbia', '', '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2007-03', '2008-04']\n['NCT02022371', 'Prostate Cancer Genomic Heterogeneity', 'PROGENY', 'COMPLETED', 'PROSTATE CANCER', 'PROCEDURE: Targeted biopsies of the prostate', 'University College London Hospitals', '', '50.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2014-09', '2016-06']\n['NCT04585971', 'A Study on Hemodynamic Relationship Including Cerebral Blood Flow Using Phase Contrast and Signal Intensity Gradient of Brain Magnetic Resonance Imaging and Carotid Doppler Ultrasound', '', 'UNKNOWN', 'Cerebral Blood Flow', 'DIAGNOSTIC_TEST: Signal intensity gradient', 'Chonbuk National University Hospital', 'Medi Image Inc', '30.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2020-09-03', '2021-01-31']\n['NCT05473871', 'Enhancing Capacity in Churches to Implement PA Programs', '', 'RECRUITING', 'Cardiovascular Diseases', 'BEHAVIORAL: Faith in Action|BEHAVIORAL: Faith in Action+|BEHAVIORAL: Faith in Action++', 'San Diego State University', 'Washington University School of Medicine|University of California Berkeley|University of California San Diego', '812.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2022-11-15', '2026-10-31']\n['NCT01523171', 'Phase II Open Label Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib', 'JAKARTA2', 'COMPLETED', 'Hematopoietic Neoplasm', 'DRUG: SAR302503', 'Sanofi', '', '97.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-04', '2014-04']\n['NCT00000571', 'Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease', '', 'COMPLETED', 'Lung Diseases|Lung Diseases Obstructive|Chronic Obstructive Pulmonary Disease', 'DEVICE: ventilators negative pressure', 'McGill University', 'National Heart Lung and Blood Institute (NHLBI)', '', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT', '1986-02', '']\n['NCT01053871', 'Propofol Versus Midazolam With Fentanyl for EGD Endomicroscopy', '', 'COMPLETED', 'Gastritis|Functional Dyspepsia', 'DRUG: propofol|DRUG: midazolam with fentanyl', 'Shandong University', '', '104.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: ', '2010-01', '2010-05']\n['NCT02370771', 'Proteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis', 'PASEO', 'COMPLETED', 'Erosive Hand Osteoarthritis', 'PROCEDURE: Biological sampling|DEVICE: Radiographic evaluation', 'University Hospital Rouen', '', '32.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2015-06-09', '2019-11-17']\n['NCT05974371', 'Episodic Memory Integration and Interference', '', 'NOT_YET_RECRUITING', 'Episodic Memory', 'OTHER: emotional context similarity', 'Boston College', '', '150.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2024-08', '2027-08']\n['NCT03713671', 'Gait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism', '', 'COMPLETED', 'Primary Hyperparathyroidism', 'DIAGNOSTIC_TEST: gait analysis', 'Recep Tayyip Erdogan University Training and Research Hospital', 'Hacettepe University|Ankara Education and Research Hospital', '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING', '2021-10-17', '2023-08-27']\n['NCT02645071', 'Brief Program in Reducing Sedentary Behavior and Promoting Physical Exercise', '', 'COMPLETED', 'Physical Activity', 'BEHAVIORAL: Physical Activity', 'The University of Hong Kong', 'Hong Kong Jockey Club Charities Trust', '141.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION', '2015-07', '2017-07']\n['NCT04004871', 'Induction Chemotherapy With Nab-paclitaxel Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma', '', 'UNKNOWN', 'Nasopharyngeal Carcinoma|Nasopharyngeal Cancer|Nasopharynx Cancer', 'DRUG: Nab-paclitaxel Cisplatin and Fluorouracil|RADIATION: concurrent chemoradiotherapy', 'Guangxi Medical University', 'Second Affiliated Hospital of Guangxi Medical University|Guilin Medical University \n\n*** WARNING: max output size exceeded, skipping output. ***\n\n', '', 'COMPLETED', 'HIV', 'DRUG: Efavirenz', 'Indiana University', '', '73.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2007-05', '2010-04']\n['NCT02136095', 'Promising Initial Experience With Intra-operative Fluorescent Cholangiography', '', 'COMPLETED', 'Gall Stone Disease', 'PROCEDURE: Intraoperative fluorescent cholangiography (IFC)', 'Hvidovre University Hospital', '', '35.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2013-09', '2013-12']\n['NCT00557895', 'Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders', '', 'TERMINATED', 'Allergy|Asthma|Allergic Rhinitis|Mastocytosis|Atopic Dermatitis|Food Allergy', '', 'National Institute of Allergy and Infectious Diseases (NIAID)', '', '288.0', 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '1996-08-26', '2019-06-25']\n['NCT02520895', 'Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia', 'RIPAL', 'COMPLETED', 'LYMPHOMA', 'BIOLOGICAL: blood samplings', 'Hospices Civils de Lyon', '', '98.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2010-09', '2013-10']\n['NCT05379595', 'A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer', 'OrigAMI-1', 'RECRUITING', 'Advanced or Metastatic Colorectal Cancer', 'DRUG: Amivantamab|BIOLOGICAL: Fluorouracil|BIOLOGICAL: Leucovorin|BIOLOGICAL: Oxaliplatin|BIOLOGICAL: Irinotecan', 'Janssen Research & Development LLC', '', '225.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2022-07-29', '2026-03-20']\n['NCT00300495', 'Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection', '', 'TERMINATED', 'Atrial Fibrillation|Lung Cancer', 'DRUG: Amiodarone|OTHER: Control arm standard care', 'Beth Israel Deaconess Medical Center', '', '19.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2006-02', '2009-10-13']\n['NCT01240395', 'Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity', '', 'COMPLETED', 'Multiple Chemical Sensitivity', 'BEHAVIORAL: Mindfulness-based Cognitive Therapy (MBCT)', 'The Danish Research Centre for Chemical Sensitivities', '', '82.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2011-09', '2013-05']\n['NCT03850795', 'HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)', '', 'ACTIVE_NOT_RECRUITING', 'Prostate Cancer Metastatic|Castration-resistant Prostate Cancer', 'DRUG: HC-1119|DRUG: Enzalutamide', 'Hinova Pharmaceuticals USA Inc.', '', '104.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2021-03-15', '2024-12-31']\n['NCT00748995', 'Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study', '', 'ACTIVE_NOT_RECRUITING', 'Stress Disorders Post-Traumatic', '', 'VA Office of Research and Development', '', '817.0', 'FED', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2010-08-31', '2025-09-30']\n['NCT01549795', 'Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy', '', 'UNKNOWN', 'Hilar Cholangiocarcinoma|Primary Sclerosing Cholangitis', 'PROCEDURE: Liver transplantation|RADIATION: 45 Gy external radiations|RADIATION: Endoluminal bile duct Brachytherapy|DRUG: Capecitabine|PROCEDURE: Pre liver transplantation laparoscopic hand assisted staging', 'Azienda Ospedaliera di Padova', '', '33.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-01', '']\n['NCT00420095', 'A Study for Patients With Diabetes Mellitus (IOPA)', 'IOPA', 'COMPLETED', 'Diabetes Mellitus Type 1|Diabetes Mellitus Type 2', 'DRUG: Human insulin 30/70|DRUG: Insulin lispro low mix', 'Eli Lilly and Company', '', '117.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', '2007-01', '2008-01']\n['NCT03810495', \"The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers\", '', 'COMPLETED', 'Opioid Use Disorder', 'DRUG: naltrexone implant', 'Go Medical Industries Pty Ltd', 'National Institute on Drug Abuse (NIDA)|New York State Psychiatric Institute|Columbia University|Clinilabs Inc.', '20.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2019-04-11', '2021-03-22']\n['NCT01246895', 'Follow-Up Study Evaluating The Long Term Safety and Efficacy of BST-CarGel and Microfracture Repair of the Knee', '', 'COMPLETED', 'Knee Injuries', 'DEVICE: Microfracture with BST-CarGel|DEVICE: Microfracture without BST-CarGel', 'Piramal Healthcare Canada Ltd', '', '67.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2011-03', '2014-03']\n['NCT02666495', 'Individual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series', '', 'UNKNOWN', 'Anorexia Nervosa', 'OTHER: Psychological Therapy - Schema Therapy', 'NHS Lothian', '', '15.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-01', '2019-01']\n['NCT01501695', 'Phase III Study of 5LGr to Treat Tic Disorder', '5LGr', 'COMPLETED', 'Tic Disorder|Tourette Syndrome|Chronic Tic Disorder', 'DRUG: 5LGr|DRUG: tiapride|DRUG: placebo', 'Tasly Pharmaceuticals Inc.', '', '603.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2008-01', '2011-10']\n['NCT02132195', 'Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome', '', 'COMPLETED', 'Nephrotic Syndrome', 'DRUG: ACTH', 'Emory University', 'Mallinckrodt', '31.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2014-05', '2018-03']\n['NCT02409095', 'Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants', '', 'TERMINATED', 'Immune Response to DTP-HB-Hib Vaccine', 'BIOLOGICAL: DTP-HB-Hib vaccine|DEVICE: Disposable Syringe Jet Injector (DSJI)|OTHER: Needle & Syringe', 'Serum Institute of India Pvt. Ltd.', 'PATH', '211.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2015-01', '2016-03']\n['NCT05031195', 'Prognostic Impact of NLR PLR and MPV in Patients Undergoing AAA Open Repair', '', 'COMPLETED', 'Abdominal Aortic Aneurysm', 'OTHER: 1st tertile 2nd tertile 3rd tertile', 'Gangnam Severance Hospital', '', '334.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2020-01-11', '2021-03-30']\n['NCT03737695', 'Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer', '', 'RECRUITING', 'Anatomic Stage IV Breast Cancer AJCC v8|Invasive Breast Carcinoma|Metastatic Breast Carcinoma|Peritoneal Effusion|Recurrent Breast Carcinoma', 'PROCEDURE: Biospecimen Collection|OTHER: Medical Chart Review', 'Mayo Clinic', 'National Cancer Institute (NCI)', '300.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2019-09-16', '2024-11-15']\n['NCT00568295', 'A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee', '', 'COMPLETED', 'Osteoarthritis of the Knee', 'DRUG: acetaminophen|DRUG: Rofecoxib|DRUG: Rofecoxib', 'Johnson & Johnson Consumer and Personal Products Worldwide', '', '403.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '1999-10', '2000-10']\n['NCT01891695', 'OPSCC N0 Nodal Control With Reduced IMRT', '', 'TERMINATED', 'Oropharyngeal Squamous Cell Carcinoma (OPSCCA)|HPV (Human Papillomavirus)-Associated', 'RADIATION: 39.6 Gy radiation', 'Paul W. Read MD', '', '1.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2013-10', '2016-12']\n['NCT02058095', 'Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)', 'Aim 3', 'COMPLETED', 'Cardiomyopathy|Renal Impairment', 'DRUG: Tadalafil|DRUG: Placebo', 'Mayo Clinic', '', '22.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE', '2014-03', '2019-12']\n['NCT04205695', 'Comparison of Catheters Orifice Configuration For Continuous Infraclavicular Analgesia', '', 'COMPLETED', 'Pain Postoperative|Catheter Blockage|Anesthesia', 'PROCEDURE: CEMP (closed-ended multiport catheter) group|PROCEDURE: OESP (open-ended single port catheter) group|PROCEDURE: Patient-controlled analgesia', 'Gulhane School of Medicine', '', '70.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2019-12-10', '2020-02-28']\n['NCT00417495', 'Sentinel Lymph Node Technique in Multifocal Breast Cancer', '', 'COMPLETED', 'Breast Cancer', 'BEHAVIORAL: Sentinel Lymph Node Technique', 'Centre Oscar Lambret', '', '216.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2006-03', '2008-09']\n['NCT02893995', 'Safety Tolerability Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension', '', 'WITHDRAWN', 'Pulmonary Arterial Hypertension', 'DRUG: Slow Dose Titration Group of Subcutaneous Treprostinil|DRUG: Rapid Dose Titration Group of Subcutaneous Treprostinil', 'United Therapeutics', 'CVie Therapeutics Co. Ltd.', '0.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2017-02', '2018-04']\n['NCT03269695', 'Efficacy Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.', '', 'TERMINATED', 'Ulcerative Colitis', 'DRUG: PF-06687234|DRUG: Placebo', 'Pfizer', '', '20.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2017-12-20', '2021-01-07']\n['NCT04001595', 'Global FKRP Registry', '', 'RECRUITING', 'LGMD2I|LGMDR9|Limb Girdle Muscular Dystrophy|Congenital Muscular Dystrophy|Muscle-Eye-Brain Disease|Walker-Warburg Syndrome|FKRP Gene Mutation', 'OTHER: Patient Registry', 'Newcastle University', 'LGMD2i Research Fund|CureLGMD2i|Ludwig-Maximilians - University of Munich', '1000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2013-11', '2025-12']\n['NCT00199095', 'Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia', '', 'COMPLETED', 'Adult Acute Lymphocytic Leukemia', 'DRUG: Adriamycin|DRUG: Cyclophosphamide|DRUG: Cytarabine|DRUG: Dexamethasone|DRUG: Idarubicin|DRUG: Ifosfamide|DRUG: Methotrexate|DRUG: Mercaptopurine|DRUG: VM26|DRUG: Vincristine', 'Goethe University', '', '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '1997-02', '2003-06']\n['NCT00901095', 'Can Diet- and Exercise-Induced Weight Loss Improve Asthma Control in Adults?', '', 'COMPLETED', 'Asthma|Obesity', 'BEHAVIORAL: Lifestyle intervention', 'Palo Alto Medical Foundation', 'National Heart Lung and Blood Institute (NHLBI)|Kaiser Permanente|Stanford University', '330.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2010-02', '2014-03']\n['NCT02255695', 'Effects of a School-based Exercise Program on Posture Trunk Range of Motion and Musculoskeletal Pain', '', 'COMPLETED', 'Musculoskeletal and Connective Tissue Disorders', 'OTHER: School-based exercise program', 'Universidade Federal de Sao Carlos', 'Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.|Conselho Nacional de Desenvolvimento Científico e Tecnológico', '300.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2008-12', '2012-12']\n['NCT03070795', 'Outcomes of Early Versus Delayed Oral Feeding After Cesarean Section in Korle-bu Teaching Hospital', '', 'UNKNOWN', 'Cesarean Section Complications', 'PROCEDURE: early feeding|PROCEDURE: delayed feeding', 'University of Ghana Medical School', '', '170.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2017-02-23', '2017-08-20']\n['NCT03723395', 'A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib', '', 'COMPLETED', 'Drug-drug Interaction', 'DRUG: tucatinib|DRUG: itraconazole|DRUG: rifampin|DRUG: gemfibrozil|DRUG: repaglinide|DRUG: tolbutamide|DRUG: midazolam|DRUG: digoxin', 'Seagen Inc.', '', '116.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2018-09-17', '2018-12-28']\n['NCT06073795', 'Ultrasongraphy Versus Fluoroscopy in Lumber Sympathetic Block in Chronic Lower Limb Ischemia', '', 'NOT_YET_RECRUITING', 'L L Ischemia', 'PROCEDURE: sympathetic block', 'Assiut University', '', '60.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-11-01', '2025-12-01']\n['NCT04564495', 'Home Based Tele-exercise for People With Chronic Neurological Impairments', 'Telex', 'ACTIVE_NOT_RECRUITING', 'Neurologic Disorder|Stroke|Spinal Cord Injuries|Cerebral Palsy|Hemiplegia|Hemiparesis|Multiple Sclerosis|Parkinson Disease|Trauma Brain|Transverse Myelitis|Friedreich Ataxia', 'BEHAVIORAL: Seated exercise', 'Burke Medical Research Institute', '', '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2021-01-22', '2024-12-31']\n['NCT01811095', 'A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing', '', 'COMPLETED', 'Neoplasms', 'OTHER: Training', 'McGill University', '', '27.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: ', '2013-03', '2013-06']\n['NCT04470895', 'Impact of Drugs on the Risk of Falls in the Fracture Department of the Paris Saint-Joseph Hospital Group', '', 'WITHDRAWN', 'Fracture|Fall', 'DIAGNOSTIC_TEST: Failure Track patients analysis', 'Fondation Hôpital Saint-Joseph', '', '0.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2021-09-24', '2021-09-24']\n['NCT04877795', 'Copeptin and HFABP in Cardiac Surgery', 'PRACTICE', 'UNKNOWN', 'Coronary Artery Disease|Valvular Heart Disease', 'DIAGNOSTIC_TEST: Blood sampling', 'Heinrich-Heine University Duesseldorf', '', '700.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2021-04-01', '2023-06-30']\n['NCT00804895', 'Cluster Headache Cortivazol Injection (CHCI)', 'CHCI', 'COMPLETED', 'Cluster Headache', 'DRUG: ALTIM cortivazol injections|DRUG: PROAMP subcutaneous serum physiological saline|DRUG: Verapamil', 'Assistance Publique - Hôpitaux de Paris', '', '43.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2008-12', '2009-10']\n['NCT03053895', 'Bedside Versus Operating Room Burr-Hole Drainage of Chronic Subdural Hematoma (DECIDE)', 'DECIDE', 'UNKNOWN', 'Chronic Subdural Hematoma', 'PROCEDURE: CSDH - Bedside twist drill technique|PROCEDURE: CSDH - Operating Room Burr-hole technique', 'Hamilton Health Sciences Corporation', '', '486.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2017-04-01', '2020-02-28']\n['NCT02782195', 'Evaluation of Gut Absorption Rate of Glucose After a Large Evening Meal in Type 1 Diabetes', '', 'COMPLETED', 'Type 1 Diabetes', '', 'University of Cambridge', 'Cambridge University Hospitals NHS Foundation Trust', '16.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2008-11', '2011-06']\n['NCT00843895', 'Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years', 'Pneumococci', 'UNKNOWN', 'Pneumococcal Disease', 'BIOLOGICAL: pneumococcal conjugate vaccine(prevenar)', 'King Saud University', '', '400.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SCREENING', '2009-03', '2009-12']\n['NCT05393895', 'An Evaluation of the Safety of CSF-1 in Presbyopic Subjects', '', 'COMPLETED', 'Presbyopia', 'DRUG: CSF-1|DRUG: Vehicle', 'Orasis Pharmaceuticals Ltd.', '', '178.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2022-04-22', '2022-12-01']\n['NCT00145795', 'A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment', '', 'COMPLETED', 'HIV Infections', 'DRUG: Kaletra + Current Dual NRTI Backbone|DRUG: Current Regimen', 'University of Chicago', 'Abbott', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2004-04', '2009-12']\n['NCT04114695', 'Aortic Calcification and Central Blood Pressure in Patients With Chronic Kidney Disease', 'ACCEPT', 'COMPLETED', 'Arterial Calcification|Kidney Diseases|Coronary Artery Disease|Aortic Calcification|Stroke|Vascular Diseases|Vascular Calcification', '', 'Central Jutland Regional Hospital', '', '185.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2019-10-15', '2022-01-01']\n['NCT01170195', 'Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms', '', 'UNKNOWN', 'Postmenopausal Symptoms|Vaginal Dryness', 'DIETARY_SUPPLEMENT: Calmera-Licorice Root Extract (Licogen)', 'F&C Licorice Ltd', '', '120.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2010-09', '2011-09']\n['NCT05409495', 'Titanium-prepared Platelet-rich Fibrin in Periodontal Regeneration', '', 'COMPLETED', 'Platelet-Rich Fibrin', 'PROCEDURE: periodontal surgical procedure (open flap debridement)|PROCEDURE: periodontal surgical procedure (OFD +autogenous Titanium-prepared platelet-rich fibrin (OFD+ T-PRF))', 'Ataturk University', '', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2021-04-01', '2022-02-15']\n['NCT05360095', 'Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education', '', 'RECRUITING', 'Genetic Counseling|Shared Decision Making|Pregnancy|Genetic Testing|Prenatal Disorder', 'BEHAVIORAL: Meaning of Screening|BEHAVIORAL: Genetic Counseling|BEHAVIORAL: Usual Care', 'Erin Rothwell', 'National Human Genome Research Institute (NHGRI)', '1125.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2023-03-07', '2025-12']\n['NCT02574195', 'Evolution of Effectiveness of Diabetes Medical Care in Russia', '', 'COMPLETED', 'Diabetes Mellitus Type 2|Diabetes Mellitus Type 1', '', 'Endocrinology Research Centre Moscow', '', '599.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-08', '2015-10']\n['NCT02975895', 'Outcome of Different IOLs in Patients With and Without Uveitis', '', 'COMPLETED', 'Uveitis|Cataract|Inflammation|Posterior Capsule Opacification', 'DEVICE: Hydrophobic IOL: Vivinex (HOYA)|DEVICE: Hydrophilic IOL: INCISE (Bausch+Lomb)', 'Vastra Gotaland Region', '', '56.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2016-12-30', '2022-03-17']\n['NCT03332095', 'Evaluating the Pharmacokinetics Safety and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents', '', 'COMPLETED', 'HIV Infections', 'DRUG: Doravirine (DOR)|DRUG: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF)|DRUG: Antiretroviral (ARV) medications', 'National Institute of Allergy and Infectious Diseases (NIAID)', '', '55.0', 'NIH', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2018-07-02', '2022-05-25']\n['NCT05191095', 'The Accuracy of Human Endoscopic Detection of Submucosal Invasive Cancer in Colorectal Polyps', '', 'COMPLETED', 'Colorectal Polyp', '', 'University Hospital Ghent', '', '82.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2021-03-01', '2021-06-01']\n['NCT01388595', 'Fluticasone and Salmeterol in Allergic Rhinitis', '', 'COMPLETED', 'Allergic Rhinitis', 'DRUG: FLUTICASONE PROPRIONATE|DRUG: Salmeterol|DRUG: PLACEBO', 'University of Dundee', '', '23.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2006-11', '2010-10']\n['NCT00382395', 'SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma', '', 'SUSPENDED', 'Glaucoma|Glaucoma Open Angle', 'DEVICE: SOLX Gold Shunt GMS-plus|DEVICE: Ahmed FP7 Glaucoma Valve', 'SOLX Inc.', '', '180.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2005-11', '2017-07']\nOut[17]: [['Id',\n  'Study Title',\n  'Acronym',\n  'Status',\n  'Conditions',\n  'Interventions',\n  'Sponsor',\n  'Collaborators',\n  'Enrollment',\n  'Funder Type',\n  'Type',\n  'Study Design',\n  'Start',\n  'Completion'],\n ['NCT03630471',\n  'Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India',\n  'PRIDE',\n  'COMPLETED',\n  'Mental Health Issue (E.G. Depression Psychosis Personality Disorder Substance Abuse)',\n  \"BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care\",\n  'Sangath',\n  'Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine',\n  '250.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT',\n  '2018-08-20',\n  '2019-02-28'],\n ['NCT05992571',\n  'Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity',\n  None,\n  'RECRUITING',\n  'Cerebrovascular Function|Cognition',\n  'OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB',\n  'McMaster University',\n  \"Alzheimer's Society of Brant Haldimand Norfolk Hamilton Halton\",\n  '30.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE',\n  '2023-10-25',\n  '2024-08'],\n ['NCT00237471',\n  'Impact of Tight Glycaemic Control in Acute Myocardial Infarction',\n  None,\n  'TERMINATED',\n  'Myocardial Infarct|Hyperglycemia',\n  'DRUG: Insulin (tight blood glucose control)',\n  'Melbourne Health',\n  'National Health and Medical Research Council Australia|Bristol-Myers Squibb',\n  '40.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT',\n  '2005-10',\n  '2006-05'],\n ['NCT03820271',\n  'New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation',\n  'SUPERMELD',\n  'RECRUITING',\n  'Decompensated Cirrhosis|Liver Transplantation',\n  'OTHER: SuperMELD',\n  'Assistance Publique - Hôpitaux de Paris',\n  None,\n  '500.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER',\n  '2020-10-01',\n  '2023-10-01']]"
     ]
    }
   ],
   "source": [
    "#Now, next stage in data preparation is removing the missing values in the dataset. To check the presence of missing values in the dataset, let's define a function:\n",
    "\n",
    "def check_missing_values(dataset):\n",
    "    missing_values = dataset.filter(lambda row: '' in row)\n",
    "    if missing_values.isEmpty():\n",
    "        print(\"No missing values\")\n",
    "    else:\n",
    "        print(\"Yes\")\n",
    "        for row in missing_values.collect():\n",
    "            print(row)\n",
    "\n",
    "# Call the function with the clinicaltrial_2023_cleaned_data_rdd in order to call out the missing values in the cleaned data RDD\n",
    "check_missing_values(clinicaltrial_2023_cleaned_data_rdd)\n",
    "\n",
    "# Now to remove these missing values with none instead: \n",
    "clinicaltrial_2023_cleaned_data_rdd_with_none = clinicaltrial_2023_cleaned_data_rdd.map(lambda row: [None if value == '' else value for value in row])\n",
    "\n",
    "# View the first few rows in order to confirm that the missing values have been removed from the cleaned RDD\n",
    "clinicaltrial_2023_cleaned_data_rdd_with_none.take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "70699827-98a3-4d3c-8386-df38d0f7ae74",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "No missing values\n"
     ]
    }
   ],
   "source": [
    "# to double confirm that the missing values have been removed from the RDD, lets call the function again:\n",
    "check_missing_values(clinicaltrial_2023_cleaned_data_rdd_with_none)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "7dce5245-ccff-40d3-a299-67a8bfa7e859",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of data rows in the clinicaltrial_2023_cleaned_data_rdd_with_none: 483423\n"
     ]
    }
   ],
   "source": [
    "# Assuming your clinicaltrial_2023_cleaned_data_rdd_with_none contains the data as an RDD\n",
    "\n",
    "# Get the count of data rows in the RDD\n",
    "row_count = clinicaltrial_2023_cleaned_data_rdd_with_none.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the clinicaltrial_2023_cleaned_data_rdd_with_none:\", row_count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0d710bd6-451e-441c-ad81-c9344a4b7b4a",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Id\nNCT03630471\nNCT05992571\nNCT00237471\nNCT03820271\nNCT06229171\nNCT02945371\nNCT01055171\nNCT01125371\nNCT02554071\nNCT01772771\nNCT02633371\nNCT03400371\nNCT00120471\nNCT04784871\nNCT02383771\nNCT03269071\nNCT01659671\nNCT04765371\nNCT02830971\nNCT00416871\nNCT05900271\nNCT02469571\nNCT05807971\nNCT02083471\nNCT01062971\nNCT03928171\nNCT00897871\nNCT00848471\nNCT06135571\nNCT01189071\nNCT00728871\nNCT05592171\nNCT00520871\nNCT05913271\nNCT04006171\nNCT04370171\nNCT04340271\nNCT03075371\nNCT05966571\nNCT03313271\nNCT03490071\nNCT05801471\nNCT00266071\nNCT04405271\nNCT02121171\nNCT01068171\nNCT04875871\nNCT00553371\nNCT04674371\nNCT02321371\nNCT02344771\nNCT03354871\nNCT02804971\nNCT04591171\nNCT04814771\nNCT00991471\nNCT05702671\nNCT02069171\nNCT00474071\nNCT02022371\nNCT04585971\nNCT05473871\nNCT01523171\nNCT00000571\nNCT01053871\nNCT02370771\nNCT05974371\nNCT03713671\nNCT02645071\nNCT04004871\nNCT05953571\nNCT02570971\nNCT03987971\nNCT01425671\nNCT04962971\nNCT02827071\nNCT04236271\nNCT01780571\nNCT05078671\nNCT02529371\nNCT02309671\nNCT03876171\nNCT05031871\nNCT04769271\nNCT06044571\nNCT01889771\nNCT03077971\nNCT02912871\nNCT03548571\nNCT01449071\nNCT03530371\nNCT05921071\nNCT04974671\nNCT00080171\nNCT00368771\nNCT04979871\nNCT04097171\nNCT06199271\nNCT04032171\nNCT05674071\nNCT00858871\nNCT01776671\nNCT01363271\nNCT01282671\nNCT05683171\nNCT05334771\nNCT04718571\nNCT05072171\nNCT05638971\nNCT05138471\nNCT00961571\nNCT03635671\nNCT01143571\nNCT02240771\nNCT03365271\nNCT06183671\nNCT02781571\nNCT03956771\nNCT03737071\nNCT05661071\nNCT03439371\nNCT03257371\nNCT06103071\nNCT05924971\nNCT04242771\nNCT05121571\nNCT01740271\nNCT00912171\nNCT01640171\nNCT00507871\nNCT03128671\nNCT00672971\nNCT04852471\nNCT02960971\nNCT02352571\nNCT00611871\nNCT04676971\nNCT01191671\nNCT01909271\nNCT03673371\nNCT05503771\nNCT05898971\nNCT04429971\nNCT02626871\nNCT00932971\nNCT02528071\nNCT04840771\nNCT06155071\nNCT03170271\nNCT01982071\nNCT03016871\nNCT05313971\nNCT02732171\nNCT00510471\nNCT04856371\nNCT00769171\nNCT03522571\nNCT00116571\nNCT00782171\nNCT05982171\nNCT00376571\nNCT00410371\nNCT03066271\nNCT02125071\nNCT02869971\nNCT01801371\nNCT05800171\nNCT04293471\nNCT05973071\nNCT03118271\nNCT00708071\nNCT01875471\nNCT01637571\nNCT01216371\nNCT00021671\nNCT05610371\nNCT00172471\nNCT03237871\nNCT04039971\nNCT01558271\nNCT04597671\nNCT03994471\nNCT06143371\nNCT04862871\nNCT02080871\nNCT06132971\nNCT01044771\nNCT05029271\nNCT03648671\nNCT02903771\nNCT05524571\nNCT02179671\nNCT00788671\nNCT05003271\nNCT02047071\nNCT04416971\nNCT06000371\nNCT00851071\nNCT02921971\nNCT00256971\nNCT00165971\nNCT05698771\nNCT01159171\nNCT01464671\nNCT04251871\nNCT00067171\nNCT04565171\nNCT03167671\nNCT03795571\nNCT00939471\nNCT01957371\nNCT03223571\nNCT00645671\nNCT04909671\nNCT06091371\nNCT00752271\nNCT04094571\nNCT05797571\nNCT02499471\nNCT04318171\nNCT01231971\nNCT04695171\nNCT03958071\nNCT03711071\nNCT03516071\nNCT01953471\nNCT03921671\nNCT02134171\nNCT04855071\nNCT01741571\nNCT00484471\nNCT02301871\nNCT03906071\nNCT03679871\nNCT03272971\nNCT01998971\nNCT03146871\nNCT01153971\nNCT05319171\nNCT05538871\nNCT00046371\nNCT01515371\nNCT06149871\nNCT03363971\nNCT05989971\nNCT02712671\nNCT04089371\nNCT02911571\nNCT01623271\nNCT02268071\nNCT05772871\nNCT02492971\nNCT03505671\nNCT04309071\nNCT04614571\nNCT00407771\nNCT01724671\nNCT05150171\nNCT06106971\nNCT00115271\nNCT04661371\nNCT04921371\nNCT01105871\nNCT05482971\nNCT05752071\nNCT02607371\nNCT03461471\nNCT01789671\nNCT06212271\nNCT00324571\nNCT03360071\nNCT05758571\nNCT01589471\nNCT06062771\nNCT04283071\nNCT00323271\nNCT03356171\nNCT01022671\nNCT01265771\nNCT00006071\nNCT02270671\nNCT02277171\nNCT03482271\nNCT05117671\nNCT04288271\nNCT01222871\nNCT02746471\nNCT02923271\nNCT06027671\nNCT04511871\nNCT00505271\nNCT04966871\nNCT05605171\nNCT06235671\nNCT01770171\nNCT04541771\nNCT03061071\nNCT02665871\nNCT00748371\nNCT02412371\nNCT04133571\nNCT03011671\nNCT04271371\nNCT00181571\nNCT03116971\nNCT01926171\nNCT03990571\nNCT00696371\nNCT02351271\nNCT02208271\nNCT02144571\nNCT02694471\nNCT04458571\nNCT01712971\nNCT01777971\nNCT01507571\nNCT04346771\nNCT03968471\nNCT00895271\nNCT01355471\nNCT02603471\nNCT01771471\nNCT03566771\nNCT02776371\nNCT02287571\nNCT04268771\nNCT02015871\nNCT03746171\nNCT01828671\nNCT04558671\nNCT02962271\nNCT01432171\nNCT02213471\nNCT00718471\nNCT02291471\nNCT01636271\nNCT02697071\nNCT02564471\nNCT02862171\nNCT01151371\nNCT03594071\nNCT04220671\nNCT05169671\nNCT01891071\nNCT03909971\nNCT06156371\nNCT06151171\nNCT04626271\nNCT00095771\nNCT04627571\nNCT05359471\nNCT02459171\nNCT00758771\nNCT00620971\nNCT01209871\nNCT04219371\nNCT02676271\nNCT02079571\nNCT06034171\nNCT05802771\nNCT01595971\nNCT01476371\nNCT04172571\nNCT03188471\nNCT01217671\nNCT01137071\nNCT02164071\nNCT05897671\nNCT02642471\nNCT04806971\nNCT02273271\nNCT03295071\nNCT02859571\nNCT05151471\nNCT01218971\nNCT00900471\nNCT00461071\nNCT01051271\nNCT00554671\nNCT01920971\nNCT01304771\nNCT03314571\nNCT04927871\nNCT00602771\nNCT02928471\nNCT00861471\nNCT00561171\nNCT02606071\nNCT05662371\nNCT02758171\nNCT05685771\nNCT00597571\nNCT04366271\nNCT05642871\nNCT00541671\nNCT00464971\nNCT01732471\nNCT02440971\nNCT06125171\nNCT01074671\nNCT03214471\nNCT02659371\nNCT03565471\nNCT05021471\nNCT02357771\nNCT01567371\nNCT04272671\nNCT04297371\nNCT02014571\nNCT00999271\nNCT02429271\nNCT01307371\nNCT03144271\nNCT03891771\nNCT04786171\nNCT04392271\nNCT02421471\nNCT04944771\nNCT03688971\nNCT01066871\nNCT00419471\nNCT00558571\nNCT04778371\nNCT03358771\nNCT03176771\nNCT00812071\nNCT05343871\nNCT04281771\nNCT06129071\nNCT02472171\nNCT03634371\nNCT05295771\nNCT01985971\nNCT02175771\nNCT02000271\nNCT00552071\nNCT00321971\nNCT01003171\nNCT05388071\nNCT05401071\nNCT03852771\nNCT01722071\nNCT05290571\nNCT00007371\nNCT01468571\nNCT01584271\nNCT01692171\nNCT01751971\nNCT02479971\nNCT00808171\nNCT02113371\nNCT04016571\nNCT02340871\nNCT03770871\nNCT04470271\nNCT00290771\nNCT00737971\nNCT02444871\nNCT05876871\nNCT04848571\nNCT00470171\nNCT05375071\nNCT01979471\nNCT05507671\nNCT00428571\nNCT04324671\nNCT03735771\nNCT06056271\nNCT00971971\nNCT05278871\nNCT03513471\nNCT00705471\nNCT04354571\nNCT04683471\nNCT04544371\nNCT04145271\nNCT05824871\nNCT04119271\nNCT00757471\nNCT05147571\nNCT00005871\nNCT04076371\nNCT03950271\nNCT05624671\nNCT04502771\nNCT01394471\nNCT03789071\nNCT00145171\nNCT01688271\nNCT01711671\nNCT04342871\nNCT01034371\nNCT02390271\nNCT04727671\nNCT01111071\nNCT01140971\nNCT05934071\nNCT02299271\nNCT02425371\nNCT01403571\nNCT00945971\nNCT02177071\nNCT04704271\nNCT02879071\nNCT01491971\nNCT04130971\nNCT03843671\nNCT04125771\nNCT00766571\nNCT03881371\nNCT02360371\nNCT04175171\nNCT05936671\nNCT03391271\nNCT04080271\nNCT01480271\nNCT00639171\nNCT00826371\nNCT02938871\nNCT04596371\nNCT03322371\nNCT03332771\nNCT04605471\nNCT04403971\nNCT05559671\nNCT01608971\nNCT05533671\nNCT03279471\nNCT00316771\nNCT00795171\nNCT01459471\nNCT00671671\nNCT00601471\nNCT03750071\nNCT03064971\nNCT00710671\nNCT05258071\nNCT02205671\nNCT00487071\nNCT00744471\nNCT04388371\nNCT02546271\nNCT05995171\nNCT04904471\nNCT00113971\nNCT03263871\nNCT01989871\nNCT05173571\nNCT04700371\nNCT04858971\nNCT02747771\nNCT00849771\nNCT05057871\nNCT01550471\nNCT03675971\nNCT05970471\nNCT00467571\nNCT02106871\nNCT04305171\nNCT03205371\nNCT05670171\nNCT00515671\nNCT02387671\nNCT02725671\nNCT01338571\nNCT05104671\nNCT05209971\nNCT00869271\nNCT05537571\nNCT02021071\nNCT04998071\nNCT03477071\nNCT01200771\nNCT00661271\nNCT03595371\nNCT02710071\nNCT05716971\nNCT02411071\nNCT04216771\nNCT00060671\nNCT04849871\nNCT02580071\nNCT05077371\nNCT00511771\nNCT03336671\nNCT02245971\nNCT01937871\nNCT03317171\nNCT02602171\nNCT03245671\nNCT04588571\nNCT04285671\nNCT00347971\nNCT04873271\nNCT01610271\nNCT05719571\nNCT03938571\nNCT02230371\nNCT01179971\nNCT00230971\nNCT01488071\nNCT03383471\nNCT00527371\nNCT04312971\nNCT01324271\nNCT05687071\nNCT00271271\nNCT03932071\nNCT03785171\nNCT00878371\nNCT02600871\nNCT01779271\nNCT01489371\nNCT02508571\nNCT06171971\nNCT05723471\nNCT03826771\nNCT01559571\nNCT03323671\nNCT02108171\nNCT01715571\nNCT02855671\nNCT03349671\nNCT04192071\nNCT03202771\nNCT04419571\nNCT05199571\nNCT02295371\nNCT02671071\nNCT02763371\nNCT01576471\nNCT05960071\nNCT05134571\nNCT02122471\nNCT00001271\nNCT01761071\nNCT05216471\nNCT03592771\nNCT00405171\nNCT03331471\nNCT01896271\nNCT05091671\nNCT04182971\nNCT04732871\nNCT05109871\nNCT05653271\nNCT01850771\nNCT01685671\nNCT00002671\nNCT04267471\nNCT01325571\nNCT03722771\nNCT02034071\nNCT04002271\nNCT02569671\nNCT04669171\nNCT01096771\nNCT05840471\nNCT06162871\nNCT04270071\nNCT00546871\nNCT01328171\nNCT05546671\nNCT02866071\nNCT04925271\nNCT00966771\nNCT06221371\nNCT04064671\nNCT02927171\nNCT02437071\nNCT05906771\nNCT03638271\nNCT06195371\nNCT01810471\nNCT01433471\nNCT01642771\nNCT02377271\nNCT05566171\nNCT00229671\nNCT00349271\nNCT02156271\nNCT00429871\nNCT05859971\nNCT01013571\nNCT01677871\nNCT00740571\nNCT04492371\nNCT02790671\nNCT03744871\nNCT00562471\nNCT01251471\nNCT00935571\nNCT04493671\nNCT03488771\nNCT05068271\nNCT04442971\nNCT03665571\nNCT00001571\nNCT05128071\nNCT00927771\nNCT02646371\nNCT00670371\nNCT00268671\nNCT00570271\nNCT02286271\nNCT02901171\nNCT01352871\nNCT04007471\nNCT03525171\nNCT02741271\nNCT03341871\nNCT03070171\nNCT02850471\nNCT03636971\nNCT04916171\nNCT00048971\nNCT05038371\nNCT01611571\nNCT04844671\nNCT02681471\nNCT00003471\nNCT04632771\nNCT02834871\nNCT00202371\nNCT03129971\nNCT03683771\nNCT01142271\nNCT02743871\nNCT03880071\nNCT05792371\nNCT00388271\nNCT05330871\nNCT02654171\nNCT04121871\nNCT04023071\nNCT05304871\nNCT05676671\nNCT05766371\nNCT01018771\nNCT00001071\nNCT02193971\nNCT03600571\nNCT00978471\nNCT00150371\nNCT02919371\nNCT05666271\nNCT00666471\nNCT03258671\nNCT05540171\nNCT01152671\nNCT01855971\nNCT03321071\nNCT03185871\nNCT02100371\nNCT01644071\nNCT03227471\nNCT03712371\nNCT03653871\nNCT00656071\nNCT03107871\nNCT01234571\nNCT02967471\nNCT00503971\nNCT04484571\nNCT06066671\nNCT04533971\nNCT04608071\nNCT04050371\nNCT01276171\nNCT03929471\nNCT00630071\nNCT03668171\nNCT02067871\nNCT00497471\nNCT02235571\nNCT05112471\nNCT00019071\nNCT05170971\nNCT00771771\nNCT01333371\nNCT01878071\nNCT02687971\nNCT00956371\nNCT01322971\nNCT03803371\nNCT01408771\nNCT01767571\nNCT00925171\nNCT02153671\nNCT05603871\nNCT04364971\nNCT00555971\nNCT03926871\nNCT00005571\nNCT01026571\nNCT00578071\nNCT01087671\nNCT06075771\nNCT06165471\nNCT03072771\nNCT03239171\nNCT05333471\nNCT03023371\nNCT02096471\nNCT02495571\nNCT05042271\nNCT05300971\nNCT00908271\nNCT00797771\nNCT02707471\nNCT03867071\nNCT05263271\nNCT06019871\nNCT06009471\nNCT02485171\nNCT04273971\nNCT00442871\nNCT03022071\nNCT03794271\nNCT02625571\nNCT03942471\nNCT05511571\nNCT01471171\nNCT02971371\nNCT03919071\nNCT01267071\nNCT00929071\nNCT03811171\nNCT03133871\nNCT05941871\nNCT03561571\nNCT03454971\nNCT05835271\nNCT06088771\nNCT05212571\nNCT02902471\nNCT00402571\nNCT04522271\nNCT05382871\nNCT01319071\nNCT03579771\nNCT01156571\nNCT04345471\nNCT05395871\nNCT04968171\nNCT02218671\nNCT06222671\nNCT02265471\nNCT05628571\nNCT01848171\nNCT03048071\nNCT00002271\nNCT02992171\nNCT04488471\nNCT05233371\nNCT05347771\nNCT00337571\nNCT04019171\nNCT00926471\nNCT03907371\nNCT06131671\nNCT05393271\nNCT04670471\nNCT02005471\nNCT05740371\nNCT01099371\nNCT00058071\nNCT05484271\nNCT01078571\nNCT05919771\nNCT01892371\nNCT03521271\nNCT06123871\nNCT03569371\nNCT00678171\nNCT02942771\nNCT03824171\nNCT04908371\nNCT05609071\nNCT00502671\nNCT05372471\nNCT02009371\nNCT02559271\nNCT00606671\nNCT02772471\nNCT05939271\nNCT03326271\nNCT04571671\nNCT05441371\nNCT00263471\nNCT05089071\nNCT02563171\nNCT01836471\nNCT03798171\nNCT04851171\nNCT04595071\nNCT03837171\nNCT04467671\nNCT05287971\nNCT00776971\nNCT05026671\nNCT05935371\nNCT00059371\nNCT01629771\nNCT01072071\nNCT02032771\nNCT05765071\nNCT03761771\nNCT03297671\nNCT00865371\nNCT00420771\nNCT03175471\nNCT02420171\nNCT02768571\nNCT00563771\nNCT02226471\nNCT04965571\nNCT00346671\nNCT04647071\nNCT01861171\nNCT04301271\nNCT05268471\nNCT05399771\nNCT05308771\nNCT05403671\nNCT01147471\nNCT04046471\nNCT03709771\nNCT00995371\nNCT01075971\nNCT01790971\nNCT01242371\nNCT03618771\nNCT04791371\nNCT00017771\nNCT00659971\nNCT05328271\nNCT02595671\nNCT05688371\nNCT05737771\nNCT00132171\nNCT05499871\nNCT01521871\nNCT04049071\nNCT02841371\nNCT05889871\nNCT02234271\nNCT06067971\nNCT03730571\nNCT06160271\nNCT05281471\nNCT02002871\nNCT05817071\nNCT02669771\nNCT05463471\nNCT02173171\nNCT05677971\nNCT04752371\nNCT01241071\nNCT02065271\nNCT03991871\nNCT00102271\nNCT01871571\nNCT01573871\nNCT01082471\nNCT04913571\nNCT03025971\nNCT00799071\nNCT00584571\nNCT00390871\nNCT04706871\nNCT05200871\nNCT04160871\nNCT01924871\nNCT04532671\nNCT01424371\nNCT02829671\nNCT01824771\nNCT06035471\nNCT02317471\nNCT01244971\nNCT01634971\nNCT04654871\nNCT03547271\nNCT03089671\nNCT04289571\nNCT01473771\nNCT03961971\nNCT02232971\nNCT03829371\nNCT05810571\nNCT04613271\nNCT06142071\nNCT03211871\nNCT04146571\nNCT00227071\nNCT04341571\nNCT01755871\nNCT00721071\nNCT05402371\nNCT04563871\nNCT02258971\nNCT02487771\nNCT04977271\nNCT05848271\nNCT02053571\nNCT01894971\nNCT00775671\nNCT04489771\nNCT05416671\nNCT03796871\nNCT01194271\nNCT03369171\nNCT04081571\nNCT03620071\nNCT04969471\nNCT03036371\nNCT04134871\nNCT02019771\nNCT00958971\nNCT00982371\nNCT01221571\nNCT01514071\nNCT05857371\nNCT01762371\nNCT04427371\nNCT02737371\nNCT00001671\nNCT00307671\nNCT00866671\nNCT05655871\nNCT05260671\nNCT04069871\nNCT01033071\nNCT00519571\nNCT00979771\nNCT05750771\nNCT01434771\nNCT04244071\nNCT02375971\nNCT05167071\nNCT02568371\nNCT01196871\nNCT01452971\nNCT06017271\nNCT01320371\nNCT00871871\nNCT04566471\nNCT00099671\nNCT01562171\nNCT06181071\nNCT02997371\nNCT05883371\nNCT02135471\nNCT05248971\nNCT02777671\nNCT00186771\nNCT01606371\nNCT01723371\nNCT00750971\nNCT06209671\nNCT00800371\nNCT04400071\nNCT00450671\nNCT03743571\nNCT04316871\nNCT01800071\nNCT00579371\nNCT01454271\nNCT00325871\nNCT03014271\nNCT04981171\nNCT05163171\nNCT05616871\nNCT06242171\nNCT05545371\nNCT06170671\nNCT01287871\nNCT04826471\nNCT01833871\nNCT05384171\nNCT01065571\nNCT03102671\nNCT04983771\nNCT03596671\nNCT00002471\nNCT05700071\nNCT00394771\nNCT01385371\nNCT03570671\nNCT03122171\nNCT01233271\nNCT04329871\nNCT00444171\nNCT00843271\nNCT02833571\nNCT03376971\nNCT02760771\nNCT05602571\nNCT06161571\nNCT05763771\nNCT01467271\nNCT04562571\nNCT00957671\nNCT04574271\nNCT03642171\nNCT05074771\nNCT01174771\nNCT05312671\nNCT01615471\nNCT02320071\nNCT01618071\nNCT02929771\nNCT04173871\nNCT00944671\nNCT01787071\nNCT02537171\nNCT02552771\nNCT00828971\nNCT00853671\nNCT01445171\nNCT05703971\nNCT02863471\nNCT03564171\nNCT02915471\nNCT04899271\nNCT06036771\nNCT03917771\nNCT04865471\nNCT05229471\nNCT01646671\nNCT01237171\nNCT03984071\nNCT00501371\nNCT01378871\nNCT06158971\nNCT03256071\nNCT02229071\nNCT04929171\nNCT02615171\nNCT02689271\nNCT01059071\nNCT04073771\nNCT04190771\nNCT02430571\nNCT01138371\nNCT05770271\nNCT02581371\nNCT04835571\nNCT05557071\nNCT03397771\nNCT03379571\nNCT04960371\nNCT04734171\nNCT04186871\nNCT05103371\nNCT04376671\nNCT05819671\nNCT02040571\nNCT05293171\nNCT03235271\nNCT02438371\nNCT05406271\nNCT04540471\nNCT02148471\nNCT00471471\nNCT02892071\nNCT03284671\nNCT02577471\nNCT04903171\nNCT03464071\nNCT06257771\nNCT01638871\nNCT05390671\nNCT05027971\nNCT04513171\nNCT00680771\nNCT04116671\nNCT01144871\nNCT01525771\nNCT04657471\nNCT03922971\nNCT05918471\nNCT05053971\nNCT04764071\nNCT05612971\nNCT02985671\nNCT03094871\nNCT00003171\nNCT03714971\nNCT03114371\nNCT04726371\nNCT01915771\nNCT01568671\nNCT03659071\nNCT03877471\nNCT02565771\nNCT06218771\nNCT00485771\nNCT02082171\nNCT05515471\nNCT00220571\nNCT05380271\nNCT03912571\nNCT01837771\nNCT02473471\nNCT02522871\nNCT00875771\nNCT04258371\nNCT03526471\nNCT03028571\nNCT04171271\nNCT04774471\nNCT05820971\nNCT05434871\nNCT01582971\nNCT05063071\nNCT01397071\nNCT02637271\nNCT03300271\nNCT02590471\nNCT05506371\nNCT03868371\nNCT03270371\nNCT03092271\nNCT01364571\nNCT00344071\nNCT05690971\nNCT03508271\nNCT04140071\nNCT04554771\nNCT00904371\nNCT02816671\nNCT03985371\nNCT02379871\nNCT00334971\nNCT04033471\nNCT02115971\nNCT00259571\nNCT05469971\nNCT00342771\nNCT03902171\nNCT04227171\nNCT01429571\nNCT00005971\nNCT01607671\nNCT01268371\nNCT00386971\nNCT04215471\nNCT00327171\nNCT02214771\nNCT03951571\nNCT05649371\nNCT02453971\nNCT05505071\nNCT00830271\nNCT04973371\nNCT04011371\nNCT05367271\nNCT03727971\nNCT01593371\nNCT03471871\nNCT05954871\nNCT02898571\nNCT05696171\nNCT04498871\nNCT02673671\nNCT00004571\nNCT01697371\nNCT04624971\nNCT02282371\nNCT05962671\nNCT03657771\nNCT02074371\nNCT03183271\nNCT03623971\nNCT03682471\nNCT01758471\nNCT02658071\nNCT05385471\nNCT05726071\nNCT00100971\nNCT01410071\nNCT05905471\nNCT03375671\nNCT02940171\nNCT00896571\nNCT01660971\nNCT00996671\nNCT01047371\nNCT01165671\nNCT02212171\nNCT03830671\nNCT00333671\nNCT00275171\nNCT01281371\nNCT01120171\nNCT00667771\nNCT02050971\nNCT04418271\nNCT06145971\nNCT03009071\nNCT03344471\nNCT06265571\nNCT04158271\nNCT05741671\nNCT04717271\nNCT05492071\nNCT00492271\nNCT04455971\nNCT03335371\nNCT03752671\nNCT04335071\nNCT04877171\nNCT06058871\nNCT04102371\nNCT00288171\nNCT06012071\nNCT03215771\nNCT03578471\nNCT02334371\nNCT00518271\nNCT04892771\nNCT04705571\nNCT05430971\nNCT00931671\nNCT02717871\nNCT02500771\nNCT02372071\nNCT04439071\nNCT00295971\nNCT05421871\nNCT03604471\nNCT00654771\nNCT01311271\nNCT03812471\nNCT00477971\nNCT00191971\nNCT01963871\nNCT03885271\nNCT06251271\nNCT03591471\nNCT03462771\nNCT02386371\nNCT04910971\nNCT02303171\nNCT03790371\nNCT03213171\nNCT00002171\nNCT00357071\nNCT02769871\nNCT02576171\nNCT03766971\nNCT04879771\nNCT03518671\nNCT00398671\nNCT01679171\nNCT00068471\nNCT04739371\nNCT04141371\nNCT02030171\nNCT03726671\nNCT02238171\nNCT02353871\nNCT03825471\nNCT05828771\nNCT05362071\nNCT05529771\nNCT04229771\nNCT01839071\nNCT06061471\nNCT04749771\nNCT05276271\nNCT03622671\nNCT00311571\nNCT01021371\nNCT02520271\nNCT03275571\nNCT04445571\nNCT05394571\nNCT01121471\nNCT03032471\nNCT05692271\nNCT06253871\nNCT01919671\nNCT03291171\nNCT03915171\nNCT00171171\nNCT02190071\nNCT05791071\nNCT00909571\nNCT00005171\nNCT00981071\nNCT05360771\nNCT00702871\nNCT02667171\nNCT03414671\nNCT06018571\nNCT04042571\nNCT02061371\nNCT03842371\nNCT05633771\nNCT00147771\nNCT03475771\nNCT05095571\nNCT04151771\nNCT01441271\nNCT04743271\nNCT04320771\nNCT00767871\nNCT05358171\nNCT05728671\nNCT02489071\nNCT01619371\nNCT02088671\nNCT00163371\nNCT00441571\nNCT00674271\nNCT03584971\nNCT05443971\nNCT00652171\nNCT02093871\nNCT04504071\nNCT01358071\nNCT04770571\nNCT02767271\nNCT04990271\nNCT01052571\nNCT04738071\nNCT04956471\nNCT02873871\nNCT00149071\nNCT03271671\nNCT00254371\nNCT00091871\nNCT04062071\nNCT01788371\nNCT03191071\nNCT05853471\nNCT03828071\nNCT04228471\nNCT04383171\nNCT05376371\nNCT05830071\nNCT04869371\nNCT02403271\nNCT04452071\nNCT01683071\nNCT02105571\nNCT06256471\nNCT00840671\nNCT03969771\nNCT00714571\nNCT05869071\nNCT04058171\nNCT04650971\nNCT01485471\nNCT04598971\nNCT05562271\nNCT01707771\nNCT03074071\nNCT01104571\nNCT00124371\nNCT01503671\nNCT01519271\nNCT02101671\nNCT04845971\nNCT03382171\nNCT00086671\nNCT01885871\nNCT04047771\nNCT05844371\nNCT00711971\nNCT03292471\nNCT02433171\nNCT02678871\nNCT02771171\nNCT03529071\nNCT05116371\nNCT06204471\nNCT06090071\nNCT05658471\nNCT04448171\nNCT00723671\nNCT00207571\nNCT02505971\nNCT05425771\nNCT04368871\nNCT03226171\nNCT03947671\nNCT05631171\nNCT04822571\nNCT05731271\nNCT00787371\nNCT06175871\nNCT00623571\nNCT00905671\nNCT03859271\nNCT03408171\nNCT01512771\nNCT04037371\nNCT05914571\nNCT00005371\nNCT03791671\nNCT05965271\nNCT03855371\nNCT05684471\nNCT05265871\nNCT05479071\nNCT00240071\nNCT02336971\nNCT03427671\nNCT06194071\nNCT04621071\nNCT01641471\nNCT00064571\nNCT01744171\nNCT00648271\nNCT01996371\nNCT05349071\nNCT01742871\nNCT02847871\nNCT05237271\nNCT02426671\nNCT05446571\nNCT05215171\nNCT00039871\nNCT04433871\nNCT03087071\nNCT00854971\nNCT02981771\nNCT04123171\nNCT00544271\nNCT00003671\nNCT02668471\nNCT05232071\nNCT00000871\nNCT06041971\nNCT01263171\nNCT05157971\nNCT01940471\nNCT06152471\nNCT00662571\nNCT06203171\nNCT01633671\nNCT01369771\nNCT01428271\nNCT04468971\nNCT00112671\nNCT03020771\nNCT06084871\nNCT01295671\nNCT01213771\nNCT02070471\nNCT03330171\nNCT06157671\nNCT04237571\nNCT00370071\nNCT01027871\nNCT04223271\nNCT02308371\nNCT00001971\nNCT05354271\nNCT04653571\nNCT03633071\nNCT02468271\nNCT04836871\nNCT00965471\nNCT03718871\nNCT00697671\nNCT02481271\nNCT04038671\nNCT00076271\nNCT00593671\nNCT05195671\nNCT05224271\nNCT04891471\nNCT03755271\nNCT03106571\nNCT03896971\nNCT00844571\nNCT05784571\nNCT01793571\nNCT03484871\nNCT01077271\nNCT02955771\nNCT05064371\nNCT04280471\nNCT00415571\nNCT04426071\nNCT01255371\nNCT04093271\nNCT02147171\nNCT01783171\nNCT03298971\nNCT01130571\nNCT01416571\nNCT01997671\nNCT04920071\nNCT01858571\nNCT00418171\nNCT01166971\nNCT04211571\nNCT01959971\nNCT03402971\nNCT03860571\nNCT04507971\nNCT04315571\nNCT03440671\nNCT03545971\nNCT00359671\nNCT05554471\nNCT00968071\nNCT01668771\nNCT01025271\nNCT01867671\nNCT05066971\nNCT03103971\nNCT04787471\nNCT03695471\nNCT00709371\nNCT03135171\nNCT00305071\nNCT04817371\nNCT02836171\nNCT03558971\nNCT03815071\nNCT04832971\nNCT00783471\nNCT05822271\nNCT00936871\nNCT06262971\nNCT05590871\nNCT05707871\nNCT02931071\nNCT02749071\nNCT03085771\nNCT02702271\nNCT04385771\nNCT04860271\nNCT01575171\nNCT01874171\nNCT01945671\nNCT02486471\nNCT02655471\nNCT05991271\nNCT01689571\nNCT05937971\nNCT01393171\nNCT00857571\nNCT02027571\nNCT03473171\nNCT04415671\nNCT05980871\nNCT02356471\nNCT01530971\nNCT03856671\nNCT00006471\nNCT00001471\nNCT01737671\nNCT04104971\nNCT02474771\nNCT05679271\nNCT00983671\nNCT02801071\nNCT04713371\nNCT03274271\nNCT05043571\nNCT02820571\nNCT01203371\nNCT00203671\nNCT00399971\nNCT02349971\nNCT01719471\nNCT02087371\nNCT05310071\nNCT02641171\nNCT00084071\nNCT02895971\nNCT01133171\nNCT03669471\nNCT04736771\nNCT03120871\nNCT03573271\nNCT02660671\nNCT01572571\nNCT04549571\nNCT01341171\nNCT01954771\nNCT03644771\nNCT03456271\nNCT02715271\nNCT04610671\nNCT01356771\nNCT02335671\nNCT00340171\nNCT04015271\nNCT05337371\nNCT01545271\nNCT05550571\nNCT02736071\nNCT02780271\nNCT02392871\nNCT06028971\nNCT04198571\nNCT03543371\nNCT03514771\nNCT03084471\nNCT03196271\nNCT04957771\nNCT01312571\nNCT02452671\nNCT05521971\nNCT03054571\nNCT02131571\nNCT00004771\nNCT03504371\nNCT05198271\nNCT03141671\nNCT02789371\nNCT00841971\nNCT05681871\nNCT01376271\nNCT01090271\nNCT02209571\nNCT01675271\nNCT06190171\nNCT05338671\nNCT02278471\nNCT02526771\nNCT01495871\nNCT04361071\nNCT05161871\nNCT03621371\nNCT01657071\nNCT05863871\nNCT00375271\nNCT01387971\nNCT01447771\nNCT01286571\nNCT00445471\nNCT01554371\nNCT03029871\nNCT00090571\nNCT01693471\nNCT03965871\nNCT04276571\nNCT05917171\nNCT00107471\nNCT03350971\nNCT01603771\nNCT04164771\nNCT01988571\nNCT04637971\nNCT04311671\nNCT02843971\nNCT06086171\nNCT02620371\nNCT00188071\nNCT05749471\nNCT00745771\nNCT05993871\nNCT02907671\nNCT04543071\nNCT04991571\nNCT04687371\nNCT01100671\nNCT05183971\nNCT05303571\nNCT00247871\nNCT01508871\nNCT02993471\nNCT04387071\nNCT00298571\nNCT01254071\nNCT03510871\nNCT05659771\nNCT05272371\nNCT03042871\nNCT04930471\nNCT05854771\nNCT04795271\nNCT04082871\nNCT06231771\nNCT01792271\nNCT01046071\nNCT03105271\nNCT02959671\nNCT04946071\nNCT04203771\nNCT03154671\nNCT01560871\nNCT06247371\nNCT01337271\nNCT03109171\nNCT05875571\nNCT03786471\nNCT04029571\nNCT03757871\nNCT02136771\nNCT00245271\nNCT01114971\nNCT01462071\nNCT03865771\nNCT01351571\nNCT03768271\nNCT00496171\nNCT05549271\nNCT06077071\nNCT02980471\nNCT00280371\nNCT04847271\nNCT01238471\nNCT01588171\nNCT05037071\nNCT03083171\nNCT04397471\nNCT05867771\nNCT01540071\nNCT02888171\nNCT04072471\nNCT02880371\nNCT03404271\nNCT04065971\nNCT05601271\nNCT02797171\nNCT02685371\nNCT01417871\nNCT05594771\nNCT01536171\nNCT04401371\nNCT04931771\nNCT00198471\nNCT04394871\nNCT02925871\nNCT02759471\nNCT01709071\nNCT04411771\nNCT03435471\nNCT01367171\nNCT00085371\nNCT01972971\nNCT05761171\nNCT04949971\nNCT04266171\nNCT00498771\nNCT04617171\nNCT03747471\nNCT00141271\nNCT01976871\nNCT00427271\nNCT04679571\nNCT04531371\nNCT03997071\nNCT01958671\nNCT04556071\nNCT00433771\nNCT06002971\nNCT04041271\nNCT03334071\nNCT04761471\nNCT02365571\nNCT03443271\nNCT04107571\nNCT05291871\nNCT03194971\nNCT05241171\nNCT04883671\nNCT02200471\nNCT01497171\nNCT02972671\nNCT01901471\nNCT04156971\nNCT02330471\nNCT00250471\nNCT01381471\nNCT01775371\nNCT06071871\nNCT01872871\nNCT03666871\nNCT05896371\nNCT02733471\nNCT05135871\nNCT02112071\nNCT00988871\nNCT03646071\nNCT01127971\nNCT00234871\nNCT05033171\nNCT05879471\nNCT05940571\nNCT05846971\nNCT05059171\nNCT06225271\nNCT01185171\nNCT02165371\nNCT06192771\nNCT04055571\nNCT02734771\nNCT01620671\nNCT02391571\nNCT00880971\nNCT03431571\nNCT02698371\nNCT00180271\nNCT01407471\nNCT04393571\nNCT00366171\nNCT01373671\nNCT05577871\nNCT03943771\nNCT02589171\nNCT04839471\nNCT02182271\nNCT03005171\nNCT00001171\nNCT06213571\nNCT03228771\nNCT00754871\nNCT00152971\nNCT03847571\nNCT00350571\nNCT02672371\nNCT00002571\nNCT03651271\nNCT05226871\nNCT02970071\nNCT01042171\nNCT05429671\nNCT05815771\nNCT01681771\nNCT02102971\nNCT00815971\nNCT02292771\nNCT05472571\nNCT03690271\nNCT05107271\nNCT04202471\nNCT00934271\nNCT04816071\nNCT03724071\nNCT00910871\nNCT02243371\nNCT02937571\nNCT06169371\nNCT01354171\nNCT04461171\nNCT04552171\nNCT04024371\nNCT05932771\nNCT06136871\nNCT03465371\nNCT01007071\nNCT02398071\nNCT03886571\nNCT00457171\nNCT01296971\nNCT06207071\nNCT02126371\nNCT05235971\nNCT05581771\nNCT02975271\nNCT03748771\nNCT00940771\nNCT05351671\nNCT01911871\nNCT01316471\nNCT05597371\nNCT03041571\nNCT02795871\nNCT01666171\nNCT05542771\nNCT00522171\nNCT04715971\nNCT02572271\nNCT02048371\nNCT02643771\nNCT03079271\nNCT00281671\nNCT06188871\nNCT01952171\nNCT00529971\nNCT04635371\nNCT06233071\nNCT05251571\nNCT05423171\nNCT06264271\nNCT05222971\nNCT01735071\nNCT00302471\nNCT05259371\nNCT03127371\nNCT03560271\nNCT01614171\nNCT02858271\nNCT04530071\nNCT00253071\nNCT04972071\nNCT02756871\nNCT02726971\nNCT04994171\nNCT02556671\nNCT05680571\nNCT04110171\nNCT01676571\nNCT05563571\nNCT05762471\nNCT01477671\nNCT02451371\nNCT04691271\nNCT05841771\nNCT00043771\nNCT02418871\nNCT01651871\nNCT05745571\nNCT01359371\nNCT03841071\nNCT05194371\nNCT03421171\nNCT02578771\nNCT06255171\nNCT05944471\nNCT02745171\nNCT01888471\nNCT05646771\nNCT02543671\nNCT05923671\nNCT00732771\nNCT02821871\nNCT03703271\nNCT03538171\nNCT00839371\nNCT04474171\nNCT01475071\nNCT05148871\nNCT06064071\nNCT02417571\nNCT01406171\nNCT03058471\nNCT03361371\nNCT02364271\nNCT05239871\nNCT00134771\nNCT05576571\nNCT03813771\nNCT00592371\nNCT00914771\nNCT03430271\nNCT06080971\nNCT01229371\nNCT04987671\nNCT00756171\nNCT06025071\nNCT02721771\nNCT01094171\nNCT02450071\nNCT04526171\nNCT00743171\nNCT00155571\nNCT05299671\nNCT03995771\nNCT03808571\nNCT04808271\nNCT02846571\nNCT01511471\nNCT05211271\nNCT02388971\nNCT00189371\nNCT01212471\nNCT05978271\nNCT04051671\nNCT06138171\nNCT00051571\nNCT04988971\nNCT04708171\nNCT01967771\nNCT05156671\nNCT03639571\nNCT03577171\nNCT00883571\nNCT01060371\nNCT02988271\nNCT01000571\nN\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n895\nNCT00308295\nNCT04936295\nNCT03707795\nNCT04095195\nNCT05809895\nNCT05530395\nNCT00808795\nNCT03467295\nNCT03571295\nNCT04299295\nNCT02035995\nNCT04031495\nNCT02110095\nNCT05412095\nNCT05297695\nNCT04535895\nNCT02442895\nNCT04842695\nNCT05916495\nNCT05934695\nNCT02741895\nNCT04084795\nNCT02510495\nNCT03888495\nNCT03644095\nNCT01618695\nNCT00962195\nNCT02866695\nNCT00902395\nNCT04659395\nNCT00279695\nNCT01176695\nNCT00039195\nNCT02033395\nNCT02514395\nNCT00605995\nNCT04777695\nNCT03562195\nNCT00547495\nNCT00101595\nNCT05887895\nNCT01885195\nNCT00388895\nNCT02311595\nNCT04365595\nNCT02853695\nNCT04243395\nNCT02169895\nNCT01596595\nNCT01366495\nNCT02160795\nNCT05802095\nNCT04138095\nNCT03290495\nNCT03891095\nNCT04746495\nNCT06007495\nNCT00637195\nNCT00587795\nNCT05569395\nNCT04089995\nNCT01857895\nNCT05952895\nNCT03831295\nNCT01331395\nNCT01241695\nNCT05350995\nNCT00035295\nNCT00343395\nNCT04747795\nNCT02814695\nNCT01569295\nNCT04437095\nNCT04993495\nNCT05038995\nNCT05106595\nNCT02571595\nNCT01456195\nNCT01120795\nNCT04083495\nNCT03104595\nNCT01757795\nNCT00326495\nNCT00451295\nNCT04136795\nNCT03528395\nNCT01280695\nNCT01408095\nNCT04021095\nNCT00057395\nNCT05100095\nNCT04804995\nNCT00232895\nNCT06085495\nNCT02700295\nNCT04728295\nNCT03021395\nNCT02670395\nNCT03866395\nNCT01640795\nNCT01998295\nNCT04931095\nNCT00833495\nNCT02843295\nNCT01526395\nNCT00950495\nNCT04538495\nNCT01746095\nNCT05324995\nNCT01423695\nNCT00635895\nNCT01168895\nNCT02679495\nNCT04641195\nNCT04622995\nNCT03945695\nNCT05496595\nNCT05782595\nNCT01821495\nNCT05226195\nNCT00540995\nNCT01476995\nNCT02511795\nNCT03928795\nNCT03244995\nNCT02344095\nNCT00000495\nNCT03820895\nNCT02966795\nNCT04043195\nNCT02455895\nNCT01045395\nNCT04390295\nNCT04093895\nNCT02962895\nNCT03404895\nNCT04431895\nNCT05711095\nNCT04732195\nNCT04047095\nNCT02371395\nNCT05985395\nNCT04140695\nNCT03182595\nNCT03057795\nNCT02242695\nNCT03893695\nNCT01154595\nNCT05363995\nNCT03382795\nNCT05666895\nNCT04608695\nNCT04661995\nNCT04232995\nNCT03742895\nNCT01010295\nNCT00258895\nNCT02104895\nNCT02341495\nNCT01840995\nNCT00028795\nNCT02167295\nNCT05508295\nNCT05399095\nNCT00617695\nNCT00914095\nNCT00247195\nNCT03391895\nNCT03207295\nNCT02665195\nNCT01653795\nNCT03930095\nNCT04074395\nNCT00583895\nNCT04591795\nNCT00819195\nNCT00660595\nNCT04416295\nNCT04200495\nNCT03631095\nNCT01625195\nNCT05545995\nNCT05878795\nNCT05517395\nNCT05776095\nNCT05701995\nNCT01296295\nNCT00505895\nNCT03334695\nNCT04530695\nNCT00543595\nNCT03490695\nNCT01709695\nNCT03697395\nNCT05388695\nNCT04500795\nNCT00745095\nNCT00462995\nNCT01103895\nNCT01041495\nNCT04561895\nNCT05638295\nNCT01400295\nNCT05384795\nNCT03581695\nNCT03452995\nNCT00004695\nNCT00986895\nNCT05955495\nNCT01623895\nNCT01645995\nNCT05152095\nNCT03911895\nNCT00000895\nNCT05924295\nNCT05063695\nNCT03400995\nNCT03481595\nNCT01181895\nNCT03959995\nNCT05103995\nNCT03668795\nNCT01024595\nNCT00682695\nNCT04928495\nNCT02818595\nNCT04234295\nNCT04862195\nNCT05649995\nNCT04808895\nNCT04803695\nNCT00954395\nNCT04595695\nNCT00706095\nNCT04439695\nNCT05683795\nNCT03654495\nNCT00128895\nNCT00355095\nNCT00548795\nNCT03048695\nNCT04626895\nNCT01072695\nNCT05556395\nNCT06194695\nNCT04295395\nNCT05613595\nNCT04899895\nNCT00001295\nNCT05269095\nNCT00537095\nNCT03020095\nNCT00325195\nNCT05002595\nNCT03172195\nNCT05449795\nNCT04583995\nNCT01573195\nNCT02580695\nNCT05119595\nNCT05675995\nNCT05284695\nNCT01669395\nNCT01591395\nNCT02163395\nNCT04304495\nNCT06150495\nNCT02498795\nNCT01359995\nNCT01967095\nNCT02701595\nNCT00349895\nNCT01136395\nNCT00089895\nNCT05938595\nNCT04314895\nNCT01842295\nNCT02958995\nNCT01695395\nNCT05804695\nNCT05500495\nNCT04108195\nNCT04806295\nNCT03204695\nNCT00524095\nNCT00269295\nNCT00875095\nNCT03478995\nNCT03979495\nNCT02653495\nNCT00219895\nNCT01751295\nNCT02441595\nNCT00003595\nNCT02877095\nNCT02249195\nNCT04582695\nNCT03924895\nNCT01989195\nNCT06012695\nNCT01681095\nNCT05974995\nNCT05178095\nNCT00144495\nNCT00001495\nNCT01538095\nNCT01807195\nNCT04326595\nNCT00319995\nNCT05808595\nNCT06025695\nNCT04039295\nNCT04723095\nNCT01409395\nNCT00845195\nNCT01978795\nNCT02393495\nNCT06210295\nNCT05337995\nNCT06251895\nNCT05850195\nNCT03426995\nNCT01452295\nNCT02939495\nNCT00604695\nNCT00228995\nNCT06179095\nNCT00004195\nNCT01853995\nNCT00754195\nNCT04421495\nNCT05586295\nNCT03231995\nNCT06011395\nNCT04340895\nNCT06215495\nNCT00401895\nNCT04460495\nNCT05072795\nNCT03692195\nNCT00975195\nNCT05436795\nNCT05659095\nNCT00001395\nNCT03287895\nNCT01877395\nNCT01904695\nNCT06093295\nNCT02533895\nNCT02197195\nNCT02020395\nNCT01562795\nNCT05760495\nNCT05443295\nNCT06184295\nNCT00104195\nNCT03212495\nNCT03592095\nNCT00436995\nNCT00171795\nNCT06138795\nNCT01660295\nNCT03105895\nNCT04474795\nNCT00065195\nNCT02047695\nNCT01203995\nNCT00945295\nNCT04955795\nNCT00520195\nNCT03194295\nNCT01518595\nNCT06234995\nNCT01059695\nNCT01528995\nNCT05713695\nNCT03017495\nNCT03398395\nNCT05447195\nNCT03709095\nNCT04288895\nNCT00561795\nNCT05681195\nNCT02336295\nNCT00871195\nNCT05989295\nNCT05523895\nNCT06216795\nNCT05491395\nNCT00687895\nNCT05594095\nNCT05829395\nNCT06229795\nNCT04242095\nNCT00971295\nNCT02158195\nNCT00105495\nNCT02440295\nNCT06219395\nNCT01894295\nNCT05716295\nNCT05920395\nNCT02072395\nNCT03364595\nNCT05408195\nNCT01571895\nNCT06244095\nNCT05818995\nNCT01495195\nNCT05519995\nNCT05085795\nNCT04381195\nNCT03174795\nNCT04490395\nNCT02787395\nNCT00570895\nNCT04684095\nNCT00293995\nNCT03546595\nNCT01262495\nNCT02826395\nNCT01512095\nNCT03317795\nNCT05616195\nNCT03787095\nNCT00478595\nNCT00838695\nNCT02789995\nNCT00880295\nNCT00696995\nNCT01599195\nNCT00327795\nNCT04604795\nNCT05590195\nNCT05289895\nNCT01402895\nNCT04309695\nNCT06253195\nNCT03841695\nNCT03031795\nNCT01720095\nNCT00663195\nNCT01224795\nNCT00102895\nNCT00652795\nNCT00785395\nNCT02497495\nNCT00966095\nNCT04301895\nNCT03677895\nNCT04660695\nNCT04391595\nNCT01779895\nNCT03164395\nNCT05179395\nNCT04222595\nNCT03142295\nNCT00274495\nNCT04541095\nNCT00780195\nNCT04435795\nNCT04704895\nNCT04071795\nNCT02615795\nNCT02555995\nNCT05685095\nNCT03298295\nNCT05647395\nNCT00332995\nNCT02513095\nNCT04893395\nNCT02610595\nNCT05607095\nNCT04486495\nNCT03767595\nNCT00404495\nNCT00496795\nNCT01905995\nNCT05097495\nNCT05536895\nNCT02960295\nNCT00286195\nNCT01489995\nNCT00849095\nNCT01798095\nNCT02251795\nNCT01398995\nNCT03827395\nNCT02293395\nNCT05882695\nNCT04442295\nNCT03688295\nNCT01153295\nNCT01580995\nNCT01939795\nNCT00885495\nNCT02723695\nNCT03098095\nNCT06016595\nNCT01092195\nNCT04694495\nNCT04975295\nNCT03762395\nNCT03012295\nNCT01268995\nNCT02220595\nNCT00498095\nNCT00409695\nNCT01662895\nNCT04268095\nNCT02429895\nNCT06266195\nNCT05132595\nNCT00221195\nNCT02138695\nNCT03044795\nNCT03220295\nNCT04279795\nNCT02089295\nNCT05362695\nNCT01890395\nNCT01310595\nNCT03970395\nNCT04369495\nNCT05492695\nNCT01609595\nNCT06051695\nNCT03754595\nNCT01531595\nNCT02086695\nNCT03627195\nNCT00353795\nNCT02682095\nNCT05822895\nNCT03878095\nNCT04291495\nNCT05310695\nNCT01046695\nNCT05834595\nNCT04565795\nNCT05539495\nNCT03265795\nNCT05204095\nNCT03335995\nNCT03477695\nNCT04015895\nNCT01727895\nNCT02241395\nNCT06262295\nNCT03237195\nNCT03858595\nNCT00080795\nNCT01838395\nNCT04351295\nNCT00721695\nNCT01040195\nNCT04110795\nNCT00881595\nNCT03195595\nNCT02674295\nNCT02531295\nNCT02269995\nNCT02206295\nNCT01574495\nNCT03322995\nNCT02663895\nNCT04378595\nNCT03931395\nNCT04300595\nNCT04568395\nNCT03300895\nNCT05560295\nNCT03283995\nNCT01250795\nNCT04000295\nNCT05291195\nNCT04963595\nNCT02375295\nNCT03381495\nNCT02323295\nNCT02254395\nNCT03533595\nNCT04706195\nNCT03224195\nNCT02423395\nNCT04465695\nNCT04191395\nNCT05854095\nNCT01319695\nNCT06254495\nNCT04860895\nNCT05828095\nNCT02212795\nNCT01809795\nNCT06003595\nNCT04885595\nNCT05306795\nNCT00137995\nNCT02938195\nNCT00850395\nNCT02669095\nNCT01766895\nNCT04179695\nNCT06212895\nNCT02992795\nNCT05207995\nNCT01353495\nNCT03135795\nNCT06257095\nNCT02392195\nNCT02796495\nNCT00830895\nNCT01111695\nNCT05077995\nNCT02307695\nNCT00738595\nNCT04828395\nNCT01220895\nNCT04290195\nNCT00257595\nNCT01638195\nNCT03343795\nNCT00032695\nNCT06106295\nNCT04478695\nNCT00482495\nNCT04127695\nNCT01123395\nNCT03715595\nNCT00976495\nNCT00456495\nNCT01647295\nNCT01627795\nNCT01305395\nNCT01314495\nNCT03662295\nNCT01843595\nNCT02524795\nNCT04946695\nNCT04949295\nNCT05770895\nNCT03771495\nNCT04915495\nNCT02522195\nNCT01657695\nNCT05789095\nNCT05166395\nNCT05833295\nNCT05088395\nNCT05161195\nNCT03547895\nNCT00722995\nNCT05971095\nNCT00079495\nNCT01847495\nNCT05740995\nNCT01344395\nNCT03385395\nNCT02929095\nNCT03701295\nNCT04231695\nNCT02165995\nNCT05994495\nNCT03982095\nNCT02588495\nNCT01768195\nNCT02558595\nNCT01330095\nNCT04616495\nNCT04364295\nNCT01441895\nNCT03849495\nNCT05159895\nNCT03603795\nNCT00916695\nNCT02325895\nNCT00344695\nNCT00802295\nNCT00264095\nNCT03407495\nNCT03168295\nNCT01800695\nNCT00888095\nNCT05224895\nNCT00373295\nNCT00967395\nNCT05863195\nNCT05133895\nNCT02910895\nNCT00063895\nNCT05042895\nNCT03187795\nNCT00469495\nNCT01632995\nNCT05205395\nNCT03775395\nNCT02381795\nNCT01617395\nNCT00244595\nNCT03234595\nNCT01083095\nNCT00331695\nNCT01071395\nNCT04149795\nNCT04693195\nNCT02494895\nNCT03251495\nNCT01725295\nNCT06020495\nNCT01868295\nNCT06127095\nNCT04951895\nNCT05521295\nNCT01772095\nNCT01349595\nNCT04586595\nNCT04162795\nNCT02730195\nNCT01701895\nNCT02386995\nNCT02736695\nNCT02552095\nNCT02425995\nNCT05514795\nNCT04236895\nNCT04457895\nNCT03901495\nNCT01389895\nNCT06189495\nNCT05558995\nNCT00109395\nNCT00150995\nNCT01367795\nNCT05565495\nNCT01067495\nNCT01532895\nNCT00387595\nNCT05395195\nNCT00789295\nNCT00210795\nNCT04555395\nNCT03326895\nNCT01508195\nNCT01162395\nNCT02173795\nNCT02461095\nNCT00130195\nNCT05623995\nNCT04651595\nNCT02527395\nNCT04271995\nNCT01469195\nNCT04944095\nNCT03621995\nNCT00283595\nNCT02641795\nNCT04444895\nNCT01444495\nNCT04919395\nNCT05757895\nNCT06002295\nNCT04056195\nNCT04798495\nNCT01189695\nNCT00187395\nNCT00774995\nNCT01902095\nNCT01565395\nNCT03857295\nNCT05705895\nNCT03875495\nNCT00806195\nNCT04521595\nNCT02084095\nNCT04977895\nNCT00186095\nNCT03114995\nNCT04112095\nNCT02923895\nNCT02698995\nNCT04511195\nNCT04201795\nNCT00906295\nNCT05109195\nNCT04824495\nNCT03772795\nNCT05534295\nNCT05087095\nNCT02333695\nNCT00139295\nNCT04347395\nNCT02282995\nNCT04526795\nNCT02324595\nNCT05547295\nNCT03330795\nNCT00477295\nNCT02410395\nNCT02150395\nNCT04424095\nNCT04106895\nNCT05951595\nNCT00167895\nNCT01544595\nNCT02190695\nNCT04908995\nNCT06058195\nNCT04656795\nNCT03974295\nNCT03311295\nNCT04697095\nNCT03941795\nNCT01466595\nNCT05274295\nNCT03263195\nNCT00134095\nNCT00621595\nNCT00713895\nNCT05950295\nNCT04655495\nNCT04958395\nNCT02338895\nNCT05218395\nNCT02481895\nNCT01509495\nNCT01278095\nNCT04923295\nNCT02836795\nNCT00395395\nNCT05977595\nNCT04677595\nNCT06112795\nNCT01311895\nNCT04537195\nNCT00002195\nNCT06231095\nNCT02319395\nNCT01491295\nNCT03985995\nNCT01696695\nNCT03033095\nNCT06132295\nNCT05378295\nNCT03978195\nNCT03113695\nNCT03442595\nNCT02896595\nNCT03753295\nNCT01443195\nNCT04572295\nNCT03936595\nNCT01648595\nNCT03971695\nNCT00960895\nNCT04483895\nNCT01283295\nNCT02591095\nNCT04713995\nNCT06136195\nNCT06017895\nNCT02912195\nNCT04607395\nNCT06026995\nNCT00920595\nNCT04229095\nNCT03417895\nNCT03998995\nNCT01313195\nNCT04151095\nNCT01968395\nNCT02776995\nNCT00479895\nNCT03913195\nNCT01981395\nNCT01406795\nNCT03607695\nNCT02611895\nNCT00734695\nNCT05965895\nNCT01131195\nNCT03430895\nNCT03040895\nNCT03714295\nNCT01473095\nNCT05348395\nNCT05070195\nNCT03898895\nNCT05724095\nNCT00015795\nNCT00759395\nNCT02675595\nNCT05211895\nNCT02383095\nNCT00633295\nNCT03645395\nNCT05873595\nNCT02835495\nNCT04218695\nNCT03796195\nNCT06094595\nNCT05928195\nNCT01886495\nNCT02797795\nNCT00741195\nNCT03946995\nNCT03038295\nNCT02672995\nNCT06067295\nNCT03950895\nNCT05727995\nNCT00204295\nNCT06065995\nNCT00764595\nNCT00560495\nNCT01557595\nNCT04361695\nNCT00556595\nNCT02697695\nNCT01665495\nNCT06221995\nNCT06059495\nNCT01601795\nNCT04404595\nNCT05410795\nNCT04117295\nNCT02289495\nNCT00266695\nNCT00108095\nNCT05309395\nNCT00004095\nNCT02424695\nNCT06046495\nNCT02546895\nNCT00329095\nNCT04374695\nNCT04451395\nNCT04270695\nNCT03876795\nNCT05584995\nNCT05001295\nNCT04102995\nNCT02506595\nNCT02977195\nNCT01097395\nNCT03129295\nNCT02355795\nNCT03458195\nNCT00698295\nNCT02996695\nNCT02059395\nNCT04667195\nNCT00787995\nNCT01913795\nNCT01934595\nNCT03582995\nNCT01137695\nNCT06225895\nNCT01158495\nNCT00717795\nNCT01722695\nNCT02812095\nNCT04642495\nNCT05662995\nNCT03797495\nNCT04057495\nNCT05980195\nNCT01215695\nNCT01161095\nNCT01163695\nNCT02454595\nNCT03728595\nNCT02458495\nNCT03638895\nNCT03967795\nNCT04469595\nNCT04123795\nNCT01903395\nNCT03868995\nNCT02245295\nNCT01395095\nNCT00739895\nNCT00453895\nNCT03354195\nNCT01291095\nNCT01773395\nNCT05562895\nNCT05262595\nNCT01957995\nNCT01028495\nNCT03906695\nNCT04749095\nNCT00882895\nNCT06188195\nNCT00173095\nNCT01872195\nNCT05880095\nNCT03473795\nNCT01668095\nNCT00002595\nNCT04294095\nNCT01855295\nNCT02735395\nNCT01825395\nNCT02874495\nNCT05707195\nNCT00940095\nNCT04430595\nNCT03286595\nNCT04886895\nNCT02952495\nNCT00280995\nNCT03329495\nNCT04101695\nNCT02474095\nNCT04903795\nNCT00641095\nNCT06043895\nNCT00670995\nNCT01579695\nNCT02321995\nNCT05763095\nNCT01417195\nNCT02784795\nNCT04317495\nNCT06028295\nNCT03664895\nNCT04643795\nNCT05422495\nNCT00992095\nNCT01055795\nNCT05093595\nNCT05219695\nNCT04264195\nNCT00665795\nNCT03879395\nNCT05098795\nNCT06192095\nNCT02312895\nNCT00206895\nNCT01058395\nNCT00685295\nNCT03681795\nNCT01405495\nNCT02302495\nNCT04452695\nNCT05592795\nNCT00865995\nNCT00699595\nNCT01551095\nNCT04472195\nNCT00677495\nNCT00100295\nNCT04654195\nNCT03529695\nNCT01753895\nNCT03606395\nNCT05451095\nNCT01339195\nNCT05037695\nNCT04762095\nNCT03368495\nNCT01985295\nNCT02940795\nNCT02861495\nNCT03784495\nNCT01597895\nNCT04849195\nNCT03679195\nNCT03112395\nNCT00654095\nNCT02320695\nNCT05434195\nNCT00573495\nNCT03408795\nNCT05236595\nNCT04782895\nNCT05937295\nNCT00733395\nNCT01122095\nNCT04396795\nNCT04335695\nNCT04245995\nNCT03163095\nNCT04208295\nNCT03510195\nNCT04329195\nNCT03350295\nNCT04251195\nNCT02279095\nNCT06249295\nNCT05798195\nNCT01515995\nNCT06227195\nNCT00253695\nNCT05361395\nNCT02526095\nNCT04216095\nNCT03923595\nNCT01519895\nNCT05484895\nNCT04815395\nNCT00825695\nNCT02585895\nNCT00778895\nNCT03927495\nNCT04491695\nNCT05183295\nNCT02935595\nNCT05375695\nNCT02969395\nNCT00942695\nNCT02899195\nNCT04128995\nNCT04957095\nNCT02528695\nNCT04775095\nNCT02578095\nNCT02411695\nNCT01909895\nNCT05114395\nNCT01228695\nNCT03520595\nNCT05461495\nNCT01322295\nNCT00569595\nNCT00503295\nNCT05777395\nNCT05371795\nNCT01401595\nNCT03185195\nNCT06177795\nNCT01201395\nNCT05122195\nNCT04758195\nNCT01376895\nNCT00091195\nNCT05460195\nNCT04303195\nNCT00631995\nNCT03397095\nNCT00546195\nNCT02216695\nNCT02895295\nNCT03660995\nNCT00136695\nNCT04339595\nNCT03083795\nNCT01426295\nNCT01025895\nNCT03634995\nNCT02221895\nNCT04884295\nNCT03315195\nNCT03952195\nNCT05231395\nNCT00041795\nNCT04183595\nNCT03854695\nNCT00620295\nNCT05588895\nNCT03463395\nNCT01982695\nNCT02268695\nNCT02654795\nNCT03228095\nNCT03324295\nNCT00790595\nNCT06224595\nNCT04773795\nNCT04838795\nNCT01293695\nNCT00223795\nNCT06242795\nNCT05292495\nNCT03247595\nNCT05509595\nNCT00429195\nNCT01227395\nNCT02986295\nNCT03745495\nNCT04030195\nNCT03319095\nNCT01341795\nNCT05564195\nNCT05661695\nNCT04257695\nNCT02292095\nNCT02444195\nNCT02913495\nNCT00798395\nNCT03672695\nNCT04648995\nNCT04821895\nNCT01306695\nNCT02942095\nNCT00719095\nNCT04596995\nNCT01960595\nNCT00347295\nNCT05954195\nNCT05142995\nNCT04635995\nNCT02006095\nNCT05506995\nNCT04060095\nNCT01630395\nNCT04499495\nNCT02550795\nNCT00162695\nNCT00000295\nNCT03642795\nNCT06023095\nNCT00611195\nNCT03608995\nNCT03844295\nNCT02243995\nNCT03378895\nNCT00743795\nNCT05861895\nNCT04260295\nNCT01094795\nNCT00180895\nNCT04814095\nNCT03052595\nNCT02763995\nNCT00339495\nNCT02401295\nNCT03718195\nNCT03712995\nNCT05725395\nNCT01369095\nNCT04733495\nNCT04741295\nNCT00262795\nNCT02614495\nNCT00629395\nNCT04466995\nNCT01294995\nNCT04869995\nNCT02185495\nNCT03281395\nNCT00878995\nNCT05406895\nNCT01864395\nNCT01474395\nNCT01521195\nNCT03008395\nNCT01764295\nNCT03437395\nNCT00511095\nNCT03367195\nNCT02633995\nNCT06160895\nNCT00014495\nNCT05239195\nNCT01001195\nNCT00340795\nNCT01942395\nNCT01500395\nNCT05673395\nNCT05747495\nNCT00449995\nNCT01673295\nNCT06038695\nNCT01820195\nNCT05644795\nNCT05717595\nNCT05825495\nNCT00564395\nNCT01718795\nNCT05319795\nNCT05248295\nNCT00002995\nNCT05783895\nNCT00381095\nNCT01980095\nNCT03107195\nNCT02364895\nNCT01639495\nNCT00576095\nNCT03636295\nNCT03445195\nNCT04765995\nNCT03007095\nNCT04139395\nNCT03798795\nNCT05722795\nNCT03213795\nNCT02925195\nNCT04863495\nNCT04970095\nNCT06015295\nNCT01271595\nNCT03598595\nNCT00423995\nNCT01522495\nNCT02026895\nNCT05807295\nNCT02050295\nNCT05686395\nNCT00577395\nNCT00074295\nNCT04817995\nNCT05366595\nNCT05739695\nNCT01336595\nNCT05912595\nNCT02626195\nNCT04167995\nNCT00018395\nNCT00501995\nNCT06090695\nNCT01430195\nNCT00919295\nNCT04980495\nNCT05577195\nNCT03788395\nNCT01575795\nNCT00720395\nNCT04164095\nNCT01684995\nNCT04962295\nNCT04507295\nNCT01392495\nNCT01664195\nNCT04615195\nNCT04881695\nNCT01777295\nNCT01484795\nNCT01865695\nNCT01309295\nNCT02156895\nNCT05730595\nNCT01921595\nNCT02180295\nNCT05458895\nNCT03094195\nNCT02802995\nNCT01261195\nNCT02834195\nNCT05343195\nNCT02904395\nNCT05027295\nNCT00868595\nNCT03740295\nNCT00069095\nNCT01878695\nNCT02997995\nNCT00981695\nNCT01135095\nNCT00013195\nNCT02809495\nNCT04134195\nNCT05428995\nNCT00769795\nNCT02297295\nNCT06154395\nNCT01987895\nNCT02936895\nNCT00370695\nNCT01826695\nNCT03124095\nNCT01935895\nNCT01372995\nNCT05445895\nNCT02043795\nNCT00022295\nNCT00426595\nNCT05295095\nNCT04143295\nNCT00000195\nNCT02541695\nNCT01358695\nNCT04379895\nNCT01102595\nNCT02815995\nNCT01285895\nNCT02198495\nNCT00192595\nNCT04002895\nNCT02229695\nNCT01900795\nNCT05799495\nNCT01492595\nNCT05648695\nNCT00392795\nNCT04901195\nNCT06121895\nNCT00972595\nNCT01661595\nNCT06143995\nNCT03507595\nNCT05245695\nNCT02152995\nNCT01460095\nNCT01999595\nNCT02490995\nNCT04672395\nNCT05712395\nNCT04357795\nNCT04113395\nNCT00309595\nNCT03572595\nNCT01431495\nNCT01202695\nNCT01254695\nNCT03143595\nNCT04487795\nNCT00664495\nNCT00903695\nNCT01253395\nNCT03226795\nNCT01530295\nNCT02467595\nNCT02984995\nNCT00284895\nNCT03255395\nNCT05392595\nNCT00657995\nNCT02536495\nNCT04048395\nNCT02310295\nNCT05826795\nNCT01073995\nNCT04035395\nNCT04482595\nNCT01714895\nNCT04037995\nNCT01735695\nNCT03047395\nNCT00245895\nNCT05679895\nNCT03896295\nNCT00690495\nNCT05999695\nNCT05629195\nNCT01805895\nNCT05597995\nNCT01791595\nNCT01918995\nNCT04628195\nNCT06163495\nNCT05452395\nNCT01132495\nNCT02724995\nNCT02055495\nNCT05075395\nNCT02370095\nNCT01792895\nNCT03420495\nNCT04147195\nNCT06181695\nNCT02073695\nNCT03004495\nNCT04854395\nNCT04420195\nNCT03926195\nNCT01023295\nNCT01850095\nNCT01687595\nNCT03809195\nNCT02867995\nNCT02489695\nNCT04743895\nNCT03146195\nNCT05275595\nNCT05415995\nNCT00768495\nNCT02032095\nNCT03623295\nNCT01814995\nNCT04717895\nNCT04502095\nNCT00821795\nNCT05189795\nNCT06081595\nNCT01206595\nNCT02806895\nNCT04226495\nNCT04275895\nNCT03485495\nNCT05213195\nNCT04334395\nNCT06206395\nNCT04650295\nNCT01418495\nNCT05781295\nNCT03096795\nNCT00522795\nNCT05181995\nNCT05305495\nNCT02129595\nNCT02267395\nNCT04196595\nNCT01379495\nNCT03758495\nNCT02563795\nNCT00430495\nNCT04182295\nNCT00953095\nNCT04053595\nNCT00004895\nNCT05883995\nNCT01861795\nNCT00182195\nNCT04476095\nNCT03199495\nNCT01986595\nNCT04941495\nNCT06134895\nNCT03205995\nNCT03116295\nNCT06169995\nNCT02609295\nNCT04890795\nNCT04165395\nNCT00267995\nNCT05718895\nNCT02631395\nNCT02604095\nNCT02420795\nNCT05532995\nNCT05688995\nNCT03961295\nNCT04556695\nNCT02662595\nNCT05583695\nNCT05778695\nNCT00526695\nNCT04552795\nNCT00813995\nNCT03276195\nNCT05595395\nNCT03316495\nNCT02459795\nNCT03355495\nNCT05655195\nNCT04578795\nNCT01739595\nNCT01631695\nNCT05465395\nNCT01833195\nNCT00985595\nNCT03280095\nNCT05656495\nNCT00202995\nNCT04633395\nNCT05796895\nNCT05889195\nNCT02403895\nNCT05926895\nNCT03060395\nNCT05817695\nNCT02208895\nNCT01679795\nNCT06123195\nNCT02930395\nNCT05044195\nNCT03612895\nNCT03813095\nNCT02713295\nNCT03291795\nNCT02909595\nNCT04069195\nNCT03984695\nNCT02397395\nNCT04082195\nNCT05157295\nNCT02347995\nNCT00544895\nNCT03640195\nNCT03848195\nNCT00773695\nNCT00011895\nNCT00702195\nNCT03590795\nNCT01301495\nNCT02164695\nNCT00222495\nNCT01513395\nNCT04092595\nNCT02576795\nNCT02240095\nNCT02900495\nNCT00288795\nNCT00800995\nNCT02884895\nNCT03853395\nNCT02203695\nNCT04097795\nNCT03676595\nNCT03577795\nNCT01670695\nNCT02613195\nNCT00559195\nNCT01129895\nNCT05471895\nNCT00811395\nNCT00317395\nNCT06082895\nNCT05055895\nNCT03176095\nNCT01465295\nNCT02294695\nNCT00408395\nNCT04206995\nNCT04751695\nNCT01496495\nNCT03460795\nNCT05841095\nNCT06214195\nNCT00318695\nNCT04569695\nNCT00517595\nNCT06103695\nNCT05691595\nNCT04630795\nNCT02011295\nNCT01167595\nNCT04801095\nNCT03862495\nNCT02640495\nNCT02607995\nNCT00673595\nNCT02718495\nNCT02453295\nNCT05746195\nNCT05080595\nNCT02091895\nNCT00746395\nNCT05748795\nNCT05353595\nNCT05040295\nNCT00834795\nNCT00551395\nNCT00999895\nNCT03029195\nNCT00626795\nNCT00048295\nNCT06232395\nNCT02359695\nNCT05751395\nNCT06104995\nNCT01635595\nNCT06168695\nNCT04450095\nNCT03402295\nNCT03560895\nNCT01226095\nNCT03320395\nNCT02971995\nNCT04756895\nNCT00837395\nNCT00483795\nNCT05876195\nNCT04395495\nNCT02704195\nNCT05020795\nNCT04100395\nNCT03650595\nNCT05068895\nNCT04846595\nNCT00828295\nNCT06201195\nNCT02306395\nNCT05365295\nNCT01284595\nNCT03502395\nNCT02009995\nNCT03014895\nNCT05571995\nNCT03082495\nNCT03751995\nNCT05753995\nNCT02943395\nNCT05986695\nNCT04619095\nNCT05051995\nNCT04312295\nNCT03495895\nNCT05214495\nNCT02645695\nNCT03062995\nNCT03711695\nNCT03958695\nNCT00886795\nNCT03358095\nNCT02207595\nNCT02800395\nNCT05386095\nNCT05896995\nNCT05367895\nNCT05820295\nNCT03920995\nNCT00929695\nNCT00647595\nNCT05172895\nNCT03750695\nNCT00448695\nNCT05895695\nNCT01636895\nNCT02529995\nNCT02566395\nNCT00166595\nNCT02956395\nNCT04539795\nNCT01098695\nNCT04580095\nNCT02838095\nNCT06263595\nNCT05419895\nNCT00908895\nNCT02779595\nNCT05981495\nNCT02509195\nNCT02016495\nNCT04544995\nNCT04525495\nNCT03181295\nNCT05933395\nNCT03593395\nNCT03464695\nNCT01917695\nNCT01184495\nNCT05025995\nNCT02955095\nNCT01908595\nNCT04075695\nNCT04079595\nNCT03108495\nNCT04853095\nNCT04855695\nNCT05237895\nNCT04401995\nNCT00863395\nNCT04297995\nNCT03250195\nNCT05756595\nNCT01410695\nNCT05690295\nNCT02722395\nNCT03152695\nNCT03475095\nNCT06233695\nNCT02103595\nNCT03746795\nNCT02624895\nNCT03939195\nNCT02350595\nNCT04734795\nNCT00361595\nNCT03304795\nNCT00084695\nNCT04331795\nNCT03325595\nNCT00117195\nNCT05341895\nNCT03439995\nNCT02553395\nNCT04611295\nNCT03472495\nNCT00998595\nNCT00756795\nNCT01029795\nNCT00316095\nNCT00087295\nNCT00364195\nNCT05969795\nNCT01237795\nNCT04737395\nNCT04873895\nNCT02601495\nNCT04823195\nNCT05083195\nNCT04049695\nNCT04283695\nNCT03140995\nNCT02854995\nNCT05759195\nNCT00572195\nNCT02048995\nNCT00438295\nNCT01348295\nNCT02406495\nNCT05041595\nNCT01926795\nNCT01326195\nNCT05405595\nNCT00314795\nNCT03504995\nNCT05414695\nNCT05578495\nNCT04702295\nNCT05185895\nNCT00407095\nNCT01612195\nNCT05296395\nNCT01127295\nNCT05622695\nNCT02021695\nNCT05859295\nNCT01279395\nNCT00241995\nNCT02172495\nNCT01044095\nNCT00872495\nNCT04840095\nNCT01848795\nNCT01716195\nNCT00195195\nNCT05265195\nNCT01297595\nNCT01876095\nNCT05737095\nNCT02702895\nNCT04570995\nNCT05591495\nNCT02968095\nNCT02922595\nNCT05852795\nNCT03657095\nNCT02354495\nNCT02054195\nNCT06052995\nNCT02728895\nNCT01993095\nNCT06218095\nNCT01666795\nNCT06064695\nNCT05150795\nNCT03233295\nNCT04122495\nNCT00053495\nNCT00894595\nNCT03261895\nNCT04985695\nNCT04976595\nNCT01440595\nNCT05479695\nNCT04422795\nNCT00000695\nNCT05997095\nNCT04868695\nNCT04284995\nNCT03217695\nNCT00615095\nNCT00667095\nNCT04212195\nNCT04802395\nNCT03333395\nNCT02373995\nNCT01610895\nNCT03260595\nNCT03811795\nNCT05552495\nNCT01856595\nNCT03963895\nNCT04794595\nNCT05792995\nNCT04235595\nNCT02029495\nNCT05587595\nNCT05081895\nNCT03517995\nNCT04019795\nNCT03170895\nNCT01276795\nNCT01782495\nNCT02178995\nNCT01090895\nNCT01974895\nNCT01272895\nNCT03027895\nNCT04947995\nNCT04135495\nNCT00384995\nNCT02230995\nNCT02705495\nNCT04023695\nNCT03264495\nNCT00418795\nNCT02944695\nNCT04238195\nNCT00595595\nNCT03991195\nNCT05280795\nNCT03625895\nNCT01590095\nNCT02318095\nNCT01194895\nNCT02115295\nNCT03781895\nNCT00000995\nNCT04125095\nNCT03406195\nNCT03081195\nNCT03855995\nNCT03803995\nNCT01101295\nNCT05877495\nNCT05990595\nNCT05555095\nNCT01922895\nNCT05322395\nNCT05110495\nNCT04557995\nNCT04173195\nNCT04997395\nNCT01938495\nNCT01141595\nNCT01834495\nNCT00990795\nNCT02731495\nNCT01231295\nNCT01435395\nNCT05354895\nNCT01175395\nNCT05345795\nNCT01242995\nNCT00425295\nNCT02008695\nNCT00218595\nNCT04988295\nNCT01380795\nNCT06004895\nNCT03246295\nNCT03637595\nNCT02987595\nNCT03573895\nNCT00933595\nNCT03736395\nNCT02832895\nNCT02121795\nNCT03871595\nNCT02204995\nNCT00936195\nNCT06117995\nNCT03919695\nNCT01318395\nNCT03424395\nNCT05089695\nNCT02602795\nNCT03922295\nNCT05244395\nNCT04793295\nNCT01106495\nNCT00609895\nNCT01937195\nNCT02106195\nNCT05301595\nNCT03651895\nNCT01703195\nNCT00414895\nNCT04810195\nNCT03429595\nNCT00895895\nNCT03499795\nNCT05279495\nNCT00772395\nNCT05470595\nNCT02594995\nNCT05885295\nNCT02022995\nNCT01995695\nNCT01736995\nNCT02067195\nNCT04516395\nNCT00005495\nNCT02562495\nNCT01198795\nNCT00052195\nNCT03949595\nNCT02445495\nNCT00538395\nNCT02693795\nNCT04517695\nNCT05692895\nNCT00446095\nNCT05503095\nNCT00599495\nNCT02994095\nNCT06153095\nNCT03036995\nNCT04214795\nNCT02581995\nNCT02865395\nNCT02589795\nNCT00071695\nNCT01556295\nNCT03091595\nNCT04938895\nNCT04776395\nNCT02188095\nNCT04156295\nNCT03421795\nNCT05699395\nNCT02598895\nNCT05516095\nNCT04620395\nNCT01089595\nNCT03894995\nNCT04534595\nNCT03818295\nNCT00362895\nNCT02186795\nNCT04674995\nNCT00816595\nNCT06167395\nNCT02225795\nNCT04668495\nNCT02901795\nNCT00791895\nNCT06030895\nNCT02627495\nNCT03134495\nNCT03917095\nNCT05252195\nNCT04508595\nNCT01447095\nNCT03519295\nNCT05898295\nNCT06202495\nNCT00864695\nNCT05610995\nNCT00668395\nNCT02136095\nNCT00557895\nNCT02520895\nNCT05379595\nNCT00300495\nNCT01240395\nNCT03850795\nNCT00748995\nNCT01549795\nNCT00420095\nNCT05023395\nNCT03810495\nNCT01246895\nNCT02666495\nNCT01501695\nNCT02132195\nNCT02409095\nNCT05031195\nNCT03737695\nNCT00568295\nNCT01891695\nNCT02058095\nNCT04205695\nNCT00417495\nNCT02893995\nNCT03469895\nNCT03269695\nNCT04001595\nNCT00199095\nNCT00901095\nNCT02255695\nNCT03070795\nNCT03723395\nNCT04080895\nNCT03049995\nNCT06073795\nNCT04564495\nNCT01811095\nNCT04470895\nNCT04877795\nNCT00804895\nNCT03053895\nNCT02782195\nNCT00843895\nNCT05393895\nNCT00145795\nNCT06182995\nNCT04061395\nNCT04114695\nNCT01170195\nNCT05409495\nNCT05360095\nNCT02574195\nNCT02975895\nNCT03332095\nNCT05191095\nNCT01388595\nNCT00382395\n"
     ]
    }
   ],
   "source": [
    "#Now let's start the deep analysis of each row to find whether all the data values are getting in each column is as per the requirement so as to continue with the data in-depth analysis\n",
    "\n",
    "# Extract the values of the first column from each row\n",
    "Id = clinicaltrial_2023_cleaned_data_rdd_with_none.map(lambda row: row[0])\n",
    "\n",
    "# Display the first column values\n",
    "for value in Id.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "4186239f-7889-49e3-bdfc-a2114b34f331",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Not all values in the 'Id' column have 11 characters.\n"
     ]
    }
   ],
   "source": [
    "# to ckec whether the column contains only 11 characters, since the Id is a 11 character Alphanumeric value, viewing the header row\n",
    "header_row = clinicaltrial_2023_cleaned_data_rdd_with_none.first()\n",
    "\n",
    "# let's define a function to check if the value has 11 characters\n",
    "def check_id_length(row):\n",
    "    id_value = row[0]\n",
    "    return len(id_value) == 11\n",
    "\n",
    "# Check if all values in the \"Id\" column have 11 characters\n",
    "all_ids_correct = clinicaltrial_2023_cleaned_data_rdd_with_none.filter(lambda row: row != header_row).map(check_id_length).reduce(lambda x, y: x and y)\n",
    "\n",
    "if all_ids_correct:\n",
    "    print(\"All values in the 'Id' column have 11 characters.\")\n",
    "else:\n",
    "    print(\"Not all values in the 'Id' column have 11 characters.\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "8b3b2ac6-0655-488f-bf9a-c5274f54be07",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rows where 'Id' column doesn't have 11 characters:\n['taluña|Public Health Service of Madrid|Public Health Service of Galicia|Cantabria Health Service', '97.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2005-01', '2010-06']\n"
     ]
    }
   ],
   "source": [
    "# Lets define a Function to check if the value has 11 characters and return the row if not\n",
    "def check_id_length_and_return(row):\n",
    "    id_value = row[0]\n",
    "    if len(id_value) != 11:\n",
    "        return row\n",
    "    return None\n",
    "\n",
    "# Check if all values in the \"Id\" column have 11 characters\n",
    "invalid_ids = clinicaltrial_2023_cleaned_data_rdd_with_none.filter(lambda row: row != header_row).map(check_id_length_and_return).filter(lambda x: x is not None).collect()\n",
    "\n",
    "if not invalid_ids:\n",
    "    print(\"All values in the 'Id' column have 11 characters.\")\n",
    "else:\n",
    "    print(\"Rows where 'Id' column doesn't have 11 characters:\")\n",
    "    for row in invalid_ids:\n",
    "        print(row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "be609d8a-40d8-4b97-8c7c-3ce91c9eed1e",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Row number: 293058\nRow data: ['taluña|Public Health Service of Madrid|Public Health Service of Galicia|Cantabria Health Service', '97.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2005-01', '2010-06']\n"
     ]
    }
   ],
   "source": [
    "# Hence, we need to remove the row since there is no significance in the row without a distinct Id column in it\n",
    "\n",
    "target_data = ['taluña|Public Health Service of Madrid|Public Health Service of Galicia|Cantabria Health Service', '97.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2005-01', '2010-06']\n",
    "\n",
    "# Adding index to each row\n",
    "indexed_rdd = clinicaltrial_2023_cleaned_data_rdd_with_none.zipWithIndex()\n",
    "\n",
    "# Filter the indexed RDD to find the row containing the target data\n",
    "result = indexed_rdd.filter(lambda row: row[0] == target_data).collect()\n",
    "\n",
    "# Check if any rows match the target data\n",
    "if result:\n",
    "    for row in result:\n",
    "        print(\"Row number:\", row[1] + 1) \n",
    "        print(\"Row data:\", row[0])\n",
    "else:\n",
    "    print(\"Target data not found in the RDD.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "bcf28ad8-2fc0-4032-8a03-f406f6d4a73f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[24]: [['Id',\n  'Study Title',\n  'Acronym',\n  'Status',\n  'Conditions',\n  'Interventions',\n  'Sponsor',\n  'Collaborators',\n  'Enrollment',\n  'Funder Type',\n  'Type',\n  'Study Design',\n  'Start',\n  'Completion'],\n ['NCT03630471',\n  'Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India',\n  'PRIDE',\n  'COMPLETED',\n  'Mental Health Issue (E.G. Depression Psychosis Personality Disorder Substance Abuse)',\n  \"BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care\",\n  'Sangath',\n  'Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine',\n  '250.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT',\n  '2018-08-20',\n  '2019-02-28'],\n ['NCT05992571',\n  'Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity',\n  None,\n  'RECRUITING',\n  'Cerebrovascular Function|Cognition',\n  'OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB',\n  'McMaster University',\n  \"Alzheimer's Society of Brant Haldimand Norfolk Hamilton Halton\",\n  '30.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE',\n  '2023-10-25',\n  '2024-08'],\n ['NCT00237471',\n  'Impact of Tight Glycaemic Control in Acute Myocardial Infarction',\n  None,\n  'TERMINATED',\n  'Myocardial Infarct|Hyperglycemia',\n  'DRUG: Insulin (tight blood glucose control)',\n  'Melbourne Health',\n  'National Health and Medical Research Council Australia|Bristol-Myers Squibb',\n  '40.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT',\n  '2005-10',\n  '2006-05'],\n ['NCT03820271',\n  'New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation',\n  'SUPERMELD',\n  'RECRUITING',\n  'Decompensated Cirrhosis|Liver Transplantation',\n  'OTHER: SuperMELD',\n  'Assistance Publique - Hôpitaux de Paris',\n  None,\n  '500.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER',\n  '2020-10-01',\n  '2023-10-01']]"
     ]
    }
   ],
   "source": [
    "# since the row without ID is in the Extract column names from the first row\n",
    "column_names = clinicaltrial_2023_cleaned_data_rdd_with_none.first()\n",
    "\n",
    "# Filter out rows where the 'Id' column doesn't have 11 characters\n",
    "filtered_rdd = clinicaltrial_2023_cleaned_data_rdd_with_none.filter(lambda row: len(row[0]) == 11)\n",
    "\n",
    "# Prepend the column attribute names to the filtered data\n",
    "filtered_data_with_header = [column_names] + filtered_rdd.collect()\n",
    "\n",
    "# Convert the filtered data with header into an RDD\n",
    "filtered_rdd_with_header = sc.parallelize(filtered_data_with_header)\n",
    "filtered_rdd_with_header.take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "97258437-a264-4b00-b9dd-90ec3414bcf1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "All values in the 'Id' column have 11 characters.\n"
     ]
    }
   ],
   "source": [
    "#To confirm that we filtered the row without ID column\n",
    "# Extract the header row\n",
    "header_row = filtered_rdd_with_header.first()\n",
    "\n",
    "# Function to check if the value has 11 characters and return the row if not\n",
    "def check_id_length_and_return(row):\n",
    "    id_value = row[0]\n",
    "    if len(id_value) != 11:\n",
    "        return row\n",
    "    return None\n",
    "\n",
    "# Check if all values in the \"Id\" column have 11 characters\n",
    "invalid_ids = filtered_rdd_with_header.filter(lambda row: row != header_row).map(check_id_length_and_return).filter(lambda x: x is not None).collect()\n",
    "\n",
    "if not invalid_ids:\n",
    "    print(\"All values in the 'Id' column have 11 characters.\")\n",
    "else:\n",
    "    print(\"Rows where 'Id' column doesn't have 11 characters:\")\n",
    "    for row in invalid_ids:\n",
    "        print(row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "2bdf4066-6dd8-4c42-8a8e-67961b2ff5a2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Row number: ['Id', 'Study Title', 'Acronym', 'Status', 'Conditions', 'Interventions', 'Sponsor', 'Collaborators', 'Enrollment', 'Funder Type', 'Type', 'Study Design', 'Start', 'Completion']\nRow content: 0\n"
     ]
    }
   ],
   "source": [
    "\n",
    "#just to double confirm that only required rows are coming in the dataset \n",
    "# Add index to each row\n",
    "rows_with_index = filtered_rdd_with_header.zipWithIndex()\n",
    "\n",
    "# Filter rows where 'Id' column contains 'Id' and is not None\n",
    "rows_with_valid_type = rows_with_index.filter(lambda row_index: row_index[0][0] and 'Id' in row_index[0][0])\n",
    "\n",
    "# Print the row number and rows\n",
    "for row_index, row in rows_with_valid_type.collect():\n",
    "    print(\"Row number:\", row_index)\n",
    "    print(\"Row content:\", row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "954f4552-6273-4909-a027-cd12b41bd404",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Study Title\nEffectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India\nOral Ketone Monoester Supplementation and Resting-state Brain Connectivity\nImpact of Tight Glycaemic Control in Acute Myocardial Infarction\nNew Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation\nInTake Care: Development and Validation of an Innovative Personalized Digital Health Solution for Medication Adherence Support in Cardiovascular Prevention\nTailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life\nNeuromodulation of Trauma Memories in PTSD & Alcohol Dependence\nComputerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women\nManitoba Pharmacist Initiated Smoking Cessation Pilot Project\nMolecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program\nA Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults\nBiology of Juvenile Myoclonic Epilepsy\nSafety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies\nPromoting Wellbeing: The Five Ways to All Intervention\nReversal of the Anti-platelet Effects of Ticagrelor\nNeural Stem Cell Transplantation in Multiple Sclerosis Patients\nRCT of the Effect of Uvulopalatopharyngoplasty Compared to Expectancy in Patients With Obstructive Sleep Apnea\nComparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy With CoViD-19\nDeveloping a Standardized Learning Curve\nInterleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer\nDutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS\nModulation of Gut Microbiota in Early Sepsis: A Pilot Study\nAssessment of Safety Tolerability Pharmacokinetics and Pharmacodynamics of ATH-063 in Healthy Subjects\nCow's Milk and Hen's Egg Hyposensitization in Adults\nClinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide\nThe Effect of Intra-abdominal Pressure on Peritoneal Perfusion During Laparoscopic Colorectal Surgery\nEvaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer\nValidation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems)\nStudy on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer\nPreoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain\nThe Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis\nOcclusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC\nThe Water-Blueberry Study\nStudy on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure\nComparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women\nManagement of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic\nThe Clinical Utility of Extracorporeal Shock Wave Therapy on Burns\nHomeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa\nOvarian Innervation Study in Patients With Polycystic Ovary Syndrome (PCOS)\nChina Lymphoma Patient Registry Study\nLong-term Follow up of Patients With Longstanding Hip and Groin Pain\nClinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression\nStudy of the Cutaneous Microcirculation in Elderly People\nTAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)\nCombined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma\nDeveloping a Diabetic Foot Ulcer Protocol\nParticle-based Partial Tumor Irradiation of Unresectable Bulky Tumors\nFollow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer\nGerman Point Prevalence Study on CVC\nEffect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.\nPerioperative Endothelial Dysfunction\nDeveloping Models for Fatigue Monitoring in Obstetrics and Gyne- Cology Residents Using Wearables\nCardiovascular Comorbidities and Bronchiectasis\nAssessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney Disease\nMass Balance Study of TS-142 in Healthy Adult Subjects.\nThe Effect of an Physician-Nurse Supplementary Triage Assistance Team on Emergency Department Patient Wait Times\nKenota 1 CWS Method Comparison Validation Study\nCross-sectional and Questionnaire Study for Leg Lymphedema\nOptimum Dose of Remifentanil for Intubation in Small Children\nProstate Cancer Genomic Heterogeneity\nA Study on Hemodynamic Relationship Including Cerebral Blood Flow Using Phase Contrast and Signal Intensity Gradient of Brain Magnetic Resonance Imaging and Carotid Doppler Ultrasound\nEnhancing Capacity in Churches to Implement PA Programs\nPhase II Open Label Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib\nTrial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease\nPropofol Versus Midazolam With Fentanyl for EGD Endomicroscopy\nProteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis\nEpisodic Memory Integration and Interference\nGait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism\nBrief Program in Reducing Sedentary Behavior and Promoting Physical Exercise\nInduction Chemotherapy With Nab-paclitaxel Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma\nLaparoscopic Assisted Dismembered Pyeloplasty Versus Open Pyeloplasty in (UPJO) With Poorly Function Kidney in Pediatrics\nMannitol Versus Supportive Care in Ciguatera Fish Poisoning\nAcupuncture on GB26 to Treat Chronic Low Back Pain\nNeural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States\nComparative Effect of 3 Different Cranberry Extracts on Cystitis Related Urinary Comfort in Women\nOcular Imaging Study Using Advanced OCT\nTELEsurveillance of Patients in PostopErative Bridge surgeryAge CoronairE\nCPAP/PSV Preoxygenation in Obese Patients\nPharmacokinetic Boosting of Olaparib to Improve Exposure Tolerance and Cost-effectiveness\nPre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients\nA Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment\nCulturally Modified Family Based Therapy for Haitian Youth in South Florida\nPharmacokinetics of HR17031 Injection in Healthy Subjects\nIntra-pocket Application of Tea Tree Oil Gel in the Treatment of Stage-2 Periodontitis\nOptimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults\nA Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline\nEffectiveness of Acceptance and Commitment Therapy Self-Help for Carers of People With Multiple Sclerosis\nSubthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease\nDendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy\nStudy Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)\nIntranasal Dexmedetomidine for Sedated Hearing Testing\nDo Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood Comparing to Patients Who Did Not?\nTrial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma\nOsteoarthritis Initiative (OAI): A Knee Health Study\nA Six-month Study to Compare Outcome Differences and Visceral Response ... Irritable Bowel Syndrome\nSARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19\nThe Effect of Diet Composition on Performance Expenditure Blood Lipids and Appetite Hormones in Highly Trained Cyclists\nNeoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma\nStudy of Evobrutinib in Participants With RMS\nApplying an Osteopathic Intervention to Improve Mental Health Symptoms: a Mixed-methods Feasibility Study Protocol.\nFirst Line Hepato Cellular Carcinoma (HCC)\nOnce Daily Gabapentin in the Treatment of Post Amputation Pain\nCost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients\nEffects of Deep Breathing Exercises Two Months After Cardiac Surgery\nA Phase 1/2 Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma\nEarly Detection of Endolymphatic Hydrops in Hypothyroid Patients\nAn Ecological Analysis of Nontuberculous Mycobacteria in the Geneva Area (2015-2020)\nEvidence of Myogenic Growth Factors in 3D Dynamic Inguinal Hernia Scaffold ProFlor\nOptical Detection Infiltration/Extravasation in Neonates (ODINE)\nAddition of Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation to an Education and Exercise Program in Subjects With Chronic Pain Due to Knee Osteoarthritis\nSunitinib and Capecitabine for First Line Colon Cancer\nDiabetic Retinopathy and Subclinical Signs of Disease Transition\nEvaluation of Skin Colonic and Oral Microbiome and Effect of Time and Antibiotic Treatment on Organism Diversity at Each Site\nTransarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma\nThe Post-operative Effect of Applying Drainage on Total Knee Arthroplasty\nA Study to Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics of JX09 in Healthy Subjects.\nSofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant\nNeurofeedback for Treatment-resistant Obsessive-compulsive Disorder (OCD)\nThe Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial Fluxes\nNeuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions\nMicro-transplantation in Elderly Patients With Acute Myeloid Leukemia\nA Biologic Joint Replacement Strategy to Treat Patients With Severe Knee Trauma and Post-Traumatic Knee Osteoarthritis\nRole of Membrane Sweeping on Initiation of Labor and Vaginal Birth in Previous Cesarean Section\nAspirin for Postpartum Patients With Preeclampsia\nMindfulness Meditation for Insomnia\nThe Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study\nA Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients\nEfficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children\nAnesthesia Preference for Intravitreal Injection: Topical or Subconjunctival\nTransmission and the Respiratory Tract in Cryptosporidiosis\nFamily Automated Voice Reorientation Study\nSafety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice\nImproving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging\nNeuropathic Pain After Lung Surgery\nSafety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer\nThe Use of Propranolol to Block Memory Reconsolidation in PTSD\nEfficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia\nLanguage and Deglutition in Children\nTailored Approaches to Stroke Health Education\nWomen's-Specific Footwear With Prosthetic Feet\nImproving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record\nRobotic Hand on Hand Functions in Strokes\nPre-Exposure Prophylaxis in the Emergency Department\nAtrial Fibrillation Stroke and Bleeding in Patients Undergoing Aortic Biovalve Implantation\nHIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis\nPrognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis\nPredictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery\nEffects of 8 Week Plyometric Training on Physical Fitness and Technical Skills of Domestic Cricket Players\nA Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.\nA Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or Candidemia\nNivolumab Ifosfamide Carboplatin and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL\nImpact of Self-awareness in Medical Students\nPENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer\nPersonalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma\nStudy of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+ HER2- Advanced Breast Cancer\nDragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)\nExperimental Gingivitis in Patients With Altered Passive Eruption\nPhotodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)\nEvaluation of Immediate Versus Delayed Loading of Dental Implants With a Modified Surface\nTranscutaneous Spinal Cord Stimulation to Promote Walking Recovery After Spinal Cord Injury\nNordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?\nStudy to Compare Two Formulations of Lamotrigine in Healthy Subjects\nPre Radiotherapy Daily Exercise Training in Non-Small Cell Lung Cancer\nStudy on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation\nProstatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia\n68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma\nEfficacy of Single Use Disposable Elevator Cap (DEC) Duodenoscopy\nPrediction of Outcome by Echocardiography in Left Bundle Branch Block\nClinical Use of a Contraceptive Decision Aid and Patient Outcomes\nComparison of the Effect of Lumbar Traction Spinal Manipulation and Surgery in the Treatment of Lumbar Disc Herniation\nEfficacy and Safety Study of Fibrin Sealant With 4 IU/mL Thrombin Vapor Heated Solvent Detergent Treated (FS VH S/D 4) in Face-Lift Procedures\nClinical Evaluation of Two Daily Disposable Contact Lenses\nDexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain\nResection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)\nAntibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission\nIntrauterine Anesthesia in Operative Awake Office Hysteroscopy. A Randomized Double-blind Placebo-controlled Trial\nThe Relationship Between Sleep Disorders and Cytokine Levels Among Hemodialysis and Peritoneal Dialysis Patients\nThe EMERGE Project: Feasibility of Assessing Economic and Sexual Risk Behaviors Using Text Messages in Young Adults\nTendon-Bone Versus All-Soft-Tissue for ACL Reconstruction: A Patient-Blinded Randomized Clinical Trial\nA Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus\nDurvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28)\nEfficacy and Safety of XyloCore Peritoneal Dialysis Solution.\nA Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis.\nEnhancing Analgesia in Chronic Pain Through Exercise\nA Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.\nMulti-court Trial of NBP to Prevent Substance Abuse and Mental Health Disorders (MTC)\nPilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria\nInPen User Experience\nPain in Parkinson's Disease With Motor Fluctuations.\nPhase I Study of Cantrixil in Patients With Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer.\nStudy to Assess Batoclimab in Participants With Active Thyroid Eye Disease\nImmune-Modulated Study of Selected Small Molecules (Gefitinib AZD9291 or Selumetinib + Docetaxel) or a 1st Immune-Mediated Therapy (IMT; Tremelimumab) With a Sequential Switch to a 2nd IMT (MEDI4736) in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer\nLevonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer\nPulmonary Rehabilitation Post-COVID-19\nEffect of CPAP Treatment in Women With Moderate-to-severe OSA.\nClinical Values of Mature Fistulas in Hemodialysis\nCutoff Value of Ankle Brachial Pressure Index for Vacuum Assisted Closure Application in Diabetic Foot Ulcers\nInterventional Study of Anxiety Symptoms in the Implantable Cardioverter Defibrillator (ICD) Patient\nEffectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis\nBalance in Patients After Surgery for Torn Meniscus\nRecovery From General Anesthesia\nNAD-brain: a Pharmacokinetic Study of NAD Replenishment Therapy\nA Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.\nAngiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention\nTreatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection\nTelephone Enhancement Procedure for Continuing Care - 1\nPharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD\nThe Effect of AposTherapy on Pain and Function in a Non Specific Low Back Pain\nLenalidomide Rituximab Gemcitabine Oxaliplatin and Dexamethasone in Relapse and Refractory DLBCL\nSafety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis\nMindful Yoga Therapy for Veterans With PTSD and Pain\nBrain Plasticity Mapping Post-stroke\nLoteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery\nEvaluation of ArTificial Intelligence System (Gi-Genius) for adenoMa dEtection in Lynch Syndrome.\nArthrorisis of the Subtalar Joint With a Polymeric Endorthesis for Flexible Flatfoot Treatment During the Growth Age Prospective Evaluation\nAMS Study: Inflammatory and Biomechanical Contributors to Arthritis Development Following Arthroscopic Meniscectomy\nMuscle Delay Characterization\nSOSteniamoci: Stakeholders' Survey\nBrown Adipose Tissue Activity and Thyroid Hormone\nThe Evaluation of Tomographic 3D Ultrasound for the Assessment of Vascular Pathology\nAlzheimer's Disease Neuroimaging Initiative 2\nLINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm\nA Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking\nIdeas Concerns Expectations. Implementing Patient-centered Communication\nA Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC\nProspective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)\nRamucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)\nEarly Predictive Factors of Cardiac and Cerebral Involvement in TMA\nRadiofrequency and Pelvic Organ Prolapse\nTrial of Endobronchial Ultrasound Guided Fine Needle Aspiration Techniques\nABLE: Abilify in Bipolar Disorder for Long-term Effectiveness\nThe Effect of Soft Tissue Mobilization in Myofascial Neck Pain\nPhase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer\nSpiritual Assessment in Chronic Pain Patients\nFeasibility Study of the RF Ablation Catheter to Ablate Lung Tumors\nA Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma\nRecombinant EphB4-HSA Fusion Protein and Azacitidine or Decitabine for Relapsed or Refractory Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia Patients Previously Treated With a Hypomethylating Agent\nA Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas\nPerformance of Currently Available traNscaTHEter Aortic Valve Platforms in Inoperable Patients With Pure Aortic regurgitatiON of a Native Valve. The PANTHEON International Project.\nBody Structure and Capacity Evaluation of Adults With Scoliosis\nSafety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients\nDose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring\nEffectiveness of Individual Physical Activity Programs to Prevent Sarcopenia and Frailty Among Older Adults\nTreatment of Posttraumatic Swelling and Pain With Zhi Kang Capsule\nThe Effect of Continuous Renal Replacement Therapy on the Efficiency of Extracorporeal CO2 Removal\nTesting for Tuberculosis in the United Kingdom HIV Infected Population\nA Post-Market Clinical Evaluation of the ReUnion Reversible Fracture (RFX) System\nPRospective Multiple Myeloma Impact Study\nTreatment of Complex Regional Pain Syndrome With Once Daily Gastric-Retentive Gabapentin (Gralise)\nStopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)\nThe Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children\nFunction-oriented Assistive Technology Indexing System Development and Promotion\nAcupuncture in Reducing Chemotherapy-Induced Peripheral Neuropathy in Participants With Stage I-III Breast Cancer\nSaliva Insulin Responses to a Standardized Meal Tolerance Test in Humans\nT Cell Receptor (TCR) Sequencing and Transcriptional Profiling in Adult Celiac Disease Patients Undergoing Gluten Challenge\nThe Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention\nVancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline\nHappy Hands E-self-management Pilot Study\nBalloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding\nAntenatal Micronutrient Supplementation and Birth Weight\nNecessity of Preoperative Empirical Antibiotic Use in Acute Cholecystitis\nSix Week Study of Experimental Mouth Rinses: Effect on Gingivitis and Plaque\nSubjective Analgesic Effects of Naloxone and Virtual Reality\nA Single-arm Multicenter Study to Assess the Efficacy Safety and Tolerability of P1101 in Adults With ET\nGastrointestinal Stimulation as a Treatment of Postoperative Ileus Following Extensive Surgery\nAnticoagulation Preference by AF Patients Study\nExercise in All ChemoTherapy\nPeer Counseling in Family-Based Treatment for Childhood Obesity\nA Mechanistic Clinical Trial of Colchicine in Patients Undergoing Femoral Endarterectomy\nDialysis Clinical Outcomes Revisited (DCOR) Trial\nA Novel Biologic Therapy for Perennial Allergic Rhinitis\nOxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients\nThe Value of Botox-A for Management of Low Anterior Resection Syndrome\nEfficacy and Safety of the Use of Ophthalmic Viscosurgical Devices (OVD) FIDIAL PLUS vs IAL®-F During Cataract Surgery\nKinematic Assessment In Multiple Sclerosis\nCognitive-behavior Therapy for MS-Related Chronic Pain\nCardiac Coherence Combined With Personal Physical Activity in Patients With Cancer\nStudy of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy\nOptimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions\nEffects of Rosiglitazone on Blood Vessels in Patients With High Blood Pressure and High Cholesterol\nAttention Bias Modification Training for Young People\nEvaluation of Safety and Tolerability of Nitric Oxide Impregnated Urinary Catheters\nConnected Yorkshire: A Data-linkage Study of Pre-hospital Emergency Department and Out of Hours Service Data\nIs the EBJIS Definition of Prosthetic Joint Infection Meaningful in Our Clinical Practice?\nTeen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3\nTreatment of Early Nasal Polyposis With Topical Triamcinolone\nReveal LINQ Registry\nPromoting Intrafamily Accountability for Reducing Cellphone Use While Driving in Adults and Their Teen Children\nStructured Peer-delivered ART and Reentry Community Strategy\nA Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors\nSafety and Efficacy Study\n\n*** WARNING: max output size exceeded, skipping output. ***\n\ni-inflammatory Agents and Cholesterol Metabolism\nAntiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome\nSpiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice\nStudy of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus\nEvaluation of Non-Invasive Assays for the Detection of Urothelial Cancer\nDynamic Connectivity Under Metabolic Constraints\nEndoBarrier Versus Intragastric Balloon in Obese Diabetic Patients\nInduction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer\nStudy Evaluating Rapamune in Transplant Recipients in the Nordic Countries\nPeriviAble DeLiveries: ALIgning PArental aNd PhysiCian PrioritiEs (ALLIANCE)\nRelative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule\nDiscontinuing Inappropriate Medication in Nursing Home Residents\nStudy of the Feasibility of Early Lung Ultrasound in Neonatal Respiratory Distress in Premature Newborns Born Between 32 Weeks of Amenorrhea and 36 Weeks Plus 6 Days of Amenorrhea Hospitalized in the Neonatal Pediatrics and Intensive Care Units of the Dijon University Hospital\nAssessment of ASPIRE and HOPE Adherence\nEffect of Fish Oil on Athlete's Executive Function\nThe Role of Laparoscopy in Upper Abdominal Surgical Emergencies in Adults: A Retrospective Observational Study.\nText Message Support to Prevent Smoking Relapse\nComparison of iLTS-D® and ILMA® for Intubation With Fiberoptic Control\nVirtual Reality Experiences as Tools to Support Mental Health in Parents of Children With Autism\nA Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension\nIndividualized Metabolic Assessment and Nutritional Optimization in Children With Chronic Respiratory Insufficiency\nTraining Model on Insertion Techniques for Postplacental Intra Uterine Device\nObservational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.\nDose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT\nFlexToBa for People With Multiple Sclerosis\nPregnancy and Postpartum Period Venous Thromboembolism and Simulation\nAutoantibody Specificity and Response to IVIG in ITP\nEffects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis\nEffect of Preoperative Oral Pregabalin Versus Intraoperative Fentanyl on Postoperative Analgesia\nA Prospective Single-centre Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency\nTreatment of Upper and Lower Respiratory Tract Infections in Young Children Using Probiotic\nEffect of Dose Safety Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination\nPreventing Knee Injuries in Adolescent Female Football Players\nEffectiveness of a Nurse-led Integrative Health and Wellness Programme Among Newly Diagnosed Type 2 Diabetes Patients\nInfluence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy\nA Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel\nGrazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)\nThe Effect Insoles on Functional Capacity With Adolescent Idiopathic Scoliosis Using Spinal Orthosis\nThe Evaluation of External Thermomechanical Stimulation for Pain Reduction in Patients Undergoing Nail Injection\nOpen Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma\nPost-operative Electrical Muscle Stimulation to Stimulate Muscle Protein Synthesis in Humans\nSubjective and Objective Outcome of ESS in CRSwNP\nA Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction\nA Study on the Effect of Mindfulness-based Yoga on Youth With Persistent Concussion Symptoms\nDifferential Risks for Melanoma: p16 and DNA Repair\nOver Active Bladder Instillation Study - Botox\nCohort Research on Wilson's Disease\nReal World Evidence Clinical Utility Study of KidneyIntelX\nNebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD\nRole of the Microbiome in Graves' Orbitopathy\nSplit Dose Polyethylene Glycol (PEG) + Clear Fluids Versus Split Dose PEG + Low-Residue Diet\nA Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis\nCryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib\nClinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions\nPF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients\nSafety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis\nClinical Features and Outcomes of CBP Versus Non-CBP in Septic Children\nFoundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes\nComparison of the Effects of TENS and CTM on Primary Dysmenorrhea\nStudy of Efficacy Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis\nTransition From Paediatric Intensive Care to General Paediatrics and Pneumology Units : a Study of the Post-intensive Care Syndrome\nVentilation and Perfusion in the Respiratory System\nRandomized Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention\nModulated Light Therapy in Participants With Pattern Hair Loss\nCombination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD\nWhey Protein-based Enteral Nutrition Support to Improve Protein Economy in Surgical Patients\nA Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients\nMethylphenidate Treatment of Attention Deficits in Epilepsy\nTreatment of Reperfusion Event by Vitamin C Infusion\nStudy to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age\nOCT Evaluation of Early Healing of EPC Capturing (GENOUS) Stent (EGO Study)\nEndoscopic Ultrasound-guided Drainage of Walled Off Necrosis (WON)\nMulti-Omics Noninvasive Inspection of TumOr Risk for Gastric Cancer\nA Phase 2 Study to Evaluate the Safety Tolerability PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele\nBicarbonate v Saline to Prevent Contrast Nephropathy\nBioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Metformin Extended Release Compared With Mono Compound Tablets in Healthy Subjects\nAcupuncture for Prevention of Recurrent Urinary Tract Infections.\nTrigger Finger Corticosteroid Injection With and Without Local Anesthetic\nMeasuring the Quantities of Food Consumed by Patients Hospitalised in a Geriatric Centre\nPorphozym in the Treatment of Acute Attacks in AIP\nAudit of Bronchoscopy Practice in Egypt: Adherence to Safety and Infection Control Guidelines\nA Single-Dose Randomized Placebo- and Active-Control Four-Way Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects\nDevelopment of a Model to Evaluate Regenerative Endodontic Techniques Using Extract Human Teeth\nIntervention of Intestinal Microorganism in Mild Cognitive Impairment\nAudit on Anemia Variation After Major Gynacological Surgery\nAgrylin Drug Use-Result Survey\nWASH Benefits Bangladesh\nGemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer\nA Trial to Evaluate the Impact of Lung-protective Intervention in Patients Undergoing Esophageal Cancer Surgery\nCladribine Idarubicin Cytarabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia High-Risk Myelodysplastic Syndrome or Blastic Phase Chronic Myeloid Leukemia\nEffect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients\nA Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection\nEstimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images\nModulation of Episodic Memory Using Theta Burst Stimulation (TBS)\nSMART Africa (Strengthening Mental Health Research and Training)\nA Study to Evaluate the Safety Effectiveness and Impact of the GlaxoSmithKline Biologicals' Malaria Vaccine- RTS S/AS01E in Young Children in Sub-Saharan Africa\nMapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundle Branch Block\nThe ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.\nFood Safety Security and Waste Prevention Intervention on the KAB-P Approach of University Students\nEvaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control\nExamining Digital Health Care Delivery Models Through Medicaid Collaborative\nNovel Therapies in Moderately Severe Acute Alcoholic Hepatitis\nPragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway\nWindows Trial of INsulin-like Growth Factor Neutralising Antibody Xentuzumab in MEN Scheduled for Radical Prostatectomy (WINGMEN)\nClinical Efficacy of Erythropheresis in High Altitude Polycythemia\nComfort Talk (CT) During Outpatient Chemotherapy\nFeasibility of Cannabidiol for the Treatment of Long COVID\nDiaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)\nTetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders\nEfficacy of Balloon-Expandable Stent Versus Self-Expandable Stent for the Atherosclerotic ILIAC Arterial Disease\nTrial of Cyclosporine for Myocardial Protection During Open Heart Surgery\nEffect of Epigallocatechin -3-gallate Supplementation in Traumatic Brain Injury Patients\nIsotopic Imaging for Prodromal Alzheimer's Disease\nTrial of Temozolomide Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme\nOxygenating the Brain With Laser Therapy\n20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)\nInterstitial Lung Disease Trajectories in Patients With Systemic Sclerosis\nEndoscopic Retrograde Cholangiopancreatography (ERCP) With Cholangiopancreatoscopy Using a Thin Scope\nEffectiveness of Human Simulation Training for Medical Crisis Management Skills\nYouth and Adult Microfinance to Improve Resilience Outcomes in Democratic Republic of Congo\nDBT Compared to I/GDC for the Treatment of Opiate Addiction in Emotionally Dysregulated Patients. - 1\nA Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure\nFeasibility of the Research for Mutation of K-ras and EGFR in CTCs From Metastatic Non Small Cells Bronchial Carcinomas\nMechanisms of Light-based Therapies for Dry Eye Disease\nIdentification of Gestational Diabetes Mellitus Related Urinary Biomarkers Along Pregnancy (From Early Pregnancy to Postpartum) by Using Proteomics and Metabolomics Analysis\nEfficacy and Mechanisms of Energy Medicine to Decrease Chronic Knee Pain in Outpatient Settings\nEffects of Lignan-rich Diet on Cardiometabolic Risk Factors\nStretching vs Foam-rolling\nLongitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)\nScaling up Schoolwide Positive Behavioral Interventions and Supports (SWPBIS) in Rural Idaho Schools\nFrontal Bone Window in ICUF (FBW-ICU)\nSwitch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF\nA Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood\nSurgical Treatment for Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 4\nUniversal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial\nSperm Motility and IUI Live Birth Rate\nDevelopment of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda\nAliskiren on Retinal Vasculature Treatment Study\nPersonalized Dietary Program and Markers of Wellness\nHelmet NIV vs. CPAP vs. High-flow Nasal Oxygen in Hypoxemic Respiratory Failure\nDistress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence\nEndoscopic Tympanoplasty: Single Versus Double Flap Technique\nDevelopment of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy\nStudy to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects\nEffect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis\nThe Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing\nAccuCath™ Intravenous (IV) Device Used by Vascular Access Team (VAT)\nA Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris\nTAP vs QL for Postoperative Analgesia After DIEP Free Flap Breast Reconstruction\nMetformin to Reduce Airway Glucose in COPD Patients\nMagnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina\nAbsolute Myocardial Perfusion Measurement in the Transplanted Heart\nEarly neo2 Registry of the Acurate neo2 TAVI Prosthesis\nStudy Evaluating the Safety Tolerability PK and Activity of Topical ATx201 Gel in Outpatients With Impetigo\nStudy Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease\nVGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2\nDouble-Blind Study Determining the Efficacy of CannaXR in Decreasing UVA Premutagenic and Photoaging Markers\nCan Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty\nA Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung\nThe Impact of NBP on the Collateral Circulation in ICA/M1 Occlusion\nThe Imperial Comprehensive Cognitive Assessment in Cerebrovascular Disease (IC3)\nInvestigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients\nSafety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults\nFamily and Adolescent Motivational Incentives for Leveraging Youth\nAggressive hydraTion in Patients With ST -Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention to prevenT Contrast-Induced Nephropathy\nOptimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae\nPrimary Prevention of CHD Risk Factors Occurring in US\nUltrasound to Evaluate the Quadriceps Muscle Wasting\nSafety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder\nInvestigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People\nRapid Eating Is Linked to Emotional Eating in Obese Women Relieving From Bariatric Surgery\nChart Review of the Efficacy of the GenesisPlus 1064 nm Nd:YAG Laser in the Treatment of Onychomycosis\nIntensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer\nBaduanjin Exercise Prevents Post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER Trial)\nBlood Volume Assessment in COVID-19 and Bacterial Sepsis\nPDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact\nEfficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma\nPCSK9 Polymorphism and Risk of Cardiac Rupture\nMatched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT\nA Pilot Study of a Community Health Agent-led Diabetes Self-Management Program\nA Study of IMPT-514 in Active Refractory Systemic Lupus Erythematosus (SLE)\nRepigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO\nAntenatal Steroids Effect on Mortality and Respiratory Outcomes in Preterm Infants\nInvestigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.\nTiming of B and O Suppositories to Help Relieve Post-operative Bladder Spasms\nSafety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers\nDuloxetine vs. Active Comparator in the Treatment of Patients With Depression\nGesture Behavior and Knowledge on Low Back Pain Among Nurses\nE4/DRSP Ovarian Function Inhibition Study\nWillingness to Participate in Clinical Trials Among Black and African Americans\nIberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma\nPost Market Clinical Follow-Up Study of Excia T® Hip Prosthesis\nPercutaneous Mitral Valve Intervention: Predicting Improvements in Left Ventricular Performance\nEffectiveness of a Pain Assessment and Management Program for Respite Workers Supporting Children With Disabilities\nQuick Recognition of Aortic Dissection\nDocetaxel and Carboplatin in Treating Patients With Metastatic Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway\nThe Antidepressant Effect of Intermittent Theta Burst Stimulation (iTBS)\nPercutaneous Punch Biopsy for Diagnosis of Septic and Aseptic Prosthetic Joint Failure\nTrial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)\nOptimizing Ventilation to Improve Health\nData Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire\nA Trial to Study the Absorption Metabolism and Excretion of [14C]-Praliciguat in Healthy Male Volunteers\nA Bioequivalence Study of Tobradex AF\nTotal Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia\nStent Versus Balloon Dilatation in Patients With Tracheal Benign Stenosis\nPentostatin Cyclophosphamide and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma\nStudy to Analyze the Aerobic Performance Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists\nPilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.\nImpact of Timing of PD Assessments on Measures of Platelet Reactivity in Patients Undergoing PCI Treated With Cangrelor\nEarly Detection of Chorioamnionitis in Preterm Premature Rupture of Membranes\nEfficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs\nSorafenib In Egyptian Patients With Hepatocellular Carcinoma.\nPredicting Pain Response to Transcranial Direct Current Stimulation for Phantom Limb Pain in Limb Amputees\nthe Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections.\nThe Safety and Efficacy of TET Enema in the Treatment of UC\nOptimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS)\nThe RestEaze Ambulatory Sleep Monitor for Detection of Leg Movements During Sleep in Adults and Children With a Sleep Disturbance\nEffects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage\nA Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma\nAssessment of the Behavior of the Preterm Newborns\nDentine Hypersensitivity Treated With Laser and Fluoride.\nRole of Anesthesiologist-Patient Relationship\nFeasibility Study of Early Return-home After Colorectal Surgery Using a SENSIUM® Vital Parameter Monitoring Device\nEffects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics\nPromising Initial Experience With Intra-operative Fluorescent Cholangiography\nEvaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders\nImmunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia\nA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer\nStudy of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection\nMindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity\nHC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)\nNeuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study\nLiver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy\nA Study for Patients With Diabetes Mellitus (IOPA)\nSafety and Efficacy of MEE-HU Medicus\nThe O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers\nFollow-Up Study Evaluating The Long Term Safety and Efficacy of BST-CarGel and Microfracture Repair of the Knee\nIndividual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series\nPhase III Study of 5LGr to Treat Tic Disorder\nAdrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome\nStudy Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants\nPrognostic Impact of NLR PLR and MPV in Patients Undergoing AAA Open Repair\nClinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer\nA Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee\nOPSCC N0 Nodal Control With Reduced IMRT\nStudy to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)\nComparison of Catheters Orifice Configuration For Continuous Infraclavicular Analgesia\nSentinel Lymph Node Technique in Multifocal Breast Cancer\nSafety Tolerability Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension\nAutoimmune Cytopenia and BcR Inhibitors\nEfficacy Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.\nGlobal FKRP Registry\nTreatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia\nCan Diet- and Exercise-Induced Weight Loss Improve Asthma Control in Adults?\nEffects of a School-based Exercise Program on Posture Trunk Range of Motion and Musculoskeletal Pain\nOutcomes of Early Versus Delayed Oral Feeding After Cesarean Section in Korle-bu Teaching Hospital\nA Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib\nPharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects\nStress Echo 2020 - The International Stress Echo Study\nUltrasongraphy Versus Fluoroscopy in Lumber Sympathetic Block in Chronic Lower Limb Ischemia\nHome Based Tele-exercise for People With Chronic Neurological Impairments\nA Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing\nImpact of Drugs on the Risk of Falls in the Fracture Department of the Paris Saint-Joseph Hospital Group\nCopeptin and HFABP in Cardiac Surgery\nCluster Headache Cortivazol Injection (CHCI)\nBedside Versus Operating Room Burr-Hole Drainage of Chronic Subdural Hematoma (DECIDE)\nEvaluation of Gut Absorption Rate of Glucose After a Large Evening Meal in Type 1 Diabetes\nMulticenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years\nAn Evaluation of the Safety of CSF-1 in Presbyopic Subjects\nA Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment\nAnticipating Decline and Providing Therapy\nGuselkumab for Hidradenitis Suppurativa a Mode of Action Study.\nAortic Calcification and Central Blood Pressure in Patients With Chronic Kidney Disease\nEffectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms\nTitanium-prepared Platelet-rich Fibrin in Periodontal Regeneration\nComparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education\nEvolution of Effectiveness of Diabetes Medical Care in Russia\nOutcome of Different IOLs in Patients With and Without Uveitis\nEvaluating the Pharmacokinetics Safety and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents\nThe Accuracy of Human Endoscopic Detection of Submucosal Invasive Cancer in Colorectal Polyps\nFluticasone and Salmeterol in Allergic Rhinitis\nSOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the second column from each row of the final RDD filtered_rdd_with_header\n",
    "\n",
    "study_title = filtered_rdd_with_header.map(lambda row: row[1])\n",
    "\n",
    "# Display the first column values\n",
    "for value in study_title.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "22ff412c-149c-4680-b4f5-3a2e4c31f3e7",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Acronym\nPRIDE\nNone\nNone\nSUPERMELD\nInTakeCare\nREV\nNone\nNone\nNone\nNone\nNone\nBIOJUME\nNone\n5WaysA\nREVERSAL\nSTEMS\nSKUP3\nCOPreDex\nNone\nNone\nDDOT\nMGM-sepsis\nNone\nNone\nNone\nPERFUSION\nNone\nProtocol Quark\nNone\nNone\nNone\nSEASON-HCC\nNone\nNone\nCNP\nTeleCoviDiab\nNone\nNone\nNone\nCLAP\nLund LHGP\nNone\nNone\nNone\nNone\nNone\nPARTICLE-PATHY\nNone\nNone\nNone\nNone\nIoT4Resident\nBRONCOCA\nNone\nNone\nMDRNSTAT\nNone\nNone\nNone\nPROGENY\nNone\nNone\nJAKARTA2\nNone\nNone\nPASEO\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTELE-PEACE\nNone\nPROACTIVE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nDEN-STEM\nNone\nNone\nNone\nNone\nNone\nNone\nDER-CoV2-001\nDCAP\nNone\nNone\nNone\nBRISK FL\nNone\nNone\nNone\nNone\nNone\nNone\nHERNIA\nODINE\nNone\nNone\nDIRECTION\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMTSA\nNone\nNone\nASAPP\nNone\nNone\nNone\nSB-OSAS\nNone\nNone\nFAVoR\nNone\nNone\nNone\nNone\nNone\nNone\nLDC\nTASHE\nWSF\nNone\nNone\nPrEPPED\nCAREAVR\nHIDIT-II\nSLA\nNone\nNone\nANDHI\nNone\nNone\nNone\nNone\nNone\nNone\nDRAGON\nNone\nNone\nNone\nNone\nBIFI\nNone\nPRIME\nLT\nPARTEM\nGRGDG\nNone\nEchoLBBB\nNone\nNone\nNone\nNone\nDexilant\nSMAT\nNone\nNone\nNone\nNone\nNone\nNone\nNVALT28\nELIXIR\nNone\nNone\nVBXFLEX\nMTC\nRALPIR\nNone\nPAINinPD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNAD-brain\nNone\nSTATUS PCI\nNone\nNone\nNone\nAposBack\nR2-GOD\nINTACT\nNone\nMAPPY\nNone\nTimely\nNone\nNone\nNone\nNone\nNone\nNone\nADNI2\nNone\nNone\nICE\nNone\nNone\nRELEVENT\nMATRISK\nNone\nNone\nABLE\nNone\nSAPPHIRE\nNone\nNone\nNone\nNone\nNone\nPANTHEON\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPROMMIS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNarcan\nNone\nSTIMULATE\nPRiSMA-AF\nEnACT\nEPICH\nNone\nNone\nNone\nNone\nNone\nNone\nKAIMS\nNone\nAPACCHE\nNone\nTELEMARC2\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSPARCS\nNone\nNone\nNone\nNone\nCAN\nMITOBEVAEND2\nNEC\nNone\nNone\nNone\nNone\nNone\nNone\nPROSPER\nNone\nNone\nNone\nNone\nNone\nCOMFORT\nNone\nSISTAS\nBEDREST\nNone\nNone\nNone\nDignityDK\nNone\nNone\nNone\nNone\nALCTXT\nNone\nNone\nNone\nNone\nRI-01-007\nPandaExtension\nBIRD\nSOYT-2013\nRESPIRE\nNone\nNone\nNone\nATOLL\nNone\nNone\nNone\nMALRAB\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMLD\nNone\nNone\nNone\nNone\nTheratech\nNone\nGIST\nNone\nNone\nNone\nNone\nNone\nNone\nLANTERN\nRESPIRANET\nNone\nNone\nNone\nNone\nNone\nGAH\nNone\nNone\nNone\nEVIDENCE\nREALITY\nNone\nNone\nNone\nNone\nNone\nNone\nMEDIC-1\nNone\nNone\nAOMHE\nHITS\nNone\nIM-LOSEIT-I\nNone\nNone\nIRON-MPP\nNone\nNone\nSMART\nNone\nMESCEL-COVID19\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMAMMARED\nNone\nNone\nNone\nNone\nNone\nEARLY-MYO-CTD\nNone\nNone\nMIRTOS\nNone\nNone\nSEMONE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPRIHS\nNone\nFDA-OPD\nNone\nAPPOSE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMCS-2-US-pk\nNone\nORIENT\nREST\nNone\nNone\nNone\nNone\nNone\nNone\nPSGtraits-O2\nNone\nNone\nNone\nPRIVATE\nNGS\nRCT\nNone\nNone\nATEMD\nNone\nNone\nNone\nURSONASH\nNone\nRxEACH\nSARS-CoV-2\nNone\nNone\nNone\nCOMPANION AI\nNone\nNone\nEarlyAna\nNone\nNone\nNone\nNone\nP-PRO\nWISH\nDHBHH\nNone\nNAUTILUS\nNone\nNone\nNone\nNone\nFungi-up\nOTS-12WK\nNone\nNone\nNone\nNone\nFam-CT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOPTIMIZE-HFPEF\nLOSS\nNone\nSPARE\nTHC-Gender-II\nMAV-endovasc\nIM1\nPredict\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPET/CT\nNone\nNone\nEXTEND II\nNone\nNone\nNone\nSOTA-GLIM\nNone\nNone\nNone\nPROTT\nNone\nSTAAR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nGPS\nTransEAsome\nNone\nNone\nNone\nNone\nPSPi-IPF\nFIRESTEP\nNone\nNorTriP\nNone\nNone\nNone\nCOPE\nIMPLICATION\nNone\nPCC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFUO-TEP\nNone\nNone\nnebhctz\nDensiron\nNone\nNone\nNone\nBreaStBRT\nNone\nElkarLaguntz\nNone\nNone\nNone\nNone\nPRO1\nVALEEvE\nNone\nNone\nNone\nNone\nTITAN 1\nABS\nNone\nNone\nNone\nNone\nNone\nREVIVE\nNone\nPVP\nNorcal\ninVENT-IO\nNone\nGON\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCS-PEDIA\nPROGRESS\nPOWER-D\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMIPC\nNone\nCogniDo-GI\nTRUST-I\nNone\nNone\nCIC\nNone\nNone\nNone\nTHRIVE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSIDNEY\nNone\nNone\nNone\nNone\nNone\nVOLFI\nNone\nNone\nNone\nIUD EC\nTNK-PLUS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMUCUS\nNone\nENDOTHELION\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOff-label\nEMN-COVID\nNone\nASPIRE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPTEpD\nNone\nNone\nDAPsvs\nclamp-GHD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRPM\nNone\nNone\nNone\nNone\nSTAC2\nNone\nNone\nNone\nNone\nNone\nDIABOLO\nNone\nNone\nNone\nVICTOR\nOC\nNone\nNone\nNone\nNone\nAPPRAISET2\nNone\nNone\nNone\nOSII-TTP\nCANACTFAST\nNone\nNone\nMICE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSerogen\nNone\nNone\nNone\nNone\nValEAR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nI-BrEATHe\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nERISRP\nNone\nNone\nNone\nDRF\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nErgonomics\nNone\nBAV Genetics\nPOXX\nNone\nDTA-2\nNone\nNone\nNone\nNone\nNone\nMEK Inhibitor\nNone\nNone\nNone\nNone\nNone\nNone\nEPREX\nNone\nNone\nNone\nSAFEER\nNone\nNone\nMOP\nPUPIL_pain\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAD-1016\nNone\nNone\nCHRONODIET\nCOMPLETE\nMinOS\nNone\nNone\nKetCRPS-2\nOSCILLOMOELL\nNone\nNone\nCOVID-19\nNone\nNone\nCHAMPION\nNone\nNone\nDiab1Fit\nNone\nNone\nPerceptR\nNone\nNone\nNone\nNone\nNone\nNone\nDeStreSs\nPANDA\nNone\nEXTRA\nNone\nNone\nNone\nNone\nNone\nMURANO\nSAICoDis\nNone\nNone\nNone\nDALI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPPFEvL\nAM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTRANSPORT\nTEVG-2\nPERCUSSION\nNone\nNone\nCOMPaRE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSIMCODE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nREACH\nNone\nNone\nBBA\nNone\nNone\nNone\nNone\nNone\nTG-CYANO\nNone\nNone\nNone\nNone\nENDORA2\nNone\nHEFITEP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nHerbie\nHARTEC\nNone\nNone\nNone\nNone\nTEMPLATE\nNone\niPOD\nNone\nANIST\nNone\nHONUS\nNone\nNone\nNone\nNone\nSOLSTIS\nNone\nNone\nNone\nNone\nEDIDPD\nNone\nNone\nNone\nNone\nNone\nNone\nGluST1\nNone\nNone\nFVR\nSALUTE\nNone\nNone\nNone\nNone\nBiobankII\nNone\nASCEND\nBLOSSOM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nDERMAPOL\nNone\nMYO\nNone\nGoalKeeper\nNATURE\nNone\nWORtH\nNone\nNone\nNone\nNone\nNone\nSURF\nNone\nNone\nORALMAD\nNone\nCORTAGE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRAINBOW\nNone\nbio-Share\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nLEN-0-2012\nNone\nIL1ra\nNone\nNone\nTF-CBT\nNone\nNone\nNone\nNone\nASSIST\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nVIA-MG\nUPtimum-PsA\nNone\nNone\nREACH\nNone\nNone\n3D\nMBTA\nNone\nNone\nNone\nOASIS\nNone\nGLIOMRS\nNone\nNone\nNAVIGATOR\nNone\nDELIOS 02\nNone\nNone\nMESA-LUNG\nNone\nNone\nEASE-IT-TF\nNone\nNone\nNone\nNSsaFe\nNone\nNone\nNone\nCCDDIUUT\nRICOMINCIARE\nNone\nNone\nLose Now NC\nQualiFunc\nNone\nNone\nNone\nNone\nFENICE\nNone\nCAMRA\nMERAK\nNone\nTRITON\nAcclaim-3\nPanHIPEC\nNone\nNone\nNone\nNone\nNone\nRAPID-Padova\nREDUCE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nINNOVATE\nNone\nNone\nNAT-FM\nNone\nINFLAME\nNone\nNone\nCARMA\nNone\nNone\nEPIRAN\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\ntDCS-TOC\numpiraskaus\nNone\nNone\nABS2\nPainCOACH\nNone\nNone\nNone\nNone\nNone\nNone\nXPID\nNone\nNone\nPREPARE\nNone\nNone\nNone\nEiffel\nFACE-PC\nNone\nNone\nOxyjeune\nNone\nNone\nNone\nSIDONY\nMSCLCTWPOI\nSALTO_GyV\nNone\nNone\nMINDED\nNone\nNone\nNone\nNone\nNone\nNone\nPROTECT\nAVAXIRI\nDAPA-SWEET\nNone\nNone\nNone\nNone\nCONSORT-PR\nNone\nNone\nNone\nNone\nBRDI\nNone\nNone\nNone\nNone\nMCO-IF\nStep2Health\nNone\nNone\nNone\nNone\nNone\nBASALT\nNone\nMATCH\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBESS\nNone\nNATION1907II\nNone\nDAFNE\nNone\nNone\nPsSt\nNone\nNone\nNone\nNone\nNone\nPRO_ART\nNone\nNone\nNone\nNone\nROBIICCA\nNone\nGTECHPOI\nNone\nNone\nNone\nNone\nNone\nFREE\nCABG PRD\nNone\nNone\nNone\nNone\nTRIGGERFISH\nNone\nNone\nNone\nNone\nNone\nRACKED\nEARLYBURN\nNone\nNone\nFTIH\nNone\nCLEOPATRA\nTRIAP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCBTi 4 DS:SCED\nNone\nPTSD-preterm\nNone\nTUBE\nMYOVASC\nNone\nVMD\nNone\nNone\nSimpliciT1\nINTREUR\nCORON-ACT\nNone\nNone\nPRoMPT BOLUS\nNone\nZircImpl\nNone\nNone\nNone\nNone\nPied-REM\nNone\nNone\nNone\nNone\nNone\nNone\nFITE19\nNone\nNone\nNone\nUPREE\nNone\nEPICEA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRE-IORT01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSoFT\nNone\nNone\nBRIGHT\nNone\nSENIOREA\nNone\nFIINAAL\nNone\nPLURICLEF\nNone\nNone\nBTX-A-HAC NG\nNone\nNone\nRED\nTREAT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nODS\nNone\nSAINT\nNone\nWDS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEUS-FNA\nNone\nNone\nNone\nNone\nNone\nNone\nCORe\nCSCPE\nNone\nCOMOVA\nNone\nNone\nHYRISS\nNone\nNone\nNone\nLL-BFRT COPD\nNone\nFACT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCYT-500\nIMPACT\nFELICIA\nNone\nNone\nPISH-2\nNone\nNGR018\nNone\nNone\nNone\nNone\nIMPROVE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nUltraPro\nNone\nNone\nPReSPON\nNone\nCJC-TraC\nNone\nNone\nNone\nNone\nNone\nSHIFT\nNone\nCERE-LYSE-1\nNone\nNone\nNone\nNone\nNone\nNone\nPHURINE\nLoRD-KNeA\nNone\nNone\nEPHOS-B\nNone\nALEVENT\nNone\nNone\nCOral-MAF1\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTAVI-LAAC\nNone\nNone\nNone\nNone\nNone\nSREC22\nNone\nNone\nNone\nNone\nARMA\nNone\nNone\nNone\nCOVIDAI\nCAM-FAI relia\nNone\nNone\nReabFalls\nNone\nNone\nNone\nNone\nPTSD\nNone\nNone\nNone\nNone\nNone\nPANDA-T0\nNone\nNone\nNone\nNone\nNone\nNone\nMUST²\nPROVID-19\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPRISME-3P\nNone\nNone\nCYMEVAL3-step2\nNone\nNone\nPEDONCOVID\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nLEGEND\nNone\nNone\nCOPERNICUS\nNone\nNone\nASF-BC\nACAM\nNone\nNone\nNone\nNone\nRESOLVE\nNone\nNone\nPaBMiCS\nBASH III\nNone\nNone\nMV/VV/Hep-AV\nNone\nNone\nNone\nNone\nHEADstart\nPPV\nNone\nHIIT-AF\niniCASPR2\nNone\nNone\nNone\nNone\nNone\nNone\nMBM_Galle\nNone\nNone\nNone\nNone\nNone\nWHOBI-STER\nNone\nPOMA-MA-Ph1\nNone\nNone\nPerform\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nALISA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOPTIMISE\nNone\nNone\nNone\nTHREAD\nNone\nEVA\nNone\nNone\nNone\nNone\nNone\nNone\nReliaSeal\nNone\nNone\nNone\nIMPACT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nVOCSARSCOVDep\nNone\nNone\nNone\nARCHES-2\nDOPERLO\nNone\nNone\nNone\nNone\nCEV\nNone\nNone\nDESIRED\nPINNACLE FLX\nCYCOV-II\nNone\nNone\nDe-ESCALaTE\nNone\nNone\nNone\nNone\nCHF6001_POC2\nNone\nOARS\nNone\nPROP-ABC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nINVENT\nNone\nNone\nNone\nNone\nNone\nOPAL\nNone\nNone\nNone\nNone\nNone\nPROCOM\nENVISION\nNone\nNone\nEPIGETBO III\nNone\nNone\nEvolution\nMISS\nNone\nNone\nUS-UHP\nSHARES\nNone\nNone\nActhar\nNone\nSH-TBL\nNone\nPennSCAPE\nNone\nNone\nNone\nCArPEM\nCoolXenon2\nTORNADO-US\nNone\nNone\nCombiRT\nNone\nNone\nNone\nNone\nSTRONG\nNone\nNone\nSOFIE-8\nNone\nNone\nNone\nFractaVIH\nNone\nNone\nDISRUPT-estRA\nNone\nNone\nNone\nSAPSOS2\nNone\nNone\nNone\nANS-EXE\nNone\nNone\nNone\nNone\nTBIS\nNone\nNone\nNone\nNone\nMA-LYM-RWS-001\nNone\nNone\nNone\nNone\nNone\nNone\nNSCLC\nNone\nNone\nNone\nBRAVE\nNone\nNone\nNone\nNAC\nNone\nNone\nNone\nNone\nPIO-WDT\nNone\nNone\nNone\nSEXVENO\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBidof\nNone\nNone\nNone\nNone\nNone\nARI114694\nNone\nOffR\nChIm-NB-PL\nSMILE\nNone\nNone\nFOOTprevent\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nD-CARE\nNone\nELAROP\nNone\nNone\nNone\nRBC\nEPIMEM\nNone\nAPACHE\nNone\nYOMEGA 5-7y\nNone\nNone\nNone\nIMPA\nNone\nNone\nNone\nNone\nCOMET20d\nNone\nNone\nNone\nSATURATES\nNone\nNone\nHEARTH-OF\nNone\nNone\nSCOPED\nNone\nNone\nNone\nNone\nFAST III\nNone\nNone\nMissing Link\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nDAMP\nNone\nSWITCH\nNone\nNone\nagitation\nRetroBRACE\nNone\nAVANIRA3\nNone\nNone\nNone\nEMBRACE\nNone\nNone\nNone\nASBA-CABG\nNone\nNone\nNone\nNone\nNone\nNone\nDESSOLVEJ\nCLOTILDE\nNone\nCONE-1\nNone\nNone\nNone\nPORTAL\nNone\nTRAILBLAZER\nPRODIGY-1\nLIDOGTC\nNone\nDKD-EXT\nPICC\nNone\nPBI Registry\nTANDEM\nNone\nNone\nNone\nNone\nNone\nEFVF\nNone\nNone\nESSI-SURG\nNone\nBV mini CHP\nNone\nNone\nNone\nV1601CI\nSEMMAP\nMADIT-CRT\nSPIREPI\nNone\nNone\nDBT\nNone\nR3DP-A\nNone\nBEAR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAZ\nNone\nNone\nNone\nNone\nNone\nSTIC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nDOPABIEB\nEvaLongCovid\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBRE-09\nASIST\nNone\nNone\nRTOC\nNone\nNone\nCSCPII\nGHD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAUBURN\nNone\nNone\nNone\nSUFEMYO\nNone\nNone\nNone\nPrenatal Dex\nNone\nBATMAN\nLBL\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOPTIMUM\nNone\nNone\nNone\nNone\nNone\nGHOPPG\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBLOCK-CVS\nNone\nNone\nNone\nNone\nHFrEF\nNone\nNone\nNone\nAnaesthEthics\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSCI&U\nCoMet\nNone\nNone\nACCURATE\nNone\nNone\nSNOT\nNone\nNone\nNone\nNone\nTEEMS\nNone\nNone\nENGAGE\nNone\nNone\nNone\nCOPE\nRIGHT\nNone\nNone\nPHAST\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPSYCHOFIBRO\nNone\nNone\nPROGRAM\nNone\nAGNES-19\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRACHIDOL\nEvol-CLI\nNone\nNone\nNone\nNone\nNone\nTC325\nMDM-PK\nNone\nNone\nNone\nNone\nNone\nNone\nNIRVANA\nNone\nNone\nASOTIAPWST\nNone\nFANTIB\nNone\nNone\nEASTER\nPiezoRx\nORACLE\nNone\nConMex\nNone\nMADC\nNone\nNone\nNone\nVEILLETDAH\nNone\nNone\nNone\nSOT13\nNone\nNone\nNone\nBIVISTA\nPEROXY4G\nNone\nNone\nNone\nNone\nSSO\nNone\nSPARC\nNone\nHAV-EHL-MIS\nNone\nReACH3\nNone\nNone\nNone\nARC-25\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMOHfollowup\nPOD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nIMPACT\nNone\nNone\nNone\nNone\nNone\nPATH-VHD\nMERIT\nNone\nPLEASIN\nmpMRI\nNone\nCycloCT\nGRIP-COMPASS\nNone\nNone\nNone\nPCS IV\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nElasto\nNone\nADAPTSC+\nMEDEAS\nNone\nNone\nNone\nNone\nSFATI-IRC\nINSUREA\nNone\nNone\nJADE Mono-2\nNone\nNone\nIMPACT\nSUMMER\nNone\nNone\nCast-OFF\nNone\nNone\nNone\nReverse-DM\nNone\nNone\nMAVIS\nNone\nNone\nPRP\nNone\nMTBVAC-Ph1b\nNone\nProstate-04\nNone\nNone\nNone\nNone\nRapid-LTCF\nNone\nNone\nNone\nNone\nNone\nPPI\nNone\nNone\nNORDIC-SUN\nNone\nHCC\nULTIMATE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPARTNER-MH\nPFCD\nNone\nHYPID-2\nNone\nNone\nNone\nNone\nNone\nAdipFollowup\nNone\nNone\nNone\nNone\nHSDD\nNone\nNone\nNone\nRIA\nNone\nNone\nNone\nNone\nEtherBil\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMARINOL\nFARGO\nNone\nNone\nNone\nNone\nNone\nInCreAS\nNone\nNone\nNone\nPreCARA\nWHO\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTTOP\nNone\nNone\nNone\nNone\nNone\nSTEP 10\nNone\nNone\nNone\nMYOMEC\nNone\nIVFAct\nNone\nNone\nNone\nACTIVA\nDeprogrammer\nNone\nALRIAL\nPOETS\nCOVID-19\nMalbec\nNone\nNone\nIRIS BVS AMI\nNone\nTIPPS\nNone\nNone\nNone\nSERENAT\nNone\nNone\nEVALECOM2\nNone\nSTRESSREA\nURODETECT-WP2\nCHD\nOPTIMIZATION\nCL\nNone\nNone\nNone\neMOM\nREAL-AF\nNone\nCTDTTIE\nSB-IBS\nNone\nNone\nNone\nSCI Pain\nNone\nNone\nNone\nFBB ACC\nNone\nRESTORE\nNone\nNone\nNone\nNone\nNone\nNone\nICA\nNone\nHESTIA\nNone\nMixedWM\nNone\nNone\nNone\nNone\nNone\nREQUIP RLS PMS\nNone\nNone\nNone\nDynaCT\nNone\nNone\nNone\nNone\nNone\nVISTA\nNone\nNone\nCTCNeoBC\nNone\nNone\nNone\nNone\nCECS\nNone\nNone\nNone\nInsula-TOP\nAUSC\nNone\nEOS60\nDAM\nNone\nNone\nNone\nGUIDED\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nVALOR\nNone\nNone\nNone\nBALTAZAR\nNone\nNone\nNone\nNone\nTVUS\nNone\nNone\nNone\nITALICO\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMAP-VS\nNone\nNone\nNone\nEBUS-TBNA\nNone\nCONFER\nPENTA15\nRVOTCARE\nNone\nNone\nNone\nNone\nNone\nFoDCO\nNone\nNone\nWART\nNone\nNone\nNone\nNone\nNone\nMPGLM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nKETA\nNone\nNone\nNone\nUZ-CHS-BC\nNone\nISITOE\nNone\nNone\nNone\nNone\nKONDI-immun\nNone\nNone\nNone\nNone\nPCW\nNone\nNone\nNone\nNone\nNone\nMOSS\nIMRT-FU\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRICAC\nNone\nNone\nNone\nESKO\nTOSS-2\nNone\nESIMRT\nNone\nNone\nNICER\nNone\nNone\nNone\nDMAT\nNone\nNone\nANSS-ALP\nNone\nKARCHER-1\nESOGIA\nNone\nNone\nNone\nNone\nNone\nNone\nSMOFbrain\nHEP-SC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nJAVA\nLoad & Go\nA-DONUT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nWISE\nNone\nNone\nESTIMEC\nNone\nNone\nALTTO\nNone\nNone\nNone\nROXIC\nNone\nNone\nNone\nNone\nNone\nESPII\nNone\nNone\nRAPID XT\nNone\nNone\nNone\nAOS\nNone\nNone\nCARE1000\nAdmIRE\nLIPOKINES\nCOVID-19\nNone\nNone\nNone\nNone\nNone\nNone\nDE\nNone\nNone\nNone\nNone\nMPFS\nNone\nNone\nNone\nTESS\nDUPSHE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nIRUSESOM0428\nNone\nOPTIMA\nGloVitAS-P\nNone\nNone\nDULOX\nNone\nNone\nNone\nSMWS03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nGNET\nAMinO\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPAPO\nBabyFeed\nPETMYO\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEVOLVE\nNone\nHEALTHOX\nNone\nNone\nTHOR\nNone\nCTHBVACADCHB\nNone\nSIAXI\nNone\nNone\nGRADS Sarc\nNone\nNANOM-FIM\nNone\nNone\nNone\nNone\nLAUREL\nNone\nNone\nNone\nNone\nNone\nLean-DM\nNone\nNone\nROSE\nNone\nNone\nETAPE\nNone\nNone\nNone\nNone\nNone\nNone\nUCM301\nNone\nNone\nPREMISS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMIRON-NATIONAL\nICON\nNone\nNone\nNone\nRAPID STEMI\nMeshPlace\nDIASCOP\nNone\nFCD\nICE-CANCER\nBEETHOCKEY\nMODIFY II\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSPHERE-HF\nUH3\nNone\nNone\nNone\nA09F0401\nNone\nNone\nNone\nULTRA\nAdDePi_KS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nDASH\nSPIRIT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOxidStressHR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOWL\nNone\nFSHD\nNone\nNone\nNone\nNone\nTAMDMD\nNone\nNone\nNone\nNone\nNone\nFREEDOM2\nEGID\nNone\nLapLAND\nREALIsM-HF\nFood4Me\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCPF-DC\nPOFA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEMBOL-AF\nNone\nNone\nNone\nEDRMT\nALSParadigm\nARNICFH\nNone\nNone\nNone\nICAN-NC\nNone\nRyggbra\nVLE EMR\nNone\nNone\nNone\nNone\nSEA-ICU\nCRP-IE\nNone\nLEADER\nNone\nNone\nNone\nEF099\nGBM\nNone\nNone\nGREAT1\nNone\nNone\nNone\nNone\nNone\nHB-RCT2-2015\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nACME\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSPF Assay\nCEUS\nNone\nNone\nNone\nTRANSFORM™\nDPE\nNone\nNone\nNone\nNone\nNone\nRally CRT-P\nNEMOCARD\nNone\nNone\nFLASH\nNone\nNone\nNone\nNone\nNone\nTBCOX2\nFRESH\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nLDE255\nNone\nNone\nNone\nNone\nEPIPAGE2\nMIAMI\nRESPIVAC\nNone\nNone\nNone\nNone\nNone\nIFIE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nArineta\nNone\nNone\nNone\nPROTECT+\nNone\nNone\nEXPANT\nNone\nNone\nNone\nNone\nNone\nSQUARE\nNone\nNone\nNone\nPN\nNone\nNone\nNone\nNone\nNone\nNone\nPBMT\nNone\nNone\nSAFE MRI\nNone\nSlowAge\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nHAND-OUT\nNone\nETA\nengAGE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nKIDNEY-PAGER\nTx-Treatment\nNone\nNone\nNone\nALLAY\nNone\nNone\nMAGMA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOL_5FU\nSTOPEROPCHEM\nNone\nNone\nNone\nNone\nNone\nNone\nREPLACES\nNone\nNone\nNone\nMARFANLOMB\nNone\nNone\nSDPPNCU\nNone\nNone\nBRUCY\nNone\nNone\nNone\nSPARCS\nNone\nNone\nNone\nCTCS\nNone\nNone\nNone\nAbroSkib\nNone\nTaBLFood-MGB\nNone\nNivo-TIL\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPTW\nFORECAST\nHCV\nASPIRE\nFARAONIC\nNone\nNone\nCOLOSSAL\nPREDIP\nNone\nSTEPS\nNone\nTAnBrainDam\nNone\nNone\nNone\nNone\nNone\nSHVE\nNone\nNone\nNone\nNone\nNone\nMOBILE IC\nVARIABLE\nRAPIT\nNone\nNone\nLAMRES\nNone\nNone\nCASPAR\nNone\nMOSART\nNone\nNone\nNone\nRIEHO\nNone\nHEALTH-DB ACS\nNone\nNone\nNone\nNone\nNone\nket_Fol_Up\nNone\nNone\nMEGA\nPLaDays\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nProMPX\nNone\nVOYAGE\nSIT LESS 2\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPROMISE\nNone\nDONATION\nRamp-it-Up\nNone\nNone\nNone\nENDEAVOR OCT\nAFFORD COVID\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nLipidPRC\npreterm\nNone\nNone\nDANCEREX-DTx\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPATH\nIRUSBUPR0045\nNone\nNone\nNone\nNone\nPSV\nNone\nFRAILMERIT\nNone\nTRACER\n4-EVER\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBoLD\nNone\nNone\nSABER-C\nNone\nTSLA ES\nNone\nPark-IMPULSE\nSeaCare\nNone\nNone\nNone\nPEDAL\nNone\nNone\nNone\nANSHIN\nNone\nSTEPS-PD\nAMEERA-2\nNone\nNone\nNone\nUVa\nNone\nNone\nNone\nTOMUS\nNone\nNone\nNone\nNone\nNone\nOPTICAP\nPROSTAGRAM\nNone\nROSA-IC\nNone\nI-FIGS\nNone\nNone\nMANP-HTN-MS\nNone\nNone\nROBIN\nNone\nLAPC-NGS-A/001\nNone\nNone\nNone\nNone\nNone\nEMST\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPISCES\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCOVID-19\nNone\nNone\nNone\nTTP\nTAF-DBS\nMET\nNone\nNone\nCAPS\nNone\nNone\nNone\nNone\nNone\nMDX1106-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nVALOBAB-D\nINSPIRE\nNone\nNone\nNone\nNone\nCR_KMN\nNone\nNone\nOTC℞&COVID19\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNICE\nTIMET\nNone\nNone\nNone\nNone\nNone\nmSILSC\nNone\nNone\nNone\nNone\nNone\nNone\nJoeCare\nCCFRRBA\nCORGI\nNone\nMoDA\nCYTO-CHIP\nHoloUS\nAHVACA\nNone\nNone\nNone\nNone\nNone\nPREDIGAZ\nNone\nRAmP\nNone\nNone\nSTRATEGIC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSAPL-LUPUS\nNone\nONE&ONLY\nNone\nGAMMA\nPOSITIVE\nNone\nNone\nNone\nRECoVER\nFLUID-AHF\nNone\nPEACH\nNone\nTRACK\nNone\nNone\nNone\nHIT\nSTAMP\nNone\nRECARE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCOATS\nPON\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMinnelide 101\nNone\nNone\nBF\nNone\nNone\nPROFOUND\nNone\nNone\nNone\nOSS-IRM\nNone\nNone\nWE\nNone\nGIANT\nNone\nNone\nOvoVid\nNone\nSNIF REF V\nECHOSI\nNone\nNone\nNone\nNone\nBOLD FETUS\nNone\nNone\nNone\nNone\nNone\nROMICAT-II\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nKeynote-559\nNone\nDANCE\nHFNC\nTRANSFORM\nNone\nSIMPLIFY\nSV PCC ARM1\nCSA\nNone\nNone\nNone\nNone\nANGEL-ACT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSHAPE\nNone\nNone\nNone\nNone\nNone\nVINGEM\nNone\nNone\nNone\nResistance\nNone\nPEARL-HF\nNone\nNone\nNone\nNone\nPICB\nEndoSorb\nBoxSwitch\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSHINE-TRAUMA\nNone\nESSENTIAL\nNone\nICY\nHEPPE-PSMI\nNone\nNone\nNone\nINOVASHOCK\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBADIRMS\nNone\nNone\nNone\nNone\nNone\nPIRAMIDES\nNone\nSHARI\nFALCON\nOMLET\nNone\nNone\nNone\nCCFMPCA\nNone\nNone\nNone\nNone\nHOROSCOPE\nNone\nNone\nNone\nNone\nGIU-PPA-0420\nGAIA\nSALIVA-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPURPOSE\nNone\nNone\nNone\nNone\nBaseTIL-03M\nVELRAD\nNone\nNone\nNone\nNone\nNone\nEPOC\nNone\nNone\nGIF\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPFR\nNone\nNone\nCARPAPA\nNone\nNone\nNone\nNone\nNone\nNone\nNICAS\nNone\nHBS\nNone\nNone\nHTPLC\nNone\nNone\nNone\nNone\nDOSE RPW-CRI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nKetonutri\nRCTM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFRAILBRAIN\nNone\nNone\nNone\nNone\nLAMSpigBil\nNone\nNone\nNone\nNEOTAX\nNone\nNone\nNone\nNone\nCAUSALITY\nProspeC-F\nNone\nTANDEM\nNone\nVapechat\nCICERO\nNone\nNone\nORBE-II\nNone\nNone\nNone\nNone\nNone\nSMART-Finder\nNone\nNone\nNone\nNone\nNone\nCareME\nHFpEF\nINCA\nNone\nAFTERCOR\nNone\nNone\nNone\nNone\nLIFT-plug\nNone\nNone\nACRE\nNone\nIMPACT\nNone\nNone\nNone\nMASTER@HEART\nNone\nIMPACD\nNone\nPREDIX HER2\nNone\nNone\nNone\nNone\nPULsE AI\nNone\nTeamCare-PCN\nNone\nNone\nNK1 NK3 PET\nVALFRID\nNone\nWAVE\nNone\nNone\nNone\nSMART-AN\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEPITHINK\nNone\nNone\nMiniClini\nREZUM\nCOVIDMES\nNone\nNone\nNone\nNone\nNone\nVENEZUELA\nNone\nSNIFFLE\nNone\nNone\nNone\nReStOre@Home\nNone\nFA\nNone\nNone\nNone\nEXOCEP2GER\nPRECADIW\nNone\nPICASSO\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTEAM\nR3ACT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOPMD\nNone\nNone\nNone\nNone\nTenex\nNone\nNone\nNone\ngame-ready\nSUCCEED\nNone\nNone\n01-DMPT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPASO-DOBLE\nNone\nNone\nNone\nPeriRen\nNone\nNone\nNone\nNone\nTHRIVE\nNone\nVLZ-MD-23\nNone\nNone\nNone\nNone\nACAR1\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCARe-MRI\nNone\nNone\nNone\nREG-HYPO\nNone\nNone\nIDCST\nNone\nMELAG\nSWEET\nNone\nMOS\nNone\nNone\nNone\nTIVA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCSI\nNone\nNone\nNone\nNone\nNone\nEBV-TCL-01\nNone\nNone\nNone\nSTAND\nNone\nHCV\nISBvsICB-SSB\nNone\nNone\nNone\nNone\nNone\nSAPS\nNone\nNone\nNone\nB-GOOD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBELONG\nNone\nNone\nLacAVC\nNone\nNone\nNone\nSURPASS-SWITCH\nNone\nNone\nNone\nNone\nNone\nDRV900100QD\nNone\nERUPTION-3\nNone\nMSESB\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nUSECARE\nNone\nOpti-PEP\nNone\nNone\nNone\nNone\nHIF\nPULSE\nNone\nNone\nEIPSP\nNone\nECHOTnT\nMAP\nNone\nIDENTITY\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nVaccis\nCRAB-PH\nNone\nNone\nNone\nFORTEe\nNone\nPRESCIENCE\nNone\nNone\nNone\nNone\nVEREEFY\nNone\nNone\nNone\nHYPTHENOL\nNone\nNone\nNone\nNone\nNone\nNone\nIIHTT\nNone\nNone\nERA-EP2\nAMETHYST\nNone\nAJI-APA\nSAAFIR\nEX-Light\nNone\nNone\nreCoVery\nNone\nIMPEDE-HF\nNone\nINTENSIFY\nNone\nReSeT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nALFACHIN\nNone\nNone\nNone\nNone\nMulisa\nNone\nNone\nNone\nNone\nNone\nNone\nPROVETTA\nNone\nJumpSTART\nGRAY-B\nPOMEcolon\nNone\nNone\nNone\nNone\nPRINCESS\nNone\nNone\nNone\nINSPIRE-2\nXopenex\nNone\nNone\nNone\nNone\nNone\nNone\nACRIN6682\nTOBACO\nNone\nNone\nNone\nNone\nGRACE\nCARDDI-BEL\nNone\nNone\nNone\nOSCAR\nNone\nNone\nIULID\nNone\nNone\nSAFIR\nITAP\nNone\nNone\nNone\nNone\nRACE\nBODYCON\nPRESTO\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNMSICRCT\nNone\nMTM2018\nNone\nNone\nROaR+\nNone\nNone\nNone\nNone\nPL-CBT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSANCTUARY\nRhythm\nBL\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTURK-UIP\nPROCTO\nNone\nNone\nNone\nPHD2\nNone\nNone\nNone\nNone\nNone\nSEVURO-CN\nNICU MRI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nREP-COVID\nNone\nNone\nNone\nNone\nNone\nGLEAM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTKA\nTHC-PREG-I\nNone\nNone\nNone\nNone\nNone\nNone\nNone\niSite\nNone\nOmiDETCHD\nNone\nATTAC\nNone\nNone\nNone\nNone\nNone\nNone\nDXM_Hydro\nNone\nWiZen\nNone\nNone\nMBSR\nNone\nNone\nVRanx\nPROMISE-MG\nMAC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSCIG-MG\nSecurAcath\nNone\nNone\nNone\nNone\nNone\nesp -dex\nmiRinFMF\nNON\nNone\nNone\nNone\nDiaakine\nNone\nNone\nNone\nNone\nNone\nGeospatial\nKEM-VOC\nHYCAN\nNone\nNone\nNone\nNone\nNone\nNone\nOpti-HER\nIAAO-AF\nMacu'ta\nNone\nNone\nCOVIDHELP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nANCHRR\nNone\nSDILCM\nVBT\nSYNPHENY-3\nNone\nNone\nNone\nPETEP\nNone\nSECURE\nNone\nNone\nNone\nNone\nSP NSM\nNone\nNone\nGENELIP\nNone\nNone\nNone\nO-BRIDGE\nNone\nDAIR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAthenaValve\nNone\nNone\nCaPaCT\nNone\nNone\nNone\nonline-RASSL\nSEDI\nNone\nVAMOS\nLiP\nAIR-LEAK\nTritube\nNone\nHYPE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNUTRAOLEUM\nGENIUS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCAST\nNone\nNone\nExPeCT\nRESTHONE\nDIAT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAMERICA\nNone\nNone\nNone\nNone\nS-HEMO\nNone\nNone\nFIL_DLCL10\nFEVGECMO\nNone\nNone\nNone\nNone\nSVCGTN\nNone\nNone\nPIPAC EstoK 01\nNone\nNone\nNone\nCPT\nNone\nNone\nNone\nNone\nINTERA\n\n*** WARNING: max output size exceeded, skipping output. ***\n\ne\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNAT-I\nNone\nCiQ-SGLT2\nEVOLVE-2\nNone\nNone\nNone\nNone\nRLS\nTELO - DMRD\nNone\nPalisade-2\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSMART-GDM\nNone\nDRIVE-SHIFT\nNone\nNone\nNone\nNone\nNone\nMAST\nNone\nINSPiRE-ICU2\nNone\nCMSI&Child\nACCURATE-CT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nmLOWER\nNone\nNone\nNone\nNone\nNone\nNone\nCOPsyCAT\nNone\nLPS\nNone\nNone\nNone\nNone\nNone\nPREMATEMP\nNone\nNone\nNone\nNone\nNone\nNone\nANI-LOOP\nPerAF APAC\nClad'Action\nNone\nNone\nBABY\nNone\nDynaCovid\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSMART\nAMINOCANCER\nMACS\nNone\nNone\nNone\nNone\nSymplicityHF\nNone\nNone\nNone\nNone\nSTATIS\nNone\nNone\nOPTIMATE\nNone\nATOL\nNone\nNone\nNone\nKTAP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRPI\nNone\nSAEACG\nNone\nNSCLC\nNone\nNone\nNone\nNone\nNone\nLALGFA2019\nNone\nPS-PICS\nHICOSIRS\nNone\nNone\nBeAT-HF\nNone\nMEPS\nNone\nT-DM1\nNone\nNone\nNone\nGREAT-HF Care\nMeasure\nNone\nNone\nNone\nNone\nNone\nACCOF\nNone\nPERFECTION\nNone\nNone\nNone\nMTC-ITWL\nACLEIC\nNone\nNOR-SYSII\nROSALIND\nDISCO-TWIN\nNone\nNone\nNone\nNone\nNone\nPEDIPAIN\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nB-PHORE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nID-HFpEF\nNone\nNone\nNone\nHEPATOCHLORD\nDELTA-HF\nNone\nNone\nRVA Flavors\nNone\nNone\nDOME-6\nbCPAP\nNone\nREST\nIMABio3\nNone\nPROMISE\nNone\nASYMOT\nNone\nCD2 SCD\nNone\nNone\nNone\nNone\nNone\nHPI2022\nNone\nNone\nNone\nNone\nNone\nNone\nEARLY-HEP-C\nMONET\nNone\n1207\nNone\nNone\nNone\nNone\nNone\nNone\nAZA\nNone\nNone\nPCOSCCTvUSS\nNone\nCABAL\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPERI\nECMO-RESCUE\nNone\nNone\nGIP-1\nNone\nNone\nNone\nNone\nNone\nNone\nROSE2\nNone\nNone\nNone\nTRISEP\nNone\nICARE\nNone\nNone\nNone\nNone\nNone\nNone\nCORD-IV\nNone\nHEPTIDES\nNone\nRECETAS-BCN\nNone\nMENSTRUAL\nEXIT-V\nNone\nNone\nNone\nNone\nEASY-PREDICT\nNone\nNone\nWinterBAT\nNone\nCEDAR\nNone\nACCESS\nETNA-AF-CHINA\nNone\nNone\nNone\nSA&M-I\nNone\nNone\nNone\nNone\nTARHF\nPEM-PRO\nSWEPT\nNone\nNone\nFIT Teens\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPTOA-ECC\nNone\nFMT_CRE\nNone\nNone\nNone\nrTMS\nNone\nNextGen\nNone\nNone\nNone\nNone\nNone\nPROMISE\nNone\nNone\nPAMP-Phase2\nIOM-ADHD\nPROPOSE\nSAMAS\nOPTIMA\nNone\nNone\nNone\nSTRICTSTARLUNG\nNone\nNone\nD-Velocity\nPEACOCS\nNone\nNone\nKTX\nNone\nNone\nNone\nRIFLE\nCOMBO\nNone\nNone\nSCRIPT\nNone\nNone\nHD-FFRct\nNone\nMESF\nMS-IL2\nNone\nNone\nNone\nEPIC\nNone\nNone\nNone\nVITDALIZE\nNone\nNone\nNone\nNone\nNone\nNone\nINTREPID\nNone\nNone\nTACTIC\nMYLOFRANCE2\nNone\nNone\nSartSep\nALLEGORY\nCROHN-PREP\nNone\nAutoChron\nNone\nNone\nNone\nLENAS\nHEMOCARD\nNone\nNone\nGEMECULI\nOSI-DM\nAVANCE\nNone\nNone\nNone\nMOTION\nGLIMMER\nNone\nNone\nNone\nNone\nANTICOV\nNone\nIMOGEN\nNone\nNone\nLYMPHGO\nNone\nESPER\nNone\nNone\nRESCOM\nNone\nNone\nNone\nSOLUS-D\nNone\nNone\nNone\nNone\nNone\nREMYELIKIDS\nNone\nTwo-for-2\nDESTINATION\nPHBR\nNone\nNone\nNone\nNone\nNone\nEOLE\nNone\nGO-REVEAL\nDECRIVAM\nAB-ULTRA\nNone\nNone\nJUBILEE\nFastTrack-G\nNone\nNone\nNone\nNone\nTrainStrain\nCADENCE\nHIDRATE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nVCU-Alpha1RT\nNone\nNone\nNone\nTROS-8\nNone\nBIS-MA\nGLOBAL-HTN\nPCD 2\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nIVMprt\nNone\nNone\nMPH-BS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTCI\nPATIPS\nNone\nNone\nLOTIS-8\nGENMetS\nNone\nNone\nNone\nNone\nNone\nMETSYND\nIRBOcomp\nNone\nNone\nNone\nNone\nNone\nNone\nDHIODE\nPROVIDENCE\nNone\nNone\nREMAIN\nNone\nNone\nNone\nNone\nASCENT-J02\nNone\nABC CAC\nNone\nNone\nSKIP\nECLIPSE 1\nCAPRI\nTARGET-READ\nNone\nNone\nNone\nGliomiR\nMAMBA\nPhaST\nJADE MOA\nBALANCE\nSCAN-B\nNone\nNone\nMULTIPROS\nNone\nNone\nPreedom\nNone\nNone\nNone\nFILSLAN-NF\nVIPER\nIGFC\nTEAM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNeoBCT\nNone\neDIT-pilot\nNone\nNone\nNone\nNone\nOptimize\nNone\nNone\nFlavanol\nNone\nNone\nOOPS\nNone\nNone\nMOVE-HF\nGAITSTIM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFIL_BIOWM\nQoL-CHD-5-7\nNone\nNone\nNone\nGAinS\nPREP\nNone\nC-ACHDiR\nESCAPE\nCD64\nEPIC\nNone\nNone\nVacciPrema\nNone\nTENSE1\nNone\nCMCBRAF\nsRAGE\nNone\nNone\nNone\nNone\nQDOT-FAST\nNone\nNone\nNone\nNone\nSOPHIA\nNone\nNone\nNone\nEPAP-LOMB\nMR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRxWell\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMB07133\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nGEMCOL\nNone\nTAVIguide\nNone\nTRASOS\nNone\nPREVFUNKTION\nExoReBLy\nPEDIFLUID\nNone\nMART\nNone\nROMANOV\nNone\nUDiReCT\nNone\nNone\nCAMP\nNone\nNone\nNone\nRE-DEFINE\nNone\nNone\nNone\nMITOR\nNone\nNone\nNone\nNone\nNone\nNone\nSHIP-AC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nICARO\nEVAS FORWARD 2\nNone\nNone\nNone\nPoseidon\nNone\nNone\nNone\nPICTURE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEXCIMAG\nsafendoscopy\nCLEEONI\nNone\nCareACT\nNone\nNone\nNone\nNone\nNone\nNone\nCo-Stars\nOUtMATCH\nNone\nNone\nNone\nREPLICCAR\nNone\nBARDA II\nNone\nNone\nNone\nDIGNICAP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nendovascular\nNone\nNone\nDCLP4\nNone\nNone\nNone\nTE-Prove\nEx-Factor\nNone\nNone\nTEVAW\nLIR-CG\nNone\nSAPIT\nAUSSIE-1\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSTIMASEP\nNone\nUC\nNICOREA\nNone\nNone\nNone\nrhAAT-Fc\nNone\nNone\nNone\nNone\nMSC\nCURVE\nNone\nNone\nNone\nNone\nSTABLE\nNone\nNone\nNone\nWINTHER\nPHE-LEEP\nTUGETHER\nNone\nNone\nvenipuncture\nNone\nNone\nFOM\nNone\nNIRS BOLUS\nNone\nNone\nCOLOR-ACS\nNone\nNone\nINCREASE\nPROLIFIC\nNone\nNone\nNone\nCardio pilot\nNone\nPOINT II\nNone\nNone\nSGB-PsychoED\nNone\nNone\nNone\nCHANCE2202\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSTARS\nRESILIENTExt\nNone\nNone\nNone\nNone\nNone\nNone\nHIP ATTACK\nNone\nPREGAB\nNone\nNone\nNone\nNone\nNone\nNone\nLuban\nNone\nNone\nNone\nTOOL_TOUCH\nNone\nNone\nNone\nNone\nNone\nEPO-T\nNone\nENERGY\nNone\nALL IN LUNG\nNone\nNone\nNone\nNone\nNone\nNone\nDAPA-TURK\nNone\nNone\nNone\nCARDIOSA-12\nNone\nNone\nNone\nNone\nNone\nSTALLO\nMARBLE\nNone\nNone\nRUBY\nNone\nNone\nMUKtwelve\nSCARIS\nNone\nNone\nPTCA199-4\nNone\nNone\nNone\nBLISS-SC\nBiELLA\nNone\nReGIFT\nNone\nBTC-BGB\nNone\nNone\nNone\nHAPI\nNone\nNone\nNone\nNone\nNone\nNone\nED-TBI\nNone\nULT-218\nNone\nMAPUS2\nTAPER-LTC\nNone\nNone\nNone\nSTAD-1\nNone\nPIL\nNone\nSMARTPRT\nALIMS\nPOPIMAGE\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nDIAGNOSED\nNone\nVisibility\nCONCORDE\nNone\nNone\nNone\nEchoCRT\nREACH Hope\nGA-CARES\nNone\nNone\nNone\nNone\nKg-Free\nNone\nLUCHAR\nTUBOGTEP\nNone\nNone\nLOCAAL\nNone\nNone\nEENCD\nNone\nGRETA\nNone\nNone\nNone\nNone\nNone\nNone\nBMI\nPRODEFAR\nNone\nNone\nCSTF3PGPSR\ntDCS(HE)\nNone\nNone\nNone\nNone\nPLaSSo\nNone\nMINDdiet\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPROCLAIM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFAQR-Malawi\nNone\nNone\nNone\nNone\nBigpAK-2\nNone\nNone\nNone\nNone\nExparel\nNone\nNone\nNone\nNone\nNone\nTERTAOT\nNone\nPRELUDE\nNone\nDiast Dysfkt\nNone\nTHYB-02\nNone\nPROXYMA\nNone\nSIMPle-AF\nNone\nNone\nHC\nNone\nSAFE-SVC\nNone\nALGO-REA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAVCyclES\nNone\nNone\nESSENCE\nNone\nNone\nNone\nNone\nNone\nPREDESCI\nEASY TAVI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTODAY\nBMI-INK\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFreSH\nNone\nCIT-HD\nNone\nBREAST-MRI\nVandevol\nNone\nNone\nNone\nFAITH!\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nESSACWVM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAPHERESE\nSPARC-C\nNone\nNone\nNone\nNone\nNone\nConTRol\nNone\nETOC\nNone\nNone\nLongPAP\nNone\nNone\nCIRCE\nNone\nNone\nNone\nNone\nProPAC-COVID\nNone\nNone\nNone\nRxIALTA\nNone\nNone\nSMARTKids\nNone\nNone\nNone\nNone\nCEASe\nFATSOMCAN\nBME-1\nMKET\nNone\nNone\nNone\nLOGICAN\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOncolab\nContrast RISK\nECMO PFA-100\nTiP\nNone\nNone\nNone\nNone\nCORI RCT TKA\nNone\nNone\nNone\nNone\nCareStress\nNone\nNone\nCANARI-AF\nMT110-101\nNone\nSleepWell\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEMMA\nNone\nNone\nBILIHEALTH\nNone\nNone\nNone\nNone\nNone\nNone\nMAST\nNone\nNone\nNone\nNone\nNone\nCPEX-011\nNone\nDEPICT\nNone\nRP\nNone\nNone\nNone\nBIBE\nNone\nNone\nVDATH\nADIE-FS\nNone\nOSP\nNone\nPJI\nNone\nNone\nDiffLung2\nNone\nPARACHUTEIII\nNone\nNone\nPOTENT\nNone\nFLIP\nDCCS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nORBEX\nNone\nPROTESIED\nNone\nPIO-TACE\nNone\nHEMO-TIN\nNone\nNone\nEARLY-QoR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBIOMARK\nNone\nNone\nNone\nNUC-CAP\nNone\nNone\nNone\nNone\nETDT\nNone\nNone\nADAPTHRO\nNone\nNone\nIGL\nNICIM\nNGDS\nNone\nNone\nNone\nBEZAFIBRAMI\nNone\nNone\nCALCIMIP\nNone\nNone\nNone\nPLATEL-EVAL\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOVER\nAPEC\nNone\nNone\nNone\nNone\nBARBICAN\nKISSING DEBBIE\nNone\nNone\nNone\nNone\nGlycosade GSD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTPCDT\nNone\nNone\nNone\n3P\nDESIVI\nPOC-OP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nVitamin D\nNone\nNone\nNone\nNone\nPreVent\nNone\nNone\nTIC-TDCS\nNone\nNone\nNone\nNone\nNone\nTakeCare!\nNone\nUS-SCB\nNone\nPRETEA\nTime2Quit\nIMTCO\nNone\nCOVERAGE\nNone\nNone\nNone\nNone\nNone\nFINDER\nNone\nPLATE NOX\nNone\nNone\nNone\nMERIDIEN\nNone\nNone\nNone\nBARIS\nNone\nMAD\nNone\nNone\nNone\nSleepICU\nIMH-HV RCT\nNone\nNone\nNone\nNone\nNone\nPERFECT-VR\nNone\nCOPICADS\nRev-CLL\nNone\nNone\nMAGIC\nNone\nNone\nNone\ninVENT\nNone\nNone\nNone\nNone\nMR-ICANS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAIPDAP\nNone\nNone\nNone\nPLARAS\nNone\nNone\nRIC in burns\nNone\nSUSTAIN 10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nP1\nNone\nPRMRP-FPA2\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRESIST-2\nNone\nNone\nNone\nNone\nNone\nPoly-ICLC\nNone\nB4371004\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCAM-FAI\nNone\nCOMPANION\nNone\nNone\nNone\nNone\nNone\nNone\nCYTORECT\nNone\nNone\nNone\nNone\nNone\nNone\nVAB\nNone\nNone\nTRUST\nGIW - J-J\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPLACATE-MS\nNone\nPACEMAN-HF\nNone\nDISCOVER\nMRx\nNone\nNone\niLTB\nNone\nTI-TFCE\nNone\nNone\nNone\nNone\nNone\nNone\nCOPC\nNone\nNone\nNone\nPEACEIIa\nNone\nVILC\nNone\nNone\nNone\nNone\nNone\nNone\nREDEFINE 1\nNone\nMWA\nNone\nNone\nNone\nNUTRISCLER\nNone\nTOR\nGAS\nNone\nPsychPC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nIACE Scan\nNone\nNone\nNone\nNone\nNone\nNALPILO\nNone\nNone\nREPLACE\nChampion-HMB\nNone\nNone\nNone\nNone\nNone\nESPITAP\nNone\nNone\nNone\nNone\nNone\nLipo-Hip\nEPON\nNone\nDEEP1C\nNone\nCBTRPat\nNeoVanc\nNone\nNone\nNone\nNone\nPHYSIO_PRONE\nNone\nEASE-CG\nNone\nCPP\nNone\nNone\nNone\nNone\nPIMS-TS INT\nC-ICR-CD\n4DCT\nNone\nFAV ss ALR\nNone\nFin-Can\nNone\nNone\nBayston\nESCAPED\nNone\nRADAR\nRELF IIa\nNone\nNone\nMA-51\nCRIDD\nYourMove\nTEAM\nNone\nNone\nNone\nNone\nNone\nGLAM\nNone\nFlowVAD\nNone\nNone\nEx-6-rate\nNone\nAbSeS\nGLORI-COPD\nNone\nNone\nEV-AICS\nPROHIBITSodium\nNone\nPOW\nNone\nNone\nNITRAD-Sub\nNone\nBARICENTRE\nNone\nNone\nACP-PSH\nNone\nNone\nNone\nNone\nSNACS\nNone\nNone\nNone\nNone\nCTCs\nNEP-TUNE\nNone\nNone\nNone\nACCOLaDE\nNone\nNone\nNone\nOBLITAM\nNone\nNSAIvsNM\nEtudePL\nNone\nNone\nBTX0621\nNone\nSPOTSMA\nSPBT\nNone\nNone\nKITS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nECO-BIP\nNone\nNone\nTriMix-Ipi\nNone\nNone\nNone\nWESENS-OA\nUP FOR 5\nNone\nNone\nESVLSD\nNone\nREAL\nWELL\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nJ-POPS\nNone\nNone\nPROVALF-PCD\nNone\nNone\nNone\nVASCUORG\nNone\nCRIPES\nNone\nNone\nNone\nNone\nSHIFTPLAN\nCPB\nNone\nNone\nNone\nNone\nAKIpredValid\nNone\nNone\nNone\nNone\nMINT\nAIRE\nNone\nA-Brave\nNone\nNone\nACROPOSE\nNone\nNone\nSPIRIT SV\nNone\nNone\nTXA\nNone\nAURA\nNone\nNone\nNone\nNone\nBIOMIS-DIM\nBIPLONG\nNone\nNone\nMETRO\nNone\nNone\nNone\nPoD\nCHONI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMICS-Reduce\nNone\nNone\nNone\nNone\nNone\nTPRT-SIPS\nLASST\nSTAR-V\nNone\nNone\nNone\nNone\nNone\nOMCAT\nALPINIST\nNone\nNone\nREDUCE\nNone\nNone\nMR-O-MICS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCarniPrema\nNone\nRuxo-Sim-20\nNeupoNET\nNone\nNone\nWestPORTS\nNone\nTTT-AIS CHINA\nNone\nNone\nRCC\nNone\nNone\nNone\npain\nCGTOA\nEIHPOAKIAD\nNone\nNone\nPROFISCOV\nNone\nNone\nSTOP-STOMA\nG4\nNone\nMcCAVE\nEDITION II\nHip\nNone\nNone\nNone\nNone\nDMT BDR\nNone\nNone\nNone\nTEAM EFFORT\nNone\nNone\nFIBREC\nNone\nuChekBangla\nNone\nNone\nNone\nPROSE\nNone\nHCC-CAP\nPRIISM\nNone\nNone\nLeucineDBA\nGrannyFit\nSMART-HABITS\nWAVE\nOPTIDOSE\nOASIS\nPXF\nNone\nNone\nNone\nNone\nSEGATROM\nNone\nPACIFIC\nNone\nN16LND\nSAFT\nNone\nNone\nMOSAIC\nNone\nNone\nLiver-CG\nNone\nSTEP\nAVICOVID-3\nNone\nPONVACS\nNone\nADVANCE\nDERIVE\nNone\nRenaissance\nNone\nNone\nNone\nQUASAR\nNone\nNone\nNone\nNone\nNone\nPRECREST\nVIBE\nCOMPASS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPAAG\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBEAT\nNone\nNone\nNone\nPOD\nROTEM\nNone\nLAAC-SBI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPREVAIL\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCRISTAL\nNone\nGREAT\nNone\nNIH fracture\nNeoTPPF\nICU\nNone\nBOSCH1\nPROFILE 1001\nNone\nNone\nLASER-1\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFOOTFIT\nNone\nNone\nLabyDys\nNone\nBAFF/IL-17\nNone\nSENSeo-ADCY5\nNone\nMel-ImmAdj\nNone\nNone\nNone\nNone\nKYLEADSII\nPctIbfFKUI\nNone\nCHIMERA\nNone\nNone\nNone\nNone\nPainMusic\nPNBCP\nNone\nNone\nNone\nNone\nTANGO\nNone\nNone\nNone\nNone\nHelZinki\nIST_MG\nNone\nEGELY\nNone\nNone\nNone\nBABE\nNone\nNone\nSSS\nCORE-THROMB\nRACOST\nNone\nNone\nNone\nIL2 for GVHD\nNone\nNone\nNone\nNone\nVaxiRIS\nMOTION\nNone\nNone\nNone\nDDI\nNone\nNone\nNone\nProFluGP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCOBRA\nNone\nNone\nNone\nNone\nNone\nNone\nPROS-2\nDIRECT\nNone\nTAXIO\nHEMOSTIR\nNone\nLOGIC\nNone\nNone\nETH-TVT\nNone\nNone\nNone\nFICare\nNone\nAFX5931\nNone\nNone\nNone\nNone\nNone\nNone\nISAR-AF\nLixibrain01\nNone\nNone\nNone\nBOLERO-1\nHUM21469\nCOVID-19\nNone\nNone\nEARS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMHOPEEP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSILVER\nDisCOVID\nNone\nBaCyst\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTRANSLATE\nIRFARPC\nAdvanTIG-211\nNone\nNone\nTOUCH\nLearnaBlade\nNone\nNone\nNone\nNone\nMUSCA\nNone\nNone\nNone\nELECAPUN\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nASSIST\nNone\nNone\nNone\nNone\nNone\nSIGNATURE\nNone\nNone\nNone\nNone\nS55\nNone\nLSS of 4-SITE\nNone\nNone\nNone\nNone\nNone\nNone\nENOVA\nNone\nNone\nNone\nNone\nCOATS+\nNone\nNone\nNone\nTCM-P002\nNone\nEVAPAUR\nNone\nNone\nc-easie\nProbiotics\nTugela\nNone\nTCL\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRestriMIS\nNone\nNone\nNone\nHPPD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPCT\nNone\nNone\nCATAPULT\nNone\nNone\nNone\nNone\nNone\nNone\nFM\nNone\nNone\nNone\nBENZORT\nNone\nNone\nNone\nNone\nNone\nNone\nGBMC\nNone\nNone\nNone\nPOPOPO\nNone\nNone\nENDURANCE-5 6\nNSCLC\nNone\nPCA\nNone\nNone\nNone\nNone\nNone\nStrongplant\nNone\nNone\nNone\nNone\nEPIONE2\nNone\nNone\nNone\nNone\nPREAMA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nIELSG27\nNone\nNone\nEXJADE\nNone\nNone\nBCDBQCDWT\nNone\nSUPER-DMEK\nNone\nPARKGAIT-II\nNone\nNone\nNone\nNone\nNone\nABBT-GAD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMOP201109\nNone\nNone\nNone\nNone\nARTISTYK\nESPIROTAB\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSELECT\nNone\nNone\nNone\nNone\nPRECOMIN\nATELHO\nNone\nLINFOTAPE\nNone\nNone\nLOS\nNone\nREFORM\nNone\nNone\nNone\nSTAK-VKM\nPectusESC\nNone\nNone\nNone\nACTLIFE\nNone\nNone\nISS OBS T-001\nGERFHS\nNone\nPREMAVOIX\nNone\nNone\nNone\nAsperum\nNone\nDULCIS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCCGLC-009\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nVIRCH\nNone\nNone\nNone\nNone\nCRANFLAP\nNone\nNone\nNone\nNone\nNone\nGAPcareII\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBARIASPERM\nNone\nMEMENTA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nmFOCUS\nNone\nNone\nNone\nMBCP\nNone\nSUBQ-Pilot\nREVEAL\nNone\nNone\nNone\nNone\nNone\nRObese\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNeCTuR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nDAP-SPEED\nICE T-TIMI 49\nNone\nNone\nNone\nFLMGM\nNone\nNone\nNone\nBMIG\nSWIPER-HEALTH\nOPTIMISE\nNone\nNone\nNone\nPUMA\nNone\nNone\nNone\nNone\nNone\niCANACP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n4477\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nVISIBLE\nNone\nNone\nWOMAN\nRICE\nNone\nTALC\nNone\nNone\nNone\nNone\nCervixLimburg\nKISS\nSTAR-LS\nNone\nNone\nNone\nSprintSCI\nNone\nNone\nNone\nNone\nNAFTnet RHD\nNone\nNone\nNone\nPROMART\nNone\nNone\nmetaverse\nNone\nNone\nNone\nIAHAI\nNone\nNone\nWCE-IDA\nNone\nORCHID-1\nNone\nGP and Band\nNone\nONCO-CHATBOT\nNone\nNone\nNone\nSDC\nNone\nNone\nREALS\nNone\nNone\nSR-SD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSYMPHONY\nNone\nDISCUSS\nNone\nStart\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPReCISE\nNone\nNone\nPENGUIN\nNone\nNone\nNone\nBrasthesis\nNone\nSHUTUP\nNone\nNone\nNone\nCONTAIN\nNone\nNone\nNone\nNone\nACTI-PARK\nIRCATT\nNone\nNone\nNone\nNone\nNone\nNone\nMINIMAX\nNone\nNone\nDDP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n03\nNone\nNone\nNone\nGEMINI ACS 1\nNone\nNone\nABAP\nNone\nHSV1/HCV\nNone\nNone\nORIENTIMPLANT\nNone\nNone\nNone\nNone\nNone\nALMA; LIMA\nNone\nISINODAT\nNone\nNone\nNone\nHI-DEF\nNone\nNone\nPROVEIR_1\nNone\nProFEIBA\nNone\nREPAIR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBAFF\nTOGETHER\nST20-P2T\nEVEREST-2\nNone\nNone\nASPER\nNone\nNone\nNone\nCOPILOT\nNone\nAndrosi-Test\nNSAC\nNone\nNone\nURIPRENE\nNone\nNone\nAI\nSPICE\nNone\niDEFCO\nBG\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSA02\nNone\nNone\nNone\nNone\nNone\nVREA\nPANC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEAPER-P\nNone\nNone\nNone\nMISTIC\nNone\nNone\nNone\nNone\nNone\nBacteriocide\nWild Blueberry\nREMOVE\nCryo-Nodule\nNone\nNone\nNone\nNone\nNone\nNone\nPARKINSUN\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEPIONE\nNone\nNone\nVAPO\nNone\nNone\nF&C\nCMV-ACE/ASPECT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nT2TRAonSSDM\nNone\nNone\nISEOP\nNone\nSTOPCAV\nNone\nNone\nREFIT\nOM3LES\nTelefisio\nNone\nNone\nNone\nNone\nNone\nUniRer\nNone\nNone\nNone\nALCINA4\nNone\nNone\nSLEEVE\nNEPFAR\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nASTRHA\nPCa_LS\nNone\nNone\nNone\nNone\nTRASMETIR\nNone\nNone\nNone\nNone\nEPAG2015\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRAhealing\nNone\nNone\nSarcomaPDX\nNone\nNone\nMOSET-SCI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nChallengeII\nNone\nNone\nNone\nBLUEPRINT\nNone\nNone\nNST\nDASSOH\nNone\nNone\nPosterior Disk\nNone\nADVANCE\nNone\nNone\nNone\nNone\nNone\nNone\nSLD3\nNone\nNone\nNone\nNone\nSKYPE2\nDiaanaRCT#2\nNone\nNone\nKETOMDD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEMBRACE\nNone\nNone\nNone\nEPMCS-CA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCovid-19-Abs\nNone\nNone\nMIRACI\nNone\nNone\nNone\nNone\nNone\nNone\nHAPPY\nBIDI-MONO\nNone\nNone\nToothpowder\nXeomin\nINS\nNone\nNone\nNone\nWeigh Smart\nNone\nNone\nNone\nNone\nACCESS\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nStrokecopilot\nNone\nSCIMAG\nNone\nNone\nFDFDR\nNone\nMISSION\nEDUCESCARRES\nBOLT-BMT\nNone\nNICUM\nNone\nVEDIPEDI\nNone\nFD-TACT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMAVERIC US\nSURViVOR\nBJCH-MM-0624\nNone\nNone\nHIV ZIP\nNone\nNone\nNone\nNone\nFODMAP2019\nNone\nAMOSS\nNone\nNone\nSIM-HF\nNone\nNone\nNone\nNone\nAdipoSCAR\nGeoMETry-C\nNone\nNone\nADSMP-C\nNone\nNone\nBADGE-PD\nNone\nCANAB I\nAXEL\nPRESA\nNone\nNone\nNone\nNone\nMedstarBC2\nNone\nNone\nNone\nNone\nPoTrRec\nNone\nNone\nLAM-PH\nNone\nIMP\nMONAVI-1\nNone\nNone\nNone\nNone\nR2\nNone\nNone\nNone\nPASSION\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nGen-Ex\nRALNOVO\nNone\nNone\nNone\nNone\nICDP RCT\nBACTERIB\nNone\nNone\nNone\nCORRECT\nEARTH\nNone\nNone\nNone\nPACIFIC-8\nNone\nNone\nNone\nCURVE-PD\nHELP Vets\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEFESO\nNone\nStoMakker\nGISTs\nNone\nADHD\nNone\nCPVA-PAF\nNone\nDROP\nNone\nDEWI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFoodRx\nNone\nNone\nNone\nNone\nNone\nCOVHYP\nNone\nNone\nINTERFACE\nNone\nNone\nAPH204\nNone\nNP137\nNone\nNone\nNone\nPOP-REMIND\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nRevacom HD\nNone\nSpeedwheel\nNone\nHISTORY\nNone\nNone\nNone\nNone\nSUUBI\nNone\nNone\nDiabetes MAP\nECAL\nPREDICT\nNEW DAY\nCIMcare\nFAMKOL\nNone\nNone\nOPTICARE\nNone\nSIRAC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nENSATI\nNone\nNone\nNone\nMBMM+\nNone\nNone\n3 4-DAP\nDouleur IRMf\nRECOMPENSE\nCONSCIOUS-3\nNone\nBHCOEMobi\nNone\nNone\nNone\nNone\nNone\nNone\nBRiTE\nMCLPIII\nNone\nNone\nNone\nNone\nNone\nCOMBINE\nNone\nNone\nNone\nNone\nNone\nGATE\nNone\nBEL\nTrans\nNone\nPEPS-MIT\nNone\nSurgMelMet\nNone\nNone\nNone\nNone\nTBI\nFAIRTOP\nGlutaTour\nCOPTSD\nIFM2012-03\nNone\nNone\nNone\nHEPP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nGRECogVASC\nSAFE-PCI\nNone\nNone\nPASART-1\nNone\nNone\nMelAASarc\nNone\nNone\nNone\nNone\nNone\nNone\nCAREFOL-HT\nNone\nNone\nNone\nNone\nFusionVAC22\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nACORES-2\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFREGAT\nNone\nPHCVM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTREND\nNone\nketamine\nRESET2pilot\nNone\nNone\nPrE0505\nST2OMP\nNone\nATI-DM2\nBLaDE\nNone\nNone\nPUME\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCOMFORTATTOO\nNES\nADME\nI-SCREEN\nNone\nGRAPE\nTAILARS\nPower\nNone\nNone\nNone\nNone\nS-CURE\nNone\nNone\nCHOICE\nSLI:COGGEN\nNone\nMODIFY\nNone\nCaphosol\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNBMI-Hg-COL\nNone\nNone\nPICTURE\nNone\nNone\nTPExtreme\nASSAM\nVolatolome\nNone\nNone\nNone\nNone\nSisonke\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSMARTDESK-MX\nNone\nNone\nNone\nNone\nPOCOR\nNone\nTapPro\nNone\nNone\nVIP\nNone\nNone\nNone\nGIST\nNOCIP\nNone\nNone\nmyOpportunITy3\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nBetaNOL\nNone\nNone\nNone\nNone\nNone\nCQR-F\nNone\nNone\nPREMAQUICK\nAIRSTIM\nNone\nCEPPPIA\nNone\nNone\nSTARS\nNone\nNone\nPREDiCTc\nMS-MIDY\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nESTCTFLC\nNone\nNone\nNone\nNone\nNone\nMUF\nNone\nNone\nEMMA\nNone\nAPBI\nNone\nNone\nNone\nNone\nNone\nDEVICE\nNone\nNone\nNone\nNone\nNone\nRECADE\nNone\nRING\nNone\nNone\nNone\nBREADFRUIT\nNone\nNone\nNone\nNone\nNone\nNone\nTicTac\nCOPE\nERADICATE Hp\nNone\nNone\nNone\nNone\nLIMIT\nNone\nNone\nTERM-COG\nNone\nNone\nI-CONIC\nTAMBE\nINVITE\nNone\nNone\nNone\nAUTO-ACUSAR\nNone\nNone\nNone\nVISLISI\nNone\nNone\nNone\nNone\nNone\nFOREST\nNone\nNone\nNone\nNone\nNone\nADHD\nNone\nNone\nCRADLING\nCUV102\nNone\nADAPT NXT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nE-COCCON\nDESIOP\nNone\nNone\nNone\nNone\nNone\nFLORA-01\nNone\nNone\nNone\nEMPHENE\nNone\nNone\nCLASS-MS\nNone\nDEPIPOMP1\nNone\nNone\nNone\nNone\nNAC\nULTIMATE\nPedVacc002\nNone\nNone\nNone\nNone\nAWAKECMACTRA\nNone\nNone\nNone\nNone\nNone\nNone\nFM\n+Vida\nNone\nR21 HL-110044\nNone\nDISAPEAR\nNone\nNone\nEXTUBPOS\nDITPA\nNone\nCORAL\nNone\nNone\nNone\nNone\nNone\nCOPEFER\nTICO\nFoliglurax\nTACACS\nNone\nNone\nTBcontact\nNone\nBRAIN-ICU\nBE HEARD EXT\nNone\nNone\nNone\nCREATIVE\nNone\nNone\nNone\nIA3\nTENS\nNone\nSCB-2019\nNICE\nNone\nCAMOMILLE\nSIT-UP\nNone\n(CAPP)\nNone\nNone\nNone\nNone\nNone\nMemoryXL\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFLPOD24\nIBeTA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nLIMMITLESS\nNone\nCARxALL\nNone\nNone\nNone\nPICC\nMACH\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPARO\nNone\nCNP\nNone\nNEXSCOT\nINVOPE\nROTATE\nNone\nNone\nNone\nMANTA-RAy\nNone\nNone\nNone\nHypnoCrohns\nNone\nAXIPAP\nNone\nNone\nCCCRDQ\nNone\nCLI-Pre/Post\nNone\nDYNAMO\nMoMM\nPREUV\nNone\nVIISTA\nNone\nNone\nNone\nNone\nNone\nCOGNIPOST\nNone\nNone\nNone\nNone\nNone\nNone\nPEDIALOCK\nNone\nNone\nNone\nDRIP-AHF-1\nNone\nNone\nNone\nNone\nNone\nNone\nAUGUST I\nNone\nNone\nNone\nNone\nNone\nNone\nLOVS\nNone\nNone\nNone\nNone\nNone\naHUS\nNone\nNone\nNone\nNone\nNone\nNone\nCLINCH\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nmimi\nNone\nNone\nNone\nART-AD\nNone\nNone\nERI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOAR\nCASALEAP\nNone\nNone\nNone\nNone\nNone\nmicroDRIVE\nNone\nCS\nNone\nMICRA-SYNK\nNone\nNone\nNone\nRUGBYPROS100B\nNone\nNone\nNone\nCONCORDIA\nNone\nNone\nNone\nSHE-WOMEN\nNone\nNone\nNone\nREPS\nNEOBRAIN\nNone\nHFU-60\nNone\nNone\nNone\nNone\nNone\nCAPRI\nNone\nNone\nNone\nNone\nMPFS-2\nNone\nNone\nNone\nNone\nBIOTIPRA\nNone\nPreColo CU\nNone\nACO-Registry\nNone\nHRCSDBD\nNone\nPHASE\nIVIIRun\nNone\nSEPIA-ACS1\nNone\nNone\nCiPP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nHEB-PEP\nSTART\nNone\nNone\nNone\nNone\nNUTRICARE\nNone\nBMAC\nPEPuP\nNone\nRCT\nARIMTIA\nSTEREOplus\nNone\nNone\nNone\nNone\nTAP-LT\nNone\nNone\nNone\nCenturion\nNone\nNone\nNone\nETOS\nEgyCleft\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nGBRAM003r\nUSETT\nNone\nNone\nPROSTEPIRM\nVancoDATABayes\nNone\nNone\nNone\nNone\nSTIMSYM\nProFATE\nNone\nMRgFLA\nNone\nASPEGIC\nNone\nNone\nNone\nTDAH-DRM\nNone\nNone\nDARE-Bands\nNone\nTRIMOSH\nEXERT\nNone\nNone\nNone\nNudge\nNone\nFAB\nNone\nMTB\nNone\nNone\nMAESTRO\nNone\nNone\nTAHOE\nNone\nNone\nGERIOX\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nOR1\nAURAChinaPK\nNone\nNone\nNextcare_CCP\nCOSTA\nEarly Steps\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSWYW\nGERTRUDE\nST3P-UP\nO2MATIC\nNone\nNone\nNone\nNone\nNone\nUWFARVO\nNone\nNone\nPerFix\nNone\nNone\nNone\nCTCL\nNone\nNone\nNone\nNone\nMUSCLE-CLIM\nNone\nHIFU\nNone\nGBDAL-HF\nNone\nEIT\nSILQ\nQUAOBARE\nFISK2\nNone\nNone\nNone\nNone\nCOVIDOSE\nNone\nNone\nNone\nGOLD\nNone\nTELENS-ED\nOVID RAF\nNone\nI-PAP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTACE-Ax-HCQ\nNone\nCMAG\nNone\nICAN\nNone\nNone\nBXO\nRegoRec\nNone\nLightEyeBD\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\neMOB\nVACCINATE\nNone\nNone\nNone\nNone\nPHACS\nADOPTS\nNone\nELOM\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nALLIANCE\nNone\nNone\nREchoPP\nNone\nNone\nNone\nNone\nNone\nMind-VR\nBEAT OLE\nNutriCAPE\nPTKP\nElidel-SEA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNIHaW\nQorRecCath\nNone\nNone\nNone\nNone\nNone\nPoEMS\nNone\nCEL-02\nNone\nNone\nNone\nCROWD\nNone\nNone\nIndigo\nBP\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAMVISION-1\nPresage-SPSI\nNone\nNone\nNone\nNone\nNone\nCORAL-I\nNone\nTREVI\nNone\nEGO\nNone\nMONITOR- GAC\nNone\nNone\nNone\nSARUTI\nNone\nPESALI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSMART\nEPI-MAL-003\nMAP HIS HF\nITP-RITUX\nNone\nADL\nMIC\nNTAH-Mod\nMACROS2\nWINGMEN\nNone\nNone\nNone\nDPS in ALS\nNone\nNone\nCYCLO1\nNone\nISALP\nNone\nNone\n20089/Combo\nSCLEROPIDEVOL\nNone\nNone\nNone\nNone\nMARIPOSA-2\nCTC-Poumon\nMOLT\nNone\nNone\nNone\nNone\nLHIV\nI-RIM\nFBW-ICU\nNone\nNone\nNone\nUMA\nIUI\nNone\nARTS\nNone\nHENIVOT2\nNone\nNone\nNone\nNone\nSESA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCNXR-001D\nPREVENT\nLCNEC-ALPINE\nINCIMO\nIC3\nNone\nNone\nFAMILY\nATTEMPT\nNone\nNone\nECHOSCAN\nNone\nNone\nBS-Women\nNone\nNone\nNone\nBVAC19\nNone\nNone\nNone\nNone\nNone\nNone\nRapid Vitiligo\nNone\nAQUA\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPMVI-PiP\nNone\nNone\nNone\nNone\nSHARP\nNone\nNone\nSBHC\nNone\nNone\nTHA\nSTROBE\nNone\nB-AC3\nNone\nNone\nAiRPM\nNone\nNone\nNone\nUTOPIE\nNone\nNone\nNone\nNone\nSCARCE\nGOCSM\nNone\nNone\nColo-SENSIUM\nNone\nNone\nNone\nRIPAL\nOrigAMI-1\nNone\nNone\nNone\nNone\nNone\nIOPA\n(SEM)\nNone\nNone\nNone\n5LGr\nNone\nNone\nNone\nNone\nNone\nNone\nAim 3\nNone\nNone\nNone\nCABRI\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nALAQ\nSE2020\nNone\nTelex\nNone\nNone\nPRACTICE\nCHCI\nDECIDE\nNone\nPneumococci\nNone\nNone\nADAPT\nHiGUS\nACCEPT\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the third column from each row of the final RDD filtered_rdd_with_header\n",
    "\n",
    "acronym = filtered_rdd_with_header.map(lambda row: row[2])\n",
    "\n",
    "# Display the first column values\n",
    "for value in acronym.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "367cf3dc-e311-4529-92fe-e9d5e4382660",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "No other values found.\n"
     ]
    }
   ],
   "source": [
    "# I guess, as per I looked into the dataset, the List of expected values in the fourth column are:\n",
    "expected_values = {'Status', 'COMPLETED', 'ACTIVE_NOT_RECRUITING', 'RECRUITING', 'NOT_YET_RECRUITING', 'UNKNOWN', 'WITHDRAWN', 'NO_LONGER_AVAILABLE', 'ENROLLING_BY_INVITATION', 'SUSPENDED', 'AVAILABLE', 'WITHHELD', 'TEMPORARILY_NOT_AVAILABLE', 'APPROVED_FOR_MARKETING','TERMINATED'}\n",
    "\n",
    "# Convert the set of expected values to an RDD\n",
    "expected_values_rdd = sc.parallelize(expected_values)\n",
    "\n",
    "# Extract the values of the forth column from each row\n",
    "status = filtered_rdd_with_header.map(lambda row: row[3])\n",
    "\n",
    "# Check for values other than the expected ones\n",
    "other_values_rdd = status.subtract(expected_values_rdd)\n",
    "\n",
    "# Collect the other values found\n",
    "other_values = other_values_rdd.collect()\n",
    "\n",
    "# Print any other values found - just to make sure that only these values are coming in the forth column - status\n",
    "if other_values:\n",
    "    print(\"Other values found:\")\n",
    "    for value in other_values:\n",
    "        print(value)\n",
    "else:\n",
    "    print(\"No other values found.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "cd9abd82-88c2-43a8-8005-89546479c2c7",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Conditions\nMental Health Issue (E.G. Depression Psychosis Personality Disorder Substance Abuse)\nCerebrovascular Function|Cognition\nMyocardial Infarct|Hyperglycemia\nDecompensated Cirrhosis|Liver Transplantation\nHypertension|Treatment Adherence and Compliance|Digital Health\nSmoking|Alcohol Drinking|Prescription Drug Abuse|Substance-Related Disorders|Oral Intake Reduced\nAlcohol Dependence|PTSD\nAlcohol; Harmful Use|Binge Drinking|Risk Behavior|HIV Infection\nSmoking Cessation\nGlioma|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Melanoma|Sarcoma\nHyperhidrosis\nJuvenile Myoclonic Epilepsy\nHIV Infections\nWellbeing|Health Attitude|Quality of Life\nCoronary Artery Disease\nProgressive Multiple Sclerosis\nObstructive Sleep Apnea Syndrome\nCoronavirus Infection\nRegistered Nurses|Nursing Personnel|Motor Skills\nKidney Cancer\nTreatment Resistant Depression\nSepsis\nInflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Autoimmune Diseases\nEgg Allergy|Cow's Milk Allergy\nPrimary Open Angle Glaucoma|Ocular Hypertension\nLaparoscopic Surgery|Pneumoperitoneum\nUnspecified Childhood Solid Tumor Protocol Specific\nHealthy|Obesity\nColorectal Cancer|Lymph Node Metastasis\nOveractive Bladder|Renal Colic|Pain Postoperative\nCervical Cancer|Cervical Intraepithelial Neoplasia\nHCC\nCardiovascular Disease\nHeart Failure|Levosimendan|Efficacy|Safety\nPolycystic Ovary Syndrome|c Type Natriuretic Peptide|Menstrual Irregularity|Hyperandrogenism\nDiabetes|Covid-19\nBurn Scar\nAnorexia Nervosa|Healthy\nPolycystic Ovary Syndrome\nLymphoma\nHip Pain Chronic\nGlaucoma\nElderly People\nHealthcare Workers|COVID-19|SARS-CoV 2\nCongenital Glaucoma\nDiabetic Foot Ulcers\nCancer\nTesticular Germ Cell Tumor\nData Collection\nAcute-On-Chronic Liver Failure\nMyocardial Injury\nFatigue\nBronchiectasis\nHypertension|Chronic Kidney Diseases\nHealthy Male Subjects\nEmergencies\nAllergy|Immunoglobulin E-Mediated Allergic Disorder\nGynecologic Cancer\nEndotracheal Intubation\nPROSTATE CANCER\nCerebral Blood Flow\nCardiovascular Diseases\nHematopoietic Neoplasm\nLung Diseases|Lung Diseases Obstructive|Chronic Obstructive Pulmonary Disease\nGastritis|Functional Dyspepsia\nErosive Hand Osteoarthritis\nEpisodic Memory\nPrimary Hyperparathyroidism\nPhysical Activity\nNasopharyngeal Carcinoma|Nasopharyngeal Cancer|Nasopharynx Cancer\nUretro-pelvic Junction Obstruction|Poorly Function Kidney\nCiguatoxin\nChronic Low-back Pain\nSchizophrenia|Schizoaffective Disorder|Schizophreniform Disorder\nRecurrent Cystitis\nRetinal Vascular Disorder|Macular Degeneration\nCoronary Artery Bypass\nObesity|Anaesthesia\nCancer\nUrinary Incontinence\nInfertility\nProblem Behavior\nType 2 Diabetes Mellitus\nPeriodontitis\nObesity|Multiple Chronic Conditions\nSmoking Cessation\nCarer Stress Syndrome\nParkinson's Disease\nGlioblastoma\nSystemic Lupus Erythematosus\nAuditory Brainstem Response\nVaginal Hysterectomy\nRenal Cell Carcinoma|Metastatic Renal Cell Carcinoma|Oligoprogressive|Progression\nOsteoarthritis|Knee Osteoarthritis\nIrritable Bowel Syndrome\nVaccine Reaction\nEndurance Cycling Performance\nHead and Neck Squamous Cell Carcinoma\nRelapsing-remitting Multiple Sclerosis\nMental Health Issue\nHepato Cellular Carcinoma (HCC)\nPain|Quality of Life\nComplicated Skin and Structure Infection|Nosocomial Pneumonia\nCABG|Valve Surgery\nLymphoma\nHypothyroidism\nEcology of Nontubercuous Mycobacteria|Geneva Area\nInguinal Hernia\nExtravasation Injury|Infant Premature Diseases\nOsteo Arthritis Knee|Chronic Pain\nMetastatic Colorectal Cancer\nDiabetic Retinopathy\nBMI|General Demographics Characteristics\nHepatocellular Carcinoma\nKnee Osteoarthritis\nResistant Hypertension\nHepatitis C Virus Infection\nObsessive-Compulsive Disorder|OCD\nFatty Liver\nDuchenne Muscular Dystrophy\nAcute Myeloid Leukemia\nPost-traumatic Osteoarthritis\nVaginal Birth After Cesarean Section\nPreeclampsia Postpartum\nInsomnia\nHepatocellular Carcinoma\nBreast Neoplasms\nObstructive Sleep Apnea Syndrome\nAge-related Macular Degeneration|Central Retinal Vein Occlusion|Diabetic Macular Edema\nCryptosporidiosis\nDelirium|Cognitive Impairment|Health Subjective|Sleep\nHead Lice\nGynecologic Cancer\nChronic Neuropathic Pain Postoperative|Chronic Pain Postoperative|Chronic Chemotherapy-induced Neuropathic Pain|Chronic Chemotherapy-induced Pain|Chronic Chemotherapy-induced Peripheral Neuropathy\nNeoplasm Metastasis|Gastric Cancer|Colorectal Cancer\nPosttraumatic Stress Disorders\nCOVID-19\nChild|Development\nStroke\nLower Limb Amputation Below Knee (Injury)|Lower Limb Amputation Above Knee (Injury)\nSudden Infant Death|Sudden Unexplained Infant Death\nCVA (Cerebrovascular Accident)\nHIV/AIDS|PrEP\nAtrial Fibrillation|Stroke|Transient Ischemic Attack|Bleeding|Aortic Stenosis\nHepatitis D\nALS (Amyotrophic Lateral Sclerosis)\nPituitary Adenoma\nPhysical Fitness|Technical Skills\nAsthma\nCandidemia|Candidiasis\nRecurrent Hodgkin Lymphoma|Refractory Hodgkin Lymphoma\nBurnout Student|Stress Psychological|Compassion|Self-Perception\nBreast Cancer\nNon-Hodgkin's Lymphoma\nAdvanced Breast Cancer\nInfection Intra-abdominal\nAltered Passive Eruption of Teeth\nProstatic Hyperplasia\nPartial Edentulism\nSpinal Cord Injuries\nCoronary Artery Disease\nMental Disorders\nNon-Small Cell Lung Cancer Stage|Chemoradiation\nLiver Cirrhosis|Chronic Hepatitis B\nBenign Prostatic Hyperplasia\nGlioma\nCholangitis\nLeft Bundle-Branch Block\nContraceptive Usage\nLumbar Disc Herniation|Lumbar Traction|Spinal Manipulation|Lumbar Surgery\nFacial Rhytidectomy (Face-lift)\nRefractive Error\nChest Pain|Gastrointestinal Reflux Disease\nRenal Cell Carcinoma|Pulmonary Metastases\nHIV Infections\nAnesthesia Local|Office Hysteroscopy\nRenal Failure|Sleep Disorder|Hemodialysis|Peritoneal Dialysis\nFeasibility\nAnterior Cruciate Ligament Injuries|Anterior Cruciate Ligament Rupture|Anterior Cruciate Ligament Tear\nType 2 Diabetes Mellitus\nCarcinoma Non-Small-Cell Lung\nEnd Stage Renal Disease\nHealthy|Plaque Psoriasis\nPain|Chronic Widespread Pain|Fibromyalgia\nPeripheral Arterial Disease\nDivorce|Drug Abuse|Mental Health Disorder\nHIV Infections|Proteinuria\nDiabetes Type 1\nParkinson Disease\nOvarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms\nThyroid Eye Disease\nLocally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)\nAtypical Endometrial Hyperplasia|Stage I Uterine Corpus Cancer AJCC v7|Stage IA Uterine Corpus Cancer AJCC v7|Stage IB Uterine Corpus Cancer AJCC v7|Stage II Uterine Corpus Cancer AJCC v7\nCOVID-19\nObstructive Sleep Apnea\nHemodialysis Access Failure|Hemodialysis Complication\nDiabetic Foot\nAnxiety\nSystemic Sclerosis\nTorn Menisci\nAnesthesia General|Recovery Period Anesthesia\nHealthy\nColorectal Cancer\nCoronary Artery Disease\nPneumonia Caused by Human Coronavirus (Disorder)\nSubstance-Related Disorders\nRenal Impairment\nLow Back Pain\nDiffuse Large B-cell Lymphoma Recurrent|Diffuse Large B Cell Lymphoma Refractory\nChronic Sinusitis\nPTSD|Chronic Pain\nStroke\nOcular Inflammation\nLynch Syndrome\nSubtalar Arthrorisis|Flat Feet|Growth Age\nOsteoarthritis\nNeurological Disorders\nInformal Caregivers\nHypothyroidism|Hyperthyroidism|Obesity\nCarotid Artery Plaque\nMild Cognitive Impairment (MCI)|Alzheimer's Disease (AD)|Significant Memory Concern (SMC)|Early Mild Cognitive Impairment (EMCI)|Late Mild Cognitive Impairment (LMCI)\nHiatal Hernia Large|Gastro Esophageal Reflux|Hiatal Hernia|Hiatal Hernia Paraesophageal|Reflux Gastroesophageal|Reflux Acid\nIdiopathic Pulmonary Fibrosis\nCommunication|Back Pain\nHepatocellular Carcinoma (HCC)\nAllergic Rhinitis Due to Grass Pollen\nThymic Carcinoma|Thymoma\nThrombotic Microangiopathies|Thrombotic Thrombocytopenic Purpura\nPelvic Organ Prolapse\nLung Cancer\nBipolar Disorder\nNeck Pain\nMetastatic Non-Squamous Non-Small Cell Lung Cancer\nChronic Pain|Spirituality\nLung Cancer|Lung Cancer Metastatic|Lung Cancer Non-small Cell\nMultiple Myeloma\nAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome|Chronic Myelomonocytic Leukemia|Previously Treated Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes|Recurrent Adult Acute Myeloid Leukemia\nNon-Hodgkin's Lymphoma\nAortic Regurgitation\nScoliosis\nBreast Neoplasms\nHabitual Snoring\nSarcopenia|Frailty\nSoft Tissue Injuries\nRespiratory Failure With Hypercapnia\nHIV|Latent Tuberculosis\nArthroplasty|Hemiarthroplasty|Shoulder Pain\nMultiple Myeloma\nComplex Regional Pain Syndrome I (CRPS I)\nHypertension\nNephrotic Syndrome in Children\nMultiple Disability\nAnatomic Stage I Breast Cancer AJCC v8|Anatomic Stage IA Breast Cancer AJCC v8|Anatomic Stage IB Breast Cancer AJCC v8|Anatomic Stage II Breast Cancer AJCC v8|Anatomic Stage IIA Breast Cancer AJCC v8|Anatomic Stage IIB Breast Cancer AJCC v8|Anatomic Stage III Breast Cancer AJCC v8|Anatomic Stage IIIA Breast Cancer AJCC v8|Anatomic Stage IIIB Breast Cancer AJCC v8|Anatomic Stage IIIC Breast Cancer AJCC v8|Grade 1 Peripheral Motor Neuropathy CTCAE|Grade 1 Peripheral Sensory Neuropathy CTCAE|Grade 2 Peripheral Motor Neuropathy CTCAE|Grade 2 Peripheral Sensory Neuropathy CTCAE|Prognostic Stage I Breast Cancer AJCC v8|Prognostic Stage IA Breast Cancer AJCC v8|Prognostic Stage IB Breast Cancer AJCC v8|Prognostic Stage II Breast Cancer AJCC v8|Prognostic Stage IIA Breast Cancer AJCC v8|Prognostic Stage IIB Breast Cancer AJCC v8|Prognostic Stage III Breast Cancer AJCC v8|Prognostic Stage IIIA Breast Cancer AJCC v8|Prognostic Stage IIIB Breast Cancer AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8\nDiet Modification|Insulin Resistance|Hyperinsulinemia\nCeliac Disease\nCoronary Artery Disease\nMRSA Infection|Bacteremia|ABSSSI|Pneumonia\nHand Osteoarthritis\nGastric Varices Bleeding|Liver Decompensation\nLow Birth Weight|Infant Mortality|Pregnancy|Nutritional Status\nCholecystitis Acute\nGingivitis|Plaque\nPain\nEssential Thrombocythemia\nPostoperative Ileus|Bowel Paralysis\nAtrial Fibrillation\nChemotherapy|Exercise\nChildhood Obesity\nPeripheral Artery Disease\nChronic Kidney Disease\nAllergic Rhinitis\nInterstitial Pneumonia|Neoplasms Malignant\nLow Anterior Resection Syndrome|Rectal Cancer\nCataract\nMultiple Sclerosis\nMultiple Sclerosis\nPhysical Activity|Cancer|Hematologic Diseases\nCarcinoma Non-Small-Cell Lung\nArrhythmia|Children\nHypercholesterolemia|Hypertension\nAnxiety|Depression\nUrinary Tract Infection|Bacteriuria\nEmergency and Urgent Care Pathways\nPeriprosthetic Joint Infection (PJI)\nMedication Adherence|Kidney Transplantation\nNasal Polyps\nArrhythmias Cardiac\nTeen Drivers|Motor Vehicle Accidents\nRetention in Care\nSolid Tumor|Gastric Cancer|Breast Cancer|Ovarian Cancer|Sarcoma\nBreast Cancer\nMalaria\nProstate Cancer\nCancer|Fatigue\nStage III-IV or Recurrent Endometrial Cancer\nNecrotizing Enterocolitis|Sepsis\nSleep Apnea Syndromes\nInfluenza\nPlatelet Aggregation\nNon-small Cell Lung Cancer Stage III\nBladder Discomfort\nMalignant Glioma of Brain\nSmoking|Smoking Reduction|Electronic Cigarette Use\nADHD\nSmall Cell Lung Cancer\nNon-small-cell Lung Cancer\nMetastatic Adenoid Cystic Carcinoma|Progressive Disease|Recurrent Adenoid Cystic Carcinoma\nHealthy\nCataract\nArthritis Failure of Total Hip\nPrevention Harmful Effects\nMuscular Atrophy\nAKI|Sepsis\nSurgery|Pancreatic Tumour|Peri-ampullary Tumour|Blood Loss\nCirrhosis|Hepatic Encephalopathy|Ascites|Fatigue\nCancer\nDepressive Symptoms\nEwing Sarcoma of Bone\nPrimary Immunodeficiency|DOCK8|Virus Susceptibility\nRosacea\nHIV Infections|Alcohol Dependence\nDegenerative Disc Disease\nChildhood Obesity\nHelicobacter Pylori Eradication Rate\nHip Fractures|Complication of Traction Procedure|Pain|Splints\nRheumatoid Arthritis\nProstate Cancer\nColonic Polyp\nHealthy\nPreschool Severe Asthma\nEnthesopathy\nMalignant Glioma\nElevated Risk for Melanoma\nPrimary PCI - STEMI\nRheumatic Diseases\nCoronary Heart Disease\nHeadache\nRabies\nHIV Prevention\nMyopia\nBankart Lesion|Acetabular Labrum Tear|SLAP Lesion|Acromioclavicular Sprain|Capsular Shift/Capsulolabral Reconstruction|Deltoid Repair|Rotator Cuff Repair|Bicep Tendinitis|Extra-capsular Repair|Medial Collateral Ligament|Lateal Collateral Ligament|Posterior Oblique Ligament|IBT|Vastus Medialis|Obliquus Advancement|Joint Capsule Closure\nMeasles Vaccine|Hospital Admission|Mortality|Non-specific (Heterologous) Effects of Vaccines\nHealthy Volunteers\nMultiple Sclerosis\nCarcinoma Non-Small-Cell Lung\nInterdialytic Weight Gain|Fatigue\nCoenzyme Q10 Pharmacokinetics\nAlbuminuria\nBrain and Central Nervous System Tumors\nNeurotrophic Keratitis\nVisceral Steatosis|Hiv|NAFLD\nInfluenza\nCystic Fibrosis\nNon Small Cell Lung Cancer\nLymphoplasmacytic Lymphoma\nCoagulation Disorder\nLegg-Calvé-Perthes Disease\nHealthy Subjects With Different Constitutions\nDental Implant|Hydroxyapatite\nNon Small Cell Lung Cancer\nAsthma\nMental Disorders\nHepatocellular Carcinoma\nOvarian Hyperstimulation Syndrome|GnRH Antagonist|Aspirin|Vascular Endothelial Growth Factor|Pigment Epithelium Derived Factor\nEmphysema\nFallopian Tube Cancer|Ovarian Cancer|Peritoneal Cavity Cancer\nMyelodysplastic Syndromes|Leukemia Myeloid Acute|Multiple Myeloma|Leuklemia Lymphocytic Chronic\nFull Thickness Macular Hole\nCervical Cancer|Surgery|Quality of Life\nPeriodontitis|Polymorphism Restriction Fragment Length\nNon-small Cell Lung Carcinoma\nLeber Hereditary Optic Neuropathy\nIntemittant Continue Oxytocin\nALS\nAlcohol Dependence\nUnspecified Adult Solid Tumor Protocol Specific|Unspecified Childhood Solid Tumor Protocol Specific\nBulimia Nervosa\nAkathisia\nDiabetes Mellitus|Cardiovascular Diseases\nChronic Low Back Pain\nInfluenza\nEpidural Analgesia|Hospital Follow-up\nObesity|Overweight|PreDiabetes|Diabetes Mellitus Type 2|Risk Factor Cardiovascular\nAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid Leukemia With Del(5q)|Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)|Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)|Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)|Adult Acute Myelomonocytic Leukemia (M4)|Adult Erythroleukemia (M6a)|Adult Pure Erythroid Leukemia (M6b)|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia\nOsteoarthritis|Obesity\nProstate Cancer|Prostatic Neoplasms\nHypertension|Type II Diabetes Mellitus\nHeart Failure|Ventricular Fibrillation|Ventricular Tachycardia\nOpioid Use Unspecified|Pain Postoperative\nHealthy\nDepression|Healthy\nNone\nCOVID\nMalignant Tumor of the Ovary|XRCC2 Gene Mutation\nNausea\nMenopause|Postmenopausal Vaginal Atrophy\nPhenylketonuria\nAcute Decompensated Heart Failure|Sleep Disordered Breathing\nOsteosarcoma\nMitral Valve Insufficiency\nObesity\nWeight Loss|Hypertrophy\nAtrial Septal Defect|Pulmonary Hypertension\nPostural; Defect\nMalocclusion\nCardiac Surgery\nOpioid-Related Disorders|Benzodiazepine-Related Disorders|Falls Injury\nConnective Tissue Diseases|Right Ventricular Hypertrophy\nHepatitis C Chronic\nHealthy Subjects\nMyocardial Infarction|ST Segment Elevation Myocardial Infarction (STEMI)\nLeft Ventricular Function Systolic Dysfunction|Left Ventricular Function Diastolic Dysfunction|Death|Myocardial Reperfusion Injury\nDiabetes|Diabetes Mellitus Type 2|Healthy\nQuality of Life\nCopd|Emphysema|Hyperinflation\nHealthy\nActinic Keratosis\nSolid and Hematological Malignancies\nSeborrheic Dermatitis\nIsolated Cartilage Injury of the Knee\nDepressive Disorder|Coronary Disease\nDiabetes Mellitus Type 2\nOverweight\nPulmonary Disease Chronic Obstructive\nTardive Dyskinesia\nHealthy\nCOVID-19\nTranscatheter Aortic Valve Replacement|Hemodynamic Monitoring|Aortic Valve Insufficiency|Aortic Valve Stenosis|Heyde's Syndrome|Acquired Von Willebrand Disease\nTrigeminal Neuralgia\nInflammation\nHealthy\nThin Gingiva|Transverse Maxillary Deficiency|Cross Bite\nBrain Metastases From Breast Cancer\nPersistent Asthma\nVaginal Packing Following Pelvic Reconstructive Surgery\nAcromegaly\nDepression\nHealthy\nTelemedicine|Disaster Medicine|Emergency Medicine\nTuberculosis Pulmonary\nRestless Legs Syndrome\nFocus of Study: Neural Correlates of Oxytocin Administration\nHealthy Aging|Fall\nBlood Disease|Hemophilia A|Hepatitis Viral Human\nPulmonary Hypertension\nAcute Otitis Externa\nHealthy\nSleep Apnea\nPain\nLeukemia|Non Hodgkin Lymphoma\nWounds and Injuries|Health Promotion\nCystic Fibrosis\nNeurological Diseases\nDental Caries\nViral Hepatitis C\nRecurrent Glioblastoma Multiforme (GBM)\nDiabetic Macular Edema\nSepsis\nPelvic Fracture\nPregnant Women\nSerum Levels of ALAT Transaminases|Serum Markers for Fibrosis and Hepatic Inflammation\nPatellofemoral Joint Dislocation|Bicep Tendon Rupture\nDiabetes|Chronic Kidney Disease|Established Atherosclerotic Vascular Disease|Framingham Risk Score More Than 20 Percent\nCOVID-19\nType 2 Diabetes\nSnoring\nLabor Pain\nAtrial Fibrillation\nAcute Kidney Injury|Acute Renal Failure\nLymphedema of Upper Arm|Breast Cancer\nAsthma\nCrohn Disease\nAnalgesia\nSpinal Cord Diseases\nAspiration Pneumonia\nEmergencies|Trauma Injury|Trauma Multiple\nRifampicin-resistant Tuberculosis\nPoor Asthma Control\nIdiopathic Macular Holes\nEpilepsy|Idiopathic Generalized Epilepsy|Generalized Tonic Clonic Seizure\nPancreatic Cancer\nSchizophrenia\nGastric Cancer\n18-45 Range of Age|Cesarean Section|Primigravid\nIntensive Care Unit Patients\nSchizophrenia|Schizoaffective Disorder\nDifficult Intubation\nParkinson Disease\nPain Management|Simulation|Training|Ultrasonography\nMultiple Myeloma\nNeoplasms|Cancer|Parenting|Communication|Parents|Parent-Child Relations\nCoronary Artery Disease\nSchizophrenia\nIn Vitro Fertilization|Intracytoplasmic Sperm Injection|Infertility|Polycystic Ovary Syndrome\nAcute Coronary Syndrome\nPregnancy Prolonged|Pre Eclampsia|Oligohydramnios\nHeart Failure|Ventricular Remodeling|Ventricular Dysfunction\nOsteoarthritis of the Hip\nHeart Failure Diastolic\nDiabetes Mellitus|Overweight|Obesity\nAttention Deficit/Hyperactivity Disorder\nCrohn's Disease\nCannabis\nArteriovenous Malformations\nProstate Cancer\nColorectal Neoplasms\nSquamous Cell Carcinoma of the Head and Neck\nPain\nCongenital Abnormalities|Birth Defects|Congenital Defects\nParkinson Disease\nOpioid Sensitivity|Individual Difference|Abuse Opioids\nMetastatic Breast Cancer\nLaparoscopic Gynecological Surgery\nBreast Cancer\nBone Metastases\nRhinitis Allergic Seasonal\nBreast Tumors\nAge Related Macular Degeneration\nLiver Disease\nLung Cancer\nSleep Deprivation|Sleep\nType 2 Diabetes Mellitus\nHypersensitivity\nHospital-acquired Pneumonia\nSystemic Lupus Erythematosus\nBleeding|Hemorrhage\nPatella Dislocation\nAutism Spectrum Disorder|Anxiety\nRheumatoid Arthritis\nHormone Refractory Prostate Cancer\nComplication of Surgical Procedure|Leak; Blood\nHepatitis Chronic|Hepatitis C Virus\nAnkle Sprain|Ankle Injuries|Sprain\nRecurrent Glioblastoma\nTobacco Use Cessation\nHIV+ YMSM\nParkinson Disease\nProviding Care for People With Memory Problems\nHigh-type Anal Fistulae\nArthritis|Osteoarthritis|Osteoarthritis Hip\nLymphangioleiomyomatosis (LAM)\nRisk Behavior\nEsophageal Atresia\nCOVID-19\nLupus Erythematosus Systemic\nEnvironmental Enteric Dysfunction\nBody Weight Changes|Feeding and Eating Disorders of Childhood|Breast Feeding|Evoked Response Audiometry\nIdiopathic Pulmonary Fibrosis\nPeripheral Arterial Disease|Popliteal Artery Stenosis\nDietary Guidelines\nTrichotillomania\nScapula Fracture|Clavicle Fracture\nShoulder Pain|Musculoskeletal Diseases|Subacromial Impingement Syndrome|Shoulder Injuries and Disorders\nAsthma|Allergic Rhinitis\nArthroplasty Replacement Knee\nPreference Patient|Pharmacist-Patient Relations|Caregiver|Cancer\nChronic Idiopathic Thrombocytopenic Purpura|Helicobacter Pylori Infection\nPancreatic Cancer|Cholangiocarcinoma\nCoronary Heart Disease|Periodontitis\nMeningitis Meningococcal\nPeripheral Arterial Disease\nSchizophrenia|Schizo-affective Disorder\nBody Weight\nCoronary Heart Disease|Coronary Artery Disease|Ischemic Heart Disease\npH|Weight Gain\nImpingement Shoulder\nMacular Edema\nUnresectable Liver Metastasis of Colorectal Cancer\nCardiovascular Diseases|Atherosclerosis|Lipoprotein(a)\nGastrointestinal Diseases|Bone Diseases|Muscular Diseases|Spinal Diseases|Vascular Diseases\nPostoperative Pain\nUnrecognized Condition\nFever\nStress Psychological\nSchnitzler Syndrome\nHypertension\nRetinal Detachment Multiple Breaks\nHIV-infection\nAML in Remission\nLymphoma Follicular|Lymphoma Mixed-Cell Follicular|Lymphoma Small Cleaved-Cell Follicular|Lymphoma Low-Grade\nBreast Carcinoma|Breast Cancer|Stage 0 Breast Cancer|Stage I Breast Cancer\nAcute Leukemia\nNeoplasms|Social Skills|Psychological Distress\nIrritable Bowel Syndrome With Constipation|Chronic Idiopathic Constipation\nChronic Sinusitis|Adenoid Disease - Chronic\nGastric Adenoma and Early Gastric Cancer\nBenign Prostate Hyperplasia|Erectile Dysfunction\nMuscular Dystrophies|Muscle Inflammation\nHearing Loss\nLumbar Spinal Stenosis\nAtherosclerosis|Ischemia Limb|Superficial Femoral Artery Occlusion|Popliteal Artery Occlusion\nMetastatic Lung Non-Small Cell Carcinoma|Refractory Lung Non-Small Cell Carcinoma|Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8\nLymphoma Non-Hodgkin\nOveractive Bladder\nSurgical Site Infection\nHealthy\nObesity|Surgery|Metabolic Syndrome|Malnutrition\nMyofascial Pain|Temporomandibular Disorders\nRheumatoid Arthritis\nAppendicitis|Cholecystitis|Diverticulitis|Intra-Abdominal Abscess|Intra-Abdominal Infection|Peritonitis\nMajor Depressive Disorder\nOsteoarthritis\nBenign Prostatic Hyperplasia\nCardiac Surgery|Cardiopulmonary Bypass\nOtitis Media\nHyper-low-density Lipoprotein (LDL) Cholesterolemia\nNon Small Cell Lung Cancer\nLung Metastases|Tumor Necrosis\nMoyamoya Disease|Magnetic Resonance Imaging\nDissecting Aneurysm of the Thoracic Aorta\nSkin Diseases Infectious|Soft Tissue Infections\nAcute Upper Respiratory Infection|Fever\nOvarian Clear Cell Cystadenocarcinoma|Ovarian Endometrioid Adenocarcinoma|Ovarian Seromucinous Carcinoma|Ovarian Serous Cystadenocarcinoma|Ovarian Undifferentiated Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal Carcinoma\nPremature Birth of Newborn|Intervention Studies\nPediatric Solid Tumors\nCancer\nStroke|Depression\nRetinopathy of Prematurity\nPrimary Dysmenorrhea\nBenign Neoplasm of Vocal Fold - Glottis\nOrganic Erectile Dysfunction\nSepsis\nPre-Eclampsia\nColorectal Cancer\nConstipation|Dyssynergia\nCOVID-19|Emergency General Surgery\nRelapsing Multiple Sclerosis\nMedication Incidents\nCervix Cancer\nCognitive Function\nCrohn's Disease\nBariatric Surgery Candidate\nMucopolysaccharidosis I\nChronic Idiopathic Constipation\nB Cell Lymphoma\nMyopes Who Have Undergone PRK.\nCoronavirus Disease 2019\nBreast Neoplasm Female\nHIV Infections|Hypercholesterolemia|Antiretroviral Therapy\nOxygen Deficiency\nMetastatic Clear Cell Renal Cell Carcinoma\nMusculoskeletal Pain|Fear of Falling\nGlycemic Index\nRespiratory Syncytial Virus Infections\nAnterior Cruciate Ligament Injuries|Anterior Cruciate Ligament Rupture|Anterior Cruciate Ligament Tear\nB-cell Lymphoma|Non Hodgkin Lymphoma|DLBCL|Primary Mediastinal Large B Cell Lymphoma|Marginal Zone Lymphoma|Follicular Lymphoma\nRadiculopathy|Herniated Disc|Disc Degeneration\nAnemia\nOvarian Cancer\nHypertension\nMyasthenia Gravis\nDental Anxiety|Sedative; Anxiety Disorder\nPrader-Willi Syndrome\nPostoperative Pain\nTooth Loss\nFollicular Lymphoma|Marginal Zone Lymphoma\nAcute Respiratory Distress Syndrome\nVaginal Bleeding|Prolonged Pregnancy\nHealthy Aging\nCoronary Heart Disease|Stable Angina\nPrimary Immunodeficiency Diseases (PID)\nMetastatic Colorectal Cancer\nSarcopenia|Frailty\nAcute Traumatic Pain\nPolyp of Colon|Fistula\nPregnancy\nIschemic Stroke Acute|Thrombolysis|Endovascular Treatment\nErectile Dysfunction|Gender Dysphoria\nPhysical Deconditioning\nMetastatic Colorectal Cancer\nDiet Mediterranean|Antioxidant Effect|Body Weight|Cardiovascular Diseases|Densitometry|Body Composition\nCardiac Magnetic Resonance Imaging in Non Ischemic Cardiomyopathy\nBreast Cancer\nChronic Ankle Instability\nUlcerative Colitis\nBreast Cancer\nIschemic Optic Neuropathy\nGastrointestinal Dysfunction\nPediatric ALL\nChagas Cardiomyopathy\nInsomnia\nBreast Cancer\nBreast Cancer\nDiabetes Mellitus Type 2\nChronic Liver Disease With Tuberclosis\nCancer|Neuralgia\nMultiple Myeloma|Covid19|Corona Virus Infection\nPharmacokinetics\nAir Pollution\nMyoma\nDepression\nLung Cancer|Neoplasms Lung\nPulmonary Disease|Tuberculosis Pulmonary|Tuberculosis|Multi Drug Resistant Tuberculosis|Drug Sensitive Tuberculosis|Drug-resistant Tuberculosis|Mycobacterium Tuberculosis Infection\nKidney Transplant Infection|Kidney Transplant Rejection\nExercise Training|Executive Function|Aging\nNeurologic Disorder|Traumatic Brain Injury|Disorder of Consciousness\nPancreatic Neoplasms\nHIV Infections|Lymphoma AIDS-Related|Lymphoma Non-Hodgkin\nMethamphetamine-dependence|Postpartum Abstinence\nMelanosis\nShigellosis\nFunctional Psychoses|Informal Caregivers\nHead and Neck Neoplasms\nBlood Pressure\nEpilepsy\nSmoking\nInnate Immune Response\nAdolescent Dysmenorrhea\nGrowth Horm\n\n*** WARNING: max output size exceeded, skipping output. ***\n\noma AJCC v7|Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7|Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7|Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7\nDiabetes Mellitus\nTranscutaneous Electrical Nerve Stimulation|Blunt Pressure Pain|Pad Size|Pulse Frequency|Analgesia\nAnxiety Linked to the Surgery and / or Anesthesia\nCOVID-19\nClaudication|Peripheral Artery Disease\nDry Eye Disease\nMeningioma\nSuperficial Femoral Artery Occlusions\nColo-rectal Cancer|Recurrence\nCoronary Disease\nAnthrax\nFecal Incontinence\nCognitive Decline|Age Problem|Outcome\nCrystalline Cataract|Lens; Anomaly\nObesity\nMild Cognitive Impairment\nFibromyalgia\nCystic Fibrosis\nProstate Cancer\nMuscle Relaxants\nLeukemia Myeloid Acute\nObesity|Asthma\nPhantom Limb Pain|Residual Limbs|Amputation\nVertigo\nPancreatic Neoplasm\nRecurrent Squamous Cell Lung Carcinoma|Stage IV Squamous Cell Lung Carcinoma\nFollicular Lymphoma\nDiabetic Macular Edema\nCoronary Artery Disease\nRadiculopathy\nDiabetes Mellitus Type 2|Behavior Health\nCOVID-19|Long COVID|Pulmonary Fibrosis|Post-acute Respiratory Complications of COVID-19\nType 1 Diabetes|Continuous Glucose Monitoring|Hypoglycemia\nEnd Stage Liver DIsease|Complication\nPregnancy\nPsoriasis\nProstate Cancer|Anemia\nT-cell Acute Lymphoblastic Leukemia|Lymphoblastic T-Cell Lymphoma\nGeneralized Myasthenia Gravis\nAnesthesia\nAcute Coronary Syndromes\nComplications; Catheter\nIntracerebral Hemorrhage\nEpidermoid Cyst\nAdult Solid Tumor|Diffuse Large B Cell Lymphoma|Burkitt Lymphoma\nHealthy Volunteers\nCovid19|Acute Cor Pulmonale|Cardiac Failure\nTime Face to Face With Friends|Screen Media Use\nFrailty|Retrospective Study\nCoronary Artery Disease\nRare Diseases\nFlatfeet\nPediatric ALL|Critical Illness|Physical Therapy Modalities|Occupational Therapy|Animal Assisted Therapy\nRespiratory Distress Syndrome Adult\nNeck Pain\nObsessive-Compulsive Disorder\nNon-alcoholic Fatty Liver Disease|Nonalcoholic Steatohepatitis\nVaso-occlusive Crisis\nProximal Humeral Fracture\nCopd\nPain Acute|Opioid Use|Analgesia\nLung Transplant\nRheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis|Non-Radiographical Axial Spondyloarthritis\nPolypoidal Choroidal Vasculopathy\nAcne|Quality of Life\nHerpes Simplex Type 2\nPediatric Crohns Disease\nGlaucoma\nPapillary Renal Cell Carcinoma\nSternotomy\nPelvic Organ Prolapse|Normal Pelvic Floor\nChronic Kidney Diseases|COVID-19 Infection|Acute Kidney Injury|Chronic Renal Failure in Children|COVID-19 Pandemic\nPeripheral Artery Disease\nChronic Limb Ischemia|Non-Healing Ulcers\nEnd Stage Renal Disease\nHemophilia\nGestational Diabetes Mellitus With Baby Delivered\nAutonomous Subjects Aged 65 and Afraid of Falling\nBladder Carcinoma|Refractory Bladder Carcinoma|Urinary Tract Infection\nType 2 Diabetes Mellitus\nRenal Dialysis|Exercise\nRelapsed Ovarian Cancer\nPostoperative Pain\nObstructive Sleep Apnea|Excessive Sleepiness\nAnesthesia\nAttention Deficit|Mobility|Postural Activity\nCerebral Atherosclerosis\nRefractory Metastatic Colorectal Cancer\nStage IV Colon Cancer\n2D Speckle Tracking Echocardiography|Breast Cancer|Cardiac Magnetic Resonance\nCirrhosis|Muscle Cramp|Ascites\nLocalized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Neurotoxicity Syndrome|Pain|Regional Neuroblastoma|Stage 4 Neuroblastoma|Stage 4S Neuroblastoma\nChildren|Medical Device|Primary Prevention|Oncology\nPart I (SAD) - Healthy Participants|Part II (MAD) - Chronic Obstructive Pulmonary Disease|Part III (J-SD) - Healthy Japanese Participants\nEsophageal Cancer\nPTSD\nAcute Heart Failure|Chronic Kidney Diseases\nPre-diabetes\nPlaying Related Musculoskeletal Disorders\nMenstrual Cycle|Ovulation|Menstruation|Polycystic Ovary Syndrome|Infertility|Menopause|Reproduction|Reproductive Health\nBurns\nSchizophrenia|Depressive Disorder Major\nMaternal Hypotension|Anesthesia\nRheumatoid Arthritis\nMuscle Soreness\nAutism Spectrum Disorder\nPerioperative/Postoperative Complications|Morality\nColorectal Cancer|Constipation Impaction and Bowel Obstruction|Extrahepatic Bile Duct Cancer|Gastric Cancer|Gastrointestinal Stromal Tumor|Nausea and Vomiting|Ovarian Cancer|Pancreatic Cancer|Peritoneal Cavity Cancer|Small Intestine Cancer\nBone Infection\nNon-invasive Ventilatory Support|Infant Respiratory Distress Syndrome\nAcute Respiratory Distress Syndrome\nLow Back Pain\nAcupuncture\nNeuroblastoma\nChronic Neck Pain\nShivering\nThrombotic Microangiopathies|Atypical Hemolytic Uremic Syndrome\nParkinson Disease\nSedation in the Upper Gastrointestinal Endoscopy\nHypercholesterolemia\nSmall Cell Lung Cancer\nSpinal Cord Injuries\nCongenital Disorders\nAdvanced/Metastatic Solid Tumors\nShoulder Pain\nAcanthosis Nigricans|Obesity\nCentral Nervous System Lymphoma|Gastric Mantle Cell Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Non-Hodgkin Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Non-Hodgkin Lymphoma|Splenic Mantle Cell Lymphoma\nCOVID-19\nMenstrual Irregularity\nHealthy Volunteers\nSedentary Behavior\nMeasles\nMindfulness|Music Therapy|Blind|Elderly|Mood\nParkinson Disease|Lewy Body Dementia|Parkinson Disease Dementia\nIschemia/Reperfusion Injury\nAlzheimer Disease Early Onset\nType 2 Diabetes Mellitus\nTuberous Sclerosis Complex\nElectrolyte Imbalance|Volume Overload|Hyperosmolality\nTobacco Use Cessation\nActinic Keratosis\nColonic Adenoma|Colonic Cancer\nAlzheimer Disease|Alzheimer Disease Early Onset|Alzheimer Disease Late Onset|Alzheimer's Disease (Incl Subtypes)|Alzheimer's|Alzheimer's Disease\nRenal Stones\nSecondary Hypogonadism\nSurgery|Pain|Postoperative Pain\nStress\nCardiac Transplant Failure|Cardiac Transplant Rejection|Heart Diseases\nAdolescent Substance Abuse\nHealthy\nCOVID-19\nRelapsing Remitting Multiple Sclerosis\nPregnancy Related|Sleep Disturbance|Insomnia\nCancer\nUrothelial Carcinoma\nSquamous Non Small Cell Lung Cancer\nCentral Sensitisation|Subacromial Impingement Syndrome\nMilk Intolerance\nBradycardia\nPleural Effusions\nFlow-mediated Dilation Evaluation of the Brachial Artery\nChronic Kidney Disease|Constipation\nConcussion|Professional TOP14 Rugby Players\nInfluenza Human\nSmoking Tobacco\nAddiction|Opioid Dependence|Opioid Withdrawal\nModerate to Severe Plaque Psoriasis\nCognitive Decline|Age-Related Memory Disorders|Postoperative Complications|Age-Related Atrophy|Postoperative Cognitive Dysfunction\nBiliary Calculi\nInflammation|Pregnancy Related\nCervical Cancer|Breast Cancer|Contraceptive Usage|Sexually Transmitted Diseases\nRenal Impairment|End-stage Renal Disease\nPediatric Nutrition\nOveractive Bladder Syndrome|Overactive Bladder\nStroke\nBrain Damage Chronic\nHead and Neck Cancer\nHip Fractures\nBreast Cancer\nHIV Infections\nPregnancy\nSleep\nEsophageal Cancer\nST-segment Elevation Myocardial Infarction\nPsychotic Disorders|Schizophrenia|Schizophreniform Disorders|Schizoaffective Disorders\nCervical Assessment|Focal Myometrial Contractions\nHealthy Volunteers\nSevere Haemophilia A\nMedical and Nursing Students' Evidence Retrieval Skills\nNocturnal Enuresis|Bedwetting\nFatigue\nAge Related Macular Degeneration\nAdverse Anesthesia Outcome\nArthritis Rheumatoid\nAdenocarcinoma of the Prostate\nColorectal Cancer|Surgery\nDiabetic Neuropathy Peripheral\nPulmonary Disease Chronic Obstructive\nIgG4-related Disease\nEvidence of Liver Transplantation\nAnemia|Fatigue|Unspecified Adult Solid Tumor Protocol Specific\nPersonal Experience and Personal Initiation Program|Health Prevention Activities|Impact on Patients\nSexual Violence|Abortion\nMultiple Sclerosis\nCoronary Disease\nSelf Efficacy\nDelirium|Anticholinergic Adverse Reaction|Alzheimer Disease\nCeliac Disease in Children\nScoliosis\nBacterial Infections\nInfluenza\nSkin Cancer\nCovid-19 Vaccine\nMyelodysplastic Syndromes\nLiver Cirrhosis\nChronic Hepatitis b\nCardiotoxicity Induced by Drug Therapy for Breast Cancer\nEczema|Asthma|Allergic Rhinitis\nHealthy\nNon-Small Cell Lung Cancer\nPsoriasis\nNutrition Disorders in Old Age\nDiabetic Foot\nOsteochondral Lesions of Talus\nCritically Ill\nAdvanced Solid Tumor|Metastatic Solid Tumor|Colorectal Cancer|Lung Cancer|Pancreatic Cancer|Cholangiocarcinoma|Head and Neck Cancer\nChlamydia Trachomatis Infection\nMalaria\nObesity|Extreme Obesity\nSmoking\nCystic Fibrosis\nMastectomy Related Lymphedema|Lymphedema of Upper Limb|Lymphedema of Lower Extremity\nColon Adenocarcinoma|Colorectal Carcinoma|Rectal Adenocarcinoma\nLiver Transplantation\nLower Gastrointestinal Disorders\nInflammatory Bowel Disease\nMicrobial Colonization\nMuscle Protein Synthesis\nHealthy Participants\nHealthy\nGlaucoma\nSchizophrenia\nCleft Lip Palate|Cleft Lip Unilateral Complete\nImpetigo|Secondarily Infected Traumatic Lesions\nCrohn's Disease\nGastric Cancer\nInfertility\nCentral Venous Catheter\nLow Back Pain\nAdenocarcinoma of the Esophagus|Adenocarcinoma of the Gastric Cardia\nCross Bite|Malocclusion|Speech|Quality of Life\nKidney Failure Acute\nMultiple Myeloma|Effects of Chemotherapy\nAirway Complication of Anesthesia\nOsteoarthritis|Pain|Morning Stiffness\nAngiodysplasia\nProstatic Neoplasm|Positron-Emission Tomography|Fluorocholine\nVancomycin|Adult|Area Under Curve\nAsthma\nCorneal Staining\nImmune Response\nRAS Mutation|Neurofibromatosis 1|Noonan Syndrome|Noonan Syndrome With Multiple Lentigines|Noonan Neurofibromatosis Syndrome|Cardiofaciocutaneous Syndrome|Costello Syndrome|Legius Syndrome|Smith-Kingsmore Syndrome|MTOR Gene Mutation|GATOR-1 Gene Mutation|SYNGAP1-Related Intellectual Disability|DLG4|MAPK1 Gene Mutation\nParkinson Disease\nStroke|Occlusion Cerebrovascular\nStudy of Hemostatic Profile in Traumatic Patients\nProstate Cancer|Low and Intermediate Risk Prostate Cancer\nDiabetic Angiopathies|Diabetes Mellitus Type 2\nHIV Infections\nPostoperative Nausea and Vomiting\nPain Measurement|Knee Replacement Arthroplasty|Nerve Block\nFemale Infertility Due to Nonimplantation of Ovum\nADHD\nHealthy\nCancer Breast\nType 2 Diabetes\nHealthy Male Volunteers\nOccupational Injuries|Occupational Diseases\nRectal Cancer\nAdvanced Cancer|Depression|Anxiety\nGlioblastoma\nTooth Discoloration\nHeart Failure\nFunctional Abdominal Pain Syndrome\nDepressive Symptoms|Expectations|Antidepressants\nChronic Kidney Diseases\nFamily|Pregnancy High Risk\nMucositis Oral\nAtelectasis\nImmunity\nArrythmia Cardiac\nStress Urinary Incontinence\nUrticaria\nPancreatic Cancer|Biliary Stasis\nHealthy Volunteers\nAlzheimer Disease\nAcute Postoperative Pain|Motor Activity\nBack Pain\nCOVID-19\nCardiovascular Diseases|Myocardial Infarction|Atrial Fibrillation|Diabetes Mellitus|Heart Failure|Hyperlipidemias|Hypertension|Ischemic Heart Disease|Stroke|Transient Ischemic Attack\nMultiple Sclerosis\nGraft Versus Host Disease|Recurrent Adult Acute Lymphoblastic Leukemia\nObesity|Pregnancy|Diabetes Mellitus\nCeliac Disease\nPregnancy Complications|Obesity|Pre-Eclampsia|Gestational Diabetes\nProstate Cancer\nCongenital Ptosis\nPregnancy Complications Parasitic\nCarcinoma Non-Small-Cell Lung With EGFR Mutation Positive\nAcute Lymphoblastic Leukemia|Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Chronic Myelogenous Leukemia|Non-Hodgkin Lymphoma|Hodgkin Lymphoma\nChild Development Disorders Pervasive\nChronic Disease|Integrated Care|Telemedicine\nCovid19\nSubstance Use|Conduct Disorder|Depression|Anxiety\nHeart Diseases\nSleep Deprivation|Sleep\nPulmonary Aspiration\nAutism Spectrum Disorder|Autism\nRadius Fractures\nPulmonary Infection|Respiratory Insufficiency|Aspiration Pneumonitis|Bronchospasm|Atelectasis\nTuberculosis Pulmonary|Tuberculosis Extrapulmonary|Tuberculosis Active\nHIV\nPregnancy\nNeoplasms\nNeonates and Preterm Infants\nPhysical Activity\nAdvanced Breast Cancer\nSickle Cell Disease\nCOPD Exacerbation|Hypoxia|Hyperoxia|Respiratory Failure|Respiratory Insufficiency|Copd Exacerbation Acute\nCarcinoma Cervix\nComparison of the Efficacy of Two Formulations of Epoetin in Patients Undergoing Hemodialysis\nEating Behavior\nSmoking|Smoking Cessation\nPsoriasis\nRetinal Vein Occlusion\nBrain Tumor|Brain Metastases|Small Cell Lung Cancer|Meningioma\nCervical Carcinoma\nProstate Cancer|Lymphocele After Surgical Procedure\nMantle Cell Lymphoma|Refractory Lymphoma\nGestational Diabetes|Endocan\nMelanoma\nCutaneous T-Cell Lymphoma\nHead and Neck Squamous Cell Carcinoma\nFertility Disorders\nShoulder Pain|Neck Pain|Back Pain|Temporal Pain|Herpes Zoster Pain\nRheumatoid Arthritis (RA)\nBreast Cancer Survivors|Postmenopause|Resistance Training\nPrimary Liver Cancer|Metastatic Liver Cancer From Any Cancer Site\nSymptomatic Abdominal Tumour\nLow Back Pain|Disc Herniated\nHeart Failure|Heart Failure With Reduced Ejection Fraction|Heart Failure NYHA Class II|Heart Failure NYHA Class III|Heart Failure NYHA Class IV\nDiabetes Mellitus Type 2 Diabetes Mellitus Type 1\nHealthy\nMetastatic Colorectal Cancer\nMacular Degeneration Exudative Eye Left|Macular Degeneration Exudative Eye Right\nOverweight|Obesity\nDysfunctional Breathing|Asthma in Children|Asthma\nOsteoporosis\nVitamin D Deficiency\nChildhood Langerhans Cell Histiocytosis|Fanconi Anemia|Leukemia|Lymphoma|Myelodysplastic Syndromes|Neuroblastoma|Sarcoma|Unspecified Childhood Solid Tumor Protocol Specific\nCOVID-19\nHealthy Volunteers\nParkinson's Disease|Parkinsonian Syndrome\nIndividuals With Multiple Sclerosis|With Ataxia Symptoms|No Secondary Disease Affecting Balance\nBrain Death|Organ Donation|Organ Transplant Failure or Rejection\nMyopia\nEmergencies|Neurologic Disorder\nAtrial Fibrillation and Flutter\nDiabetes Gestational|Postpartum Period\nHead and Neck Cancer\nDiabetes Mellitus Type 2\nHypertension|Dyslipidemias\nBladder Cancer|Transitional Cell Cancer of the Renal Pelvis and Ureter|Urethral Cancer\nMetastatic Breast Cancer\nPregnancy Related|Infertility Female\nDental Plaque|Denture Stomatitis|Oral Candidiasis|Oral Hygiene\nStroke\nColorectal Neoplasms Malignant\nDepression|Anxiety|Eating Disorders|Drug Use Disorders|Stress Disorders Post-Traumatic\nHearing Loss GJB2 Cis Regulation DFNB1\nStroke\nBreast Cancer Survivors|Cognitive Dysfunction\nLeukopenia\nRheumatoid Arthritis|Inflammatory Arthritis\nBalanitis Xerotica Obliterans (BXO)\nGlioblastoma|Glioblastoma IDH-wildtype\nEpilepsy\nBipolar Depression\nRenal Failure Chronic\nMechanical Ventilation|Children|Neonates|Pediatric Intensive Care\nMyopia|Hyperopia\nLyme Disease|Healthy\nTibial Fractures\nDating Violence|HIV Infections\nAdvanced/Metastatic Solid Tumors\nAnemia|Chronic Kidney Disease|Chronic Renal Failure|Pure Red Cell Aplasia\nProstate Cancer|Prostate Adenocarcinoma\nMyofascial Pain|Craniofacial Pain\nExercise|Sedentary Behavior|Non Communicable Diseases|Comorbidities and Coexisting Conditions|Comorbidity|Multimorbidity|Digital Technology\nConnective Tissue Diseases|Rare Diseases|Rheumatologic Disorder\nHealthy (Controls)\nAdvanced Stage Parkinson's Disease\nComplex Anal Fistula\nVascular Aging\nHormono-depending Adjuvant Breast Cancer\nHeart Failure|Pulmonary Arterial Hypertension\nType 2 Diabetes\nMeibomian Gland Dysfunction|Dry Eye\nOsteoarthritis\nTopiramate|Lamotrigine|Memnatine|Diazepam|Placebo\nPulmonary Disease Chronic Obstructive\nInfluenza\nUrothelial Cancer|Cancer|Bladder Neoplasms|Urinary Bladder Cancer\nInsulin Resistance|Healthy|Diet Modification|Aging\nType 2 Diabetes|Obesity\nHead and Neck Cancer\nTransplantation\nPeriviable Infants|Extreme Prematurity|Communication\nHealthy\nPolypharmacy Because of Multimorbidity in Geriatric Nursing Home Residents\nNeonatal Respiratory Distress|Preterm Birth\nHIV Prevention\nBrain Health|Brain Function|Brain Development\nAcute Abdomen\nTobacco Use Disorder\nIntubation; Difficult\nAutism Spectrum Disorder|Parents\nPulmonary Arterial Hypertension\nNutrition\nIntra-uterine Device Complication\nMild to Moderate Atopic Dermatitis\nAllogeneic Hematopoietic Stem Cell Transplantation\nMultiple Sclerosis\nSimulation|Venous Thromboembolism\nImmune Thrombocytopenia (ITP)\nGeneralized Myasthenia Gravis\nPost Operative Pain Acute\nVitamin D Deficiency\nRespiratory Infection (for Example Pneumonia Bronchitis)\nSmallpox\nKnee Injury\nDiabetes Mellitus Type 2\nLaparotomy\nHypogonadism\nHepatitis C Chronic\nScoliosis; Adolescence|Pressure Area|Scoliosis|Orthosis\nNail Diseases\nSarcoma Kaposi|HIV Infections\nSkeletal Muscle Atrophy\nCRS\nCoronary Disease|Myocardial Infarction|Heart Diseases|Vascular Diseases|STEMI - ST Elevation Myocardial Infarction\nBrain Concussion|Mild Traumatic Brain Injury\nMelanoma|Skin Melanoma\nOveractive Bladder|Urinary Urge Incontinence|Urinary Incontinence|Detrusor Hyperreflexia|Urge Incontinence\nWilson's Disease\nChronic Kidney Diseases|Diabetic Kidney Disease\nMechanically Ventilated Patients\nGraves' Disease\nColorectal Cancer\nHealthy|Atopic Dermatitis\nAtrial Fibrillation\nHypertension and Dyslipidemia\nDiabetes Mellitus Type 2\nEnd Stage Renal Disease|Thrombosis\nSepsis|Children Only\nNon-small Cell Lung Cancer\nPrimary Dysmenorrhea\nPsoriatic Arthritis\nPediatric Post-intensive Care Syndrome|Intensive Care Unit Syndrome\nRespiratory Failure|Respiratory Distress Syndrome Adult|Critical Illness|Pulmonary Disease|Ventilator-Induced Lung Injury\nBladder Cancer|Bladder Tumor|Urothelial Carcinoma\nAndrogenetic Alopecia\nAML|FLT3-ITD Mutation\nProtein Metabolism|Colorectal Neoplasms\nChronic Hepatitis C Infection\nEpilepsy|Cognitive Deficits|Attention Deficits\nAngina Pectoris\nInfluenza\nCoronary Artery Disease\nPancreatic Pseudocyst\nGastric Cancer\nCystic Fibrosis\nKidney Failure Acute|Contrast Media\nHealthy\nRecurrent Urinary Tract Infection\nTrigger Finger\nAge ≥ 65 Years|Hospitalisation in the Champmaillot Geriatric Centre\nAcute Intermittent Porphyria\nInfection Control\nTQT Study\nDental Pulp Regeneration|Dental Pulp Diseases\nGut Microbiota|Mild Cognitive Impairment|Dementia Alzheimer Type|Neuroimaging\nAnemia\nEssential Thrombocythemia (ET)\nMalnutrition|Diarrhea|Child Development\nResectable Pancreatic Cancers\nAcute Lung Injury\nAcute Biphenotypic Leukemia|Acute Myeloid Leukemia|Blast Phase Chronic Myelogenous Leukemia BCR-ABL1 Positive|Blasts 10 Percent or More of Bone Marrow Nucleated Cells|Blasts 10 Percent or More of Peripheral Blood White Cells|de Novo Myelodysplastic Syndrome|Myelodysplastic Syndrome|Previously Treated Myelodysplastic Syndrome|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelogenous Leukemia BCR-ABL1 Positive|Refractory Acute Myeloid Leukemia|Refractory Chronic Myelogenous Leukemia BCR-ABL1 Positive|Secondary Acute Myeloid Leukemia|Untreated Adult Acute Myeloid Leukemia\nStable COPD Patients\nCytomegalovirus Infections|HIV Infections\nPediatric Cancer\nAging\nComparison Group|Multiple Family Groups by Parent Peers|Multiple Family Groups by Community Health Workers\nMalaria|Malaria Vaccines\nHeart Failure|Left Bundle-Branch Block\nPurpura Thrombocytopenic Idiopathic|Autoimmune Thrombocytopenia\nEducational Problems\nHyperlipidemia|Hyperglycemia|Type 2 Diabetes\nHypertension|Diabetes Mellitus|Maternal Health\nAcute Alcoholic Hepatitis\nAcute Coronary Syndrome|Troponin|Chest Pain|Point-of-care Systems\nProstate Cancer\nHigh Altitude Polycythemia\nChemotherapy Effect\nLong COVID\nAmyotrophic Lateral Sclerosis (ALS)\nAutism Spectrum Disorder\nPeripheral Artery Disease|Atherosclerosis\nCardiac Surgical Procedures\nTraumatic Brain Injury\nAlzheimer Disease\nGlioblastoma Multiforme\nBipolar Disorder\nAge-Related Macular Degeneration|Choroidal Neovascularization\nSystemic Sclerosis|Interstitial Lung Disease\nDisorders of the Pancreatobiliary System\nEducation\nMental Health Disorders\nDialectical Behavior Therapy|Individual and Group Drug Counseling\nCarcinoma Non-Small-Cell Lung\nNon-small Cell Lung Cancer Metastatic\nDry Eye Syndromes|Meibomian Gland Dysfunction\nGestational Diabetes Mellitus\nOstheoporosis of the Knee\nMetabolic Syndrome|Overweight|Central Obesity|Impaired Glucose Tolerance\nMuscle Relaxation\nPulmonary Complications|HIV Infections\nProblem Behavior\nAcute Brain Injury\nHIV-1 Infection\nHealthy\nTrapeziometacarpal Osteoarthritis|Thumb Carpometacarpal Osteoarthritis\nHIV Infection|Pregnancy|Breastfeeding|HIV Infections\nInfertility\nAlcohol Use Disorder|HIV-infection/Aids\nArterial Hypertension\nHealthy|Metabolism\nRespiratory Failure|Hypoxemic Respiratory Failure\nOpiate Dependence|Sexually Transmitted Diseases|HIV\nTympanic Membrane Perforation\nDuchenne Muscular Dystrophy|Gait Disorders in Children|Gait Disorders Neurologic\nHealthy Subjects\nAtherosclerosis\nDiabetes Mellitus\nVascular Access Complication\nPsoriasis Vulgaris\nBreast Cancer\nChronic Obstructive Pulmonary Disease\nVaginal Cancer\nCardiac Transplantation\nAortic Valve Stenosis\nImpetigo\nAlzheimer Disease\nAnal Neoplasm\nPhotoaging\nBone Loss\nLarge Cell Neuroendocrine Carcinoma of the Lung\nCerebrovascular Occlusion|Collateral Blood Circulation|Anterior Cerebral Circulation Infarction\nStroke|Stroke (CVA) or TIA|Dementia Vascular|Cerebrovascular Disorders|Small Vessel Cerebrovascular Disease|Cognitive Impairment\nColon Cancer Adenocarcinoma\nInfluenza A Virus H7N9 Subtype\nSubstance-Related Disorders\nST Elevation Myocardial Infarction\nDrug Resistance|Carbapenem-Resistant Enterobacteriaceae Infection|Sepsis|Septic Shock|Critical Illness|Clinical Outcomes|Treatment Outcomes\nCardiovascular Diseases|Heart Diseases|Coronary Heart Disease Risk Reduction|Coronary Disease|Hypertension|Hypercholesterolemia\nSevere Cerebral Pathology\nMajor Depressive Disorder\nTuberculosis|HIV Infections\nObesity\nOnychomycosis\nBreast Cancer\nMyocardial Infarction\nCovid19|Acute Respiratory Distress Syndrome|Bacterial Sepsis|Bacterial Infections\nPDL1- Colorectal Carcinoma\nLymphoma\nPost-Infarction Heart Rupture|Gene Polymorphism\nMultiple Myeloma\nType2 Diabetes\nSystemic Lupus Erythematosus|Lupus Nephritis\nVitiligo\nMorbidity;Newborn\nMacular Edema\nOveractive Bladder\nHIV\nDepression\nLow Back Pain\nPrevention of Pregnancy\nResearcher-Subject Relations\nSmoldering Plasma Cell Myeloma\nHip Arthritis\nMitral Regurgitation|Mitral Valve Insufficiency\nPain\nAortic Dissection\nCastration Levels of Testosterone|Castration-Resistant Prostate Carcinoma|Metastatic Prostate Carcinoma|Prostate Carcinoma Metastatic in the Bone|PSA Progression|Stage IV Prostate Cancer\nDepression|Executive Dysfunction\nWear of Articular Bearing Surface of Internal Prosthetic Joint|Infection Prosthetic|Infections Joint Prosthetic|Prosthetic Joint Infection|Prosthetic Pain\nGIST|Metastatic Disease\nPollution; Exposure\nCOVID-19 Experience\nHealthy Volunteers\nCataract\nArthroplasty|Replacement Hip|Arthritis\nTracheal Stenosis\nLeukemia|Lymphoma\nBeta Alanine Supplementation\nCrohn's Disease\nCoronary Artery Disease\nFetal Membranes Premature Rupture\nDiabetes|Diabetes Mellitus Type 2\nHepatocellular Carcinoma\nPhantom Limb Pain\nCommunity Infections\nUlcerative Colitis Chronic Mild|Ulcerative Colitis Chronic Moderate\nMultiple Sclerosis\nSleep\nSubarachnoid Hemorrhage\nAnal Cancer\nPremature Birth\nSensitive Dentin\nPreoperative|Anesthesia|Postoperative\nPremature Exit After Colorectal Surgery\nHIV\nGall Stone Disease\nAllergy|Asthma|Allergic Rhinitis|Mastocytosis|Atopic Dermatitis|Food Allergy\nLYMPHOMA\nAdvanced or Metastatic Colorectal Cancer\nAtrial Fibrillation|Lung Cancer\nMultiple Chemical Sensitivity\nProstate Cancer Metastatic|Castration-resistant Prostate Cancer\nStress Disorders Post-Traumatic\nHilar Cholangiocarcinoma|Primary Sclerosing Cholangitis\nDiabetes Mellitus Type 1|Diabetes Mellitus Type 2\nUrinary Tract Infections\nOpioid Use Disorder\nKnee Injuries\nAnorexia Nervosa\nTic Disorder|Tourette Syndrome|Chronic Tic Disorder\nNephrotic Syndrome\nImmune Response to DTP-HB-Hib Vaccine\nAbdominal Aortic Aneurysm\nAnatomic Stage IV Breast Cancer AJCC v8|Invasive Breast Carcinoma|Metastatic Breast Carcinoma|Peritoneal Effusion|Recurrent Breast Carcinoma\nOsteoarthritis of the Knee\nOropharyngeal Squamous Cell Carcinoma (OPSCCA)|HPV (Human Papillomavirus)-Associated\nCardiomyopathy|Renal Impairment\nPain Postoperative|Catheter Blockage|Anesthesia\nBreast Cancer\nPulmonary Arterial Hypertension\nAutoimmune Cytopenia Associated With Chronic Lymphocytic Leukemia\nUlcerative Colitis\nLGMD2I|LGMDR9|Limb Girdle Muscular Dystrophy|Congenital Muscular Dystrophy|Muscle-Eye-Brain Disease|Walker-Warburg Syndrome|FKRP Gene Mutation\nAdult Acute Lymphocytic Leukemia\nAsthma|Obesity\nMusculoskeletal and Connective Tissue Disorders\nCesarean Section Complications\nDrug-drug Interaction\nPharmacokinetic|Healthy|Drug Combination\nCoronary Artery Disease|Heart Failure|Hypertrophic Cardiomyopathy|Aortic Valve Disease|Athletes Heart|Tetralogy of Fallot|Pulmonary Arterial Hypertension\nL L Ischemia\nNeurologic Disorder|Stroke|Spinal Cord Injuries|Cerebral Palsy|Hemiplegia|Hemiparesis|Multiple Sclerosis|Parkinson Disease|Trauma Brain|Transverse Myelitis|Friedreich Ataxia\nNeoplasms\nFracture|Fall\nCoronary Artery Disease|Valvular Heart Disease\nCluster Headache\nChronic Subdural Hematoma\nType 1 Diabetes\nPneumococcal Disease\nPresbyopia\nHIV Infections\nCognitive Impairment|Dementia|Post ICU Syndrome|Critical Illness|Cognitive Impairment Mild\nHidradenitis Suppurativa\nArterial Calcification|Kidney Diseases|Coronary Artery Disease|Aortic Calcification|Stroke|Vascular Diseases|Vascular Calcification\nPostmenopausal Symptoms|Vaginal Dryness\nPlatelet-Rich Fibrin\nGenetic Counseling|Shared Decision Making|Pregnancy|Genetic Testing|Prenatal Disorder\nDiabetes Mellitus Type 2|Diabetes Mellitus Type 1\nUveitis|Cataract|Inflammation|Posterior Capsule Opacification\nHIV Infections\nColorectal Polyp\nAllergic Rhinitis\nGlaucoma|Glaucoma Open Angle\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the fifth column from each row of the final RDD filtered_rdd_with_header\n",
    "\n",
    "conditions = filtered_rdd_with_header.map(lambda row: row[4])\n",
    "\n",
    "# Display the first column values\n",
    "for value in conditions.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "7fcc47d2-dbed-415b-a2fe-5960a000ade3",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Interventions\nBEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care\nOTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB\nDRUG: Insulin (tight blood glucose control)\nOTHER: SuperMELD\nOTHER: adherence support system based on a vocal assistant\nBEHAVIORAL: Person-centered inhibitory control training|BEHAVIORAL: Active behavioral response training\nDRUG: Propranolol|DRUG: Placebo\nBEHAVIORAL: Computerized brief alcohol intervention + IVR booster calls|BEHAVIORAL: Computerized brief alcohol intervention|BEHAVIORAL: Attention Control\nOTHER: Pharmacist - Smoking Cessation Support\nPROCEDURE: Biospecimen Collection|OTHER: Genetic Testing|OTHER: Medical Chart Review\nDRUG: Oxybutynin 3% gel\nOTHER: Blood draw|OTHER: Existing samples\nDRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate\nBEHAVIORAL: 5waysA Intervention|BEHAVIORAL: 5waysA Active wait-list control|BEHAVIORAL: 5waysA Inactive wait-list control\nDRUG: Ticagrelor|DRUG: Aspirin + Ticagrelor|DRUG: Control|DRUG: Aspirin + Ticagrelor\nDRUG: human fetal-derived Neural Stem Cells (hNSCs)\nPROCEDURE: Uvulopalatopharyngoplasty\nDRUG: DEXAMETHASONE|DRUG: PREDNISOLONE\nPROCEDURE: Doing Different ICU techniques and skills\nBIOLOGICAL: aldesleukin|BIOLOGICAL: recombinant interferon alfa\nDEVICE: rTMS|DEVICE: iTBS\nDIETARY_SUPPLEMENT: Winclove 607|DIETARY_SUPPLEMENT: Placebo\nDRUG: ATH-063|DRUG: Placebo\nDIETARY_SUPPLEMENT: Specific Oral Tolerance Induction with Egg or Cow's milk\nDRUG: dorzolamide-timolol-brimonidine\nOTHER: Intra-abdominal pressure during laparoscopy\nDRUG: carboplatin|DRUG: cyclophosphamide|DRUG: etoposide phosphate|GENETIC: gene expression analysis|GENETIC: polymorphism analysis|OTHER: pharmacological study\nDEVICE: Quark RMR|DEVICE: Deltatrac II\nPROCEDURE: Laparoscopic colorectal surgery\nDRUG: Darifenacin\nPROCEDURE: peripheral blood isolation\nPROCEDURE: Microwave ablation + Occlusafe + DEB-TACE|PROCEDURE: Microwave ablation + Occlusafe|PROCEDURE: Microwave ablation + DEB-TACE\nDRUG: Blueberry juice\nNone\nDIAGNOSTIC_TEST: C type natriuretic peptide\nOTHER: care modalities|OTHER: Teleconsultation either by phone or by computer consultation\nOTHER: Extracorporeal shock wave therapy|OTHER: conventional occupational therapy\nOTHER: Glucose|OTHER: Placebo\nPROCEDURE: Ovary Biopsie\nNone\nNone\nNone\nBEHAVIORAL: Cutaneous response\nDRUG: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|DRUG: Placebo\nDEVICE: Ologen Collagen Matrix|PROCEDURE: Combined trabeculotomy-trabeculectomy\nOTHER: type of footwear|OTHER: collagen dressing with and without silver\nRADIATION: Particle radiotherapy|DIAGNOSTIC_TEST: Magnetic resonance imaging|DIAGNOSTIC_TEST: Computertomography|DIAGNOSTIC_TEST: Copper-64-Diacetyl-bis (N4-methylthiosemicarbazone) Positron Emission Tomography-Computer Tomography (64Cu-ATSM-PET-CT)|DIAGNOSTIC_TEST: 18-F-FluorDesoxyGlukose Positron Emission Tomography-Computer Tomography (18F-FDG-PET-CT)|DIAGNOSTIC_TEST: Blood sampling\nOTHER: biomarker analysis|PROCEDURE: computed tomography\nOTHER: central venous catheter insertion\nDRUG: Lactulose + Rifaximin|DRUG: Lactulose\nPROCEDURE: Elective colon cancer surgery\nNone\nNone\nPROCEDURE: n-of-1 trial guided clinical decision making\nDRUG: [14C] TS-142\nBEHAVIORAL: Interaction with MDRN STAT|BEHAVIORAL: No MDRNSTAT\nDIAGNOSTIC_TEST: Total Immunoglobulin E Obtained From Fingerstick Sample\nNone\nDRUG: Remifentanil\nPROCEDURE: Targeted biopsies of the prostate\nDIAGNOSTIC_TEST: Signal intensity gradient\nBEHAVIORAL: Faith in Action|BEHAVIORAL: Faith in Action+|BEHAVIORAL: Faith in Action++\nDRUG: SAR302503\nDEVICE: ventilators negative pressure\nDRUG: propofol|DRUG: midazolam with fentanyl\nPROCEDURE: Biological sampling|DEVICE: Radiographic evaluation\nOTHER: emotional context similarity\nDIAGNOSTIC_TEST: gait analysis\nBEHAVIORAL: Physical Activity\nDRUG: Nab-paclitaxel Cisplatin and Fluorouracil|RADIATION: concurrent chemoradiotherapy\nPROCEDURE: Dismembered Pyeloplasty\nDRUG: Mannitol\nOTHER: acupuncture\nNone\nDIETARY_SUPPLEMENT: X|DIETARY_SUPPLEMENT: Y|DIETARY_SUPPLEMENT: Z\nNone\nDEVICE: connected objects\nPROCEDURE: CPAP 5 cm H2O + PSV 5 cm H2O\nDRUG: Olaparib|DRUG: Cobicistat\nDEVICE: UriCap-RM\nDRUG: FE 999049|DRUG: follitropin beta\nBEHAVIORAL: Haitian youth and family intervention study: family functioning|BEHAVIORAL: Haitian youth intervention study: youth psychoeducational|BEHAVIORAL: Haitian family intervention study: family psychoeducational|BEHAVIORAL: Diversion Programs\nDRUG: HR17031 injection ；INS068 injection；SHR20004 injection|DRUG: HR17031 injection ；INS068 injection；SHR20004 injection|DRUG: HR17031 injection ；INS068 injection；SHR20004 injection|DRUG: HR17031 injection ；INS068 injection；SHR20004 injection\nPROCEDURE: Scaling and Root Planing|DRUG: Scaling and Root Planing with tea tree oil\nOTHER: Prescriptive|BEHAVIORAL: Behavioral\nDRUG: Nicotine Patch\nBEHAVIORAL: ACT Self-Help|BEHAVIORAL: ACT Self-Help with Telephone Support\nOTHER: MRIgHIFU unilateral subthalamotomy\nBIOLOGICAL: Dendritic cell immunization|DRUG: Adjuvant temozolomide\nBIOLOGICAL: Placebo|BIOLOGICAL: Epratuzumab 400 mg|BIOLOGICAL: Epratuzumab 1200 mg|BIOLOGICAL: Epratuzumab 100 mg|BIOLOGICAL: Epratuzumab 600 mg\nDRUG: Dexmedetomidine Hydrochloride\nDRUG: Tranexamic acid|DRUG: Placebo\nRADIATION: Stereotactic Body Radiation Therapy\nNone\nBEHAVIORAL: IBS Stress Management|BEHAVIORAL: IBS Symptom Management|BEHAVIORAL: IBS Educational Training\nPROCEDURE: Venous bleeding\nOTHER: Diet\nDRUG: Adebrelimab and dalpiciclib\nDRUG: Evobrutinib|DRUG: Avonex®|DRUG: Avonex® matched Placebo|DRUG: Evobrutinib matched Placebo\nBEHAVIORAL: Articulation/HVT|BEHAVIORAL: Soft-tissue massage|BEHAVIORAL: Craniosacral techniques|BEHAVIORAL: Combination of the three interventions: HVT soft-tissue and craniosacral techniques\nDRUG: Brivanib|DRUG: Placebo|DRUG: Sorafenib|DRUG: Placebo\nDRUG: Gralise\nDRUG: Linezolid|DRUG: Vancomycin|DRUG: Linezolid|DRUG: Vancomycin\nOTHER: Breathing exercises\nDRUG: Rituximab|DRUG: Lenalidomide|DRUG: Valemetostat\nDEVICE: Dual band pure tune audiometer\nNone\nPROCEDURE: Inguinal hernia repair with dynamic prosthesis\nDEVICE: ivWatch\nDEVICE: transcranial direct current stimulation (tDCS)|DEVICE: TENS|BEHAVIORAL: Exercise and General Education\nDRUG: sunitinib and capecitabine\nDIAGNOSTIC_TEST: Optical Coherence Tomography Angiography\nNone\nPROCEDURE: Transarterial chemotherapy|DRUG: Oral chemotherapy\nPROCEDURE: drainage|PROCEDURE: non-drainage\nDRUG: JX09 or placebo SAD|DRUG: JX09 or placebo MAD|DRUG: JX09\nDRUG: SOF/VEL\nBEHAVIORAL: Real neurofeedback|BEHAVIORAL: Sham neurofeedback\nBEHAVIORAL: Low Carbohydrate Diet\nOTHER: Modified Mini Mental Test:|OTHER: The Controlled Oral Word Association Test|OTHER: The Central Nervous System Vital Signs|OTHER: Conners' Parent Rating Scale-48 (Parent Report)|OTHER: Child Behavior Checklist 6-18 ages (Parent Report)|OTHER: Strengths and Difficulties Questionnaire (Self-Reported)|OTHER: Brooke Lower Extremity Functional Classification|OTHER: Motor Function Measurement-32 Items|OTHER: Four Square Step Test|OTHER: Six Minutes Walk Test|OTHER: Timed Performance Test\nOTHER: HLA-mismatched micro-transplantation after induction chemotherapy\nNone\nPROCEDURE: Sweeping of membranes\nDRUG: Aspirin 81Mg Ec Tab\nBEHAVIORAL: Mindfulness\nPROCEDURE: HAIC|DRUG: Sorafenib\nDRUG: Epirubicin\nDRUG: budesonide (Aircort 50 nasal spray)|DRUG: montelukast (Singulair)\nPROCEDURE: Xylocaine 2% Injectable Anesthetic|DRUG: Proparacaine Hydrochloride 0.5% Drop|DRUG: Tetravisc 0.5% Gel|DRUG: Acuvail|DRUG: Intra-vitreal Anti-VEGF Drug\nNone\nBEHAVIORAL: FAVoR Intervention\nOTHER: 4% dimethicone foam|OTHER: 1% permethrin\nBEHAVIORAL: Standard Post-Operative Counseling + FACT-G|BEHAVIORAL: PROM symptom tracker\nPROCEDURE: Thoracic surgery for lung cancer\nBIOLOGICAL: GC1118\nDRUG: Propranolol|DRUG: Placebo\nDRUG: hzVSF-v13|DRUG: Placebo (Normal saline solution)\nNone\nBEHAVIORAL: Stroke Education Film Viewing|OTHER: Stroke Education Pamphlet Exposure\nOTHER: Questionnaire\nBEHAVIORAL: ISA-MI|OTHER: Standard of Care (SOC)\nOTHER: Robotic|OTHER: Mirror|OTHER: Traditional Physical Therapy\nOTHER: PrEP screening program|OTHER: PrEP starter pack\nNone\nDRUG: PEG-IFN alfa-2a Tenofovir|DRUG: PEG-IFN alfa-2a placebo\nOTHER: Diaphragmatic endurance test\nPROCEDURE: Endoscopic Endonasal Pituitary Surgery\nOTHER: Plyometric Training|OTHER: Conventional Exercises\nDRUG: Benralizumab (Medi-563)|DRUG: Placebo\nDRUG: Micafungin\nDRUG: Carboplatin|DRUG: Etoposide|DRUG: Ifosfamide|OTHER: Laboratory Biomarker Analysis|BIOLOGICAL: Nivolumab\nOTHER: Self knowledge course\nOTHER: Research Blood Collection\nDRUG: autologous immunoglobulin idiotype-KLH conjugate vaccine\nDRUG: CYH33|DRUG: Fulvestrant|DRUG: Letrozole|DRUG: Palbociclib\nDRUG: Avelox (Moxifloxacin BAY12-8039)|DRUG: Ceftriaxone + Metronidazole\nBEHAVIORAL: Experimental gingivitis\nDRUG: Lemuteporfin for injection|DEVICE: Transurethral drug delivery system|DEVICE: Transurethral light delivery system\nDEVICE: SLActive dental implant\nDEVICE: Exo + TSCS|DEVICE: Exo + Sham\nPROCEDURE: Percutaneous coronary intervention\nDRUG: Lamotrigine|DRUG: GI267119\nOTHER: Exercise +|OTHER: Control +\nOTHER: Blood Sample Collection\nDEVICE: Embosphere® (Prostatic Arteries Embolization)|DRUG: Drug therapy\nDRUG: 68Ga-BNOTA-PRGD2\nNone\nNone\nBEHAVIORAL: Tuune Supplemented Contraceptive Visit|BEHAVIORAL: Traditional Contraceptive Visit\nDEVICE: lumbar traction|PROCEDURE: spinal manipulation|PROCEDURE: surgery\nBIOLOGICAL: Fibrin Sealant with 4 IU/ml Thrombin Vapor-Heated Solvent Detergent Treated Containing Synthetic Aprotinin (FS VH S/D 4)\nDEVICE: delefilcon A|DEVICE: narafilcon A\nDRUG: Dexilant|DRUG: Dexilant Placebo\nDRUG: Sunitinib|DRUG: Placebo\nDRUG: Erythromycin|DRUG: Nevirapine|DRUG: Ampicillin sodium|DRUG: Metronidazole\nDRUG: Lidocaine|DRUG: Saline\nNone\nBEHAVIORAL: Text-message survey and informational text messages\nPROCEDURE: ACL Reconstruction\nDRUG: LY2189265|DRUG: Placebo|DRUG: Liraglutide\nDRUG: Durvalumab|RADIATION: low-dose PCI\nDRUG: XyloCore Low Strenght XyloCore Medium Strenght XyloCore High Strenght|DRUG: 1.36%1.50%2.27%2.50%3.86% 2.25% Glucose PD Solution\nBIOLOGICAL: CAN10|BIOLOGICAL: CAN10 - Placebo\nBEHAVIORAL: Physical Activity - Pediatric Pain Rehabilitation Center\nDEVICE: Stenting of the Common and/or External Iliac Arteries\nBEHAVIORAL: New Beginnings Program\nDRUG: change from tenofovir to raltegravir\nDEVICE: InPen with Guardian 4 System\nDRUG: safinamide metansolfonato (12 weeks)|DRUG: safinamide metansolfonato (12 weeks)|DRUG: rasagilina mesilato (12 weeks)|DRUG: rasagilina mesilato (12 weeks)\nDRUG: Part A: Dose Escalation of Cantrixil|DRUG: Part B: Expansion Cohort of Cantrixil\nDRUG: Batoclimab|DRUG: Placebo\nDRUG: Gefitinib|DRUG: AZD9291|DRUG: Selumetinib+Docetaxel|DRUG: Tremelimumab\nOTHER: Laboratory Biomarker Analysis|DEVICE: Levonorgestrel-Releasing Intrauterine System|OTHER: Quality-of-Life Assessment\nOTHER: Exercise program (virtual/remote)\nDEVICE: Continuous positive airways pressure\nPROCEDURE: AVF puncture\nDEVICE: Vacuum assisted Closure application\nBEHAVIORAL: Cognitive Behavioral Therapy\nDRUG: SAR156597|DRUG: Placebo\nPROCEDURE: meniscectomy\nPROCEDURE: BIS monitoring\nDIETARY_SUPPLEMENT: nicotinamide riboside|DIETARY_SUPPLEMENT: nicotinamide mononucleotide\nDRUG: bevacizumab [Avastin]|DRUG: capecitabine [Xeloda]|DRUG: oxaliplatin\nDRUG: Bivalirudin|DRUG: Heparin\nDRUG: Conventional medicines (Oxygen therapy alfa interferon via aerosol inhalation and lopinavir/ritonavir) and Traditional Chinese Medicines (TCMs) granules|DRUG: Conventional medicines (Oxygen therapy alfa interferon via aerosol inhalation and lopinavir/ritonavir)\nBEHAVIORAL: Behavior Therapy\nDRUG: Yimitasvir Phosphate Capsule\nDEVICE: AposTherapy|OTHER: Traditional Physical Therapy\nDRUG: Rituximab|DRUG: Gemcitabine|DRUG: Oxaliplatin|DRUG: Dexamethasone|DRUG: Lenalidomide Oral Capsule\nDEVICE: Relieva™ Balloon Sinuplasty™ System\nBEHAVIORAL: Mindful Yoga Therapy\nOTHER: Motor rehabilitation training\nDRUG: 0.5% Loteprednol Etabonate Ophthalmic Ointment|DRUG: Vehicle of Loteprednol Etabonate Ophthalmic Ointment\nDEVICE: Gi Genius Medtronic|OTHER: White light standart colonoscopy\nNone\nNone\nDEVICE: Functional Electrical Stimulation (FES) Control Protocol|DEVICE: Functional Electrical Stimulation (FES) Angle Protocol\nNone\nOTHER: Levothyroxine therapy (137.75 ± 23.75 μg/day)\nDEVICE: 3D Imaging.\nDRUG: Florbetapir|DRUG: Flortaucipir\nDEVICE: LINX Reflux Management System|PROCEDURE: Fundoplication\nDRUG: Nintedanib|DRUG: Pirfenidone|OTHER: Untreated Cohort\nOTHER: Workshop ICE training\nDRUG: Brivanib 800 mg QD|DRUG: Brivanib 400 mg BID\nOTHER: Allergic rhinitis\nCOMBINATION_PRODUCT: Ramucirumab\nOTHER: Biological and imaging investigations\nDEVICE: Non-ablative radiofrequency application|OTHER: Usual intervention\nDEVICE: EBUS guided FNA with and without suction\nDRUG: aripiprazole|DRUG: valproate|DRUG: placebo\nDEVICE: Dr. Gene's Health and Wellness|PROCEDURE: Muscle Energy Technique|PROCEDURE: Static stretching and Cervical non thrust manipulation\nBIOLOGICAL: Nivolumab|DRUG: Sitravatinib|DRUG: Docetaxel\nOTHER: Questionnaire validation\nDEVICE: Radio-frequency Ablation\nDRUG: Daratumumab|DRUG: Velcade|DRUG: Pomalidomide|DRUG: Dexamethasone|DRUG: Melphalan|DRUG: Prednisone|DRUG: Thalidomide|DRUG: Diphenhydramine|DRUG: Acetaminophen|DRUG: Carfilzomib|DRUG: Lenalidomide|DRUG: Montelukast\nDRUG: Azacitidine|DRUG: Decitabine|OTHER: Laboratory Biomarker Analysis|OTHER: Pharmacological Study|BIOLOGICAL: Recombinant EphB4-HSA Fusion Protein\nDRUG: rituximab\nDEVICE: TAVR\nDIAGNOSTIC_TEST: Survey + Physical exam\nDRUG: THERATOPE® vaccine\nDRUG: IncobotulinumtoxinA|DRUG: Placebo Comparator\nBEHAVIORAL: Physical activity\nDRUG: Zhi Kang Capsule|DRUG: Simulant agent for Zhi Kang Capsule\nOTHER: continuous renal replacement therapy\nRADIATION: Chest radiograph|PROCEDURE: Blood interferon gamma release assay|PROCEDURE: Tuberculin skin testing (TST)|PROCEDURE: Sputum induction for mycobacterial microscopy and culture|OTHER: Mycobacterium tuberculosis polymerase chain reaction testing|PROCEDURE: Spirometry\nDEVICE: ReUnion Total Shoulder Arthroplasty (TSA)|DEVICE: ReUnion Reverse Shoulder Arthroplasty (RSA)\nDEVICE: MMprofiler SKY92 gene signature\nDRUG: Gabapentin\nDRUG: Antihypertensive treatment will be stopped for 1 year unless hypertension recurrence\nDRUG: Huaiqihuang granule|DRUG: Prednisone|DRUG: Levamisole placebo|DRUG: Levamisole|DRUG: Huaiqihuang Granule placebo\nNone\nPROCEDURE: Acupuncture Therapy|OTHER: Best Practice|OTHER: Quality-of-Life Assessment|OTHER: Questionnaire Administration\nOTHER: Dietary intervention\nDIETARY_SUPPLEMENT: Gluten Powder\nDRUG: Tirofiban\nNone\nOTHER: e-self-management intervention\nDRUG: Sodium tetradecyl sulfate|DRUG: Cyanoacrylate\nDRUG: Nutritional supplements\nPROCEDURE: Laparoscopic cholecystectomy\nOTHER: Colgate® Cavity Protection Toothpaste|OTHER: Listerine® Cool Mint®|OTHER: Concept Curve Winter Series Toothbrush|OTHER: 5% Hydroalcohol Mouthrinse|OTHER: Mouthrinse Prototype 1|OTHER: Mouthrinse Prototype 2\nDRUG: naloxone|DRUG: Placebo\nDRUG: Ropeginterferon alfa-2b-njft (P1101)\nDEVICE: Gastric electric pacemaker\nOTHER: VKAs|OTHER: NOACs including Rivaroxaban (Xarelto BAY59-7939)|OTHER: Edoxaban|OTHER: Apixaban|OTHER: Dabigatran-etexilate\nBEHAVIORAL: Exercise Intervention\nBEHAVIORAL: Family-based behavioral intervention\nDRUG: Colchicine|DRUG: Placebo\nDRUG: Sevelamer hydrochloride|DRUG: Calcium-based phosphate binder\nDRUG: Allergen Immunotherapy Extract|DRUG: Allergen Immunotherapy Control\nDRUG: EGCG\nDRUG: intra-rectal Botulinum toxin A injection\nDEVICE: FIDIAL PLUS|DEVICE: IAL®-F\nDEVICE: Boxed infrared gross kinematic assessment tool\nBEHAVIORAL: Cognitive-behavior therapy|OTHER: Interventional\nPROCEDURE: Cardiac Coherence|PROCEDURE: Adapted Physical Activity\nDRUG: Belotecan\nDEVICE: Prolonged telemetric Full Disclosure ECG recording.|DEVICE: Repeated 24 hours ECG Holter monitoring\nNone\nBEHAVIORAL: ABMT|OTHER: Placebo\nDEVICE: Nitric Oxide impregnated catheter\nOTHER: No intervention - data collection only\nOTHER: data collection to classify infection status\nBEHAVIORAL: Adherence Intervention|OTHER: Healthy living education intervention\nDRUG: Triamcinolone|DRUG: Saline soaked sponge\nDEVICE: Reveal LINQ\nDEVICE: CellControl\nBEHAVIORAL: Group SPARCS Intervention|BEHAVIORAL: ART-SPARCS Intervention\nBIOLOGICAL: CCT303-406\nGENETIC: Rexin-G\nBIOLOGICAL: PfSPZ Vaccine|BIOLOGICAL: PfSPZ Challenge (7G8) for CHMI|OTHER: Normal Saline\nPROCEDURE: Posterior reconstruction urethrovesical anastomosis.|PROCEDURE: Conventional vesicourethral anastomosis.\nPROCEDURE: Chiropractic care\nDRUG: Bevacizumab|DRUG: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles\nDRUG: Lactobacillus Reuteri DSM 17938|DRUG: Placebo\nDEVICE: NightBalance Sleep Position Trainer (SPT)|DEVICE: Automated Adjusting Positive Airway Pressure (APAP)\nBIOLOGICAL: one dose of Influenza Vaccine|BIOLOGICAL: one dose of Influenza Vaccine|BIOLOGICAL: placebo|BIOLOGICAL: placebo\nDRUG: aspirin|DRUG: aspirin|DRUG: placebo\nDRUG: Paclitaxel|DRUG: Placebo for Veliparib|DRUG: Carboplatin|DRUG: Veliparib|RADIATION: Radiotherapy\nDRUG: 0.05% Lidocaine\nDRUG: Acetazolamide|DRUG: Temozolomide\nOTHER: Not yet developed\nDRUG: methylphenidate HCl (Concerta)|DRUG: Placebo\nDRUG: M3814|DRUG: Cisplatin|DRUG: Etoposide\nDRUG: Icotinib plus WBRT\nDRUG: Avelumab|DRUG: Axitinib\nNone\nDEVICE: Femto LDV Z8|DEVICE: Manual capsulorhexis&lens fragmentation\nNone\nBEHAVIORAL: Lifestyle\nBEHAVIORAL: physical inactivity or bed rest with supervised recovery\nNone\nNone\nNone\nOTHER: Dignity Therapy\nBEHAVIORAL: Working memory training|BEHAVIORAL: Positive ABMT\nBEHAVIORAL: Scoring tool in Chemotherapy-induced necrosis in Ewing sarcoma\nNone\nDRUG: CD07805/47 Gel|DRUG: Placebo\nOTHER: Informational group|BEHAVIORAL: Text Messaging CBT (TXT-CBT)\nBIOLOGICAL: NuQu|OTHER: Placebo\nBEHAVIORAL: Usual care|BEHAVIORAL: CLOSS\nDRUG: Modified non-clarithromycin triple therapy|DRUG: Sequential therapy\nDEVICE: Derotation splint|DEVICE: elastic bandage\nBIOLOGICAL: Experimental: Arm A: DRL_RI|BIOLOGICAL: Arm B: Rituxan®/Mabthera®\nDRUG: Degarelix\nDIAGNOSTIC_TEST: Colonic polyp characterization by BLI\nOTHER: Oral Glucose Solution 296 mls|OTHER: Corn Tortilla|OTHER: Low Soy Flour Corn Tortilla|OTHER: Moderate Soy Flour Corn Tortilla|OTHER: High Soy Flour Corn Tortilla\nOTHER: asthma exacerbations\nDEVICE: Musculoskeletal Ultrasound\nDRUG: Lacosamide|OTHER: Placebo\nNone\nDRUG: Enoxaparin|DRUG: UFH (unfractionated heparin)\nDRUG: T0001，10mg|DRUG: T0001，20mg|DRUG: T0001，35mg|DRUG: T0001，50mg|DRUG: T0001，65mg|DRUG: T0001，75mg\nDRUG: darapladib|DRUG: placebo\nDRUG: Ketamine|DRUG: Normal Saline\nDRUG: Chloroquine|DRUG: Atovaquone and Proguanil|DRUG: Doxycycline|BIOLOGICAL: Rabies Vaccine\nDRUG: Dapivirine Vaginal Ring-004\nDEVICE: narafilcon B contact lens|DEVICE: nelfilcon A contact lens|DEVICE: lotrafilcon B contact lens\nDEVICE: The Q-Fix™ All-Suture Anchor\nBIOLOGICAL: measles vaccine|OTHER: Saline\nDRUG: ATH-1020|DRUG: Placebo\nPROCEDURE: Lung volume recruitment\nDRUG: Lorlatinib\nOTHER: lymphatic drainage massage|OTHER: classic massage\nDIETARY_SUPPLEMENT: CoQ10\nDEVICE: ACR | U.S. Urine Analysis Test System|DEVICE: URiSCAN Optima Urine Analyzer\nDRUG: arsenic trioxide|RADIATION: radiation therapy\nDRUG: Cenegermin Ophthalmic Solution [Oxervate]\nDEVICE: Bone densitometry|OTHER: Questionnaires|DEVICE: Review of medical chart\nOTHER: Questionnaire|OTHER: Blood sample|OTHER: Nasal wash|OTHER: Throat swab\nNone\nDRUG: Vinorelbine|DRUG: Cisplatin|DRUG: Bevacizumab|DRUG: Docetaxel|DRUG: Gemcitabine|DRUG: Bevacizumab|DRUG: Docetaxel|DRUG: Cisplatin|DRUG: Bevacizumab\nBIOLOGICAL: Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine|OTHER: Laboratory Biomarker Analysis\nDIAGNOSTIC_TEST: Quantra System\nPROCEDURE: Proximal varus derotational osteotomy\nDIETARY_SUPPLEMENT: Coconut water|DIETARY_SUPPLEMENT: ginger tea\nDEVICE: dental implant\nPROCEDURE: surgical resection\nBEHAVIORAL: Continuing education|OTHER: usual care\nBEHAVIORAL: Mindfulness-based group treatment\nBIOLOGICAL: AK105|DRUG: Anlotinib Hydrochloride\nDRUG: GnRH antagonist|DRUG: aspirin\nBIOLOGICAL: Kamada AAT for inhalation|OTHER: Placebo\nBIOLOGICAL: Monoclonal antibody Hu3S193\nOTHER: Geriatric Assessment of Health Status Scale administration\nOTHER: retrospective data analysis\nPROCEDURE: no systematic pelvic lymphadenectomy\nNone\nOTHER: 18F-FLT-PET/CT and DWI-MRI\nOTHER: Patient-reported outcomes (PROs)\nDRUG: Oxytocin\nDRUG: MT-1186|DRUG: Placebo\nDRUG: Medisorb naltrexone 190 mg|DRUG: Medisorb naltrexone 380 mg\nOTHER: biologic sample preservation procedure|OTHER: medical chart review\nBEHAVIORAL: Guided Self-help for Bulimia nervosa\nDRUG: midazolam\nOTHER: Algorithm driven medication titration|BEHAVIORAL: Monitoring|BEHAVIORAL: Group support|BEHAVIORAL: Self efficacy\nRADIATION: infrared therapy\nBIOLOGICAL: Synbiotic AKSB\nOTHER: analgesia for labor\nBEHAVIORAL: Total Diet Replacement (TDR)|BEHAVIORAL: Medical Nutritional Therapy (MNT)|BEHAVIORAL: Diabetes Prevention Program 4 months|BEHAVIORAL: Diabetes Prevention Program\nDRUG: tipifarnib|DRUG: etoposide\nDIETARY_SUPPLEMENT: Intensive dietary intervention\nDRUG: Docetaxel|DRUG: Imatinib Mesylate\nDRUG: SPP635\nDEVICE: CRT-D\nDEVICE: Nociception Level monitor (NOL)|DEVICE: Standard care\nDRUG: Empagliflozin|DRUG: Linagliptin\nDEVICE: Phase-targeted auditory stimulation\nNone\nBIOLOGICAL: Mesenchymal cells|DRUG: Standard of care\nRADIATION: DKI and APT\nDRUG: Saline|DRUG: Phenergan\nDRUG: estradiol 25 mcg\nDRUG: Kuvan®\nDEVICE: S9-Autoset CS-A\nDRUG: Tucidinostat Apatinib\nDEVICE: CG Future Annuloplasty Ring/Band\nBEHAVIORAL: Lifestyle intervention\nDIETARY_SUPPLEMENT: Low energy diet\nDIAGNOSTIC_TEST: Echocardiography|DIAGNOSTIC_TEST: Right side catheterization|DIAGNOSTIC_TEST: Exercise test|DIAGNOSTIC_TEST: Holter monitor\nOTHER: biofeedback|OTHER: hamstrings stretching\nDRUG: Probiotic (L. brevis CD2 lozenges)|DRUG: Placebo\nDEVICE: LiDCO rapid monitor\nOTHER: Educational Intervention\nDIAGNOSTIC_TEST: CMR examination\nDRUG: GSK2878175|DRUG: Placebo\nOTHER: Incretin hormone - Glucose-dependent insulinotropic polypeptide (GIP)\nDRUG: Ticagrelor|DRUG: Clopidogrel|PROCEDURE: Percutaneous Coronary Intervention (PCI)|PROCEDURE: Coronary Angiography\nNone\nDRUG: semaglutide|DRUG: Placebo\nDEVICE: Telemonitoring sensors\nDIAGNOSTIC_TEST: 4D X-ray Velocimetry\nDRUG: LY3372689|DIAGNOSTIC_TEST: [18F]LSN3316612\nDRUG: Ingenol mebutate 0.015 percent or 0.05 percent gel\nDRUG: Capivasertib|DRUG: Rabeprazole\nDRUG: Omiganan|DRUG: Ketoconazole|DRUG: Placebo\nDRUG: Sprifermin (AS902330) 10 mcg|DRUG: Sprifermin (AS902330) 30 mcg|DRUG: Sprifermin (AS902330) 100 mcg|OTHER: Placebo\nDRUG: Escitalopram|DRUG: Placebo\nDRUG: BI 10773 low dose|DRUG: placebo to BI 10773|DRUG: BI 10773 medium dose|DRUG: BI 10773 high dose\nOTHER: Almonds|OTHER: Placebo\nOTHER: COPD discharge care bundle|OTHER: COPD discharge care bundle & coordinator\nDRUG: MT-5199|DRUG: Placebo\nBIOLOGICAL: RiVax\nBIOLOGICAL: Sinovac|BIOLOGICAL: AZD1222|BIOLOGICAL: BNT162b2\nPROCEDURE: cardiac MRI\nPROCEDURE: US guided block of maxillary nerve\nDIETARY_SUPPLEMENT: High saturated fat meal placebo powder and sunflower oil|DIETARY_SUPPLEMENT: High saturated fat meal blueberry powder and sunflower oil|DIETARY_SUPPLEMENT: High saturated fat meal placebo powder and DHA\nDRUG: Drug Levothyroxine 150 mcg|DRUG: Drug Eutirox 150 mcg\nPROCEDURE: Gingival Phenotype Modification\nRADIATION: PET/CT Imaging\nDRUG: Fp MDPI|DRUG: FS MDPI|DRUG: FLOVENT HFA|DRUG: ADVAIR DISKUS|DRUG: albuterol/salbutamol HFA\nPROCEDURE: Vaginal packing|PROCEDURE: No vaginal packing\nDRUG: Octreotide LAR 30 MG Injection\nBEHAVIORAL: PST-MCI/AD Caregiving|BEHAVIORAL: NT-MCI/AD Caregiving\nDRUG: MCS-2 soft-gel capsule\nOTHER: Usage of telemedicine and tele-consultation for treatment\nOTHER: Short Regimen with Rifapentine 10mg/kg|COMBINATION_PRODUCT: Standardized Regimen|OTHER: Short Regimen with Rifapentine 15mg/kg|OTHER: Short Regimen with Rifapentine 20mg/kg\nDEVICE: Cirvo(TM) therapy\nDRUG: Placebo|DRUG: Oxytocin\nOTHER: Modified Otago Exercise Program with music|OTHER: Modified Otago Exercise Program\nNone\nDRUG: Spironolactone|DRUG: Placebo\nDEVICE: Natural Ear Comfort(TM) a botanical ear drops product\nDRUG: Heparin Low-Molecular-Weight\nDRUG: Inspired oxygen (40%)|OTHER: Sham\nDRUG: Clindamycin-gentamicin irrigation|DRUG: Normal saline irrigation\nDRUG: Livopan|DRUG: Livopan|DRUG: EMLA\nBEHAVIORAL: Intervention\nNone\nGENETIC: Genetic testing\nDRUG: Indirect pulp treatment using Dycal (TM)|DRUG: Indirect pulp treatment using Vitrebond (TM )\nOTHER: Patients with hepatitis C lost follow up\nDRUG: Imatinib tablets|DRUG: Hydroxyurea capsules\nDRUG: Bevacizumab intravitreal|DRUG: Triamcinolone|DRUG: Triamcinolone + Bevacizumab\nNone\nDIAGNOSTIC_TEST: Pelvic Binder Radiography\nCOMBINATION_PRODUCT: Fetal Protection Pill\nDRUG: Ursodesoxycholic acid\nOTHER: Blood Flow Restriction (BFR) Therapy|OTHER: Physical Therapy\nOTHER: Advanced Care\nBIOLOGICAL: BCG (Bacillus Calmette-Guérin) vaccine|O\n\n*** WARNING: max output size exceeded, skipping output. ***\n\ntone|DRUG: Placebo\nPROCEDURE: bronchoscopy brochoalveolar lavage\nDIETARY_SUPPLEMENT: Insect protein|BEHAVIORAL: Running exercise\nDRUG: ritlecitinib|DRUG: ritlecitinib|DRUG: ritlecitinib\nDRUG: Carvedilol 25 mg tablets|DRUG: COREG® 25 mg tablets\nPROCEDURE: selective laser trabeculoplasty - early completion|PROCEDURE: Selective laser trabeculoplasty - late completion\nNone\nDEVICE: Nasoalveolar molding therapy\nDRUG: TD1414 2% cream|DRUG: TD1414 2% cream|DRUG: Bactroban® (mupirocin) 2% cream\nDRUG: Alicaforsen\nDIAGNOSTIC_TEST: DNA test\nDRUG: Growth Hormone\nDEVICE: Central Venous Access\nOTHER: Interventional video|OTHER: Control video\nPROCEDURE: Subtotal esophagectomy and gastric pull up|PROCEDURE: Subtotal esophagectomy at the azygos vein total gastrectomy\nDEVICE: removable anterior expansion screw|DIAGNOSTIC_TEST: Speech and language evaluation|OTHER: Oral Health Related Quality of Life (OHRQoL) Assessment\nDRUG: Ambrisentan 10 MG\nDRUG: Bortezomib cyclophosphamide thalidomide dexamethasone\nDEVICE: cuffed endotracheal tube|DEVICE: Uncuffed endotracheal tube\nNone\nDEVICE: Small bowel RFA treatment\nDEVICE: PET Scan ou TEP-TDM|DEVICE: mpMRI\nOTHER: Vancomycin dose adjustment using the Bayesian method|OTHER: Vancomycin dose adjustment using the trough level method\nNone\nDRUG: sodium citrate sodium chloride sodium borate propylene glycol. citrate tetronic 1304 AMP 95\nBIOLOGICAL: Keyhole-Limpet Hemocyanin|DRUG: Saline|DRUG: Montanide ISA 51 VG|DRUG: Alhydrogel\nNone\nPROCEDURE: Unilateral reduction of stimulation|PROCEDURE: Chronic Subthalamic nucleus stimulation\nPROCEDURE: Endovascular thrombectomy\nDEVICE: sonoclot\nDEVICE: The TRANBERGCLS|Thermal Therapy\nOTHER: liquid chromatography-mass spectrometry\nOTHER: self questionnaire\nDRUG: palonosetron|DRUG: palonosetron\nPROCEDURE: Adductor canal blockade|PROCEDURE: Distal adductor canala blockade and anterior cutaneus nerve blockade\nPROCEDURE: Endometrial local injury\nOTHER: DRM (Deese Roediger et McDermott task)\nDRUG: [14C] AZD8931\nDRUG: Lidocaine|DRUG: Normal saline\nBEHAVIORAL: Aerobic Training (AT)|BEHAVIORAL: AT plus Primarily Home-Based Resistance Band Training\nDRUG: Placebo|DRUG: E3112\nBEHAVIORAL: TRIMOSH\nBEHAVIORAL: Exercise\nBEHAVIORAL: Mindfulness meditation\nDIAGNOSTIC_TEST: PET imaging\nOTHER: E.Max CAD Laminate Veneers cemented with dual cure amine free adhesive resin cement|OTHER: E.Max CAD Laminate Veneers cemented with light cured adhesive resin cement\nBEHAVIORAL: Alert|BEHAVIORAL: Peer comparison report\nDIETARY_SUPPLEMENT: Psyllium|DIETARY_SUPPLEMENT: Placebo\nDRUG: Open-label placebo|OTHER: No-treatment\nBEHAVIORAL: ACP-SCT program\nBEHAVIORAL: Minding the Baby|BEHAVIORAL: Usual Care\nDRUG: topical oral Omega-3 hydrogel|DRUG: conventional preventive treatment\nDEVICE: routine pulmonary rehabilitation|DEVICE: chest wall vibration technique\nOTHER: Infant Formula with added synbiotics|OTHER: Standard Infant formula\nDEVICE: iBeat wristwatch device\nDEVICE: Tunable-tension transobturator tape Urosling-T (Lintex LLC)|DEVICE: Transobturator mid-urethral tape Urosling (Lintex LLC)\nDRUG: abatacept (Orencia ®)\nDEVICE: Tannenbaum Fr 10 stent or WallFlex stent\nDRUG: UCB5857|OTHER: Placebo\nPROCEDURE: Malnutrition screening and perioperative nutritional support\nPROCEDURE: 0.25%Bupivacaine Axillary brachial plexus block|PROCEDURE: 0.19% Bupivacaine Axillary brachial plexus block\nOTHER: Pilates Exercise|OTHER: Mckenzie Exercise\nBIOLOGICAL: COVID-19 Vaccine (Vero Cell) Inactivated\nBEHAVIORAL: Care coordination delivered based on perceived need|BEHAVIORAL: Care coordination delivered based on usual care (e.g. discharge from hospital)\nNone\nDRUG: prednisone|DRUG: methylprednisolone|OTHER: questionnaire administration\nBEHAVIORAL: Experimental group\nOTHER: Presence prevalence severity and morphological characteristics of anemia|OTHER: Effect of gluten-free diet on anemia\nBEHAVIORAL: Resistance exercise|BEHAVIORAL: Aerobic Exercise|BEHAVIORAL: Rest\nPROCEDURE: MRI Targeted Focal Thermal Therapy of Prostate Cancer\nPROCEDURE: levator muscle resection|PROCEDURE: levator muscle plication\nDRUG: Efficacy of suphladoxine/pyrimethamine as IPTp|DRUG: Efficacy of suphladoxine/pyrimethamine as IPTp\nDRUG: AZD9291 40 mg|DRUG: AZD9291 80 mg\nRADIATION: Radiation|DRUG: Cyclophosphamide|BIOLOGICAL: Donor Lymphocyte Infusion (DLI)|BIOLOGICAL: Haploidentical Stem Cell Transplantation\nDRUG: Risperidone\nOTHER: Integrated care intervention\nDRUG: Alvelestat|DRUG: Placebo\nOTHER: Ecological Family Intervention and Treatment (EcoFIT)\nOTHER: AI algorithm for apical foreshortening in echocardiography\nBEHAVIORAL: Nap\nDEVICE: gastric antral sonography\nBEHAVIORAL: Early Diagnostic Response Model (EDRM)\nPROCEDURE: Radio-radial fixator|PROCEDURE: Percutaneous pinning\nOTHER: Perioperative pulmonary function tests\nDEVICE: NanoDetect-TB\nDRUG: Triumeq\nDIETARY_SUPPLEMENT: Magnesium plus alpha-lipoic acid|DRUG: Placebo\nDRUG: Niraparib|DRUG: Dostarlimab|DRUG: Niraparib\nDRUG: Dopamine\nBEHAVIORAL: Personalized exercise Rx and resources\nDRUG: Fulvestrant|DRUG: Neratinib|DRUG: Alpelisib|DRUG: Everolimus|DRUG: Abemaciclib\nOTHER: Peer Mentoring [PM]|OTHER: Structured Education Based Transition Program STE\nDEVICE: O2matic\nDRUG: Chemotherapy|RADIATION: External Beam Radiotherapy|RADIATION: Brachytherapy|PROCEDURE: Radical Hysterectomy\nDRUG: Epoetin Alfa-BioManguinhos|DRUG: Epoetin Alfa-BioSimilar\nBEHAVIORAL: Serious health game\nDEVICE: Quit Smoking Phone Application\nDRUG: M518101\nNone\nDEVICE: Head immobilization mask\nBIOLOGICAL: LN-145|BIOLOGICAL: LN-145 + pembrolizumab\nPROCEDURE: Peritoneal fixation (PerFix)|PROCEDURE: Standard of care\nDRUG: Acalabrutinib|DRUG: Venetoclax|DRUG: Obinutuzumab\nDIAGNOSTIC_TEST: Serum Endocan Levels\nDRUG: Vidutolimod (CMP-001)|BIOLOGICAL: Nivolumab|OTHER: [18F]F-AraG PET/CT\nPROCEDURE: skin biopsy\nDRUG: HLX10|DRUG: HLX07|DRUG: HLX07 placebo|DRUG: Cisplatin/Carboplatin|DRUG: 5-FU\nDIAGNOSTIC_TEST: PET/MRI\nDRUG: HA35(L20200708MP07707 Ministry of Health Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)\nDRUG: masitinib 3 mg|DRUG: masitinib 6.0 mg|DRUG: methotrexate|DRUG: Placebo (methotrexate)|DRUG: Placebo (masitinib)\nOTHER: Prolonged resistance-type exercise training\nNone\nDEVICE: High-intensity focused ultrasound\nOTHER: Tuina\nDRUG: Potassium sparing diuretic\nDEVICE: Accu-Chek FlexLink|DEVICE: Accu-Chek FlexLink Plus\nDEVICE: Spirometric examinations realized using the EIT|DEVICE: Simultaneous measurement by spirometer and EIT\nNone\nOTHER: Follow-up\nOTHER: Lean fish|OTHER: Fatty fish\nNone\nDRUG: zoledronic acid\nNone\nBIOLOGICAL: anti-thymocyte globulin|DRUG: busulfan|DRUG: cyclophosphamide|DRUG: fludarabine phosphate|DRUG: melphalan|DRUG: methylprednisolone|RADIATION: radiation therapy\nDRUG: Tocilizumab|DRUG: Tocilizumab\nDRUG: AEF0117|DRUG: Placebo\nDEVICE: Automated Neuropsychological Assessment Matrix\nOTHER: Kinesiotape\nOTHER: Open lung protective ventilation|OTHER: Conventional ventilation\nDEVICE: Phenacite (Test) contact lens|DEVICE: comfilcon A contact lens\nPROCEDURE: Teleneurological evaluation and support\nDRUG: Diltiazem Oral Product|DRUG: Diltiazem Injectable Product\nOTHER: Promotora\nBEHAVIORAL: Intervention group\nDRUG: LY2599506|DRUG: Glyburide|DRUG: Placebo\nDRUG: telmisartan|DRUG: simvastatin\nDRUG: Depsipeptide\nDRUG: Tesmilifene (YMB1002)\nDIAGNOSTIC_TEST: Transvaginal ultrasound|DIAGNOSTIC_TEST: Serial serum LH E2 P4|DRUG: Progesterone 100 Mg Vaginal Insert|DIAGNOSTIC_TEST: Serum P4 day of ET - Control Group|DIAGNOSTIC_TEST: Serum P4 day of ET - Study Group|PROCEDURE: Embryo transfer|DIAGNOSTIC_TEST: Serum hCG 10 days after ET|DIAGNOSTIC_TEST: Serum P4 10 days after ET\nOTHER: Dentifrice\nDEVICE: upper extremity training program (MeditouchMSQUARE)\nDRUG: Axitinib 5 MG|DRUG: Hydroxychloroquine Pill|PROCEDURE: trans arterial chemoembolization\nBEHAVIORAL: Women in a court diversion program\nNone\nOTHER: Home-based Telerehabilitation|OTHER: Exercise Brochure\nBEHAVIORAL: Exercise|BEHAVIORAL: Control\nDRUG: GX-I7 or [14C] GX-I7\nBEHAVIORAL: Walking Programme\nPROCEDURE: circumcision|PROCEDURE: preputioplasty with intralesional injection of triamcinolone:\nDIAGNOSTIC_TEST: Biomolecular tumor analysis\nDEVICE: RNS® System\nNone\nPROCEDURE: temperature control\nOTHER: Observation\nDEVICE: filcon IV 1|DEVICE: ocufilcon D\nDIAGNOSTIC_TEST: Lyme diagnostic assay\nPROCEDURE: Short leg cast|PROCEDURE: No Immobilization\nBEHAVIORAL: Cognitive-Behavioral Dating Violence and HIV Prevention Group|BEHAVIORAL: Psycho-educational Dating Violence and HIV prevention group\nDRUG: ADG126\nDRUG: Peginesatide\nDEVICE: Focal irreversible electroporation of the prostate cancer\nDEVICE: real acupuncture|DEVICE: Placebo acupuncture\nOTHER: Accelerometer data\nNone\nPROCEDURE: 15 minutes eccentric cycling|PROCEDURE: 15 minutes concentric (normal) cycling\nDRUG: Pardoprunox\nPROCEDURE: Anal fistula plug\nOTHER: Lactobacillus Plantarum 299v in fermented oat drink|OTHER: Heat-Killed Placebo control fermented drink\nDRUG: Tamoxifen Letrozole Anastrozole or Exemestane\nDEVICE: catheterization\nNone\nDEVICE: Red Low-Level Light Therapy\nNone\nDRUG: Anticonvulsants\nDRUG: Tiotropium bromide\nBIOLOGICAL: FluMist® live attenuated intranasal seasonal influenza vaccine|BIOLOGICAL: Fluzone® inactivated influenza virus vaccine\nNone\nDRUG: Ketones|DRUG: Glucose\nDEVICE: EndoBarrier Gastrointestinal Liner|DEVICE: Easy life balloon\nRADIATION: Induction Chemotherapy followed by Response Adapted Chemoradiation\nDRUG: Sirolimus\nOTHER: Mixed Methods study\nDRUG: crizotinib\nPROCEDURE: Multidisciplinary medication review\nPROCEDURE: Pulmonary ultrasound\nBEHAVIORAL: In-depth Interview (IDIs) or Focus Group Discussion (FGD)\nDIETARY_SUPPLEMENT: Fish Oil|DIETARY_SUPPLEMENT: Safflower Oil\nPROCEDURE: laparoscopy in upper abdominal surgical emergencies in adults\nBEHAVIORAL: Text Message Craving Program|BEHAVIORAL: Self-Help Manual Plus Control Texts\nDEVICE: Intubation through ILMA®|DEVICE: Intubation through ILTS®\nOTHER: Virtual Reality-mediated Mindfulness-Based Interventions|OTHER: Virtual Reality-mediated Mindfulness-Based Interventions without audio guided experience\nDRUG: Esuberaprost|DRUG: Placebo\nDIETARY_SUPPLEMENT: Changes in energy and protein intake\nBEHAVIORAL: Training|BEHAVIORAL: No Training\nDRUG: Elidel 1% Topical Cream\nDRUG: Vedolizumab\nBEHAVIORAL: Home-based DVD-delivered physical activity|BEHAVIORAL: Behavioral: Usual care/Wait list\nOTHER: Simulation application\nNone\nDEVICE: Whole-body Electrical Muscle Stimulation Exercise\nDRUG: Pregabalin 150mg|DRUG: Fentanyl 100 micrograms ampoule\nDRUG: Vitamin D3 B.O.N. Injection\nDIETARY_SUPPLEMENT: Probiotic|DIETARY_SUPPLEMENT: Placebo\nBIOLOGICAL: Vaccinia virus: ACAM2000 smallpox vaccine|BIOLOGICAL: vaccinia virus (calf lymph): Dryvax\nBEHAVIORAL: Knäkontroll SISU Idrottsböcker© Sweden 2005\nBEHAVIORAL: Nurse-led Integrative health and wellness programme\nDRUG: Epidural analgesia|DRUG: Bilateral rectus sheath block|PROCEDURE: Laparotomy\nDRUG: Natesto\nDRUG: Grazoprevir|DRUG: Placebo to Grazoprevir|DRUG: Peginterferon alfa-2b (Peg-IFN)|DRUG: Ribavirin (RBV)\nDEVICE: Spinal Orthoses and Insoles|DEVICE: Spinal Orthoses\nDEVICE: External thermomechanical device delivering cold and vibration stimuli|DEVICE: External thermomechanical device without delivering cold and vibration stimuli|DRUG: Ethyl chloride skin refrigerant spray\nDRUG: Interferon beta-1b|DRUG: Zidovudine\nOTHER: Neuromuscular electrical stimulation (NMES/0\nPROCEDURE: 1) Fronto-Sphenoethmoidektomie 2) Draf 2b 3) Draf 3\nDRUG: RUC-4 Compound\nBEHAVIORAL: Mindfulness-based Yoga Arm\nOTHER: self-administered questionnaire and blood draw|OTHER: self-administered questionnaire and blood draw|OTHER: health questionnaire blood draw and skin exam\nDRUG: Botox Instillation|DRUG: DMSO Instillation\nGENETIC: Next generation sequencing|DIAGNOSTIC_TEST: Imaging and fluid biomarkers\nDIAGNOSTIC_TEST: KidneyIntelX\nDRUG: Nebulized heparin and salbutamol|DRUG: Nebulized salbutamol\nBIOLOGICAL: LAB4\nOTHER: Split-dose PEG Based Lavage (2L + 2L) with Low-Fibre Lunch Dietary instructions|OTHER: Split-dose PEG Based Lavage (2L + 2L) with Standard Dietary Instructions\nDRUG: Crisaborole ointment 2%|DRUG: Vehicle\nOTHER: ECG monitoring with a Kardia Mobile monitor\nDRUG: CKD-386(4) F1|DRUG: CKD-386(4) F2|DRUG: D013 D326 D337\nDRUG: PF-06291874|DRUG: Placebo\nDRUG: AB002 Dose 1|DRUG: AB002 Dose 2|DRUG: placebo\nPROCEDURE: CBP\nDRUG: Sindillimab\nOTHER: Connective Tissue Manipulation|OTHER: Transcutaneous Electrical Nerve Stimulation\nDRUG: 210 mg brodalumab|DRUG: 140 mg brodalumab|DRUG: Placebo\nOTHER: questionnaires & data collection\nDEVICE: Electrical Impedance tomography|OTHER: Lung mechanics and gas exchange\nDRUG: Sulforaphane Administration|OTHER: Placebo Administration|PROCEDURE: Standard of Care Surgery\nDEVICE: REVIAN 101|DEVICE: REVIAN 102|DEVICE: REVIAN 103|DEVICE: REVIAN 100\nDRUG: Sorafenib|DRUG: Omacetaxine Mepesuccinate Injection\nDIETARY_SUPPLEMENT: Oral Nutrition Support\nDRUG: ombitasvir/paritaprevir/ritonavir and dasabuvir|DRUG: ombitasvir/paritaprevir/ritonavir|DRUG: ribavirin\nDRUG: Methylphenidate\nDRUG: Vitamin C|DRUG: Placebo\nBIOLOGICAL: FluLaval® Quadrivalent|BIOLOGICAL: Fluzone®\nDEVICE: Coronary Intervention (GENOUS stent)\nDEVICE: Lumen-apposing metal stent (LAMS)|DEVICE: Double pigtail plastic stent (DPPS)\nDEVICE: ctDNA multi-omics test\nDRUG: ELX-02|DRUG: Ivacaftor\nDRUG: 0.9% (154 mEq/L) IV Sodium Chloride|DRUG: 1/6 M (166 mEq/L) IV Sodium Bicarbonate\nDRUG: metformin|DRUG: empagliflozin/metformin|DRUG: empagliflozin\nOTHER: acupuncture|DRUG: Cranberry products\nDRUG: Corticosteroid with lidocaine with epinephrine|DRUG: Corticosteroid with normal saline\nOTHER: Weight the food served minus the left-overs\nDRUG: recombinant human porphobilinogen deaminase (Porphozym)\nOTHER: audit\nDRUG: Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) + Placebo|DRUG: Moxifloxacin 400mg|OTHER: Placebo for Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr)|DRUG: Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr)\nNone\nDIETARY_SUPPLEMENT: Probiotic supplemented intervention|DIETARY_SUPPLEMENT: Placebo\nNone\nNone\nBEHAVIORAL: Water quality|BEHAVIORAL: Sanitation|BEHAVIORAL: Hand washing|BEHAVIORAL: Water quality Sanitation Hand washing (Combined WASH)|BEHAVIORAL: Nutrition|BEHAVIORAL: Nutrition Water quality Sanitation Hand washing\nDRUG: Gemcitabine/nab-Paclitaxel|RADIATION: Radiation therapy|OTHER: Sugical resection|DRUG: Adjuvant chemotheapy\nOTHER: protective ventilation|OTHER: conventional ventilation\nDRUG: Cladribine|DRUG: Cytarabine|DRUG: Gilteritinib|DRUG: Idarubicin|OTHER: Laboratory Biomarker Analysis|DRUG: Midostaurin|DRUG: Venetoclax\nDRUG: Cholecalciferol\nDRUG: Zidovudine|DRUG: Ganciclovir\nNone\nDEVICE: Transcranial magnetic stimulation (TMS)\nBEHAVIORAL: MFG\nPROCEDURE: Whole blood sample\nPROCEDURE: Mapping and Pacing the His Bundle|PROCEDURE: Placing a guidewire in Coronary sinus for measurement of Q-LV during His Bundle pacing or if needed for LV pacing\nNone\nBEHAVIORAL: Nutritional Education Intervention\nDIETARY_SUPPLEMENT: Adlay with white rice|DIETARY_SUPPLEMENT: white rice\nBEHAVIORAL: digital health delivered multicomponent intervention\nDIETARY_SUPPLEMENT: Lactobacillus Rhamnosus GG|DRUG: Placebo for Probiotic\nDIAGNOSTIC_TEST: ESC 0/1 hour troponin pathway\nDRUG: Xentuzumab\nPROCEDURE: Erythropheresis\nOTHER: Comfort Talk\nDRUG: MediCabilis Cannabis sativa 50\nDEVICE: NeuRx® Diaphragm Pacing System™ (DPS)\nDRUG: sapropterin dihydrochloride\nDEVICE: Balloon expandable stent|DEVICE: Self expandable stent\nDRUG: cyclosporine|DRUG: saline solution\nDIETARY_SUPPLEMENT: EGCG|DIETARY_SUPPLEMENT: Placebo (deionized water)\nNone\nDRUG: Temozolomide bevacizumab and bortezomib\nDEVICE: Transcranial infrared laser stimulation\nDRUG: IBI-20089/Lucentis\nNone\nPROCEDURE: Endoscopic Retrograde Cholangiopancreatography (ERCP)with Cholangiopancreatoscopy using the thin scope\nBEHAVIORAL: Human Simulation Training\nBEHAVIORAL: adult microfinance|BEHAVIORAL: Youth microfinance only|BEHAVIORAL: youth and adult micro finance\nBEHAVIORAL: DBT|BEHAVIORAL: I/GDC\nDRUG: Lazertinib|DRUG: Amivantamab|DRUG: Pemetrexed|DRUG: Carboplatin\nBIOLOGICAL: CTC\nDEVICE: Actual IPL|DEVICE: Sham IPL|DEVICE: LLLT\nOTHER: lifestyle intervention or insulin treatment\nPROCEDURE: Acupuncture|PROCEDURE: Enery Medicine Intervention|PROCEDURE: Sham Energy Medicine\nOTHER: Whole-grain rye high lignan|OTHER: Whole-grain wheat low lignan\nOTHER: Foam-Roller|OTHER: Neuromuscular stretching|OTHER: Pasive stretching\nOTHER: Smoking Cessation\nBEHAVIORAL: Idaho Rural Implementation Model|BEHAVIORAL: Control\nOTHER: Transcranial doppler examination\nDRUG: FTC/TDF|DRUG: F/TAF|DRUG: Allowed third antiretroviral agent|DRUG: FTC/TDF Placebo|DRUG: F/TAF Placebo\nDRUG: BI 894416\nPROCEDURE: Trapeziectomy with LRTI|PROCEDURE: Trapeziectomy\nDRUG: Efavirenz-Tenofovir-Emtricitabine|DRUG: Zidovudine-Lamivudine-Lopinavir/Ritonavir\nOTHER: Assessment the pre-washed sperm motility before IUI\nBEHAVIORAL: Behavioral and Structural Intervention|BEHAVIORAL: Screening and Referral\nDRUG: Aliskiren|DRUG: Placebo\nOTHER: Personalized dietary and wellness program\nDEVICE: Noninvasive respiratory support\nBEHAVIORAL: Acceptance and Commitment Therapy|BEHAVIORAL: Information Motivation Behavioral Model\nPROCEDURE: Endoscopic tympanoplasty\nOTHER: Duchenne Muscular Dystrophy Gait Assessment Scale\nDRUG: MT-7117\nDEVICE: Enhanced External Counterpulsation (EECP)|DRUG: Simvastatin\nDRUG: INSULIN GLARGINE\nDEVICE: AccuCath Intravenous Catheter System\nDRUG: Belumosudil\nPROCEDURE: TAP block|PROCEDURE: QL Block\nDRUG: Metformin|DRUG: Placebo\nPROCEDURE: Magnetic Resonance Imaging (MRI)|PROCEDURE: Diffusion Weighted Magnetic Resonance Imaging (DWMR)\nNone\nDEVICE: Boston Scientific Acurate neo2 TAVR device\nDRUG: ATx201|OTHER: ATx201 GEL Vehicle\nDRUG: Placebo|DRUG: SAM-531 1.5 mg|DRUG: SAM-531 3.0 mg|DRUG: SAM-531 5.0 mg|DRUG: Donepezil\nBIOLOGICAL: VGX-3100|DEVICE: CELLECTRA™ 5PSP\nDEVICE: In a double-blinded fashion 250 mg CANNAXR cream|DEVICE: Topical VEHICLE cream\nDRUG: Risedronate|DRUG: Placebo\nDRUG: Atezolizumab\nDRUG: NBP\nDIAGNOSTIC_TEST: MRI brain Blood tests cognitive assessments\nNone\nBIOLOGICAL: Live attenuated H7N9 A/Anhui/13 ca influenza virus vaccine|BIOLOGICAL: Inactivated subvirion H7N9 influenza vaccine\nBEHAVIORAL: Functional Family Therapy|BEHAVIORAL: Motivational Enhancement Tx/Cognitive Behavioral Tx|BEHAVIORAL: Contingency Management\nDRUG: Receiving hydration with a 1 mL/kg bolus of intravenous isotonic saline (0.9% sodium chloride)|DRUG: 3 mL/kg.hour bolus of intravenous isotonic saline (0.9% sodium chloride)\nOTHER: Combined antibiotic regimens|OTHER: Standard antibiotic regimens\nNone\nDEVICE: CT Scan and ultrasonography\nDRUG: Escitalopram\nBIOLOGICAL: SRL-172\nOTHER: Data collection\nDEVICE: GenesisPlus 1064 nm Nd:YAG laser\nDRUG: Adriamycin Taxol and Cytoxan\nOTHER: Baduanjin exercise|OTHER: aerobic exercise\nDEVICE: BVA-100|DEVICE: Transpulmonary Thermodilution (TPTD)|DEVICE: Sublingual Microcirculation\nNone\nDRUG: fostamatinib\nGENETIC: Genetic analysis for PCSK9 polymorphisms\nPROCEDURE: allogeneic HSCT\nBEHAVIORAL: Pilot Study\nBIOLOGICAL: IMPT-514|BIOLOGICAL: IMPT-514|BIOLOGICAL: IMPT-514\nDRUG: Apremilast|OTHER: Placebo\nOTHER: Observational study. Postnatal variables are recorded\nDRUG: Eylea (Aflibercept VEGF Trap-Eye BAY86-5321)\nDRUG: Belladonna and Opium Suppository|PROCEDURE: Rectal Exam\nBIOLOGICAL: DNA-C CN54ENV|BIOLOGICAL: CN54gp140|DEVICE: Trigrid Delivery System - Intramuscular|DEVICE: Trigrid Delivery System - Intradermal\nDRUG: Duloxetine Hydrochloride|DRUG: Venlafaxine Extended Release\nNone\nDRUG: 15 mg E4/3 mg DRSP|DRUG: 20 mcg EE/3 mg DRSP\nBEHAVIORAL: Black Respondents Exposure to a Photo\nDRUG: Dexamethasone|DRUG: Iberdomide Hydrochloride|OTHER: Quality-of-Life Assessment\nNone\nNone\nOTHER: Let's Talk About Pain Training|OTHER: Family Centered Care Training\nDIAGNOSTIC_TEST: Non interventional\nDRUG: Carboplatin|DRUG: Docetaxel|OTHER: Laboratory Biomarker Analysis\nDEVICE: Transcranial magnet stimulation|DEVICE: Sham Transcranial magnet stimulation\nDIAGNOSTIC_TEST: Punch biopsy\nDRUG: Nilotinib|DRUG: Nilotinib with Imatinib\nOTHER: Installation of ventilation\nOTHER: COVID-19\nDRUG: [14C]-praliciguat\nDRUG: Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension|DRUG: Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX)\nNone\nPROCEDURE: Stent placement\nBIOLOGICAL: bevacizumab|BIOLOGICAL: pegfilgrastim|BIOLOGICAL: rituximab|DRUG: cyclophosphamide|DRUG: pentostatin\nDIETARY_SUPPLEMENT: Beta Alanine high dose|DIETARY_SUPPLEMENT: Beta Alanine low dose|DIETARY_SUPPLEMENT: Control product\nOTHER: Hematopoietic stem cell transplantation\nNone\nNone\nDRUG: biphasic insulin aspart 30\nDRUG: Sorafenib Tablets\nDEVICE: transcranial Direct Current Stimulation (tDCS): (Soterix ©)\nOTHER: all children with at least one prescription of PPI|OTHER: all children with no prescription of PPI\nDEVICE: The Colonic Transendoscopic enteral Tubing.|DRUG: Glutamine|DRUG: Mesalazine\nNone\nDIAGNOSTIC_TEST: RestEaze\nDRUG: Prostacyclin 1 ng/kg/min|DRUG: Prostacyclin 2 ng/kg/min|DRUG: Placebo\nDRUG: MPDL3280A|DRUG: mDCF\nOTHER: no intervention\nDEVICE: Laser and Fluoride|OTHER: Fluoride\nOTHER: Supportive care\nDEVICE: SENSIUM Patch\nDRUG: Efavirenz\nPROCEDURE: Intraoperative fluorescent cholangiography (IFC)\nNone\nBIOLOGICAL: blood samplings\nDRUG: Amivantamab|BIOLOGICAL: Fluorouracil|BIOLOGICAL: Leucovorin|BIOLOGICAL: Oxaliplatin|BIOLOGICAL: Irinotecan\nDRUG: Amiodarone|OTHER: Control arm standard care\nBEHAVIORAL: Mindfulness-based Cognitive Therapy (MBCT)\nDRUG: HC-1119|DRUG: Enzalutamide\nNone\nPROCEDURE: Liver transplantation|RADIATION: 45 Gy external radiations|RADIATION: Endoluminal bile duct Brachytherapy|DRUG: Capecitabine|PROCEDURE: Pre liver transplantation laparoscopic hand assisted staging\nDRUG: Human insulin 30/70|DRUG: Insulin lispro low mix\nDRUG: MEE-HU Medicus|OTHER: Placebo\nDRUG: naltrexone implant\nDEVICE: Microfracture with BST-CarGel|DEVICE: Microfracture without BST-CarGel\nOTHER: Psychological Therapy - Schema Therapy\nDRUG: 5LGr|DRUG: tiapride|DRUG: placebo\nDRUG: ACTH\nBIOLOGICAL: DTP-HB-Hib vaccine|DEVICE: Disposable Syringe Jet Injector (DSJI)|OTHER: Needle & Syringe\nOTHER: 1st tertile 2nd tertile 3rd tertile\nPROCEDURE: Biospecimen Collection|OTHER: Medical Chart Review\nDRUG: acetaminophen|DRUG: Rofecoxib|DRUG: Rofecoxib\nRADIATION: 39.6 Gy radiation\nDRUG: Tadalafil|DRUG: Placebo\nPROCEDURE: CEMP (closed-ended multiport catheter) group|PROCEDURE: OESP (open-ended single port catheter) group|PROCEDURE: Patient-controlled analgesia\nBEHAVIORAL: Sentinel Lymph Node Technique\nDRUG: Slow Dose Titration Group of Subcutaneous Treprostinil|DRUG: Rapid Dose Titration Group of Subcutaneous Treprostinil\nDRUG: ibrutinib ou idelalisib\nDRUG: PF-06687234|DRUG: Placebo\nOTHER: Patient Registry\nDRUG: Adriamycin|DRUG: Cyclophosphamide|DRUG: Cytarabine|DRUG: Dexamethasone|DRUG: Idarubicin|DRUG: Ifosfamide|DRUG: Methotrexate|DRUG: Mercaptopurine|DRUG: VM26|DRUG: Vincristine\nBEHAVIORAL: Lifestyle intervention\nOTHER: School-based exercise program\nPROCEDURE: early feeding|PROCEDURE: delayed feeding\nDRUG: tucatinib|DRUG: itraconazole|DRUG: rifampin|DRUG: gemfibrozil|DRUG: repaglinide|DRUG: tolbutamide|DRUG: midazolam|DRUG: digoxin\nDRUG: Artemether-lumefantrine|DRUG: Amodiaquine|DRUG: Artemether-lumefantrine|DRUG: Artemether-lumefantrine + Amodiaquine\nPROCEDURE: Left ventricular contractile reserve SE|PROCEDURE: B-lines SE|PROCEDURE: Left ventricular outflow tract gradient SE|PROCEDURE: Diastolic function SE|PROCEDURE: Mitral regurgitation SE|PROCEDURE: Pulmonary hemodynamics SE|PROCEDURE: Coronary flow reserve SE\nPROCEDURE: sympathetic block\nBEHAVIORAL: Seated exercise\nOTHER: Training\nDIAGNOSTIC_TEST: Failure Track patients analysis\nDIAGNOSTIC_TEST: Blood sampling\nDRUG: ALTIM cortivazol injections|DRUG: PROAMP subcutaneous serum physiological saline|DRUG: Verapamil\nPROCEDURE: CSDH - Bedside twist drill technique|PROCEDURE: CSDH - Operating Room Burr-hole technique\nNone\nBIOLOGICAL: pneumococcal conjugate vaccine(prevenar)\nDRUG: CSF-1|DRUG: Vehicle\nDRUG: Kaletra + Current Dual NRTI Backbone|DRUG: Current Regimen\nBEHAVIORAL: Usual Care post-Intensive Care Unit (ICU)|BEHAVIORAL: Anticipating Decline and Providing Therapy (ADAPT)\nBIOLOGICAL: Guselkumab\nNone\nDIETARY_SUPPLEMENT: Calmera-Licorice Root Extract (Licogen)\nPROCEDURE: periodontal surgical procedure (open flap debridement)|PROCEDURE: periodontal surgical procedure (OFD +autogenous Titanium-prepared platelet-rich fibrin (OFD+ T-PRF))\nBEHAVIORAL: Meaning of Screening|BEHAVIORAL: Genetic Counseling|BEHAVIORAL: Usual Care\nNone\nDEVICE: Hydrophobic IOL: Vivinex (HOYA)|DEVICE: Hydrophilic IOL: INCISE (Bausch+Lomb)\nDRUG: Doravirine (DOR)|DRUG: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF)|DRUG: Antiretroviral (ARV) medications\nNone\nDRUG: FLUTICASONE PROPRIONATE|DRUG: Salmeterol|DRUG: PLACEBO\nDEVICE: SOLX Gold Shunt GMS-plus|DEVICE: Ahmed FP7 Glaucoma Valve\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the sixth column from each row of the final RDD filtered_rdd_with_header\n",
    "\n",
    "interventions = filtered_rdd_with_header.map(lambda row: row[5])\n",
    "\n",
    "# Display the first column values\n",
    "for value in interventions.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "6a1076b5-148b-4a8b-8b45-19fcfd7a6bdb",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sponsor\nSangath\nMcMaster University\nMelbourne Health\nAssistance Publique - Hôpitaux de Paris\nIstituto Auxologico Italiano\nUniversity of Oregon\nMedical University of South Carolina\nJohns Hopkins University\nUniversity of Manitoba\nM.D. Anderson Cancer Center\nUniversity of Colorado Denver\nKing's College London\nNational Institute of Allergy and Infectious Diseases (NIAID)\nUniversity of Oslo\nThe First Affiliated Hospital with Nanjing Medical University\nIRCCS San Raffaele\nKarolinska University Hospital\nHôpital NOVO\nBaqiyatallah Medical Sciences University\nCentre Leon Berard\nAmsterdam UMC location VUmc\nMedical University of Graz\nAthos Therapeutics Inc\nTurku University Hospital\nLaboratorios Sophia S.A de C.V.\nRadboud University Medical Center\nChildren's Cancer and Leukaemia Group\nHospices Civils de Lyon\nCancer Institute and Hospital Chinese Academy of Medical Sciences\nUniversity of Missouri-Columbia\nNational Taiwan University Hospital\nUniversity of Pisa\nUniversity of Oslo\nYi Han\nNear East University Turkey\nUniversity Hospital Strasbourg France\nHangang Sacred Heart Hospital\nUniversity of Heidelberg Medical Center\nAlbanian University\nJun Zhu\nLund University\nCentervue SpA\nUniversity Hospital Angers\nHospital Italiano de Buenos Aires\nNational Centre of Ophthalmology named after academician Zarifa Aliyeva\nThe University of Texas Health Science Center Houston\nEBG MedAustron GmbH\nRoyal Marsden NHS Foundation Trust\nWolfram Schummer MD PhD\nInstitute of Liver and Biliary Sciences India\nZealand University Hospital\nHillel Yaffe Medical Center\nCentre Hospitalier Intercommunal Creteil\nThe University of Texas Health Science Center Houston\nTaisho Pharmaceutical Co. Ltd.\nSunnybrook Health Sciences Centre\nKenota Inc.\nNational Cancer Center Korea\nUniversity of British Columbia\nUniversity College London Hospitals\nChonbuk National University Hospital\nSan Diego State University\nSanofi\nMcGill University\nShandong University\nUniversity Hospital Rouen\nBoston College\nRecep Tayyip Erdogan University Training and Research Hospital\nThe University of Hong Kong\nGuangxi Medical University\nAl-Azhar University\nUniversity of South Florida\nWenzhou Medical University\nUniversity of Maryland Baltimore\nCEN Biotech\nUniversity of California Los Angeles\nAssistance Publique - Hôpitaux de Paris\nKarolinska Institutet\nRadboud University Medical Center\nG.R. Dome Medical Ltd.\nFerring Pharmaceuticals\nUniversity of Miami\nJiangsu HengRui Medicine Co. Ltd.\nAlexandria University\nUniversity of North Carolina Chapel Hill\nUniversity of Colorado Denver\nUniversity of Nottingham\nFundación de investigación HM\nOslo University Hospital\nUCB Pharma\nFondation Lenval\nWolfson Medical Center\nYale University\nNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\nUniversity of California Los Angeles\nUniversity of Zurich\nTexas Christian University\nZhongzheng Xiang\nEMD Serono Research & Development Institute Inc.\nSwansea University\nBristol-Myers Squibb\nChicago Anesthesia Pain Specialists\nPfizer\nUppsala University\nM.D. Anderson Cancer Center\nAssiut University\nUniversity Hospital Geneva\nUniversity of Palermo\nFondazione Policlinico Universitario Agostino Gemelli IRCCS\nUniversidad de Murcia\nGeorgetown University\nUniversity of British Columbia\nNational Cancer Institute (NCI)\nAll India Institute of Medical Sciences New Delhi\nPeking University People's Hospital\nJi Xing Pharmaceuticals Australia Pty Ltd\nGilead Sciences\nPedro Morgado\nHelsinki University Central Hospital\nHacettepe University\nCentre Hospitalier Universitaire de Saint Etienne\nJames Stannard\nHITEC-Institute of Medical Sciences\nMemorialCare Health System\nBeth Israel Deaconess Medical Center\nSun Yat-sen University\nAHS Cancer Control Alberta\nUniversity of Bologna\nRetina Vitreous Associates of Florida\nTufts University\nUniversity of Miami\nOystershell NV\nUniversity of Michigan Rogel Cancer Center\nDanish Pain Research Center\nGreen Cross Corporation\nWayne State University\nImmuneMed Inc.\nFortaleza University\nColumbia University\nMinneapolis Veterans Affairs Medical Center\nJohns Hopkins University\nCairo University\nIcahn School of Medicine at Mount Sinai\nUniversity of Turku\nHepNet Study House German Liverfoundation\nCentre Hospitalier Universitaire de Saint Etienne\nFederico II University\nRiphah International University\nAstraZeneca\nAstellas Pharma China Inc.\nCity of Hope Medical Center\nUniversity of Coimbra\nAbramson Cancer Center at Penn Medicine\nGenitope Corporation\nHaihe Biopharma Co. Ltd.\nBayer\nRustam Aghazada\nQLT Inc.\nInstitut Straumann AG\nCraig Hospital\nAarhus University Hospital Skejby\nGlaxoSmithKline\nRigshospitalet Denmark\nDong-Gu Kim\nAssistance Publique - Hôpitaux de Paris\nPeking Union Medical College Hospital\nSeoul National University Hospital\nUniversity Hospital of North Norway\nTexas Christian University\nShin Kong Wu Ho-Su Memorial Hospital\nBaxter Healthcare Corporation\nJohnson & Johnson Vision Care Inc.\nUniversity of Iowa\nAssociation of Urologic Oncology (AUO)\nNational Institute of Allergy and Infectious Diseases (NIAID)\nAssuta Ashdod Hospital\nNational Taiwan University Hospital\nJohns Hopkins Bloomberg School of Public Health\nUniversity of Colorado Denver\nEli Lilly and Company\nAssociation NVALT Studies\nIperboreal Pharma Srl\nCantargia AB\nBoston Children's Hospital\nW.L.Gore & Associates\nArizona State University\nMetropolis Medical\nMedtronic Diabetes\nUniversita di Verona\nKazia Therapeutics Limited\nImmunovant Sciences GmbH\nAstraZeneca\nM.D. Anderson Cancer Center\nUniversity of Manitoba\nFrancisco Campos-Rodriguez\nShanghai Zhongshan Hospital\nMansoura University\nThe Cleveland Clinic\nSanofi\nHadassah Medical Organization\nEmory University\nHaukeland University Hospital\nHoffmann-La Roche\nStony Brook University\nBeijing 302 Hospital\nDuke University\nSunshine Lake Pharma Co. Ltd.\nMontefiore Medical Center\nThe First Affiliated Hospital with Nanjing Medical University\nAcclarent\nVA Connecticut Healthcare System\nUniversity Hospital Montpellier\nBausch & Lomb Incorporated\nHospital Clinic of Barcelona\nIstituto Ortopedico Rizzoli\nNational Institute on Aging (NIA)\nUniversity of Florida\nIstituto Auxologico Italiano\nMaastricht University Medical Center\nImperial College London\nUniversity of Southern California\nForegut Research Foundation\nBoehringer Ingelheim\nUniversity of Erlangen-Nürnberg Medical School\nZai Lab (Shanghai) Co. Ltd.\nHopital Foch\nMarina Garassino\nAssistance Publique - Hôpitaux de Paris\nFundació d'investigació Sanitària de les Illes Balears\nAmerican University of Beirut Medical Center\nKorea Otsuka International Asia Arab\nMaharishi Markendeswar University (Deemed to be University)\nMirati Therapeutics Inc.\nUniversity of Zurich\nBroncus Medical Inc\nJanssen Research & Development LLC\nUniversity of Southern California\nHoffmann-La Roche\nIRCCS Policlinico S. Donato\nUniversity of Alberta\nOncothyreon Canada Inc.\nMerz Pharmaceuticals GmbH\nMinistry of Health Thailand\nPeking University People's Hospital\nSoutheast University China\nUniversity College London\nStryker Trauma GmbH\nSkylineDx\nMassachusetts General Hospital\nCentral Hospital Nancy France\nJianhua Zhou\nChang Gung Memorial Hospital\nWake Forest University Health Sciences\nUniversity of British Columbia\nRegeneron Pharmaceuticals\nJordan Hospital\nCPL Associates\nDiakonhjemmet Hospital\nKaohsiung Veterans General Hospital.\nJohns Hopkins Bloomberg School of Public Health\nSeoul St. Mary's Hospital\nJohnson & Johnson Consumer Inc. (J&JCI)\nUniversity of Washington\nPharmaEssentia\nUniversity of Aarhus\nBayer\nMilton S. Hershey Medical Center\nSeattle Children's Hospital\nUniversity of Pennsylvania\nGenzyme a Sanofi Company\nJohns Hopkins University\nShandong Cancer Hospital and Institute\nCentre hospitalier de l'Université de Montréal (CHUM)\nFidia Farmaceutici s.p.a.\nThe Leeds Teaching Hospitals NHS Trust\nUS Department of Veterans Affairs\nCentre Hospitalier Universitaire de la Réunion\nChong Kun Dang Pharmaceutical\nNational Institute of Cardiology Warsaw Poland\nNational Heart Lung and Blood Institute (NHLBI)\nUniversity College Dublin\nEnox Israel Ltd\nUniversity of Sheffield\nUniversity Hospital Basel Switzerland\nMcGill University Health Centre/Research Institute of the McGill University Health Centre\nSteward St. Elizabeth's Medical Center of Boston Inc.\nMedtronic Cardiac Rhythm and Heart Failure\nChildren's Hospital of Philadelphia\nJohns Hopkins University\nShanghai PerHum Therapeutics Co. Ltd.\nEpeius Biotechnologies\nSanaria Inc.\nSt. Joseph's Healthcare Hamilton\nLife University\nCatholic University of the Sacred Heart\nChildren's Hospital and Institute of Child Health Multan\nNightBalance\nBeijing Chaoyang District Centre for Disease Control and Prevention\nVanderbilt University\nAbbVie\nKaohsiung Medical University Chung-Ho Memorial Hospital\nUniversity of Chicago\nUniversity of Nottingham\nMassachusetts General Hospital\nEMD Serono Research & Development Institute Inc.\nBetta Pharmaceuticals Co. Ltd.\nM.D. Anderson Cancer Center\nNational Institute of Mental Health (NIMH)\nZiemer Ophthalmic Systems AG\nOrthoCarolina Research Institute Inc.\nUniversity of South Carolina\nUniversity of Primorska\nUniversity of Colorado Denver\nBaki Topal\nNYU Langone Health\nBispebjerg Hospital\nHunan Normal University\nIstituto Ortopedico Rizzoli\nNational Institute of Allergy and Infectious Diseases (NIAID)\nGalderma R&D\nUniversity of California Los Angeles\nISTO Technologies Inc.\nKarolinska Institutet\nShandong University\nSaglik Bilimleri Universitesi Gulhane Tip Fakultesi\nDr. Reddy's Laboratories Limited\nFerring Pharmaceuticals\nValduce Hospital\nUniversity of Manitoba\nUniversity Hospital Bordeaux\nChinese PLA General Hospital\nM.D. Anderson Cancer Center\nMaria Wei\nAssistance Publique - Hôpitaux de Paris\nShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd.\nGlaxoSmithKline\nCarilion Clinic\nState University of New York - Upstate Medical University\nInternational Partnership for Microbicides Inc.\nJohnson & Johnson Vision Care Inc.\nSmith & Nephew Inc.\nBandim Health Project\nAthira Pharma\nOttawa Hospital Research Institute\nPfizer\nMersin University\nFactors Group of Nutritional Companies Inc.\nHealthy.io Ltd.\nSidney Kimmel Comprehensive Cancer Center at Johns Hopkins\nUniversity of California Los Angeles\nMcGill University Health Centre/Research Institute of the McGill University Health Centre\nSt. Jude Children's Research Hospital\nUniversity of California San Francisco\nHellenic Oncology Research Group\nM.D. Anderson Cancer Center\nHemoSonics LLC\nAssaf-Harofeh Medical Center\nNational Taiwan University Hospital\nSmileDent Kft.\nFondazione Policlinico Universitario Agostino Gemelli IRCCS\nHospital de Clinicas de Porto Alegre\nLund University\nAkeso\nFirst Affiliated Hospital Sun Yat-Sen University\nKamada Ltd.\nRecepta Biopharma\nCelgene\nVienna Institute for Research in Ocular Surgery\nSun Yat-sen University\nMarmara University\nEuropean Organisation for Research and Treatment of Cancer - EORTC\nGenSight Biologics\nZeynep Kamil Maternity and Pediatric Research and Training Hospital\nMitsubishi Tanabe Pharma America Inc.\nAlkermes Inc.\nWake Forest University Health Sciences\nMedical University of Vienna\nPamukkale University\nVA Office of Research and Development\nTaipei Medical University\nMayo Clinic\nUniversity Hospital Clermont-Ferrand\nFoundation for Public Health and Epidemiological Research of Venezuela\nNational Cancer Institute (NCI)\nHenrik Gudbergsen\nNYU Langone Health\nSpeedel Pharma Ltd.\nUniversity of Rome Tor Vergata\nUniversity of Southern Denmark\nBoehringer Ingelheim\nGiulia Da Poian\n[Redacted]\nHospital Infantil Universitario Niño Jesús Madrid Spain\nQianqian Qu\nChristiana Care Health Services\nNovo Nordisk A/S\nMerck KGaA Darmstadt Germany\nSt Vincent's University Hospital Ireland\nWuhan Union Hospital China\nMedtronic Bakken Research Center\nUniversity College London\nCopenhagen University Hospital at Herlev\nUniversity of Aarhus\nRiphah International University\nNext Gen Pharma India Pvt. Ltd.\nNationwide Children's Hospital\nUniversity of North Carolina Chapel Hill\nRenJi Hospital\nGlaxoSmithKline\nHvidovre University Hospital\nHellenic Cardiovascular Research Society\nXijing Hospital\nNovo Nordisk A/S\nUniversidad de Valparaiso\nVanderbilt University Medical Center\nEli Lilly and Company\nLEO Pharma\nAstraZeneca\nMaruho Co. Ltd.\nMerck KGaA Darmstadt Germany\nChonnam National University Hospital\nBoehringer Ingelheim\nFlorida State University\nUniversity of Alberta\nMitsubishi Tanabe Pharma Corporation\nUniversity of Texas Southwestern Medical Center\nAlbert B. Sabin Vaccine Institute\nRadboud University Medical Center\nVarazdin General Hospital\nUSDA Western Human Nutrition Research Center\nTecnoquimicas\nUniversity of Alberta\nAbramson Cancer Center at Penn Medicine\nTeva Branded Pharmaceutical Products R&D Inc.\nTriHealth Inc.\nCedars-Sinai Medical Center\nUniversity of Pittsburgh\nHealth Ever Bio-Tech Co. Ltd.\nRWTH Aachen University\nHuashan Hospital\nRadial Medical Inc.\nTiffany Love\nTung Wah College\nUniversity of North Carolina Chapel Hill\nBaylor College of Medicine\nAssuta Hospital Systems\nAzidus Brasil\nBrigham and Women's Hospital\nHospital General Universitario Elche\nFederal University of Minas Gerais\nOregon Health and Science University\nBelfast Health and Social Care Trust\nRabin Medical Center\nCairo University\nAustral University Argentina\nNovartis\nRubens Belfort Jr.\nGoethe University\nUniversity of Southern California\nShanghai Meiji Health Science and Technology Co. Ltd.\nAxcan Pharma\nMayo Clinic\nUniversity of Alberta\nOswaldo Cruz Foundation\nHamilton Health Sciences Corporation\nAssiut University\nSamuel Lunenfeld Research Institute Mount Sinai Hospital\nVolta Medical\nSao Jose do Rio Preto Medical School\nMicroelastic Ultrasound Systems Inc\nUniversity of North Carolina Chapel Hill\nMerck Sharp & Dohme LLC\nAlexandria University\nNiche Biomedical Inc. dba ANEUVO\nFayoum University Hospital\nBarts & The London NHS Trust\nShanghai Jiatan Pharmatech Co. Ltd\nDuke University\nThe Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery\nNeuroPace\nAstex Pharmaceuticals Inc.\nBeijing HuiLongGuan Hospital\nHenan Cancer Hospital\nAtaturk University\nHospices Civils de Lyon\nUniversity of North Carolina Chapel Hill\nAugusta University\nMylan Bertek Pharmaceuticals\nVA Palo Alto Health Care System\nLeap Therapeutics Inc.\nUNC Lineberger Comprehensive Cancer Center\nChina National Center for Cardiovascular Diseases\nInstitut de Recherche Biomedicale des Armees\nDamascus University\nUniversity College London\nMunicipal Hospital Vila Nova Cachoeirinha\nFondazione Policlinico Universitario Agostino Gemelli IRCCS\nThe Christ Hospital\nGöteborg University\nUnity Health Toronto\nMeir Medical Center\nGroupe d'Etude Therapeutique des Affections Inflammatoires Digestives\nYale University\nFondation Ophtalmologique Adolphe de Rothschild\nFerring Pharmaceuticals\nSahlgrenska University Hospital Sweden\nNational Baromedical Services\nAljazeera Hospital\nNational Human Genome Research Institute (NHGRI)\nZambon SpA\nJohns Hopkins University\nGenor Biopharma Co. Ltd.\nGangnam Severance Hospital\nHasselt University\nAssiut University\nGlaxoSmithKline\nState University of New York - Upstate Medical University\nNovartis Pharmaceuticals\nHospital de Clinicas de Porto Alegre\nShanghai Zhongshan Hospital\nUniversity of Utah\nLexicon Pharmaceuticals\nBayer\nNational Cheng-Kung University Hospital\nNYU Langone Health\nHeart and Diabetes Center North-Rhine Westfalia\nColumbia University\nUniversity of California Davis\nHoffmann-La Roche\nMedical University of Vienna\nUniversity of Rome Tor Vergata\nPfizer\nUniversity of Virginia\nVaximm GmbH\nCase Comprehensive Cancer Center\nUniversity of North Carolina Chapel Hill\nIntegrative Research Laboratories AB\nStanford University\nChinese University of Hong Kong\nPfizer\nVanderbilt University Medical Center\nToronto Metropolitan University\nUniversity Hospital Lille\nWestVac Biopharma Co. Ltd.\nUCB Pharma\nUniversity of Virginia\nSheba Medical Center\nInstitut d'Investigació Biomèdica de Bellvitge\nKantonsspital Aarau\nUSDA Grand Forks Human Nutrition Research Center\nOslo University Hospital\nVanderbilt University\nAfyonkarahisar Health Sciences University\nWest Penn Allegheny Health System\nUnity Health Toronto\nCentre Hospitalier Universitaire de Besancon\nMahidol University\nThe University of Texas Medical Branch Galveston\nMahidol University\nSanofi Pasteur a Sanofi Company\nXuanwu Hospital Beijing\nVA Office of Research and Development\nBoston Medical Center\nJohns Hopkins University\nPennington Biomedical Research Center\nmanar sameh el taher\nSohag University\nFudan University\nSilence Therapeutics plc\nPhilips Clinical & Medical Affairs Global\nQueen Sirikit National Institute of Child Health\nCentre Hospitalier Universitaire de Nice\nUniversity Hospital Limoges\nJohns Hopkins University\nOlatec Therapeutics LLC\nUniversity of California San Diego\nDar El Oyoun Hospital\nUniversity Hospital Essen\nFujian Medical University\nCTI BioPharma\nWashington University School of Medicine\nChina Medical University Hospital\nJoana Perez Tejada\nNovartis\nState University of New York - Upstate Medical University\nYonsei University\nEli Lilly and Company\nFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico\nUniversity of Zurich\nHospital for Special Surgery New York\nMeshalkin Research Institute of Pathology of Circulation\nJonsson Comprehensive Cancer Center\nZymoGenetics\nMedtronicNeuro\nNimbic Systems LLC\nRiphah International University\nVärmland County Council Sweden\nKarolinska Institutet\nCharite University Berlin Germany\nWyeth is now a wholly owned subsidiary of Pfizer\nH. Lundbeck A/S\nKolon Life Science\nSt. Joseph's Healthcare Hamilton\nImam Abdulrahman Bin Faisal University\nAcclarent\nOtsuka Pharmaceutical Co. Ltd.\nSanofi\nSecond Affiliated Hospital School of Medicine Zhejiang University\nChinese PLA General Hospital\nNova Scotia Health Authority\nThe University of Texas Health Science Center at San Antonio\nDaewon Pharmaceutical Co. Ltd.\nGynecologic Oncology Group\nSeoul National University Hospital\nUniversity Hospital Strasbourg France\nUniversity Hospital Toulouse\nMedical University of South Carolina\nPediatrix\nHanan Nabil\nGuangzhou First People's Hospital\nJohns Hopkins University\nUniversity Hospitals Leicester\nAssiut University\nUniversity of Florida\nAugusta University\nBarking Havering and Redbridge University Hospitals NHS Trust\nNovartis Pharmaceuticals\nUniversity of Zurich\nLatin American Cooperative Oncology Group\nResearch Institute of Child Nutrition Dortmund\nCoronado Biosciences Inc.\nAlexandria University\nGenzyme a Sanofi Company\nBausch Health Americas Inc.\nNational Cancer Institute (NCI)\nYonsei University\nAssiut University\nEmory University\nUniversity Hospital Caen\nGachon University Gil Medical Center\nUniversity of Texas Southwestern Medical Center\nTalita Cumi Ltd.\nPepsiCo Global R&D\nGlaxoSmithKline\nLiverpool University Hospitals NHS Foundation Trust\nAcepodia Biotech Inc.\nRegenexx LLC\nChong Kun Dang Pharmaceutical\nNYU Langone Health\nChengdu University of Traditional Chinese Medicine\nAstellas Pharma Inc\nNazife Begüm KARAN\nEssentialis Inc.\nThe University of Hong Kong\nInstitut Straumann AG\nEnterome\nMethodist Research Institute Indianapolis\nHawler Medical University\nUniversity of Cagliari\nGuang'anmen Hospital of China Academy of Chinese Medical Sciences\nBaxalta now part of Shire\nAIO-Studien-gGmbH\nKartal Kosuyolu High Speciality Training and Research Hospital\nJason McMullan\nThomas Jefferson University\nUniversity of Utah\nBeijing Tiantan Hospital\nUniversity Hospital Ghent\nVA Office of Research and Development\nMemorial Sloan Kettering Cancer Center\nUniversity of Alicante\nReham Sameeh\nGehad Salah El-Din shaker\nUniversity Hospital Heidelberg\nNYU Langone Health\nChina Breast Cancer Clinical Study Group\nUniversity Hospital Grenoble\nEastern Mediterranean University\nWeill Medical College of Cornell University\nMinistry of Health Brazil\nDuke University\nHellenic Oncology Research Group\nUniversity of Wisconsin Madison\nSanofi\nInstitute of Liver and Biliary Sciences India\nRadboud University Medical Center\nStichting European Myeloma Network\nDaiichi Sankyo\nUniversity Hospitals Cleveland Medical Center\nAngiotech Pharmaceuticals\nMedical University of Vienna\nAsan Medical Center\nGlobal Alliance for TB Drug Development\nClinical Hospital Merkur\nNational Taiwan Normal University\nBDH-Klinik Hessisch Oldendorf\nAsan Medical Center\nNational Cancer Institute (NCI)\nUniversity of Utah\nCallender Center for Clinical Research\nLimmaTech Biologics AG\nAstraZeneca\nSanofi\nCharite University Berlin Germany\nUniversity of Edinburgh\nUniversity College Dublin\nRadboud University Medical Center\nRennes University Hospital\nUniversity of Palermo\nOrganon and Co\nAbbVie\nBoehringer Ingelheim\nShengjing Hospital\nBrigitte Jolles MD\nKanuni Sultan Suleyman Training and Research Hospital\nAlliance for Clinical Trials in Oncology\nJohns Hopkins University\nColumbia University\nFirst Affiliated Hospital Xi'an Jiaotong University\nIstanbul University\nBurzynski Research Institute\nUniversity of California Davis\nFondation Ophtalmologique Adolphe de Rothschild\nSanquin Research & Blood Bank Divisions\nQinghai University\nAljazeera Hospital\nAjou University School of Medicine\nPfizer\nUniversity Hospital Montpellier\nChang Gung Memorial Hospital\nSingapore General Hospital\nSeventh Medical Center of PLA General Hospital\nShanghai Ark Biopharmaceutical Co. Ltd.\nIslamia University of Bahawalpur\nFate Therapeutics\nDartmouth-Hitchcock Medical Center\nUniversity of Sao Paulo\nUniversity of California San Francisco\nBaxter Healthcare Corporation\nNational Institute of Allergy and Infectious Diseases (NIAID)\nSeoul National University Hospital\nNanfang Hospital Southern Medical University\nCentre Leon Berard\nPfizer's Upjohn has merged with Mylan to form Viatris Inc.\nKing Faisal Specialist Hospital & Research Center\nSeoul National University Hospital\nUniversity of Calgary\nLuBing\nAminu Kano Teaching Hospital\nHoffmann-La Roche\nParc de Salut Mar\nUniversity of South Carolina\nUniversity of Wisconsin Madison\nUniversity Health Network Toronto\nRWTH Aachen University\nVertex Pharmaceuticals Incorporated\nMedical University of South Carolina\nAdventHealth\nVanderbilt University\nAlbert Park\nRambam Health Care Campus\nThe Third Affiliated Hospital of Southern Medical University\nSpanish Lung Cancer Group\nAzienda USL Toscana Nord Ovest\nUniversidade Federal do Para\nPomeranian Medical University Szczecin\nSecond Affiliated Hospital School of Medicine Zhejiang University\nUniversity of California San Francisco\nUniversity of Iowa\nUniversity of Alberta\nRuhr University of Bochum\nXijing Hospital of Digestive Diseases\nMarco Aurélio Vaz PhD\nHospital Clinic of Barcelona\nEmory University\nAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia\nNational Cancer Institute (NCI)\nNingbo Medical Center Lihuili Hospital\nHaukeland University Hospital\nHand and Upper Limb Clinic Canada\nUniversity of Iowa\nDrugs for Neglected Diseases\nOno Pharmaceutical Co. Ltd\nStanford University\nPfizer\nAssaf-Harofeh Medical Center\nGlaxoSmithKline\nUniversity of East Anglia\nPATH\nAl-Azhar University\nBezmialem Vakif University\nDavid Lang\nRosimeire Simprini Padula\nNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\nBoston University\nBrian Czito\nSanten Oy\nEmory University\nUniversiti Sains Malaysia\nWashington University School of Medicine\nFuda Cancer Hospital Guangzhou\nNational Institute of Allergy and Infectious Diseases (NIAID)\nPeking Union Medical College Hospital\nUniversity of Alabama at Birmingham\nIRCCS San Camillo Venezia Italy\nPrince of Songkla University\nUniversity of Colorado Boulder\nAstraZeneca\nNiliMedix\nDuke University\nCentre Hospitalier Universitaire de Nīmes\nChangchun GeneScience Pharmaceutical Co. Ltd.\nUniversity of Aarhus\nAffiliated Hospital of Nantong University\nUniversity Hospital Toulouse\nUniversidade Federal de Santa Maria\nGlaxoSmithKline\nOslo University Hospital\nDaegu Catholic University Medical Center\nMilton S. Hershey Medical Center\nDuquesne University\nDerya Öztürk Özen\nAstraZeneca\nIRCCS Centro Neurolesi Bonino-Pulejo\nNational Cancer Institute (NCI)\nGlaxoSmithKline\nWeinkle Susan H. M.D.\nSonoMotion\nChelsea and Westminster NHS Foundation Trust\nAzienda Ospedaliero-Universitaria Careggi\nHospices Civils de Lyon\nGroupe Hospitalier Mutualiste de Grenoble\nWest Park Healthcare Centre\nIcahn School of Medicine at Mount Sinai\nErasmus Medical Center\nHopital Foch\nDenver Health and Hospital Authority\nChildren's Hospital of Eastern Ontario\nChina National Biotec Group Company Limited\nHillel Yaffe Medical Center\nEmory University\nThe Medicines Company\nMochida Pharmaceutical Company Ltd.\nImperial College London\nPoznan University of Medical Sciences\nBoehringer Ingelheim\nSunshine Guojian Pharmaceutical (Shanghai) Co. Ltd.\nAssistance Publique - Hôpitaux de Paris\nHospital Israelita Albert Einstein\nShandong Provincial Hospital\nPierre Wauthy\nLederle Laboratories\nUniversity of Pittsburgh\nSheffield Teaching Hospitals NHS Foundation Trust\nCentre Hospitalier Universitaire Dijon\nNational Institute of Allergy and Infectious Diseases (NIAID)\nOtsuka Pharmaceutical Development & Commercialization Inc.\nUniversité de Reims Champagne-Ardenne\nVirginia Polytechnic Institute an\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nrsity\nUniversidad Autonoma de San Luis Potosí\nCiusss de L'Est de l'Île de Montréal\nSeoul National University Hospital\nFerring Pharmaceuticals\nGachon University Gil Medical Center\nGustave Roussy Cancer Campus Grand Paris\nNational Institute on Drug Abuse (NIDA)\nCentre Hospitalier Universitaire de Nīmes\nEli Lilly and Company\nThomas Erb\nUniversity Hospital Clermont-Ferrand\nUniversity Hospital Grenoble\nMaastricht University Medical Center\nUniversity Hospital Clermont-Ferrand\nGilead Sciences\nHighField Biopharmaceuticals Corporation\nHuashan Hospital\nBristol-Myers Squibb\nGustave Roussy Cancer Campus Grand Paris\nBritish Columbia Cancer Agency\nSlovak Academy of Sciences\nElza Aparecida Machado Domingues\nNational Cancer Institute (NCI)\nUniversity of Iowa\nSociété des Produits Nestlé (SPN)\nHospital Universitario 12 de Octubre\nThomas Caruso\nBristol-Myers Squibb\nOhio State University Comprehensive Cancer Center\nNanjing University\nGerman CLL Study Group\nHutchison Medipharma Limited\nDuke University\nBakirkoy Dr. Sadi Konuk Research and Training Hospital\nZhejiang University\nCentre Hospitalier de Troyes\nShanghai Changzheng Hospital\nUniversity Hospital Antwerp\nThe University of Texas Medical Branch Galveston\nLouisiana State University Health Sciences Center in New Orleans\nUniversity of Saskatchewan\nNathan Kline Institute for Psychiatric Research\nThe Hospital for Sick Children\nNova Scotia Health Authority\nDaewoong Pharmaceutical Co. LTD.\nSentara Norfolk General Hospital\nDynavax Technologies Corporation\nDexa Medica Group\nKasr El Aini Hospital\nChia Tai Tianqing Pharmaceutical Group Co. Ltd.\nMemorial Sloan Kettering Cancer Center\nVanderbilt University Medical Center\nAllergan\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\nUniversity of Michigan\nXijing Hospital\nKyu Jae Lee\nFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina\nTechnical University of Munich\nFrédéric A. Houssiau MD PhD\nI-Ching Wang\nImam Khomeini Hospital\nUniversity of Palermo\nAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)\nLi-Jen Hsin\nMontefiore Medical Center\nMichael Baubin MD\nUniversity Health Network Toronto\nMGH Institute of Health Professions\nChildren's Oncology Group\nCentral Hospital Nancy France\nPfizer's Upjohn has merged with Mylan to form Viatris Inc.\nRedHill Biopharma Limited\nBoston Children's Hospital\nSunnybrook Health Sciences Centre\nBiosense Webster Inc.\nStanford University\nPopulation Health Research Institute\nEntasis Therapeutics\nHangzhou Grand Biologic Pharmaceutical Inc.\nCHU de Reims\nCarina Mari Aparici\nTechnical University of Munich\nVastra Gotaland Region\nIRCCS San Raffaele\nUniversity of Washington\nNYU Langone Health\nFaculty of Dental Medicine for Girls\nM.D. Anderson Cancer Center\nCharite University Berlin Germany\nM.D. Anderson Cancer Center\nOrganon and Co\nGeorgetown University\nUniversity Hospital Strasbourg France\nGazi University\nUniversity of Alberta\nTanta University\nWarner Chilcott\nSWOG Cancer Research Network\nVilnius University\nMansoura University\nIlya Sivokozov\nEwha Womans University\nSheikh Shakhbout Medical City\nNational Cancer Center Korea\nAin Shams University\nUS Department of Veterans Affairs\nJohns Hopkins University\nMassachusetts General Hospital\nClinuvel Pharmaceuticals Limited\nMahidol University\nargenx\nUniversitätsklinikum Hamburg-Eppendorf\nIstituto per la Ricerca e l'Innovazione Biomedica\nUniversity of Patras\nNational Institute of Mental Health (NIMH)\nRenJi Hospital\nThe Miriam Hospital\nPeking University Third Hospital\nCairo University\nNovartis Pharmaceuticals\nAzidus Brasil\nUniversity Hospital Toulouse\nAssistance Publique - Hôpitaux de Paris\nGlaxoSmithKline\nCentro Universitário Augusto Motta\nSheffield Teaching Hospitals NHS Foundation Trust\nHoffmann-La Roche\nPfizer\nCancer Institute and Hospital Chinese Academy of Medical Sciences\nYonsei University\nMerck Sharp & Dohme LLC\nOhio State University Comprehensive Cancer Center\nNovartis Pharmaceuticals\nUniversity of Witwatersrand South Africa\nKaohsiung Medical University Chung-Ho Memorial Hospital\nHospices Civils de Lyon\nLithuanian Sports University\nCentre Hospitalier de Cayenne\nCornea and Laser Eye Institute\nBellicum Pharmaceuticals\nFundación Universidad Católica de Valencia San Vicente Mártir\nHoffmann-La Roche\nSidney Kimmel Cancer Center at Thomas Jefferson University\nUNICANCER\nMedical Research Council\nSpectrum Dynamics\nUS Department of Veterans Affairs\nUniversity of Sao Paulo General Hospital\nMasaryk University\nHospital Clinico Universitario de Santiago\nUniversity of Washington\nCliniques universitaires Saint-Luc- Université Catholique de Louvain\nHarbin Medical University\nActelion\nHormozgan University of Medical Sciences\nBoston Scientific Corporation\nUniversidad de Granada\nFederal University of Pelotas\nUniversidade Federal do vale do São Francisco\nEmory University\nSK Chemicals Co. Ltd.\nChangi General Hospital\nKazia Therapeutics Limited\nUniversity Hospital Ghent\nUniversity Hospital Lille\nRoy E. Weiss M.D.\nYale University\nNIZO Food Research\nAnterios Inc.\nRambam Health Care Campus\nGrupo Español de Investigación en Neurooncología\nM.D. Anderson Cancer Center\nNantes University Hospital\nMedical University of Vienna\nKirby Institute\nH. Lundbeck A/S\nSoroka University Medical Center\nPurdue Pharma LP\nPfizer\nEpicentre\nUniversity of Las Palmas de Gran Canaria\nVanderbilt University Medical Center\nUCB Biopharma SRL\nAnkara Etlik City Hospital\nMerck Sharp & Dohme LLC\nThe University of Texas Medical Branch Galveston\nGuangdong Provincial People's Hospital\nXinhua Hospital Shanghai Jiao Tong University School of Medicine\nAspira Women's Health\nNational Cancer Institute (NCI)\nYaounde Central Hospital\nChang Gung University\nUniversity Hospital Montpellier\nClover Biopharmaceuticals AUS Pty Ltd\nUniversity of Oklahoma\nSun Pharmaceutical Industries Limited\nFondation Ophtalmologique Adolphe de Rothschild\nCordis Corporation\nAssiut University\nLes Laboratoires des Médicaments Stériles\nEmergent BioSolutions\nUniversity of Aarhus\nZhongda Hospital\nYune Zhao\nQueen's University\nUniversity of Oklahoma\nMayo Clinic\nHospices Civils de Lyon\nHanjong Ahn\nKorea University Anam Hospital\nDaiichi Sankyo Co. Ltd.\nNational Jewish Health\nRambam Health Care Campus\nRiphah International University\nKochi University\nErin Bertino\nSamsung Medical Center\nUniversity of Sao Paulo\nKhon Kaen University\nHorizon Health Network\nThe University of Texas Health Science Center Houston\nHumanetics Corporation\nFundación para la Investigación del Hospital Clínico de Valencia\nHuashan Hospital\nLaniado Hospital\nAbbVie\nUniversity of Washington\nOneChain Immunotherapeutics\nMomenta Pharmaceuticals Inc.\nB. Braun Melsungen AG\nTaipei Veterans General Hospital Taiwan\nFirst People's Hospital of Foshan\nAugusta University\nGoldman Butterwick Fitzpatrick and Groff\nCancer Research UK\nAstellas Pharma Global Development Inc.\nPontificia Universidad Catolica de Chile\nUniversity of Southern Denmark\nTaipei City Hospital\nAbbott Medical Devices\nUniversity of Kentucky\nUniversity of Utah\nUniversity of Nebraska\nUniversity of North Carolina Chapel Hill\nUniversidad Rey Juan Carlos\nMassachusetts General Hospital\nNovartis Pharmaceuticals\nAssistance Publique - Hôpitaux de Paris\nTorbay and South Devon NHS Foundation Trust\nChiesi Farmaceutici S.p.A.\nRegionshospitalet Silkeborg\nNYU Langone Health\nGalapagos NV\nMateon Therapeutics\nMarco Alexandre Dias da Rocha\nAgenus Inc.\nVanderbilt University Medical Center\nBoston Medical Center\nCentre Leon Berard\nArthrex Inc.\nNanfang Hospital Southern Medical University\nHamad Medical Corporation\nZhejiang Zylox Medical Device Co. Ltd.\nHyperMed\nJapan Blood Products Organization\nAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)\nMcGill University Health Centre/Research Institute of the McGill University Health Centre\nGérond'if\nRoswell Park Cancer Institute\nDennis G. Karounos M.D.\nHealth Science Center of Xi'an Jiaotong University\nJin Li\nPacira Pharmaceuticals Inc\nJazz Pharmaceuticals\nUniversity of Nebraska\nCentral Hospital Nancy France\nMateria Medica Holding\nZhejiang University\nMahidol University\nAssiut University\nUniversity of Michigan\nNational Cancer Institute (NCI)\nInstitut Curie\nMedImmune LLC\nBrown University\nAptinyx\nMcGill University Health Centre/Research Institute of the McGill University Health Centre\nMaastricht University Medical Center\nVanderbilt University\nApple Inc.\nUniversity of Sao Paulo\nVA Office of Research and Development\nAnkara University\nEMD Serono\nKyunghee University\nHealth Resources and Services Administration (HRSA)\nUniversità Politecnica delle Marche\nNorthwestern University\nHospices Civils de Lyon\nTakeda\nHamilton Health Sciences Corporation\nUniversity of Nove de Julho\nChanghua Christian Hospital\nNational Taiwan University Hospital\nMir Arif Hussain\nZiauddin University\nOmeros Corporation\nBial - Portela C S.A.\nJiangsu HengRui Medicine Co. Ltd.\nYonsei University\nAdvenchen Laboratories Nanjing Ltd.\nCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal\nChildren's Healthcare of Atlanta\nAntengene Biologics Limited\nNorwegian University of Science and Technology\nShanghai 10th People's Hospital\nM.D. Anderson Cancer Center\nAssociation pour la Complementarite des Connaissances et des Pratiques de la Pneumologie\nUniversity of Jordan\nTakeda\nQueen's University Belfast\nBandim Health Project\nThe Hong Kong Polytechnic University\nUniversity of Michigan\nUniversity of Zurich\nBess Frost PhD\nMerck Sharp & Dohme LLC\nTranslational Genomics Research Institute\nMedical University of Vienna\nUniversity of Benin\nPadagis LLC\nMemorial University of Newfoundland\nMassachusetts Institute of Technology\nMenoufia University\nRepros Therapeutics Inc.\nMedasense Biometrics Ltd\nLife University\nCareDx\nThe National Center on Addiction and Substance Abuse at Columbia University\nGalen Limited\nPromomed LLC\nTeva Branded Pharmaceutical Products R&D Inc.\nUniversity of Aarhus\nAga Khan University\nPacific Edge Limited\nAstraZeneca\nSultan Abdulhamid Han Training and Research Hospital Istanbul Turkey\nUniversity of Reading\nFirst People's Hospital of Hangzhou\nUniversity of Oklahoma\nFederal University of Minas Gerais\nUniversity of Tennessee\nUniversity Hospital Clermont-Ferrand\nSeqirus\nMassachusetts General Hospital\nAphios\nAbbVie\nDuke University\nAnhui Provincial Hospital\nWalter Reed National Military Medical Center\nUniversity of Kansas Medical Center\nJanssen R&D Ireland\nCenter for Communication and Change India\nAugusta University\nVA Office of Research and Development\nHannover Medical School\nChang Gung Memorial Hospital\nLund University\nHoffmann-La Roche\nGlaxoSmithKline\nOrganon and Co\nPhilips Respironics\nWeill Medical College of Cornell University\nYonsei University\nUniversity of Minnesota\nBeth Israel Deaconess Medical Center\nPfizer\nBioMarin Pharmaceutical\nMcMaster University\nNorthwell Health\nUniversity of Rochester\nCentre de Recherche en Nutrition Humaine Rhone-Alpe\nBnai Zion Medical Center\nUniversity of Manchester\nSidney Kimmel Comprehensive Cancer Center at Johns Hopkins\nRadboud University Medical Center\nTaipei Medical University Hospital\nAstraZeneca\nPeking Union Medical College Hospital\nRenJi Hospital\nCentre Hospital Regional Universitaire de Limoges\nUnilever Israel\nCentre Hospitalier Universitaire de la Réunion\nSanofi\nSanofi\nTuğba Sarı\nGulhane Training and Research Hospital\nLund University\nSpineForm LLC\nDomonkos Trásy\nNovartis Vaccines\nBournemouth University\nIzmir Bakircay University\nArray Biopharma now a wholly owned subsidiary of Pfizer\nNanjing Medical University\nErasmus Medical Center\nZhejiang Cancer Hospital\nNational University Hospital Singapore\nJanssen Research & Development LLC\nAccelerated Community Oncology Research Network\nPsoriasis Treatment Center of Central New Jersey\nIRCCS Policlinico S. Donato\nStaffordshire University\nDuke University\nClinical Evaluation Research Unit at Kingston General Hospital\nWellmarker Bio\nUniversity of North Carolina Chapel Hill\nUniversity of Oxford\nUniversity of Ulm\nMayo Clinic\nProteostasis Therapeutics Inc.\nUniversity of Ottawa\nUniversity of California San Francisco\nUniversity of Southern California\nYonsei University\nUniversity of South Alabama\nAssiut University\nMaastricht University Medical Center\nPfizer\nTeva Pharmaceuticals USA\nQueen's University\nAstraZeneca\nAlexandria University\nLEO Pharma\nIonis Pharmaceuticals Inc.\nSUZHOU HUHU HEALTH & TECHNOLOGY Inc.\nCentro de Infertilidad y Reproducción Humana\nDeutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin\nBern University of Applied Sciences\nUniversity of Bologna\nTanta University\nBnai Zion Medical Center\nGrupo de Estudos Multicentricos em Onco-Hematologia\nAssiut University\nAbbott\nThe Cleveland Clinic\nLille Catholic University\nCR-CSSS Champlain-Charles-Le Moyne\nOhio State University\nInnovative Medical\nUniversity of Oxford\nChildren's Hospital Medical Center Cincinnati\nUniversity Hospital Grenoble\nNottingham University Hospitals NHS Trust\nAssiut University\nUniversity Health Network Toronto\nZhiming Zhu\nCentre Hospitalier Annecy Genevois\nHelsinn Healthcare SA\nDiskapi Teaching and Research Hospital\nNavy General Hospital Beijing\nUniversity Hospital Angers\nAstraZeneca\nAssiut University\nUniversity of Calgary\nEA Pharma Co. Ltd.\nUniversiti Putra Malaysia\nUniversity of Alberta\nKaiser Permanente\nKepler University Hospital\nCairo University\nVA Office of Research and Development\nUniversity of Calgary\nUniversitätsklinikum Hamburg-Eppendorf\nKaohsiung Medical University Chung-Ho Memorial Hospital\nVIVE - The Danish Center for Social Science Research\nBasma Morsy\nILKE KUPELI\nNutricia Research\nUniversity of California San Francisco\nSaint Petersburg State University Russia\nJohns Hopkins University\nHelsinki University Central Hospital\nUCB Celltech\nHospices Civils de Lyon\nCairo University\nIstanbul Medipol University Hospital\nSinovac Research and Development Co. Ltd.\nWeill Medical College of Cornell University\nUniversity at Buffalo\nFred Hutchinson Cancer Center\nNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\nUniversity of Palermo\nDuke University\nUniversity Health Network Toronto\nSohag University\nMalaria Consortium UK\nAstraZeneca\nNorthwell Health\nChildren's Hospital Medical Center Cincinnati\nHospital Clinic of Barcelona\nUniversity of Alabama at Birmingham\nUniversity of Oregon\nHelse Nord-Trøndelag HF\nDuke-NUS Graduate Medical School\nUniversity of Calgary\nEmory University\nHopital de l'Enfant-Jesus\nWuerzburg University Hospital\nNanoPin Technologies Inc.\nSt Stephens Aids Trust\nAGUNCO Obstetrics and Gynecology Centre\nGlaxoSmithKline\nSeoul National University Hospital\nWomen's College Hospital\nDartmouth-Hitchcock Medical Center\nWake Forest University Health Sciences\nHvidovre University Hospital\nRajkumar Kottayasamy Seenivasagam\nHospital de Clinicas de Porto Alegre\nTilburg University\nNYU Langone Health\nMaruho North America Inc.\nRenmin Hospital of Wuhan University\nUniversity of Zurich\nIovance Biotherapeutics Inc.\nUniversity Hospital Olomouc\nAustin I Kim\nGaziosmanpasa Research and Education Hospital\nDiwakar Davar\nUniversity of Minnesota\nShanghai Henlius Biotech\nRigshospitalet Denmark\nDove Medical Press Ltd\nAB Science\nUniversidad de La Frontera\nDuke University\nNational Taiwan University Hospital\nThe First Affiliated Hospital of Zhejiang Chinese Medical University\nAlexandria University\nHoffmann-La Roche\nCzech Technical University in Prague\nAmgen\nCentre Hospitalier Intercommunal Creteil\nUniversity of Bergen\nKolding Sygehus\nThe Cleveland Clinic\nDongGuk University\nMilton S. Hershey Medical Center\nUniversity of Chicago\nAelis Farma\nInstitute for Neurodegenerative Disorders\nFirat University\nVanderbilt University Medical Center\nCoopervision Inc.\nAzienda Ospedaliero-Universitaria di Modena\nVirginia Commonwealth University\nUniversity of Southern California\nUniversity of Nebraska\nEli Lilly and Company\nBoehringer Ingelheim\nSWOG Cancer Research Network\nYM BioSciences\nART Fertility Clinics LLC\nRaphael Freitas de Souza\nSheba Medical Center\nAbramson Cancer Center at Penn Medicine\nLaureate Institute for Brain Research Inc.\nUniversity Hospital Brest\nIstanbul University - Cerrahpasa (IUC)\nUniversity of California San Diego\nSeoul National University Hospital\nUniversity Hospital of Limerick\nAlder Hey Children's NHS Foundation Trust\nFondazione Policlinico Universitario Agostino Gemelli IRCCS\nNeuroPace\nNorthwestern University\nRegional Hospital Holstebro\nUniversity of Oulu\nCoopervision Inc.\nDiaSorin Inc.\nPrisma Health-Upstate\nRhode Island Hospital\nAdagene Inc\nTakeda\nI.M. Sechenov First Moscow State Medical University\nUniversidad de la Republica\nUniversity Hospital Clermont-Ferrand\nUniversity of Pisa\nUniversity of Zurich\nSolvay Pharmaceuticals\nUniversity Hospital Basel Switzerland\nMedical College of Wisconsin\nInstitut Claudius Regaud\nSilverleaf Medical Sciences INC\nWeill Medical College of Cornell University\nUniversity of Houston\nWinthrop University Hospital\nSt. Petersburg State Pavlov Medical University\nBoehringer Ingelheim\nArmed Forces Research Institute of Medical Sciences Thailand\nLahey Clinic\nMassachusetts General Hospital\nThe Mediterranean Institute for Transplantation and Advanced Specialized Therapies\nUniversity of California Davis\nWyeth is now a wholly owned subsidiary of Pfizer\nManchester University NHS Foundation Trust\nPfizer\nUniversity of Groningen\nCentre Hospitalier Universitaire Dijon\nMicrobicide Trials Network\nWake Forest University Health Sciences\nZagazig University\nMiami University\nPatrick SchoettkerMD PD\nIstituto per la Ricerca e l'Innovazione Biomedica\nLung Biotechnology PBC\nBoston Children's Hospital\nShowa University\nMEDA PHARMA SPA a Viatris company\nTakeda\nUniversity of Illinois at Urbana-Champaign\nSaglik Bilimleri Universitesi\nShandong University\nUniversity of Missouri-Columbia\nAin Shams University\nKwang Dong Pharmaceutical co. ltd.\nUniversiti Sains Malaysia\nEmergent BioSolutions\nRegion Skane\nChinese University of Hong Kong\nCentre Hospitalier Régional Metz-Thionville\nAcerus Pharmaceuticals Corporation\nMerck Sharp & Dohme LLC\nIstanbul Medipol University Hospital\nWeill Medical College of Cornell University\nNational Institute of Allergy and Infectious Diseases (NIAID)\nUniversity of Nottingham\nUniversity of Zurich\nCeleCor Therapeutics\nHolland Bloorview Kids Rehabilitation Hospital\nMemorial Sloan Kettering Cancer Center\nMayo Clinic\nUniversity College London\nRenalytix AI Inc.\nAin Shams University\nFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico\nUniversity of Calgary\nPfizer\nValley Health System\nChong Kun Dang Pharmaceutical\nPfizer\nAronora Inc.\nChildren's Hospital of Fudan University\nXin-Hua Xu\nIzmir Bakircay University\nBausch Health Americas Inc.\nAssistance Publique - Hôpitaux de Paris\nUniversity of California San Diego\nH. Lee Moffitt Cancer Center and Research Institute\nPhotonMD Inc\nThe University of Hong Kong\nMcGill University Health Centre/Research Institute of the McGill University Health Centre\nAbbVie\nKimford Jay Meador\nUniversity of Roma La Sapienza\nGlaxoSmithKline\nProf. Stephen Lee\nYiqi Du\nGeneCast Biotechnology Co. Ltd.\nEloxx Pharmaceuticals Inc.\nItalian Society of Nephrology\nBoehringer Ingelheim\nMedical University of Graz\nVanderbilt University Medical Center\nCentre Hospitalier Universitaire Dijon\nZymenex A/S\nAssiut University\nSpero Therapeutics\nThe University of Texas Health Science Center at San Antonio\nXuanwuH 2\nAssiut University\nTakeda\nInternational Centre for Diarrhoeal Disease Research Bangladesh\nDuke University\nShanghai Zhongshan Hospital\nM.D. Anderson Cancer Center\nBangabandhu Sheikh Mujib Medical University Dhaka Bangladesh\nNational Institute of Allergy and Infectious Diseases (NIAID)\nSt. Jude Children's Research Hospital\nDuke University\nWashington University School of Medicine\nGlaxoSmithKline\nAbbott Medical Devices\nHenri Mondor University Hospital\nSelcuk University\nNational Taiwan University Hospital\nOSF Healthcare System\nUniversity of Texas Southwestern Medical Center\nLiverpool University Hospitals NHS Foundation Trust\nUniversity of Oxford\nThird Military Medical University\nHopital du Sacre-Coeur de Montreal\nBod Australia\nBarrow Neurological Institute\nThe University of Texas Health Science Center Houston\nKorea University Guro Hospital\nThe University of Texas Health Science Center Houston\nNational Nutrition and Food Technology Institute\nCentre Hospitalier Universitaire de Nīmes\nEmory University\nUniversity of Texas at Austin\nUniversity of Illinois at Chicago\nCentral Hospital Nancy France\nUniversity of Florida\nUniversity of Pittsburgh\nJohns Hopkins University\nDuke University\nJanssen Research & Development LLC\nCentre Georges Francois Leclerc\nAston University\nPeking Union Medical College Hospital\nNYU Langone Health\nSwedish University of Agricultural Sciences\nUniversitat Internacional de Catalunya\nNational Heart Lung and Blood Institute (NHLBI)\nBoise State University\nUniversity Hospital Montpellier\nGilead Sciences\nBoehringer Ingelheim\nIsala\nFrench National Agency for Research on AIDS and Viral Hepatitis\nMỹ Đức Hospital\nSan Diego State University\nUniversity of Erlangen-Nürnberg Medical School\nHabit LLC\nFondazione Policlinico Universitario Agostino Gemelli IRCCS\nRhode Island Hospital\nMansoura University\nHacettepe University\nMitsubishi Tanabe Pharma America Inc.\nSun Yat-sen University\nSanofi\nC. R. Bard\nKadmon Corporation LLC\nOttawa Hospital Research Institute\nImperial College London\nM.D. Anderson Cancer Center\nInsel Gruppe AG University Hospital Bern\nAndreas Rück\nUNION therapeutics\nPfizer\nInovio Pharmaceuticals\nMINO Labs LLC\nDanderyd Hospital\nTechnische Universität Dresden\nSecond Affiliated Hospital School of Medicine Zhejiang University\nImperial College London\nNational Taiwan University Hospital\nNational Institute of Allergy and Infectious Diseases (NIAID)\nOregon Research Institute\nGuangdong Provincial People's Hospital\nPhramongkutklao College of Medicine and Hospital\nNational Heart Lung and Blood Institute (NHLBI)\nCentre Hospitalier Universitaire de Saint Etienne\nForest Laboratories\nDartmouth-Hitchcock Medical Center\nCHU de Reims\nJason K Rivers MD FRCPC FAAD\nKing Faisal Specialist Hospital & Research Center\nGuangdong Provincial Hospital of Traditional Chinese Medicine\nNYU Langone Health\nSohag University\nRigel Pharmaceuticals\nMaastricht University Medical Center\nUniversitätsklinikum Hamburg-Eppendorf\nUniversity of Michigan\nImmPACT Bio\nCentre Hospitalier Universitaire de Nice\nHospital General Universitario Gregorio Marañon\nBayer\nCampbell Grant\nImperial College London\nEli Lilly and Company\nFederal University of São Paulo\nEstetra\nHarvard University\nEmory University\nAesculap AG\nGuy's and St Thomas' NHS Foundation Trust\nUniversity of Guelph\nShanghai Zhongshan Hospital\nUniversity of Washington\nUniversity Hospital of North Norway\nVivantes Netzwerk für Gesundheit GmbH\nFox Chase Cancer Center\nStanford University\nUnity Health Toronto\nCyclerion Therapeutics\nAlcon Research\nMedical University of South Carolina\nUniversity of Modena and Reggio Emilia\nMayo Clinic\nUniversidad Católica San Antonio de Murcia\nTriStar Health\nUniversity of Florida\nRennes University Hospital\nNovo Nordisk A/S\nDamanhour University\nSpaulding Rehabilitation Hospital\nCentre Hospitalier Universitaire Dijon\nThe Second Hospital of Nanjing Medical University\nUniversity of Michigan\nTanzen Medical Inc\nRune Rasmussen\nGERCOR - Multidisciplinary Oncology Cooperative Group\nUniversity Hospital Geneva\nUniversity of Pavia\nUPECLIN HC FM Botucatu Unesp\nUniversity Hospital Grenoble\nIndiana University\nHvidovre University Hospital\nNational Institute of Allergy and Infectious Diseases (NIAID)\nHospices Civils de Lyon\nJanssen Research & Development LLC\nBeth Israel Deaconess Medical Center\nThe Danish Research Centre for Chemical Sensitivities\nHinova Pharmaceuticals USA Inc.\nVA Office of Research and Development\nAzienda Ospedaliera di Padova\nEli Lilly and Company\nDr. Ahmed Ismail\nGo Medical Industries Pty Ltd\nPiramal Healthcare Canada Ltd\nNHS Lothian\nTasly Pharmaceuticals Inc.\nEmory University\nSerum Institute of India Pvt. Ltd.\nGangnam Severance Hospital\nMayo Clinic\nJohnson & Johnson Consumer and Personal Products Worldwide\nPaul W. Read MD\nMayo Clinic\nGulhane School of Medicine\nCentre Oscar Lambret\nUnited Therapeutics\nInstitut Paoli-Calmettes\nPfizer\nNewcastle University\nGoethe University\nPalo Alto Medical Foundation\nUniversidade Federal de Sao Carlos\nUniversity of Ghana Medical School\nSeagen Inc.\nUniversity of Oxford\nFatebenefratelli Hospital\nAssiut University\nBurke Medical Research Institute\nMcGill University\nFondation Hôpital Saint-Joseph\nHeinrich-Heine University Duesseldorf\nAssistance Publique - Hôpitaux de Paris\nHamilton Health Sciences Corporation\nUniversity of Cambridge\nKing Saud University\nOrasis Pharmaceuticals Ltd.\nUniversity of Chicago\nWake Forest University Health Sciences\nBarbara Horváth Principal Investigator\nCentral Jutland Regional Hospital\nF&C Licorice Ltd\nAtaturk University\nErin Rothwell\nEndocrinology Research Centre Moscow\nVastra Gotaland Region\nNational Institute of Allergy and Infectious Diseases (NIAID)\nUniversity Hospital Ghent\nUniversity of Dundee\nSOLX Inc.\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the seventh column from each row of the final RDD filtered_rdd_with_header\n",
    "\n",
    "sponsor = filtered_rdd_with_header.map(lambda row: row[6])\n",
    "\n",
    "# Display the first column values\n",
    "for value in sponsor.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "3328b150-821a-40fb-ae01-a92ee42e0bb3",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collaborators\nHarvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine\nAlzheimer's Society of Brant Haldimand Norfolk Hamilton Halton\nNational Health and Medical Research Council Australia|Bristol-Myers Squibb\nNone\nIstituti Clinici Scientifici Maugeri SpA|Politecnico di Milano\nNone\nNational Institute on Alcohol Abuse and Alcoholism (NIAAA)\nNational Institute on Alcohol Abuse and Alcoholism (NIAAA)\nGovenment of Manitoba|Canadian Foundation for Pharmacy|Neighbourhood Pharmacy Association of Canada\nNational Cancer Institute (NCI)\nSociety for Pediatric Dermatology\nKing's College Hospital NHS Trust|Charles University Czech Republic|Hopital Universitaire Robert-Debre|Vestre Viken Hospital Trust|The Hospital for Sick Children|Cardiff University|Odense University Hospital\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute on Drug Abuse (NIDA)|National Institute of Mental Health (NIMH)\nNorwegian Institute of Public Health|Norwegian Council for Mental Health|The Dam Foundation\nNational Natural Science Foundation of China\nFondazione Italiana Sclerosi Multipla\nKarolinska Institutet\nNone\nShahid Beheshti University|Tehran University of Medical Sciences\nNone\nRadboud University Medical Center|University Medical Center Groningen|Maastricht University|Trimbos|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)\nNone\nSyneos Health|Athos Therapeutics Australia Pty Ltd\nNone\nNone\nNone\nNone\nCentre de Recherche en Nutrition Humaine Rhone-Alpe\nPeking Union Medical College Hospital|Peking University Cancer Hospital & Institute|China-Japan Friendship Hospital|Chinese PLA General Hospital\nNone\nNone\nAzienda Ospedaliera Città della Salute e della Scienza di Torino|Fondazione Policlinico Universitario Agostino Gemelli IRCCS|Azienda Ospedaliera Universitaria Policlinico|IRCCS Azienda Ospedaliero-Universitaria di Bologna|Terumo Europe N.V.|Azienda Ospedaliero Universitaria Pisana\nUllevaal University Hospital\nQianfoshan Hospital\nNone\nNone\nNone\nGerman Research Foundation\nNone\nPeking University First Hospital|Tianjin Medical University Cancer Hospital|Zhejiang Cancer Hospital|Heilongjiang Cancer Hospital|Sipai(Beijing)Network Technology Co Ltd\nNone\nNone\nNone\nSociedad Argentina de Infectología (SADI) (Argentine Society of Infectious Diseases)\nAeon Astron Europe B.V.\nHarris County Hospital District|Baylor College of Medicine\nCW-Research & Management GmbH|Medical University of Vienna|Landesklinkum Wiener Neustadt|Klinik Ottakring\nNone\nNone\nNone\nNone\nInternational Business Machines (IBM)\nNone\nChildren's Hospital of Philadelphia|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\nNone\nNone\nNone\nNone\nNone\nNone\nMedi Image Inc\nWashington University School of Medicine|University of California Berkeley|University of California San Diego\nNone\nNational Heart Lung and Blood Institute (NHLBI)\nNone\nNone\nNone\nHacettepe University|Ankara Education and Research Hospital\nHong Kong Jockey Club Charities Trust\nSecond Affiliated Hospital of Guangxi Medical University|Guilin Medical University China|Liuzhou Workers Hospital|Wuzhou Red Cross Hospital\nUniversity Hospital Fattouma Bourguiba\nFlorida Poison Control Center\nQingtian People's hospital\nNational Institute of Mental Health (NIMH)\nNexira|CEN Nutriment\nNone\nGFI\nNone\nNone\nNone\nNone\nNational Institute on Drug Abuse (NIDA)\nNone\nNone\nNational Institute on Aging (NIA)\nNone\nNone\nInsightech\nNone\nNone\nNone\nNone\nNone\nGlaxoSmithKline|Merck Sharp & Dohme LLC|Novartis|Pfizer\nNational Institute of Nursing Research (NINR)\nNone\nNone\nNone\nMerck KGaA Darmstadt Germany\nOsteopathic Foundation|University College of Osteopathy\nNone\nNone\nUniversity of Maryland|Lodise & Lodise LLC\nThe Swedish Research Council|Örebro County Council\nDaiichi Sankyo\nNone\nNone\nNone\nNone\nNone\nPfizer\nNone\nNone\nIndian Council of Medical Research\nNone\nNovotech (Australia) Pty Limited\nNone\nHospital de Braga|Clinical Academic Center (2CA)\nNone\nNone\nInstitut de Cancérologie de la Loire\nNone\nNone\nUniversity of California Irvine\nNone\nNone\nNone\nNone\nNone\nNational Institute of Allergy and Infectious Diseases (NIAID)\nUniversity of South Florida|National Institute of Nursing Research (NINR)\nNone\nNone\nDOLORisk Consortium|Aarhus University Hospital\nNone\nJohn D. Dingell VA Medical Center|New York University\nNone\nNone\nNational Institute of Neurological Disorders and Stroke (NINDS)\nUnited States Department of Defense\nNational Institute on Minority Health and Health Disparities (NIMHD)\nBatterjee Medical College\nNone\nHelsinki University Central Hospital|Oulu University Hospital|Kuopio University Hospital\nHannover Medical School|Hoffmann-La Roche|Gilead Sciences\nNone\nNone\nNone\nNone\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nJohnson & Johnson\nNone\nUniversity of Copenhagen\nGreen Cross Corporation\nMinistry of Health France\nBeijing Tiantan Hospital\nNone\nOslo University Hospital|University of Bergen|Norwegian University of Science and Technology|University of Tromso|KU Leuven\nOklahoma State University\nNone\nNone\nNone\nNone\nUniversity Hospital Essen\nNational Institute of Mental Health (NIMH)|National Institute on Drug Abuse (NIDA)\nNone\nNone\nNational Institute of Mental Health (NIMH)\nChildren's Hospital Colorado\nNone\nNone\nNone\nNone\nNone\nNone\nNational Institute on Drug Abuse (NIDA)\nMerck Sharp & Dohme LLC\nNone\nAzienda Ospedaliera Universitaria Integrata Verona\nNone\nNone\nQuintiles Inc.\nNational Cancer Institute (NCI)\nHealth Sciences Centre Foundation Manitoba|Health Sciences Centre Winnipeg Manitoba\nFondo de Investigacion Sanitaria|Sociedad Española de Neumología y Cirugía Torácica\nNone\nNone\nNone\nNone\nNone\nCogState Ltd.\nNone\nNone\nNone\nNone\nNone\nNone\nApos Medical and Sports Technology Ltd.\nNone\nNone\nNone\nNone\nNone\nEuropean Society of Gastrointestinal Endoscopy\nNone\nNone\nNational Science Foundation\nNone\nNone\nNone\nNorthern California Institute of Research and Education|National Institute on Aging (NIA)|Alzheimer's Therapeutic Research Institute\nNone\nNone\nGerman Federal Ministry of Education and Research|University of Erlangen-Nürnberg\nNone\nNone\nNone\nNone\nUniversity of the Balearic Islands\nNone\nNone\nNone\nBristol-Myers Squibb\nSwiss National Science Foundation\nUptake Medical Technology Inc.\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nNone\nChulalongkorn University\nNone\nNone\nNone\nNone\nMedex15\nNone\nNone\nLinkDoc Technology (Beijing) Co. Ltd.\nNone\nNational Cancer Institute (NCI)\nMitacs|Core-Health Technologies Inc.\nNone\nMerck Sharp & Dohme LLC\nForest Laboratories\nThe Norwegian Rheumatism Association\nNone\nUnited States Agency for International Development (USAID)|Bill and Melinda Gates Foundation|Johns Hopkins University\nNone\nNone\nNone\nNone\nDanish Cancer Society\nNone\nNone\nNone\nDoris Duke Charitable Foundation\nNone\nNone\nNone\nAllergan\nNone\nUniversity of Leeds\nNone\nNone\nAsan Medical Center|Samsung Medical Center|Seoul National University Hospital|Ulsan University Hospital\nNone\nNone\nTel Aviv University\nRabin Medical Center\nNorthern Health Science Alliance (NHSA)\nNone\nNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\nNone\nNone\nUniversity of Pennsylvania\nAurum Institute|Seoul National University|National Institute of Mental Health (NIMH)\nShanghai Zhongshan Hospital\nNone\nFred Hutchinson Cancer Center\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nHer Majesty's Prison and Probation Service (HMPPS)|Public Health England|Cancer Research UK|Plymouth University Peninsula Schools of Medicine & Dentistry (PUPSMD)\nMcNeil Consumer & Specialty Pharmaceuticals a Division of McNeil-PPC Inc.\nMerck KGaA Darmstadt Germany\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nCharlotte Orthopedic Hospital\nNone\nUniversity of Trieste|University of Udine|University of Padova|Università degli Studi di Ferrara|University of Nottingham|DLR German Aerospace Center|Izola General Hospital|National Institute of Public Health Slovenia\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPPD\nNone\nNone\nManitoba Pulse Growers\nNone\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nVirginia Polytechnic Institute and State University\nWalter Reed Army Institute of Research (WRAIR)|Kansas State University\nNone\nVisioncare Research Ltd.\nNone\nNone\nBiotrial Inc.|Alturas Analytics Inc.\nThe Ottawa Hospital\nNone\nNone\nIsura\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nDepartment of Health and Human Services|Human Link\nGenentech Inc.\nUniversity Hospital of Crete\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nS.G.S International Kft.\nTechnische Universität Dresden|University of Debrecen|Hospital de la Santa creu i Sant Pau - Barcelona|Koc University Hospital|Accademia del Paziente Esperto EUPATI Rome Italy\nFederal University of Rio Grande do Sul\nNone\nAkeso Tiancheng Inc\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNational Cancer Institute (NCI)\nNational Bank of Austria\nNone\nNone\nNational Science Council Taiwan\nNational Center for Complementary and Integrative Health (NCCIH)\nNone\nNone\nNone\nNone\nNovartis\nNone\nNone\nNone\nEli Lilly and Company\nETH Zurich|University of Zurich|Psychiatric University Hospital Zurich\nNone\nApices Soluciones S.L.\nNone\nNone\nNone\nNone\nResMed\nNone\nNone\nNone\nNone\nAarhus University Hospital\nNone\nPeoples University Bhanpur Bhopal\nNone\nCenters for Disease Control and Prevention\nNone\nPPD\nNone\nNone\nNone\nNone\nServicio de Vivienda y Urbanismo Chile|Ilustre Municipalidad de San Antonio Chile|Corporación Municipal de Valparaíso Chile\nAmerican Thoracic Society\nNone\nNone\nParexel\nNone\nNone\nH. Lundbeck A/S\nNone\nAlmond Board of California\nUniversity of Calgary|Alberta Health services|Alberta Innovates Health Solutions\nNone\nNone\nAga Khan University|Oswaldo Cruz Foundation|Stanford University\nNone\nNone\nUniversity of California Davis\nNone\nGeistlich Pharma AG\nNone\nNone\nNone\nNovartis Pharmaceuticals\nNational Institute of Mental Health (NIMH)\nNone\nNone\nNone\nNone\nUniversity of Michigan\nNone\nNational Heart Lung and Blood Institute (NHLBI)\nNational Heart Lung and Blood Institute (NHLBI)\nNone\nBlau Farmaceutica S.A.\nNational Heart Lung and Blood Institute (NHLBI)|American Heart Association\nNone\nNone\nNational Institute for Occupational Safety and Health (NIOSH/CDC)\nQueen's University Belfast\nCharite University Berlin Germany|National Institute on Aging (NIA)\nNone\nNone\nNone\nNone\nNone\nNone\nShanghai Institute of Palnned parenthood research\nNone\nNone\nAlberta Health & Wellness|Alberta Health services|Merck Frosst Canada Ltd.\nUniversity of Sao Paulo|Federal University of Juiz de Fora\nNone\nNone\nNone\nHeart Rhythm Clinical and Research Solutions LLC\nFundação de Amparo à Pesquisa do Estado de São Paulo\nDuke Health\nNational Heart Lung and Blood Institute (NHLBI)\nCentocor Inc.\nNone\nNone\nNone\nNone\nNone\nReinvestment Partners\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNational Institute of Mental Health (NIMH)\nNone\nNone\nStanford University\nNone\nNone\nNone\nNone\nNone\nBarts & The London NHS Trust|Queen Mary University of London|University of Bristol|Yale University\nNone\nNone\nNone\nUmeå University|Karolinska Institutet|Uppsala University|Vastra Gotaland Region\nCanadian Diabetes Association\nNone\nSaint-Louis Hospital Paris France\nNone\nNone\nNone\nGöteborg University\nMayo Clinic|Dartmouth-Hitchcock Medical Center|CISSS de Chaudière-Appalaches|Memorial Hermann Hospital|David Grant U.S. Air Force Medical Center|59th Medical Wing|Prisma Health Richland Hospital|William Jennings Bryan Dorn VA Medical Center\nCairo University\nNone\nNone\nNational Institute on Drug Abuse (NIDA)\nNone\nNone\nJessa Hospital\nNone\nNone\nNone\nNone\nNone\nNone\nEpitel Inc.\nSanofi\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAmerican Physical Therapy Association\nMerck KGaA Darmstadt Germany|Pfizer\nAmerican Cancer Society Inc.|Consumer Wellness Solutions|North Carolina Tobacco Quitline\nNational Institute on Drug Abuse (NIDA)|National Institute of Mental Health (NIMH)\nNone\nNone\nNone\nNone\nThe LAM Foundation\nNone\nInstitut National de la Santé Et de la Recherche Médicale France\nWest China Hospital\nNone\nInternational Centre for Diarrhoeal Disease Research Bangladesh|Virginia Commonwealth University\nNone\nNone\nNone\nNone\nSorlandet Hospital HF|St. Olavs Hospital|Texas A&M University|University of Michigan\nNone\nNone\nNone\nNone\nNone\nRamathibodi Hospital\nNone\nNone\nNone\nThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|The Second Hospital of Hebei Medical University|Shanxi Bethune Hospital|First Affiliated Hospital Xi'an Jiaotong University|The Affiliated Hospital of Qingdao University|Shanghai Pudong Hospital|Tianjin Medical University General Hospital|China-Japan Union Hospital Jilin University|Fudan University\nIndiana University|Dartmouth College\nBoston University\nEnverdis Corp.\nNone\nCairo University\nNone\nNone\nNone\nNone\nNone\nInstitut National de la Santé Et de la Recherche Médicale France\nNone\nNational Center for Complementary and Integrative Health (NCCIH)\nRadboud University Medical Center\nNone\nCairo University\nJanssen Medical Affairs\nNone\nNone\nThe Foundation for Barnes-Jewish Hospital\nNone\nUniversity of the Basque Country (UPV/EHU)\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEli Lilly and Company|Genentech Inc.\nNone\nNone\nNational Institute of General Medical Sciences (NIGMS)|Baylor College of Medicine\nNone\nNone\nFolktandvården Stockholms län AB\nUniversity of Jena\nNone\nNone\nNone\nOntario Ministry of Health and Long Term Care\nNone\nNone\nNone\nNone\nNone\nNone\nDalhousie University\nNone\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\nNone\nNone\nNone\nNone\nAssociation of Anaesthetists of Great Britain and Ireland\nNone\nNational Cancer Institute (NCI)\nNational Institutes of Health (NIH)\nNone\nNone\nUniversity of Lausanne\nEVA - Grupo Brasileiro de Tumores Ginecológicos|Roche Pharma AG\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNational Cancer Institute (NCI)|West Cancer Center|Vector Oncology\nBoehringer Ingelheim\nNone\nPrometheus Laboratories\nNone\nNone\nNone\nNone\nNone\nNone\nSeoul National University Hospital\nNational Cancer Institute (NCI)|Eastern Cooperative Oncology Group\nNone\nAstellas Pharma China Inc.\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAmgen|ClinAssess GmbH\nNone\nNone\nNone\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Society of Family Planning\nLinyi People's Hospital\nNone\nUniversity of Colorado Denver\nMerck Sharp & Dohme LLC\nNone\nAssiut University\nAssiut University\nNone\nNone\nNone\nNone\nNone\nBrigham and Women's Hospital|Boston Children's Hospital|The Commonwealth Fund\nFinanciadora de Estudos e Projetos\nNone\nUniversity Hospital of Crete\nOnLume Inc.|National Cancer Institute (NCI)\nNone\nNone\nErasmus Medical Center|University of Amsterdam\nFondazione EMN Italy Onlus\nNone\nUniversity of Michigan|Peking University\nNone\nNone\nNone\nNone\nClinical Hospital Centre Zagreb\nNone\nNone\nNone\nNone\nNone\nNone\nJohns Hopkins Bloomberg School of Public Health\nNone\nNone\nNone\nNHS Lothian\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nEngin Oral|Berna Dilbaz|Gürkan Bozdag|Cem Atabekoğlu|Nuray Bozkurt|Gokce Anik Ilhan|Ali Kolusari|Cihan Kaya|Banu Yılmaz|Engin Yildirim|Ahmet Başar Tekin|Servet Ozden hacivelioglu\nNational Cancer Institute (NCI)\nOlix Pharmaceuticals Inc.\nAlliance for Better Bone Health\nNone\nNone\nNone\nUniversity of Ghana|Newcastle University|Penn State University|Helen Keller International\nNone\nMinistry of Health Welfare and Sports The Netherlands\nNone\nKasr El Aini Hospital|National Research Centre Egypt\nNone\nNone\nINSERM 1061  Neuropsychiatry: epidemiological and clinical research Montpellier\nNone\nSanofi\nNone\nArk Biosciences Pty Ltd.\nNone\nNone\nNone\nNone\nMerck Sharp & Dohme LLC|Prostate Cancer Foundation\nApatech Inc.\nNone\nBoston Scientific Korea Co. Ltd|Dio|Terumo Corporation|Abbott\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNIH Office of AIDS Research (OAR)|Fogarty International Center of the National Institute of Health\nNone\nNone\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nDr. Phillips Center for the Performing Arts\nNone\nNational Institute on Deafness and Other Communication Disorders (NIDCD)|Genentech Inc.\nNone\nNone\nMerck Sharp & Dohme LLC\nScuola Superiore Sant'Anna Pisa\nNone\nNone\nNone\nSan Francisco AIDS Foundation|California HIV/AIDS Research Program\nNone\nNone\nNone\nNone\nFundação de Amparo à Pesquisa do Estado do Rio Grande do Sul Brazil|Conselho Nacional de Desenvolvimento Científico e Tecnológico\nAgencia Española de Cooperación Internacional|World Health Organization\nColumbia University|Northwestern University|Satellite Healthcare|Norman S. Coplon Extramural Grant Program\nNone\nNone\nNone\nUniversity of Bergen|Municipality of Bergen Norway|Kavli Research Centre for Ageing and Dementia\nCanadian Orthopaedic Foundation\nOsseointegration Foundation|University of Iowa Institute of Clinical and Translational Science\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nInstitute of Experimental Medicine Russia|Research Institute of Influenza Russia\nNone\nNone\nGenentech Inc.\nNone\nNone\nMassachusetts General Hospital|Brigham and Women's Hospital|National Heart Lung and Blood Institute (NHLBI)\nAmgen\nNone\nNational Institute of Mental Health (NIMH)\nNone\nAmgen\nShengxin Biotechnology Institute Beijing\nNone\nNone\nNone\nNone\nNone\nNone\nBristol-Myers Squibb\nNone\nNone\nNone\nRuijin Hospital|Shanghai Tong Ren Hospital|First Affiliated Hospital of Zhejiang University\nNone\nNone\nSafe Step and Walk Movement (SSWM) Toulouse France\nConselho Nacional de Desenvolvimento Científico e Tecnológico|Federal University of Rio Grande do Sul\nNone\nNone\nNone\nNone\nNone\nHacettepe University|Saglik Bilimleri Universitesi\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFondation de l'Avenir\nNone\nNone\nNone\nNone\nMcNeil Consumer & Specialty Pharmaceuticals a Division of McNeil-PPC Inc.\nNone\nBeijing Institute of Biological Products Co Ltd.|Wuhan Institute of Biological Products Co. Ltd|The University of Hong Kong\nWingate Institute\nCelgene|National Institutes of Health (NIH)|National Cancer Institute (NCI)\nNone\nPfizer\nNHS England (NHSE/I) London\nNone\nNone\nNone\nNone\nColgate Palmolive|Associação Latinoamericana para Promoção de Saúde Bucal e Pesquisa Odontológica (LAOHA)\nNone\nNone\nNone\nAmerican Cancer Society Inc.\nNone\nNone\nChildhood Asthma in Urban Settings (CAUSE)|Regeneron Pharmaceuticals|Rho Federal Systems Division Inc.\nOtsuka America Pharmaceutical\nNone\nNational Institute of Mental Health (NIMH)\nNone\nLeonhardt Ventures LLC\nNone\nUniversity Medical Center Groningen|QPS Holdings LLC\nAbbVie\nNone\nFundação de Amparo à Pesquisa do Estado de São Paulo\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nDuke Clinical Research Institute|Alzheimer's Association\nNone\nNone\nNone\nNone\nNone\nNone\nState University of New York College of Optometry\nDiabetesforeningen|Danish Hospital foundation for medical research. region Copenhagen The Faroe Islands and Greenland.|Aage Bangs Fond\nOslo University Hospital\nIsala|Innofeet|Vektis health care information center|National Institute for Public Health and the Environment (RIVM)\nSunderby Hospital|Karolinska Institutet\nInstituto Valenciano de Infertilidad IVI VALENCIA\nNone\nGeneralkonsul Einar Høyvalds Fond|Jørgen Bagenkop Nielsens Myopi-Fond|Chr. Andersen og hustru Ingeborg Andersen f. Schmidts legat (fond) oprettet af deres datter frk. Lilli Ellen Andersen.\nSeoul National University\nNone\nNone\nNone\nNone\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\nNone\nNational Heart Lung and Blood Institute (NHLBI)|Gunze Limited|National Institutes of Health (NIH)\nNone\nLG Life Sciences\nNone\nImperial College Healthcare NHS Trust\nNone\nNone\nNone\nNone\nCanadian Academy of Sport and Exercise Medicine (CASEM)|Kinesis Medical Centre Inc.\nNone\nThe Hospital for Sick Children|Grand Challenges Canada\nNone\nNational Institute on Drug Abuse (NIDA)\nNone\nBanon IVF Center Assiut Egypt\nEver Neuro Pharma GmbH\nNone\nNone\nNone\nNational Center for Complementary and Integrative Health (NCCIH)\nNone\nNone\nNeuroCure Clinical Research Center Charite Berlin|University Medical Center Goettingen\nPhilips Healthcare\nThermofield\nNone\nLounais-Suomen Syöpäyhdistys\nSynthes Inc.\nNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\nNone\nVertos Medical Inc.\nReckitt Benckiser LLC\nNone\nStanley Medical Research Institute\nMedacta International SA\nUniversity of Virginia|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\nNone\nQuintiles Inc.\nNNB Nutrition\nKU Leuven|iMinds|Brand New Health|Yorbody|Delhaize\nNone\nNone\nNone\nNone\nNone\nUniversity of Oxford|Hoffmann-La Roche\nNone\nNone\nNone\nNone\nCyndRx LLC\nNone\nGOG Foundation\nNone\nNone\nPfizer\nNone\nNone\nTakeda Development Center Americas Inc.\nNone\nHospital Arnau de Vilanova\nNone\nNone\nNone\nNational Cancer Institute (NCI)\nNone\nChiltern International Ltd.|HFL Ltd.\nNone\nNone\nNone\nNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\nNone\nNone\nNone\nUniversity of Valencia\nNone\nNone\nNovartis Pharmaceuticals\nNone\nNone\nNone\nCure&Sure Biotech Co. LTD\nThe Swedish Research Council|Bayer\nNone\nNone\nNone\nSunnybrook Health Sciences Centre|Women's College Hospital\nNone\nUnited States Department of Defense|U.S. Army Medical Research and Development Command\nNovartis Pharmaceuticals\nThe Novo Nordic Foundation|University of Copenhagen\nNone\nNone\nCenter for Research and Development of Health Resources and Services National Institute of Health Research and Development (NIHRD) Indonesia\nSwansea University\nNone\nNone\nSaskatchewan Health Research Foundation\nNone\nNovartis Pharmaceuticals\nNone\nNone\nAstraZeneca\nNone\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\nNone\nNew York University|Universität Tübingen|Heinrich-Heine University Duesseldorf\nSiemens Medical Solutions\nNone\nNone\nNone\nNone\nNone\nBristol-Myers Squibb\nNone\nAin Shams University|Mansoura University|Alexandria University|Fayoum University|Tanta University|National Cancer Institute (NCI)\nNational Cancer Institute (NCI)|Harvard University\nNone\nColumbia University\nNone\nNone\nNone\nCanadian Institutes of Health Research (CIHR)|McMaster University\nNone\nNone\nNone\nNone\nNone\nSimbecRresearch Ltd.\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNoninvasive Medical Technologies Inc.|United States Department of Defense\nKoç University\nNone\nNone\nNational Research Agency France\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nGlycemic Index Laboratories Inc|Agriculture and Agri-Food Canada|Saskatchewan Pulse Growers\nNone\nCambridge University Hospitals NHS Foundation Trust\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPeking University People's Hospital\nNone\nChildren's Mercy Hospital Kansas City|Ann & Robert H Lurie Children's Hospital of Chicago|Riley Hospital for Children at Indiana University Health|National Institute of Nursing Research (NINR)\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nUniversity of Rochester|Texas Tech University|Colorado Department of Public Health and Environment|Centers for Disease Control and Prevention\nNone\nGeneral medicine department of Clermont-Ferrand's university\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nThe Broad Foundation|University of Chicago\nJessa Hospital\nUniversity of Oxford\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNational Heart Lung and Blood Institute (NHLBI)\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nUniversity of Lorraine\nThe Moody Foundation\nNone\nProdimed S.A.|CCD\nUniversità Politecnica delle Marche\nNone\nGenentech Inc.\nNone\nHvidovre University Hospital\nRoyal Veterinary College\nNone\nProtac A/S\nNone\nNone\nNone\nOttawa Heart Institute Research Corporation|London Health Sciences Centre\nNone\nAstellas Pharma Inc\nNone\nNone\nNone\nUniversity Health Network Toronto\nNone\nNone\nNone\nNone\nIstituto Oncologico Veneto IRCCS\nG. d'Annunzio University\nNone\nNone\nNone\nNone\nNone\nNIH/NCI - Grant award number: R01CA218357\nThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|Jiangsu University|Xuzhou Medical University|Southeast University China\nTigermed Consulting Co. Ltd\nNone\nWorcester Polytechnic Institute|National Heart Lung and Blood Institute (NHLBI)\nNone\nCancer Prevention Pharmaceuticals Inc.|University of Arizona|University of Hawaii\nBaxter Healthcare Corporation\nParc Sanitari Sant Joan de Déu|Universitat Autonoma de Barcelona\nNone\nKaneka Medical America LLC\nNone\nNone\nRegion Östergötland|Region Jönköping County|FORSS Forskningsrådet i Sydöstra Sverige\nNone\nNone\nNone\nNone\nNew York State Psychiatric Institute\nNone\nNone\nNone\nNone\nJuvenile Diabetes Research Foundation|Medtronic\nCelerion\nNone\nNone\nNone\nNone\nCanadian Liver Foundation|Canadian Institutes of Health Research (CIHR)|American College of Gastroenterology\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nNone\nCarle Foundation Hospital\nNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\nNone\nNone\nTongji Hospital\nNational Institute of Nursing Research (NINR)\nNone\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Ka\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n Care Inc.\nNone\nNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\nMetabolic Health Solutions UK\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPfizer\nStryker Orthopaedics\nNone\nMassachusetts General Hospital|Beth Israel Deaconess Medical Center\nNone\nNone\nJina Pharmaceuticals Inc.|National Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nUniversity-Town Hospital of Chongqing Medical University|Children's Hospital of Chongqing Medical University|Chongqing Medical Center for Women and Children\nNone\nNone\nMinisterio de Ciencia e Innovación Spain|CIBER Fisiopatología de la Obesidad y la Nutrición\nDuke University|Johns Hopkins University\nNational Cancer Institute (NCI)\nNone\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\nNone\nNone\nNone\nNone\nNone\nNone\nThe Seventh Affiliated Hospital of Sun Yat-sen University\nNone\nNone\nUniversity of Southern California\nIonis Pharmaceuticals Inc.\nNone\nNone\nNone\nNone\nCancer Research UK\nNone\nColumbia University\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNovartis|Genentech Inc.\nNone\nNone\nJahangirnagar University Bangladesh|Midwestern University|University of Dhaka Bangladesh\nNone\nNone\nUniversity of Maryland College Park\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAmgen\nNone\nNone\nNone\nNone\nGI Supply\nNone\nUniversity of Trieste|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia|University of Eastern Piedmont\nNone\nAl-Azhar University\nAntelope Valley Partners for Health|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Cedars-Sinai Medical Center\nNone\nNone\nNone\nNone\nNone\nNone\nCenters for Disease Control and Prevention|Ministry of Public Health Argentina\nGlaxoSmithKline\nNone\nNuVasive|St. Louis University\nNone\nPfizer\nNone\nAtrium Innovations\nVenenklinik Bellevue|Kantonsspital Nidwalden|Spital Männedorf\nNone\nNone\nNational Institute for Health Research United Kingdom|British Heart Foundation|Merck & Cie\nNone\nHokkaido University\nNone\nXiamen Innovax Biotech Co. Ltd|Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.\nNone\nNone\nAmgen\nNone\nNone\nNone\nAlberta Health services\nNone\nNone\nGroupe Hospitalier Pitié-Salpêtrière\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNational Heart Lung and Blood Institute (NHLBI)\nNone\nFrench Eso-Gastric Tumors Working Group|National Cancer Institute France\nNagy A. Youssef (Consultant on the MST technique)\nNone\nNone\nAnhui Medical University|Rutgers University|University of Arkansas|National Institute of Mental Health (NIMH)\nNone\nMasterFoods\nNone\nNone\nFirst Affiliated Hospital of Suzhou Medical College\nNone\nNone\nNone\nHvidovre University Hospital|University of Leeds|Salk Institute for Biological Studies|University of Copenhagen\nNone\nParamount Farms\nAstraZeneca\nChildren's Hospital Colorado\nUniversity of California Los Angeles|National Institute of Neurological Disorders and Stroke (NINDS)\nNone\nNovartis\nNone\nH. Lundbeck A/S\nNational Heart Lung and Blood Institute (NHLBI)\nNone\nIsraeli association for lung disease\nNone\nNYU Langone Health|Rutgers University\nSt. Olavs Hospital\nNone\nNone\nNone\nNone\nForest Laboratories\nQuotient Clinical\nNational Institute on Aging (NIA)|Case Western Reserve University\nNational Institute of Dental and Craniofacial Research (NIDCR)|HealthPartners Institute|Kaiser Permanente|Permanente Dental Associates Group Oregon|University of Alabama at Birmingham|University of Florida|University of Copenhagen\nNone\nNone\nCook County Health\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nPalo Alto Medical Foundation|Patient-Centered Outcomes Research Institute\nNone\nNational Institute on Aging (NIA)\nNone\nNone\nJazz Pharmaceuticals\nNone\nNone\nNone\nNone\nRamathibodi Hospital\nNone\nNone\nNone\nNone\nMedImmune LLC\nNone\nNone\nNone\nBoston Children's Hospital|University of California Davis|Unverisity of Kansas Medical Center|University of Minnesota|St. Louis Children's Hospital\nGrupo Español de Tratamiento de Tumores de Cabeza y Cuello|AIO-Studien-gGmbH\nNone\nTechnion Israel Institute of Technology|Riga East University Hospital|JLM Innovation GmbH\nNone\nPfizer\nNone\nNone\nNational Department of Health of South Africa|National Institute for Communicable Diseases South Africa|KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP|Fred Hutchinson Cancer Center|Hutchinson Center Research Institute of South Africa (HCRISA)|Janssen Vaccines & Prevention B.V.|Bio Analytical Research Corporation|Dis-Chem Pharmacy|BioVac|Biocair|Right to Care|Clinical Laboratory Services\nNational Center for Complementary and Integrative Health (NCCIH)|National Institutes of Health (NIH)\nNone\nCystic Fibrosis Foundation\nNone\nNone\nNone\nUniversity of Reading|University of Oslo|Institut National de la Santé Et de la Recherche Médicale France|Maastricht University Medical Center|Universidad Nacional de Córdoba|Jagiellonian University|Uppsala University\nAltmarc Inc.\nMeril Life Sciences Pvt. Ltd.|Terumo Corporation\nUnited States Agency for International Development (USAID)\nNone\nNone\nNone\nErsta Hospital Sweden\nUniversity of Miami|National Institutes of Health (NIH)|National Heart Lung and Blood Institute (NHLBI)\nNational Institute on Drug Abuse (NIDA)\nNone\nNone\nBaystate Medical Center|George Washington University|Vriginia Commonwealth University|Ohio State University\nNone\nADIR a Servier Group company\nLumenis Be Ltd.|Taipei Medical University Shuang Ho Hospital\nNational Taiwan University Hospital|Taipei Veterans General Hospital Taiwan|Tri-Service General Hospital|Mackay Memorial Hospital|Chang Gung Memorial Hospital|China Medical University Hospital|Taichung Veterans General Hospital|Changhua Christian Hospital|Kaohsiung Veterans General Hospital.|National Cheng-Kung University Hospital|Kaohsiung Medical University Chung-Ho Memorial Hospital|Taoyuan General Hospital\nNational Institute on Minority Health and Health Disparities (NIMHD)\nMillennium: The Takeda Oncology Company\nNational Institute on Drug Abuse (NIDA)\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nUniversity of Minnesota\nNone\nNone\nNone\nMr. Thierry PAPER - Biosynex Company\nInspire Medical Systems Inc.\nild care foundation\nEuropean Regional Development Fund|Conseil Régional Auvergne-Rhône-Alpes Clermont-Ferrand France.|Agence Régionale de Santé Rhône-Alpes|Ligue Contre le Cancer Puy de Dôme Allier et Cantal|GIE Auvergne Thermale|Centre Jean Perrin|UFR Médecine|UFR STAPS|Laboratoire d'Informatique de Modélisation et d'Optimisation des Systèmes (LIMOS)|Centre de Recherche en Nutrition Humaine d'Auvergne\nNone\nNone\nNone\nKarolinska Institutet\nHoffmann-La Roche\nNone\nComenius University\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nGuizhou Meijiao Co. Ltd\nNone\nShanghai Zhongshan Hospital|Shanghai Pulmonary Hospital Shanghai China|Fudan University|Ruijin Hospital|Shanghai Public Health Clinical Center\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nColumbia University\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNational Cancer Institute (NCI)\nUniversity of Colorado Denver\nNone\nNone\nNone\nShanghai Zhongshan Hospital|Changhai Hospital\nCeragem Inc.\nNone\nCharite University Berlin Germany|Technische Universität Dresden\nNone\nNone\nTehran Heart Center\nAurelio Seidita\nNone\nNone\nNone\nNone\nNone\nNational Institutes of Health (NIH)|National Institute on Deafness and Other Communication Disorders (NIDCD)\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNational Institute for Biomedical Imaging and Bioengineering (NIBIB)|Johns Hopkins University|University of Florida\nCancer Care Ontario\nNone\nNational Institutes of Health (NIH)\nHamilton Health Sciences Corporation\nNone\nPeking Union Medical College Hospital\nNone\nNone\nUniversity of Washington\nSahlgrenska University Hospital Sweden|Lund University\nNone\nNational Heart Lung and Blood Institute (NHLBI)\nNational Institute on Aging (NIA)\nNone\nBlue Earth Diagnostics\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nNone\nNone\nSanofi\nNational Cancer Institute (NCI)\nLinkoeping University\nNone\nNone\nNone\nNone\nFresenius Kabi\nNone\nNone\nNone\nMbarara University of Science and Technology\nNone\nUniversity of Texas|University of Wuerzburg\nNone\nNone\nNone\nNone\nNone\nThe First Affiliated Hospital of Dalian Medical University|Affiliated Hospital of Qinghai University|Zhejiang Cancer Hospital|Second Affiliated Hospital of Suzhou University\nNational Institute on Drug Abuse (NIDA)\nBeijing Tiantan Hospital\nNone\nNone\nNone\nNone\nNone\nRegion of Wallonia|Public Private Partnership with Institute for Medical Immunology (Universite Libre de Bruxelles)\nNone\nNone\nNone\nNone\nFudan University|Fujian Province Tumor Hospital|Guangdong Provincial People's Hospital|Shengjing Hospital|Affiliated Hospital of Qinghai University|Hebei Medical University Fourth Hospital|The Second Affiliated Hospital of Harbin Medical University|Jiangxi Provincial Cancer Hospital|The First Hospital of Jilin University|Guangdong Provincial Hospital of Traditional Chinese Medicine|Shanxi Province Cancer Hospital|Nanfang Hospital Southern Medical University|Second People's Hospital of Yunnan Province|Binzhou Medical University|The First Affiliated Hospital of University of Science and Technology of China|First Affiliated Hospital of Chengdu Medical College|The Second People's Hospital of Yibin|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nM.D. Anderson Cancer Center|The University of Texas Health Science Center Houston|Memorial Hermann Hospital|Baylor College of Medicine\nValencian Institute of Neurorehabilitation Foundation\nNone\nNone\nBreast International Group\nEuropean and Developing Countries Clinical Trials Partnership (EDCTP)\nOregon Heart and Vascular Institute|Brigham and Women's Hospital|Cedars-Sinai Medical Center\nNone\nNone\nSt. Anne's University Hospital Brno Czech Republic\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNational Heart Lung and Blood Institute (NHLBI)\nNone\nNone\nNone\nNone\nNone\nNone\nNational Institute on Drug Abuse (NIDA)\nNone\nNone\nNone\nNone\nMedImmune LLC\nNone\nNone\nThe University of New South Wales|Gilead Sciences\nNone\nNone\nNone\nNone\nMbarara University of Science and Technology|Medecins Sans Frontieres Netherlands\nUniversity of Castilla-La Mancha\nNational Institute on Aging (NIA)\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNewcastle University|University of Yaounde 1\nHung Kaung University\nNone\nCoalition for Epidemic Preparedness Innovations|International Vaccine Institute\nCase Western Reserve University|National Institute on Aging (NIA)\nNone\nNone\nNone\nNone\nNone\nNational Institutes of Health (NIH)\nLondon North West Healthcare NHS Trust\nNone\nNone\nCanadian Institutes of Health Research (CIHR)\nNone\nNone\nNone\nNone\nNone\nDaiichi Sankyo\nNone\nNone\nNone\nNone\nKaryopharm Therapeutics Inc\nNone\nNone\nNone\nNone\nHealth Resources in Action Inc.\nNYU Langone Health|National Institute of Allergy and Infectious Diseases (NIAID)\nUniversitat Politècnica de València\nNone\nNone\nNone\nAmgen\nBioClever 2005 S.L.|Hospital Clinic of Barcelona|Hospital Sant Joan de Deu\nNone\nNone\nNone\nNone\nAmerican Heart Association\nNone\nAstraZeneca\nNone\nClinica Alemana de Santiago|Hospital Barros Luco Trudeau|University of Chile\nNone\nNone\nNone\nNone\nNone\nNone\nUnited Therapeutics\nUniversidad Europea de Madrid\nObsessive Compulsive Foundation\nNone\nNone\nNone\nQuintiles Inc.\nNone\nNone\nGilead Sciences\nNone\nFleury|Associacao Fundo de Incentivo a Psicofarmcologia|Bayer\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCardiac Vascular & Thoracic Surgery Associates P.C. (CVTSA)\nNone\nNone\nCanadian Institutes of Health Research (CIHR)\nNone\nNone\nNovo Nordisk A/S\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nUniversity of Maryland Greenebaum Cancer Center\nWorldwide Clinical Trials\nNone\nDSM Nutritional Products Inc.|Diabetes Fonds\nNone\nHarvard School of Public Health (HSPH)|National Institute of Environmental Health Sciences (NIEHS)\nNone\nNone\nNone\nMerck KGaA Darmstadt Germany\nUniversity of California Davis\nUniversity of California Los Angeles|University of Washington|University of Michigan|Florida State University|Johns Hopkins University\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nCanadian Institutes of Health Research (CIHR)\nMulti Radiance Medical|Fundação de Amparo à Pesquisa do Estado de São Paulo\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMedline Industries\nNone\nNone\nNone\nNone\nNational Cancer Institute (NCI)\nMenarini Group|Hylab Grenoble|AstraZeneca\nNone\nNone\nUniversity of Ulster|University of Southern Denmark|Loughborough University\nNone\nNone\nFarmer Family Foundation\nNone\nOwens Medical Research Foundation\nNone\nUnited States Department of Defense\nKlinik Favoriten\nUBTH\nNone\nEastern Health\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSecond Affiliated Hospital School of Medicine Zhejiang University\nNone\nNone\nNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|University of Florida\nWorld Rugby Research Unit\nNone\nNone\nNone\nNone\nNational Institute on Aging (NIA)\nNone\nNational Institutes of Health (NIH)|DSM Nutritional Products Inc.|National Institute on Alcohol Abuse and Alcoholism (NIAAA)\nNone\nNone\nJohns Hopkins University|Carnegie Mellon University|Hofstra University|FriendsLearn Inc.|The Mithra Trust|Mind in Motion|Seethapathy Clinic & Hospital\nNone\nBaltimore VA Medical Center\nEuropean Commission\nNone\nUniversity of Copenhagen|University of Southern Denmark\nNorwegian Radium Hospital\nNone\nNone\nCooperative Research Center (CRC) for Alertness Safety and Productivity\nM.I.Tech Co. Ltd.\nNone\nAstraZeneca|Jensen Jonathan B. M.D.\nNone\nNone\nNone\nCanadian Institutes of Health Research (CIHR)\nFeinstein Institute for Medical Research|Albany Medical College\nNone\nNone\nNone\nNone\nAstellas Pharma Inc|Medivation Inc.\nLeading the Change: Collaboration of health Insurers in the Netherlands\nNone\nLinical Co. Ltd.\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nChildren's Hospital Medical Center Cincinnati|University Hospitals Cleveland Medical Center\nNone\nNone\nPoole Hospital NHS Foundation Trust|Dorset County Hospital NHS Foundation Trust\nCigli Regional Training Hospital|Muğla Sıtkı Koçman University\nNone\nNone\nISA Pharmaceuticals B.V.\nNone\nNational Medical Research Council (NMRC) Singapore|National University of Singapore\nNone\nEli Lilly and Company|Genentech Inc.\nNone\nASST Grande Ospedale Metropolitano Niguarda\nKing's College Hospital NHS Trust\nNone\nSociété des Produits Nestlé (SPN)\nCovance\nSouthern Medical University China\nMahidol Oxford Tropical Medicine Research Unit|Oxford University Clinical Research Unit Vietnam\nCenter for Sepsis Control and Care Germany|Zentrum für klinische Studien Essen|JobCenter Essen Mitte|Jobcenter Bottrop|Jobcenter Gelsenkirchen|Jobcenter Oberhausen|Jobcenter Mülheim an der Ruhr|Universität Duisburg-Essen\nNone\nNone\nUniversity of New Brunswick|McGill University|Horizon Health Network|New Brunswick Health Research Foundation\nNational Cancer Institute (NCI)\nNone\nNone\nTakeda|Sucampo Pharmaceuticals Inc.\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nFudan University\nNone\nNone\nHaute Ecole de Santé Vaud\nNone\nNone\nRambam Health Care Campus\nNone\nNone\nClintek\nMedtronic\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nClinical Laserthermia Systems AB\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCanadian Cancer Society (CCS)\nNone\nNone\nNone\nArizona State University\nAlberta Children's Hospital Research Institute\nPhilipps University Marburg Medical Center|Helmut Schmidt University|University Hospital Essen\nNone\nYale University|Metodecentret - Center for Effective Innovation in Social Services\nNone\nNone\nNone\niBeat Inc.\nNone\nBristol-Myers Squibb\nNone\nParexel\nNone\nNone\nNone\nNone\nAgency for Healthcare Research and Quality (AHRQ)\nCelgene\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nNone\nDepartment for International Development United Kingdom|London School of Hygiene and Tropical Medicine|University of Nigeria Enugu Campus\nNone\nNew York Blood Center\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\nBadalona Serveis Assistencials|Institut de Recerca Biomèdica de Lleida\nMereo BioPharma\nUniversity of Pittsburgh|University of Virginia\nSt. Olavs Hospital\nNational Medical Research Council (NMRC) Singapore\nAlberta Health services\nGeorgia Department of Public Health\nNone\nNone\nFortrea\nViiV Healthcare\nNone\nNone\nAsan Medical Center|Severance Hospital\nNone\nNone\nPatient-Centered Outcomes Research Institute|Atrium Health Levine Cancer Institute\nInnovation Fund Denmark\nNone\nRio Grande do Sul State Health Department - SES/RS|Oswaldo Cruz Foundation\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nAstraZeneca|Genentech Inc.\nNone\nCheckmate Pharmaceuticals|CellSight Technologies Inc.\nNone\nNone\nNone\nThe Affiliated Hospital of Qingdao University|Nakhia Impex LLC\nNone\nNone\nNone\nNone\nNone\nNone\nRoche Diagnostics\nNone\nNone\nNone\nBergen Medical Research Foundation|Skretting ASA|Leroy Seafood Group ASA\nOdense Patient Data Explorative Network\nNovartis Pharmaceuticals\nNone\nNone\nNone\nNational Institute on Drug Abuse (NIDA)\nMolecular NeuroImaging\nNone\nUniversity of California San Francisco|University of California Los Angeles|Stanford University|Donor Network West\nNone\nAzienda USL Modena\nNone\nCenters for Disease Control and Prevention|Association of American Medical Colleges\nNone\nNone\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nAleh Negev Nahalat Eran Israel|Ben-Gurion University of the Negev Israel\nPfizer\nUniversity of Oklahoma|Rutgers University|University of California San Diego\nNone\nNone\nNone\nNone\nUniversity of Limerick\nNone\nNone\nNone\nUniversity of Pittsburgh\nNone\nNone\nNone\nNone\nNone\nNone\nMerck Sharp & Dohme LLC\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nUnity Health Toronto|Women's College Hospital|St. Claraspital AG|Mount Sinai Hospital Canada\nNone\nNone\nPIH Health Good Samaritan Hospital\nHamad Medical Corporation|Weill Cornell Medical College in Qatar\nUniversity of Louisville\nNone\nNone\nNone\nNone\nNone\nMartinos Center for Biomedical Imaging\nNone\nNone\nNone\nNone\nNone\nZonMw: The Netherlands Organisation for Health Research and Development\nNone\nNational Institute of Allergy and Infectious Diseases (NIAID)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute of Mental Health (NIMH)\nNone\nNone\nNational Institute on Drug Abuse (NIDA)|University of Cincinnati\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNational Multiple Sclerosis Society\nNone\nSecond Affiliated Hospital of Medical College Shandong University|Jinan Military General Hospital|Shandong University of Traditional Chinese Medicine|West China Hospital\nNone\nNone\nNone\nBeijing Scitop Bio-Tech Shareholding Co.Ltd.\nNone\nSwedish Football Association|Folksam|Swedish National Centre for Research in Sports\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSt. Antonius Hospital|Diagram B.V.\nCanadian Institutes of Health Research (CIHR)\nUniversity of New Mexico|Yale University\nNone\nNone\nMount Sinai Hospital New York\nNone\nCultech Ltd Port Talbot UK|Universität Duisburg-Essen|School of Medicine and School of Biosciences Cardiff University Cardiff UK|IDRA Laboratory Parco Tecnologico Padano s.r.l Lodi Italy\nNone\nNone\nNone\nNone\nNone\nCelerion\nShanghai Children's Hospital|Shanghai Children's Medical Center|Xinhua Hospital Shanghai Jiao Tong University School of Medicine\nNone\nNone\nNone\nNone\nNone\nNational Institutes of Health (NIH)|Johns Hopkins University\nNone\nNone\nMcGill University\nNone\nNone\nNone\nNone\nNone\nNone\nCancer Institute and Hospital Chinese Academy of Medical Sciences\nNone\nEuropean Commission|Memorial University of Newfoundland\nEli Lilly and Company\nNone\nNone\nNone\nNone\nNone\nCelerion\nNone\nFirst Hospital of Tsinghua University|Beijing Normal University\nNone\nNone\nUniversity of California Berkeley|University of California Davis|Stanford University|Emory University|Innovations for Poverty Action\nNone\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nNational Institute of Mental Health (NIMH)|University of Ghana|University of Nairobi|Reach the Youth Uganda|New York University\nNone\nNone\nRoche Pharma AG\nNone\nNone\nNone\nNational Institute on Alcohol Abuse and Alcoholism (NIAAA)|The Cleveland Clinic|University of Massachusetts Worcester|University of Louisville\nnorthwest coast academic science network|Quidel Corporation|Siemens Corporation Corporate Technology|Abbott Diagnostics Division\nProstate Cancer UK|Boehringer Ingelheim\nNone\nNone\nDrug Science UK\nALS Association|Muscular Dystrophy Association|Synapse Biomedical\nBioMarin Pharmaceutical\nNone\nNone\nTehran University of Medical Sciences\nNone\nSchering-Plough|Genentech Inc.|Millennium Pharmaceuticals Inc.\nBaszucki Brain Research Fund|Milken Institute\nICON Bioscience Inc\nNone\nNone\nNone\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\nNational Institute on Drug Abuse (NIDA)\nNone\nAstraZeneca\nNone\nNone\nNone\nNone\nNone\nJohns Hopkins University|Johns Hopkins Bloomberg School of Public Health|New York University|Ohio State University|University of California San Francisco|University of Colorado Denver|University of Pittsburgh|University of Washington\nU.S. Department of Justice\nNone\nNone\nNone\nNone\nGilead Sciences|Merck Sharp & Dohme LLC|GlaxoSmithKline|Abbott\nMỹ Đức Phú Nhuận Hospital|Phương Chi Hospital\nMakerere University|Mildmay Uganda Limited|National Institute on Alcohol Abuse and Alcoholism (NIAAA)|University of California San Francisco\nNone\nTNO|University of California San Diego\nSocieta Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva|Catholic University of the Sacred Heart\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nSwiss National Science Foundation|Swiss Heart Foundation\nBoston Scientific Corporation\nNone\nNone\nNone\nNone\nSanofi\nRoche Pharma AG\nNone\nNone\nNone\nUniversity of Rochester\nDartmouth College\nPeking University First Hospital|Chinese PLA General Hospital|Fudan University\nNone\nNone\nNone\nNone\nNational Institute of Allergy and Infectious Diseases (NIAID)\nNone\nCutera Inc.\nNone\nNone\nDaxor Corporation\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nMedical Research Council\nNone\nNone\nNone\nNone\nBristol-Myers Squibb|National Cancer Institute (NCI)\nNone\nKing's College Hospital NHS Trust|Manchester Metropolitan University\nCanadian Institutes of Health Research (CIHR)|Society of Pediatric Psychology|Western University\nNone\nNational Cancer Institute (NCI)\nUiT The Arctic University of Norway\nNone\nNovartis\nInternational Centre for Diarrhoeal Disease Research Bangladesh|Johns Hopkins University|University at Buffalo\nNone\nNone\nNone\nNone\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nChiesi Farmaceutici S.p.A.\nNone\nNone\nMransoura University\nNone\nNone\nNone\nEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Wayne State University|University of Washington\nNone\nNone\nRoche Pharma AG\nNone\nNone\nFaculdade de Medicina de Botucatu UNESP Botucatu Brasil|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nTheodor Bilharz Research Institute|The Cairo Kidney Center|Helwan University|Zagazig University\nNational Institute on Drug Abuse (NIDA)|New York State Psychiatric Institute|Columbia University|Clinilabs Inc.\nNone\nNone\nNone\nMallinckrodt\nPATH\nNone\nNational Cancer Institute (NCI)\nNone\nNone\nNone\nNone\nNone\nCVie Therapeutics Co. Ltd.\nCHU de Reims\nNone\nLGMD2i Research Fund|CureLGMD2i|Ludwig-Maximilians - University of Munich\nNone\nNational Heart Lung and Blood Institute (NHLBI)|Kaiser Permanente|Stanford University\nCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.|Conselho Nacional de Desenvolvimento Científico e Tecnológico\nNone\nNone\nMahidol University|Mahidol Oxford Tropical Medicine Research Unit\nInstitute of Clinical Physiology CNR PisaItaly|Salerno Hospital Italy|Monaldi Hospital Napoli Italy|University of Pisa Italy|San Luca Hospital Lucca Italy|Careggi University Hospital Florence Italy|Federico II University|San Carlo Public Hospital Potenza Italy|Royal Brompton & Harefield NHS Foundation Trust|Ospedale dell'Angelo Venezia-Mestre|University of Parma|Hospital Clinics Trieste Italy|Federal University of Rio Grande do Sul|Hospital San José Criciuma Brasil|Hospital San Vicente de Paulo Passo Fundo Brasil|University of Belgrade|University of Szeged Hungary|Elisabeth Hospital Hodmezovasarhely Hungary|Sandro Pertini Hospital Rome Italy|Hospital Clinics Bari Italy|Ospedale Nottola Siena Italy|University of Catania Italy|Medika Cardiocenter Saint Petersburg Russian Federation|Acibadem City Clinic Tokuda Hospital|Investigaciones Medicas Buenos Aires Argentina|Tomsk National Research Scientific Centre of Russian Academy of Sciences Tomsk Russian Federation|Instituto Nacional de Cardiología Mexico City Mexico|Hamad Medical Corporation Heart Hospital -Doha-Qatar\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nCambridge University Hospitals NHS Foundation Trust\nNone\nNone\nAbbott\nNational Institute on Aging (NIA)\nJanssen-Cilag Ltd.\nNone\nNone\nNone\nNational Human Genome Research Institute (NHGRI)\nNone\nNone\nNone\nNone\nNone\nNone\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the eight column from each row of the final RDD filtered_rdd_with_header\n",
    "\n",
    "collaborators = filtered_rdd_with_header.map(lambda row: row[7])\n",
    "\n",
    "# Display the first column values\n",
    "for value in collaborators.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "a4aa0257-0c45-46db-90db-e1cd3d66194f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Enrollment\n250.0\n30.0\n40.0\n500.0\n206.0\n103.0\n44.0\n439.0\n119.0\n12000.0\n10.0\n1000.0\n122.0\n970.0\n64.0\n4.0\n65.0\n89.0\n60.0\n220.0\n108.0\n15.0\n76.0\n40.0\n124.0\n30.0\n60.0\n30.0\n3000.0\n3.0\n600.0\n60.0\n62.0\n352.0\n90.0\n610.0\n48.0\n85.0\n50.0\n5000.0\n81.0\n200.0\nNone\n1378.0\n40.0\n0.0\n22.0\n300.0\n537.0\n73.0\n31.0\n6.0\n200.0\n9.0\n6.0\n6300.0\n411.0\n333.0\n60.0\n50.0\n30.0\n812.0\n97.0\nNone\n104.0\n32.0\n150.0\n40.0\n141.0\n60.0\n65.0\n200.0\n114.0\n800.0\n216.0\n1000.0\n33.0\n44.0\n160.0\n30.0\n159.0\n44.0\n24.0\n30.0\n180.0\n1495.0\n24.0\n10.0\n60.0\n20.0\n60.0\n150.0\n30.0\n4796.0\n163.0\n50.0\n34.0\n30.0\n1.0\n32.0\n1714.0\n16.0\n7260.0\n357.0\n60.0\n50.0\n231.0\n15.0\n50.0\n65.0\n50.0\n5.0\n150.0\n124.0\n100.0\n92.0\n79.0\n30.0\n15.0\n74.0\n21.0\n10.0\n384.0\n86.0\n12.0\n114.0\n48.0\n45.0\n57.0\n480.0\n178.0\n31.0\n102.0\n78.0\n72.0\n12.0\n115.0\n89.0\n290.0\n100.0\n470.0\n70.0\n26.0\n850.0\n70.0\n136.0\n8.0\n22.0\n660.0\n59.0\n78.0\n46.0\n600.0\nNone\n228.0\n364.0\n18.0\n180.0\n266.0\n30.0\n413.0\n96.0\n40.0\n20.0\n90.0\n30.0\n5000.0\n2000.0\n400.0\n60.0\n45.0\n279.0\n0.0\n60.0\n3720.0\n100.0\nNone\n17.0\n150.0\n492.0\n170.0\n170.0\n80.0\n30.0\n134.0\n2415.0\n20.0\n34.0\n48.0\n28.0\n100.0\n32.0\n69.0\n14.0\n307.0\n100.0\n56.0\n28.0\n97.0\n150.0\n100.0\n6.0\n50.0\n260.0\n150.0\n339.0\n16.0\n143.0\n12.0\n44.0\n0.0\n33.0\n400.0\n404.0\n55.0\n32.0\n13.0\n150.0\n12.0\n75.0\n1182.0\n450.0\n13264.0\n48.0\n90.0\n959.0\n60.0\n119.0\n40.0\n32.0\n127.0\n33.0\n532.0\n225.0\n3.0\n242.0\n7.0\n47.0\n100.0\n108.0\nNone\n8.0\n360.0\n2200.0\n10.0\n300.0\n14.0\n250.0\n5.0\n403.0\n402.0\n175.0\n23.0\n150.0\n20.0\n44.0\n30.0\n72.0\n68.0\n5000.0\n180.0\n157.0\n50.0\n64.0\n100.0\n198.0\n168.0\n33.0\n24.0\n2000.0\n31.0\n78.0\n23.0\n50.0\n57.0\n26.0\n70.0\n52.0\n400.0\n120.0\n130.0\n15.0\n7500000.0\n1200.0\n96.0\n1.0\n1604.0\n34.0\n640.0\n15.0\n20.0\n54.0\n163.0\n20.0\n108.0\n120.0\n117.0\n80.0\n51.0\n48.0\n80.0\n60.0\n100.0\n297.0\n2.0\n80.0\n36.0\n15.0\n130.0\n174.0\n350.0\n23.0\n112.0\n0.0\n0.0\n80.0\n31.0\n474.0\n200.0\n293.0\n35.0\n44.0\n82.0\n301.0\n68.0\n140.0\n206.0\n324.0\n10.0\n56.0\n187.0\n37.0\n301.0\n910.0\n56.0\n28855.0\n34.0\n103.0\n941.0\n452.0\n294.0\n5400.0\n68.0\n35.0\n109.0\n36.0\n15.0\n250.0\n36.0\n40.0\n30.0\n2400.0\n38.0\n77.0\n9.0\n140.0\n35.0\n240.0\n50.0\n600.0\n467.0\n215.0\n31.0\n175.0\n168.0\n29.0\n363.0\n42.0\n1080.0\n200.0\n31.0\n44.0\n200.0\n202.0\n332.0\n20000.0\n150.0\n225.0\n250.0\n70.0\n22.0\n600.0\n156.0\n84.0\n200.0\n24.0\n50.0\n436.0\n60.0\n56.0\n120.0\nNone\n0.0\n2.0\n25.0\n102.0\n90.0\n40.0\n46.0\n77.0\n153.0\n6.0\n57.0\n62.0\n30.0\n30.0\n15.0\n136.0\n37.0\n30.0\n336.0\n110.0\n58.0\n69.0\n50.0\n4.0\n1324.0\n48.0\n36.0\n74.0\n300.0\n78.0\n50.0\n3710.0\n256.0\n30.0\n2354.0\n92.0\n10.0\n62.0\n80.0\n0.0\n2.0\n758.0\n77.0\n15.0\n73.0\n12.0\n404.0\n2442.0\n18.0\n20.0\n33.0\nNone\n50.0\n75.0\n32.0\n47.0\n60.0\n52.0\n210.0\n31.0\n75.0\n88.0\n1000.0\n231.0\n142.0\n30.0\n50.0\n50.0\n98.0\n68.0\n723.0\n556.0\n20.0\n40.0\n20.0\n400.0\n40.0\n21.0\n0.0\n42.0\n80.0\n12.0\n100.0\n10.0\n450.0\n26.0\n60.0\n100.0\nNone\n1640.0\n25.0\n143.0\n200.0\n68.0\n420.0\n56.0\n32.0\n8.0\n53.0\n400.0\n10.0\n50.0\n316648.0\n180.0\n160.0\n72.0\n410.0\n77.0\n45.0\n211.0\n100.0\n1000.0\n76.0\n800.0\n400.0\n64.0\n304.0\n307.0\n100.0\n32.0\n126.0\n53.0\n66.0\n61.0\n3.0\n114.0\n76.0\n200.0\n44.0\n954.0\n132850.0\n103.0\n224.0\n30.0\n200.0\n68.0\n374.0\n60.0\n120.0\n20.0\n61.0\n30.0\n1050.0\n254.0\n165.0\n128.0\n10.0\n627.0\n5.0\n82.0\n300.0\n40000.0\n20.0\n200.0\n60.0\n95.0\n110.0\n1000.0\n75.0\n0.0\n80.0\n22.0\n220.0\n240.0\n26.0\n0.0\n28.0\n1183.0\n244.0\n118.0\n10.0\n2.0\n4.0\n60.0\n100.0\n200.0\n180.0\n24.0\n50.0\n1323.0\n116.0\n96.0\n2.0\n41.0\n52.0\n1000.0\n320.0\n800.0\n130.0\n18.0\n120.0\nNone\n4.0\n0.0\n909.0\n29.0\n20.0\n0.0\n110.0\n26.0\n23.0\n24.0\n300.0\n50.0\n56.0\n40.0\n60.0\n473.0\n495.0\n146.0\n164.0\n80.0\n85.0\n120.0\n40.0\n150.0\n100.0\n35.0\n101.0\n183.0\n16.0\n189.0\n230.0\n350.0\n48.0\n324.0\n84.0\n81.0\n11.0\n112.0\n300.0\n180.0\n100.0\n94.0\n99.0\n213.0\n638.0\n200.0\n250.0\n60.0\n12.0\n1410.0\n24.0\n94.0\n150.0\n304.0\n40.0\n64.0\n30.0\n60.0\n58.0\n1720.0\n102.0\n42.0\n8.0\n34.0\nNone\n234.0\n83.0\n126.0\n13.0\n180.0\n53.0\n60.0\n14.0\n116.0\n20.0\n80.0\n49.0\n93.0\n240.0\n224.0\n40.0\n548.0\n390.0\n100.0\n104.0\n34.0\n60.0\n50.0\n60.0\n40.0\n4.0\n636.0\n86.0\n102.0\n6341.0\n182.0\n75.0\n272.0\n10.0\n493.0\n120.0\n130.0\n1054.0\n26.0\n30.0\n76.0\n26.0\n400.0\n107.0\n150.0\n100.0\n66.0\n100.0\n20.0\n40.0\n30.0\n67.0\n100.0\n45.0\n90.0\n117.0\n150.0\n1.0\n979.0\n23.0\n181.0\n1095.0\n160.0\n100.0\n22.0\n2450.0\n308.0\n20.0\n31.0\n3000.0\n53.0\n7.0\n995.0\n40.0\n0.0\n92.0\n120.0\n120.0\n97.0\n0.0\n30.0\n0.0\n410.0\n72.0\n384.0\n72.0\n2550.0\n104.0\n48.0\n100.0\n24.0\n3384.0\n164.0\n44.0\n1100.0\n77.0\n76.0\n3.0\n160.0\n172.0\n97.0\n44.0\n180.0\n0.0\n2.0\n47.0\n225.0\n12.0\n75.0\n89.0\n52.0\n5.0\n120.0\n50.0\n60.0\n75.0\n114.0\n99.0\n48.0\n749.0\n22.0\n103.0\n200.0\n44.0\n832.0\n470.0\n32.0\nNone\n60.0\n306.0\n64.0\n73.0\n130.0\n48.0\n2.0\n60.0\n20.0\n28.0\n128.0\n43.0\n3.0\n494.0\n16.0\n133.0\n17.0\n4000.0\n29.0\n185.0\n70.0\n160.0\n14.0\n120.0\n20.0\n900.0\n19.0\n60.0\n15.0\n150.0\n7.0\n20.0\n312.0\n60.0\n58.0\n341.0\n200.0\n20.0\n30.0\n29.0\n100.0\n84.0\n13.0\n65.0\n120.0\n112.0\n24.0\n58.0\n8.0\n10.0\n30.0\n15.0\n150.0\n32.0\n64.0\n12.0\n21.0\n60.0\n110.0\n420.0\n80.0\n1804.0\n200.0\n31.0\n11145.0\n615.0\n34047.0\n100.0\n10.0\n180.0\n10000.0\n130.0\n700.0\n84.0\nNone\n60.0\n232.0\n60.0\n240.0\n218.0\n43.0\n30.0\n238.0\n30.0\n73.0\n28.0\n389.0\n50.0\n70.0\n100.0\n125.0\n705.0\n50.0\n200.0\n23.0\n30.0\n10.0\n30.0\n35.0\n52.0\n0.0\n10.0\n228.0\n84.0\n80.0\n40.0\n65.0\n40.0\n2808.0\n2527.0\n5000.0\n20.0\n90.0\n3046.0\n76.0\n345.0\n80.0\n140.0\n4.0\n260.0\n24.0\n0.0\n24.0\n120.0\n87.0\n2887.0\n72.0\n30.0\n33.0\n50.0\n209.0\n1654.0\n26.0\n19.0\n115.0\n360.0\n80.0\n38.0\n2000.0\n13.0\n257.0\n66.0\n30.0\n160.0\n154.0\n20.0\n15.0\n50.0\n24.0\n128.0\n2.0\n38.0\n52.0\n40.0\n65.0\n170.0\n150.0\n100.0\n223.0\n12.0\n120.0\n60.0\n40.0\n1000.0\n75.0\n64.0\n80.0\n1000.0\n916.0\n120.0\n40.0\n9.0\n72.0\n186.0\n21.0\n30.0\n1018.0\n500.0\n185.0\n160.0\n5.0\n54.0\n22.0\n50.0\n36.0\n17.0\n25.0\n517.0\n265.0\n107.0\n12.0\n55.0\n35.0\n90.0\n290.0\n124.0\n62.0\n20.0\n1000.0\n600.0\n15.0\n75.0\n45.0\n62.0\n120.0\n24.0\n1660.0\n238.0\n165.0\n1319.0\n16.0\n8.0\n450.0\n60.0\n130.0\n50.0\n60.0\nNone\n73.0\n30.0\n8.0\n95.0\n336.0\n73.0\n14.0\n190.0\n205.0\n50.0\n20.0\n40.0\n46.0\n154.0\n160.0\n200.0\n19.0\n64.0\n1080.0\n67.0\n148.0\n14.0\n54.0\n150.0\n43.0\n60.0\n28.0\n746.0\n20.0\n10.0\n100.0\n40.0\n400.0\n108.0\n28.0\n44.0\n48.0\n60.0\n1071.0\n15.0\n0.0\n200.0\n0.0\n110.0\n224.0\n61.0\n1997.0\n20.0\n200.0\n160.0\n363.0\n64.0\n200.0\n25.0\n102.0\n26.0\n60.0\n2500.0\n19.0\n26500.0\n20.0\n10.0\n32.0\n0.0\n30.0\n12.0\n20.0\n250.0\n300.0\n33.0\n88.0\n22.0\n30.0\n0.0\n30.0\n10.0\n180.0\n122.0\n450.0\n90.0\n2100.0\n250.0\n332.0\n40.0\n120.0\n43.0\n15.0\n30.0\n15.0\n200.0\nNone\n80.0\n567.0\n1501.0\n90.0\n6.0\n10.0\n100.0\n60.0\n4359.0\nNone\n23.0\n196.0\n91.0\n600.0\n75.0\n540.0\n349.0\n15.0\n340.0\n200.0\n31.0\n30.0\n63.0\n195.0\n25.0\n16.0\n40.0\n240.0\n24.0\n2304.0\n40.0\n104.0\n16.0\n50.0\n295.0\n62.0\n16.0\n63.0\n37.0\n25.0\n60.0\n44.0\n18.0\n220.0\n35.0\n0.0\n3.0\n85.0\n1.0\n10.0\n90.0\n106.0\n30.0\n64.0\n365.0\n21.0\n590.0\n169.0\n49.0\n8.0\n21.0\n30.0\n52.0\n28.0\n84.0\n631.0\n200.0\n1200.0\n119.0\n150.0\n90.0\n400.0\n28.0\n38.0\n220.0\n49.0\n100.0\n130.0\n205.0\n22.0\n0.0\n20.0\n1000.0\n130.0\n30.0\n88.0\n113.0\n260.0\n201.0\n434.0\n28.0\n10.0\n1216.0\n37.0\n1300.0\n303.0\n88.0\n30.0\n60.0\n480.0\n110.0\n60.0\nNone\n127.0\n40.0\n5350.0\n15.0\n120.0\n1187.0\n28.0\n6.0\n80.0\n403.0\n210.0\n312.0\n600.0\n60.0\n28.0\n25.0\n35.0\n300.0\n80.0\n50.0\n20.0\n0.0\n54.0\n68.0\n243.0\n40.0\n256.0\n150.0\n11.0\n32.0\n129.0\n50.0\n50.0\n12.0\n50.0\n301.0\n456.0\n250.0\n120.0\n60000.0\n20000.0\n41.0\n211.0\n100.0\n3.0\n90.0\n116.0\n20.0\n10.0\n0.0\n170.0\n2033.0\n30.0\n534.0\n90.0\n17.0\n0.0\n1462.0\n13.0\n30.0\n218.0\n296.0\n88.0\n60.0\n1465.0\n0.0\n150.0\n98.0\n21.0\n65.0\n66.0\n98.0\n146.0\n172.0\n10.0\n550.0\nNone\n150.0\n3420.0\n35.0\n2000.0\n16.0\n72.0\n22.0\n44.0\n20.0\n500.0\n201.0\n160.0\n10.0\n36.0\n50.0\n9.0\n153.0\n15.0\n81.0\n470.0\n92.0\n19.0\n38.0\n200.0\n100.0\n10000.0\n515.0\n15.0\n90.0\n9.0\n64.0\n70.0\n40.0\n1400.0\n6.0\n30.0\n48.0\n40.0\n60.0\n760.0\n40.0\n80.0\n31.0\n46.0\n115.0\n198.0\n5.0\n84.0\n518.0\n8800.0\n0.0\n24.0\n16.0\n44.0\n10.0\n120.0\n129.0\n41.0\n200.0\n40.0\n35.0\n12.0\n111.0\n189.0\n21.0\n52.0\n75.0\n76.0\n2.0\n265.0\n89.0\n40.0\n10.0\n56.0\n200.0\n500.0\n30.0\n66.0\n60.0\n100.0\n90.0\n6.0\nNone\n219.0\n20.0\n30.0\n160.0\n100.0\n11.0\n50.0\n489.0\nNone\n40.0\n38.0\n158.0\n101.0\n346.0\n185.0\n80.0\n15.0\n33.0\n266.0\n2.0\n109.0\n150.0\n180.0\n91.0\n62.0\n28.0\n959.0\n242.0\n8.0\n160.0\n250.0\n55.0\n128.0\n48.0\n287.0\n2007.0\n56.0\n50.0\n252.0\n73.0\n30.0\n10.0\nNone\n32.0\n242.0\n50.0\n134.0\n160.0\n946.0\n88.0\n40.0\n90.0\n562.0\n10.0\n100.0\n300.0\n30.0\n1.0\n14.0\n18.0\n46.0\n42.0\n12.0\n26.0\n21.0\n76.0\n28.0\n30.0\n200.0\n80.0\n11.0\n34.0\n20.0\n30.0\n119.0\n150.0\n30.0\n92.0\n120.0\n3730.0\n20.0\n600.0\n61.0\n100.0\n150.0\n50.0\n300.0\n700.0\n469.0\n30.0\n22.0\n840.0\n12.0\n220.0\n95.0\n75.0\n124.0\n92.0\n297.0\n472.0\n200.0\n119.0\n120.0\n82.0\n20.0\n55.0\n60.0\n0.0\n50.0\n114.0\n40.0\n120.0\n257.0\n200.0\n36.0\n28.0\n140.0\n97.0\n148.0\n215.0\n20.0\n10.0\n60.0\n126.0\n16.0\n8.0\n15.0\n60.0\n8.0\n144.0\n40.0\n40.0\n20.0\n60.0\n66.0\n150.0\n74.0\n15.0\n200.0\n58.0\n172.0\n58.0\n8.0\n76.0\n69.0\n92.0\n101.0\n20.0\n161.0\n40.0\n18.0\n20.0\n2000.0\nNone\n7.0\n260.0\n5.0\n70.0\n90.0\n100.0\n30.0\n64.0\n12.0\n50.0\n17.0\n116.0\n300.0\n10.0\n19.0\n15.0\n158.0\n300.0\n300.0\n251.0\n60.0\n46.0\n100.0\n2333.0\n300.0\n59.0\n86.0\n31.0\n600.0\n720.0\n59.0\n84.0\n63.0\n420.0\n36.0\n60.0\n6.0\n875.0\n100.0\n485.0\n1000.0\n44.0\n30.0\n80.0\n45.0\n17.0\n60.0\n368.0\n203.0\n279.0\n60.0\n278.0\n1000.0\n41.0\n39.0\n289.0\n165.0\n100.0\n8050.0\n150.0\n48.0\n4.0\n120.0\n20.0\n940.0\n500.0\n48.0\n108.0\n0.0\n350.0\n100.0\n131.0\n150.0\n100.0\n148.0\n19.0\n66.0\n38.0\n40.0\n30.0\n0.0\n124.0\n7.0\n158.0\n0.0\n72.0\n142.0\n0.0\n27.0\n88.0\n42.0\n240.0\nNone\n78.0\n60000.0\n350.0\n108.0\n18239.0\n65.0\n80.0\n20.0\n1000.0\n70.0\n20.0\n68.0\n260.0\n53.0\n38.0\n204.0\n71.0\n1116.0\n2.0\n146.0\n50.0\n55.0\n62.0\n9.0\n729.0\n11.0\n60.0\n192.0\n20.0\n2430.0\n10.0\n204.0\n51.0\n20.0\n66.0\n3620.0\n206.0\n25.0\n13.0\n161.0\n30.0\n458.0\n80.0\n36.0\n19.0\n334.0\n80.0\n166.0\n10.0\n150.0\n36.0\n30.0\n99.0\n12.0\n223.0\n5.0\n50.0\n300.0\n34.0\n325.0\n309.0\n11.0\n635.0\n7.0\n45.0\nNone\n48.0\n255.0\n30.0\n32.0\n500.0\n20.0\n5409.0\n0.0\n651.0\n100.0\n9.0\n0.0\n565.0\n1512.0\n5.0\n2136.0\n1416.0\n77.0\n45.0\n95.0\n54.0\n20.0\n2250.0\n100.0\n700.0\n30.0\n89.0\n40.0\n99.0\n192.0\n21.0\n323.0\n40.0\n1919.0\n15.0\n100.0\n32.0\n45.0\n210.0\n230.0\n10.0\n60.0\n600.0\n200.0\n15.0\n867.0\n26.0\n64.0\n26.0\n15.0\n173.0\n91.0\n130.0\n40.0\n80.0\n25.0\n345.0\n296.0\n200.0\n420.0\n600.0\n25.0\n60.0\n66.0\n90.0\n40.0\n303.0\n100.0\n0.0\n120.0\n30.0\n64.0\n60.0\n1000.0\n400.0\n80.0\n14.0\n14.0\n45.0\n44.0\n0.0\n200.0\n179.0\n88.0\n22.0\n40.0\n7.0\n75.0\n24.0\n120.0\n279.0\n60.0\n12500.0\n16.0\n130.0\n60.0\n240.0\n600.0\n168.0\n45.0\n40.0\n10.0\n27.0\n30.0\n120.0\n100.0\n52.0\n600.0\n100.0\n28.0\n2.0\n100.0\n86.0\n40.0\n75.0\n20.0\n54.0\n45.0\n42.0\n30.0\n73.0\n22.0\n25.0\n80.0\n60.0\n34.0\n1850.0\n38.0\n351.0\n16.0\n150.0\n20.0\n117.0\n18.0\n2176.0\n60.0\n50.0\n200.0\n480.0\n75.0\n58.0\n95.0\n5.0\n425.0\nNone\n248.0\n24.0\n20.0\n345.0\n60.0\n20.0\n7020.0\n15.0\n24.0\n10.0\n200.0\n38.0\n60.0\n0.0\n82.0\n40.0\n140.0\n50.0\n80.0\n60.0\n140.0\n276.0\n22.0\n376.0\n2228.0\n10.0\n315.0\n49.0\n54.0\n140.0\n69.0\n30.0\nNone\n116.0\n300.0\n78.0\n50.0\n50.0\n35.0\n128.0\n120.0\n536.0\n21.0\n20.0\n100.0\n105.0\n38.0\n461.0\n32.0\n74.0\n45.0\n44.0\n100.0\n70.0\n64.0\n50.0\n2000.0\n92.0\n20.0\n55.0\n66.0\n75.0\n5.0\n120.0\n0.0\n37.0\n160.0\n900.0\n11060.0\n636.0\n99.0\n80.0\n30.0\n500.0\n586.0\n45.0\n122.0\n35.0\n80.0\n145.0\n357.0\n10.0\n39.0\n41.0\n100.0\n260.0\n934.0\n70.0\n296.0\n40.0\n500.0\n24.0\n61.0\n26.0\n394.0\n374.0\n38.0\n1820.0\n26.0\n138.0\n120.0\n764.0\n36.0\n0.0\n70.0\n48.0\n8.0\n70.0\n800.0\n80.0\n30.0\n102.0\n2615.0\n20.0\n299.0\n0.0\n52.0\n100.0\n35.0\n265.0\n20.0\n80.0\n24.0\n50.0\n41.0\n300.0\n97.0\n28.0\n170.0\n300.0\n0.0\n34.0\n0.0\n51.0\n241.0\n93.0\n37.0\n50.0\n250.0\n120.0\n500.0\n160.0\n21.0\n65.0\n349.0\n11.0\n20.0\n100.0\n16.0\n0.0\n152.0\n24.0\n75.0\n51.0\n1.0\n20.0\n10.0\n30.0\n110.0\n273.0\n1000000.0\n0.0\n500.0\n458.0\n130.0\n30.0\n94.0\n22.0\n131.0\n144.0\n50.0\n9.0\n5.0\n1231.0\n117.0\n70.0\n32.0\n30.0\n30.0\n329.0\n62.0\n71.0\n29.0\n25.0\n41.0\n256.0\n0.0\n6.0\n36.0\n426.0\n14400.0\n120.0\n141.0\n74.0\n200.0\n64.0\n100.0\n16.0\n20.0\n118.0\n667.0\n10.0\n228.0\n78.0\n40.0\n53.0\n779.0\n90.0\n131.0\n100.0\n3000.0\n30.0\n123.0\n80.0\n70.0\n20.0\n3033.0\n20.0\n80.0\n45.0\n12.0\n24.0\n214.0\n375.0\n84.0\n60.0\n100.0\n200.0\n100.0\n188.0\n24.0\n60.0\n373.0\n602.0\n1078.0\nNone\n90.0\n106.0\n300.0\n722.0\n59.0\n100.0\n440.0\n14.0\n38.0\n800.0\n97.0\n400.0\n2028.0\n2483.0\n152.0\n186.0\n44.0\n131.0\n66.0\n61.0\n10.0\n20.0\n86.0\n0.0\n300.0\n840.0\n500.0\n19.0\n432.0\n60.0\n90.0\n453.0\n16.0\n16.0\n33.0\n25.0\n60.0\n800.0\n30.0\n104.0\n44.0\n80.0\n93.0\n389.0\n60.0\n24.0\n216.0\n104.0\n80.0\n51.0\n32.0\n0.0\n1.0\n34.0\n60.0\n35.0\n224.0\n14.0\n129.0\n3432.0\n20.0\n18.0\n671.0\n300.0\n88.0\n803.0\n0.0\n156.0\n60.0\n50.0\n5.0\n1060.0\n677.0\n54.0\n240.0\n38.0\n61.0\n44.0\n64.0\n6.0\n110.0\n60.0\n19.0\n150.0\n112.0\n40.0\n182.0\n20.0\n22.0\n102.0\n75.0\n60.0\n72.0\n96.0\n39.0\n51.0\n60.0\n24.0\n23.0\n50.0\n40.0\n32.0\n600.0\n33.0\n68.0\n7.0\n81.0\n540.0\n80.0\n50.0\n16.0\n104.0\n207.0\n0.0\n14105.0\n69.0\n60.0\n130.0\n25.0\n10.0\n20.0\n100.0\nNone\n340.0\n22.0\n35.0\n80.0\n52.0\n120.0\n140.0\n480.0\n360.0\n94.0\n59.0\n55.0\n58.0\n60.0\n347.0\n1225.0\nNone\n82.0\n60.0\n630.0\n100.0\n232.0\n21.0\n18.0\n88.0\n150.0\n36.0\n15.0\n98.0\n300.0\n183.0\n690.0\n200.0\n55.0\n48.0\n41.0\n90.0\n440.0\n45.0\n65.0\n391.0\n381.0\n52.0\n41.0\n288.0\n40.0\n180.0\n40.0\n109.0\n64.0\n60.0\n61.0\n111.0\n1191.0\n504.0\n29.0\n60.0\n80.0\n24.0\n54.0\n94.0\n2.0\n54.0\n3.0\n105.0\n24.0\n20.0\n105.0\n412.0\n100.0\n200.0\n10.0\n117.0\n100.0\n30.0\n400.0\n0.0\n2.0\n60.0\n30.0\n1000.0\n72.0\n21.0\n252.0\n88.0\n90.0\n200.0\n68.0\n130.0\n42.0\n61.0\n35.0\n50.0\n40.0\n90.0\n210.0\n55.0\n44.0\n27.0\n0.0\n36.0\n117.0\n300.0\n62.0\n56.0\n57.0\n723.0\n60.0\n60.0\n760.0\n22.0\n684.0\n79.0\n60.0\n184.0\n45.0\nNone\n100.0\n20.0\n407.0\n40.0\n30.0\n36.0\n320.0\n156.0\n100.0\n72000.0\n168.0\n24.0\n24.0\n437.0\n200.0\n10.0\n340.0\n100.0\n150.0\n56.0\n750.0\n80.0\n222.0\n98.0\n77.0\n50.0\n9.0\n84.0\n240.0\n65.0\n55.0\n96.0\n43.0\n2500.0\n44.0\n120.0\n17.0\n181.0\n20.0\n160.0\n1.0\n60.0\n200.0\n2728.0\n26.0\n1.0\n120.0\n46.0\n80.0\n67.0\n84.0\n180.0\n54.0\n9.0\n40.0\n17.0\n69.0\n36.0\n150.0\n0.0\n60.0\n4.0\n226.0\n238.0\n48.0\n5.0\n21.0\n208.0\n0.0\n1200.0\n313.0\n160.0\n4000.0\n16.0\n160.0\n2.0\n15000.0\n224.0\n173.0\n72.0\n24.0\n40.0\n6.0\n120.0\n56.0\n65.0\n0.0\n0.0\n183.0\n33.0\n20.0\n52.0\n5000.0\n50.0\n60.0\n0.0\n268.0\n65.0\n50.0\n88.0\n80.0\n10.0\n100.0\n60.0\n24.0\n31.0\n755.0\n60.0\n10.0\n365.0\n20.0\n7.0\n670.0\n85.0\n51.0\n830.0\n133.0\n300.0\n150.0\n29.0\n50.0\n400.0\n118.0\n30.0\n42.0\n200.0\n100.0\n55.0\n52.0\n34.0\n100.0\n160.0\n200.0\n26.0\n499.0\nNone\n1398.0\n6.0\n30.0\n80.0\n32.0\n108.0\n36.0\n1256.0\n20.0\n78.0\n97.0\n60.0\n300.0\n90.0\n1102.0\n124.0\n3828.0\n120.0\n30.0\n1067.0\n300.0\n11.0\n19.0\n12.0\n210.0\n60.0\n125.0\n42.0\n215.0\n33.0\n100.0\n0.0\n530.0\n222.0\n276.0\n60.0\n733.0\n58.0\nNone\n63.0\n150.0\n156.0\n150.0\n23.0\n380.0\n40.0\n150.0\n7.0\n130.0\n341.0\n13.0\n240.0\n70.0\n30.0\n0.0\n30.0\n100.0\n56.0\nNone\n80.0\n228.0\n10.0\n278.0\n60.0\n633.0\n60.0\n12.0\n29.0\n37.0\n355.0\n11.0\n1200.0\n22.0\n45.0\n20.0\n20.0\n59.0\n178.0\n19.0\n10.0\n6.0\n18.0\n166.0\n255.0\n6.0\n100.0\n20.0\n200.0\n79.0\n126.0\n358.0\n35.0\n60.0\n12.0\n500.0\n15.0\n55.0\n20.0\n115.0\n255.0\n44.0\n43.0\n17.0\n28.0\n160.0\n80.0\n457.0\n82.0\n24.0\nNone\n388.0\n0.0\n585.0\n150.0\n41.0\n144.0\n416.0\n39.0\n50.0\n80.0\n30.0\n490.0\n180.0\n86.0\n44.0\n50.0\n130.0\n62.0\n70.0\n544.0\n30.0\n120.0\n2000.0\n3600.0\n200.0\n50.0\n60.0\n50.0\n100.0\n24.0\n168.0\n550.0\n20.0\n0.0\n30.0\n56.0\n20.0\n136.0\n75.0\n54.0\n250.0\n120.0\n60.0\n34.0\n179.0\n35.0\n13.0\n8382.0\n74.0\n18.0\n74.0\n36.0\n183.0\n19.0\n0.0\n17.0\n11.0\n22.0\n500.0\n496.0\n47.0\n50.0\n2286.0\n0.0\n100.0\n39.0\n0.0\n360.0\n362.0\n80.0\n60.0\n7.0\n40.0\n50.0\n3.0\n66.0\n41.0\n19.0\n400.0\n24.0\n0.0\n4.0\n908.0\n60.0\n600.0\n443.0\n98.0\n30.0\n72.0\n3.0\n272.0\n80.0\n50.0\n60.0\n20.0\n375.0\n822.0\n20.0\n45.0\n50.0\n41.0\n200.0\n123.0\n30.0\n120.0\n30.0\n27.0\n9.0\n150.0\n32.0\n157.0\n677.0\n14.0\n18.0\n42.0\n150.0\n33.0\n42.0\n25.0\n66.0\n25.0\n10.0\n43.0\n10000.0\n250.0\n300.0\n200.0\n63.0\n250.0\n160.0\n25.0\n40.0\n160.0\n800.0\n20.0\n18.0\n145.0\n47.0\n126.0\n36.0\n60.0\n3883.0\n12.0\n102.0\n358.0\n8.0\n6.0\n102.0\n450.0\n280.0\n184.0\n173.0\n10.0\n368.0\n0.0\n180.0\n41.0\n17.0\n10.0\n165.0\n476.0\n2000.0\n211.0\n121.0\n0.0\n16.0\n57.0\n42.0\n70.0\n150.0\n28.0\n150.0\n398.0\n10.0\n30.0\n216.0\n11.0\n700.0\n60.0\n100.0\n24.0\n200.0\n50.0\n189.0\n120.0\n95.0\n30.0\n308.0\n50.0\n40.0\n78.0\n93.0\n5.0\n506.0\n20.0\n4.0\n242.0\n54.0\n100000.0\n1661.0\n89.0\n32.0\n150.0\n102.0\n88.0\n81.0\n120.0\n10000.0\n1.0\n11.0\n1203.0\n100.0\n5.0\n2700.0\n240.0\n33.0\n415.0\n1000.0\n30.0\n40.0\n34.0\n310.0\n100.0\n80.0\n45.0\n65.0\n1.0\n46.0\n101.0\n10.0\n90.0\n40.0\n31.0\n189.0\n18.0\n0.0\n120.0\n16.0\n40.0\n11.0\n84.0\n53.0\n789.0\n1000.0\n36.0\n240.0\n0.0\n170.0\n50.0\n10.0\n200.0\n80.0\n54.0\n250.0\n110.0\n650.0\n8.0\n60.0\n19.0\n20.0\n67.0\n344.0\n38.0\n43.0\n428.0\n18.0\n41.0\n299881.0\n275.0\n16.0\n93.0\n100.0\n0.0\n42.0\n120.0\n318.0\n202.0\n40.0\n120.0\n300.0\n27.0\n1607.0\n13.0\n130.0\n43.0\n21.0\n450.0\n86.0\n24.0\n388.0\n316.0\n1027559.0\n22.0\n72.0\n71.0\n9.0\n4.0\n24.0\n36.0\n96.0\n230.0\n16.0\n500.0\n23.0\n21.0\nNone\n27.0\n30.0\n60.0\n88.0\n44.0\n221.0\n180.0\n648.0\n90.0\n76.0\n3008.0\n22.0\n32.0\n650.0\n10.0\n102.0\n48.0\n98.0\n590.0\n106.0\n36.0\n140.0\n15.0\nNone\n1.0\n120000.0\n175.0\n51.0\n43.0\n338.0\n0.0\n32.0\n700.0\n71.0\n18.0\n150.0\n30.0\n3032.0\nNone\n28.0\n113.0\n106.0\n128.0\n440.0\n33.0\n40.0\n332.0\n11.0\n240.0\n5.0\n216.0\n240.0\n144.0\n20.0\n934.0\n34.0\n32.0\n50.0\n50.0\n185.0\n28.0\n64.0\n40.0\n2.0\n2700.0\n85.0\n0.0\n922.0\n420.0\n80.0\n250.0\n39.0\n2719.0\n10.0\n30.0\n0.0\n140.0\n172.0\n50.0\n21.0\n40.0\n62.0\n40.0\n61.0\n480.0\n0.0\n40.0\n23.0\n24.0\n50.0\n260.0\n2.0\n3404.0\n80.0\n2400.0\n10.0\n70.0\n79.0\n70.0\n1387.0\n0.0\n30.0\n30.0\n144.0\n96.0\nNone\n12.0\n20.0\n100.0\nNone\n400.0\n165.0\n475.0\n668.0\n54.0\n23.0\n35.0\n250.0\n44.0\n50.0\n450.0\n44.0\n94.0\n300.0\n48.0\n54.0\n71.0\n1339.0\n64.0\n121.0\n31.0\n60.0\n36.0\n58.0\n180.0\n122.0\n164.0\n20.0\n140.0\n80.0\n20.0\n40.0\n449.0\n47.0\n296.0\n400.0\n23.0\n502.0\n119.0\n14.0\n1000.0\n157.0\n7.0\n100.0\n90.0\n110.0\n114.0\n30.0\n114.0\n22.0\n544.0\n60.0\n51.0\n500.0\n30.0\n8.0\n27.0\n75.0\n72.0\n70.0\n230.0\n20.0\n170.0\n30.0\n9838.0\n25.0\n800.0\n47.0\n90.0\n0.0\n180.0\n25.0\n20.0\n128700.0\n100.0\n56.0\n19.0\n330.0\n36.0\n60.0\n36.0\n90.0\n6.0\n45.0\n1.0\n25.0\n10.0\n50.0\n62.0\n60.0\n172.0\n208.0\n42.0\n80.0\n173.0\n20.0\n110.0\n74.0\n6.0\n20.0\n58.0\n190.0\n68.0\n11.0\n160.0\n30.0\n30.0\n2.0\n619.0\n63.0\n12.0\n96.0\n1400.0\n99.0\n240.0\n552.0\n10.0\nNone\n2125.0\n80.0\n50.0\n47.0\n30.0\n45.0\n94.0\n200.0\n30.0\n1850.0\n29.0\n132.0\n120.0\n40.0\n62.0\n165.0\n350.0\n200.0\n100.0\n340.0\n57.0\n10.0\n712.0\n68.0\n46.0\n93.0\n81.0\n8.0\n40.0\n88.0\n116.0\n973.0\n32.0\n0.0\n18372.0\n350.0\n50.0\n500.0\n30.0\n16.0\n150.0\n13.0\n15.0\n600.0\n773.0\n30.0\n6.0\n90.0\n35.0\n0.0\n8.0\n334.0\n300.0\n150.0\n108.0\n19.0\n10.0\n135.0\n3935.0\n20.0\n15.0\n15.0\n15.0\n0.0\n30.0\n247.0\n32.0\n394.0\n200.0\n1500.0\n40.0\n0.0\n225.0\nNone\n30.0\n56.0\n140.0\n415.0\n120.0\n21.0\n200.0\n20.0\n20.0\n50.0\n12.0\n30.0\n85.0\n30.0\n593.0\n82.0\n48.0\n43.0\n16.0\n50.0\n192.0\n581.0\n552.0\n80.0\n195.0\n50.0\n57.0\n208.0\n10.0\n224.0\n301.0\n10.0\n216.0\n200.0\n0.0\n21000.0\n11.0\n20.0\n4.0\nNone\n751.0\n164.0\n800.0\n133.0\n120.0\n183.0\nNone\n20.0\n600.0\n137.0\n60.0\n651.0\n60.0\n27.0\n46.0\n60.0\n300.0\n101.0\n27.0\n45.0\n370.0\n507.0\n5.0\n16.0\n76.0\n188.0\n180.0\n488.0\n85.0\n419.0\n100.0\n10.0\n42.0\n497.0\n22510.0\n211.0\n240.0\n2500.0\n53.0\n597.0\n258.0\n362.0\n383.0\n67.0\n108.0\n250.0\n411.0\n44.0\n9.0\n48.0\n40.0\n1000.0\n103.0\n22.0\n60.0\n124.0\n6.0\n968.0\n33.0\n40.0\n205.0\n112.0\n200.0\n350.0\n90.0\n0.0\n32.0\n40.0\n92.0\n0.0\n24.0\n16.0\n26.0\n30.0\n80.0\n60.0\n0.0\n320.0\n1674.0\n54.0\n70.0\n45.0\n10000.0\n10.0\n718.0\n2762.0\n20.0\n600.0\n38.0\n240.0\n768.0\n50.0\n2010.0\n300.0\n50.0\n48.0\n22.0\n26.0\n395.0\n32.0\n30.0\n56.0\n20.0\n38.0\n30.0\n3.0\nNone\n4.0\n389.0\n465.0\n126.0\n90.0\n37.0\n80.0\n24.0\n50.0\n461.0\n160.0\nNone\n40.0\n13.0\n19.0\n128.0\n100.0\n209.0\n122.0\n2.0\n168.0\n18.0\n150.0\n30.0\n0.0\n72.0\n34.0\n41.0\n414.0\n0.0\n29.0\n210.0\n20.0\n106.0\nNone\n150.0\n275.0\n44.0\n1.0\n41.0\n45.0\n336.0\n160.0\n10.0\n398.0\n57.0\n317.0\n203.0\n240.0\n40.0\n8.0\n76.0\n10.0\n34.0\n60.0\n201.0\n100.0\n40.0\n4.0\n51.0\n42.0\n5.0\n395.0\n45.0\n580.0\n732.0\n200.0\n151.0\n300.0\n10.0\n100.0\n72.0\n43.0\n10000.0\n114.0\n80.0\n51.0\n120.0\n150.0\n76.0\n100.0\n600.0\n1297.0\n100.0\n33.0\n330.0\n1.0\n350.0\n120.0\n23.0\n74.0\n115.0\n50.0\n47.0\n200.0\n142.0\n176.0\n0.0\n60.0\n80.0\n1999.0\n90.0\n40.0\n25.0\n36.0\n40.0\n200.0\n32.0\n66.0\n52.0\n60.0\n145.0\n400.0\n7.0\n900.0\n60.0\n4.0\n411.0\n628.0\n175.0\n400.0\n133065.0\n0.0\n202.0\n16.0\n217.0\n210.0\n30.0\n439.0\n55.0\n941.0\n206.0\n95.0\n60.0\n0.0\n20.0\n3.0\n112.0\n362.0\n176.0\n1000.0\n80.0\n19.0\n500.0\n100.0\n30.0\n20.0\n32.0\n84.0\n72.0\n20.0\n87.0\n3500.0\n100.0\n207.0\n50.0\n103.0\n7409.0\n685.0\n50.0\n50.0\n18.0\n535.0\n2004.0\n300.0\n173.0\n40.0\n8.0\n150.0\n32.0\n140.0\n336.0\n17.0\n85.0\n1.0\n364.0\n26.0\n62.0\n48.0\n8.0\n12.0\n20.0\n9.0\n120.0\n20.0\n100.0\n120.0\n20.0\n323.0\n24.0\n8.0\n50.0\n100.0\n50.0\n30.0\n28.0\n240.0\n80.0\n298.0\n16.0\n140.0\n78.0\n40.0\nNone\n228.0\n30.0\n226.0\n50.0\n25.0\n29.0\n78.0\n45.0\n46.0\n3000.0\n94.0\n24.0\n99.0\n34.0\n65.0\n20.0\n303.0\n350.0\n21.0\n30.0\n24.0\n9.0\n84.0\n0.0\n56.0\n410.0\n30.0\n60.0\n40.0\n20.0\n63.0\n0.0\n265.0\n24.0\n60.0\n20.0\n653.0\n61.0\n3087.0\n15.0\n460.0\n100.0\n12.0\n11.0\n30.0\n11.0\n24.0\n109.0\n0.0\n0.0\n16.0\n100.0\n38.0\n489.0\n20.0\n60.0\n42.0\n60.0\n92.0\n108.0\n23.0\n30.0\n330.0\n125.0\n403.0\n323.0\n145.0\n1000.0\n50.0\n152.0\n84.0\n10.0\n50.0\n96.0\n89.0\n103.0\n49.0\n115.0\n595.0\n328.0\n20.0\n30.0\n20.0\n30.0\n61050.0\n89.0\n28.0\n13.0\n881.0\n40.0\n74.0\n280.0\n181.0\n300.0\n100.0\n600.0\n64.0\n27.0\n546.0\n3.0\n100.0\n100.0\n56.0\n10.0\n100.0\n47.0\n20.0\n180.0\n400000.0\n133.0\n200.0\n39.0\n58.0\n307.0\n25.0\n1000.0\n210.0\n19.0\n60.0\n240.0\n13.0\n514.0\n67.0\n26.0\n68.0\n516.0\n26.0\n100.0\n28.0\n419.0\n66.0\n20.0\n9.0\n50.0\n140.0\n39.0\n50.0\n1500.0\n0.0\n59.0\n25.0\n30.0\n200.0\n24.0\n38.0\n121.0\n100.0\n350.0\n6.0\n150.0\n2178.0\n63.0\n186.0\n221.0\n20.0\n20.0\n55.0\n162.0\n761.0\n5000.0\n250.0\n25.0\n62.0\n46.0\n78.0\n220.0\n122.0\n14.0\n0.0\n26.0\n30.0\n100.0\n200.0\n130.0\n240.0\n20.0\n9.0\n48.0\n86.0\n553.0\n500.0\n189.0\n58.0\n1800.0\n215.0\n1200.0\n9.0\n202.0\n10.0\nNone\n8.0\n124.0\n260.0\n400.0\n157.0\n52.0\n150.0\n41.0\n50.0\n0.0\n30.0\n1500.0\n12.0\n273.0\n184.0\n375.0\n89.0\n29.0\n124.0\n140.0\n20.0\n5.0\n0.0\n141.0\n40.0\n2.0\n197.0\n26.0\n70.0\n205.0\n91.0\n60.0\n98.0\n2000.0\n15.0\n282.0\n44.0\n55.0\n41.0\n12.0\n38.0\n1.0\n100.0\n9.0\n17.0\n34.0\n670.0\n71.0\n200.0\n2051.0\n40.0\n25.0\n26.0\n13.0\n520.0\n10.0\n18.0\n8.0\n12.0\n50.0\n25.0\n20.0\n27.0\n70.0\n53.0\n30.0\n179.0\n96.0\n80.0\n10982.0\n100.0\n111.0\n620.0\n40.0\n32.0\n44.0\n70.0\n139.0\n90.0\n58.0\nNone\n67.0\n40.0\n711.0\n38.0\n1000.0\n134.0\n116.0\n60.0\n13.0\n25.0\n10.0\n214.0\n41.0\n150.0\n555.0\n20.0\nNone\n145.0\n52.0\n100.0\n400.0\n29.0\n299.0\n6660.0\n39.0\n330.0\n1524.0\n33.0\n60.0\n266.0\n60.0\n50.0\n59.0\n31.0\n0.0\n120.0\n120.0\n100.0\n70.0\n19.0\n360.0\n30.0\n40.0\n30.0\nNone\n10.0\n92.0\n34.0\n600.0\n66.0\n50.0\n90.0\n150.0\n182.0\n36.0\n45.0\n40.0\n0.0\n70.0\n6894.0\n40.0\n216.0\n100.0\n336.0\n15.0\n40.0\n40.0\n790.0\n297.0\n26.0\n95.0\n117.0\n594226.0\n7.0\n500.0\n20060.0\nNone\n29.0\n20.0\n40.0\n12.0\n70.0\n200.0\n50.0\n30.0\n58.0\n270.0\n40.0\n30.0\n60.0\n100.0\n535.0\n99.0\n240.0\n2.0\n126.0\n0.0\n500.0\n45.0\n32.0\n600.0\n568.0\n394.0\n33.0\n240.0\n41.0\n0.0\n150.0\n124.0\n415.0\n30.0\n63.0\n15.0\n147.0\n250.0\n50.0\n52.0\n100.0\n38.0\n28.0\n30.0\n550.0\n562.0\n592.0\n100.0\n23.0\n10.0\n50.0\n570.0\n19.0\n30.0\n54.0\n300.0\n447.0\n31.0\n64.0\n46.0\n18.0\n10000.0\n81.0\n106.0\n1899.0\n30.0\n6498.0\n40.0\n60.0\n210.0\n7.0\n90.0\n45.0\n78.0\n45.0\n85.0\n0.0\n19.0\n100.0\n300.0\n96.0\n78.0\n80.0\n184.0\n560.0\n28.0\n100.0\n30.0\nNone\n24.0\n8.0\n175.0\n90.0\n96.0\n15.0\n200.0\n450.0\n13.0\n150.0\n214.0\n100.0\n60.0\n20.0\n252.0\n84.0\n61.0\n88.0\n12.0\n18.0\n64.0\n300.0\n450.0\n10.0\n728.0\n165.0\n2665.0\n28.0\n0.0\n30.0\n333.0\n20.0\n280.0\n74.0\n5280.0\n150.0\n40.0\n240.0\n100.0\n484.0\n300.0\n35.0\n6.0\n134.0\n31579.0\n47.0\n50.0\n191.0\n93.0\n14.0\n60.0\n420.0\n24.0\n21.0\n96.0\n63.0\n46.0\n210.0\n44.0\n198.0\n172.0\n65.0\n60.0\n60.0\n37.0\n1000.0\n352.0\n32.0\nNone\n449.0\n6.0\n39.0\n265.0\n0.0\n39.0\n58.0\n60.0\n29.0\n160.0\n72.0\n284.0\n75.0\n10.0\n15.0\n26.0\n668.0\n101.0\n12.0\n100.0\n52.0\n120.0\nNone\n36.0\n73.0\n184.0\n70.0\n100.0\n200.0\n10.0\n18.0\n1368.0\n182.0\n72.0\n4.0\n201.0\n68.0\n48.0\n25.0\n29.0\n200.0\n480.0\n97.0\n170.0\n99.0\n306.0\n1.0\n40.0\n370.0\n220.0\n13.0\n40.0\n144.0\n0.0\n111.0\n299.0\n96.0\n1293.0\n778.0\n65.0\n40.0\n96.0\n100.0\n25.0\n180.0\n80.0\n40.0\n24.0\n73.0\n26.0\n100.0\n160.0\n26.0\n600.0\n15.0\n140.0\n80.0\n30.0\n120.0\n12.0\n215.0\n5.0\n3.0\n0.0\nNone\n3.0\n140.0\n50.0\n52.0\n1678.0\n119.0\n1000.0\n210.0\n280.0\n2637.0\n80.0\n94.0\n10.0\n1065.0\n12.0\n40.0\n15.0\n15.0\n21.0\n500.0\n56.0\n50.0\n24.0\n14.0\n0.0\n36.0\n168.0\n104.0\nNone\n80.0\n61.0\n30.0\n100.0\n647.0\n101.0\n24.0\n4.0\n128.0\n19.0\n60.0\n39.0\n130.0\n13.0\n3172.0\n12.0\n150.0\n10000.0\n130.0\n46.0\nNone\n45.0\n50.0\n4000.0\n61.0\n42.0\n45.0\n127.0\n24.0\n2256.0\n100.0\n162.0\n41.0\n12.0\n670000.0\n7.0\n80.0\n60.0\n1470.0\n149.0\n80.0\n167.0\n43.0\n18.0\n30.0\n194.0\n90.0\n50.0\n71.0\n20.0\n12.0\n19.0\n403.0\n110.0\n234.0\n26.0\n217.0\n80.0\n100.0\n220.0\n77.0\n34.0\n74.0\n40.0\n35.0\n20.0\n144.0\n37.0\n30.0\n32.0\n2000.0\n80.0\n40.0\n19.0\n50.0\n240.0\n118.0\n20.0\n13.0\n2836.0\n1000.0\n264.0\n400.0\n83.0\n7.0\n36.0\n100.0\n737.0\n500.0\n40.0\n300.0\n50.0\n112.0\n400.0\n20.0\n269.0\n154.0\n179.0\n1.0\n585.0\n220.0\n30.0\n351.0\n150.0\n124.0\n1143.0\n36.0\n100.0\n40.0\n20.0\n10.0\n112.0\n30.0\n450.0\n204.0\n114.0\n19.0\n5000.0\n34.0\n50.0\n498.0\n55.0\n12.0\n736.0\n0.0\n50.0\n47.0\n26.0\n40.0\n666.0\n126.0\n280.0\n30.0\n359.0\n221.0\n0.0\n0.0\n405349.0\n4500.0\n648.0\n163.0\n2000.0\n360.0\n300.0\n48.0\n144.0\n30.0\n75.0\n18.0\n70.0\n48.0\n28.0\n78.0\n10.0\n99.0\n216.0\n42.0\n80.0\n24.0\n50.0\n700.0\n44.0\n60.0\n177.0\n3.0\n40.0\n100.0\n30.0\n10.0\n330.0\n102.0\n24.0\n20.0\n62.0\n57.0\n0.0\n60.0\n29.0\n20.0\n24.0\n270.0\n105.0\n3095.0\n148.0\n200.0\n4.0\n43.0\n0.0\n10.0\n67.0\n50.0\n15.0\n20.0\n300.0\n0.0\n23.0\n16.0\n30.0\n44.0\n99.0\nNone\n103.0\n3088.0\n284.0\n246.0\n78.0\n30.0\n109.0\n100.0\n60.0\n37.0\n14.0\n80.0\n20.0\n13.0\n102.0\n66.0\n150.0\n10000.0\n36.0\n376.0\n100.0\n0.0\n115.0\n44.0\n82.0\n355.0\n25.0\n274.0\n78.0\n354.0\n2000.0\n200.0\nNone\n300.0\n50.0\n40.0\n180.0\n12.0\n25.0\n18.0\n15.0\n75.0\n80.0\n427.0\n20.0\n33.0\n70.0\n84.0\n9.0\n6.0\n15.0\n6.0\n37.0\n20.0\n400.0\n10.0\n100.0\n25.0\n10.0\n63.0\n60.0\n0.0\n23.0\n4000.0\n26.0\n61.0\n50.0\n400.0\n9700.0\n126.0\n250.0\n52.0\n32.0\n1801.0\n90.0\n522.0\n30.0\n619.0\n1156.0\n13.0\n130.0\n31.0\n40.0\n44.0\n28.0\n60.0\n0.0\n100.0\n34.0\n78.0\n1200.0\n65.0\n15.0\n37.0\n136.0\n22.0\n24.0\n70.0\n14.0\n45.0\n40.0\n40.0\n10.0\n100.0\n35.0\n220.0\n66.0\n9.0\n34.0\n389.0\n280.0\n144.0\n60.0\n104.0\n150.0\n150.0\n100.0\n90.0\n62.0\n15.0\n20.0\n40.0\n1000.0\n58.0\n124.0\n400.0\n30.0\n300.0\n76.0\n74.0\n21.0\n217.0\n450.0\n2000.0\n34.0\n500.0\n16.0\n90.0\nNone\n258.0\n415.0\n2314.0\n45.0\n310.0\n44.0\n19.0\n60.0\n98.0\n230.0\n42.0\n1731.0\n400.0\n30.0\n160.0\n30.0\n144.0\n218.0\n207.0\n6.0\n13.0\n28.0\n350.0\n78.0\n70.0\n50.0\n94.0\n50.0\n4817.0\n444.0\n70.0\n810.0\nNone\n40.0\n101.0\n60.0\n90.0\n32.0\n100.0\n666.0\n144.0\n16.0\n46.0\n90.0\n40.0\n34.0\n793.0\n31.0\n10.0\n40.0\n150.0\n302.0\n188.0\n125.0\n59.0\n126.0\n60.0\n12687.0\n20.0\n532.0\n564.0\n250.0\n120.0\n400.0\n280.0\n40.0\n20.0\n20.0\n11.0\n5.0\n0.0\n1010.0\n113.0\n196.0\n24.0\n1368.0\n60.0\n120.0\n40.0\n849.0\n200.0\n81.0\n300.0\n61.0\n8.0\n43.0\n500.0\n80.0\n5400.0\n12.0\n327.0\n30.0\n10.0\n40.0\n33.0\n11.0\n22.0\nNone\n25.0\n50.0\n1800.0\n40.0\n50.0\n575.0\n62.0\n168.0\n12.0\n732.0\n32.0\n200.0\n169.0\n62.0\n141.0\nNone\n250.0\n112.0\n13.0\n122.0\n124.0\n19.0\n0.0\n0.0\n500.0\n100.0\n32.0\n707.0\n70.0\n58.0\n52.0\n1000.0\n2060.0\n311.0\n50.0\n92.0\n20.0\nNone\n0.0\n300.0\n105.0\n0.0\n85.0\n42.0\n50.0\n2800.0\n124.0\n70.0\n74.0\n297.0\nNone\n2.0\n44.0\n65205.0\n100.0\n360.0\n230.0\n639.0\n2123.0\n132.0\n69.0\n200.0\nNone\n2.0\n7443.0\n34.0\n126.0\n40.0\n20.0\n0.0\n19.0\n180.0\n29.0\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n61.0\n2.0\n221.0\n0.0\n39.0\n8.0\n200.0\n10.0\n15.0\n24.0\n10.0\n55.0\n60.0\n250.0\n0.0\n135.0\n10.0\n9.0\n50.0\n30.0\n2798.0\n200.0\n254.0\n37.0\n100.0\n120.0\n10.0\n9.0\n339.0\n284.0\n12.0\n100.0\n48.0\n388.0\n0.0\n100.0\n24.0\n21.0\n74.0\n40.0\n60.0\n18.0\n32.0\n140.0\n32.0\n400.0\n46.0\n120.0\n92.0\n693.0\n100.0\n120.0\n51.0\n510.0\n333.0\n22.0\n36.0\n61.0\n60.0\n660.0\n12.0\n20.0\n110.0\n45.0\n132.0\n220.0\n53.0\n30.0\n135.0\n10.0\n250.0\n1734.0\n4.0\n224.0\n33.0\n10.0\n0.0\n120.0\n12.0\n33.0\n225.0\n10.0\n352.0\n40.0\n32.0\n27.0\n500.0\n300.0\n22.0\n0.0\n40.0\n89.0\n1480.0\n130.0\n50.0\n12.0\n164.0\n100.0\n5000.0\n40.0\n26.0\n10.0\n741.0\n94.0\n22.0\n10.0\n50.0\n46.0\n60.0\n60.0\n357.0\n18.0\n80.0\n615.0\n48.0\n66.0\n58.0\n21.0\n20.0\n75.0\n18.0\n537.0\n67.0\n1500.0\n8.0\n49.0\n1.0\n2.0\n54.0\n16.0\n60.0\n60.0\n141.0\n55.0\n11.0\n20.0\n25.0\n21.0\n100.0\n950.0\n47.0\n208.0\n18.0\n22.0\n200.0\n4.0\n20.0\n0.0\n40.0\n134.0\n250.0\n145.0\n60.0\n240.0\n150.0\n34.0\n16.0\n80.0\n200.0\n58.0\n60.0\n538.0\n88.0\n118.0\n30.0\n10.0\n300.0\n12.0\n280.0\n294.0\n24.0\n340.0\n44.0\n20.0\n23.0\n30.0\n470.0\n211.0\n20.0\n53.0\n34.0\n50.0\n150.0\n22.0\n3830.0\n163.0\n82.0\n8150.0\n30.0\n3501.0\n25.0\n8.0\n67.0\n20.0\n145.0\n126.0\n64.0\n160.0\n151.0\n242.0\n18.0\n180.0\n511.0\n24.0\n250.0\n304.0\n60.0\n345.0\n62.0\n20.0\n0.0\n552.0\n30.0\n4.0\n100.0\n300.0\n60.0\n979.0\n449.0\n25.0\n60.0\n60.0\n22.0\n87.0\n10.0\n30.0\n160.0\n16.0\n60.0\n30.0\n438.0\n38.0\n70.0\n20.0\n20.0\n264.0\n90.0\n125.0\n71.0\n150.0\n2040.0\n66.0\n180.0\n130.0\n60.0\n326.0\n33.0\n59.0\n50.0\n10.0\n25.0\n65000.0\n761.0\n432.0\n61.0\n20.0\n50.0\n246.0\n100.0\n2.0\n44.0\n1.0\n50.0\n484.0\n75.0\n100.0\n50.0\n300.0\n130.0\n50.0\n300.0\n27.0\n23.0\n150.0\n50.0\n24.0\n30.0\n135.0\n20.0\n48.0\n252.0\n34.0\n0.0\n30.0\n260.0\n137.0\n3400.0\n1394.0\n90.0\n9.0\n12.0\n180.0\n22.0\n40.0\n350.0\n34.0\n24.0\n843.0\n30.0\n24.0\n83.0\n70.0\n5000.0\n57.0\n2000.0\n280.0\n30.0\n53.0\n50.0\n60.0\n25.0\n640.0\n600.0\n120.0\n77.0\n140.0\n61.0\n100.0\n56.0\n24.0\n100.0\n57.0\n24.0\n30.0\n151.0\n120.0\n24.0\n91.0\n75.0\n220.0\n15.0\n383.0\n44.0\n124.0\n98.0\n140.0\n70.0\n508.0\n400.0\n730.0\n295.0\n114.0\n17.0\n20.0\n32.0\n121.0\n34.0\n144.0\n43.0\n300.0\n200.0\n182.0\n33.0\n12.0\n28.0\n147.0\n38.0\n62.0\n58.0\n24.0\n1000.0\n340.0\n30.0\n6.0\n193.0\n9.0\n0.0\n1184.0\n18.0\n63.0\n15.0\n281.0\n40.0\nNone\n2.0\nNone\n59.0\n2000.0\n40.0\n1022.0\n800.0\n120.0\n106.0\n21.0\n80.0\n24.0\n34.0\n986.0\n12.0\n10.0\n36.0\n60.0\n15.0\n70.0\n30.0\n324.0\n200.0\n29.0\n8.0\nNone\n0.0\n48.0\n1300.0\n340.0\n220.0\n673.0\n100.0\n314.0\n56.0\nNone\n18.0\n408.0\n178.0\n235.0\n200.0\n144.0\n339.0\n71.0\n12.0\n60.0\n6.0\n250.0\n732.0\n90.0\n122.0\n138.0\n60.0\n10000.0\n79.0\n54.0\n75.0\n788.0\n57.0\n25.0\n157.0\n1334.0\n20.0\n2500.0\n17.0\n45.0\n300.0\n10.0\n40.0\n1528.0\n30.0\n58.0\n480.0\n32.0\n72.0\n52.0\n81.0\n75.0\n990.0\n103.0\n604.0\n50.0\n1709.0\n100.0\n25.0\n160.0\n50.0\n63.0\n150.0\n9.0\n216.0\n23.0\n75.0\n40.0\n0.0\n1500.0\n312.0\n39.0\n9.0\n2.0\n96.0\n478.0\n1050.0\n52.0\n30.0\n1389.0\n50.0\n300.0\n134.0\n44.0\n23.0\n60.0\n25.0\n2.0\n11.0\n322.0\n4.0\n25.0\n8.0\n26.0\n400.0\n98529.0\n40.0\n182.0\n78.0\n48.0\n178.0\n90.0\n300.0\n60.0\n2669.0\n3516.0\n420.0\n20.0\n28.0\n60.0\n30.0\n14.0\n43.0\n100.0\n30.0\n500.0\n10.0\n40.0\n0.0\n3979.0\n716.0\n1200.0\n20.0\n215.0\n4054.0\n54.0\n36.0\n21.0\n20.0\n4300.0\n15.0\n60.0\n45.0\n9.0\n95.0\n18.0\n170.0\n0.0\n117.0\n310.0\n950.0\n198.0\n1730.0\n30.0\n24.0\n130.0\n1020.0\n50.0\n138.0\n1200.0\n50.0\n86.0\n65.0\n136.0\n110.0\n42.0\n370.0\n50.0\n1.0\n210.0\n52.0\n60.0\n10.0\n52.0\n30.0\n87.0\n30.0\n300.0\n55.0\n68.0\n100.0\n18.0\n36.0\n20.0\n283.0\n50.0\n0.0\n92.0\n210.0\nNone\n88.0\n40.0\n120.0\n20.0\n30.0\n125.0\n100.0\n200.0\n80.0\n39.0\n432.0\n18.0\n956.0\n101.0\n8.0\n50.0\n54.0\n46.0\n45.0\n60.0\n635.0\n538.0\n30.0\n51.0\n62.0\n10.0\n153.0\n74.0\n450.0\n24.0\n212.0\n50.0\n402.0\n1000.0\n0.0\n0.0\n43.0\n140.0\n540.0\n0.0\n29.0\n32.0\n580.0\n24.0\n36.0\n83.0\n60.0\n357.0\n64.0\n94.0\n52.0\n400.0\n57.0\n102.0\n12.0\n100.0\n92.0\n29.0\n185.0\n136.0\n200.0\n300.0\n120.0\n0.0\n160.0\n20.0\n52.0\n95.0\n80.0\n24.0\n2000.0\n36.0\n150.0\n309.0\n204.0\n316.0\n300.0\n74.0\n26.0\n112.0\n12000.0\n250.0\n80.0\n220.0\n404.0\n28.0\n30.0\n106.0\n233.0\n41.0\n87.0\n5000.0\n150.0\n34.0\n9.0\n67.0\n48.0\n50.0\n54680.0\n111.0\n36.0\n59.0\n13.0\n100.0\n48.0\n40.0\n200.0\n100.0\n462.0\n20.0\n72.0\n24.0\n96.0\n120.0\n148.0\n54.0\n267.0\n36.0\n100.0\n30.0\n66.0\n0.0\n228.0\n600.0\n30.0\n16.0\n36.0\n24.0\n14.0\n78.0\n200.0\n140.0\n368.0\n24.0\n44.0\n100.0\n36.0\n40.0\n174.0\n259.0\n138.0\n0.0\n36.0\n40.0\n24.0\n5.0\n48.0\n100.0\n1076.0\n124.0\n34.0\n160.0\n85.0\n44.0\n40.0\n836.0\n54.0\n53.0\n302.0\n20.0\n120.0\n30.0\n12.0\n115.0\n37.0\n117.0\n350.0\n33.0\n170.0\n2400.0\n45.0\nNone\n0.0\nNone\n20.0\n132.0\n313.0\n19.0\n142.0\n2200.0\n20.0\n436.0\n25.0\n300.0\n300.0\n144.0\n64.0\n50.0\n304.0\n24.0\n700.0\n52.0\n30.0\n64.0\n500.0\n10.0\n1768.0\n94.0\n15.0\n10.0\nNone\n70.0\n733.0\n65.0\n44.0\n72.0\n35.0\n300.0\n53.0\n1030.0\n10.0\n2033.0\n20.0\n23.0\n231.0\n88.0\n121965.0\n500.0\n62.0\n30.0\n53.0\n243.0\n68.0\n20.0\n13.0\n282.0\n67.0\n30.0\n30.0\n80.0\n20.0\n300.0\n10.0\n16.0\n48.0\n180.0\n32.0\n94.0\n1599.0\n407.0\n327.0\n277.0\n30.0\n48.0\n71.0\n64.0\n28.0\n204.0\n31.0\n0.0\n65.0\n115.0\n30.0\n400.0\n300.0\n80.0\n40.0\n55.0\n25.0\n5.0\n3405.0\n10.0\n22.0\n42.0\n32.0\n44.0\n28.0\n16.0\n183.0\n200.0\n1.0\n1000.0\n169.0\n4.0\n52.0\n88.0\n320.0\n30.0\n66.0\n30.0\n100.0\n17.0\n4.0\n0.0\n72.0\n37.0\n300.0\nNone\n2.0\n41.0\n80.0\n116.0\n60.0\n331.0\n30.0\n379.0\n297.0\n64.0\n0.0\n25.0\n98.0\n84.0\n240.0\n305.0\n237.0\n200.0\n135.0\n40601.0\n826.0\nNone\n76.0\n2789.0\n210.0\n48.0\n24.0\n90.0\n16.0\n0.0\n300.0\n71.0\n261.0\n100.0\n268.0\n10.0\n40.0\n30.0\n600.0\n74.0\n255.0\n32.0\n42.0\n2000.0\n85.0\n1000.0\n35.0\n119.0\n4638.0\n532.0\n60.0\n82.0\n212.0\n143.0\n50.0\n120.0\n150.0\n186.0\n256.0\n10.0\n119.0\n1393.0\n55.0\n143.0\n123.0\n60.0\n12.0\n800.0\n46.0\n128.0\n20000.0\n36.0\n66.0\n603.0\n485.0\n129.0\n2000.0\n336.0\n11.0\n60.0\n100.0\n90.0\n150.0\n360.0\n30.0\n0.0\n88.0\n18.0\n250.0\n90.0\n343.0\n496.0\n18.0\n53.0\n10.0\n100.0\n478.0\n80.0\n64.0\n7398.0\n0.0\n30.0\n6.0\n350.0\n118.0\n300.0\n60.0\n0.0\n15.0\n36.0\n130.0\n320.0\n570.0\n50.0\n50.0\n800.0\n150.0\n30.0\n40.0\n34.0\n69.0\n119.0\n553.0\n87.0\n30.0\n400.0\n70.0\n300.0\n248.0\n334.0\n680.0\n121.0\n4000.0\n72.0\n278.0\n9000.0\n146.0\n100.0\n744.0\n30.0\n525.0\n160.0\n27.0\n15.0\n40.0\n200.0\n85.0\n1002.0\n66.0\n319.0\n102.0\n54.0\n356.0\n41.0\n14.0\n200.0\n36.0\n120.0\n78.0\n20.0\n200.0\n74.0\n461.0\n300.0\n30.0\n30.0\n30.0\n78.0\n10175.0\n5.0\n45.0\n495.0\n42.0\n32.0\n56.0\n250.0\n36.0\n36.0\n50.0\n4.0\n127.0\n30.0\n29.0\n715206.0\n60.0\n24.0\n76.0\n15.0\n91.0\n22.0\n41.0\n10.0\n40.0\n50.0\n150.0\n20.0\n115.0\n57.0\n48.0\n32.0\n32.0\n32.0\n8.0\n60.0\n1537.0\n300.0\n16.0\n56.0\n19.0\n56.0\n80.0\n27.0\n36.0\n8.0\n27.0\n90.0\n60.0\n55.0\n30.0\n50.0\n99.0\n377.0\n48.0\n156.0\n3.0\n16.0\n42.0\n114.0\n212.0\n642.0\n120.0\n40.0\n48.0\n820.0\n38.0\n72.0\n33.0\n20.0\n12.0\n400.0\n8856.0\n28.0\n800.0\n18.0\n4.0\n9.0\n49.0\n284.0\n26.0\n30.0\n100.0\n300.0\n8.0\n135.0\n30.0\n151.0\n29.0\n62.0\n70.0\n323.0\n21.0\n244.0\n60.0\n62.0\n64.0\n102.0\n88.0\n5.0\n600.0\n35.0\n65.0\n471.0\n30.0\n30.0\n4200.0\n25.0\n116.0\n50.0\n100.0\n200.0\n6.0\n115.0\n936.0\n950.0\n151.0\n60.0\n33.0\n55.0\n20.0\n100.0\n48.0\n3502.0\n471.0\n139.0\n50.0\n81.0\n9723.0\n40.0\n130.0\n50.0\n40.0\n36.0\n139.0\n800.0\n65.0\n24.0\n66.0\n29.0\n270.0\n118.0\n24.0\n60.0\n200.0\n0.0\n35.0\n100.0\n31.0\n10.0\n1014.0\n100.0\n10.0\n63.0\n900.0\n14.0\n59.0\n642.0\n34.0\n40.0\n132.0\n57.0\n30.0\n174.0\n5.0\n0.0\n9.0\n66.0\n1840.0\n20.0\n600.0\n2000.0\n24.0\n40.0\n31.0\n121.0\n50.0\n22.0\n22.0\n30.0\n132.0\n15.0\n6.0\n80.0\n649.0\n101.0\n21.0\n100.0\n100.0\n303.0\n400.0\n50.0\n9.0\n98.0\n1.0\n90.0\n183.0\n190.0\n0.0\n33.0\n284.0\n42.0\n175.0\n60.0\n773.0\n400.0\n400.0\n480.0\n51.0\n30.0\n300.0\n81.0\n1000.0\n15.0\n50.0\n1.0\n2.0\n29.0\n100.0\n220.0\n45.0\n73.0\n77.0\n160.0\n50.0\n32.0\n80.0\n13.0\n20.0\n216.0\n376.0\n100.0\n72.0\n15.0\n32.0\n45.0\n134.0\n3001.0\n100.0\n70.0\n148.0\n35.0\n250.0\n162.0\n222.0\n28.0\n100.0\n2500.0\n19.0\n100.0\n300.0\n15.0\n25.0\n323.0\n77.0\n35.0\n60.0\n400.0\n8.0\n402.0\n350.0\n250.0\n194.0\n73.0\n328.0\n500.0\n100.0\n1683.0\n10.0\n240.0\n464.0\n63.0\n120.0\n40.0\n100.0\n16.0\n1754.0\n4.0\n203.0\n150.0\n100.0\n787.0\n50.0\n500.0\n66.0\n153.0\n30.0\n572.0\n20.0\n20.0\n12.0\n17.0\n839.0\n150.0\n81.0\n594.0\n15.0\n43.0\n71.0\n40.0\n3.0\n120.0\n13.0\n14520.0\n55.0\n90.0\n35.0\n352.0\n20.0\n4.0\n20.0\n474.0\n54.0\n15.0\n0.0\n256.0\n64.0\n160.0\n10.0\n400.0\n60.0\n500.0\n440.0\n150.0\n66.0\n53.0\n130.0\n200.0\n0.0\n75.0\n72.0\n759.0\n20.0\n1200.0\n21.0\n37.0\n43.0\n217.0\n1680.0\n110.0\n1804.0\n66.0\n15.0\n200.0\n60.0\n73.0\n114.0\n53.0\n55.0\n3.0\n80.0\nNone\n40.0\n2.0\n3.0\n120.0\n193.0\n76.0\n150.0\nNone\n20.0\n150.0\n1440.0\n58.0\n179.0\n12.0\n24.0\n40.0\n14.0\n60.0\n49.0\n215.0\n10.0\n102.0\n59.0\n48.0\n184.0\n30.0\n75.0\n0.0\n21.0\n18.0\n258.0\n50.0\n85.0\n100.0\n120.0\n98.0\n46.0\n16.0\n60.0\n536.0\n50.0\n0.0\n4.0\n21.0\n100.0\n0.0\n1800.0\n6811.0\n15.0\n25.0\n75.0\n0.0\n1302.0\n39.0\n34.0\n44.0\n250.0\n34.0\n697.0\n64.0\n36.0\n38.0\n20.0\n18.0\n37.0\n111.0\n221.0\n8.0\n26.0\n20.0\n1024.0\n882.0\n69.0\n5.0\n30.0\n0.0\n219.0\n40.0\n120.0\n88.0\n1079.0\n60.0\n24.0\n100.0\n15.0\n27.0\n15.0\n1082.0\n30.0\n10.0\n260.0\n81.0\n126.0\n20.0\n124.0\n40.0\n18.0\n201.0\n300.0\n11.0\n25.0\n20.0\n60.0\n78.0\n30.0\n50.0\n1221.0\n105.0\n22.0\n60.0\n60.0\n60.0\n32.0\n10.0\n2765.0\n58.0\n66.0\n297.0\n3900.0\n91.0\n48.0\n1000.0\n54.0\n33.0\n229.0\n372.0\n20.0\n30.0\n39.0\n10.0\n37.0\n500.0\n3.0\n24.0\n38.0\n136.0\n49.0\n201.0\n12.0\n50.0\n114.0\n300.0\n202.0\n68.0\n97.0\n24.0\n100.0\n71.0\n9.0\n3500.0\n136.0\n49.0\n40.0\n100.0\n500.0\n65.0\n20.0\n30.0\n480.0\n10.0\n29.0\n116.0\n18.0\n450.0\n40.0\nNone\n56.0\n75.0\n117.0\n154.0\n62.0\n15.0\n100.0\n37.0\n855.0\n30.0\n60.0\n29.0\n30.0\n30.0\n153.0\n60.0\n70.0\n120.0\n37.0\n37.0\n45.0\n118.0\n10.0\nNone\n48.0\n153.0\n40.0\n59.0\n6.0\n16.0\n1380.0\n300.0\n10.0\n120.0\n7280.0\n5.0\n45.0\n774.0\n154.0\n223861.0\n80.0\n140.0\n24.0\n0.0\n3.0\n52.0\n40.0\n1500.0\n40.0\n0.0\n65.0\n69.0\n165.0\n54.0\n33.0\n122.0\n671.0\n74.0\nNone\n60.0\n32.0\n15.0\n179.0\n70.0\n120.0\n100.0\n120.0\n219.0\n27.0\n20.0\n242.0\n270.0\n20.0\n3.0\n120.0\n90.0\n3.0\n71.0\n2000.0\n358.0\n111.0\n1000.0\n30.0\n8734.0\n32.0\n174.0\n352.0\n94.0\n18.0\n22.0\n42.0\n600.0\n288.0\n50.0\n140.0\n552.0\n20.0\n63.0\n92.0\n20.0\n134.0\n40.0\n676.0\n23.0\n240.0\n4000.0\n15.0\n57.0\n54.0\n20.0\n166.0\n228.0\nNone\n400.0\n12.0\n102.0\n84.0\n16.0\n919.0\n30.0\n64.0\n130.0\n16.0\n822.0\n8.0\n750.0\n100.0\n60.0\n50.0\n191.0\n37.0\n280.0\n600.0\n154.0\n1400.0\n45.0\n1.0\n48.0\n188.0\n247.0\n108.0\n44.0\n72.0\n50.0\n60.0\n73.0\n320.0\n174.0\n16.0\n60.0\n104.0\n60.0\n87.0\n118.0\n38.0\n50.0\n86.0\n55.0\n38.0\n1.0\n217.0\n80.0\n100.0\n9.0\n20.0\n208.0\n47.0\n0.0\nNone\n0.0\n33.0\n30.0\n22.0\n102.0\n34.0\nNone\n25.0\n396.0\n50.0\n150.0\n200.0\n276.0\n60.0\n146.0\n0.0\n200.0\n307.0\n73.0\n533.0\n4.0\n90.0\n16.0\n5.0\n6.0\n23.0\n84.0\n40.0\n14.0\n1.0\n30.0\n44.0\n12.0\n2020.0\n30.0\n22.0\n55.0\n32.0\n200.0\n443.0\n124.0\n22.0\n710.0\n61.0\n2912.0\n76.0\n228.0\n42.0\n40.0\n140.0\n56.0\n270.0\n15.0\n29.0\n0.0\n10.0\n200.0\n19.0\n500.0\n177.0\n50.0\n45.0\n30.0\n392.0\n100.0\n3358.0\n44.0\n97.0\n640.0\n17.0\n44.0\n162.0\n132.0\n50.0\n208.0\n120.0\n17.0\n39.0\n150.0\n13.0\n16.0\n5.0\n260.0\n60.0\n74.0\n100.0\n300.0\n70.0\n143.0\n200.0\n32.0\n30.0\n18.0\n30.0\n60.0\n0.0\n15.0\n27.0\n16.0\n148.0\n61.0\n12.0\n2396.0\nNone\n0.0\n64.0\n21.0\n6810.0\n27.0\n12.0\n65.0\n140.0\n4.0\n43.0\n20.0\n16.0\n20.0\n15.0\n80.0\n70.0\n20.0\n106.0\n615.0\n4.0\n7.0\n150.0\n75.0\n114.0\n24.0\n42.0\n30.0\n2000.0\n24.0\n15.0\n402.0\n90.0\n10.0\n26.0\n203.0\n136.0\n32.0\n140.0\n6.0\n577.0\n60.0\n20.0\n20.0\n333.0\n100.0\n806.0\n110.0\n19.0\n32.0\n15.0\n43.0\n35.0\n27.0\n40.0\n44.0\n10.0\n40.0\n64.0\n200.0\n20.0\n152.0\n56.0\n100000.0\n546.0\n179.0\n106.0\n23.0\n435.0\n24.0\n22.0\n39.0\n19.0\n81.0\n28.0\n157.0\n72.0\n27.0\n12.0\n68.0\n58.0\n200.0\n0.0\n4.0\n20.0\n5000.0\n34.0\n480.0\n1000.0\n40.0\n33.0\n41.0\n10.0\n60.0\n23.0\n512.0\n0.0\n30.0\n120.0\n110.0\n60.0\n50.0\n9.0\n24.0\n200.0\n390.0\n21.0\n50.0\n9.0\n16.0\n82.0\n100.0\n1178.0\n186.0\n8.0\n58.0\n600.0\n1200.0\n15.0\n100.0\n32.0\n614.0\n25.0\n24.0\n14.0\n420.0\n71.0\n57.0\n52.0\n25.0\n363.0\n0.0\n16.0\n35.0\n2772.0\n60.0\n200.0\n60.0\n3400.0\n75.0\n60.0\n200.0\n50.0\n51.0\n150.0\n150.0\n181.0\n70.0\n60.0\n1126.0\n12.0\n0.0\n198.0\n430.0\n150.0\n100.0\n114.0\n36.0\n200.0\n23124.0\n1856.0\n3.0\n33.0\n36.0\n40.0\n25.0\n100.0\n20.0\n35.0\n50.0\n100.0\n99999.0\n40.0\n35.0\n24.0\n50.0\n60.0\n596.0\n130.0\n450.0\n360.0\n11.0\n60.0\n30.0\n500.0\n10.0\n12.0\n17.0\n80.0\n242.0\n100.0\n10.0\n38.0\n470.0\n15.0\n879.0\n40.0\n29.0\n62.0\n38.0\n10.0\n25.0\n440.0\n180.0\n159.0\n60.0\n15.0\n78.0\n22.0\n464.0\n150.0\n80.0\n0.0\n483.0\n17.0\n100.0\n64.0\nNone\n0.0\n98.0\n154.0\n386.0\n50.0\n400.0\n400.0\n20.0\n91.0\n289.0\n160.0\n159.0\n35.0\n148.0\n10.0\n16.0\n53.0\n2200.0\n920.0\n64.0\n100.0\n200.0\n27.0\n35.0\n134.0\n5.0\n254.0\n1400.0\n43.0\n5.0\n40.0\n234.0\n650.0\n52.0\n200.0\n335.0\n36.0\n3254.0\n120.0\n26.0\n70.0\n30.0\n200.0\n128.0\n60.0\n6.0\n111.0\n300.0\n34.0\n49.0\n0.0\n90.0\n0.0\n100.0\n52.0\n30.0\n260.0\n40.0\n60.0\n1000.0\n83.0\n276.0\n27.0\n121.0\n40.0\n50.0\n14.0\n30.0\n11208.0\n232.0\n5.0\n60.0\n38.0\n86.0\n39.0\n28.0\n60.0\n600.0\n60.0\n43.0\n6.0\n10.0\n60.0\n50.0\n750.0\n250.0\n25352.0\n164.0\n40.0\n19.0\n69.0\n250.0\n21.0\n60.0\n6927.0\n80.0\n323.0\n451.0\n96.0\n62.0\n12.0\n250.0\n11.0\n201.0\n65.0\n15.0\n6.0\n70.0\n176.0\n800.0\n120.0\n25.0\n150.0\n10.0\n252.0\n30.0\n40.0\n56.0\n84.0\n63.0\n45.0\n1.0\n474.0\n20.0\n0.0\n16.0\n384.0\n112.0\n150.0\n39.0\n112.0\n0.0\n10.0\n45.0\n30.0\n240.0\n100.0\n225.0\n40.0\n560.0\n18.0\n20.0\n118.0\n44.0\n89.0\n60.0\n200.0\n48.0\n42.0\n2200.0\n11.0\n800.0\n15.0\n30.0\n30.0\n71.0\n15.0\n9.0\n140.0\n96.0\n64.0\n24.0\n1.0\n459.0\n975.0\n30.0\nNone\n300.0\n200.0\n250.0\n166000.0\n100.0\n60.0\n29.0\n468.0\n10.0\n39.0\n120.0\n216.0\n37.0\n20.0\nNone\n45.0\n52.0\n64.0\n32.0\n53.0\n144.0\n94.0\n10.0\n191.0\n90.0\n320.0\n46.0\n1200.0\n84.0\n207.0\n60.0\n1.0\n40.0\n60.0\n40.0\n151.0\n206.0\n30.0\n160.0\n12688.0\n213.0\n106.0\n80.0\n33.0\n200.0\n197.0\n811.0\n140.0\n21.0\n6.0\n5.0\n0.0\n36.0\n600.0\n0.0\n969.0\n10160.0\n36.0\n0.0\n45.0\n50.0\n375.0\n314.0\n100.0\n18.0\n49.0\n615.0\n15.0\n40.0\n66.0\n2.0\n55.0\n200.0\n46.0\n60.0\n100.0\n22.0\n1500.0\n64.0\n966.0\n7.0\n15.0\n97.0\n20.0\n5500.0\n54.0\n69.0\n722.0\n1077.0\n2050.0\n50000.0\n60.0\n20.0\n24.0\n68.0\n50.0\n0.0\n1200.0\n502.0\n338.0\n23.0\n28.0\n250.0\n60.0\n150.0\n300.0\n123.0\n104.0\n757.0\n30.0\n100.0\n24.0\n365.0\n64.0\n8.0\n200.0\n50.0\n28.0\n80.0\n84.0\n93.0\n20.0\n50.0\n25.0\n66.0\n122.0\n18.0\n46.0\n200.0\n60.0\n4.0\n0.0\n99.0\n10.0\n41.0\n4007.0\n94.0\n41.0\n538.0\n240.0\n181.0\n14.0\n4.0\n42.0\n40.0\n100.0\n63.0\n30.0\n0.0\n37.0\n2195.0\n78.0\n52.0\n500.0\n16.0\n105.0\n200.0\n768.0\n18.0\n40.0\n34.0\n22.0\n6.0\n20.0\n60.0\n320.0\n50.0\n1000000.0\n37.0\n738.0\n37.0\n104.0\n9.0\n250.0\n596.0\n31.0\n160.0\n64.0\n8.0\n200.0\n112.0\n184.0\n62.0\n28.0\n257.0\n990.0\n40.0\n24.0\n48.0\n96.0\n23.0\n65.0\n0.0\n60.0\n10.0\n40.0\n1000.0\n183.0\n232.0\n40.0\n32.0\n300.0\n36.0\n50.0\n329.0\n60.0\n150.0\n60.0\n150.0\n62.0\n140.0\n979.0\n200.0\n97.0\n500000.0\n464.0\n18.0\n30.0\n28.0\n8.0\n87.0\n100.0\n1247.0\n236.0\n15.0\n25.0\n106.0\n24.0\n186.0\n30.0\n100.0\n2708.0\n25.0\nNone\n200.0\n86.0\n25.0\n242.0\n50.0\n1000.0\n30.0\n217.0\n360.0\n228.0\n60.0\n27.0\n24.0\n20.0\n100.0\n39.0\n10597.0\n26.0\n288.0\n40.0\n100.0\nNone\n140.0\n4.0\n100.0\n1.0\n2000.0\n40.0\n80.0\n40.0\n100.0\n200.0\n155413.0\n47.0\n62.0\n700.0\n152.0\n67.0\n14.0\n29.0\n20.0\n80.0\n30.0\n412.0\n30.0\n60.0\n20.0\n720.0\n52.0\n20.0\n54.0\n100.0\n30.0\n128.0\n35.0\n39.0\n120.0\n1.0\n38.0\n663.0\n211.0\n719.0\n3.0\n118.0\n0.0\n20.0\n450.0\n224.0\n48.0\n24.0\n59.0\n800.0\n23.0\n125.0\n100.0\n60.0\n40.0\n30.0\n0.0\n380.0\n1011.0\n45.0\n35.0\n3954.0\n15.0\n60.0\n79.0\n800.0\n800.0\n9000.0\n362.0\n37.0\n74.0\n10.0\n18.0\n350.0\nNone\n68.0\n25.0\n1.0\n3.0\n87.0\n27.0\n61.0\n6.0\n1000.0\n0.0\n300.0\n90.0\n2000.0\n210.0\n118.0\n76.0\n4.0\n15.0\n300.0\n126.0\n0.0\n236.0\n71.0\n100.0\n75.0\n135.0\n45.0\n1920.0\n2472.0\n30.0\n940.0\n40.0\n20.0\n41.0\n5.0\n150.0\n240.0\n98.0\n60.0\n32.0\n15.0\n64.0\n300.0\n343.0\n96.0\n12.0\n110.0\n35.0\n67.0\n58.0\n249.0\n25.0\n16.0\n1820.0\n797.0\n0.0\n60.0\n8.0\n30.0\n156.0\n0.0\n32.0\n152.0\n1.0\n18.0\n10.0\n10.0\n10.0\n12.0\n8.0\n40.0\n9600.0\n584.0\n200.0\n301.0\n40.0\n416.0\n300.0\n470.0\n100.0\n54.0\n27.0\n421.0\n55.0\n20.0\n28.0\n72.0\n51.0\n6.0\n500.0\n48.0\n129.0\n240.0\n10.0\n40.0\n52.0\n134.0\nNone\n50.0\n10.0\n50.0\n300.0\n64.0\n28.0\nNone\n45.0\n90.0\n155.0\n100.0\n99.0\n64.0\n100.0\n87.0\n146.0\n121.0\n50.0\n12.0\n350.0\n181.0\n46899.0\n44.0\n108.0\n34.0\n100.0\n90.0\n25.0\n353.0\n128.0\n100.0\n74.0\n12.0\nNone\n60.0\n84.0\n30.0\n100.0\n30.0\n450.0\n12.0\n192.0\n60.0\n20.0\n45.0\n50.0\n55.0\n1000.0\n11.0\n87.0\n36.0\n62.0\n150.0\n20.0\n2000.0\n101.0\n63.0\n100.0\n34.0\n108.0\n60.0\n390.0\n54.0\n649.0\n520.0\n4.0\n35.0\n170.0\n77.0\n300.0\n90.0\n247.0\n69.0\n113.0\n34.0\n108.0\n689.0\n180.0\n92.0\n1000.0\n25.0\n80.0\n17.0\n29.0\n60.0\n68.0\n61.0\n273.0\n200.0\n160.0\n80.0\n97.0\n174.0\n466.0\n52.0\n64.0\n0.0\n154.0\n700.0\n27.0\n1200.0\n100.0\n40.0\n360.0\n25.0\n14.0\n37.0\n224.0\n105.0\n3000.0\n141.0\n60.0\n99.0\n48.0\n32.0\n34.0\n100.0\n50.0\n112.0\n1.0\n85.0\n400.0\n220.0\n7.0\n294.0\n348.0\n27.0\n510.0\n40.0\n24.0\n1000.0\n219.0\n22.0\n24.0\n31.0\n40.0\n204.0\n96.0\n1100.0\n200.0\n18.0\n120.0\n150.0\n30.0\n131.0\n40.0\n132.0\n83.0\n15.0\n46.0\n150.0\n100.0\n150.0\n20.0\n3000.0\n2145.0\n105.0\n165.0\n38.0\n225.0\n270.0\n100.0\n120.0\n15138.0\n1285.0\n30.0\n25.0\n48.0\n113.0\n80.0\n100.0\n44.0\n197.0\n259.0\n50.0\n7.0\n53.0\n324.0\n100.0\n85.0\n9406.0\nNone\n18.0\n46.0\n2738161.0\n371.0\n8.0\n100.0\n289.0\n1000.0\n27.0\n210.0\n47.0\n8.0\n35.0\n11980.0\n17.0\n120.0\n84.0\n193.0\n120.0\n40.0\n20.0\n64.0\n857.0\n6.0\n79.0\n110.0\n566.0\n250.0\n104.0\n40.0\n37.0\n886.0\n300.0\n1095.0\n30.0\n2000.0\n40.0\n750.0\n10.0\n150.0\n25.0\n102.0\n67.0\n30.0\n241.0\n70.0\n48.0\n0.0\n75.0\n40.0\n9.0\n80.0\n28.0\n43.0\n120.0\n608.0\n32.0\n145.0\n1800.0\n250.0\n88.0\n44.0\n8.0\n49.0\n35.0\n2488.0\n600.0\n50.0\n75.0\n200.0\n342.0\n192.0\n50.0\n67.0\n8.0\n30.0\n48.0\n543.0\n108.0\n30.0\n127.0\n100.0\n50.0\n114.0\n67.0\n104.0\n32.0\n200.0\n85.0\n440.0\n345.0\n64.0\n31.0\n308.0\n77.0\n49.0\n6.0\n80.0\n220.0\n68.0\n208.0\n20.0\n200.0\n117.0\n20.0\n400.0\n12.0\n15.0\n30.0\n520.0\n32.0\n228.0\n1000.0\n120.0\n3131.0\n140.0\n42.0\n90.0\n240.0\n20.0\n27.0\n60.0\n18.0\n100.0\n96.0\n150.0\n130.0\n17.0\n60.0\n180.0\n4.0\n26.0\n10000.0\n12.0\n360.0\n20.0\n1300.0\n20.0\n40.0\n150.0\n22.0\n338.0\n360.0\n60.0\n5.0\nNone\n0.0\n18.0\n80.0\n5.0\n458.0\n106.0\n93.0\n38.0\n509.0\n18.0\n32.0\n65.0\n50.0\n220.0\n9.0\n40.0\n78.0\n60.0\n71.0\n22.0\n16.0\n1.0\n25.0\n36.0\n40.0\n105.0\n1200.0\n20.0\n200.0\n66.0\n50.0\n64.0\n31.0\n5.0\n33.0\n6.0\n30.0\n150.0\n16.0\n215.0\n210.0\n140.0\n160.0\n30.0\n0.0\n20.0\n90.0\n13.0\n34.0\n0.0\n220.0\n10.0\n549.0\n145.0\n83.0\n100.0\n10.0\n30.0\n90.0\n10.0\n0.0\n20.0\n860.0\n152.0\n52.0\n6.0\n25.0\n3037.0\n112.0\n78.0\n1476.0\n153.0\n19.0\n40.0\n17.0\n50.0\n38.0\n112.0\n64.0\n10000.0\n21.0\n60.0\n1000.0\n32.0\n60.0\n52.0\n1.0\n42.0\n60.0\n168.0\n64.0\n160.0\n34.0\n3100.0\n0.0\n52.0\n20.0\n18.0\n18.0\n80.0\n145.0\n96.0\n30.0\n2.0\n10.0\n230.0\n60.0\n100.0\n43.0\n40.0\n179.0\n12.0\n764.0\n50.0\n25.0\n2500.0\n56.0\n43.0\n87.0\n20.0\n8.0\n3000.0\n364.0\n60.0\n437.0\n15.0\n0.0\n400.0\n139.0\n70.0\n65.0\n42.0\n92.0\n60.0\n33.0\n1200.0\n0.0\n30.0\n8.0\n5.0\n300.0\n80.0\n40.0\n125.0\n12.0\n1000.0\n230.0\n24.0\n37.0\n35.0\n165.0\n64.0\n100.0\n280.0\n40.0\n100.0\n28.0\n200.0\n12.0\n8.0\n20.0\n220.0\n15.0\n100.0\n81.0\n3000.0\n15.0\n140.0\n170.0\n4400.0\n20.0\n18.0\n10.0\n28.0\n50.0\n4000.0\n481.0\n50.0\n79.0\n150.0\n1600.0\n120.0\n400.0\n353.0\n30.0\n39.0\n100.0\n300.0\n10.0\n0.0\n49.0\n30.0\n60.0\n184.0\n400.0\n65.0\n52.0\n55.0\n30.0\n18.0\n80.0\n56.0\n30.0\n1.0\n42.0\n0.0\n16.0\n2200.0\n154.0\n5.0\n150.0\n17.0\n0.0\n0.0\n1.0\n107.0\n49.0\n30.0\n36.0\n80.0\n18.0\n400.0\n221.0\n78.0\n26.0\n50.0\n21.0\n1000.0\n137.0\n80.0\n280.0\n64.0\n150.0\n0.0\n40.0\n80.0\n0.0\n70.0\n1.0\n20.0\n0.0\n240.0\n40.0\n80.0\n80.0\n36.0\n36.0\n30.0\n2285.0\n40.0\n28.0\n8.0\n110.0\n332.0\n48.0\nNone\n30.0\n488.0\n52.0\n34.0\n202.0\n70.0\n70.0\n13.0\n90.0\n408.0\n12.0\n40.0\n80.0\n150.0\n62.0\n90.0\n557.0\n258.0\n250.0\n10.0\n181.0\n235.0\n36.0\n18.0\n560.0\n68.0\n454.0\n142.0\n3056.0\n50.0\n20.0\n260.0\n70.0\n400.0\n900.0\n3600.0\n389.0\n4.0\n9.0\n468.0\n9.0\n33.0\n30.0\n200.0\n63.0\n43.0\n30.0\n114.0\n108.0\n100.0\n1.0\n30.0\n10.0\n179.0\n19.0\n26.0\n24.0\n43.0\n400.0\nNone\n504.0\nNone\n12.0\n3799.0\n168.0\n64.0\n64.0\n245.0\n55.0\n100.0\n200.0\n26.0\n121.0\n233.0\n50.0\n10000.0\n58.0\n21.0\n9.0\n73.0\n154.0\n4.0\n32.0\n300.0\n61.0\n30.0\n63.0\n132.0\n49.0\n154.0\n0.0\n150.0\n60.0\n9.0\n7744.0\n17.0\n16.0\n255.0\n0.0\n140.0\n962.0\n197.0\n180.0\n100.0\n40.0\n67.0\n7.0\n100.0\n45.0\n10000.0\n15.0\n50.0\nNone\n123.0\n1200.0\n19.0\n30.0\n100.0\n5.0\n583.0\n230.0\n82.0\n100.0\n200.0\n1440.0\n100.0\n1147.0\n92.0\n18.0\n128.0\n32.0\n400.0\n1.0\n80.0\n99.0\n73.0\n5.0\n395.0\n70.0\n166.0\n363.0\n88.0\n30.0\n20.0\n40.0\n900.0\n100.0\n20.0\n12.0\n20.0\n35.0\n56.0\n50.0\n37.0\n30.0\n350.0\n234.0\n290.0\n40.0\n332.0\n160.0\n20.0\n882.0\n50.0\n200.0\n44.0\n40.0\n4.0\n826.0\n100.0\n90.0\n50.0\n72.0\n10.0\n70.0\n61.0\n20.0\n120.0\n5000.0\n47.0\n95.0\n80.0\n178.0\n32.0\n358.0\n174.0\n26.0\n26.0\n59.0\n10.0\nNone\n19.0\n20.0\n80.0\n5.0\n46.0\n33.0\n1.0\n19.0\n120.0\n20.0\n150.0\n139.0\n15.0\n666.0\n25.0\n120.0\n30.0\n14.0\n36.0\n90.0\n30.0\n22.0\n80.0\n860.0\n9.0\n9.0\n9.0\n1000.0\n118.0\n32.0\n1.0\n240.0\n32.0\n50.0\n78.0\n50.0\n30.0\n100.0\n36.0\n150.0\nNone\n100.0\n60.0\n30.0\n5.0\n0.0\n22.0\n144.0\n200.0\n500.0\n122.0\n30.0\n59.0\n30.0\n110.0\n300.0\n10.0\n24.0\n203.0\n701.0\n720.0\n38.0\n20.0\n82.0\n2000.0\n60.0\n700.0\n196.0\n34.0\n86.0\n70.0\n50.0\n86.0\n47.0\n70.0\n35.0\n200.0\n307.0\n575.0\n60.0\n62.0\n49.0\n966.0\n353.0\n29.0\n0.0\n12.0\n40.0\n72.0\n30.0\n52.0\n30.0\n20.0\n246.0\n60.0\n100.0\n6.0\n90.0\n140.0\n170.0\n286.0\n116.0\n96.0\n151.0\n51.0\n200.0\n300.0\n150.0\n313.0\n20.0\n232.0\n914.0\n100.0\n39.0\n14.0\n80.0\n123.0\n150.0\n19.0\n13.0\n31.0\n30.0\n45.0\n18.0\n500.0\n20.0\n21000.0\n177.0\n10000.0\n10.0\n72.0\n68.0\n73.0\n110.0\nNone\n44.0\n198.0\n577.0\n100.0\n60.0\n20.0\n200.0\n12.0\n200.0\n16.0\n30.0\n18.0\n370.0\n60.0\n1864.0\n391.0\n10.0\n100.0\n122.0\n94.0\n4.0\n99.0\n224.0\n87.0\n30.0\n48.0\n14.0\n30.0\n36.0\n140.0\n80.0\n15.0\n40.0\n120.0\n73.0\n24.0\n15.0\n60.0\n24.0\n60.0\n80.0\n40.0\n75.0\n76.0\n50.0\n7.0\n182.0\n30.0\n59.0\n100.0\n156.0\n156.0\n80.0\n0.0\n1635.0\n40.0\n113.0\n851.0\n12.0\n41.0\n2.0\n159.0\n14.0\n6947.0\n73.0\n36.0\n146.0\n60.0\n128.0\n11.0\n31.0\n50.0\n488.0\n20.0\n65.0\n100.0\n61.0\n7.0\n53.0\n550.0\n80.0\n267.0\n44.0\n48.0\n30.0\n54.0\n64.0\n420.0\n50.0\n40.0\n90.0\n340.0\n15000.0\n60.0\n231.0\n140.0\n1800.0\n151.0\n60.0\n39.0\n390.0\n100.0\n420.0\n0.0\n9.0\n20.0\n41.0\n15.0\n55.0\n100.0\n120.0\n15.0\n163.0\n108.0\n40.0\n280.0\n39.0\n20.0\n60.0\n300.0\n16.0\n100.0\n53.0\n26.0\n100.0\n87.0\n9.0\n21416.0\n9813.0\n80.0\n100.0\n211.0\n51.0\n42.0\n162.0\n360.0\n120.0\n45.0\n64882.0\n1185.0\n160.0\n88.0\n47.0\n48.0\n92.0\n60.0\n118.0\n344.0\n27.0\n268.0\n94.0\n30.0\n50.0\n116.0\n0.0\n17.0\n300.0\n0.0\n23.0\n541.0\n200.0\n3000.0\n100.0\n6.0\n112.0\n45.0\n477102.0\n187.0\n53.0\n20.0\n48.0\n62.0\n15.0\n480.0\n476.0\n2000.0\n600.0\n18.0\n64.0\n100.0\n50.0\n50.0\n2.0\n260.0\n130.0\n205.0\n32.0\n37.0\n20.0\n50.0\n139.0\n9.0\n105.0\n43.0\n90.0\n253.0\n86.0\n60.0\n126.0\n207.0\n11.0\n33.0\n60.0\n11385.0\n150.0\n400.0\n0.0\n150.0\n24.0\n62.0\n220.0\n6.0\n40.0\n251.0\n252.0\n84.0\n300.0\n92635.0\n40.0\n30.0\n70.0\n42.0\n154900.0\n1.0\n19.0\n10.0\n200.0\n976.0\n20.0\n70.0\n206.0\n66.0\n9.0\n50.0\n45.0\n20.0\n3000.0\n27.0\n28.0\n200.0\n90.0\n16.0\n11.0\n0.0\n150.0\n139.0\n207.0\n32.0\n60.0\n90.0\n32.0\n1420.0\n165.0\n0.0\n18.0\n50.0\n24.0\n52.0\n73.0\n194.0\n12.0\n549.0\n30.0\n20.0\n78.0\n18.0\n78.0\n12.0\n100.0\n483.0\n200.0\n152.0\n119.0\n24.0\n75317.0\n148.0\n73.0\n2625.0\n80.0\n40.0\n56.0\n0.0\n285.0\n40.0\n562.0\n666.0\n600.0\n10.0\n20.0\n60.0\n31.0\n379.0\n31.0\n82.0\n50.0\n31.0\n90.0\n13.0\n19.0\n208.0\n72.0\n300.0\n331.0\n36.0\n50.0\n80.0\nNone\n6.0\n9000.0\n56.0\n80.0\n69.0\n198.0\n18.0\n83.0\n0.0\n160.0\nNone\n10000.0\n30.0\n17.0\n28.0\n703.0\n160.0\n81.0\n10.0\n2.0\n250.0\n111.0\n550.0\n6.0\n0.0\n75.0\n130.0\n15.0\n60.0\n111.0\n40.0\n3413.0\n170.0\n18.0\n60.0\n2035.0\n13.0\n61.0\n72.0\n101.0\n210.0\n100.0\n50.0\n90.0\n29.0\n50.0\n90.0\n632.0\n100.0\n15.0\n48.0\n30.0\n20.0\n31.0\n500.0\n15.0\n36.0\n14.0\n264.0\nNone\n0.0\n44.0\n111.0\n60.0\n102.0\n56.0\n60.0\n143.0\n36.0\n6.0\n42.0\n114.0\n239.0\n281.0\n12.0\n826.0\n658.0\n50.0\n45.0\n30.0\n2000.0\n400.0\n600.0\n34.0\n1349.0\n180.0\n80.0\n31454.0\n100.0\n135.0\n500.0\n50.0\n45.0\n219.0\n50.0\n15.0\n500.0\n230.0\nNone\n10.0\n72.0\n450.0\n70.0\n75.0\n37.0\n40.0\n10.0\n26.0\n32.0\n0.0\n80.0\n45.0\n60.0\n54.0\n353.0\n50.0\n14.0\n10000.0\n100.0\n2172.0\n20.0\n12.0\n37.0\n100.0\n104.0\n356.0\n16.0\n10.0\n53.0\n36.0\n100.0\n2000.0\n254.0\n1170.0\n0.0\n15.0\n19.0\n14.0\n61.0\n69.0\n41.0\n182.0\n2.0\n36.0\n165.0\n41.0\n109.0\n20.0\n60.0\n80.0\n40.0\n39.0\n44.0\n34.0\n80.0\n1300.0\n202.0\n60.0\n17.0\n1000.0\n36.0\n44.0\n100.0\n120.0\n500.0\n54.0\n58.0\n34.0\n64.0\n48.0\n124.0\n38.0\n135.0\n190.0\n82.0\n12.0\n148.0\n88.0\n40.0\n121.0\n25.0\n15.0\n101.0\n500000.0\n83.0\n0.0\n100.0\n256.0\n89.0\n112.0\n200.0\nNone\n1500.0\n40.0\n980.0\n72.0\n60.0\n100.0\n44.0\n190.0\n80.0\n56.0\n31.0\n86.0\n237.0\n165.0\n75.0\n156.0\n106.0\n16.0\n16.0\n600.0\n617.0\n24.0\n400.0\n1050.0\n90.0\n16.0\n10.0\n12.0\n395.0\n32.0\n64.0\n400.0\n469.0\n172.0\n50.0\n45.0\n181.0\n96.0\n40.0\n2444.0\n200.0\n50.0\n313.0\n91.0\n106.0\n70.0\n1000.0\n11.0\n36.0\n37.0\n40.0\n60.0\n60.0\n40.0\n560.0\n2044.0\n234.0\n32.0\n273.0\n6.0\n80.0\n210.0\n279.0\n0.0\n104.0\n100.0\n150.0\n600.0\n92.0\n218.0\n150.0\n400.0\n29.0\n204.0\n0.0\n118.0\n30.0\n112.0\n12.0\n15.0\n960.0\n147.0\n45.0\n46.0\n60.0\n50.0\n96.0\n72.0\n24.0\n710.0\n1000.0\n20.0\n40.0\n650.0\n1000.0\n182.0\n3241.0\n90.0\n450.0\n90.0\n6.0\n209.0\n281.0\n20.0\n20.0\n71.0\n30.0\n24.0\n276.0\n253.0\n40.0\n48.0\n30.0\n203.0\n30.0\n17.0\n1059.0\n100.0\n200.0\n0.0\n49.0\n19.0\n56.0\n60.0\n60.0\n60.0\n311.0\n45.0\n103.0\n25.0\n12.0\n36.0\n20.0\n574.0\n60.0\n773.0\n150.0\n1197.0\n64.0\n120.0\n200.0\n194.0\n50.0\n30.0\n311.0\n100.0\n519.0\n0.0\n31.0\n45.0\n24.0\nNone\n39.0\n1000.0\n12.0\n124.0\n40.0\n50.0\n74.0\n600.0\n150.0\n60.0\n100.0\n28.0\n6.0\n80.0\n72.0\n29.0\n240.0\n36.0\n142.0\n20.0\n16.0\n100.0\n0.0\n20.0\n96.0\n250.0\n36.0\n30.0\n0.0\n55.0\n320.0\n4.0\n0.0\n60.0\n350.0\n60.0\n41.0\n14000.0\n400.0\n1000.0\n164.0\n100.0\n159.0\n16.0\n12.0\n20.0\n600.0\n31.0\n10.0\n100.0\n3000.0\n15.0\n731.0\n88.0\n57.0\n90.0\n100.0\n120.0\n31.0\n460.0\n40.0\nNone\n116.0\n30.0\n537.0\n135.0\n351.0\n20.0\n180.0\n74.0\n157.0\n0.0\n480.0\n60.0\n30.0\n189.0\n260.0\n53.0\n90.0\n36.0\n6.0\n131.0\n12.0\n36.0\n324.0\n52.0\n5.0\n30.0\n90.0\n100.0\n80.0\n22.0\n296.0\n130.0\n76.0\n363.0\n35.0\n39759.0\n25.0\n32.0\n40.0\n620.0\n60.0\n154.0\n30.0\n88.0\n19.0\n216.0\n0.0\n38.0\n1695.0\n6.0\n33.0\n342.0\n36.0\n20.0\n25.0\n100.0\n30.0\n40.0\n253.0\n12.0\n20.0\n20.0\n55.0\n230.0\n91.0\n18.0\n210.0\n40.0\n450.0\n21.0\n100.0\n72.0\n22.0\n10.0\n60.0\n700.0\n250.0\n24.0\n140.0\n46.0\n20.0\n2000.0\n25.0\n249.0\n30.0\n3.0\nNone\n4700.0\n26.0\n500.0\n80.0\n90.0\n18.0\n66.0\n340.0\n22.0\n992.0\n104.0\n302.0\n22.0\n215.0\n58.0\n198.0\n21.0\n112.0\n16.0\n230.0\n130.0\n24.0\n50.0\n81.0\n672.0\n16.0\n80.0\n108.0\n120.0\n353.0\n4564.0\n128.0\n110.0\n218.0\n5.0\n42.0\n0.0\n36.0\n15.0\n99.0\n27.0\n6.0\n323.0\n25.0\n500.0\n10000.0\n60.0\n60.0\n345.0\n32.0\n50.0\n31.0\n117.0\n40.0\n90.0\n80.0\n40.0\n478.0\n80.0\n20.0\n0.0\n161.0\n5.0\n13.0\n129.0\n55.0\n80.0\n316.0\n53.0\n256.0\n450.0\n17.0\n61.0\n30.0\n136.0\n110.0\n30.0\n36.0\n80.0\n24.0\n1080.0\n90.0\n70.0\n1826.0\n5040.0\n40.0\n101.0\n458.0\n48.0\n60.0\n1000.0\n0.0\n3117.0\n77000.0\n30.0\n250.0\n110.0\n60.0\n19331.0\n45.0\n3536.0\n27.0\n100.0\n49.0\n12.0\n52.0\n10.0\n230.0\n72.0\n30.0\n143.0\n12.0\n36.0\n10.0\n600.0\n0.0\n0.0\n988.0\n39.0\n776.0\n30.0\n30.0\n140.0\n10.0\n41.0\n94.0\nNone\n40.0\n150.0\n668.0\n14.0\n62.0\n0.0\n536.0\n160.0\n56.0\n110.0\n1200.0\n14.0\n100.0\n56.0\n112.0\n150.0\n22.0\n95.0\n8.0\n0.0\n40.0\n12.0\n90.0\n554.0\n210.0\n526.0\n23.0\n20.0\n78.0\n67.0\n311.0\n700.0\n180.0\n48.0\n212.0\n560.0\n102.0\nNone\n42.0\n162.0\n1975.0\n116.0\n100.0\n100.0\n110.0\n39.0\n60.0\n81.0\n100.0\n50.0\n57.0\n30.0\n80.0\n710.0\n560.0\n23.0\n28.0\n320.0\n100.0\n82.0\n323.0\n68.0\n100.0\n8.0\n178.0\n600.0\n14.0\n84.0\n132.0\n5.0\n240.0\n851.0\n8.0\n995.0\n117.0\n66.0\n68.0\n75.0\n0.0\n17.0\n120.0\n102.0\n100.0\n9.0\n290286.0\n75.0\n250.0\n200.0\n90.0\n99.0\n100.0\n43.0\n1137.0\n88.0\n73.0\n35.0\n288.0\n98.0\n225.0\n19.0\n82.0\n104.0\n817.0\n33.0\n117.0\n200.0\n20.0\n67.0\n15.0\n603.0\n31.0\n211.0\n334.0\n300.0\n403.0\n1.0\n22.0\n70.0\n216.0\n0.0\n40.0\n20.0\n1000.0\n40.0\n330.0\n300.0\n170.0\n116.0\n16.0\n300.0\n60.0\n60.0\n27.0\n0.0\n700.0\n43.0\n486.0\n16.0\n400.0\n178.0\n20.0\n120.0\n20.0\n185.0\n120.0\n20.0\n1125.0\n599.0\n56.0\n55.0\n82.0\n23.0\n180.0\n"
     ]
    }
   ],
   "source": [
    "# Extract the values of the ninth column from each row\n",
    "enrollment = filtered_rdd_with_header.map(lambda row: row[8] if len(row) > 8 else None)\n",
    "\n",
    "# Display the ninth column values\n",
    "for value in enrollment.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "eb6ffa8c-fa73-4789-8310-f5d71f9fd7ed",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['Id', 'Study Title', 'Acronym', 'Status', 'Conditions', 'Interventions', 'Sponsor', 'Collaborators', None, 'Funder Type', 'Type', 'Study Design', 'Start', 'Completion'], ['NCT03630471', 'Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India', 'PRIDE', 'COMPLETED', 'Mental Health Issue (E.G. Depression Psychosis Personality Disorder Substance Abuse)', \"BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care\", 'Sangath', 'Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine', 250.0, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2018-08-20', '2019-02-28'], ['NCT05992571', 'Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity', None, 'RECRUITING', 'Cerebrovascular Function|Cognition', 'OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB', 'McMaster University', \"Alzheimer's Society of Brant Haldimand Norfolk Hamilton Halton\", 30.0, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE', '2023-10-25', '2024-08'], ['NCT00237471', 'Impact of Tight Glycaemic Control in Acute Myocardial Infarction', None, 'TERMINATED', 'Myocardial Infarct|Hyperglycemia', 'DRUG: Insulin (tight blood glucose control)', 'Melbourne Health', 'National Health and Medical Research Council Australia|Bristol-Myers Squibb', 40.0, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2005-10', '2006-05'], ['NCT03820271', 'New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation', 'SUPERMELD', 'RECRUITING', 'Decompensated Cirrhosis|Liver Transplantation', 'OTHER: SuperMELD', 'Assistance Publique - Hôpitaux de Paris', None, 500.0, 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER', '2020-10-01', '2023-10-01']]\n"
     ]
    }
   ],
   "source": [
    "#Since the datatype of the column named \"enrollment\" ahouls be float since there are only float values coming in it, let's define a function to convert a value to float, handling None values\n",
    "def safe_float_conversion(value):\n",
    "    try:\n",
    "        return float(value)\n",
    "    except (ValueError, TypeError):\n",
    "        return None  # Return None for non-numeric values or None\n",
    "\n",
    "# Apply the function to convert the \"enrolllment\" columns to float\n",
    "converted_rdd = filtered_rdd_with_header.map(lambda row: [safe_float_conversion(val) if idx in [8] else val for idx, val in enumerate(row)])\n",
    "\n",
    "# to confirm the value is changed to float datatype\n",
    "print(converted_rdd.take(5))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e3482202-dd94-48ba-a50a-8d5cd8141ef4",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Funder Type\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nFED\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nNETWORK\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNone\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nFED\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER_GOV\nOTHER\nNETWORK\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nINDUSTRY\nINDIV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNone\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNETWORK\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nNIH\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nNIH\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nINDUSTRY\nNETWORK\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDIV\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nNone\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nNIH\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nNone\nNIH\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nFED\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDIV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNETWORK\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nUNKNOWN\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNETWORK\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nNIH\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nNIH\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nUNKNOWN\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nNETWORK\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDIV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDIV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDIV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER\nINDUSTRY\nNETWORK\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nNIH\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nFED\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDIV\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nNIH\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nFED\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nFED\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDIV\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nNIH\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNone\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHE\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nFED\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nNIH\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nNETWORK\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nNIH\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nFED\nOTHER\nOTHER\nNIH\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDIV\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nNETWORK\nOTHER\nFED\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nFED\nNIH\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nFED\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nNone\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nINDIV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nNETWORK\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDIV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nNIH\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDIV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNone\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nFED\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nFED\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nINDIV\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nFED\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDIV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nNIH\nINDUSTRY\nOTHER_GOV\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nNone\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nNIH\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nNone\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDIV\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDIV\nNIH\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDIV\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nNone\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNone\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDIV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNETWORK\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNETWORK\nOTHER\nOTHER_GOV\nINDUSTRY\nFED\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNETWORK\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nFED\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nNIH\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nNETWORK\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nINDUSTRY\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nFED\nOTHER\nINDUSTRY\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nNETWORK\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nFED\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nINDUSTRY\nOTHER\nNETWORK\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nNETWORK\nINDUSTRY\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nOTHER\nNETWORK\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER_GOV\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nNIH\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nFED\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nINDUSTRY\nOTHER_GOV\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nINDUSTRY\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER\nOTHER_GOV\nOTHER_GOV\nNIH\nOTHER\nOTHER\nINDUSTRY\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the column \"Funder Type\" from each row of the dataset filtered_rdd_with_header\n",
    "funder_type = filtered_rdd_with_header.map(lambda row: row[9] if len(row) > 9 else None)\n",
    "\n",
    "# to View the values\n",
    "for value in funder_type.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "37ba5790-c88e-48e6-9552-2ca1f438cdc3",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Type\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nNone\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nEXPANDED_ACCESS\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nEXPANDED_ACCESS\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nNone\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nEXPANDED_ACCESS\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nNone\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nO\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nEXPANDED_ACCESS\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nNone\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nNone\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nEXPANDED_ACCESS\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nEXPANDED_ACCESS\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\nOBSERVATIONAL\nINTERVENTIONAL\nINTERVENTIONAL\n"
     ]
    }
   ],
   "source": [
    "# to get the values of the column Type from each row of the dataset filtered_rdd_with_header\n",
    "type = filtered_rdd_with_header.map(lambda row: row[10] if len(row) > 10 else None)\n",
    "\n",
    "# Display the tenth column values\n",
    "for value in type.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "bd78c1f8-8216-4e71-8839-8d484f2c24c5",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "No other values found.\n"
     ]
    }
   ],
   "source": [
    "# To check there is only expected values coming in the column type so as to smoothly get the accurate result while doing analysis:\n",
    "expected_values = {'OBSERVATIONAL', 'INTERVENTIONAL','EXPANDED_ACCESS',None,'Type'}\n",
    "# Assuming your verified_rdd contains the data as an RDD\n",
    "\n",
    "# Convert the set of expected values to an RDD\n",
    "expected_values_rdd = sc.parallelize(expected_values)\n",
    "\n",
    "\n",
    "# Check for values other than the expected ones\n",
    "other_values_rdd = type.subtract(expected_values_rdd)\n",
    "\n",
    "# Collect the other values found\n",
    "other_values = other_values_rdd.collect()\n",
    "\n",
    "# Print any other values found\n",
    "if other_values:\n",
    "    print(\"Other values found:\")\n",
    "    for value in other_values:\n",
    "        print(value)\n",
    "else:\n",
    "    print(\"No other values found.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "be5f4cb5-fefc-4174-a2ee-34de1f84995e",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Study Design\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: \nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT CARE_PROVIDER)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SCREENING\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SCREENING\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: \nAllocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SCREENING\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: DOUBLE|Primary Purpose: PREVENTION\nAllocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: \nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nObservational Model: |Time Perspective: p\nAllocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DEVICE_FEASIBILITY\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT CARE_PROVIDER)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT CARE_PROVIDER)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: S\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nModel: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT CARE_PROVIDER)|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: OTHER\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nAllocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: \nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: \nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SCREENING\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT CARE_PROVIDER)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: \nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: HEALTH_SERVICES_RESEARCH\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: DIAGNOSTIC\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: OTHER\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: OTHER\nAllocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: \nObservational Model: |Time Perspective: p\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SCREENING\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER\nObservational Model: |Time Perspective: p\nAllocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT\nAllocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\nObservational Model: |Time Perspective: p\nAllocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT\nAllocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the column \"Study Design\" from each row of the dataset RDD filtered_rdd_with_header\n",
    "study_design = filtered_rdd_with_header.map(lambda row: row[11] if len(row) > 11 else None)\n",
    "\n",
    "# Display the ninth column values\n",
    "for value in study_design.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "b465116a-db40-4b34-89c2-8c490a26c889",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Start\n2018-08-20\n2023-10-25\n2005-10\n2020-10-01\n2024-10-01\n2014-09\n2010-01\n2011-10\n2014-01\n2012-03-01\n2016-02\n2017-07-13\n2006-11\n2021-03-04\n2015-03\n2017-05-17\n2007-06\n2021-03-03\n2016-07\nNone\n2023-11-15\n2015-09-01\n2023-04-06\n2015-04\n2006-02\n2018-06-13\n2007-02\n2009-01\n2023-09-01\n2009-08\n2005-12\n2022-10-17\n2003-03\n2023-05-30\n2019-07-15\n2020-05-04\n2020-04-15\n2014-09\n2023-07-01\n2017-05-17\n2018-01-01\n2022-05-06\n2005-12\n2020-07-31\n2010-09\n2010-05\n2021-11-11\n2006-04\n2022-05-17\n2014-10-19\n2015-03\n2017-11\n2016-10-25\n2021-01-25\n2021-04-19\n2009-09\n2023-01-27\n2012-06\n2007-03\n2014-09\n2020-09-03\n2022-11-15\n2012-04\n1986-02\n2010-01\n2015-06-09\n2024-08\n2021-10-17\n2015-07\n2019-07-05\n2022-01-08\n2015-10\n2020-01\n2010-11-30\n2020-09-01\n2016-07\n2020-03-13\n2009-05\n2021-12-15\n2015-09\n2014-12\n2019-04-01\n2021-09-02\n2019-11-10\n2024-03-01\n2010-03\n2016-12-01\n2016-04\n2018-04-26\n2011-10\n2019-05-02\n2023-01-22\n2022-08-08\n2004-02\n2002-07\n2021-07-22\n2019-11-11\n2024-01-31\n2019-09-10\n2022-12-20\n2009-05\n2013-02\n2011-05\n2007-09\n2023-05-19\n2022-09\n2020-08-01\n2013-01-01\n2021-08-01\n2021-11-17\n2009-08\n2018-09-01\n2009-11-20\n2006-01\n2018-02\n2024-01-01\n2016-07-27\n2019-04-05\n2018-11-15\n2022-05-11\n2019-01-08\n2016-12-30\n2023-01-15\n2023-07-26\n2022-12-02\n2016-04-21\n2012-12\n2009-01\n2012-07\n2007-10\n2017-05-19\n2007-09\n2022-01-05\n2017-01-02\n2015-01\n2007-09\n2020-12-11\n2009-05\n2014-04-16\n2019-03-04\n2022-10-10\n2023-04-12\n2020-03-18\n2002-01\n2009-06\n2014-09-29\n2020-06-01\n2023-08-14\n2017-07-07\n2013-09-26\n2017-04-24\n2020-10-01\n2016-04\n2007-05\n2021-04\n2005-10\n2017-02-21\n2005-05\n2004-07\n2023-11-15\n2004-10\n2006-12-28\n2017-04-03\n2013-11\n2016-08\n2012-10\n2023-04-24\n2021-04-15\n2024-01-01\n2017-01\n2008-06\n2013-06\nNone\n2010-10\nNone\n2019-08-01\nNone\n2017-07-07\n2020-08-01\n2012-03\n2021-12-06\n2022-12-14\n2023-08-21\n2022-04-01\n2014-07\n2012-07-30\n2010-01\n2023-04-17\n2018-03-28\n2016-11\n2023-01-05\n2014-07-25\n2008-11-03\n2022-04-04\n2014-02\n2020-08-20\n2020-04-25\n2009-02\n2016-12-21\n2005-11\n2003-12\n2023-01-29\n2006-01\n2009-07\n2020-01-22\n2003-01\n2021-04-15\n2017-08-15\n2019-01-01\n2007-04-01\n2013-09\n2017-07-27\n2008-03\n2021-09-13\n2022-07-01\n2008-05\n2019-10-01\n2022-01-15\n2012-03\n2021-07-01\n2011-02-14\n2021-01-14\n2019-02-01\n2017-10-01\n2017-05-17\n2011-04\n2018-11-01\n2014-06-10\n2021-04-23\n2012-12\n2007-10\n2013-07\n2019-07-15\n2018-10-22\n2017-12-05\n2014-02-18\n2017-04-20\n2005-07-20\n2022-05\n2019-05-06\n2002-08\n2012-01\n2021-03-01\n2017-03-13\n2023-04-24\n2013-06\n2019-10-01\n2018-02-27\n2013-05\n2015-03-10\n2023-04-26\n2016-09\n2018-08-03\n2019-01-04\n2020-11-02\n2007-11\n2012-12\n2021-11-23\n2018-06-28\n1999-01\n2021-03-02\n2019-10-08\n2010-08\n2022-09-29\n2023-04-01\n2015-08-27\n2017-04-01\n2012-09\n2024-02\n2001-03\n2016-12-19\n2023-01-05\n2012-05\n2022-07-23\n2019-11-07\n2006-07\n2018-01\n2009-09\n2011-02\n2000-07\n2014-10\n2014-12\n2017-01-01\n2021-04-16\n2022-02-04\n2010-07\n2014-04\n2016-12-07\n2024-04-01\n2020-07-09\n2007-07\n2021-09-27\n2014-03-19\n2024-03-01\n2012-04\n2020-10\n2017-03-01\n2016-03\n2004-06\n2015-04-30\n2019-05-17\n2018-10-03\n2019-08-08\n2003-06\n2017-05-25\n2013-06\n2019-07-22\n2008-06-06\n2015-02\n2014-08-04\n2010-11\n2012-08\n2020-10-01\n2012-11\n2012-07\n2005-09\n2019-12-18\n2019-05-13\n2009-06-10\n2011-05\n2014-07\n2012-11\n2018-04-11\n2016-09\n2013-03\n2020-04-08\n2014-01\n2019-01-01\n2013-12\n2020-09-16\n2016-01\n2012-07-25\n2012-07\n2008-08\n2014-10\n2011-10\n2016-02\n2016-11-11\n2016-07-12\n2010-02-01\n2018-08-31\n2020-01-08\n2022-03-30\n2013-07\n2019-04-28\n2023-12-11\n2022-03-01\n2020-08-31\n2004-11\n2022-05-23\n2021-04-09\n2015-08-05\n2007-10\n2008-01\n2015-02-26\n2020-01-07\n2015-03\n2013-05\n2019-06-13\n2023-06-01\n2010-08-12\n2012-01\n2018-11-22\n2017-01\n2009-12\n2011-04\n2012-04-11\n2023-06-01\n2015-12\n2018-01-29\n2015-10\n2018-01-03\n2016-08\n2022-01-11\n2002-08\n2004-05\n2007-04\n2009-07\n2008-05\n2013-08\n2010-12\n2017-11\n2020-11-16\n2008-01\n2016-11\n2005-05\n2007-11\n2013-08\n2023-08-01\n2016-05-17\n2023-02-20\nNone\n2020-05-07\n2023-01-31\n2007-02\n1995-01-31\n2012-11\n2013-05\n2024-01\n2009-06\n2018-02-20\n2015-01\n2018-08-01\n2021-08-05\n2015-04\n2012-03\n2020-02-26\n2014-07\n2013-12-26\n2008-08\n2015-08\n2007-03\n2007-06-11\n2019-04-30\n2021-01-07\n2020-08-06\n2014-09\n2021-07-26\n2018-10-22\n2010-03\n2007-05\n2008-01\n2021-03-02\n2017-03-01\n2017-06-21\n2008-03\n2022-07-05\n2019-09-17\n2023-12-01\n2015-06\n2018-08-10\n2022-04-01\n2011-03\n2014-07\n2013-01\n2007-07\n2007-02\n2011-08\n2022-07-01\n2023-01-13\n2019-03-12\n2012-10\n2021-10-27\n1999-09\n2011-07\n2011-07\n2013-02-28\n2012-11\n2014-01\n2009-02\n2011-10\n2016-12-01\n2015-03\n2016-08\n2020-09-01\n2006-02\n2008-08\n2013-01\n2023-02-01\n2021-06-21\n2005-10\n2023-12\n2014-01\n2021-05-27\n2007-05\n2020-07-01\n2018-12-03\n2023-10\n2005-10\n2022-05-26\n2019-08-09\n2005-04\n2019-08-11\n2020-11-30\n2019-10-15\n2020-06-27\n2022-09-02\n2022-05-18\n2008-08\n2022-08-09\n1998-11\n2012-01\n2020-01-21\n2019-08-01\n2018-01-01\n2011-07\n2019-02-01\n2001-02\n2012-08\n2013-05\n2020-10-05\n2009-12\n2010-06\n2019-12-22\n2010-04\n2006-01\n2022-10-10\n2014-06\n2014-09\n2009-10\n2019-10-01\n2015-10-09\n2019-10-09\n2015-11-26\n2012-01\n2019-02-01\n2019-07-01\n2020-02-16\n2008-09-29\n2019-08-01\n2015-04\n2011-11-07\n2023-07-13\n2017-11-13\n2019-11-01\n2011-05-30\n2005-11\n2009-01\n2016-03\n2020-11-01\n2017-11-06\n2017-12-01\n2020-10-31\n2020-05-25\n2023-12-21\n2011-01\n2023-12\n2017-10-01\n2005-11\n2008-11\n2010-04\n2008-04\n2007-04\n2018-11-21\n2017-05-22\n2008-03\n2022-06-15\n2014-08\n2006-08\n2008-11-17\n2019-10-18\n2009-03\n2023-12-05\n2021-06-15\n2005-04\n2017-10-14\n2013-12\n2018-07-01\n2023-12-01\n2021-06-21\n2013-01\n2008-03\n2021-01-01\n2012-03\n2020-05-01\n2023-09-01\n2006-03\n2014-04\n2018-04-06\n2016-11-07\n2023-01\n2008-01\n2015-02\n2015-04\n2008-02\n2021-12-01\n2022-01\n2005-01\n2023-01-03\n2013-12\n2021-08-15\n2010-01-01\n2008-05\n2007-09\n2018-05-15\n2015-01\n2022-10-01\n2014-12\n2020-01\n2005-01\n2021-08-12\n2015-10\n2019-06-01\nNone\n2017-07-01\n2013-07-26\n2013-09\n2016-02-28\n2015-04\n2017-12\n2020-10-01\n2021-01-29\n2006-06\n2021-05-11\n2012-01\n2020-08-18\n2016-08\n2007-03\n2008-12\n2005-10\n2012-01\n2018-02-12\n2008-01\n2020-05-06\n2011-01\n2023-02-27\n2003-06\n2017-01-01\n2018-09-07\n2009-05\n2015-12\n2013-01\n2012-07-09\n2015-07\n2022-06-20\n2023-12-01\n2019-02-06\n2012-05\n2017-08-01\n2014-03\n2013-03-01\n2016-07\n2018-10\n2020-01-06\n2007-02\n2020-03-23\n2022-07-22\n2015-01\n2016-04\n2016-04\n2012-07\n2022-11-05\n2021-10-28\n2014-04\n1991-07\n2012-01\n2021-05-01\n2018-11-15\n2003-06\n2017-09-18\n2013-10-02\n2023-02-28\n2018-08-28\n2021-02-15\n2021-09-20\n2023-01-21\n2013-05\n2012-10-26\n1995-12\n2020-06\n2011-03\n2017-09-01\n2014-04\n2020-07-22\n2016-03\n2021-07-05\n2010-06\n2023-01-10\n2023-09-01\n2020-12\n2007-10-03\n2011-04\n2022-11-01\n2017-10-03\n2021-07-01\n2009-10\n2023-12-16\n2017-09-19\n2016-02-28\n2015-04\n2023-07-01\n2021-10-01\n2024-05-01\n2010-02\n2012-08\n2012-06\n2015-08\n2022-08-01\n2001-09\n2006-01\n2007-07\n2002-05\n2023-04-13\n2009-10\n2012-09\n2008-09\n2020-07-01\n2016-05\n2019-03-22\n2003-07\n2011-08\n2007-10\n2020-06-08\n2017-03-05\n2022-04-12\n2020-06-15\n2016-07\n1997-02\n2022-02-04\n2009-06\n2015-12\n2008-03\n2003-08\n2007-04\n2015-01-20\n2016-09\n2011-03\n2019-04-24\n2014-01-01\n2016-05-11\n2017-12-27\n2017-03-21\n2015-03\n2013-05-01\n2021-06-01\n2002-04\n2021-09-01\n2003-12\n2021-04-20\n2013-12\n1996-03\n2020-10-19\n2015-03\n2002-07\n2014-08\n2018-09-28\n2010-06\n2016-04-27\n2019-11-30\n2023-04-01\n2006-10\n2022-04-17\n2016-05-27\n2019-11-15\n2019-10-04\n2024-01\n2010-02\n2023-12-15\n2009-07\nNone\n2014-07\n2014-08-30\n2009-07\n2004-06\n2014-12\n2022-08-29\n2008-06\n2017-10-01\n2022-12-22\n2010-06\n2013-06-11\n2018-05-01\n2017-09-20\n2014-02\n2012-02\n2017-01-23\n2019-01-16\n2018-09-11\n2007-10\n2018-08-31\n2010-11\n2017-10\n2007-12\n2020-07-06\n2024-01-10\n2015-04-01\n2017-01-01\n2017-08-03\n2010-02\n2019-09-01\n2008-02\n2017-12-10\n2012-03\n1995-02\n2014-09\n2016-11-22\n1995-03\n2021-05-01\n2008-12\n2011-04\n2012-06\n2016-12\n2009-08\n2011-02\n2019-03-26\n2011-04\n2011-01-30\n2009-06\n2014-05\n2022-11-29\n2020-04-25\n2006-05\n2014-08-20\n2000-04\n2009-12\n2007-12\n2010-04\n2023-11-21\n2023-12-15\n2017-08-01\n2017-09-02\n2022-08-08\n2016-12\n2014-06\n2015-10\n2020-01-01\n2022-08-01\n2009-07\n2008-12\n2017-03-14\n2005-10\n2021-04-01\n2023-03-15\n2023-07-01\n2015-06-10\n2020-02-20\n2006-09-28\n2017-02-01\n2019-01-03\n2015-12\n2015-10-14\n2018-08-20\n2011-11\n2015-10\n2020-02-20\n2010-06-14\n2009-01\n2019-08-20\n2017-03-01\n2023-03-06\n2018-10-15\n2018-04-25\n2023-08-01\n2024-01\n2022-04-19\n2011-06\n2002-01\n2020-08-25\n2022-05-27\n2011-04\n2018-09-26\n2010-09\n2020-05-18\n2022-07-15\n2020-01-01\n2000-03\n2024-01-31\n2014-06\n2023-02-01\n2013-07\n2017-02-14\nNone\n2017-05-02\n2020-06-30\n2022-04-22\n2022-05-04\n2006-06\n2016-03-01\n2008-09\n2019-05-01\n2024-01-22\n2022-05-27\n2021-04-13\n2014-03-17\n2017-04-18\n2009-02\n2003-03\n2022-08-05\n2006-05\n2023-07-12\n2013-11-12\n2017-04-05\n2020-06-01\n2018-07-17\n2007-02\n2017-03-20\n2019-02-28\n2022-12\n2022-03-22\n2007-07\n2020-10-01\n2013-01\n2015-08\n2004-02\n2014-03\n2022-09-01\n2016-05-04\n2014-01-20\n2022-04-21\n2003-10\n2021-11-01\n2014-07\n2013-05\n2018-05-15\n2020-11-26\n2019-11-13\n2019-03-24\n2020-07-15\n2023-08-01\n2007-11\n2021-09-01\n2023-10-26\n2002-02\n2012-05\n2010-02\n2014-01\n2023-06-01\n2018-11-01\n2018-06-27\n2004-09\n2007-01\n2017-01-17\n2015-01\n2016-03-14\n2003-03\n2012-03\n2010-09-01\n2006-01\n2020-11-16\n2010-07\n2020-08-13\n2022-10-01\n2022-06-27\n2022-03-25\n2022-09-01\n2010-09\n2020-02-01\n2020-01-09\n2009-08\n2005-09\n2020-01\n2010-08\n2019-02-06\n2022-06-17\n2001-06\n2008-01\n2020-11-20\n2015-10\n2023-02-01\n2023-01-25\n2001-01\n2022-06-01\n2012-01\n2019-05-13\n2009-08-01\n2023-06-01\n2012-09\n2023-03-29\n2017-08-16\n2024-09-01\n2022-08-31\n2013-10\n2022-12-15\n2014-11-30\n2022-08-01\n2010-04-27\n2023-03-06\n2021-03-25\n2011-01\n2013-09\n2019-07-01\n2005-01-19\n2013-08-02\n2012-02\n2005-11\n2021-05-27\n2014-03\n2009-02\n2007-12\n2005-05\n2018-07-01\n2022-02-05\n2019-11-15\n2013-07\n2020-10-01\n2011-11\n2016-10-11\n2013-03-03\n2023-10-01\n2014-11\n2004-01\n2012-05\n2020-01-01\n2018-12-14\n2017-12-07\n2023-07-25\n2011-11\n2020-02-18\n2014-09\n2019-01-03\n2023-03-01\n2020-10-15\n2023-12\n2016-05-01\nNone\n1999-09\n2019-10-24\n2013-01\n2006-12\n2022-10-15\n2020-11-17\n2007-03\n2008-07\n2024-07-28\n2023-05-01\n2014-04\n2012-11\n2008-10\n2020-09-13\n2020-05-01\n2019-06-19\n2010-09\n2018-01-23\n2019-04-01\n2019-04-19\n2021-12-09\n2017-03-28\n2019-08-22\n2014-03-07\n2009-07\n2008-09\n2010-10\n2012-02\n2023-11\n2012-12\n2020-05-22\n2016-05\n1997-09-09\n2005-07\n2009-02\n2022-09-15\n2022-01-25\n2019-10-15\n2010-01\n2008-07\n2010-02-01\n2023-02-20\n2012-12\n2018-03-30\n2015-12-30\n2022-01-20\n2015-10-06\n2011-02-02\n2011-10\n2023-09-30\n2011-01\n2009-03\n2012-01-01\n2005-04\n2012-03\n2023-12\n2017-10\n2023-06-08\n2009-06\n2012-01-01\n2007-10\n2004-11\n2007-05\n2012-09\n2008-08\n2024-01-15\n2008-05\n2020-08-07\n2007-02\n2019-04-02\n2020-03-20\n2013-03\n2004-03-17\nNone\n2006-04\n2016-09\n2022-04-03\n2022-01-10\n2022-12-15\n2020-10-30\n2022-06-18\n2023-12-13\n2011-01\n2021-05-13\n2013-02\n2022-11-03\n2010-01\n2017-03-01\n2021-09-01\n2019-06-12\n1990-02\n2023-02-15\n2006-10\n2011-06\n2018-03-01\n2017-04-01\n2010-11\n2020-03-24\n2006-09\n2004-10\nNone\n2017-07-26\n2016-05\n2022-10-15\n2023-11-10\n2024-02-15\n2011-05\n2018-10-01\n2003-11\n2019-06-01\n2018-07-26\n2021-03-26\n2008-10\n2022-06-27\n2012-06\n2015-01\n2012-06\n2017-08-01\n2020-04-01\n2008-02\n2013-04\n2015-07\n2016-01\n2008-11\n2008-04\n2010-01\n2024-02\n2016-01\n2018-07-18\n2016-08\n2020-12-14\n2023-08-06\n2017-04-01\n2020-10-01\n2020-06-02\n2012-07\n2010-11\n2015-10-01\n2007-07\n2010-09\n2024-01-26\n2017-09\n2014-04\n2016-05-02\n2019-07-08\n2016-04\n2010-02\n2019-09-21\n2019-09-01\n2015-04\n2011-03\n2023-01-29\n2015-02\n2017-01-06\n2022-02-18\n2018-04-03\n2004-01-01\n2018-06-28\n2020-04-02\n2020-01-07\n2021-11-01\n2019-03-01\n2022-11-01\n2014-01\n2021-06-11\n2017-09-10\n2015-05\n2022-06-01\n2020-09-01\n2003-10\n2008-10\n2020-12\n2016-02-19\n2012-07\n2020-03-15\n2018-03-23\n2024-04\n2012-10\n2020-11-01\n2021-11-01\n2018-12-26\n2008-03\n2020-04-01\n2007-09\n2011-02\n2020-12-08\n2019-08-07\n2024-01-02\n2022-11-16\n2021-02-28\n2023-04-25\n2021-01\n2015-04-01\n1998-05\n2017-03-01\n2016-11-28\n2021-01-08\n2013-07-29\n2012-04-24\n2018-12\n2019-04-03\n2013-03\n2023-07-10\n2003-11\n2013-10-16\n2021-02-04\n2003-05\n2022-07-01\n2011-11-13\n2013-04\n2015-04\n2016-01-24\n2009-04\n2020-02-10\n2019-06-01\n2017-04-17\n2019-11-21\n2021-02-03\n2019-06-15\n2022-08-30\n2012-04-17\n2021-07-29\n2011-08\n2016-01\n2017-10-28\n2015-10\n2017-09-16\n2019-03-05\n2017-09-01\n2017-04-03\n2011-08\n2004-09-08\n2023-01-23\n2017-11-30\n2019-06-26\n2021-01-27\n2009-12\n2016-06\n2020-06-29\n2014-01\n2004-09\n2019-07-01\n2013-09\nNone\n2022-11-01\n2004-11-08\n2019-04-02\n2018-08-03\n2009-08\n2000-07-04\n2012-06\n2010-12\n2006-10\n2020-02-01\n2006-05\n2014-09-03\n2019-05-13\n2023-01\n2015-05\n2022-12\n2008-12\n2018-07-01\n2019-09-01\n2022-08-23\n2019-01-01\n2011-07\n2018-02-21\n2024-01-08\n2016-07\n2023-05-02\nNone\n2016-02\n2000-02-17\n2012-08-22\n2020-11\n2014-10-30\n2023-08-10\n2018-11-12\n2012-01\n2012-07-16\n2013-01-01\n2012-02-14\n2012-12\n2016-03-15\n2023-01-13\n2022-11-01\n2004-04\n2005-09\n2023-06-15\n2018-05-29\n2016-12-25\n2009-07\n2012-07-30\n2009-11-06\n2010-01\n2010-07\n2012-09\n2019-03-08\n2004-12\n2006-02\n2011-01\n2009-09\n2008-04-22\n2010-10\n2020-06-30\n2024-01-06\n2017-02-27\n2017-12-13\n2020-11-15\n2019-11-22\n2018-09-24\n2020-11-30\n2022-08-08\n2007-06\n2020-10-06\n2017-10-25\n2019-06-20\n2020-04-26\n2021-07-16\n2024-02-19\n2020-08-25\n2006-02\n2022-07-03\n2016-12\n2018-06-04\n2015-04\n2000-04\n2021-05-20\n2021-03-15\n2022-07-01\n2007-11\n2016-03\n2017-06\n2014-04\n2020-07-09\n2005-04\n2022-06\n2017-08-08\n2005-07\n2011-01\n2018-10-23\n2005-10\n2004-01\n2013-08\n2020-05-01\n2023-08-01\n2014-09\n2018-05-21\n2014-03\n2021-01-31\n2014-11\n2015-10-01\n2017-09-27\nNone\n2003-04-07\n2017-01\n2015-10-15\n2020-02-01\n2021-05-07\n2018-02-08\n2006-01\n2012-09-19\n2003-07\n2021-06-17\n2020-01-01\n2009-04\n2018-11-01\n2000-04\n2015-01\n2019-01-14\n2023-06\n2022-05-02\n2022-09-22\n2020-06-30\n2010-06\n2023-09-14\n2021-06-04\n2020-10-01\n2018-09-26\n2001-08\n2008-05\n2009-10\n2017-09-06\n2021-05-21\n2021-08-15\n2004-12\n2017-07-20\n2023-07-15\n2024-02\n2014-03\n2017-10-15\n2019-03-01\n2004-05\n2014-06\n2023-02-15\n2009-04\n1984-12\n2009-05\n2023-10-20\n2005-03\n2016-03-01\n2018-06-01\n2022-06-02\n2019-10-01\n2013-11\n2019-02-11\n2023-02-16\n2005-09\n2017-03-24\n2021-10-07\n2019-12-27\n2012-09\n2022-04-01\n2017-11-02\n2007-03\n2023-03-23\n2023-02-16\n2014-08\n2011-03\n2014-06\n2005-09\n2007-02\n2008-05\n2018-10-08\n2023-07-03\n2004-01\n2013-08\n2020-12-08\n2011-06\n2022-05-10\n2015-12-02\n2021-07-05\n2010-02\n2019-11-13\n2019-07-01\n2015-08\n2004-03\n2017-10-01\n1998-07\n2005-06-08\n2019-08-23\n2009-03\n2018-09-01\n2022-02-01\n2011-06-01\n2020-02-08\n2015-03-17\n2022-11-29\n2023-03-29\n2018-12-12\n2015-03\n2019-11-26\n2012-09\n2011-04\n2024-06-01\n2005-10\n2019-06-24\n2008-07\n2023-05-23\n2018-05-01\n2019-08-29\n2011-06\n2020-08-01\n2022-10-28\n2008-09\n2017-11-08\n2010-04\n2003-01\n2011-11\n2011-12\n2014-05\n2020-11-05\n2017-11-17\n2004-04\n2013-06\n2019-09-10\n2021-04-01\n2008-09\n2018-01-01\n2015-01\n2017-03-08\n2016-04\n2018-09-17\n2021-12-01\n2024-01-02\n2023-12\n2023-02-01\n2020-10-28\n2006-11\n2001-04\n2015-09\n2022-07-14\n2020-04-28\n2017-06-20\n2020-01-22\n2022-12-13\n2021-03-23\n2023-02-08\n2005-06\n2024-07-01\n2004-04\n2009-06\n2019-03-11\n2017-10-02\n2010-03\n2017-04-02\n2023-07\n1993-04\n2019-03-04\n2023-08-01\n2018-01-10\n2023-01-18\n2022-04-15\n2022-09-01\n2005-10\n2011-11\n2018-01-17\n2023-11-11\n2021-01-12\n2012-12\n2002-10\n2013-03-26\n2002-12\n2014-01\n2022-05-01\n2012-08\n2017-09\n2022-03-15\n2012-06\n2023-10-20\n2023-03-30\n2002-05\n2020-04-27\n2017-12-29\n2009-01\n2017-02-08\n2019-06-01\n2003-05\n1998-12\n2015-08\n2022-06-29\nNone\n2023-11-01\n2012-04\n2022-03-17\n2013-09-11\n2023-06-07\n2008-05\n2023-10-15\n2008-11\n2010-08\n2011-08\n2020-09-29\n2005-04\n2014-12\n2023-06-01\n2011-02\n2008-09\n2014-01\n2017-04-10\n2024-01-31\n2020-01-23\n2006-11\n2010-01\n2020-02-04\n2014-11\n1992-05-27\n2021-08-27\n2021-01-11\n2018-02-12\n2015-10\n2021-05-15\n2006-10\n2017-07-01\n2007-03\n2015-12\n2019-01-07\n2004-01-14\n2002-06\n2021-10-01\n2022-03-02\n2020-09-15\n2018-03-02\n2017-08-01\n2019-11-15\n2008-08\n2023-03-13\n2012-09\n2016-05\n2008-10\n2017-05-17\n2021-09-21\n2023-09-01\n2006-12\n2020-06-01\n2012-03\n2019-09-24\n2011-11\n2013-01-15\n2017-09-08\n2011-09\n2011-08-12\n2011-09\n2019-07-25\n2013-10\n2002-02\n2010-07\n2020-04-23\n2013-12\n2017-11-02\n2018-07-06\n2020-06-22\n2020-03-24\n2017-11-30\n2018-09-25\n2006-12\n2022-08-30\n2008-02\n2012-08-11\n2010-05\n2013-08-13\n2022-07-01\n2017-11-03\n2021-05-03\n2018-12-20\n2008-07\n2017-07-26\n2006-04\n2021-03-01\n2016-07\n2000-01-01\n2019-02-01\n2021-06-28\n2008-11\n2022-01-30\n2010-01\n2018-06-01\n2023-03-31\n2023-04-04\n2013-09\n2016-05\n2017-01-01\n2018-05-07\n2020-09-01\n2021-03-09\n2010-09\n2012-11-15\n2013-11\n2015-07\n2017-07-01\n2023-10-31\n2012-10\n2023-09-01\n2006-01\n2009-04\n2013-10\n2016-06-27\n2020-06-19\n2023-03-10\n2015-03\n2012-03\n2019-01-17\n2000-09\n1994-11-30\n2012-12-27\n2015-01\nNone\n2023-04-01\n2010-02\n2016-06-14\n2021-05-19\n2017-09-01\n2021-09-08\n2016-10-04\n2011-01-01\n2006-04\n2002-11\n2015-01\n2008-02\n2014-01\n2022-06-02\n2015-12\n2004-05\n2013-03-04\n2010-07\n2018-09-13\n2021-05-18\n2017-05-12\n2018-03-22\n2016-01\n2011-12\n2021-01-15\n2009-08\n2013-06\n2017-01-25\n2017-07-01\n2016-09\n2020-10-26\n2011-05\n2015-02\n1997-12-04\n2019-06-27\n2022-06-01\n2012-05\n2022-12-17\n2016-06\n2016-02\n2015-05\n2024-01-30\n2020-05-17\n2018-07-13\n2016-01-28\n2017-06-05\n2017-01-04\n2019-08-01\n2010-08\n2015-06\n2016-10-11\n2017-02\n2014-06-30\n1992-10\n2018-02-14\n2022-05-31\n2017-11-24\n2016-05\n2010-02\n2023-01-16\n2010-01\n2007-10\n2014-10\n2012-02\n2024-04-01\n2021-09-29\n2015-12\n2015-08\n2011-11\n2018-08-01\n2022-05-16\n2018-06-15\n2012-03\n2023-05\n2006-08\n2009-09\n2011-09\n2011-01\n2007-04\n2012-03-27\n2017-01-13\n1994-10\n2012-09\n2019-03-28\n2019-10-18\n2023-07-27\n2005-10\n2017-01-01\n2011-06\n2020-02\n2014-02-01\n2020-12-01\n2021-05-03\n2015-01\n2023-11-10\n2015-09\n2002-09\n2019-01-01\n2007-10\n2023-01-01\n2016-10\n2020-11-09\n2021-07-29\n2021-02-10\n2010-04\n2022-09-01\n2022-03-14\n2005-10\n2011-01\n2016-12-22\n2021-04-29\n2006-02\n2010-09-10\n2019-02-12\n2022-04-22\n2021-12-01\n2015-04\n2021-06\n2022-10-28\n2020-11-12\n2016-08-01\n2024-01\n2013-02\n2010-03\n2017-01-01\n2017-01\n2021-05-05\n2016-06\n2018-04-10\n2012-03\n2024-03\n2011-05\n2018-01-01\n2024-02-05\n2019-06-28\n2019-06-21\n2019-03-26\n2011-06\n2004-10\n2009-09-03\n2008-05\n2019-03-27\n2010-08\n2020-02-12\nNone\n2022-04-01\n2024-03-01\n2014-03\n2006-01\n2022-02-07\n2010-05\n2012-05\n2021-11-09\n2017-01-04\n2020-05\n2022-04-11\n2011-08\n2016-09\n2021-01-29\n2016-09-01\n2018-01-17\n2020-03-10\n2021-03-01\n2017-03-01\n2016-09\n2010-02\n2022-11-15\n2011-09\n2020-05-01\n2021-11-09\n2005-07\n2020-12-14\n2016-04\n2016-04\n2012-02\n2019-02-04\n2018-09-17\nNone\n2004-07\n2012-02\n2024-01-08\n2021-04-03\n2020-01-16\n2006-07\n2021-06-02\n2019-01-01\n2005-07\n2014-08\n2003-03\n2020-12-30\n2020-06-01\n2019-04-17\n2013-10-09\n2020-11-06\n2007-03\n2023-08-21\n2019-10-11\n2014-04-04\n2021-02-01\n2015-02\n2016-06-17\n2019-01-01\n2022-06-15\n2017-06-01\n2019-01-01\n2021-12-27\n2013-10\n2011-11\n2016-11-28\n2015-09\n2013-06-01\n2014-01\n2003-05\n2009-08\n2013-04\n2024-01-30\n2013-01\n2019-06-12\n2024-01-29\n2016-04\n2021-10-31\n2009-10\n2008-08\n2018-08-01\n2010-02\n2004-01\n2019-09-01\n2023-08-01\n2022-11-24\n2021-01-26\n2020-11-16\n2024-02-25\n2003-01-27\n2014-02\n2023-12-01\n2019-03-05\n2016-06\n2012-05\n2015-02\n2009-02-18\n2017-07-05\n2015-11\n2004-12\n2011-09\n2020-10-01\n2006-11\n2011-05\n2022-11-01\n2019-07\n2016-02-12\n2021-08-06\n2004-10\n2017-01\n1979-07\n2024-03-01\n2016-03\n2008-09\n2004-11\n2019-01-10\n2004-11\n2017-06\n1994-06\n2018-10-17\n2022-07-07\n2017-04-25\n2009-12\n2022-06-20\n2023-07-01\n2014-02\n2014-10\n2008-05\n2015-03-16\n2021-05-01\n2017-12-01\n2021-11-15\n2020-03-01\n2002-01\n2021-05\n2018-10-16\n2009-09\n2015-01-02\n2016-10\n2023-12-28\n2011-11\n2020-12-14\n2021-08-13\n2019-09-16\n2019-01-01\n2024-01-29\n2018-10-01\n2009-11-01\n2014-08\n2018-09-15\n2004-12\n2009-12\n2024-02\n2014-05\n2022-05-17\n2022-10-18\n2016-11\n2018-12-01\n2009-08-26\n2022-05-23\n2012-03\n2011-05\n2018-01-01\n2017-03-01\n2016-10\n2012-08\n2023-04-24\n2007-09\n2015-10-26\n2015-09\n2014-07\n2013-01\n2016-11\n2006-04-08\n2024-01-01\n2013-09-17\n2003-12\n2020-11-20\n2024-02-13\n2022-08-01\n2021-06-30\n2022-02-01\n2022-04-01\n2013-07\n2006-03\n2022-10-05\n2016-09\n2018-06-18\n2013-12\n2016-07\n2020-09-21\n2005-12\n2023-02-01\n2015-07\n2016-04\n2020-07-01\n2015-04\n2022-12-19\n2019-11-01\n2012-10\n2022-04-01\n2023-01-09\n2011-09\n2016-08\n2021-07-01\n2023-01-01\n2002-05\n2015-03-13\n2012-07\n2019-01-07\n2012-06\n2018-04-01\n2021-06-01\n2018-01-20\n2015-10\n2023-12-01\n2021-09-01\n2016-01\n2013-12-11\n2023-03-13\n2014-10\n2020-03-05\n2008-06\n2016-03\n2019-03-01\n2018-05-15\n2005-01\n2019-10-16\n2012-03\n2022-03-01\n2023-09-18\n2015-04\n2011-05\n2016-12\n2020-03-06\n2013-03\n2022-01-01\n2001-02\n2020-10-16\n2019-03\n2006-03\n2009-09\n2015-05-12\n2023-10-13\n2010-10\n2021-08-05\n2008-09\n2023-09\n2016-03\n2010-12-03\n2015-05-01\n2018-08-01\n2000-01\n2001-08\n2021-06-22\n2019-07-01\n2018-01-01\n2021-04-16\n2019-12-05\n2012-01\n2018-10-01\n2016-04\n2004-02\n2010-09\n2024-08\n2019-08-06\n2023-10-01\nNone\n2021-06-30\n2022-01-01\n2013-10\n2022-10-06\n2018-08-09\n2018-06-19\n2002-04\n2010-04\n2019-04-11\n2009-10\n2018-10-29\n1999-01\n2018-03-04\n2020-11-01\n2019-01-25\n2015-10\n2014-05\n2020-01-01\n2018-08-01\n2018-01-02\n2020-02-24\n2021-07-31\n2021-02-01\n2010-11\n2021-03\n2015-03-23\n2015-09-07\n2022-02-01\n2021-11-12\n2003-03-18\n2019-07-01\n2019-11-06\n2009-12\n2020-12-16\n2022-09-14\n2005-06\n2018-02-15\n2024-01-02\n2021-03-05\n2022-11-18\n2021-01-14\n2012-01\n2020-06-01\n2016-10\n2022-03-14\n2006-08\n2011-02\n2023-09-25\n2007-01\n2021-12-06\n2021-09-22\n2013-09\n2014-09-02\n2014-04\n1998-05\n2011-05\n2013-01\n2014-09\n2020-10-14\n2014-12\n2017-06-13\n2018-12-17\n2021-04-13\n2008-12\n2016-01\n2019-11-19\n2021-12-13\n2023-11-17\n2013-05\n2017-03-01\n2024-02-01\n2011-01\n2021-06-22\n2016-10\nNone\n2019-10-29\n2023-10-13\n2020-10-16\n2010-08\n2020-07-10\n2019-12-13\n2020-02-10\n2018-02-07\n2013-08\n2020-04-01\n2021-05-17\n2008-01\n2016-06-25\n2004-08\n2015-03\n2017-07-14\n2021-05-01\n1997-06-19\n2016-01\n2014-10\n2003-04\n2012-01\n2011-01\n2010-09\n2009-07\n2005-08\n2021-08-01\n2020-08-26\n2024-02-01\n2016-11\n2023-11-02\n2015-01\n2021-03-03\n2009-06\n1998-10\n2017-02-01\n2023-08-01\n2000-10\n2021-02-01\n2001-04-04\n2006-07\n2005-03\n2018-01-01\n2018-08-08\n2016-01\n2012-05\n2018-03-01\n2021-03-01\n2021-04-26\n2021-04-14\n2023-04-22\n2017-02-06\n2023-06-07\n2013-06\n2019-06-05\n2008-01\n2023-02-22\n2023-08\n2018-06-29\n2016-08\n2018-10-29\n2016-06\n2020-02-03\n2021-02-10\n2018-10-03\n2017-10-01\n2019-09-04\n2018-12-01\n2022-06-02\n2022-09-19\n2015-12-22\n2015-04-01\n2012-05-01\n2011-12\n2023-07\n2018-09-20\n2017-07-07\n2015-09\n2013-04\n2014-11\n2016-01-12\n2018-05-01\n2021-04\n2023-02-21\n2016-11\n2001-11\n2014-03\n2020-12-01\n2023-10-10\n2016-08\n2012-01\n2023-11\n2018-06-02\n2020-07-06\n2015-02\n2008-11\n2013-10\n2020-06-01\n2017-01-10\n2010-11\n2011-12\n1995-11\n2021-11-09\n2024-01\n2021-03-01\n2021-06-24\n2013-10\n2018-10-29\n2020-03-03\n2022-11-01\n2020-08-17\n2020-11-19\n2023-12-01\n2013-02\n2020-12-04\n2021-11-08\n2018-05-01\n2016-10\n2011-01\n2020-01-27\n1998-08\n2016-08-04\n2008-11\n2014-01\n2014-12\n2014-04\n2020-11-19\n2008-02\n2005-01\n2013-09-01\n2006-12\n1999-05\n2006-12\n2014-05\n2006-01\n2009-02\n2023-09-29\n2006-09\n2016-01-18\n2022-10\n2013-06\n2009-09\n2005-03\n2014-06\n2023-10-26\n2007-01-08\n2019-10-18\n2016-11-30\n2005-10\n2016-10\n2022-12-27\n2023-10\n2015-02\n2011-09\n2021-11-10\n1995-01\n2020-03-20\n2019-01-22\n2012-09\n2018-11-19\n2022-03-01\n2020-10-09\n2014-10\n2023-10-19\n2014-05\n2017-09-15\n2021-01-12\n2023-05-01\n2023-02-15\n2019-09-16\n2007-10\n2012-01\n2021-09-06\n2019-11\n2009-06\n2020-08-01\n2016-11\n2011-07\n2021-11-01\n2015-03-25\n2023-11-01\n2021-01-01\n2021-09\n2017-04-01\n2008-04\n2015-09-14\n2013-04\n2020-07-03\n2008-01\n2014-03\n2023-08-20\n2016-06\n2021-08-20\n2019-06-05\n2015-10-15\n2015-03\n2005-09\n2013-11\n2014-08\n2011-09\n2013-01\n2006-03\n2017-09-20\n2023-12\n2011-03\n2008-04\n2007-12\n2010-09\n2009-02\n2017-07-28\n2018-07-20\n2018-01-01\n2006-04\n2012-05\n2010-01\n2008-08\n2023-07-01\n2014-01\n2009-06\n2012-02\n2023-01-16\n2020-12-08\n2020-07\n2011-01\n2016-04-06\n2015-03\n2021-01-11\n2015-05\n2022-09-06\n2020-01-10\n2011-03-11\n2017-01\n2009-05\n2023-10-12\n2006-07\n2020-08-26\n2020-10\n2022-09-01\n1999-09-24\n2016-01-14\n2020-11-18\n2006-04-01\n2017-08-01\n2022-04-20\n2019-03-29\n2008-08\n2009-05\n2017-08-15\n2022-12-22\n2021-02-05\n2011-01-01\n2015-08\n2018-01-15\n2002-05\n2018-08-24\n2010-03\n2019-09-06\n2012-03\n2022-07-01\n2024-03\n2011-12\n2006-08\n2021-10-05\n2017-01-19\n2011-06\n2015-02\n2017-06-14\n2017-06-19\n2013-06-19\n2006-01\n2006-09\n2014-04\n2013-03\n2018-08-09\n2008-05\n2024-04-01\n2023-02-03\n2019-04-23\n2011-02\n2008-04\n2012-05\n2015-12-22\n2023-11-06\n2023-08-01\n2003-12\n2009-07\n2021-12-27\n2010-04\n2021-08-24\n2019-11-05\n2010-09-03\n2021-03-15\n2020-07-20\n2013-10-15\n2023-09\n2011-11\n2013-04\n2013-05\n2016-10\n2017-07-01\n2016-08\n2020-05-01\n2011-10\n2019-04-01\n2018-03-01\n2013-12-04\n2015-01\n2012-06-07\n2014-04\nNone\n2010-10\n2022-09-15\n2023-06-05\n2019-12-03\n2006-07\n2011-03\n2020-06-01\n2022-03-02\n2018-05-02\n2009-09-08\n1996-12\n2015-05\n2022-03-10\n2020-01-01\n2004-09\n2019-11\n2020-12-01\n2007-06\n2018-02\n2001-04\n2018-09-01\n2011-01\n2018-10-01\n2013-08\n2012-05\n2006-07\n2017-01\n2011-07\n2022-01-31\n2007-09\n2024-01-01\n2004-02\n2016-01-26\n2019-08-20\n2016-05\n2017-02-22\n2016-06\n2014-02-01\n2002-05\n2016-03-31\n2008-02\n2014-01\n2014-07-07\n2016-02\n2019-07-19\n2022-07-06\n2020-07-01\n2013-02\n2015-07\n2014-04\n2015-03\n2013-04\n2020-03-16\n2018-12-05\n2026-01-01\n2017-04-04\n2006-07\n2018-02-28\n2008-01\n2013-10\n1995-06\n2012-03\n2012-09\n2006-04\n2004-06\n2005-03\n2014-05\n2005-08\n2004-01\n2009-09-11\nNone\n2022-03-09\n2017-06-02\n2007-11\n2005-08\n1999-08\n2014-11-01\n2013-12\n2023-07-20\n2015-03\n2015-05\n2021-01-31\n2010-01\n2016-06\n1998-10\n2022-06-08\n2021-04-27\n2020-06-20\n2008-01\n2016-06\n2011-10\n2020-12-15\n2017-02-19\n2023-10-01\n2014-05\n2018-02-01\n2020-09-24\n2022-10-10\n2005-07\n2016-06\n2009-11\n2009-04\n2023-09\n2017-08-30\n2014-08\n2021-11-24\n2016-07-08\n2024-04-30\n2017-10-01\n2021-09-02\n2016-06-01\n2021-05-27\n2013-02\n2006-03\n2008-11\n2018-12-12\n2016-01\n2013-12-03\n2007-05-16\n2018-11-21\n2021-08-10\n2020-04-14\n2023-07-01\n2011-01\n2015-08-12\n2020-04-01\n2007-09\n2005-10\n2015-07\n2019-03-01\n2009-06\n2008-10\n2020-06-24\n2020-04-01\n2017-09\n2009-04\n2019-03-01\n2013-12\n2022-11-22\n2022-04-18\n2023-08-14\n2024-04\n2019-10-08\n2019-04-27\n2020-09-10\n\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n\n2011-10\n2010-02\n2017-01-01\n2014-11\n2015-04\n2013-03\n2020-02-10\n2016-11-18\nNone\n2016-11\n2007-09\n2019-09-26\n2022-10-07\n2018-10-09\n2000-03\n2015-08\n2006-12\n2019-03-01\n2011-07\n2023-02-07\n2005-03-08\n2023-03-01\n2020-11-18\n2017-01\n2021-07-01\n2014-09\n2016-01\n2022-05-01\n2012-03\n2020-06-19\n2022-01-20\n2015-02\n2008-07\n2020-11-19\n2016-02-19\n2003-09\n2017-03-30\n2023-07-10\n2022-06-27\n2021-12-01\n2009-10\n2024-03\n2020-04-01\n2023-04-28\n2011-03-01\n2009-07\n2023-07-20\n2020-07-27\n1998-01\n2020-10-20\n2011-05\n2018-07-25\n2012-01\n2023-04\n2016-11-03\n2021-03-02\n2018-08-24\n2019-11-01\n2021-05-01\n2006-11\n2022-04-22\n2019-05-09\n2013-02\n2019-05-01\n2010-09\n2014-11\n2007-01\n2023-06-09\n2016-02\n2016-03-09\n2004-03\n2007-09\n2009-09\n2019-11-21\n2021-06-08\n2011-06-15\n2018-01-03\n2010-04\n2020-01-23\n2018-08-01\n2014-02\n2012-01\n2017-08-16\n2011-02\n2022-10-01\nNone\n2015-11\n2020-01-21\n2018-02-21\n2013-11\n2005-06\n2018-04-09\n2017-11-17\n2022-12-07\n2020-10-20\n2020-07-01\n2018-06-30\n2008-05\n2005-03\n2006-09\n2022-11-14\n2020-02-04\n2023-06-15\n2005-07\n2010-03\n2017-11-07\n2017-08-23\n2014-09\n2013-11\n2023-04-06\n2022-06-29\n2012-06\n2011-09\n2022-06-01\n2015-07\n2016-07\n2022-03-21\n2022-10\n2000-01\n2005-10\n2017-12-06\n2021-01-19\n2023-11-17\n2018-05-02\n2020-01-03\n2022-06-01\n2018-10-01\n2011-05\n2018-10-23\n2020-10-01\n2018-12-14\n2016-06-17\n2009-09\n2016-01\n2017-06-17\n2010-07-01\n2012-06\n2008-10\n2017-10-15\n2002-06\n2018-04-20\n2023-06-15\n2018-07-24\n2014-11\n2017-06-12\n2023-04-01\n2002-08-15\n2021-07-20\n2013-06-13\n2022-07-27\n2017-06-22\n2021-10-27\n2021-10-11\n2013-08\n2022-11-14\n2021-03-30\n2014-02\n2023-05-02\n2016-05-01\n2012-01\n2001-05\n2009-02\n2019-11-11\n2014-04\n2021-09-28\n2023-12-01\n2017-06-27\n2021-02-01\n2015-12\n2019-02-02\n2012-04\n2019-04-01\n2012-03\n2021-08-19\n2022-03-29\nNone\n2023-04-19\n2019-09-17\n2021-07-14\n2022-08-03\n2022-08-09\n2015-07-30\n2023-05-09\n2013-12-05\n2015-02\n2009-06-30\n2023-12-19\n2016-04\n2007-04\n2023-07-01\n1995-09\n2024-04-18\n2011-08\n2018-08-28\n2019-08-29\n2008-07\n2022-03\n2020-04-12\n2016-07\n2018-01-02\n2022-09\n2017-04-26\n2017-07-21\n2023-04-02\n2019-05-13\n2009-02\n2013-07\n2012-10\n2019-09-01\n2018-05-04\n2010-11\n2008-03\n2022-04-20\n2014-02\n2004-05\n2020-07-21\n2010-08-01\n2000-01-01\n2022-08-01\n2010-05\n2021-06-24\n2014-06-30\n2011-12\n2006-08\n2021-08-23\n2011-08\n2010-03\n2016-11\n2024-03-15\n2014-07\n2018-09\n2012-09-13\n2024-01-08\n2006-06\n2020-04-06\n2019-09-30\n2021-01-01\n2014-11\n2016-03-24\n2019-12-26\n2021-12-09\n2010-01\n2021-05-07\n2006-08\n2009-03\n2016-09\n2007-05\n2013-06\n2023-02-17\n2021-07-26\n2007-11\n2024-03-01\n2021-06-09\n2010-12\n2008-11\n2016-06\n2014-05\n2009-06\n2011-12\n2021-02-12\n2015-06-01\n2004-03\n2017-01-24\n2015-07\n2005-04\n2010-06\n2014-09\n2022-07\n2011-03\n2020-05-31\n2019-07-12\n2009-01\n2021-12-15\n2007-05\n2016-02\n2006-04\n2012-09\n2020-10-30\n2018-07-12\n2017-03-28\n2022-06-09\n2006-09\n2019-05-13\n2016-11\n2009-10\n2021-04-25\n2022-01-10\n2021-11-16\n2013-08\n2007-12\n2014-10\n2017-04-07\n2009-12\n2021-01-20\n2017-01-11\n2014-08\n2013-10\n2021-07-02\n2019-01-21\n2018-03-26\n2022-06-01\n1999-09\n2019-05-29\n2022-01-01\n2011-02\n2023-01-01\n2013-09\n2010-06\n2005-08\n2013-03\n2007-01\n2010-01-01\n2008-01\n2009-02\n2016-04\n2023-05-26\n2019-04-07\n2014-04\n2005-07\n2002-09\n2012-01\n2010-07\n2013-09\n2023-09-13\n2021-09-20\n2014-05\n2013-10\n2011-01\n2019-05-07\n2021-10\n2019-02-06\n2014-09\n2023-06-15\n2001-03\n2021-06-17\n2012-03\n2017-03-21\n2020-01-10\n2011-04-21\n2024-01\n2011-05\n2006-03\n2010-11\n2019-12-01\n2015-09\n2014-05\n2021-10-15\n2018-04-16\n2014-10\n2011-01\n2006-04-19\n2015-12-15\n2022-05-01\n2015-03\n2022-06-13\nNone\n2016-09\n2015-03\n2015-07-30\n2014-06\n2017-04-26\n2021-03-01\n2009-07\n2015-04\n2010-09\n2004-07\n2016-07-05\n2012-02\n2022-02-01\n2022-03-23\n2024-07-04\n2020-10-26\n2019-01-01\n2007-05\n2012-10\n2011-08\n2014-09\n2023-06-01\n2020-06-05\n2004-01\n2021-10-01\n2021-10-01\n2008-06\n2020-07-01\n2022-07-19\n2019-04-22\n2016-04\n2019-07-08\n2024-01\n2022-05-16\n2023-04-03\n2023-11-28\n2017-08-21\n2013-06\n2016-02\n2014-07\n2017-12-01\n2021-06-17\n1984-08-28\n2023-02-17\n2008-05\n2020-09-02\n2010-07\n2012-07-11\n2017-05-02\n2009-12\n2017-11-23\n2020-04-15\n2015-05\nNone\n2017-06-01\n2018-10-01\n2007-06\n2009-05\n2020-11-09\n2019-03-01\n2018-10-16\n2022-05-31\n2019-09-01\n2009-02\n2008-07\n2011-01\n2015-03\n2016-09-01\n2018-05-18\n2006-02\n2014-10-15\n1997-11\n2010-02\n2016-10\n2018-06-04\n2001-08\n2022-06\n2012-10\n2003-06\n2013-08\n2024-03\n2011-11-29\n2009-06\n2004-08\n2019-12-01\n2007-12\n2022-09-16\n2014-11-01\n2011-10\n2012-01\n2018-09-27\n2023-11-17\n2018-06-20\n2004-04\n2018-08-03\n2008-04\n2015-01\n2005-11\n2019-04-16\n2019-10-25\n2019-08-06\n2013-03\n2010-04\n2018-09-18\n2012-02\n2018-11-01\n2012-03\n2018-02-16\n2018-11-30\n2016-12-19\n2010-11\n2019-03-18\n2018-12-15\n2014-08-13\n2021-08-30\n2009-09-10\n2010-11\n2021-01-29\n2016-08\n2007-10\n2007-02\n2009-01\n2022-09-29\n2009-01\n2015-04-27\n2019-04-15\n2010-01-05\n2019-09-05\n2004-03\n2009-06\n2009-06\n2005-01\n2014-10\n2003-12\n2016-11-16\n2013-02\n2022-11-02\n2017-12-01\n2006-12\n2006-01\n2007-07-08\n2006-05\n2021-03-31\n2016-01\n2009-03\n2019-09-09\n2008-01\n2008-03\n2006-06\n2017-01\n2004-01\n2023-08-31\n2021-06-25\n2020-04-08\n2023-08-23\n2021-05-01\n2006-04\n2021-06-16\n2017-08-21\n2019-08-20\n2023-09-15\n2023-01-01\n2006-04\n2018-01-01\n2018-07-01\n2020-06-05\n2013-01\n2019-04-22\n2014-01\n2022-05-31\n2022-04-20\n2020-04-16\n2014-02\n2020-01-07\n2023-09-29\n2023-06-30\n2016-05\n2019-09-25\n2016-02\n2017-09-15\n2009-01-16\n2012-05-15\n2009-06\n2016-10-06\n2008-06\n2019-09-19\n1996-01\n2010-04\n2006-11\n2014-01\n2012-09\n2008-02\n2021-03-01\n2018-08-29\n2004-03\n2005-01\n2023-05-23\n2013-10-10\n2002-06\n2014-12\n2020-06-03\n2016-08\n2020-01-17\n2008-09\n2013-04-04\n2011-04\n2014-03-27\n2023-05-15\n2020-10-01\n2017-09-30\n2018-12-01\n2023-02\n2023-09\n2008-03-11\n2006-04\n2023-06-15\n2019-09-30\n2013-05-16\n2018-07-01\n2019-03-13\n2011-06\n2010-11\n2022-05-13\n2001-11-08\n2006-06\n2021-06-01\n2020-08-15\n2012-06-15\n2020-08-17\n2022-07-07\n2021-04-01\n2022-05-10\n2015-05\n2011-11\n2004-02\n2019-09-17\n2017-10-30\n2013-12-23\n2006-05-10\n2007-05\n2020-01-01\n2017-05-20\n2011-02\n2011-09\n2019-07-04\nNone\n2021-12-14\n2021-03-16\nNone\n2023-12-23\n2016-02\n2021-05-14\n2017-02-08\n2016-04\n2015-03-05\nNone\n2012-05\n2022-02-17\n2009-01\n2010-09\n2011-08\n2003-10\n2020-08-01\n2013-03\n2021-01-01\n2001-02\n2006-06\n2010-07\n2015-03-12\n2021-04-22\n2021-08-01\n2018-11-01\n2022-10-26\n2023-02-10\n2013-05\n2022-01-13\n2007-06-11\n2010-09\n2015-08-06\n2018-08-27\n2017-08-06\n2014-12\n1978-12\n2016-10-01\n2017-01-25\n2019-08-14\n2015-05\n2009-09\n2017-11-02\n2019-08-26\n2017-06-27\n2018-04-13\n2020-06-11\n2023-09-21\n2022-01-20\n2015-02-01\n2015-01\n2022-03-28\n2019-10-21\n2017-03-17\n2017-04-03\n2014-11\n2019-05-25\n2010-06\n2022-05-01\n2018-01-03\n2023-01-01\n2020-07-01\n2023-03-01\n2019-03-12\n2018-12-12\n2006-09\n2005-03\n2005-03\n2013-02\n2013-04\n2002-12\n2012-12\n2023-06-20\n2022-05-23\n2003-09\n2009-10\n2005-11\n2018-02-23\n2017-07-05\n2016-01\n2012-07\n2016-02-06\n2019-10-02\n2007-12\n2018-01-01\n2008-12\n2008-09\n2019-08-01\n2019-11-20\n2018-08-10\n2012-05-01\n2022-10\n2024-03\n2022-09-10\n2023-11-10\n2023-01-31\n2005-01\n2002-01\n2017-10-16\n2022-05\n2004-08\n2019-11-14\n2011-03\n2019-04-01\n2022-04-08\n2024-01-01\n2009-03\n2006-05\n2007-07\n2009-06\n2020-01-01\n2024-10-14\n2010-12\n2022-05-16\n2018-06-20\n2017-11-30\n1997-09\n2006-09\n2023-04-19\n2007-12\n2012-03\n2021-11-13\n2019-07-01\nNone\n2023-06-20\n2021-05-01\n2018-01-05\n2018-04-17\n2010-09-01\n2019-01-15\n2013-01-01\n2011-08-01\n2007-09\n1997-09\n2021-07-15\n2013-03\n2020-01-29\n2021-05-15\n2023-01-02\n2021-04-01\n2018-03-01\n2008-09\n2020-09-03\n2008-02\n2020-06-25\n2023-01-03\n2018-01-01\n2003-06\n2006-08\n2007-08\n2017-05-18\n2019-06-04\n2010-02\n2022-04-01\n2022-02-01\n2017-11-09\n2021-11-11\n2021-03-10\n1992-01-29\n2022-03-21\n2007-09-29\n2015-08\n2006-05\n2018-01-01\n2017-10-11\n2022-11-29\n2020-09-28\n2011-03\n2015-12\n2022-03-22\n2023-01-04\n2019-01-01\n2012-09\n2010-08\n2011-10\n2021-01-06\n2019-01-01\n2019-01-01\n2010-11\n2013-10-15\n2016-02-29\n2006-08\n2010-01\n2004-11-01\nNone\n2021-04-14\n2013-02-15\n1997-01-01\n2012-02\n2020-02-20\n2021-01-01\n2020-02-21\n2017-07-24\n2017-05-29\n2006-09\n2006-02\n2007-10\n2018-03-05\n2020-08-24\n2016-01\n2004-08\n2012-12\n2015-01\n1999-01\n2016-12-19\n2014-06\n2020-12-15\n2019-07-24\n2013-05\n2023-08-11\n2012-08\n2023-09-01\n2020-09-30\n2004-02\n1995-11\n2012-02\n2013-02\n2020-12-20\n2006-03-01\n2023-04-11\n2023-09-01\n2019-07-24\n2013-05-16\n2011-09\n2009-03\n2011-08\n2015-02\n2024-03-09\n2022-03-01\n2021-08-01\n2023-06-01\n2018-03-13\n2010-06\n2016-10\n2008-07\n2004-06\n2024-02-01\n1998-09\n2009-05\n2008-09\n2020-07-16\n2021-03-03\n2019-01-15\n2023-08-30\n2019-10-14\n2024-02-15\n2006-01\n2020-07-07\n2021-11-19\n2018-11-01\n2009-02\n2023-02-02\n2021-01-01\n1994-03\n2017-10-01\n2013-06\n2013-08\n2023-11-03\n2000-02\n2014-02\n2009-06\n2012-03\n2022-09-02\n2023-03-15\n2024-01-01\n2004-02\n2017-08-01\n2020-06-04\n2006-04\n2002-11\n2023-11-20\n2011-12\n2016-09\n2020-06-18\n2003-11\n2011-02\n2010-08\n2009-01\n2023-05-04\n2007-03\n2018-01-10\n2011-10\n2021-08-09\n2010-02\n2012-02\n2023-05-24\n2017-01-01\n2017-03-01\n2021-10-10\n2017-06-01\n2020-02-20\n2007-09\n2023-09-27\n2015-02\n2009-04\n2022-01-26\n2022-08-09\n2022-05-24\n2022-06-27\n2003-07\n2022-12-30\n2023-03-20\n2023-11-07\n2020-01-31\n2007-10\n2013-07-03\n2002-12\n2015-05\n2024-03-01\n2012-06\n2023-02-08\n2023-07-01\n2012-02\n2018-04-01\n2024-01-01\n2012-02-20\n2023-11-28\n2022-07-01\n2012-02\n2022-08-20\n2021-10-04\n2021-06-28\n2017-07-11\n2021-01-05\n2016-06\n2008-01\n2021-05-26\n2006-03\n2018-07-01\n2011-01\nNone\n2013-08\n2017-11-14\n2024-12-28\n2019-08-13\n2007-04\n2009-01\n2016-06-23\n2009-03-23\n2007-01\n2010-04\n2006-01\n2020-11-04\n2024-05-01\n2022-04-01\n2011-05\n2021-02-09\n2024-04-11\n2018-12-21\n2014-07\n2009-10\n2004-01\n2010-10\n2005-04\n2004-07\n2008-06\n2014-09\n2009-12\n2019-04-30\n2018-10-08\n2019-08-15\n2020-07-08\n2012-12\n2017-07-01\n2022-07-18\n2019-10-16\n2017-06-24\n2006-01\n2023-01-16\n1998-07\n2020-09-15\n2021-02-01\n2020-01-06\n2011-03\n2015-11\n2023-02\n2018-02-01\n2022-10-01\n2005-07\n2015-09\n2021-09-01\n2015-12\n2022-11-01\n2020-07-16\n2019-02-19\n2007-04\n2007-09\n2013-07\n2021-11-01\n2024-03\n2014-09\n2004-12\n2011-10\n2009-04\n2013-02\n2007-08\n2011-05\n2019-04-12\n2015-04-20\n2023-07-03\n2020-06-03\n2019-02-01\n2008-12\n2012-04\n2009-01\n2009-01\n2014-03\n2017-04-26\n2020-01-01\n2010-06-02\n2020-11-12\n2021-07-27\n2023-02-08\n2016-08\n2009-09\n2011-04\n2006-07\n2006-12\n2013-03-18\n2019-12-31\n2015-10\n2023-03-15\n2021-11-30\n2003-06\n2014-05\n2019-11\n2017-07-28\n2020-01-20\n2014-04\n2022-05-17\n2012-12\n2010-01\n2016-09-01\n2021-01\n2022-10-01\n2012-03\n2024-03\n2018-12-01\n2012-02\n2013-06\n2018-06-07\n2005-07\n2016-04\n2023-01-02\n2020-01-30\n2018-10-23\n2023-01-16\n2010-03\n2023-05-02\n2022-07-01\n2022-09\n2018-01-01\n2022-02-10\n2017-10-18\n2018-04-01\n2019-12-04\n2013-05\n2013-08\n2024-02\n2013-01-01\n2019-03-01\n2001-07\n2013-04\n2020-04-20\n2008-05\n2009-06\n2018-06-25\n2009-02\n2020-04-01\n2016-03\n2019-06-01\n2014-03-06\n2012-09\n2008-01\n2018-06-21\n2016-10\n2020-04-10\n2019-04-16\n2020-04-01\n2020-10-01\n2017-08-14\n2016-09\n2017-09-06\n2010-11\n2019-08-16\n2018-02-01\n2021-08-01\n2015-03\n2018-05-16\n2015-07\n2016-12\n2018-11-14\n2021-08-15\n2017-10-06\n2015-01\n2020-07-14\n2019-12-11\n2023-03-13\n2011-01\n2024-05-31\n2021-02-11\n2023-04-05\n2014-05\n2013-03\n2023-08-04\n2021-04-01\n2016-01-01\n2003-06\n2016-01\n2009-07\n2016-01\n2011-01\n2020-07-21\n2023-12-01\n2016-11\n2022-03-01\n2010-04\n2017-02-06\n2023-08-09\n2013-02\n2016-05\n2009-01\n2010-01\n2021-07-25\n2014-11\n2008-08\n2021-03-01\n2010-10\n2019-06-01\n2005-08\n2012-06\n2017-07-05\nNone\n2023-12-19\n2020-09-29\n2006-04\n2020-03-03\n2010-05\n2018-11-01\n2009-10\n2007-03\n2013-02-25\n2016-12\n2010-11\n2011-09\n2018-09-03\n2013-07\n2009-03\n2021-07-15\n2021-01-01\n2023-04-03\n2018-12-21\n2023-05-05\n2011-11\n2008-06\n2023-02-28\n2024-05-01\n2023-04-24\n2022-05-19\n2022-07-07\n2015-06-01\n2008-01\n2023-06-01\n2003-07\n2013-10\n2020-12-01\n2010-03\n2018-07\n2016-10-01\n2020-03-06\n2019-12-01\n2014-09\n2024-01\n2019-09-04\n2015-10-26\n2013-01\n2015-09-22\n2007-03\n2021-09-01\n2020-03-20\n2011-09\n2019-02-19\n2021-09-24\n2018-10-11\n2009-06\n2012-08\nNone\n2008-12\n2004-07\n2018-11-22\n2016-10\n2013-04-02\n2010-07\n2022-02-15\n2006-05\n2008-01\n2023-12-19\n2020-07-15\n2017-09-09\n2003-04\n2021-08-20\n2019-04-03\n2007-02\n2012-10\n2009-01-01\n2018-12-12\n2015-07\n2012-08-15\n2003-09\n2017-11-01\n2005-01\n2006-06\n2010-01\n2020-01-15\n2020-12-09\n2015-08-01\n2017-08-29\n2003-04\n2024-01-01\n2014-04\n2023-11-24\n2020-02-20\n2022-09-01\n2013-02\n2011-12\n2020-07-30\n2019-11-12\n2016-05\n2012-10\n2013-07\n2016-07\n2013-06\n2015-04\n2022-10-01\n2018-07-10\n2021-02-11\n2019-02-28\n2011-10\n2023-12-30\n2024-01-02\n2004-09\n2001-05\n2010-07\n2022-01-01\n2006-01\n2011-09\n2003-02\n2022-12-31\n2004-03\n2004-06\n1973-01-01\n2017-11-20\n2012-01\n2010-08\n2002-10\n2015-06\n2002-09\n2022-12-15\n2021-01-01\n2015-10\n2020-03-02\n2011-12\n2021-08-10\n2018-09-10\n2006-01\n2016-07-01\n2021-02-05\n1999-01\n2021-06-16\n2023-01-01\n2020-09-12\n2019-10-11\n2018-09-01\n2010-12\n2003-04\n2008-11\n2010-11\n2012-03\n2019-03-11\n2022-01-01\n2019-03-06\n2008-12\n2020-08-11\n2014-03\n2021-01-30\n2000-12\n2012-02-01\n2019-09-06\n2016-10-11\n2015-11\n2020-07-10\n2019-11-29\n2009-06\n2021-10-26\n2021-01-07\n2017-01-01\n2022-05-10\n2022-03-23\n2015-01\n2004-10\n2016-01-29\n2012-08\n2021-04-09\n2013-12\n2022-10-27\n2017-12-01\n2007-05\n2015-05-01\n2011-07\n2020-02-01\n2019-02-21\n2024-01-01\n2004-10\n2012-06-19\n2013-04-01\n2021-05-18\n2023-10-03\n2020-12-02\n2019-07-01\n2018-04-03\n2022-06-01\n2019-11-11\n2011-09\n2022-02-28\n2017-08-23\n2004-09\n2000-11\n2001-08\n2020-09-24\n2022-02-06\n2014-11-01\n2014-09\n2021-12-20\n2014-01\n2011-12\n2011-01\n2021-06-02\n2016-04\n2006-10\n2019-01-01\n2021-05-17\n2022-10-05\n2011-01\n2020-03-06\nNone\n2023-07-01\n2011-11\n2012-09\n2019-09-16\n2011-07\n2016-07\n2023-01-01\n2021-11-05\n2019-07-01\n2017-12-20\n2016-07-01\n2016-09\n2018-12-02\n2011-10\n2020-10-09\n2019-05-06\n2006-01\n2019-06-18\n2009-08\n2019-11-15\n2007-11\n2016-01\n2020-06-22\n2024-01-01\n2023-11-01\n2016-03\n2015-02-01\n2022-03-01\n2009-06\n2021-11-17\n2018-04-20\n2018-12-13\nNone\n2019-05-06\n2013-09\n2014-11\n2007-04\n2019-05-30\n2014-01\n2010-12\n2018-02-01\n2015-03\n2009-07\n2023-08-01\n2010-07-19\n2018-01-31\n2016-02-10\n2015-04-01\n2011-11\n2023-01-06\n2021-06-07\n2019-12-10\n2023-02-20\n2001-05\n2009-01\n2016-01\n2022-02-18\n2015-05-27\n2008-06\n2019-04-08\n2023-06-20\n2017-11-15\n2020-08-24\n2019-11-13\n2022-03-01\n2022-05-16\n2011-09\n2016-12\n2008-04\n2019-03-19\n2017-03\n2018-01\n2023-02-21\nNone\n2019-07-25\n2004-01\n2022-09-30\n2008-10\n2007-05\n2011-09\n2020-02-27\n2007-11\n2014-10\n2011-12\n2023-09-25\n2023-12-18\n2012-07\n2020-10-23\n2022-09-05\n2021-07-12\n2014-11-18\n2006-01\n2004-10\n2021-08-21\n1999-08\n2015-06\n2023-11-29\n2015-09\n2005-12\n2020-05-01\n2020-08-05\n2020-03-03\n2019-11-08\n2020-08-01\n2022-09-01\n2019-08-27\n2016-02\n2017-01-09\n2010-02\n2017-04\n2014-11\n2009-12-10\n2004-09\n2017-04-06\n2013-11\n2021-03-01\n2008-10\n2013-05\n2013-09\n2018-10-23\n2010-05\n2024-02-01\n2009-01\n2008-06-10\n2012-11\n2014-08\n2019-10-01\n2022-11-28\n2018-12-18\n2019-11-11\n2023-08-31\n2010-08\n2010-08\n2005-06\n2014-11\n2018-10-29\n2015-08\n2018-11-28\n2019-06-15\n2020-08-31\n2020-01-21\n2012-03\n2019-04-01\n2014-01\n2011-09\n2007-06\n2007-07\n2018-07-01\n2011-02\n2013-01-08\n2022-12-31\n2022-03-03\n2013-11-08\n2009-05\n2019-03-15\n2021-05\n2009-05-05\n2024-02-01\n2005-01\n2013-06\n2023-07-05\n2018-03-16\n2012-08\n1991-07\n2020-09-01\n2009-11\n2011-07\nNone\n2012-01\n2023-03-01\n2009-07-01\n2020-06-01\n2015-08-19\n2022-01-07\n2013-09\n2006-01\n2018-01\n2019-09-09\n2014-11-04\n2024-12\n2006-12-07\n2023-09\n2009-11\n2013-02\n2016-06\n2023-03-15\n2011-07\n2016-11-04\n2019-08-27\n2023-09-04\n2018-09-03\n2018-10-25\n2021-01-26\n2006-08\n2010-03\n2021-10-27\n2022-01-19\n2018-10-27\n2005-07\n2010-01-01\n2021-10-20\n2024-01-01\n2014-12\n2004-11\n2010-02\n2008-08\n2018-11-26\n2012-02\n2014-01\n2020-03-10\n2022-09-01\n2008-02\n2008-09\n2012-01\n2020-08-01\n2007-05\n2005-02\n2020-12-01\n2018-11-01\n2012-12\n2018-06-06\n2022-11-07\n2010-08\n2021-07-21\n2019-03-29\n2015-11-23\n2010-06\n2016-04\n2016-09-30\n2014-01-01\n2012-07\n2021-03-01\n2018-09-12\n2017-04-25\n2007-12-01\n2015-03\n2021-06-01\n2007-11\n2016-02-01\n2021-11-24\n2021-03-14\n2023-09-26\n2008-08\n2010-04\n2020-05-21\n2019-12-13\n2020-02-05\n2019-06-02\n2019-05-01\n2018-04-27\n2020-04-09\n2018-06-14\n2019-02-12\n2014-10-27\n2024-01-31\n2023-01-01\n2012-01\n2019-01-01\n2004-07\n2022-08-24\n2014-06\n2013-06-07\n2019-07-30\n2011-06\n2021-12-15\n2017-12-19\n2009-01\n2015-12-21\n2008-11-10\n2019-05-22\n2020-09-12\n2022-04-27\n2016-10-14\n2022-04-01\n2016-04\n2009-10\n2017-06-13\n2019-12-15\n2022-02-18\n2014-11\n2021-03-08\n2015-10-30\n2015-03\n2013-09-01\n2021-03-08\n2007-01\n2016-12-01\n2023-02-01\n2011-03\n2008-11\n2007-06\n2023-01-01\n2021-10-18\n2009-12\n2016-11-22\n2023-12-18\n2009-09\n2021-06-01\n2021-03-01\n2011-07\n2004-09\n2022-01-01\n2020-08-01\n2008-04\n2018-04-03\n2007-10-15\n2014-10\n2016-09-10\n2019-06-29\n2004-10\n2020-01-29\n2017-04\n2011-04\n2010-01\n2018-08-14\n2014-03\n2021-08-26\n2017-11-25\n2015-11-01\n2022-02-25\n2002-01\n2023-10-15\n2019-02-01\n2007-03\n2023-11-27\n2020-07\n2009-03\n2014-10-10\n2013-08\n2017-07-24\n2017-01\n2006-06\n2024-03-16\n2021-06-30\n2021-02-17\n2007-09\n2006-07\n2024-02\n2022-03-31\n2017-09-26\n2022-12-07\n2004-02\n2002-07\n2016-04-01\n2018-10-15\n2020-03-24\n2017-12-12\n2011-07\n2023-01-10\n2024-03-31\n2021-05-04\n2016-01\n2015-04\n2016-09\n2007-10\n2018-11-28\n2020-12-11\n2021-08-28\n2011-03\n2017-03-06\n2006-04\n2021-01-06\n2013-08\n2006-06\n2023-07-20\n2021-09-01\n2020-12-11\n2012-11\n2021-08-01\n2019-08-27\n2012-06\n2021-10-25\n2015-09\n1995-07\n1999-04\n2022-06-23\n2023-09-21\n2008-01\n2018-08-21\n2019-03-21\n2013-01\n2017-12-01\n2008-10\n2023-12-12\n2019-11-01\n2011-03-31\n2004-06\n2021-06-30\n2017-02-01\n2013-04\n1998-05-01\n2015-05\n2018-08-21\n2011-01-01\n2023-06-20\n2011-07\n2021-04-19\n2020-02-01\n2003-09\n2016-02-24\n2007-06\n2020-02-05\n2010-10\n2021-09-01\n2014-07\n2011-08-30\n2009-06-03\n2022-05-25\n2013-07\n2012-03\n2011-10\n2017-10\n2012-09\n2009-03-11\n2007-06\n2018-08-16\n2015-12\n2023-12-26\n2000-11\n2022-03-19\n2009-11\n2005-08-04\n2012-09-18\n2011-11\n2022-06-13\n2023-11-01\n2007-03\n2014-11\n2024-01\n2013-03\n2023-01-01\n2023-02-05\n2023-05-01\n2007-08\n2012-09\n2022-03-09\n2018-12-04\n1997-08\n2023-03-01\n2006-12\n2013-11\n2017-10-31\n2013-11\n2012-07-01\n2005-08\n2019-09-05\n2018-01-17\n2021-03-01\n2017-07-20\n2019-01-15\n2017-10-01\n2023-02-06\n2017-04-12\n2017-01-11\n2021-04-19\n2021-07-15\n2024-02-28\n2009-08\n2019-01-28\n2006-11-01\n2013-04\n2013-12\n2023-04-13\n2014-02\n2023-01-01\n2008-07\n2004-03\n2021-04-22\n2019-07-31\n2022-02-01\n2003-01\n2023-05-18\n2013-10\n2020-06-09\n1997-08\n2001-02\n2021-05-01\n2011-06\n2008-12\n2021-12-16\n2022-11-17\n2019-01-10\n2012-04\n2005-08\n2020-01-01\n1996-12\n2020-10-01\n2020-08-08\n2011-06\n2013-02\n2020-06-10\n2021-05-10\n2013-02-25\n2011-01\n2013-05\n2010-11\n2018-07-17\n2023-09-01\n2013-08\n2014-07\n2021-12-02\n2017-06-27\n2016-05\n2010-03\n2013-06\n2021-03-15\n2014-04\n2021-07-30\n2009-04\n2018-10-05\n2003-07\n2012-07-26\n2017-02-15\n2009-11\n2010-06\nNone\n2016-06\n2020-02-19\n2022-06-15\n2008-10\n2014-06\n2024-01-01\n2014-03-27\n2015-01\n2006-02\n2014-01\n2016-09\n2010-09\n2011-07\n2022-12-16\n2013-07-01\n2001-08\n2007-04\n2022-06-29\nNone\n1993-01\n2015-09\n2011-05\n2020-06\n2009-12\n2016-08-16\n2009-09\n2014-09\n2004-01\n2019-06-27\n2014-10\n2013-07\n2023-05-24\n2012-04\n2022-11-01\n2007-01\n2021-05-27\n2023-11-10\n2004-06\n2012-11\n2023-07-01\n2017-09-01\n2022-07-12\n2014-08-14\n2009-03\n2010-03-01\n2014-11\n2021-03-24\n2024-06-03\n2020-06-29\n2019-12-23\n2005-12\n2018-07-01\n2010-04\n2010-08\n2010-07\n2016-07\n2020-04-15\n1999-04\n2009-06\n2006-04\n2021-01-18\n2008-07\n2015-07\n2016-12-08\n2005-11\n2017-04-24\n2022-05-30\n2007-04\n2015-09\n2019-07-08\n2009-01\n2023-04-01\n2010-03\n2016-09-29\n2020-11-11\n2011-10\n2019-09-01\n2012-12\n2017-02-27\n2003-04\n2023-01-31\n2019-08-06\n2008-05\n2022-12-11\n2022-12-01\n2013-02\n2022-11-01\n2013-04-23\n2013-05\n2020-04-01\n2023-11-17\n2020-06-19\n2010-05\n2016-02\n2010-03\n2019-07-01\n2015-02\n2011-01\n2018-05-03\n2020-06-04\n2024-05-02\n2013-01\n2016-01\n2021-04-09\n2020-10-23\n2019-05-28\n2009-07\n2012-03\n2012-10-29\n2019-02-14\n2017-03-23\n2015-10\n2021-01-04\n2016-09\n2022-03-01\n2022-03-01\n2008-10\n2013-11\n2018-01-01\n2012-01\n2022-04-24\n2020-09-02\n2009-03-11\n2021-09-06\n2023-10-30\n2005-03\n2016-07-05\n2020-10-13\n2020-09-11\n2018-04-12\n2021-12-10\n2017-01-01\n2024-02-01\n2021-01-18\n2011-05-26\n2024-01-19\n2017-05-15\n2007-08\n2021-12-13\n2022-12-22\n2014-04\n2014-11\n2019-11-14\n2010-07\n2018-11-01\n2015-05\n2006-12\n2019-10-07\n2009-04\n2020-06\n1999-10\n2023-02-01\n2013-06\n2000-08\n2020-07-15\n2017-04-17\n2013-08\n2021-06-22\n2023-08-16\n2017-02-23\n2017-06-20\n2023-12-11\n2015-02\n2020-10-19\n2019-08-19\n1994-12\n2023-03-27\n2014-09\n2014-05\n2015-11-03\n2023-02-01\n2021-09-30\n2018-02-22\n2020-09-02\n2016-03\n2021-06-01\n2023-03-09\n2005-01\n2021-02-15\n2008-12-09\n2016-05-01\n2023-02-13\n2017-03-01\n2015-05\n2019-03-01\n2022-12-14\n2020-09-01\n2012-11\n2009-11\n2021-10-12\n2013-03\n2006-01\n2014-09-23\n2022-02-28\n2004-07\n2020-12-01\n2023-05\n2023-11-02\n2015-04-15\n2023-06-02\n2017-04-01\n2022-03-01\n2014-02\n2012-02\n2024-01-01\n2016-10\n2021-09-30\n2016-04\n2023-10\n2016-06-16\n2017-08-20\n2014-11\n2019-02-01\n2019-11-11\n2015-05\n2016-06-14\n2022-01-01\n2015-08-24\n2007-10\n2016-10-01\n2015-07-29\n2008-11-07\n2001-02\n2002-01-01\n2018-06-19\n2010-11\n2015-01-31\n2002-08\n2012-01\n2019-09-26\n2015-08\n2014-09\n2016-08\n2006-01\n2005-09\n2017-04\n2019-05-31\n2015-03-28\n2019-07-01\n2013-11-20\n2018-06-19\n2012-01\n2016-01\n2005-11\n2010-04\n2023-01\n2007-10\n2006-06\n2023-10-05\n2005-01-01\n2012-03-01\n2011-08\n2012-10\n2006-11\n2021-09-01\n2021-02\n2012-01\n2020-06-01\n2023-08-04\n2024-01-20\n2004-05\n2021-03-08\n2007-08\n2023-02-27\n2022-06-01\n2023-09-01\n2014-01-29\n2010-09\n2021-07-14\n2020-05-21\n2015-10\n2015-05-28\n2007-03\n2016-07-19\n2015-06\n2023-11-03\n2022-01-24\n2014-03\n2008-04\n2023-02-01\n2022-06-03\n2021-09-10\n2001-12\n2007-09\n2009-10\n2016-03\n2008-02\n2002-05\n2024-02-18\n2013-10\n2023-03-01\n2023-11-01\n2006-01\n2023-02-04\n2018-10-11\n2009-06-15\n2018-06-25\n2010-06\n2017-06\n2014-12\n2021-03-01\n2009-02\nNone\n2023-03-01\n2017-06-27\n2014-04\n2021-10-07\n2019-09-15\n2018-03-29\n2021-06-01\n2021-02-16\n2008-08\n2023-10-01\n2014-12\n2022-06-28\n2011-03\n2017-04-04\n2014-02\n2017-01-25\n2023-12-01\n2017-06-26\n2018-10-31\n2024-01-01\n2017-01\n2023-06-09\n2022-06-01\n2022-02-17\n2019-09-19\n2018-06-10\n2022-02-09\n2014-02\n2019-06\n2018-03-22\n2020-04-01\n2009-05\n2017-11-26\n2014-08\n2014-12\n2022-05-29\n2023-05-01\n2022-07-30\n2023-05-17\n2019-05-13\n2009-06\n2007-10\n2001-01-01\n2018-11-20\n2007-03\n2023-07\n2011-01\n2015-08-24\n2014-12\n2003-02\n2018-02-01\n2021-01-25\n2003-03\n2020-09-29\n2015-08\n2024-03-01\n2022-06-16\n2003-04\n2016-06\n2023-08\n2015-08-04\nNone\n2020-10-06\n2020-04-01\n2017-02-21\n2023-10-10\n2019-01-10\n2018-05-07\n2013-08\n2008-04\n2018-04-01\n2018-08-02\n2013-08\n2019-09-18\n2019-12-09\n2017-06-22\n2019-12-01\n2021-07-02\n2022-03-03\n2020-09-02\n2008-12\n2020-07-29\n2017-08-07\n2020-07-06\n2011-07\n2023-03-22\n2016-08\n2017-01-01\n2018-03-10\n2022-10-15\n2013-11-01\n2017-10-27\n2015-12-30\n2018-12-01\n2011-08\n2021-02-05\n2006-08\n2008-01-01\n2003-09\n2020-04-04\n2017-04-06\n2003-05\n2021-11-22\n2018-07-09\n2015-09\n2020-12-01\n2018-06-01\n2009-06\n2008-04-24\n2010-02\n2006-04\n2004-06\n2006-06\n2023-09-05\n2008-02\n2020-11-22\n2022-01-24\n2015-11\n2021-06-15\n2021-10-04\n2019-09-09\n2019-07-03\n2017-10-02\n2016-10-01\n2021-01-07\n2006-04\n2014-02\n2006-08\n2010-03\n2015-04\n2021-05-03\n2013-06\n2009-05\n2022-06-15\n2006-04-06\n2018-04-19\n2022-03-14\n2023-01-01\n2021-02\n2021-12-15\n2007-08\n2007-01\n2023-02-01\n2010-06-17\n2022-10-30\n2013-09\n2023-06-07\n2010-11\nNone\n2002-06\n2009-11\n2002-09\n2015-06-19\n2013-05\n2012-10\n2005-01\n2022-05-31\n2011-03\n2014-06\n2022-11-27\n2016-06-13\n2020-11-05\n2017-01-01\n2018-08-07\n2016-09\n2022-06-01\n2018-12-10\n2013-08\n2012-08\n2023-11\n2016-06-15\n2013-10\n2023-05-15\n2005-02\n2023-07-12\n2022-01-01\n2014-10-23\n2019-08-29\n2003-01\n2008-08\n2017-05-04\n2021-10-11\n2021-07-01\n2011-11-28\n2021-05-22\n2024-02\nNone\n2023-05-22\n2021-04-01\n2020-06-02\n2016-04-04\n1997-02\n2008-04\n2018-12-06\n2021-03-02\n2017-02-01\n2015-02\n2011-12\n2017-09-13\n2018-11-27\n2022-09-23\n2013-05-13\n2019-07-05\n2020-12-01\n2021-12-21\n2015-09-01\n2014-03\n2022-10-19\n2021-08-19\n2020-04\n2017-01-05\n2017-07-01\n2010-01\n2013-02-25\n2014-08\n2010-03\n2013-10-23\n2010-06\n2018-09\n2021-06-15\n2019-11-25\n2006-12\n2014-09\n2015-05\n2017-10-01\n2016-09\n2003-06-11\n2016-10\n2020-01-19\n2007-02\n2019-08-31\n2021-12-01\n2014-11-25\n2012-05\n2015-02-17\n2010-08\n2014-05-19\n2017-03-01\nNone\n2020-01-28\n2018-12-15\n2017-10-06\n2019-03-21\n2019-03-20\n2010-04\n2022-11-21\n2023-07-07\n2022-09-26\n2013-08-01\n2021-12-10\n2021-12-17\n2020-09-21\n2019-09-23\n2022-04-14\n2013-08\n2010-07\n2012-10-28\n2010-04\n2015-03\n2011-02\n2011-12\n2022-05-01\n2010-09\n2023-05-01\n2015-05\n2006-10\n2012-08\n2004-08\n2021-11-17\n2011-03-09\n2023-10-25\n2015-10-20\n2019-06-12\n2015-06\n2018-06-20\n2007-09\n2019-01-01\n2015-07\n2014-05-06\n2019-03-20\n2014-09\n2010-01\n2023-11-01\n2020-12-07\n2010-05\n2017-10-28\n2022-03-01\n2015-12\n2017-08-24\n2020-02-10\n2021-03-23\n2010-05\n2004-01\n2013-04\n2014-04\n2022-04\n2022-05-17\n2012-11\n2006-12\n2020-09-01\n2018-02-23\n2009-05\n2018-05-15\n2023-01-15\n2006-04\n2022-01-18\n2015-07\n2021-12-01\n2014-01\n2013-10\n2012-07\n2014-07\n2020-09\n1998-07\n2016-01-21\n2010-09\n2001-09\n2011-11-01\n2013-11\n2007-09\n2016-05\n2020-08-01\n2023-02\n2007-04\n2022-01-01\n2002-11\n2014-03\n2023-12\n2017-03-20\n2012-01-01\n2015-11-19\n2016-03\n2016-08-11\n2003-07\n2012-03\n2017-02-07\n2021-06-07\n2021-08-01\n2014-09-03\n2019-03-20\n2017-05-08\n2022-12-01\n2016-01-26\n2022-06-04\n2020-08-20\n2009-02\n2018-06-19\n2019-04-30\n2019-03-01\n2006-04\n2013-04\n2012-11-01\n2009-02\n2023-12-04\n2014-08\n2021-01-28\n2018-11-02\n2003-06-26\n2022-12-12\n2015-12-01\n2015-03\n2019-05-15\n2022-05-24\n2020-08-08\n2011-10\n2018-07-22\n2021-02-19\n2024-01-05\n2007-05\n2023-07-22\n2007-05\n2013-09\n1996-08-26\n2010-09\n2022-07-29\n2006-02\n2011-09\n2021-03-15\n2010-08-31\n2012-01\n2007-01\n2021-10-23\n2019-04-11\n2011-03\n2016-01\n2008-01\n2014-05\n2015-01\n2020-01-11\n2019-09-16\n1999-10\n2013-10\n2014-03\n2019-12-10\n2006-03\n2017-02\n2017-07-21\n2017-12-20\n2013-11\n1997-02\n2010-02\n2008-12\n2017-02-23\n2018-09-17\n2022-11-01\n2016-11\n2023-11-01\n2021-01-22\n2013-03\n2021-09-24\n2021-04-01\n2008-12\n2017-04-01\n2008-11\n2009-03\n2022-04-22\n2004-04\n2024-03\n2019-09\n2019-10-15\n2010-09\n2021-04-01\n2023-03-07\n2015-08\n2016-12-30\n2018-07-02\n2021-03-01\n2006-11\n2005-11\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"start\" column from each row of the dataset filtered_rdd_with_header\n",
    "start = filtered_rdd_with_header.map(lambda row: row[12] if len(row) > 12 else None)\n",
    "\n",
    "# Display the ninth column values\n",
    "for value in start.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f22d08a7-be42-41d9-ae26-90101fb78fb1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Start column containing only none values):\n['NCT00416871', 'Interleukin-2 and Interferon in Treating Patients With Metastatic Kidney Cancer', None, 'COMPLETED', 'Kidney Cancer', 'BIOLOGICAL: aldesleukin|BIOLOGICAL: recombinant interferon alfa', 'Centre Leon Berard', None, '220.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '2006-02']\n['NCT01637571', 'Dexilant Treatment in Gastrointestinal Reflux Disease (GERD Related Non Cardiac Chest Pain', 'Dexilant', 'WITHDRAWN', 'Chest Pain|Gastrointestinal Reflux Disease', 'DRUG: Dexilant|DRUG: Dexilant Placebo', 'University of Iowa', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', None, None]\n['NCT00021671', 'Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission', None, 'COMPLETED', 'HIV Infections', 'DRUG: Erythromycin|DRUG: Nevirapine|DRUG: Ampicillin sodium|DRUG: Metronidazole', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'National Institute of Mental Health (NIMH)|National Institute on Drug Abuse (NIDA)', '3720.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2004-11']\n['NCT00172471', 'The Relationship Between Sleep Disorders and Cytokine Levels Among Hemodialysis and Peritoneal Dialysis Patients', None, 'COMPLETED', 'Renal Failure|Sleep Disorder|Hemodialysis|Peritoneal Dialysis', None, 'National Taiwan University Hospital', None, None, 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, None]\n['NCT00597571', '[Trial of device that is not approved or cleared by the U.S. FDA]', None, 'WITHHELD', None, None, '[Redacted]', None, None, None, None, None, None, None]\n['NCT00511771', 'A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic Constipation', None, 'NO_LONGER_AVAILABLE', 'Irritable Bowel Syndrome With Constipation|Chronic Idiopathic Constipation', 'DRUG: Tegaserod', 'Novartis', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT00001071', 'A Study of Stem Cells and Filgrastim', None, 'COMPLETED', 'HIV Infections', 'DRUG: Filgrastim', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '24.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1998-10']\n['NCT00002271', \"An Ascending Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects\", None, 'COMPLETED', 'HIV Infections', 'DRUG: Alovudine', 'Lederle Laboratories', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT04146571', 'Expanded Access to Ensartinib for Participants With ALK+ NSCLC', None, 'AVAILABLE', 'Non-Small Cell Lung Cancer|ALK Gene Rearrangement Positive', 'DRUG: Ensartinib', 'Xcovery Holdings Inc.', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT01454271', 'Follow up Study of Patients Undergoing Total Hip Arthroplasty CERAFIT® Grafted With Poly Sodium Styrene Sulfonate', None, 'WITHDRAWN', 'Hip Arthroplasty Replacement', 'PROCEDURE: Total Hip Arthroplasty Replacement', 'Laboratoire Ceraver-Osteal', None, '0.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION', None, None]\n['NCT02833571', '[Trial of device that is not approved or cleared by the U.S. FDA]', None, 'WITHHELD', None, None, '[Redacted]', None, None, None, None, None, None, None]\n['NCT00259571', 'Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.', None, 'WITHDRAWN', 'Ulcerative Colitis', 'DRUG: retarded release phosphatidylcholine', 'Heidelberg University', 'Dietmar Hopp Stiftung', '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2010-03']\n['NCT04498871', 'MAP to Provide Access to Nilotinib for Patients With HES', None, 'NO_LONGER_AVAILABLE', 'Hypereosinophilic Syndrome (HES)', 'DRUG: Nilotinib', 'Novartis Pharmaceuticals', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT00002171', 'A Study of Viracept in HIV-Positive Women', None, 'COMPLETED', 'HIV Infections', 'DRUG: Nelfinavir mesylate', 'Agouron Pharmaceuticals', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT00000871', 'A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1|BIOLOGICAL: MN rgp120/HIV-1 and A244 rgp120/HIV-1|BIOLOGICAL: ALVAC-HIV MN120TMG (vCP205)|BIOLOGICAL: rgp120/HIV-1 SF-2', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '420.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2000-01']\n['NCT02474771', '[Trial of device that is not approved or cleared by the U.S. FDA]', None, 'WITHHELD', None, None, '[Redacted]', None, None, None, None, None, None, None]\n['NCT00496171', 'Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers', None, 'TERMINATED', 'Healthy', None, 'Photocure', None, None, 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, None]\n['NCT01367171', '[Trial of device that is not approved or cleared by the U.S. FDA]', None, 'WITHHELD', None, None, '[Redacted]', None, None, None, None, None, None, None]\n['NCT00051571', 'Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma', None, 'COMPLETED', 'Carcinoma Non-Small-Cell Lung', 'DRUG: SGN-15|DRUG: Docetaxel', 'Seagen Inc.', None, '60.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2003-10']\n['NCT00000771', 'A Double-Blind Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3', None, 'COMPLETED', 'Cryptosporidiosis|HIV Infections', 'DRUG: Paromomycin sulfate', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '68.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT', None, '1996-09']\n['NCT03412539', 'Mechanism of Effectiveness of Neurosurgery Treatments for Durable Pain', None, 'AVAILABLE', 'Oncology Problem', None, 'Tel-Aviv Sourasky Medical Center', 'University of Haifa', None, 'OTHER_GOV', 'EXPANDED_ACCESS', None, None, None]\n['NCT05959239', 'TB006 Expanded Access (EA) Compassionate Use', None, 'AVAILABLE', 'Alzheimer Disease', 'DRUG: TB006', 'TrueBinding Inc.', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT00716339', 'Pseudophakic Accommodation', None, 'COMPLETED', 'Cataract', 'BEHAVIORAL: motivation', 'Medical University of Vienna', None, '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT00013039', 'Computerized Guidelines Enhanced by Symptoms and History: Clinical Effects', None, 'COMPLETED', 'Heart Failure', 'BEHAVIORAL: Computer reminders', 'US Department of Veterans Affairs', None, '1000.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ', None, '2001-02']\n['NCT00000739', 'Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection', None, 'COMPLETED', 'Pneumonia Pneumocystis Carinii|HIV Infections', 'DRUG: Dapsone', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Jacobus Pharmaceutical', '96.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT', None, '1998-06']\n['NCT00035139', 'Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery', None, 'COMPLETED', 'Brain Injuries', 'DRUG: methylphenidate', 'National Center for Research Resources (NCRR)', 'Murray Fellowship', None, 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT02271139', 'Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosine Kinase Inhibitor Therapy', None, 'NO_LONGER_AVAILABLE', 'Non-Small Cell Lung Cancer', 'DRUG: Alectinib', 'Genentech Inc.', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT00120939', 'Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer', None, 'COMPLETED', 'Breast Neoplasms|Ovarian Neoplasms|Prostatic Neoplasms|Lung Neoplasms|Gastrointestinal Neoplasms', 'DRUG: Motexafin Gadolinium', 'Pharmacyclics LLC.', None, '25.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', None, None]\n['NCT00526539', 'Is There Increased Polyethylene Wear and Increased Periprosthetic Bone Loss in Femur in Reverse Hybrid Technique Compared With Conventional Cemented Technique in Total Hip Replacement?', None, 'COMPLETED', 'Osteoarthritis', 'OTHER: Total hip replacement Spectron and Taperloc', 'Ullevaal University Hospital', None, None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE', None, None]\n['NCT01076439', 'An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo', None, 'WITHDRAWN', 'Allergic Rhinitis', 'DRUG: Fluticasone Furoate Nasal Spray|DRUG: Olopatadine Nasal Spray|DRUG: Saline Nasal Spray', 'ORA Inc.', None, '0.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', None, None]\n['NCT03529539', 'Expanded Access for PSV Personalized Oncolytic Viruses', 'PSV', 'NO_LONGER_AVAILABLE', 'Cancer', 'DRUG: PSV', 'EpicentRx Inc.', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT00269139', 'Outcome of Crisis Intervention for Subjects With Borderline Personality Disorder or Post-Traumatic Stress Disorder', None, 'UNKNOWN', 'Borderline Personality Disorder|Post-Traumatic Stress Disorders', 'BEHAVIORAL: Crisis resolution', 'Laddis Andreas M.D.', None, '40.0', 'INDIV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, None]\n['NCT00001039', 'Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients', None, 'COMPLETED', 'Mycobacterium Avium-intracellulare Infection|HIV Infections', 'DRUG: Ethambutol hydrochloride|DRUG: Clarithromycin', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '24.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '2002-06']\n['NCT00000839', 'A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women', None, 'COMPLETED', 'HIV Infections|Pregnancy', 'DRUG: Didanosine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Bristol-Myers Squibb', '12.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2001-06']\n['NCT00002439', \"A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Alitretinoin', 'Anderson Clinical Research', 'Ligand Pharmaceuticals', None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT04206839', '[Trial of device that is not approved or cleared by the U.S. FDA]', None, 'WITHHELD', None, None, '[Redacted]', None, None, None, None, None, None, None]\n['NCT00310739', 'Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury', None, 'UNKNOWN', 'Kidney Failure', None, 'Hamamatsu University', None, None, 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, None]\n['NCT05463939', 'Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma Patients', None, 'APPROVED_FOR_MARKETING', 'Relapsed or Refractory Multiple Myeloma', 'DRUG: Teclistamab', 'Janssen Research & Development LLC', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT00293839', 'Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder', None, 'COMPLETED', 'Urinary Incontinence', 'DRUG: oxybutynin chloride', 'Alza Corporation DE USA', None, '790.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2002-12']\n['NCT00133939', 'Proportional Ventilation and Ventilatory Synchronism', None, 'UNKNOWN', 'Mechanical Ventilation', 'PROCEDURE: Mechanical ventilation', 'Hospices Civils de Lyon', None, '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', None, None]\n['NCT00002139', 'Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.', None, 'COMPLETED', 'Bacterial Infections|HIV Infections', 'DRUG: Azithromycin', 'Pfizer', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, None]\n['NCT00360139', 'Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by Lipoatrophy', None, 'WITHDRAWN', 'Lipodystrophy|Emaciation', 'DEVICE: Sculptra Injection', 'Dermatology Cosmetic Laser Medical Associates of La Jolla Inc.', 'Sanofi', '15.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', None, '2008-12']\n['NCT00245739', 'TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.', None, 'APPROVED_FOR_MARKETING', 'HIV Infections', 'DRUG: TMC-114', 'Tibotec Pharmaceuticals Ireland', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT00006439', 'Effects of Home Visits on Medication Adherence in Children and Youth With HIV', None, 'UNKNOWN', 'HIV Infections', 'BEHAVIORAL: Counseling in the home', 'National Center for Research Resources (NCRR)', None, None, 'NIH', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: |Primary Purpose: ECT', None, None]\n['NCT00002039', 'An Open Study of Foscarnet Treatment First Episode CMV-Retinitis in AIDS Patients', None, 'COMPLETED', 'Cytomegalovirus Retinitis|HIV Infections', 'DRUG: Foscarnet sodium', 'Astra USA', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT00451139', 'Ototoxicity of Artemether / Lumefantrine (Coartem) and Other Antimalarials', None, 'COMPLETED', 'Malaria', 'DRUG: artemether/lumefantrine|DRUG: quinine|DRUG: atovaquone/proguanil', 'Jimma University', 'Ludwig-Maximilians - University of Munich', None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: ', None, None]\n['NCT02161939', 'A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C', None, 'NO_LONGER_AVAILABLE', 'Chronic Hepatitis C', 'DRUG: Daclatasvir (BMS-790052)|DRUG: Sofosbuvir', 'Bristol-Myers Squibb', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT04453839', 'ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)', 'SAMICARE', 'NO_LONGER_AVAILABLE', 'Critical COVID-19 With Respiratory Failure', 'DRUG: ZYESAMI (aviptadil acetate)', 'APR Applied Pharma Research s.a.', None, None, 'OTHER', 'EXPANDED_ACCESS', None, None, None]\n['NCT04243239', '[Trial of device that is not approved or cleared by the U.S. FDA]', None, 'WITHHELD', None, None, '[Redacted]', None, None, None, None, None, None, None]\n['NCT00414739', 'Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells', None, 'UNKNOWN', 'Eye Diseases', 'DRUG: Benzalkonium chloride', 'University of Rostock', 'Merck Sharp & Dohme LLC', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT', None, None]\n['NCT00053339', 'Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer', None, 'WITHDRAWN', 'Stage IV Breast Cancer|Recurrent Breast Cancer', 'DRUG: tamoxifen|DRUG: trastuzumab', 'Alliance for Clinical Trials in Oncology', 'National Cancer Institute (NCI)', '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, None]\n['NCT00000639', 'A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis', None, 'COMPLETED', 'Meningitis Cryptococcal|HIV Infections', 'DRUG: Itraconazole|DRUG: Flucytosine|DRUG: Fluconazole|DRUG: Amphotericin B', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Washington University School of Medicine', '400.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1997-09']\n['NCT00003939', 'Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma', None, 'COMPLETED', 'Brain and Central Nervous System Tumors|Endometrial Cancer|Gastrointestinal Stromal Tumor|Ovarian Cancer|Sarcoma|Small Intestine Cancer', 'DRUG: trabectedin', 'European Organisation for Research and Treatment of Cancer - EORTC', None, '132.0', 'NETWORK', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT06099639', 'Medical Access Program for Patritumab Deruxtecan', None, 'AVAILABLE', 'Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer', 'DRUG: HER3-DXd', 'Daiichi Sankyo', None, None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT00000939', 'A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible', None, 'COMPLETED', 'HIV Infections', 'DRUG: Hydroxyurea|DRUG: Efavirenz|DRUG: Stavudine|DRUG: Didanosine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '150.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '2000-01']\n['NCT00004979', 'Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors', None, 'COMPLETED', 'Unspecified Adult Solid Tumor Protocol Specific', 'DRUG: paclitaxel|DRUG: topotecan hydrochloride', 'Jonsson Comprehensive Cancer Center', 'National Cancer Institute (NCI)', None, 'OTHER', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2000-09']\n['NCT00002179', 'The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection', None, 'COMPLETED', 'HIV Infections', 'DRUG: Indinavir sulfate|DRUG: Lamivudine|DRUG: Zidovudine', 'Merck Sharp & Dohme LLC', None, '200.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT00571779', 'AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB', 'RESTORE SR IIB', 'WITHDRAWN', 'Atrial Fibrillation', 'DEVICE: AtriCure Bipolar System', 'AtriCure Inc.', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: ', None, None]\n['NCT00236379', 'A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder', None, 'COMPLETED', 'Schizophrenia|Diabetes Mellitus', 'DRUG: Olanzapine|DRUG: Risperidone', 'Janssen LP', None, '59.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2003-08']\n['NCT00693979', 'A Prospective Evaluation in a Randomized Trial of TAXUS in the Treatment of De Novo Coronary Artey Lesions', None, 'UNKNOWN', 'Coronary Heart Disease', 'DEVICE: TAXUS Element Stent or TAXUS Express Stent', 'National University Hospital Singapore', 'Boston Scientific Corporation', None, 'OTHER', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: ', None, None]\n['NCT00002379', 'The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs', None, 'COMPLETED', 'HIV Infections', 'DRUG: Indinavir sulfate|DRUG: Levocarnitine|DRUG: Adefovir dipivoxil|DRUG: Lamivudine|DRUG: Stavudine|DRUG: Zidovudine', 'Gilead Sciences', None, '100.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT00051779', 'An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer', None, 'COMPLETED', 'Breast Neoplasms|Breast Cancer|Metastasis', 'DRUG: CAL', 'Chugai Pharma USA', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT00002079', 'Phase II Study of the Safety and Surrogate Marker Efficacy of Butyldeoxynojirimycin (SC-48334) and AZT in Symptomatic HIV-1 Infected Patients With 200 - 500 CD4+ Cells/mm3. (NOTE: Asymptomatic HIV-1 Infected Patients Also Eligible)', None, 'COMPLETED', 'HIV Infections', 'DRUG: Butyldeoxynojirimycin|DRUG: Zidovudine', 'G D Searle', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, None]\n['NCT00002279', 'A Study of ddC in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Have Not Had Success With Zidovudine (AZT)', None, 'COMPLETED', 'HIV Infections', 'DRUG: Zalcitabine', 'Hoffmann-La Roche', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, None]\n['NCT01368679', 'A Clinical Study to Evaluate the Safety and Performance of the Modular AAA Stent-Graft System', 'Stent-Graft', 'WITHDRAWN', 'Cardiovascular Diseases|Abdominal Aortic Aneurysm', 'PROCEDURE: Endoprothesis Implantation', 'Scitech Produtos Medicos Ltda', None, '0.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', None, None]\n['NCT03955679', 'AveXis Managed Access Program Cohort for Access to AVXS-101', None, 'APPROVED_FOR_MARKETING', 'Spinal Muscular Atrophy', 'GENETIC: AVXS-101', 'United BioSource LLC', 'AveXis Inc.', None, 'INDUSTRY', 'EXPANDED_ACCESS', None, None, None]\n['NCT03122379', '[Trial of device that is not approved or cleared by the U.S. FDA]', None, 'WITHHELD', None, None, '[Redacted]', None, None, None, None, None, None, None]\n['NCT02174679', '68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)', None, 'NO_LONGER_AVAILABLE', 'Carcinoid Cancer|Neuroendocrine Tumors|Medullary Thyroid Cancer|Cancers Expressing Somatostatin Receptors', 'DRUG: 68Ga DOTATATE', 'Jonsson Comprehensive Cancer Center', None, None, 'OTHER', 'EXPANDED_ACCESS', None, None, None]\n['NCT01171079', 'Use of an Oxidized Regenerated Cellulose After Thyroid Surgery: A Prospective Randomized Study', 'ORC', 'COMPLETED', 'Thyroidectomy', 'DEVICE: application of oxidized regenerated cellulose', 'Seoul National University Hospital', None, None, 'OTHER', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: ', None, None]\n['NCT05968079', '[Trial of device that is not approved or cleared by the U.S. FDA]', None, 'WITHHELD', None, None, '[Redacted]', None, None, None, None, None, None, None]\n['NCT00998179', 'Effect of Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) on Post-exercise Expiratory Flow V\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n0']\n['NCT00300495', 'Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection', None, 'TERMINATED', 'Atrial Fibrillation|Lung Cancer', 'DRUG: Amiodarone|OTHER: Control arm standard care', 'Beth Israel Deaconess Medical Center', None, '19.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2006-02', '2009-10-13']\n['NCT01240395', 'Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity', None, 'COMPLETED', 'Multiple Chemical Sensitivity', 'BEHAVIORAL: Mindfulness-based Cognitive Therapy (MBCT)', 'The Danish Research Centre for Chemical Sensitivities', None, '82.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2011-09', '2013-05']\n['NCT03850795', 'HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)', None, 'ACTIVE_NOT_RECRUITING', 'Prostate Cancer Metastatic|Castration-resistant Prostate Cancer', 'DRUG: HC-1119|DRUG: Enzalutamide', 'Hinova Pharmaceuticals USA Inc.', None, '104.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2021-03-15', '2024-12-31']\n['NCT00748995', 'Neuropsychological and Mental Outcomes of Operation Iraqi Freedom (OIF): A Longitudinal Cohort Study', None, 'ACTIVE_NOT_RECRUITING', 'Stress Disorders Post-Traumatic', None, 'VA Office of Research and Development', None, '817.0', 'FED', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2010-08-31', '2025-09-30']\n['NCT01549795', 'Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy', None, 'UNKNOWN', 'Hilar Cholangiocarcinoma|Primary Sclerosing Cholangitis', 'PROCEDURE: Liver transplantation|RADIATION: 45 Gy external radiations|RADIATION: Endoluminal bile duct Brachytherapy|DRUG: Capecitabine|PROCEDURE: Pre liver transplantation laparoscopic hand assisted staging', 'Azienda Ospedaliera di Padova', None, '33.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-01', None]\n['NCT00420095', 'A Study for Patients With Diabetes Mellitus (IOPA)', 'IOPA', 'COMPLETED', 'Diabetes Mellitus Type 1|Diabetes Mellitus Type 2', 'DRUG: Human insulin 30/70|DRUG: Insulin lispro low mix', 'Eli Lilly and Company', None, '117.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', '2007-01', '2008-01']\n['NCT05023395', 'Safety and Efficacy of MEE-HU Medicus', '(SEM)', 'ACTIVE_NOT_RECRUITING', 'Urinary Tract Infections', 'DRUG: MEE-HU Medicus|OTHER: Placebo', 'Dr. Ahmed Ismail', 'Theodor Bilharz Research Institute|The Cairo Kidney Center|Helwan University|Zagazig University', '200.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2021-10-23', '2024-05-11']\n['NCT03810495', \"The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers\", None, 'COMPLETED', 'Opioid Use Disorder', 'DRUG: naltrexone implant', 'Go Medical Industries Pty Ltd', 'National Institute on Drug Abuse (NIDA)|New York State Psychiatric Institute|Columbia University|Clinilabs Inc.', '20.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2019-04-11', '2021-03-22']\n['NCT01246895', 'Follow-Up Study Evaluating The Long Term Safety and Efficacy of BST-CarGel and Microfracture Repair of the Knee', None, 'COMPLETED', 'Knee Injuries', 'DEVICE: Microfracture with BST-CarGel|DEVICE: Microfracture without BST-CarGel', 'Piramal Healthcare Canada Ltd', None, '67.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2011-03', '2014-03']\n['NCT02666495', 'Individual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series', None, 'UNKNOWN', 'Anorexia Nervosa', 'OTHER: Psychological Therapy - Schema Therapy', 'NHS Lothian', None, '15.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-01', '2019-01']\n['NCT01501695', 'Phase III Study of 5LGr to Treat Tic Disorder', '5LGr', 'COMPLETED', 'Tic Disorder|Tourette Syndrome|Chronic Tic Disorder', 'DRUG: 5LGr|DRUG: tiapride|DRUG: placebo', 'Tasly Pharmaceuticals Inc.', None, '603.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2008-01', '2011-10']\n['NCT02132195', 'Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome', None, 'COMPLETED', 'Nephrotic Syndrome', 'DRUG: ACTH', 'Emory University', 'Mallinckrodt', '31.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2014-05', '2018-03']\n['NCT02409095', 'Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants', None, 'TERMINATED', 'Immune Response to DTP-HB-Hib Vaccine', 'BIOLOGICAL: DTP-HB-Hib vaccine|DEVICE: Disposable Syringe Jet Injector (DSJI)|OTHER: Needle & Syringe', 'Serum Institute of India Pvt. Ltd.', 'PATH', '211.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2015-01', '2016-03']\n['NCT05031195', 'Prognostic Impact of NLR PLR and MPV in Patients Undergoing AAA Open Repair', None, 'COMPLETED', 'Abdominal Aortic Aneurysm', 'OTHER: 1st tertile 2nd tertile 3rd tertile', 'Gangnam Severance Hospital', None, '334.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2020-01-11', '2021-03-30']\n['NCT03737695', 'Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer', None, 'RECRUITING', 'Anatomic Stage IV Breast Cancer AJCC v8|Invasive Breast Carcinoma|Metastatic Breast Carcinoma|Peritoneal Effusion|Recurrent Breast Carcinoma', 'PROCEDURE: Biospecimen Collection|OTHER: Medical Chart Review', 'Mayo Clinic', 'National Cancer Institute (NCI)', '300.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2019-09-16', '2024-11-15']\n['NCT00568295', 'A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee', None, 'COMPLETED', 'Osteoarthritis of the Knee', 'DRUG: acetaminophen|DRUG: Rofecoxib|DRUG: Rofecoxib', 'Johnson & Johnson Consumer and Personal Products Worldwide', None, '403.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '1999-10', '2000-10']\n['NCT01891695', 'OPSCC N0 Nodal Control With Reduced IMRT', None, 'TERMINATED', 'Oropharyngeal Squamous Cell Carcinoma (OPSCCA)|HPV (Human Papillomavirus)-Associated', 'RADIATION: 39.6 Gy radiation', 'Paul W. Read MD', None, '1.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2013-10', '2016-12']\n['NCT02058095', 'Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)', 'Aim 3', 'COMPLETED', 'Cardiomyopathy|Renal Impairment', 'DRUG: Tadalafil|DRUG: Placebo', 'Mayo Clinic', None, '22.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE', '2014-03', '2019-12']\n['NCT04205695', 'Comparison of Catheters Orifice Configuration For Continuous Infraclavicular Analgesia', None, 'COMPLETED', 'Pain Postoperative|Catheter Blockage|Anesthesia', 'PROCEDURE: CEMP (closed-ended multiport catheter) group|PROCEDURE: OESP (open-ended single port catheter) group|PROCEDURE: Patient-controlled analgesia', 'Gulhane School of Medicine', None, '70.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2019-12-10', '2020-02-28']\n['NCT00417495', 'Sentinel Lymph Node Technique in Multifocal Breast Cancer', None, 'COMPLETED', 'Breast Cancer', 'BEHAVIORAL: Sentinel Lymph Node Technique', 'Centre Oscar Lambret', None, '216.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2006-03', '2008-09']\n['NCT02893995', 'Safety Tolerability Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension', None, 'WITHDRAWN', 'Pulmonary Arterial Hypertension', 'DRUG: Slow Dose Titration Group of Subcutaneous Treprostinil|DRUG: Rapid Dose Titration Group of Subcutaneous Treprostinil', 'United Therapeutics', 'CVie Therapeutics Co. Ltd.', '0.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2017-02', '2018-04']\n['NCT03469895', 'Autoimmune Cytopenia and BcR Inhibitors', 'CABRI', 'UNKNOWN', 'Autoimmune Cytopenia Associated With Chronic Lymphocytic Leukemia', 'DRUG: ibrutinib ou idelalisib', 'Institut Paoli-Calmettes', 'CHU de Reims', '40.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2017-07-21', '2018-07']\n['NCT03269695', 'Efficacy Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.', None, 'TERMINATED', 'Ulcerative Colitis', 'DRUG: PF-06687234|DRUG: Placebo', 'Pfizer', None, '20.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2017-12-20', '2021-01-07']\n['NCT04001595', 'Global FKRP Registry', None, 'RECRUITING', 'LGMD2I|LGMDR9|Limb Girdle Muscular Dystrophy|Congenital Muscular Dystrophy|Muscle-Eye-Brain Disease|Walker-Warburg Syndrome|FKRP Gene Mutation', 'OTHER: Patient Registry', 'Newcastle University', 'LGMD2i Research Fund|CureLGMD2i|Ludwig-Maximilians - University of Munich', '1000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2013-11', '2025-12']\n['NCT00199095', 'Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia', None, 'COMPLETED', 'Adult Acute Lymphocytic Leukemia', 'DRUG: Adriamycin|DRUG: Cyclophosphamide|DRUG: Cytarabine|DRUG: Dexamethasone|DRUG: Idarubicin|DRUG: Ifosfamide|DRUG: Methotrexate|DRUG: Mercaptopurine|DRUG: VM26|DRUG: Vincristine', 'Goethe University', None, '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '1997-02', '2003-06']\n['NCT00901095', 'Can Diet- and Exercise-Induced Weight Loss Improve Asthma Control in Adults?', None, 'COMPLETED', 'Asthma|Obesity', 'BEHAVIORAL: Lifestyle intervention', 'Palo Alto Medical Foundation', 'National Heart Lung and Blood Institute (NHLBI)|Kaiser Permanente|Stanford University', '330.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2010-02', '2014-03']\n['NCT02255695', 'Effects of a School-based Exercise Program on Posture Trunk Range of Motion and Musculoskeletal Pain', None, 'COMPLETED', 'Musculoskeletal and Connective Tissue Disorders', 'OTHER: School-based exercise program', 'Universidade Federal de Sao Carlos', 'Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.|Conselho Nacional de Desenvolvimento Científico e Tecnológico', '300.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2008-12', '2012-12']\n['NCT03070795', 'Outcomes of Early Versus Delayed Oral Feeding After Cesarean Section in Korle-bu Teaching Hospital', None, 'UNKNOWN', 'Cesarean Section Complications', 'PROCEDURE: early feeding|PROCEDURE: delayed feeding', 'University of Ghana Medical School', None, '170.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2017-02-23', '2017-08-20']\n['NCT03723395', 'A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib', None, 'COMPLETED', 'Drug-drug Interaction', 'DRUG: tucatinib|DRUG: itraconazole|DRUG: rifampin|DRUG: gemfibrozil|DRUG: repaglinide|DRUG: tolbutamide|DRUG: midazolam|DRUG: digoxin', 'Seagen Inc.', None, '116.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2018-09-17', '2018-12-28']\n['NCT04080895', 'Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects', 'ALAQ', 'RECRUITING', 'Pharmacokinetic|Healthy|Drug Combination', 'DRUG: Artemether-lumefantrine|DRUG: Amodiaquine|DRUG: Artemether-lumefantrine|DRUG: Artemether-lumefantrine + Amodiaquine', 'University of Oxford', 'Mahidol University|Mahidol Oxford Tropical Medicine Research Unit', '16.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', '2022-11-01', '2023-08-31']\n['NCT03049995', 'Stress Echo 2020 - The International Stress Echo Study', 'SE2020', 'UNKNOWN', 'Coronary Artery Disease|Heart Failure|Hypertrophic Cardiomyopathy|Aortic Valve Disease|Athletes Heart|Tetralogy of Fallot|Pulmonary Arterial Hypertension', 'PROCEDURE: Left ventricular contractile reserve SE|PROCEDURE: B-lines SE|PROCEDURE: Left ventricular outflow tract gradient SE|PROCEDURE: Diastolic function SE|PROCEDURE: Mitral regurgitation SE|PROCEDURE: Pulmonary hemodynamics SE|PROCEDURE: Coronary flow reserve SE', 'Fatebenefratelli Hospital', \"Institute of Clinical Physiology CNR PisaItaly|Salerno Hospital Italy|Monaldi Hospital Napoli Italy|University of Pisa Italy|San Luca Hospital Lucca Italy|Careggi University Hospital Florence Italy|Federico II University|San Carlo Public Hospital Potenza Italy|Royal Brompton & Harefield NHS Foundation Trust|Ospedale dell'Angelo Venezia-Mestre|University of Parma|Hospital Clinics Trieste Italy|Federal University of Rio Grande do Sul|Hospital San José Criciuma Brasil|Hospital San Vicente de Paulo Passo Fundo Brasil|University of Belgrade|University of Szeged Hungary|Elisabeth Hospital Hodmezovasarhely Hungary|Sandro Pertini Hospital Rome Italy|Hospital Clinics Bari Italy|Ospedale Nottola Siena Italy|University of Catania Italy|Medika Cardiocenter Saint Petersburg Russian Federation|Acibadem City Clinic Tokuda Hospital|Investigaciones Medicas Buenos Aires Argentina|Tomsk National Research Scientific Centre of Russian Academy of Sciences Tomsk Russian Federation|Instituto Nacional de Cardiología Mexico City Mexico|Hamad Medical Corporation Heart Hospital -Doha-Qatar\", '300.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2016-11', '2021-12']\n['NCT06073795', 'Ultrasongraphy Versus Fluoroscopy in Lumber Sympathetic Block in Chronic Lower Limb Ischemia', None, 'NOT_YET_RECRUITING', 'L L Ischemia', 'PROCEDURE: sympathetic block', 'Assiut University', None, '60.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-11-01', '2025-12-01']\n['NCT04564495', 'Home Based Tele-exercise for People With Chronic Neurological Impairments', 'Telex', 'ACTIVE_NOT_RECRUITING', 'Neurologic Disorder|Stroke|Spinal Cord Injuries|Cerebral Palsy|Hemiplegia|Hemiparesis|Multiple Sclerosis|Parkinson Disease|Trauma Brain|Transverse Myelitis|Friedreich Ataxia', 'BEHAVIORAL: Seated exercise', 'Burke Medical Research Institute', None, '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2021-01-22', '2024-12-31']\n['NCT01811095', 'A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing', None, 'COMPLETED', 'Neoplasms', 'OTHER: Training', 'McGill University', None, '27.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: ', '2013-03', '2013-06']\n['NCT04470895', 'Impact of Drugs on the Risk of Falls in the Fracture Department of the Paris Saint-Joseph Hospital Group', None, 'WITHDRAWN', 'Fracture|Fall', 'DIAGNOSTIC_TEST: Failure Track patients analysis', 'Fondation Hôpital Saint-Joseph', None, '0.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2021-09-24', '2021-09-24']\n['NCT04877795', 'Copeptin and HFABP in Cardiac Surgery', 'PRACTICE', 'UNKNOWN', 'Coronary Artery Disease|Valvular Heart Disease', 'DIAGNOSTIC_TEST: Blood sampling', 'Heinrich-Heine University Duesseldorf', None, '700.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2021-04-01', '2023-06-30']\n['NCT00804895', 'Cluster Headache Cortivazol Injection (CHCI)', 'CHCI', 'COMPLETED', 'Cluster Headache', 'DRUG: ALTIM cortivazol injections|DRUG: PROAMP subcutaneous serum physiological saline|DRUG: Verapamil', 'Assistance Publique - Hôpitaux de Paris', None, '43.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2008-12', '2009-10']\n['NCT03053895', 'Bedside Versus Operating Room Burr-Hole Drainage of Chronic Subdural Hematoma (DECIDE)', 'DECIDE', 'UNKNOWN', 'Chronic Subdural Hematoma', 'PROCEDURE: CSDH - Bedside twist drill technique|PROCEDURE: CSDH - Operating Room Burr-hole technique', 'Hamilton Health Sciences Corporation', None, '486.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2017-04-01', '2020-02-28']\n['NCT02782195', 'Evaluation of Gut Absorption Rate of Glucose After a Large Evening Meal in Type 1 Diabetes', None, 'COMPLETED', 'Type 1 Diabetes', None, 'University of Cambridge', 'Cambridge University Hospitals NHS Foundation Trust', '16.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2008-11', '2011-06']\n['NCT00843895', 'Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years', 'Pneumococci', 'UNKNOWN', 'Pneumococcal Disease', 'BIOLOGICAL: pneumococcal conjugate vaccine(prevenar)', 'King Saud University', None, '400.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SCREENING', '2009-03', '2009-12']\n['NCT05393895', 'An Evaluation of the Safety of CSF-1 in Presbyopic Subjects', None, 'COMPLETED', 'Presbyopia', 'DRUG: CSF-1|DRUG: Vehicle', 'Orasis Pharmaceuticals Ltd.', None, '178.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2022-04-22', '2022-12-01']\n['NCT00145795', 'A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment', None, 'COMPLETED', 'HIV Infections', 'DRUG: Kaletra + Current Dual NRTI Backbone|DRUG: Current Regimen', 'University of Chicago', 'Abbott', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2004-04', '2009-12']\n['NCT06182995', 'Anticipating Decline and Providing Therapy', 'ADAPT', 'NOT_YET_RECRUITING', 'Cognitive Impairment|Dementia|Post ICU Syndrome|Critical Illness|Cognitive Impairment Mild', 'BEHAVIORAL: Usual Care post-Intensive Care Unit (ICU)|BEHAVIORAL: Anticipating Decline and Providing Therapy (ADAPT)', 'Wake Forest University Health Sciences', 'National Institute on Aging (NIA)', '120.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2024-03', '2027-03']\n['NCT04061395', 'Guselkumab for Hidradenitis Suppurativa a Mode of Action Study.', 'HiGUS', 'UNKNOWN', 'Hidradenitis Suppurativa', 'BIOLOGICAL: Guselkumab', 'Barbara Horváth Principal Investigator', 'Janssen-Cilag Ltd.', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER', '2019-09', '2020-12']\n['NCT04114695', 'Aortic Calcification and Central Blood Pressure in Patients With Chronic Kidney Disease', 'ACCEPT', 'COMPLETED', 'Arterial Calcification|Kidney Diseases|Coronary Artery Disease|Aortic Calcification|Stroke|Vascular Diseases|Vascular Calcification', None, 'Central Jutland Regional Hospital', None, '185.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2019-10-15', '2022-01-01']\n['NCT01170195', 'Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms', None, 'UNKNOWN', 'Postmenopausal Symptoms|Vaginal Dryness', 'DIETARY_SUPPLEMENT: Calmera-Licorice Root Extract (Licogen)', 'F&C Licorice Ltd', None, '120.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2010-09', '2011-09']\n['NCT05409495', 'Titanium-prepared Platelet-rich Fibrin in Periodontal Regeneration', None, 'COMPLETED', 'Platelet-Rich Fibrin', 'PROCEDURE: periodontal surgical procedure (open flap debridement)|PROCEDURE: periodontal surgical procedure (OFD +autogenous Titanium-prepared platelet-rich fibrin (OFD+ T-PRF))', 'Ataturk University', None, '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2021-04-01', '2022-02-15']\n['NCT05360095', 'Comparing Game Facilitated Interactivity to Genetic Counseling for Prenatal Screening Education', None, 'RECRUITING', 'Genetic Counseling|Shared Decision Making|Pregnancy|Genetic Testing|Prenatal Disorder', 'BEHAVIORAL: Meaning of Screening|BEHAVIORAL: Genetic Counseling|BEHAVIORAL: Usual Care', 'Erin Rothwell', 'National Human Genome Research Institute (NHGRI)', '1125.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2023-03-07', '2025-12']\n['NCT02574195', 'Evolution of Effectiveness of Diabetes Medical Care in Russia', None, 'COMPLETED', 'Diabetes Mellitus Type 2|Diabetes Mellitus Type 1', None, 'Endocrinology Research Centre Moscow', None, '599.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-08', '2015-10']\n['NCT02975895', 'Outcome of Different IOLs in Patients With and Without Uveitis', None, 'COMPLETED', 'Uveitis|Cataract|Inflammation|Posterior Capsule Opacification', 'DEVICE: Hydrophobic IOL: Vivinex (HOYA)|DEVICE: Hydrophilic IOL: INCISE (Bausch+Lomb)', 'Vastra Gotaland Region', None, '56.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2016-12-30', '2022-03-17']\n['NCT03332095', 'Evaluating the Pharmacokinetics Safety and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents', None, 'COMPLETED', 'HIV Infections', 'DRUG: Doravirine (DOR)|DRUG: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF)|DRUG: Antiretroviral (ARV) medications', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '55.0', 'NIH', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2018-07-02', '2022-05-25']\n['NCT05191095', 'The Accuracy of Human Endoscopic Detection of Submucosal Invasive Cancer in Colorectal Polyps', None, 'COMPLETED', 'Colorectal Polyp', None, 'University Hospital Ghent', None, '82.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2021-03-01', '2021-06-01']\n['NCT01388595', 'Fluticasone and Salmeterol in Allergic Rhinitis', None, 'COMPLETED', 'Allergic Rhinitis', 'DRUG: FLUTICASONE PROPRIONATE|DRUG: Salmeterol|DRUG: PLACEBO', 'University of Dundee', None, '23.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2006-11', '2010-10']\n['NCT00382395', 'SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma', None, 'SUSPENDED', 'Glaucoma|Glaucoma Open Angle', 'DEVICE: SOLX Gold Shunt GMS-plus|DEVICE: Ahmed FP7 Glaucoma Valve', 'SOLX Inc.', None, '180.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2005-11', '2017-07']\n"
     ]
    }
   ],
   "source": [
    "# we can notice here that none values are coming, and two data formats of date value is coming in the dataset YYYY-MM-DD and YYYY-MM-DD. Hence we need to change this non-uniform data format into the standard one of YYYY-MM-DD. For, that, Assume all the data where YYYY-MM format started with the first day of the month given\n",
    "\n",
    "# For achieving this, let's split the RDD into two --> start_with_none --> containing only none values in it and start_without_none --> containing the two other data formats.\n",
    "start_with_none = filtered_rdd_with_header.filter(lambda row: len(row) > 12 and row[12] is None)\n",
    "\n",
    "# Filter RDD to create start_without_none containing rows without None values in the thirteenth column\n",
    "start_without_none = filtered_rdd_with_header.filter(lambda row: len(row) > 12 and row[12] is not None and row[12] != 'Start')\n",
    "\n",
    "# Print the first_part_start RDD\n",
    "print(\"Start column containing only none values):\")\n",
    "for row in start_with_none.collect():\n",
    "    print(row)\n",
    "\n",
    "# Print the second_part_start RDD\n",
    "print(\"\\nStart column containing values with the format YYYY-MM-DD and YYYY-MM):\")\n",
    "for row in start_without_none.collect():\n",
    "    print(row)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "8dcbef01-4292-46e3-8b37-e360d6efe20b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of data rows in the filtered_rdd_with_header: 483422\nNumber of data rows in the start_with_none: 5144\nNumber of data rows in the start_without_none: 478276\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# Get the count of data rows in the RDD\n",
    "row_count = filtered_rdd_with_header.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the filtered_rdd_with_header:\", row_count)\n",
    "# Get the count of data rows in the RDD\n",
    "row_count = start_with_none.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the start_with_none:\", row_count)\n",
    "# Get the count of data rows in the RDD\n",
    "row_count = start_without_none.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the start_without_none:\", row_count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "3910ba29-c245-4034-b5ab-097d55f0a782",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rows not included in either start_with_none or start_without_none:\n('NCT00146315', 'ESCAP: Supervised Exercise for Patients With Coronary Heart Disease in the Primary Care Setting', None, 'COMPLETED', 'Coronary Heart Disease', 'BEHAVIORAL: Supervised exercise on a stationary bicycle 3-5 days a week|BEHAVIORAL: Secondary prevention program for coronary heart disease', 'Basque Health Service', 'Preventive Services and Health Promotion Research Network|Castilla-La Mancha Health Service|Castilla-León Health Service|Dalt Sant Joan primary care center (Balears Islans Health Service)|Public Health Service of C')\n('Id', 'Study Title', 'Acronym', 'Status', 'Conditions', 'Interventions', 'Sponsor', 'Collaborators', 'Enrollment', 'Funder Type', 'Type', 'Study Design', 'Start', 'Completion')\n"
     ]
    }
   ],
   "source": [
    "# Convert lists into tuples for start_with_none and start_without_none RDDs\n",
    "start_with_none_tuples = start_with_none.map(tuple)\n",
    "start_without_none_tuples = start_without_none.map(tuple)\n",
    "\n",
    "# Create a set of all rows in start_with_none and start_without_none RDDs\n",
    "start_with_none_rows = set(start_with_none_tuples.collect())\n",
    "start_without_none_rows = set(start_without_none_tuples.collect())\n",
    "\n",
    "# Convert the original RDD into tuples\n",
    "filtered_rdd_tuples = filtered_rdd_with_header.map(tuple)\n",
    "\n",
    "# Create a set of all rows in filtered_rdd_with_header RDD\n",
    "all_rows = set(filtered_rdd_tuples.collect())\n",
    "\n",
    "# Find the rows that are not included in either start_with_none or start_without_none\n",
    "not_in_either = all_rows - (start_with_none_rows.union(start_without_none_rows))\n",
    "\n",
    "# Print the rows not included in either start_with_none or start_without_none\n",
    "print(\"Rows not included in either start_with_none or start_without_none:\")\n",
    "for row in not_in_either:\n",
    "    print(row)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0ae2fe45-6999-45cf-a925-2408b5d13458",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index: 293056\nRow: ['NCT00146315', 'ESCAP: Supervised Exercise for Patients With Coronary Heart Disease in the Primary Care Setting', None, 'COMPLETED', 'Coronary Heart Disease', 'BEHAVIORAL: Supervised exercise on a stationary bicycle 3-5 days a week|BEHAVIORAL: Secondary prevention program for coronary heart disease', 'Basque Health Service', 'Preventive Services and Health Promotion Research Network|Castilla-La Mancha Health Service|Castilla-León Health Service|Dalt Sant Joan primary care center (Balears Islans Health Service)|Public Health Service of C']\n"
     ]
    }
   ],
   "source": [
    "# Find the row where Id = NCT00146315 along with its index\n",
    "matching_row_with_index = filtered_rdd_with_header.zipWithIndex() \\\n",
    "    .filter(lambda row_index: row_index[0][0] == 'NCT00146315') \\\n",
    "    .collect()\n",
    "\n",
    "# Check if a matching row was found\n",
    "if matching_row_with_index:\n",
    "    # Extract the row and its index\n",
    "    matching_row, index = matching_row_with_index[0]\n",
    "    # Print the index and the row\n",
    "    print(\"Index:\", index)\n",
    "    print(\"Row:\", matching_row)\n",
    "else:\n",
    "    print(\"No row found with Id = NCT00146315 in filtered_rdd_with_header.\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f83c6de3-7dc0-4ec7-beb8-def3939e7707",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "start column values (Containing date values in YYYY-MM-DD format):\n['NCT03630471', 'Effectiveness of a Problem-solving Intervention for Common Adolescent Mental Health Problems in India', 'PRIDE', 'COMPLETED', 'Mental Health Issue (E.G. Depression Psychosis Personality Disorder Substance Abuse)', \"BEHAVIORAL: PRIDE 'Step 1' problem-solving intervention|BEHAVIORAL: Enhanced usual care\", 'Sangath', 'Harvard Medical School (HMS and HSDM)|London School of Hygiene and Tropical Medicine', '250.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2018-08-20', '2019-02-28']\n['NCT05992571', 'Oral Ketone Monoester Supplementation and Resting-state Brain Connectivity', None, 'RECRUITING', 'Cerebrovascular Function|Cognition', 'OTHER: Placebo|DIETARY_SUPPLEMENT: β-OHB', 'McMaster University', \"Alzheimer's Society of Brant Haldimand Norfolk Hamilton Halton\", '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE', '2023-10-25', '2024-08']\n['NCT03820271', 'New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation', 'SUPERMELD', 'RECRUITING', 'Decompensated Cirrhosis|Liver Transplantation', 'OTHER: SuperMELD', 'Assistance Publique - Hôpitaux de Paris', None, '500.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER', '2020-10-01', '2023-10-01']\n['NCT06229171', 'InTake Care: Development and Validation of an Innovative Personalized Digital Health Solution for Medication Adherence Support in Cardiovascular Prevention', 'InTakeCare', 'NOT_YET_RECRUITING', 'Hypertension|Treatment Adherence and Compliance|Digital Health', 'OTHER: adherence support system based on a vocal assistant', 'Istituto Auxologico Italiano', 'Istituti Clinici Scientifici Maugeri SpA|Politecnico di Milano', '206.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: OTHER', '2024-10-01', '2026-04-01']\n['NCT01772771', 'Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program', None, 'RECRUITING', 'Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Melanoma|Sarcoma', 'PROCEDURE: Biospecimen Collection|OTHER: Genetic Testing|OTHER: Medical Chart Review', 'M.D. Anderson Cancer Center', 'National Cancer Institute (NCI)', '12000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-03-01', '2033-03-01']\n['NCT03400371', 'Biology of Juvenile Myoclonic Epilepsy', 'BIOJUME', 'RECRUITING', 'Juvenile Myoclonic Epilepsy', 'OTHER: Blood draw|OTHER: Existing samples', \"King's College London\", \"King's College Hospital NHS Trust|Charles University Czech Republic|Hopital Universitaire Robert-Debre|Vestre Viken Hospital Trust|The Hospital for Sick Children|Cardiff University|Odense University Hospital\", '1000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2017-07-13', '2026-06-30']\n['NCT04784871', 'Promoting Wellbeing: The Five Ways to All Intervention', '5WaysA', 'COMPLETED', 'Wellbeing|Health Attitude|Quality of Life', 'BEHAVIORAL: 5waysA Intervention|BEHAVIORAL: 5waysA Active wait-list control|BEHAVIORAL: 5waysA Inactive wait-list control', 'University of Oslo', 'Norwegian Institute of Public Health|Norwegian Council for Mental Health|The Dam Foundation', '970.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2021-03-04', '2023-02-24']\n['NCT03269071', 'Neural Stem Cell Transplantation in Multiple Sclerosis Patients', 'STEMS', 'COMPLETED', 'Progressive Multiple Sclerosis', 'DRUG: human fetal-derived Neural Stem Cells (hNSCs)', 'IRCCS San Raffaele', 'Fondazione Italiana Sclerosi Multipla', '4.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT', '2017-05-17', '2021-07-31']\n['NCT04765371', 'Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy With CoViD-19', 'COPreDex', 'COMPLETED', 'Coronavirus Infection', 'DRUG: DEXAMETHASONE|DRUG: PREDNISOLONE', 'Hôpital NOVO', None, '89.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2021-03-03', '2022-05-13']\n['NCT05900271', 'Dutch-Depression Outcome Trial Comparing 5 Day Multi Daily Neuronavigated Theta Burst Sessions With 6 Weeks rTMS', 'DDOT', 'ACTIVE_NOT_RECRUITING', 'Treatment Resistant Depression', 'DEVICE: rTMS|DEVICE: iTBS', 'Amsterdam UMC location VUmc', 'Radboud University Medical Center|University Medical Center Groningen|Maastricht University|Trimbos|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)', '108.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2023-11-15', '2027-12']\n['NCT02469571', 'Modulation of Gut Microbiota in Early Sepsis: A Pilot Study', 'MGM-sepsis', 'COMPLETED', 'Sepsis', 'DIETARY_SUPPLEMENT: Winclove 607|DIETARY_SUPPLEMENT: Placebo', 'Medical University of Graz', None, '15.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2015-09-01', '2018-03-01']\n['NCT05807971', 'Assessment of Safety Tolerability Pharmacokinetics and Pharmacodynamics of ATH-063 in Healthy Subjects', None, 'RECRUITING', 'Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis|Autoimmune Diseases', 'DRUG: ATH-063|DRUG: Placebo', 'Athos Therapeutics Inc', 'Syneos Health|Athos Therapeutics Australia Pty Ltd', '76.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2023-04-06', '2024-02-08']\n['NCT03928171', 'The Effect of Intra-abdominal Pressure on Peritoneal Perfusion During Laparoscopic Colorectal Surgery', 'PERFUSION', 'COMPLETED', 'Laparoscopic Surgery|Pneumoperitoneum', 'OTHER: Intra-abdominal pressure during laparoscopy', 'Radboud University Medical Center', None, '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2018-06-13', '2018-12-24']\n['NCT06135571', 'Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer', None, 'RECRUITING', 'Colorectal Cancer|Lymph Node Metastasis', 'PROCEDURE: Laparoscopic colorectal surgery', 'Cancer Institute and Hospital Chinese Academy of Medical Sciences', 'Peking Union Medical College Hospital|Peking University Cancer Hospital & Institute|China-Japan Friendship Hospital|Chinese PLA General Hospital', '3000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-09-01', '2026-09-01']\n['NCT05592171', 'Occlusafe® Assisted MW Alone or With DEB-TACE Compared to MW With DEB-TACE in the Treatment of HCC', 'SEASON-HCC', 'RECRUITING', 'HCC', 'PROCEDURE: Microwave ablation + Occlusafe + DEB-TACE|PROCEDURE: Microwave ablation + Occlusafe|PROCEDURE: Microwave ablation + DEB-TACE', 'University of Pisa', 'Azienda Ospedaliera Città della Salute e della Scienza di Torino|Fondazione Policlinico Universitario Agostino Gemelli IRCCS|Azienda Ospedaliera Universitaria Policlinico|IRCCS Azienda Ospedaliero-Universitaria di Bologna|Terumo Europe N.V.|Azienda Ospedaliero Universitaria Pisana', '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2022-10-17', '2025-10-17']\n['NCT05913271', 'Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure', None, 'RECRUITING', 'Heart Failure|Levosimendan|Efficacy|Safety', None, 'Yi Han', 'Qianfoshan Hospital', '352.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-05-30', '2025-05-30']\n['NCT04006171', 'Comparison of Serum C Type Natriuretic Peptide Levels Between Polycystic Ovary Syndrome Patients and Healthy Women', 'CNP', 'COMPLETED', 'Polycystic Ovary Syndrome|c Type Natriuretic Peptide|Menstrual Irregularity|Hyperandrogenism', 'DIAGNOSTIC_TEST: C type natriuretic peptide', 'Near East University Turkey', None, '90.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2019-07-15', '2020-09-01']\n['NCT04370171', 'Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic', 'TeleCoviDiab', 'COMPLETED', 'Diabetes|Covid-19', 'OTHER: care modalities|OTHER: Teleconsultation either by phone or by computer consultation', 'University Hospital Strasbourg France', None, '610.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2020-05-04', '2020-05-29']\n['NCT04340271', 'The Clinical Utility of Extracorporeal Shock Wave Therapy on Burns', None, 'COMPLETED', 'Burn Scar', 'OTHER: Extracorporeal shock wave therapy|OTHER: conventional occupational therapy', 'Hangang Sacred Heart Hospital', None, '48.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2020-04-15', '2020-05-31']\n['NCT05966571', 'Ovarian Innervation Study in Patients With Polycystic Ovary Syndrome (PCOS)', None, 'RECRUITING', 'Polycystic Ovary Syndrome', 'PROCEDURE: Ovary Biopsie', 'Albanian University', None, '50.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-07-01', '2024-12-01']\n['NCT03313271', 'China Lymphoma Patient Registry Study', 'CLAP', 'RECRUITING', 'Lymphoma', None, 'Jun Zhu', 'Peking University First Hospital|Tianjin Medical University Cancer Hospital|Zhejiang Cancer Hospital|Heilongjiang Cancer Hospital|Sipai(Beijing)Network Technology Co Ltd', '5000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2017-05-17', '2027-08-30']\n['NCT03490071', 'Long-term Follow up of Patients With Longstanding Hip and Groin Pain', 'Lund LHGP', 'RECRUITING', 'Hip Pain Chronic', None, 'Lund University', None, '81.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2018-01-01', '2024-12-31']\n['NCT05801471', 'Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression', None, 'RECRUITING', 'Glaucoma', None, 'Centervue SpA', None, '200.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2022-05-06', '2025-11-06']\n['NCT04405271', 'TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)', None, 'UNKNOWN', 'Healthcare Workers|COVID-19|SARS-CoV 2', 'DRUG: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|DRUG: Placebo', 'Hospital Italiano de Buenos Aires', 'Sociedad Argentina de Infectología (SADI) (Argentine Society of Infectious Diseases)', '1378.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2020-07-31', '2020-11-15']\n['NCT04875871', 'Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors', 'PARTICLE-PATHY', 'RECRUITING', 'Cancer', 'RADIATION: Particle radiotherapy|DIAGNOSTIC_TEST: Magnetic resonance imaging|DIAGNOSTIC_TEST: Computertomography|DIAGNOSTIC_TEST: Copper-64-Diacetyl-bis (N4-methylthiosemicarbazone) Positron Emission Tomography-Computer Tomography (64Cu-ATSM-PET-CT)|DIAGNOSTIC_TEST: 18-F-FluorDesoxyGlukose Positron Emission Tomography-Computer Tomography (18F-FDG-PET-CT)|DIAGNOSTIC_TEST: Blood sampling', 'EBG MedAustron GmbH', 'CW-Research & Management GmbH|Medical University of Vienna|Landesklinkum Wiener Neustadt|Klinik Ottakring', '22.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2021-11-11', '2024-12']\n['NCT04674371', 'German Point Prevalence Study on CVC', None, 'COMPLETED', 'Data Collection', 'OTHER: central venous catheter insertion', 'Wolfram Schummer MD PhD', None, '537.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2022-05-17', '2022-05-20']\n['NCT02321371', 'Effect of Goal Directed Ammonia Lowering Therapy in Acute on Chronic Liver Failure Patients With Hepatic Encephalopathy.', None, 'COMPLETED', 'Acute-On-Chronic Liver Failure', 'DRUG: Lactulose + Rifaximin|DRUG: Lactulose', 'Institute of Liver and Biliary Sciences India', None, '73.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2014-10-19', '2016-01-31']\n['NCT02804971', 'Cardiovascular Comorbidities and Bronchiectasis', 'BRONCOCA', 'ACTIVE_NOT_RECRUITING', 'Bronchiectasis', None, 'Centre Hospitalier Intercommunal Creteil', None, '200.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2016-10-25', '2023-12']\n['NCT04591171', 'Assessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney Disease', None, 'COMPLETED', 'Hypertension|Chronic Kidney Diseases', 'PROCEDURE: n-of-1 trial guided clinical decision making', 'The University of Texas Health Science Center Houston', \"Children's Hospital of Philadelphia|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)\", '9.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2021-01-25', '2022-02-18']\n['NCT04814771', 'Mass Balance Study of TS-142 in Healthy Adult Subjects.', None, 'COMPLETED', 'Healthy Male Subjects', 'DRUG: [14C] TS-142', 'Taisho Pharmaceutical Co. Ltd.', None, '6.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2021-04-19', '2021-05-19']\n['NCT05702671', 'Kenota 1 CWS Method Comparison Validation Study', None, 'COMPLETED', 'Allergy|Immunoglobulin E-Mediated Allergic Disorder', 'DIAGNOSTIC_TEST: Total Immunoglobulin E Obtained From Fingerstick Sample', 'Kenota Inc.', None, '411.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-01-27', '2023-04-07']\n['NCT04585971', 'A Study on Hemodynamic Relationship Including Cerebral Blood Flow Using Phase Contrast and Signal Intensity Gradient of Brain Magnetic Resonance Imaging and Carotid Doppler Ultrasound', None, 'UNKNOWN', 'Cerebral Blood Flow', 'DIAGNOSTIC_TEST: Signal intensity gradient', 'Chonbuk National University Hospital', 'Medi Image Inc', '30.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2020-09-03', '2021-01-31']\n['NCT05473871', 'Enhancing Capacity in Churches to Implement PA Programs', None, 'RECRUITING', 'Cardiovascular Diseases', 'BEHAVIORAL: Faith in Action|BEHAVIORAL: Faith in Action+|BEHAVIORAL: Faith in Action++', 'San Diego State University', 'Washington University School of Medicine|University of California Berkeley|University of California San Diego', '812.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2022-11-15', '2026-10-31']\n['NCT02370771', 'Proteomic Analysis in Sera From Patients With Erosive Hand Osteoarthritis', 'PASEO', 'COMPLETED', 'Erosive Hand Osteoarthritis', 'PROCEDURE: Biological sampling|DEVICE: Radiographic evaluation', 'University Hospital Rouen', None, '32.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2015-06-09', '2019-11-17']\n['NCT03713671', 'Gait and Balance Parameters Before and After Parathyroidectomy in Patients With Primary Hyperparathyroidism', None, 'COMPLETED', 'Primary Hyperparathyroidism', 'DIAGNOSTIC_TEST: gait analysis', 'Recep Tayyip Erdogan University Training and Research Hospital', 'Hacettepe University|Ankara Education and Research Hospital', '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING', '2021-10-17', '2023-08-27']\n['NCT04004871', 'Induction Chemotherapy With Nab-paclitaxel Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma', None, 'UNKNOWN', 'Nasopharyngeal Carcinoma|Nasopharyngeal Cancer|Nasopharynx Cancer', 'DRUG: Nab-paclitaxel Cisplatin and Fluorouracil|RADIATION: concurrent chemoradiotherapy', 'Guangxi Medical University', 'Second Affiliated Hospital of Guangxi Medical University|Guilin Medical University China|Liuzhou Workers Hospital|Wuzhou Red Cross Hospital', '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2019-07-05', '2022-06-30']\n['NCT05953571', 'Laparoscopic Assisted Dismembered Pyeloplasty Versus Open Pyeloplasty in (UPJO) With Poorly Function Kidney in Pediatrics', None, 'COMPLETED', 'Uretro-pelvic Junction Obstruction|Poorly Function Kidney', 'PROCEDURE: Dismembered Pyeloplasty', 'Al-Azhar University', 'University Hospital Fattouma Bourguiba', '65.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2022-01-08', '2023-06-30']\n['NCT01425671', 'Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States', None, 'ACTIVE_NOT_RECRUITING', 'Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder', None, 'University of Maryland Baltimore', 'National Institute of Mental Health (NIMH)', '800.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2010-11-30', '2024-06']\n['NCT04962971', 'Comparative Effect of 3 Different Cranberry Extracts on Cystitis Related Urinary Comfort in Women', None, 'COMPLETED', 'Recurrent Cystitis', 'DIETARY_SUPPLEMENT: X|DIETARY_SUPPLEMENT: Y|DIETARY_SUPPLEMENT: Z', 'CEN Biotech', 'Nexira|CEN Nutriment', '216.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2020-09-01', '2022-02-01']\n['NCT04236271', 'TELEsurveillance of Patients in PostopErative Bridge surgeryAge CoronairE', 'TELE-PEACE', 'COMPLETED', 'Coronary Artery Bypass', 'DEVICE: connected objects', 'Assistance Publique - Hôpitaux de Paris', 'GFI', '33.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER', '2020-03-13', '2022-12-31']\n['NCT05078671', 'Pharmacokinetic Boosting of Olaparib to Improve Exposure Tolerance and Cost-effectiveness', 'PROACTIVE', 'RECRUITING', 'Cancer', 'DRUG: Olaparib|DRUG: Cobicistat', 'Radboud University Medical Center', None, '160.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2021-12-15', '2025-12-31']\n['NCT03876171', 'Culturally Modified Family Based Therapy for Haitian Youth in South Florida', None, 'COMPLETED', 'Problem Behavior', 'BEHAVIORAL: Haitian youth and family intervention study: family functioning|BEHAVIORAL: Haitian youth intervention study: youth psychoeducational|BEHAVIORAL: Haitian family intervention study: family psychoeducational|BEHAVIORAL: Diversion Programs', 'University of Miami', 'National Institute on Drug Abuse (NIDA)', '44.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2019-04-01', '2022-12-31']\n['NCT05031871', 'Pharmacokinetics of HR17031 Injection in Healthy Subjects', None, 'COMPLETED', 'Type 2 Diabetes Mellitus', 'DRUG: HR17031 injection ；INS068 injection；SHR20004 injection|DRUG: HR17031 injection ；INS068 injection；SHR20004 injection|DRUG: HR17031 injection ；INS068 injection；SHR20004 injection|DRUG: HR17031 injection ；INS068 injection；SHR20004 injection', 'Jiangsu HengRui Medicine Co. Ltd.', None, '24.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', '2021-09-02', '2021-11-19']\n['NCT04769271', 'Intra-pocket Application of Tea Tree Oil Gel in the Treatment of Stage-2 Periodontitis', None, 'COMPLETED', 'Periodontitis', 'PROCEDURE: Scaling and Root Planing|DRUG: Scaling and Root Planing with tea tree oil', 'Alexandria University', None, '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2019-11-10', '2020-08-25']\n['NCT06044571', 'Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults', None, 'NOT_YET_RECRUITING', 'Obesity|Multiple Chronic Conditions', 'OTHER: Prescriptive|BEHAVIORAL: Behavioral', 'University of North Carolina Chapel Hill', 'National Institute on Aging (NIA)', '180.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: DOUBLE (PARTICIPANT CARE_PROVIDER)|Primary Purpose: TREATMENT', '2024-03-01', '2027-09-01']\n['NCT03077971', 'Effectiveness of Acceptance and Commitment Therapy Self-Help for Carers of People With Multiple Sclerosis', None, 'UNKNOWN', 'Carer Stress Syndrome', 'BEHAVIORAL: ACT Self-Help|BEHAVIORAL: ACT Self-Help with Telephone Support', 'University of Nottingham', None, '24.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE', '2016-12-01', '2018-06']\n['NCT03548571', 'Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy', 'DEN-STEM', 'ACTIVE_NOT_RECRUITING', 'Glioblastoma', 'BIOLOGICAL: Dendritic cell immunization|DRUG: Adjuvant temozolomide', 'Oslo University Hospital', None, '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2018-04-26', '2025-05-01']\n['NCT03530371', 'Intranasal Dexmedetomidine for Sedated Hearing Testing', None, 'COMPLETED', 'Auditory Brainstem Response', 'DRUG: Dexmedetomidine Hydrochloride', 'Fondation Lenval', None, '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2019-05-02', '2021-12-31']\n['NCT05921071', 'Do Patients Who Received Tranexamic Acid in Vaginal Hysterectomy Loose Les Blood Comparing to Patients Who Did Not?', None, 'RECRUITING', 'Vaginal Hysterectomy', 'DRUG: Tranexamic acid|DRUG: Placebo', 'Wolfson Medical Center', None, '150.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE', '2023-01-22', '2025-01-01']\n['NCT04974671', 'Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma', None, 'RECRUITING', 'Renal Cell Carcinoma|Metastatic Renal Cell Carcinoma|Oligoprogressive|Progression', 'RADIATION: Stereotactic Body Radiation Therapy', 'Yale University', None, '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2022-08-08', '2027-04-01']\n['NCT04979871', 'SARS-CoV-2 Antibodies and Virus Neutralisation in a Cohort Vaccinted Against COVID-19', 'DER-CoV2-001', 'COMPLETED', 'Vaccine Reaction', 'PROCEDURE: Venous bleeding', 'University of Zurich', None, '50.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2021-07-22', '2021-12-31']\n['NCT04097171', 'The Effect of Diet Composition on Performance Expenditure Blood Lipids and Appetite Hormones in Highly Trained Cyclists', 'DCAP', 'COMPLETED', 'Endurance Cycling Performance', 'OTHER: Diet', 'Texas Christian University', None, '34.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2019-11-11', '2020-03-30']\n['NCT06199271', 'Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma', None, 'NOT_YET_RECRUITING', 'Head and Neck Squamous Cell Carcinoma', 'DRUG: Adebrelimab and dalpiciclib', 'Zhongzheng Xiang', None, '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2024-01-31', '2026-12-31']\n['NCT04032171', 'Study of Evobrutinib in Participants With RMS', None, 'TERMINATED', 'Relapsing-remitting Multiple Sclerosis', 'DRUG: Evobrutinib|DRUG: Avonex®|DRUG: Avonex® matched Placebo|DRUG: Evobrutinib matched Placebo', 'EMD Serono Research & Development Institute Inc.', 'Merck KGaA Darmstadt Germany', \n\n*** WARNING: max output size exceeded, skipping output. ***\n\n', '560.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION', '2014-07', '2017-07']\n['NCT04516395', 'Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae', None, 'UNKNOWN', 'Drug Resistance|Carbapenem-Resistant Enterobacteriaceae Infection|Sepsis|Septic Shock|Critical Illness|Clinical Outcomes|Treatment Outcomes', 'OTHER: Combined antibiotic regimens|OTHER: Standard antibiotic regimens', 'Phramongkutklao College of Medicine and Hospital', None, '102.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2020-09', '2021-04']\n['NCT00005495', 'Primary Prevention of CHD Risk Factors Occurring in US', None, 'COMPLETED', 'Cardiovascular Diseases|Heart Diseases|Coronary Heart Disease Risk Reduction|Coronary Disease|Hypertension|Hypercholesterolemia', None, 'National Heart Lung and Blood Institute (NHLBI)', None, None, 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '1998-07', '1999-06']\n['NCT01198795', 'Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder', None, 'COMPLETED', 'Major Depressive Disorder', 'DRUG: Escitalopram', 'Forest Laboratories', None, '162.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2010-09', '2013-04']\n['NCT00052195', 'Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People', None, 'COMPLETED', 'Tuberculosis|HIV Infections', 'BIOLOGICAL: SRL-172', 'Dartmouth-Hitchcock Medical Center', 'National Institute of Allergy and Infectious Diseases (NIAID)', '1975.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2001-09', '2009-05']\n['NCT02445495', 'Chart Review of the Efficacy of the GenesisPlus 1064 nm Nd:YAG Laser in the Treatment of Onychomycosis', None, 'COMPLETED', 'Onychomycosis', 'DEVICE: GenesisPlus 1064 nm Nd:YAG laser', 'Jason K Rivers MD FRCPC FAAD', 'Cutera Inc.', '100.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2013-11', '2014-11']\n['NCT00538395', 'Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer', None, 'UNKNOWN', 'Breast Cancer', 'DRUG: Adriamycin Taxol and Cytoxan', 'King Faisal Specialist Hospital & Research Center', None, '100.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2007-09', '2013-09']\n['NCT02693795', 'Baduanjin Exercise Prevents Post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER Trial)', None, 'UNKNOWN', 'Myocardial Infarction', 'OTHER: Baduanjin exercise|OTHER: aerobic exercise', 'Guangdong Provincial Hospital of Traditional Chinese Medicine', None, '110.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2016-05', '2018-12']\n['NCT05692895', 'PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact', None, 'NOT_YET_RECRUITING', 'PDL1- Colorectal Carcinoma', None, 'Sohag University', None, '60.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-02', '2023-07']\n['NCT00446095', 'Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma', None, 'COMPLETED', 'Lymphoma', 'DRUG: fostamatinib', 'Rigel Pharmaceuticals', None, '81.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2007-04', '2010-10']\n['NCT00599495', 'Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT', None, 'COMPLETED', 'Multiple Myeloma', 'PROCEDURE: allogeneic HSCT', 'Universitätsklinikum Hamburg-Eppendorf', None, '50.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2002-11', '2009-12']\n['NCT02994095', 'A Pilot Study of a Community Health Agent-led Diabetes Self-Management Program', None, 'COMPLETED', 'Type2 Diabetes', 'BEHAVIORAL: Pilot Study', 'University of Michigan', None, '57.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2014-03', '2014-12']\n['NCT06153095', 'A Study of IMPT-514 in Active Refractory Systemic Lupus Erythematosus (SLE)', None, 'NOT_YET_RECRUITING', 'Systemic Lupus Erythematosus|Lupus Nephritis', 'BIOLOGICAL: IMPT-514|BIOLOGICAL: IMPT-514|BIOLOGICAL: IMPT-514', 'ImmPACT Bio', None, '30.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2023-12', '2027-02']\n['NCT02865395', 'Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms', None, 'TERMINATED', 'Overactive Bladder', 'DRUG: Belladonna and Opium Suppository|PROCEDURE: Rectal Exam', 'Campbell Grant', None, '23.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2016-03', '2017-06']\n['NCT00071695', 'Duloxetine vs. Active Comparator in the Treatment of Patients With Depression', None, 'COMPLETED', 'Depression', 'DRUG: Duloxetine Hydrochloride|DRUG: Venlafaxine Extended Release', 'Eli Lilly and Company', None, '320.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', '2003-07', '2004-05']\n['NCT01556295', 'Gesture Behavior and Knowledge on Low Back Pain Among Nurses', None, 'UNKNOWN', 'Low Back Pain', None, 'Federal University of São Paulo', None, '100.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-03', '2013-04']\n['NCT01089595', 'Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)', None, 'TERMINATED', 'GIST|Metastatic Disease', 'DRUG: Nilotinib|DRUG: Nilotinib with Imatinib', 'Fox Chase Cancer Center', 'Novartis', '5.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2009-02', '2012-03']\n['NCT00362895', 'A Bioequivalence Study of Tobradex AF', None, 'COMPLETED', 'Cataract', 'DRUG: Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension|DRUG: Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX)', 'Alcon Research', None, '995.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2006-04', '2006-08']\n['NCT02186795', 'Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia', 'THA', 'COMPLETED', 'Arthroplasty|Replacement Hip|Arthritis', None, 'Medical University of South Carolina', None, '117.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2013-04', '2014-03']\n['NCT00816595', 'Pentostatin Cyclophosphamide and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma', None, 'COMPLETED', 'Leukemia|Lymphoma', 'BIOLOGICAL: bevacizumab|BIOLOGICAL: pegfilgrastim|BIOLOGICAL: rituximab|DRUG: cyclophosphamide|DRUG: pentostatin', 'Mayo Clinic', 'National Cancer Institute (NCI)', '68.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2009-02', '2016-11-29']\n['NCT02225795', \"Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.\", None, 'WITHDRAWN', \"Crohn's Disease\", 'OTHER: Hematopoietic stem cell transplantation', 'TriStar Health', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2014-08', '2019-12']\n['NCT03134495', 'the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections.', 'UTOPIE', 'COMPLETED', 'Community Infections', 'OTHER: all children with at least one prescription of PPI|OTHER: all children with no prescription of PPI', 'Centre Hospitalier Universitaire Dijon', None, '290286.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-03', '2017-04']\n['NCT01447095', 'Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage', None, 'COMPLETED', 'Subarachnoid Hemorrhage', 'DRUG: Prostacyclin 1 ng/kg/min|DRUG: Prostacyclin 2 ng/kg/min|DRUG: Placebo', 'Rune Rasmussen', None, '90.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2011-10', '2014-06']\n['NCT00864695', 'Role of Anesthesiologist-Patient Relationship', None, 'COMPLETED', 'Preoperative|Anesthesia|Postoperative', 'OTHER: Supportive care', 'UPECLIN HC FM Botucatu Unesp', 'Faculdade de Medicina de Botucatu UNESP Botucatu Brasil|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.', '1137.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2007-05', '2008-05']\n['NCT00668395', 'Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics', None, 'COMPLETED', 'HIV', 'DRUG: Efavirenz', 'Indiana University', None, '73.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2007-05', '2010-04']\n['NCT02136095', 'Promising Initial Experience With Intra-operative Fluorescent Cholangiography', None, 'COMPLETED', 'Gall Stone Disease', 'PROCEDURE: Intraoperative fluorescent cholangiography (IFC)', 'Hvidovre University Hospital', None, '35.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2013-09', '2013-12']\n['NCT02520895', 'Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia', 'RIPAL', 'COMPLETED', 'LYMPHOMA', 'BIOLOGICAL: blood samplings', 'Hospices Civils de Lyon', None, '98.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2010-09', '2013-10']\n['NCT00300495', 'Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection', None, 'TERMINATED', 'Atrial Fibrillation|Lung Cancer', 'DRUG: Amiodarone|OTHER: Control arm standard care', 'Beth Israel Deaconess Medical Center', None, '19.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2006-02', '2009-10-13']\n['NCT01240395', 'Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity', None, 'COMPLETED', 'Multiple Chemical Sensitivity', 'BEHAVIORAL: Mindfulness-based Cognitive Therapy (MBCT)', 'The Danish Research Centre for Chemical Sensitivities', None, '82.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2011-09', '2013-05']\n['NCT01549795', 'Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy', None, 'UNKNOWN', 'Hilar Cholangiocarcinoma|Primary Sclerosing Cholangitis', 'PROCEDURE: Liver transplantation|RADIATION: 45 Gy external radiations|RADIATION: Endoluminal bile duct Brachytherapy|DRUG: Capecitabine|PROCEDURE: Pre liver transplantation laparoscopic hand assisted staging', 'Azienda Ospedaliera di Padova', None, '33.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-01', None]\n['NCT00420095', 'A Study for Patients With Diabetes Mellitus (IOPA)', 'IOPA', 'COMPLETED', 'Diabetes Mellitus Type 1|Diabetes Mellitus Type 2', 'DRUG: Human insulin 30/70|DRUG: Insulin lispro low mix', 'Eli Lilly and Company', None, '117.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', '2007-01', '2008-01']\n['NCT01246895', 'Follow-Up Study Evaluating The Long Term Safety and Efficacy of BST-CarGel and Microfracture Repair of the Knee', None, 'COMPLETED', 'Knee Injuries', 'DEVICE: Microfracture with BST-CarGel|DEVICE: Microfracture without BST-CarGel', 'Piramal Healthcare Canada Ltd', None, '67.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2011-03', '2014-03']\n['NCT02666495', 'Individual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series', None, 'UNKNOWN', 'Anorexia Nervosa', 'OTHER: Psychological Therapy - Schema Therapy', 'NHS Lothian', None, '15.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-01', '2019-01']\n['NCT01501695', 'Phase III Study of 5LGr to Treat Tic Disorder', '5LGr', 'COMPLETED', 'Tic Disorder|Tourette Syndrome|Chronic Tic Disorder', 'DRUG: 5LGr|DRUG: tiapride|DRUG: placebo', 'Tasly Pharmaceuticals Inc.', None, '603.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2008-01', '2011-10']\n['NCT02132195', 'Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome', None, 'COMPLETED', 'Nephrotic Syndrome', 'DRUG: ACTH', 'Emory University', 'Mallinckrodt', '31.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2014-05', '2018-03']\n['NCT02409095', 'Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants', None, 'TERMINATED', 'Immune Response to DTP-HB-Hib Vaccine', 'BIOLOGICAL: DTP-HB-Hib vaccine|DEVICE: Disposable Syringe Jet Injector (DSJI)|OTHER: Needle & Syringe', 'Serum Institute of India Pvt. Ltd.', 'PATH', '211.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2015-01', '2016-03']\n['NCT00568295', 'A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee', None, 'COMPLETED', 'Osteoarthritis of the Knee', 'DRUG: acetaminophen|DRUG: Rofecoxib|DRUG: Rofecoxib', 'Johnson & Johnson Consumer and Personal Products Worldwide', None, '403.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '1999-10', '2000-10']\n['NCT01891695', 'OPSCC N0 Nodal Control With Reduced IMRT', None, 'TERMINATED', 'Oropharyngeal Squamous Cell Carcinoma (OPSCCA)|HPV (Human Papillomavirus)-Associated', 'RADIATION: 39.6 Gy radiation', 'Paul W. Read MD', None, '1.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2013-10', '2016-12']\n['NCT02058095', 'Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)', 'Aim 3', 'COMPLETED', 'Cardiomyopathy|Renal Impairment', 'DRUG: Tadalafil|DRUG: Placebo', 'Mayo Clinic', None, '22.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE', '2014-03', '2019-12']\n['NCT00417495', 'Sentinel Lymph Node Technique in Multifocal Breast Cancer', None, 'COMPLETED', 'Breast Cancer', 'BEHAVIORAL: Sentinel Lymph Node Technique', 'Centre Oscar Lambret', None, '216.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2006-03', '2008-09']\n['NCT02893995', 'Safety Tolerability Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension', None, 'WITHDRAWN', 'Pulmonary Arterial Hypertension', 'DRUG: Slow Dose Titration Group of Subcutaneous Treprostinil|DRUG: Rapid Dose Titration Group of Subcutaneous Treprostinil', 'United Therapeutics', 'CVie Therapeutics Co. Ltd.', '0.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2017-02', '2018-04']\n['NCT04001595', 'Global FKRP Registry', None, 'RECRUITING', 'LGMD2I|LGMDR9|Limb Girdle Muscular Dystrophy|Congenital Muscular Dystrophy|Muscle-Eye-Brain Disease|Walker-Warburg Syndrome|FKRP Gene Mutation', 'OTHER: Patient Registry', 'Newcastle University', 'LGMD2i Research Fund|CureLGMD2i|Ludwig-Maximilians - University of Munich', '1000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2013-11', '2025-12']\n['NCT00199095', 'Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia', None, 'COMPLETED', 'Adult Acute Lymphocytic Leukemia', 'DRUG: Adriamycin|DRUG: Cyclophosphamide|DRUG: Cytarabine|DRUG: Dexamethasone|DRUG: Idarubicin|DRUG: Ifosfamide|DRUG: Methotrexate|DRUG: Mercaptopurine|DRUG: VM26|DRUG: Vincristine', 'Goethe University', None, '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '1997-02', '2003-06']\n['NCT00901095', 'Can Diet- and Exercise-Induced Weight Loss Improve Asthma Control in Adults?', None, 'COMPLETED', 'Asthma|Obesity', 'BEHAVIORAL: Lifestyle intervention', 'Palo Alto Medical Foundation', 'National Heart Lung and Blood Institute (NHLBI)|Kaiser Permanente|Stanford University', '330.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2010-02', '2014-03']\n['NCT02255695', 'Effects of a School-based Exercise Program on Posture Trunk Range of Motion and Musculoskeletal Pain', None, 'COMPLETED', 'Musculoskeletal and Connective Tissue Disorders', 'OTHER: School-based exercise program', 'Universidade Federal de Sao Carlos', 'Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.|Conselho Nacional de Desenvolvimento Científico e Tecnológico', '300.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2008-12', '2012-12']\n['NCT03049995', 'Stress Echo 2020 - The International Stress Echo Study', 'SE2020', 'UNKNOWN', 'Coronary Artery Disease|Heart Failure|Hypertrophic Cardiomyopathy|Aortic Valve Disease|Athletes Heart|Tetralogy of Fallot|Pulmonary Arterial Hypertension', 'PROCEDURE: Left ventricular contractile reserve SE|PROCEDURE: B-lines SE|PROCEDURE: Left ventricular outflow tract gradient SE|PROCEDURE: Diastolic function SE|PROCEDURE: Mitral regurgitation SE|PROCEDURE: Pulmonary hemodynamics SE|PROCEDURE: Coronary flow reserve SE', 'Fatebenefratelli Hospital', \"Institute of Clinical Physiology CNR PisaItaly|Salerno Hospital Italy|Monaldi Hospital Napoli Italy|University of Pisa Italy|San Luca Hospital Lucca Italy|Careggi University Hospital Florence Italy|Federico II University|San Carlo Public Hospital Potenza Italy|Royal Brompton & Harefield NHS Foundation Trust|Ospedale dell'Angelo Venezia-Mestre|University of Parma|Hospital Clinics Trieste Italy|Federal University of Rio Grande do Sul|Hospital San José Criciuma Brasil|Hospital San Vicente de Paulo Passo Fundo Brasil|University of Belgrade|University of Szeged Hungary|Elisabeth Hospital Hodmezovasarhely Hungary|Sandro Pertini Hospital Rome Italy|Hospital Clinics Bari Italy|Ospedale Nottola Siena Italy|University of Catania Italy|Medika Cardiocenter Saint Petersburg Russian Federation|Acibadem City Clinic Tokuda Hospital|Investigaciones Medicas Buenos Aires Argentina|Tomsk National Research Scientific Centre of Russian Academy of Sciences Tomsk Russian Federation|Instituto Nacional de Cardiología Mexico City Mexico|Hamad Medical Corporation Heart Hospital -Doha-Qatar\", '300.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2016-11', '2021-12']\n['NCT01811095', 'A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing', None, 'COMPLETED', 'Neoplasms', 'OTHER: Training', 'McGill University', None, '27.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: ', '2013-03', '2013-06']\n['NCT00804895', 'Cluster Headache Cortivazol Injection (CHCI)', 'CHCI', 'COMPLETED', 'Cluster Headache', 'DRUG: ALTIM cortivazol injections|DRUG: PROAMP subcutaneous serum physiological saline|DRUG: Verapamil', 'Assistance Publique - Hôpitaux de Paris', None, '43.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2008-12', '2009-10']\n['NCT02782195', 'Evaluation of Gut Absorption Rate of Glucose After a Large Evening Meal in Type 1 Diabetes', None, 'COMPLETED', 'Type 1 Diabetes', None, 'University of Cambridge', 'Cambridge University Hospitals NHS Foundation Trust', '16.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2008-11', '2011-06']\n['NCT00843895', 'Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years', 'Pneumococci', 'UNKNOWN', 'Pneumococcal Disease', 'BIOLOGICAL: pneumococcal conjugate vaccine(prevenar)', 'King Saud University', None, '400.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SCREENING', '2009-03', '2009-12']\n['NCT00145795', 'A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment', None, 'COMPLETED', 'HIV Infections', 'DRUG: Kaletra + Current Dual NRTI Backbone|DRUG: Current Regimen', 'University of Chicago', 'Abbott', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2004-04', '2009-12']\n['NCT06182995', 'Anticipating Decline and Providing Therapy', 'ADAPT', 'NOT_YET_RECRUITING', 'Cognitive Impairment|Dementia|Post ICU Syndrome|Critical Illness|Cognitive Impairment Mild', 'BEHAVIORAL: Usual Care post-Intensive Care Unit (ICU)|BEHAVIORAL: Anticipating Decline and Providing Therapy (ADAPT)', 'Wake Forest University Health Sciences', 'National Institute on Aging (NIA)', '120.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2024-03', '2027-03']\n['NCT04061395', 'Guselkumab for Hidradenitis Suppurativa a Mode of Action Study.', 'HiGUS', 'UNKNOWN', 'Hidradenitis Suppurativa', 'BIOLOGICAL: Guselkumab', 'Barbara Horváth Principal Investigator', 'Janssen-Cilag Ltd.', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER', '2019-09', '2020-12']\n['NCT01170195', 'Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms', None, 'UNKNOWN', 'Postmenopausal Symptoms|Vaginal Dryness', 'DIETARY_SUPPLEMENT: Calmera-Licorice Root Extract (Licogen)', 'F&C Licorice Ltd', None, '120.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2010-09', '2011-09']\n['NCT02574195', 'Evolution of Effectiveness of Diabetes Medical Care in Russia', None, 'COMPLETED', 'Diabetes Mellitus Type 2|Diabetes Mellitus Type 1', None, 'Endocrinology Research Centre Moscow', None, '599.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-08', '2015-10']\n['NCT01388595', 'Fluticasone and Salmeterol in Allergic Rhinitis', None, 'COMPLETED', 'Allergic Rhinitis', 'DRUG: FLUTICASONE PROPRIONATE|DRUG: Salmeterol|DRUG: PLACEBO', 'University of Dundee', None, '23.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2006-11', '2010-10']\n['NCT00382395', 'SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma', None, 'SUSPENDED', 'Glaucoma|Glaucoma Open Angle', 'DEVICE: SOLX Gold Shunt GMS-plus|DEVICE: Ahmed FP7 Glaucoma Valve', 'SOLX Inc.', None, '180.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2005-11', '2017-07']\n"
     ]
    }
   ],
   "source": [
    "# Now, let's split the start_without_none column into two such that first part start_without_none_with_day --> contains the format YYYY-MM--DD and second part start_without_none_with_month --> contains the format YYYY-MM in order to do the required data transformation. #since, the row no.293056 doesn't contain the last values, we can remove it from the dataset\n",
    "\n",
    "start_without_none_with_day = start_without_none.filter(lambda row: len(row) > 12 and row[12] is not None and len(row[12]) == 10)\n",
    "\n",
    "start_without_none_with_month = start_without_none.filter(lambda row: len(row) > 12 and row[12] is not None and len(row[12]) == 7)\n",
    "\n",
    "# Print the start_without_none_with_day RDD\n",
    "print(\"start column values (Containing date values in YYYY-MM-DD format):\")\n",
    "for row in start_without_none_with_day.collect():\n",
    "    print(row)\n",
    "\n",
    "# Print the start_without_none_with_month RDD\n",
    "print(\"\\nstart column values (Containing date values in YYYY-MM format):\")\n",
    "for row in start_without_none_with_month.collect():\n",
    "    print(row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "8441cfe4-58ca-4ca1-be26-dc858ac7bfd2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Rows that don't fit in either condition:\n"
     ]
    }
   ],
   "source": [
    "# Convert each row in start_without_none RDD to a tuple\n",
    "start_without_none_tuples = start_without_none.map(tuple)\n",
    "\n",
    "# Now, let's split the start_without_none column into two such that first part \n",
    "# start_without_none_with_day contains the format YYYY-MM-DD and second part \n",
    "# start_without_none_with_month contains the format YYYY-MM in order to do the required data transformation\n",
    "\n",
    "start_without_none_with_day = start_without_none_tuples.filter(lambda row: len(row) > 12 and row[12] is not None and len(row[12]) == 10)\n",
    "\n",
    "start_without_none_with_month = start_without_none_tuples.filter(lambda row: len(row) > 12 and row[12] is not None and len(row[12]) == 7)\n",
    "\n",
    "# Find the rows that don't fit in either condition\n",
    "not_in_either = start_without_none_tuples.subtract(start_without_none_with_day).subtract(start_without_none_with_month)\n",
    "\n",
    "# Print the rows that don't fit in either condition\n",
    "print(\"Rows that don't fit in either condition:\")\n",
    "for row in not_in_either.collect():\n",
    "    print(row)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "cfc3d2fb-aabd-4b10-9857-37fe8bf95c32",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of data rows in the start_with_none: 5144\nNumber of data rows in the start_without_none_with_day: 263582\nNumber of data rows in the start_without_none_with_month: 214694\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# Get the count of data rows in the RDD\n",
    "row_count = start_with_none.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the start_with_none:\", row_count)\n",
    "# Get the count of data rows in the RDD\n",
    "row_count = start_without_none_with_day.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the start_without_none_with_day:\", row_count)\n",
    "# Get the count of data rows in the RDD\n",
    "row_count = start_without_none_with_month.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the start_without_none_with_month:\", row_count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e080df3e-6c7d-4100-88a3-58e2393e9ec7",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "All values in the start_without_none_with_month have the format YYYY-MM\n"
     ]
    }
   ],
   "source": [
    "# Now, let's initialize a variable to track if all values have the format YYYY-MM\n",
    "required_format = True\n",
    "\n",
    "# Iterate through each row in the RDD start_without_none_with_month and to check the format it\n",
    "for row in start_without_none_with_month.collect():\n",
    "    if len(row[12]) != 7:\n",
    "        required_format = False\n",
    "        break  # Exit the loop early if a value with unexpected format is found\n",
    "\n",
    "# Print the result\n",
    "if required_format:\n",
    "    print(\"All values in the start_without_none_with_month have the format YYYY-MM\")\n",
    "else:\n",
    "    print(\"Not all values in the start_without_none_with_month have the format YYYY-MM\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "6215fa7c-57ed-4f3e-a75a-5115175b72b8",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('NCT00237471', 'Impact of Tight Glycaemic Control in Acute Myocardial Infarction', None, 'TERMINATED', 'Myocardial Infarct|Hyperglycemia', 'DRUG: Insulin (tight blood glucose control)', 'Melbourne Health', 'National Health and Medical Research Council Australia|Bristol-Myers Squibb', '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2005-10-01', '2006-05')\n('NCT02945371', 'Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life', 'REV', 'COMPLETED', 'Smoking|Alcohol Drinking|Prescription Drug Abuse|Substance-Related Disorders|Oral Intake Reduced', 'BEHAVIORAL: Person-centered inhibitory control training|BEHAVIORAL: Active behavioral response training', 'University of Oregon', None, '103.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION', '2014-09-01', '2016-05')\n('NCT01055171', 'Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence', None, 'COMPLETED', 'Alcohol Dependence|PTSD', 'DRUG: Propranolol|DRUG: Placebo', 'Medical University of South Carolina', 'National Institute on Alcohol Abuse and Alcoholism (NIAAA)', '44.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2010-01-01', '2012-08')\n('NCT01125371', 'Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women', None, 'COMPLETED', 'Alcohol; Harmful Use|Binge Drinking|Risk Behavior|HIV Infection', 'BEHAVIORAL: Computerized brief alcohol intervention + IVR booster calls|BEHAVIORAL: Computerized brief alcohol intervention|BEHAVIORAL: Attention Control', 'Johns Hopkins University', 'National Institute on Alcohol Abuse and Alcoholism (NIAAA)', '439.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2011-10-01', '2016-06-07')\n('NCT02554071', 'Manitoba Pharmacist Initiated Smoking Cessation Pilot Project', None, 'COMPLETED', 'Smoking Cessation', 'OTHER: Pharmacist - Smoking Cessation Support', 'University of Manitoba', 'Govenment of Manitoba|Canadian Foundation for Pharmacy|Neighbourhood Pharmacy Association of Canada', '119.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2014-01-01', '2014-11')\n('NCT02633371', 'A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults', None, 'COMPLETED', 'Hyperhidrosis', 'DRUG: Oxybutynin 3% gel', 'University of Colorado Denver', 'Society for Pediatric Dermatology', '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-02-01', '2017-05')\n('NCT00120471', 'Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies', None, 'COMPLETED', 'HIV Infections', 'DRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute on Drug Abuse (NIDA)|National Institute of Mental Health (NIMH)', '122.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2006-11-01', '2011-12')\n('NCT02383771', 'Reversal of the Anti-platelet Effects of Ticagrelor', 'REVERSAL', 'COMPLETED', 'Coronary Artery Disease', 'DRUG: Ticagrelor|DRUG: Aspirin + Ticagrelor|DRUG: Control|DRUG: Aspirin + Ticagrelor', 'The First Affiliated Hospital with Nanjing Medical University', 'National Natural Science Foundation of China', '64.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT', '2015-03-01', '2016-12')\n('NCT01659671', 'RCT of the Effect of Uvulopalatopharyngoplasty Compared to Expectancy in Patients With Obstructive Sleep Apnea', 'SKUP3', 'COMPLETED', 'Obstructive Sleep Apnea Syndrome', 'PROCEDURE: Uvulopalatopharyngoplasty', 'Karolinska University Hospital', 'Karolinska Institutet', '65.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2007-06-01', '2014-05')\n('NCT02830971', 'Developing a Standardized Learning Curve', None, 'COMPLETED', 'Registered Nurses|Nursing Personnel|Motor Skills', 'PROCEDURE: Doing Different ICU techniques and skills', 'Baqiyatallah Medical Sciences University', 'Shahid Beheshti University|Tehran University of Medical Sciences', '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2016-07-01', '2021-04-12')\n('NCT02083471', \"Cow's Milk and Hen's Egg Hyposensitization in Adults\", None, 'UNKNOWN', \"Egg Allergy|Cow's Milk Allergy\", \"DIETARY_SUPPLEMENT: Specific Oral Tolerance Induction with Egg or Cow's milk\", 'Turku University Hospital', None, '40.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2015-04-01', '2017-05')\n('NCT01062971', 'Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide', None, 'COMPLETED', 'Primary Open Angle Glaucoma|Ocular Hypertension', 'DRUG: dorzolamide-timolol-brimonidine', 'Laboratorios Sophia S.A de C.V.', None, '124.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2006-02-01', '2008-06')\n('NCT00897871', 'Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer', None, 'UNKNOWN', 'Unspecified Childhood Solid Tumor Protocol Specific', 'DRUG: carboplatin|DRUG: cyclophosphamide|DRUG: etoposide phosphate|GENETIC: gene expression analysis|GENETIC: polymorphism analysis|OTHER: pharmacological study', \"Children's Cancer and Leukaemia Group\", None, '60.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2007-02-01', None)\n('NCT00848471', 'Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems)', 'Protocol Quark', 'UNKNOWN', 'Healthy|Obesity', 'DEVICE: Quark RMR|DEVICE: Deltatrac II', 'Hospices Civils de Lyon', 'Centre de Recherche en Nutrition Humaine Rhone-Alpe', '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2009-01-01', '2009-12')\n('NCT01189071', 'Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain', None, 'TERMINATED', 'Overactive Bladder|Renal Colic|Pain Postoperative', 'DRUG: Darifenacin', 'University of Missouri-Columbia', None, '3.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2009-08-01', '2011-07')\n('NCT00728871', 'The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis', None, 'UNKNOWN', 'Cervical Cancer|Cervical Intraepithelial Neoplasia', 'PROCEDURE: peripheral blood isolation', 'National Taiwan University Hospital', None, '600.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2005-12-01', '2011-12')\n('NCT00520871', 'The Water-Blueberry Study', None, 'COMPLETED', 'Cardiovascular Disease', 'DRUG: Blueberry juice', 'University of Oslo', 'Ullevaal University Hospital', '62.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: PREVENTION', '2003-03-01', '2004-04')\n('NCT03075371', 'Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa', None, 'COMPLETED', 'Anorexia Nervosa|Healthy', 'OTHER: Glucose|OTHER: Placebo', 'University of Heidelberg Medical Center', 'German Research Foundation', '85.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE', '2014-09-01', '2019-02')\n('NCT00266071', 'Study of the Cutaneous Microcirculation in Elderly People', None, 'UNKNOWN', 'Elderly People', 'BEHAVIORAL: Cutaneous response', 'University Hospital Angers', None, None, 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2005-12-01', None)\n('NCT02121171', 'Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma', None, 'UNKNOWN', 'Congenital Glaucoma', 'DEVICE: Ologen Collagen Matrix|PROCEDURE: Combined trabeculotomy-trabeculectomy', 'National Centre of Ophthalmology named after academician Zarifa Aliyeva', 'Aeon Astron Europe B.V.', '40.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2010-09-01', '2015-09')\n('NCT01068171', 'Developing a Diabetic Foot Ulcer Protocol', None, 'WITHDRAWN', 'Diabetic Foot Ulcers', 'OTHER: type of footwear|OTHER: collagen dressing with and without silver', 'The University of Texas Health Science Center Houston', 'Harris County Hospital District|Baylor College of Medicine', '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2010-05-01', '2012-06')\n('NCT00553371', 'Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer', None, 'UNKNOWN', 'Testicular Germ Cell Tumor', 'OTHER: biomarker analysis|PROCEDURE: computed tomography', 'Royal Marsden NHS Foundation Trust', None, '300.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2006-04-01', None)\n('NCT02344771', 'Perioperative Endothelial Dysfunction', None, 'COMPLETED', 'Myocardial Injury', 'PROCEDURE: Elective colon cancer surgery', 'Zealand University Hospital', None, '31.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-03-01', '2015-06')\n('NCT03354871', 'Developing Models for Fatigue Monitoring in Obstetrics and Gyne- Cology Residents Using Wearables', 'IoT4Resident', 'UNKNOWN', 'Fatigue', None, 'Hillel Yaffe Medical Center', 'International Business Machines (IBM)', '6.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2017-11-01', '2018-02-28')\n('NCT00991471', 'The Effect of an Physician-Nurse Supplementary Triage Assistance Team on Emergency Department Patient Wait Times', 'MDRNSTAT', 'COMPLETED', 'Emergencies', 'BEHAVIORAL: Interaction with MDRN STAT|BEHAVIORAL: No MDRNSTAT', 'Sunnybrook Health Sciences Centre', None, '6300.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2009-09-01', '2010-02')\n('NCT02069171', 'Cross-sectional and Questionnaire Study for Leg Lymphedema', None, 'COMPLETED', 'Gynecologic Cancer', None, 'National Cancer Center Korea', None, '333.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-06-01', '2012-11')\n('NCT00474071', 'Optimum Dose of Remifentanil for Intubation in Small Children', None, 'COMPLETED', 'Endotracheal Intubation', 'DRUG: Remifentanil', 'University of British Columbia', None, '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2007-03-01', '2008-04')\n('NCT02022371', 'Prostate Cancer Genomic Heterogeneity', 'PROGENY', 'COMPLETED', 'PROSTATE CANCER', 'PROCEDURE: Targeted biopsies of the prostate', 'University College London Hospitals', None, '50.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2014-09-01', '2016-06')\n('NCT01523171', 'Phase II Open Label Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib', 'JAKARTA2', 'COMPLETED', 'Hematopoietic Neoplasm', 'DRUG: SAR302503', 'Sanofi', None, '97.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-04-01', '2014-04')\n('NCT00000571', 'Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease', None, 'COMPLETED', 'Lung Diseases|Lung Diseases Obstructive|Chronic Obstructive Pulmonary Disease', 'DEVICE: ventilators negative pressure', 'McGill University', 'National Heart Lung and Blood Institute (NHLBI)', None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT', '1986-02-01', None)\n('NCT01053871', 'Propofol Versus Midazolam With Fentanyl for EGD Endomicroscopy', None, 'COMPLETED', 'Gastritis|Functional Dyspepsia', 'DRUG: propofol|DRUG: midazolam with fentanyl', 'Shandong University', None, '104.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: ', '2010-01-01', '2010-05')\n('NCT05974371', 'Episodic Memory Integration and Interference', None, 'NOT_YET_RECRUITING', 'Episodic Memory', 'OTHER: emotional context similarity', 'Boston College', None, '150.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2024-08-01', '2027-08')\n('NCT02645071', 'Brief Program in Reducing Sedentary Behavior and Promoting Physical Exercise', None, 'COMPLETED', 'Physical Activity', 'BEHAVIORAL: Physical Activity', 'The University of Hong Kong', 'Hong Kong Jockey Club Charities Trust', '141.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION', '2015-07-01', '2017-07')\n('NCT02570971', 'Mannitol Versus Supportive Care in Ciguatera Fish Poisoning', None, 'UNKNOWN', 'Ciguatoxin', 'DRUG: Mannitol', 'University of South Florida', 'Florida Poison Control Center', '200.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2015-10-01', None)\n('NCT03987971', 'Acupuncture on GB26 to Treat Chronic Low Back Pain', None, 'UNKNOWN', 'Chronic Low-back Pain', 'OTHER: acupuncture', 'Wenzhou Medical University', \"Qingtian People's hospital\", '114.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2020-01-01', '2021-07')\n('NCT02827071', 'Ocular Imaging Study Using Advanced OCT', None, 'UNKNOWN', 'Retinal Vascular Disorder|Macular Degeneration', None, 'University of California Los Angeles', None, '1000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2016-07-01', None)\n('NCT01780571', 'CPAP/PSV Preoxygenation in Obese Patients', None, 'COMPLETED', 'Obesity|Anaesthesia', 'PROCEDURE: CPAP 5 cm H2O + PSV 5 cm H2O', 'Karolinska Institutet', None, '44.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION', '2009-05-01', '2012-12')\n('NCT02529371', 'Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients', None, 'UNKNOWN', 'Urinary Incontinence', 'DEVICE: UriCap-RM', 'G.R. Dome Medical Ltd.', None, '30.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2015-09-01', '2015-10')\n('NCT02309671', 'A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment', None, 'COMPLETED', 'Infertility', 'DRUG: FE 999049|DRUG: follitropin beta', 'Ferring Pharmaceuticals', None, '159.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2014-12-01', '2016-09')\n('NCT01889771', 'A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline', None, 'COMPLETED', 'Smoking Cessation', 'DRUG: Nicotine Patch', 'University of Colorado Denver', None, '1495.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2010-03-01', '2012-03')\n('NCT02912871', \"Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease\", None, 'COMPLETED', \"Parkinson's Disease\", 'OTHER: MRIgHIFU unilateral subthalamotomy', 'Fundación de investigación HM', 'Insightech', '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-04-01', '2017-01')\n('NCT01449071', 'Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)', None, 'COMPLETED', 'Systemic Lupus Erythematosus', 'BIOLOGICAL: Placebo|BIOLOGICAL: Epratuzumab 400 mg|BIOLOGICAL: Epratuzumab 1200 mg|BIOLOGICAL: Epratuzumab 100 mg|BIOLOGICAL: Epratuzumab 600 mg', 'UCB Pharma', None, '20.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2011-10-01', '2013-03')\n('NCT00080171', 'Osteoarthritis Initiative (OAI): A Knee Health Study', None, 'COMPLETED', 'Osteoarthritis|Knee Osteoarthritis', None, 'National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)', 'GlaxoSmithKline|Merck Sharp & Dohme LLC|Novartis|Pfizer', '4796.0', 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2004-02-01', '2015-10')\n('NCT00368771', 'A Six-month Study to Compare Outcome Differences and Visceral Response ... Irritable Bowel Syndrome', None, 'COMPLETED', 'Irritable Bowel Syndrome', 'BEHAVIORAL: IBS Stress Management|BEHAVIORAL: IBS Symptom Management|BEHAVIORAL: IBS Educational Training', 'University of California Los Angeles', 'National Institute of Nursing Research (NINR)', '163.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2002-07-01', '2010-05')\n('NCT00858871', 'First Line Hepato Cellular Carcinoma (HCC)', 'BRISK FL', 'COMPLETED', 'Hepato Cellular Carcinoma (HCC)', 'DRUG: Brivanib|DRUG: Placebo|DRUG: Sorafenib|DRUG: Placebo', 'Bristol-Myers Squibb', None, '1714.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2009-05-01', '2013-09')\n('NCT01776671', 'Once Daily Gabapentin in the Treatment of Post Amputation Pain', None, 'UNKNOWN', 'Pain|Quality of Life', 'DRUG: Gralise', 'Chicago Anesthesia Pain Specialists', None, '16.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2013-02-01', '2018-12')\n('NCT01363271', 'Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients', None, 'COMPLETED', 'Complicated Skin and Structure Infection|Nosocomial Pneumonia', 'DRUG: Linezolid|DRUG: Vancomycin|DRUG: Linezolid|DRUG: Vancomycin', 'Pfizer', 'University of Maryland|Lodise & Lodise LLC', '7260.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2011-05-01', '2012-05')\n('NCT01282671', 'Effects of Deep Breathing Exercises Two Months After Cardiac Surgery', None, 'COMPLETED', 'CABG|Valve Surgery', 'OTHER: Breathing exercises', 'Uppsala University', 'The Swedish Research Council|Örebro County Council', '357.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2007-09-01', '2012-08')\n('NCT05334771', 'Early Detection of Endolymphatic Hydrops in Hypothyroid Patients', None, 'NOT_YET_RECRUITING', 'Hypothyroidism', 'DEVICE: Dual band pure tune audiometer', 'Assiut University', None, '50.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2022-09-01', '2025-04')\n('NCT00961571', 'Sunitinib and Capecitabine for First Line Colon Cancer', None, 'TERMINATED', 'Metastatic Colorectal Cancer', 'DRUG: sunitinib and capecitabine', 'Georgetown University', 'Pfizer', '50.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2009-08-01', '2011-03')\n('NCT02240771', 'Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma', None, 'UNKNOWN', 'Hepatocellular Carcinoma', 'PROCEDURE: Transarterial chemotherapy|DRUG: Oral chemotherapy', 'All India Institute of Medical Sciences New Delhi', 'Indian Council of Medical Research', '124.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2006-01-01', '2015-03')\n('NCT03365271', 'The Post-operative Effect of Applying Drainage on Total Knee Arthroplasty', None, 'UNKNOWN', 'Knee Osteoarthritis', 'PROCEDURE: drainage|PROCEDURE: non-drainage', \"Peking University People's Hospital\", None, '100.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2018-02-01', '2019-02')\n('NCT01740271', 'A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients', None, 'RECRUITING', 'Breast Neoplasms', 'DRUG: Epirubicin', 'AHS Cancer Control Alberta', None, '48.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-12-01', '2025-06')\n('NCT00912171', 'Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children', 'SB-OSAS', 'COMPLETED', 'Obstructive Sleep Apnea Syndrome', 'DRUG: budesonide (Aircort 50 nasal spray)|DRUG: montelukast (Singulair)', 'University of Bologna', None, '45.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2009-01-01', '2010-06')\n('NCT01640171', 'Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival', None, 'COMPLETED', 'Age-related Macular Degeneration|Central Retinal Vein Occlusion|Diabetic Macular Edema', 'PROCEDURE: Xylocaine 2% Injectable Anesthetic|DRUG: Proparacaine Hydrochloride 0.5% Drop|DRUG: Tetravisc 0.5% Gel|DRUG: Acuvail|DRUG: Intra-vitreal Anti-VEGF Drug', 'Retina Vitreous Associates of Florida', None, '57.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2012-07-01', '2013-10')\n('NCT00507871', 'Transmission and the Respiratory Tract in Cryptosporidiosis', None, 'COMPLETED', 'Cryptosporidiosis', None, 'Tufts University', 'National Institute of Allergy and Infectious Diseases (NIAID)', '480.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2007-10-01', '2009-01')\n('NCT00672971', 'Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice', None, 'COMPLETED', 'Head Lice', 'OTHER: 4% dimethicone foam|OTHER: 1% permethrin', 'Oystershell NV', None, '31.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2007-09-01', '2007-11')\n('NCT02352571', 'Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer', None, 'UNKNOWN', 'Neoplasm Metastasis|Gastric Cancer|Colorectal Cancer', 'BIOLOGICAL: GC1118', 'Green Cross Corporation', None, '72.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2015-01-01', '2017-06')\n('NCT00611871', 'The Use of Propranolol to Block Memory Reconsolidation in PTSD', None, 'TERMINATED', 'Posttraumatic Stress Disorders', 'DRUG: Propranolol|DRUG: Placebo', 'Wayne State University', 'John D. Dingell VA Medical Center|New York University', '12.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2007-09-01', '2015-09')\n('NCT01191671', 'Language and Deglutition in Children', 'LDC', 'COMPLETED', 'Child|Development', None, 'Fortaleza University', None, '89.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Pers\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n4516395', 'Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae', None, 'UNKNOWN', 'Drug Resistance|Carbapenem-Resistant Enterobacteriaceae Infection|Sepsis|Septic Shock|Critical Illness|Clinical Outcomes|Treatment Outcomes', 'OTHER: Combined antibiotic regimens|OTHER: Standard antibiotic regimens', 'Phramongkutklao College of Medicine and Hospital', None, '102.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2020-09-01', '2021-04')\n('NCT00005495', 'Primary Prevention of CHD Risk Factors Occurring in US', None, 'COMPLETED', 'Cardiovascular Diseases|Heart Diseases|Coronary Heart Disease Risk Reduction|Coronary Disease|Hypertension|Hypercholesterolemia', None, 'National Heart Lung and Blood Institute (NHLBI)', None, None, 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '1998-07-01', '1999-06')\n('NCT01198795', 'Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder', None, 'COMPLETED', 'Major Depressive Disorder', 'DRUG: Escitalopram', 'Forest Laboratories', None, '162.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2010-09-01', '2013-04')\n('NCT00052195', 'Investigational Vaccine for the Prevention of Disseminated Tuberculosis in HIV Infected People', None, 'COMPLETED', 'Tuberculosis|HIV Infections', 'BIOLOGICAL: SRL-172', 'Dartmouth-Hitchcock Medical Center', 'National Institute of Allergy and Infectious Diseases (NIAID)', '1975.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2001-09-01', '2009-05')\n('NCT02445495', 'Chart Review of the Efficacy of the GenesisPlus 1064 nm Nd:YAG Laser in the Treatment of Onychomycosis', None, 'COMPLETED', 'Onychomycosis', 'DEVICE: GenesisPlus 1064 nm Nd:YAG laser', 'Jason K Rivers MD FRCPC FAAD', 'Cutera Inc.', '100.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2013-11-01', '2014-11')\n('NCT00538395', 'Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer', None, 'UNKNOWN', 'Breast Cancer', 'DRUG: Adriamycin Taxol and Cytoxan', 'King Faisal Specialist Hospital & Research Center', None, '100.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2007-09-01', '2013-09')\n('NCT02693795', 'Baduanjin Exercise Prevents Post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER Trial)', None, 'UNKNOWN', 'Myocardial Infarction', 'OTHER: Baduanjin exercise|OTHER: aerobic exercise', 'Guangdong Provincial Hospital of Traditional Chinese Medicine', None, '110.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2016-05-01', '2018-12')\n('NCT05692895', 'PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact', None, 'NOT_YET_RECRUITING', 'PDL1- Colorectal Carcinoma', None, 'Sohag University', None, '60.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2023-02-01', '2023-07')\n('NCT00446095', 'Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma', None, 'COMPLETED', 'Lymphoma', 'DRUG: fostamatinib', 'Rigel Pharmaceuticals', None, '81.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2007-04-01', '2010-10')\n('NCT00599495', 'Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT', None, 'COMPLETED', 'Multiple Myeloma', 'PROCEDURE: allogeneic HSCT', 'Universitätsklinikum Hamburg-Eppendorf', None, '50.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2002-11-01', '2009-12')\n('NCT02994095', 'A Pilot Study of a Community Health Agent-led Diabetes Self-Management Program', None, 'COMPLETED', 'Type2 Diabetes', 'BEHAVIORAL: Pilot Study', 'University of Michigan', None, '57.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2014-03-01', '2014-12')\n('NCT06153095', 'A Study of IMPT-514 in Active Refractory Systemic Lupus Erythematosus (SLE)', None, 'NOT_YET_RECRUITING', 'Systemic Lupus Erythematosus|Lupus Nephritis', 'BIOLOGICAL: IMPT-514|BIOLOGICAL: IMPT-514|BIOLOGICAL: IMPT-514', 'ImmPACT Bio', None, '30.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2023-12-01', '2027-02')\n('NCT02865395', 'Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms', None, 'TERMINATED', 'Overactive Bladder', 'DRUG: Belladonna and Opium Suppository|PROCEDURE: Rectal Exam', 'Campbell Grant', None, '23.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2016-03-01', '2017-06')\n('NCT00071695', 'Duloxetine vs. Active Comparator in the Treatment of Patients With Depression', None, 'COMPLETED', 'Depression', 'DRUG: Duloxetine Hydrochloride|DRUG: Venlafaxine Extended Release', 'Eli Lilly and Company', None, '320.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', '2003-07-01', '2004-05')\n('NCT01556295', 'Gesture Behavior and Knowledge on Low Back Pain Among Nurses', None, 'UNKNOWN', 'Low Back Pain', None, 'Federal University of São Paulo', None, '100.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-03-01', '2013-04')\n('NCT01089595', 'Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)', None, 'TERMINATED', 'GIST|Metastatic Disease', 'DRUG: Nilotinib|DRUG: Nilotinib with Imatinib', 'Fox Chase Cancer Center', 'Novartis', '5.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2009-02-01', '2012-03')\n('NCT00362895', 'A Bioequivalence Study of Tobradex AF', None, 'COMPLETED', 'Cataract', 'DRUG: Tobramycin 0.3% / Dexamethasone 0.033% ophthalmic suspension|DRUG: Tobramycin 0.3% / Dexamethasone 0.1% ophthalmic suspension (TOBRADEX)', 'Alcon Research', None, '995.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2006-04-01', '2006-08')\n('NCT02186795', 'Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia', 'THA', 'COMPLETED', 'Arthroplasty|Replacement Hip|Arthritis', None, 'Medical University of South Carolina', None, '117.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2013-04-01', '2014-03')\n('NCT00816595', 'Pentostatin Cyclophosphamide and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma', None, 'COMPLETED', 'Leukemia|Lymphoma', 'BIOLOGICAL: bevacizumab|BIOLOGICAL: pegfilgrastim|BIOLOGICAL: rituximab|DRUG: cyclophosphamide|DRUG: pentostatin', 'Mayo Clinic', 'National Cancer Institute (NCI)', '68.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2009-02-01', '2016-11-29')\n('NCT02225795', \"Pilot Study of Stem Cell Transplantation for Children and Young Adults With Refractory Crohn's Disease.\", None, 'WITHDRAWN', \"Crohn's Disease\", 'OTHER: Hematopoietic stem cell transplantation', 'TriStar Health', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2014-08-01', '2019-12')\n('NCT03134495', 'the Impact of Paediatric Use of Proton Pump Inhibitors on the Risk of Community Acquired Infections.', 'UTOPIE', 'COMPLETED', 'Community Infections', 'OTHER: all children with at least one prescription of PPI|OTHER: all children with no prescription of PPI', 'Centre Hospitalier Universitaire Dijon', None, '290286.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-03-01', '2017-04')\n('NCT01447095', 'Effects of Prostacyclin Infusion on Cerebral Vessels and Metabolism in Patients With Subarachnoid Haemorrhage', None, 'COMPLETED', 'Subarachnoid Hemorrhage', 'DRUG: Prostacyclin 1 ng/kg/min|DRUG: Prostacyclin 2 ng/kg/min|DRUG: Placebo', 'Rune Rasmussen', None, '90.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2011-10-01', '2014-06')\n('NCT00864695', 'Role of Anesthesiologist-Patient Relationship', None, 'COMPLETED', 'Preoperative|Anesthesia|Postoperative', 'OTHER: Supportive care', 'UPECLIN HC FM Botucatu Unesp', 'Faculdade de Medicina de Botucatu UNESP Botucatu Brasil|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.', '1137.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2007-05-01', '2008-05')\n('NCT00668395', 'Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics', None, 'COMPLETED', 'HIV', 'DRUG: Efavirenz', 'Indiana University', None, '73.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2007-05-01', '2010-04')\n('NCT02136095', 'Promising Initial Experience With Intra-operative Fluorescent Cholangiography', None, 'COMPLETED', 'Gall Stone Disease', 'PROCEDURE: Intraoperative fluorescent cholangiography (IFC)', 'Hvidovre University Hospital', None, '35.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2013-09-01', '2013-12')\n('NCT02520895', 'Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia', 'RIPAL', 'COMPLETED', 'LYMPHOMA', 'BIOLOGICAL: blood samplings', 'Hospices Civils de Lyon', None, '98.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2010-09-01', '2013-10')\n('NCT00300495', 'Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection', None, 'TERMINATED', 'Atrial Fibrillation|Lung Cancer', 'DRUG: Amiodarone|OTHER: Control arm standard care', 'Beth Israel Deaconess Medical Center', None, '19.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2006-02-01', '2009-10-13')\n('NCT01240395', 'Mindfulness-based Cognitive Therapy for Individuals With Multiple Chemical Sensitivity', None, 'COMPLETED', 'Multiple Chemical Sensitivity', 'BEHAVIORAL: Mindfulness-based Cognitive Therapy (MBCT)', 'The Danish Research Centre for Chemical Sensitivities', None, '82.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2011-09-01', '2013-05')\n('NCT01549795', 'Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy', None, 'UNKNOWN', 'Hilar Cholangiocarcinoma|Primary Sclerosing Cholangitis', 'PROCEDURE: Liver transplantation|RADIATION: 45 Gy external radiations|RADIATION: Endoluminal bile duct Brachytherapy|DRUG: Capecitabine|PROCEDURE: Pre liver transplantation laparoscopic hand assisted staging', 'Azienda Ospedaliera di Padova', None, '33.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-01-01', None)\n('NCT00420095', 'A Study for Patients With Diabetes Mellitus (IOPA)', 'IOPA', 'COMPLETED', 'Diabetes Mellitus Type 1|Diabetes Mellitus Type 2', 'DRUG: Human insulin 30/70|DRUG: Insulin lispro low mix', 'Eli Lilly and Company', None, '117.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', '2007-01-01', '2008-01')\n('NCT01246895', 'Follow-Up Study Evaluating The Long Term Safety and Efficacy of BST-CarGel and Microfracture Repair of the Knee', None, 'COMPLETED', 'Knee Injuries', 'DEVICE: Microfracture with BST-CarGel|DEVICE: Microfracture without BST-CarGel', 'Piramal Healthcare Canada Ltd', None, '67.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2011-03-01', '2014-03')\n('NCT02666495', 'Individual Schema-mode Therapy for Anorexia Nervosa: a Pilot Case Series', None, 'UNKNOWN', 'Anorexia Nervosa', 'OTHER: Psychological Therapy - Schema Therapy', 'NHS Lothian', None, '15.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-01-01', '2019-01')\n('NCT01501695', 'Phase III Study of 5LGr to Treat Tic Disorder', '5LGr', 'COMPLETED', 'Tic Disorder|Tourette Syndrome|Chronic Tic Disorder', 'DRUG: 5LGr|DRUG: tiapride|DRUG: placebo', 'Tasly Pharmaceuticals Inc.', None, '603.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2008-01-01', '2011-10')\n('NCT02132195', 'Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome', None, 'COMPLETED', 'Nephrotic Syndrome', 'DRUG: ACTH', 'Emory University', 'Mallinckrodt', '31.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2014-05-01', '2018-03')\n('NCT02409095', 'Study Comparing DTP-HB-Hib by Disposable-Syringe Jet Injector To Vaccination By Needle And Syringe In Infants', None, 'TERMINATED', 'Immune Response to DTP-HB-Hib Vaccine', 'BIOLOGICAL: DTP-HB-Hib vaccine|DEVICE: Disposable Syringe Jet Injector (DSJI)|OTHER: Needle & Syringe', 'Serum Institute of India Pvt. Ltd.', 'PATH', '211.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2015-01-01', '2016-03')\n('NCT00568295', 'A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee', None, 'COMPLETED', 'Osteoarthritis of the Knee', 'DRUG: acetaminophen|DRUG: Rofecoxib|DRUG: Rofecoxib', 'Johnson & Johnson Consumer and Personal Products Worldwide', None, '403.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '1999-10-01', '2000-10')\n('NCT01891695', 'OPSCC N0 Nodal Control With Reduced IMRT', None, 'TERMINATED', 'Oropharyngeal Squamous Cell Carcinoma (OPSCCA)|HPV (Human Papillomavirus)-Associated', 'RADIATION: 39.6 Gy radiation', 'Paul W. Read MD', None, '1.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2013-10-01', '2016-12')\n('NCT02058095', 'Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)', 'Aim 3', 'COMPLETED', 'Cardiomyopathy|Renal Impairment', 'DRUG: Tadalafil|DRUG: Placebo', 'Mayo Clinic', None, '22.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE', '2014-03-01', '2019-12')\n('NCT00417495', 'Sentinel Lymph Node Technique in Multifocal Breast Cancer', None, 'COMPLETED', 'Breast Cancer', 'BEHAVIORAL: Sentinel Lymph Node Technique', 'Centre Oscar Lambret', None, '216.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2006-03-01', '2008-09')\n('NCT02893995', 'Safety Tolerability Pharmacokinetics and Efficacy of Two Different Rates of Subcutanous Remodulin® Dose Titration in Pulmonary Arterial Hypertension', None, 'WITHDRAWN', 'Pulmonary Arterial Hypertension', 'DRUG: Slow Dose Titration Group of Subcutaneous Treprostinil|DRUG: Rapid Dose Titration Group of Subcutaneous Treprostinil', 'United Therapeutics', 'CVie Therapeutics Co. Ltd.', '0.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2017-02-01', '2018-04')\n('NCT04001595', 'Global FKRP Registry', None, 'RECRUITING', 'LGMD2I|LGMDR9|Limb Girdle Muscular Dystrophy|Congenital Muscular Dystrophy|Muscle-Eye-Brain Disease|Walker-Warburg Syndrome|FKRP Gene Mutation', 'OTHER: Patient Registry', 'Newcastle University', 'LGMD2i Research Fund|CureLGMD2i|Ludwig-Maximilians - University of Munich', '1000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2013-11-01', '2025-12')\n('NCT00199095', 'Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia', None, 'COMPLETED', 'Adult Acute Lymphocytic Leukemia', 'DRUG: Adriamycin|DRUG: Cyclophosphamide|DRUG: Cytarabine|DRUG: Dexamethasone|DRUG: Idarubicin|DRUG: Ifosfamide|DRUG: Methotrexate|DRUG: Mercaptopurine|DRUG: VM26|DRUG: Vincristine', 'Goethe University', None, '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '1997-02-01', '2003-06')\n('NCT00901095', 'Can Diet- and Exercise-Induced Weight Loss Improve Asthma Control in Adults?', None, 'COMPLETED', 'Asthma|Obesity', 'BEHAVIORAL: Lifestyle intervention', 'Palo Alto Medical Foundation', 'National Heart Lung and Blood Institute (NHLBI)|Kaiser Permanente|Stanford University', '330.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2010-02-01', '2014-03')\n('NCT02255695', 'Effects of a School-based Exercise Program on Posture Trunk Range of Motion and Musculoskeletal Pain', None, 'COMPLETED', 'Musculoskeletal and Connective Tissue Disorders', 'OTHER: School-based exercise program', 'Universidade Federal de Sao Carlos', 'Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.|Conselho Nacional de Desenvolvimento Científico e Tecnológico', '300.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2008-12-01', '2012-12')\n('NCT03049995', 'Stress Echo 2020 - The International Stress Echo Study', 'SE2020', 'UNKNOWN', 'Coronary Artery Disease|Heart Failure|Hypertrophic Cardiomyopathy|Aortic Valve Disease|Athletes Heart|Tetralogy of Fallot|Pulmonary Arterial Hypertension', 'PROCEDURE: Left ventricular contractile reserve SE|PROCEDURE: B-lines SE|PROCEDURE: Left ventricular outflow tract gradient SE|PROCEDURE: Diastolic function SE|PROCEDURE: Mitral regurgitation SE|PROCEDURE: Pulmonary hemodynamics SE|PROCEDURE: Coronary flow reserve SE', 'Fatebenefratelli Hospital', \"Institute of Clinical Physiology CNR PisaItaly|Salerno Hospital Italy|Monaldi Hospital Napoli Italy|University of Pisa Italy|San Luca Hospital Lucca Italy|Careggi University Hospital Florence Italy|Federico II University|San Carlo Public Hospital Potenza Italy|Royal Brompton & Harefield NHS Foundation Trust|Ospedale dell'Angelo Venezia-Mestre|University of Parma|Hospital Clinics Trieste Italy|Federal University of Rio Grande do Sul|Hospital San José Criciuma Brasil|Hospital San Vicente de Paulo Passo Fundo Brasil|University of Belgrade|University of Szeged Hungary|Elisabeth Hospital Hodmezovasarhely Hungary|Sandro Pertini Hospital Rome Italy|Hospital Clinics Bari Italy|Ospedale Nottola Siena Italy|University of Catania Italy|Medika Cardiocenter Saint Petersburg Russian Federation|Acibadem City Clinic Tokuda Hospital|Investigaciones Medicas Buenos Aires Argentina|Tomsk National Research Scientific Centre of Russian Academy of Sciences Tomsk Russian Federation|Instituto Nacional de Cardiología Mexico City Mexico|Hamad Medical Corporation Heart Hospital -Doha-Qatar\", '300.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2016-11-01', '2021-12')\n('NCT01811095', 'A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing', None, 'COMPLETED', 'Neoplasms', 'OTHER: Training', 'McGill University', None, '27.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: ', '2013-03-01', '2013-06')\n('NCT00804895', 'Cluster Headache Cortivazol Injection (CHCI)', 'CHCI', 'COMPLETED', 'Cluster Headache', 'DRUG: ALTIM cortivazol injections|DRUG: PROAMP subcutaneous serum physiological saline|DRUG: Verapamil', 'Assistance Publique - Hôpitaux de Paris', None, '43.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2008-12-01', '2009-10')\n('NCT02782195', 'Evaluation of Gut Absorption Rate of Glucose After a Large Evening Meal in Type 1 Diabetes', None, 'COMPLETED', 'Type 1 Diabetes', None, 'University of Cambridge', 'Cambridge University Hospitals NHS Foundation Trust', '16.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2008-11-01', '2011-06')\n('NCT00843895', 'Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years', 'Pneumococci', 'UNKNOWN', 'Pneumococcal Disease', 'BIOLOGICAL: pneumococcal conjugate vaccine(prevenar)', 'King Saud University', None, '400.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SCREENING', '2009-03-01', '2009-12')\n('NCT00145795', 'A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment', None, 'COMPLETED', 'HIV Infections', 'DRUG: Kaletra + Current Dual NRTI Backbone|DRUG: Current Regimen', 'University of Chicago', 'Abbott', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2004-04-01', '2009-12')\n('NCT06182995', 'Anticipating Decline and Providing Therapy', 'ADAPT', 'NOT_YET_RECRUITING', 'Cognitive Impairment|Dementia|Post ICU Syndrome|Critical Illness|Cognitive Impairment Mild', 'BEHAVIORAL: Usual Care post-Intensive Care Unit (ICU)|BEHAVIORAL: Anticipating Decline and Providing Therapy (ADAPT)', 'Wake Forest University Health Sciences', 'National Institute on Aging (NIA)', '120.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2024-03-01', '2027-03')\n('NCT04061395', 'Guselkumab for Hidradenitis Suppurativa a Mode of Action Study.', 'HiGUS', 'UNKNOWN', 'Hidradenitis Suppurativa', 'BIOLOGICAL: Guselkumab', 'Barbara Horváth Principal Investigator', 'Janssen-Cilag Ltd.', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER', '2019-09-01', '2020-12')\n('NCT01170195', 'Effectiveness of Licorice Extract Dietary Supplement on the Treatment of Postmenopausal Symptoms', None, 'UNKNOWN', 'Postmenopausal Symptoms|Vaginal Dryness', 'DIETARY_SUPPLEMENT: Calmera-Licorice Root Extract (Licogen)', 'F&C Licorice Ltd', None, '120.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2010-09-01', '2011-09')\n('NCT02574195', 'Evolution of Effectiveness of Diabetes Medical Care in Russia', None, 'COMPLETED', 'Diabetes Mellitus Type 2|Diabetes Mellitus Type 1', None, 'Endocrinology Research Centre Moscow', None, '599.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-08-01', '2015-10')\n('NCT01388595', 'Fluticasone and Salmeterol in Allergic Rhinitis', None, 'COMPLETED', 'Allergic Rhinitis', 'DRUG: FLUTICASONE PROPRIONATE|DRUG: Salmeterol|DRUG: PLACEBO', 'University of Dundee', None, '23.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2006-11-01', '2010-10')\n('NCT00382395', 'SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma', None, 'SUSPENDED', 'Glaucoma|Glaucoma Open Angle', 'DEVICE: SOLX Gold Shunt GMS-plus|DEVICE: Ahmed FP7 Glaucoma Valve', 'SOLX Inc.', None, '180.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2005-11-01', '2017-07')\n"
     ]
    }
   ],
   "source": [
    "from datetime import datetime\n",
    "\n",
    "# Now let's define a Function to convert YYYY-MM format of start_without_none_with_month to YYYY-MM-01 format as mentioned before\n",
    "def convert_to_first_day_of_month(date_str):\n",
    "    try:\n",
    "        # Parse the input date string\n",
    "        date = datetime.strptime(date_str, '%Y-%m')\n",
    "        # Convert the date to YYYY-MM-01 format\n",
    "        return date.strftime('%Y-%m-01')\n",
    "    except ValueError:\n",
    "        return date_str  # Return the original date string if not in YYYY-MM format\n",
    "\n",
    "# To apply the function to convert the date format for each row in the RDD\n",
    "start_Without_none_with_month_with_new_format = start_without_none_with_month.map(lambda row: tuple(row[:12]) + (convert_to_first_day_of_month(row[12]),) + tuple(row[13:]) if len(row[12]) == 7 else row)\n",
    "\n",
    "# Print the RDD with the new date format\n",
    "for row in start_Without_none_with_month_with_new_format.collect():\n",
    "    print(row)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "7d21aa07-5ddf-4055-9d37-4a5c625af693",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Yes\n"
     ]
    }
   ],
   "source": [
    "# for the final confirmation, check if any rows have the format \"YYYY-MM-DD\" in the thirteenth column\n",
    "has_yyyy_mm_dd_format = start_Without_none_with_month_with_new_format.filter(lambda row: len(row[12]) == 10 and row[12][4] == '-' and row[12][7] == '-').count() > 0\n",
    "\n",
    "# Print the result\n",
    "if has_yyyy_mm_dd_format:\n",
    "    print(\"Yes\")\n",
    "else:\n",
    "    print(\"No\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "89721433-f26f-46c9-9f79-4ac1f6d7a1eb",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "No, all rows have either None or YYYY-MM-DD format in the start column.\n"
     ]
    }
   ],
   "source": [
    "# since, we got all the values in the start column to the required format we expected, we can combine the splitted RDD's into the final one\n",
    "rdd_finalized = start_Without_none_with_month_with_new_format.union(start_without_none_with_day).union(start_with_none)\n",
    "\n",
    "# Check if any row contains data other than None or the \"YYYY-MM-DD\" format in the start column\n",
    "def check_format(row):\n",
    "    if row[12] is not None and len(row[12]) != 10 and not (len(row[12]) == 7 and row[12][4] == '-'):\n",
    "        return True\n",
    "    return False\n",
    "\n",
    "contains_other_format = rdd_finalized.filter(check_format).count() > 0\n",
    "\n",
    "# Print the result\n",
    "if contains_other_format:\n",
    "    print(\"Yes, some rows contain data other than None or YYYY-MM-DD format in the start column.\")\n",
    "else:\n",
    "    print(\"No, all rows have either None or YYYY-MM-DD format in the start column.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "aacbf743-7155-4321-80eb-a291dae92c21",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[52]: [['Id',\n  'Study Title',\n  'Acronym',\n  'Status',\n  'Conditions',\n  'Interventions',\n  'Sponsor',\n  'Collaborators',\n  'Enrollment',\n  'Funder Type',\n  'Type',\n  'Study Design',\n  'Start',\n  'Completion'],\n ('NCT00237471',\n  'Impact of Tight Glycaemic Control in Acute Myocardial Infarction',\n  None,\n  'TERMINATED',\n  'Myocardial Infarct|Hyperglycemia',\n  'DRUG: Insulin (tight blood glucose control)',\n  'Melbourne Health',\n  'National Health and Medical Research Council Australia|Bristol-Myers Squibb',\n  '40.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT',\n  '2005-10-01',\n  '2006-05'),\n ('NCT02945371',\n  'Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life',\n  'REV',\n  'COMPLETED',\n  'Smoking|Alcohol Drinking|Prescription Drug Abuse|Substance-Related Disorders|Oral Intake Reduced',\n  'BEHAVIORAL: Person-centered inhibitory control training|BEHAVIORAL: Active behavioral response training',\n  'University of Oregon',\n  None,\n  '103.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION',\n  '2014-09-01',\n  '2016-05'),\n ('NCT01055171',\n  'Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence',\n  None,\n  'COMPLETED',\n  'Alcohol Dependence|PTSD',\n  'DRUG: Propranolol|DRUG: Placebo',\n  'Medical University of South Carolina',\n  'National Institute on Alcohol Abuse and Alcoholism (NIAAA)',\n  '44.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT',\n  '2010-01-01',\n  '2012-08'),\n ('NCT01125371',\n  'Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women',\n  None,\n  'COMPLETED',\n  'Alcohol; Harmful Use|Binge Drinking|Risk Behavior|HIV Infection',\n  'BEHAVIORAL: Computerized brief alcohol intervention + IVR booster calls|BEHAVIORAL: Computerized brief alcohol intervention|BEHAVIORAL: Attention Control',\n  'Johns Hopkins University',\n  'National Institute on Alcohol Abuse and Alcoholism (NIAAA)',\n  '439.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT',\n  '2011-10-01',\n  '2016-06-07')]"
     ]
    }
   ],
   "source": [
    "#to attach header to our RDD \n",
    "rdd_with_header_finalized = sc.parallelize([column_names]).union(rdd_finalized)\n",
    "rdd_with_header_finalized.take(5)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "9ab71ddb-d3ea-42ca-b257-5152814e512b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Row number: ['Id', 'Study Title', 'Acronym', 'Status', 'Conditions', 'Interventions', 'Sponsor', 'Collaborators', 'Enrollment', 'Funder Type', 'Type', 'Study Design', 'Start', 'Completion']\nRow content: 0\n"
     ]
    }
   ],
   "source": [
    "\n",
    "#just to double confirm that only required rows are coming in the dataset \n",
    "# Add index to each row\n",
    "rows_with_index = rdd_with_header_finalized.zipWithIndex()\n",
    "\n",
    "# Filter rows where 'Id' column contains 'Id' and is not None\n",
    "rows_with_valid_type = rows_with_index.filter(lambda row_index: row_index[0][0] and 'Id' in row_index[0][0])\n",
    "\n",
    "# Print the row number and rows\n",
    "for row_index, row in rows_with_valid_type.collect():\n",
    "    print(\"Row number:\", row_index)\n",
    "    print(\"Row content:\", row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "a5e7c4d4-aa2a-4f46-852b-7d16a9d927ea",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of data rows in the rdd_with_header_finalized: 483421\n"
     ]
    }
   ],
   "source": [
    "# Assuming your clinicaltrial_2023_cleaned_data_rdd_with_none contains the data as an RDD\n",
    "\n",
    "# Get the count of data rows in the RDD\n",
    "row_count = rdd_with_header_finalized.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the rdd_with_header_finalized:\", row_count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "1f495a60-74c1-4982-8928-9abe4d4b1769",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Completion\n2006-05\n2016-05\n2012-08\n2016-06-07\n2014-11\n2017-05\n2011-12\n2016-12\n2014-05\n2021-04-12\n2017-05\n2008-06\nNone\n2009-12\n2011-07\n2011-12\n2004-04\n2019-02\nNone\n2015-09\n2012-06\nNone\n2015-06\n2018-02-28\n2010-02\n2012-11\n2008-04\n2016-06\n2014-04\nNone\n2010-05\n2027-08\n2017-07\nNone\n2021-07\nNone\n2012-12\n2015-10\n2016-09\n2012-03\n2017-01\n2013-03\n2015-10\n2010-05\n2013-09\n2018-12\n2012-05\n2012-08\n2025-04\n2011-03\n2015-03\n2019-02\n2025-06\n2010-06\n2013-10\n2009-01\n2007-11\n2017-06\n2015-09\n2009-12\n2015-12\n2017-08-02\n2026-04\nNone\n2022-12\n2007-01\n2006-12\n2010-02\n2011-03\n2015-09\n2022-03-25\n2017-12\n2019-12\n2008-09\n2013-08\n2015-10\n2014-05\n2018-10\n2011-06\n2020-03-24\n2015-07\n2017-12-20\n2008-01\n2007-02\n2010-07\n2014-09\n2004-01\n2015-11\n2009-03\n2010-05\n2014-07\n2011-12\n2017-01\n2012-11\n2014-05\n2022-11\n2005-08\n2012-11\n2024-09\n2014-06\n2017-11\n2008-12\n2013-12\n2001-05\n2014-06\n2014-06\n2026-01\n2006-02\n2015-11\n2011-03\n2019-06\n2010-03\n2013-01\n2001-03\n2015-05\n2015-09\n2012-08\n2021-06-04\n2011-06\n2017-12\n2021-01\n2016-09\n2011-02\n2007-08\n2016-12\n2017-02-28\n2015-06\n2015-01\n2014-06\n2014-10\n2007-09\n2012-01\n2016-12\n2020-09\n2018-02\n2014-07\n2017-08-01\n2014-05\n2016-12\n2013-07\n2010-08\n2015-02\n2014-04\n2017-03\n2017-04\n2011-01\n2012-12\n2010-04\n2015-10\nNone\n2014-04\n2018-03\n2015-06\n2015-06\n2022-12\n2017-02\n2017-01\n2004-09\n2025-05\n2010-04\n2009-11\n2012-06\n2014-07\n2011-04\n2020-12-31\n2011-10\n2019-03\n2010-05\n2008-09\n2018-09\n2009-11\n2013-10\n2019-09\n2025-12\n2011-09\n2016-05\n2015-09\n2015-03\n2016-11\n2009-09\n2019-02\n2011-12\n2018-01-19\n2013-04\n2013-03\nNone\n2012-05\n2017-11\n2016-08-19\n2015-07\n2014-06\n2014-03\n2011-12\n2012-12\n2015-10\n2004-08\n2015-12\n2013-12\n2016-07\n2015-06\n2011-08\n2016-09\n2018-07\n2018-07\n2008-08\n2013-12\n2013-07\n2008-11\n2024-01\n2015-12\n2015-04\n2027-12\n2009-09\n2007-09\n2015-08\nNone\n2018-12\n2015-01\n2002-08\n2014-07\n2015-07\nNone\n2011-06\n2014-12\n2009-01\n2016-12\n2019-07\n2015-08\n2012-11\n2021-05\n2015-08\nNone\n2018-01\n2012-03\n2032-09\n2008-03\n2011-07\n2010-09\n2008-12\n2010-01\n2009-06\n2017-03\n2014-02\n2013-11\n2007-06\n2015-12\n2019-12\n2009-01\n2015-08\n2008-12\n2017-06\n2025-12\n2013-09\n2015-07\n2020-06-26\n2008-07\n2022-12\n2007-12\n2014-06\n2014-02\n2012-03\n2016-04\n2016-12\n2024-05\n2006-01\n2017-08\n2015-12\n2015-12\n2019-04\n2008-04\n2015-04\n2029-01\n2014-12\n2010-01\n2008-09\nNone\n2013-10\n2012-05\n2006-10\n2013-02\n2017-05-30\nNone\n2026-06\n2020-05-15\n2014-07\n2019-02-01\n2019-12\n2011-07\n2016-01\n2021-12\n2016-12\n2014-10\n2015-07\n2001-04\n2012-12\n2006-02\n2016-05\nNone\n2022-12\n2014-05\n2015-05\n2024-03\n2012-11\n2021-12\n2022-01\n2011-08\n2024-04\n2010-12\n2015-05\n2020-05\n2025-12\n2005-07\n2011-12\nNone\n2007-11\n2012-01\n2014-09\n2010-12\n2016-06\n2005-01\n2015-03\n2009-09\n2019-10\n2000-12\n2010-12\n2017-07\n2009-11\n2006-04\n2008-02\n2018-07\n2011-05\n2016-08\n2006-11\n2011-11\n2015-04\n2003-07\n2015-07\n2005-07\n2018-12\n2012-05\n2007-12\n2027-12\n2020-02\n2012-12\n2022-06\n2018-10-29\n2005-05\n2021-12\n2009-06\n2010-08\n2017-05\n2014-06\n2008-08\nNone\n2018-12\n2011-12\n2015-04\n2008-08\n2012-12\n1999-07\n2017-09\nNone\n2013-12\n2014-03\nNone\n2019-09-10\nNone\n2012-06\n2011-07\n2012-06\n2014-09\n2016-02\n2001-12\n2030-12\n2012-06\n2010-10\n2026-12\n2018-08-01\n2016-06\n2009-08\n2010-01\n2012-07\n2017-06-30\n2012-06\n2016-02\n2009-02\n2032-03\n2015-09\n2004-07\n2012-12\n2012-12\nNone\n2016-02\n2023-07\n2008-06\n2013-01\n2011-02\nNone\n2010-05\n2010-03\n2024-01\n2012-03\n2015-07\n2015-12\n2006-05\n2014-12\n2006-03\n2015-05\n2016-02\n2008-09\n2006-12\n2012-06\n2012-03\n2016-02\n2004-09\n2011-01\n2015-12\n2004-01\n2014-02\n2010-06\n2012-09\n2014-08\n2013-05\n2005-11\n2020-08\n2012-08\n2004-07\n2008-06\n2016-04\n2001-12\n2013-02\n2013-08\n2014-03\n2013-03\n2014-02\n2012-09\n2006-12\n2020-04\n2010-08\n2019-12-31\n2007-12\n2014-03\n2013-06\n2017-12\nNone\n2016-12\n2018-08\n2015-07\n2024-08\n2002-06\n2016-02\n2008-05\nNone\n2016-05\n2016-08-04\n2014-12\n2011-06\n2015-10\n2011-03\n2011-12\n2013-06\n2013-07\n2028-04\n2014-02\n2017-05-22\n2011-07\n2014-09\n2010-11\n2009-07\n2012-12\nNone\n2014-01\n2010-03\n2007-04\n2014-09\n2024-01\n2021-10\n2012-11\n2007-12\n2015-01\n2007-10\nNone\n2020-08\n2010-06\n2013-05-09\n2017-03-10\n2009-04\n2019-09-11\n2012-10\n2013-12\n2014-01\n2003-01\n2008-03\n2012-08\n2011-04\n2007-02\n2012-11\n2017-12\n2017-06\n2015-10\n2012-02\n2012-11\n2016-04\n2012-10\n2008-03\n2013-12\n2016-10\n2020-01\n2009-10\n2010-04\n2017-12\n2027-08\n2018-10\n2019-08-30\n2013-02\n2010-11\n2009-10\n2013-01\n2021-09\n2016-10-30\n2019-12\n2015-05\n2016-09\n2012-03\n2017-02\n2015-12\n2019-10-10\n2015-08\n2011-12\n2022-09\n2012-10\n2028-08\n2014-02\n2010-07\n2011-08\n2014-12\n2021-10\n2003-06\n2020-05\n2016-06\n2005-01\n2007-03\nNone\n2016-11\n2012-05\n2012-08\n2016-06\n2019-11\n2013-01\nNone\n2018-09\n2015-12\n2018-01\n2015-08\n2010-12\n2013-11\n2015-07\n2009-12\n2010-03\n2024-12\n2015-12\n2023-12\n2011-04\n2012-01\nNone\n2023-12\n2020-11\n2012-11\n2014-06\n2007-03\n2009-08\n2011-08\n2010-08\n2015-01\n2014-10\n2007-04\n2009-09\n2013-06\n2015-05\n2015-12\n2007-09\n2008-06\n2020-06-12\n2016-03\n2002-06\n2008-05\n2020-10\n2020-12\n2015-06\n2011-12\n2022-11\n2006-06\nNone\n2014-12\n2006-09\nNone\n2018-12\n2023-09-18\n2025-06\n2020-07\nNone\n2007-10\n2014-04\nNone\n2015-08\n2023-12\n2014-05\n2003-06\n2009-02\n2014-06\n2006-11\n2028-04\n2016-11\nNone\n2016-03\n2010-03\n1993-03\n2010-04\n2006-04\n2014-12\n2009-09\n2013-09\n2008-12\n2018-08\n2011-05\n2016-10\n2005-12\nNone\n2018-05\n2006-01\n2018-06\n2016-12\n2014-08\n2017-12\n2006-01\n2007-02\n2013-07\n2017-08\n2013-12\n2017-03\n2008-07\n2014-09\n2015-06\n2012-09\n2025-09\n2005-10\n2015-10\n2014-06\n2014-12\n2006-11\n2014-08\n2013-01\n2017-06-27\n2016-08\n2024-07\n2013-12\n2005-10\n2020-06-30\n2006-07\n2005-10\n2011-08\n2014-08\n2024-12\n1995-03\n2011-04\n2016-08\n2015-06\n2005-10\n2003-01\n2020-05\n2014-01\n2020-09\n2012-10\n2007-09\n2010-01\n2004-01\n2009-02\n2016-08-30\n2015-11\n2013-02\n2011-12\n2012-06\n2012-06\n2010-05\n2017-06\n2015-11\n2011-06\nNone\n2008-09\n2011-01\n2016-06\n2019-07-31\n2009-06\n2013-05\n2017-06\n2007-01\n2009-12\n2013-03\n2019-04\n2011-05\n2008-08\n2014-12\n2014-04\n2014-12\n2013-09\n2017-01\n2007-04\nNone\n2015-05\n2007-07\n2012-08\n2011-05\n2009-07\nNone\n2017-02\n2010-06\n2010-03\n2018-10\n2019-10\n2015-05\n2015-05\n2016-02\n2013-04\n2018-04-01\n2009-05\n2018-10\n2016-10\n2013-03\n2004-07\n2021-03\n2013-12\n2007-05\n2009-12\n2020-10-03\n2014-12\n2018-01-29\n2016-10-04\n2008-07\n2011-07\n2016-09\n2013-12\n2018-10\n2016-06\n2023-07\n2016-02\n2023-01\n2015-03\nNone\n2020-09-11\n2020-04-17\n2016-02\n2017-02\n2017-04\nNone\n2018-03\n2014-05\n2013-09\n2008-06\n2015-12\n2016-01\n2018-06-27\n2017-12\n2014-07\n2012-04\n2027-06\n2007-06\n2012-08\n2012-03\nNone\n2012-12\n2009-09\n2013-01\nNone\n2012-12\n2020-07\n2015-05\n2016-03\n2003-08\n2008-11\n2018-12\n2011-08\n2012-12\nNone\n2007-10\n2018-07\n2023-12\n2024-12-30\n2016-05\n2011-02\n2020-01\n2017-05\n2018-01\n2025-02\n2013-09\n2014-08\n2011-03\n2013-03\n2011-08\n2014-04\n2007-05\n2012-07\n2013-11\n2021-12\n2015-12\n2019-03-30\n2020-02\n2011-08\n2012-07\n2006-11\n2022-12-07\n2016-08\n2013-05\nNone\n2016-07\n2013-06\n2008-02\n2015-12\n2007-01\n2008-05\n2015-05\n2015-12\n2013-05\n2015-10\n2015-03\n2004-09\n2010-05\n2016-02\n2014-01\n2017-05\n2013-10\n2009-06\n2013-09\nNone\n2016-03\n2024-06\n2013-01\n2015-03\n2018-05\n2010-09\n2012-05\n2007-10\n2014-05\n2020-04\nNone\n2017-08\n2005-09\n2018-08-15\n2009-09\nNone\n2009-11\n2018-09\n2011-07\n2010-06\n2015-06\n2019-06-06\n2011-05\n2008-01\n2022-03\n2013-01\n2024-10\n2017-12\n2015-03\nNone\n2009-12\n2026-04\n2015-01\n2017-01-17\n2015-03\n2015-11\n2019-12\nNone\n2009-04\n2017-11-16\n2022-05\n2017-10\n2017-12\n2006-12\n2018-03-18\n2007-10\n2021-04-01\n2015-12\n2016-07\n2012-03\n2017-02\n2016-08\n2015-12\nNone\n2013-12\n2016-12\n2002-09\n2013-05\n2013-03\n2016-01\n2016-06\n2015-06\nNone\n2016-09\n2007-12\n2013-03\n2019-12\n2011-06\n2018-05\n2014-10\n2003-06\n2023-02\n2012-09\n2009-12\n2010-12\n2009-12\n2025-10\n2016-10\n2007-12\nNone\n2012-02\n2016-04\n2005-12\n2011-12\n2026-08\n2014-01\n2008-12\n2024-05-19\n2011-06\n2001-03\n2017-12-31\n2016-03\n2011-05\n2023-01\n2010-02\n2008-01\n2019-02-27\n2019-12\n2006-09\n2012-02\n2012-09\n2018-01\n2021-03\n2003-05\n2012-09\n2017-10-04\n2017-12\n2017-04\nNone\n2019-03\n2016-01\n2011-05\n2017-12\n2013-10\n2017-08\n2010-05\n2006-01\n2015-07\n2026-12\n2015-08\n2008-09\n2012-10\n2011-11\n2012-10\n2013-09\n2007-09\n2017-12\n2019-03\n2012-01\nNone\n2023-12-31\n2009-02\n2006-10\n2018-05-31\n2018-01-01\n2016-12\n2010-09\n2025-07\n2020-05\n2022-09\n2015-10\n2024-04\n2018-03\n2015-12\n2016-04-07\n2021-07\n2019-10-31\n2014-10\n2014-12\n2016-08\n2012-09\n2024-12\n2022-02\n2012-04\n2022-11\n2011-09\n2013-10\n1998-07\n2028-01\n2017-04\n2022-02\n2017-04-01\n2013-01\n2006-01\n2011-06\n2015-09\n2017-06-30\n2017-03\n2008-06\n2013-01\n2007-09\n2007-10\n2011-07\n2017-05\n2006-08\n2010-10\n2009-11\n2023-12\n2013-07\n2013-05\n2009-12\n2016-12\n2007-08\n2022-12-30\n2026-12\n2023-06-30\n2025-05\nNone\n2013-06\n2015-11\n2016-05\n2009-10\n2012-09\n2021-01\n2016-04-29\n2017-09\n2014-06\n2022-09\n2012-06\n2015-12\nNone\nNone\n2017-12\nNone\n2010-03\n2017-11-26\n2019-02-04\n2014-12\n2016-07\n2008-03\n2023-12\nNone\n2009-07\n2010-06\n2010-11\n2020-03-21\n2019-12\n2012-09\n2011-12\n2011-01\n2018-01-03\n2030-12\n2012-05\n2021-07\n2012-07\n2017-12\n2020-09\n2017-08\n2010-08\n2010-08\n2022-04\n2010-06\n2010-09\n2022-05\n2005-07\n2011-03\n2015-01\n2025-07\n2014-07\n2007-08\n2026-12\n2015-11\n2009-12\n2006-11\n2017-07-31\n2015-03\n2015-10\n2012-08\nNone\n2013-08\nNone\n2015-06\n2011-03\n2025-05\n2012-12\n2015-11\n2015-10\n2019-01\n2017-07\n2015-08\n2017-12\n2014-07\n2015-11-20\n2009-06\n2016-06\n2008-12\n2023-06\n2006-09\n2020-06\nNone\n2020-01\n2004-03\n2012-01\n2018-08\n2014-12\n2008-08\n2017-08\n2012-06\n2007-09\n2010-08\n2016-07\n2016-06\n2010-07\n2009-05\n2015-08\n2020-10-31\n2018-01\n2016-03\n2014-11\n2015-12\n2014-06\n2008-04\n2018-03\n2015-06\n2000-04\n2013-01\n2017-09\n2007-03\n2007-03\n2008-07\n2020-10\n2009-01\n2007-12\n2010-06\n2011-05\n2002-05\n2014-11\n2016-09\n2015-11\n2014-07\n2019-12\n2005-07\n2011-06\n2018-01\n2012-10\n2015-03\nNone\n2017-11-30\n2010-12\nNone\n2027-09\n2019-08\n2015-04\n2009-07\n2010-07\n2017-06\n2017-11-03\nNone\n2014-08\n2015-11\n2010-07\n2013-07\n2017-12\n2011-03\nNone\n2025-03\n2018-04\n2013-03\n2009-04\n2014-02\n2000-01\n2009-06\n2014-10\n2018-05\n2016-12\n2019-08\n2011-09\n2013-03\n2010-03\n2017-03\n2011-12\n2007-09\n2015-10\n2005-04\n2014-09\n2014-04\n2015-07\n2009-01\n2017-01\n2023-03\n2027-04\n2024-12\n2022-12\n2014-07\n2014-01\n2015-06\n2015-12\n2015-07\n2017-08\n2013-09\n2018-02\n2025-04\n2018-11\n2024-02\n2016-11\n2011-12\n2015-09\n2021-12-23\n2009-07\n2014-03\n2005-07\n2013-06\n2006-02\n2011-05\n2010-10\n2010-11\n2013-09\n2004-07\n2022-12\n2019-10\n2008-06\n2019-03\n2019-03\n2014-11\n2005-04\n2014-01\n2012-01\n2006-09\n2018-10\n2007-11\n2005-12\n2013-03\n2014-06\n2023-06\n2014-12\n2016-12\n2019-09-30\nNone\n2016-12\n2019-06\n2015-08\n2013-02\n2026-03\n2016-02\n2013-07\n2008-03\n2016-12-01\n2014-12\n2024-09\n2014-05\n2016-12\n2020-06\n2014-09\n2009-11\n2012-06\n2017-02-28\n2008-06\n2019-03-01\n2018-01\n2016-02\n2019-03-15\n2008-01\n2007-06\n2010-02\n2013-08\n2018-09\n2015-12\n2014-12\n2011-04\n2010-03\n2016-05\n2021-12\n2025-12\n2013-12\n2015-07\n2014-07\n2015-10\n2025-07\n2017-07-27\n2017-03\n2018-06\n2007-02\n2020-12\n2023-08-10\n2016-02\n2015-04\n2016-07\n2007-12\n2016-04\n2014-12\n2012-03\n2005-02\n2015-03\n2017-02\n2018-08\n2015-08\n2014-02\n2015-09\n2006-10\n2008-07\n2015-09\n2015-01\n2016-09\n2019-01\n2020-07-01\n2008-06\n2015-05\n2017-03\n2019-01\n2022-07\n2013-10\n2013-03\n2020-03-23\n2022-05-31\n2012-12\n2015-03\n2021-09\n2025-05\n2012-12\n2014-12\n2005-12\n2012-08\n2014-07\n2024-10\n2025-03\n2017-12\n2012-11\n2004-11\nNone\n2022-11\n2009-07\n2007-04\n2018-08\n2014-03\n2014-04\n2011-03\n2007-12\n2017-09\n2010-07\n2019-11\n2017-05\n2013-10\n2013-09\n2006-04\n2016-03\n2018-12\n2006-05\n2009-03\n2009-05\n2021-05\n2015-10\n2020-11-15\n2015-07\n2026-07\n2017-06\n2025-11\n2012-05\n2008-12\n2022-02\n2021-08\n2006-10\n2016-03\n2018-03-26\nNone\n2024-01\n2013-12\n2010-05\n2015-08\n2015-01\n2018-06\n2027-12\n2012-11\n2016-12\n2013-12\n2015-11\n2017-10\n2013-12\n2019-09\n2012-04\n2018-06-01\n2016-12\n2008-07\n2012-11\n2017-08\n2018-05\n2009-06\n2016-04\n2017-11\n2010-04\nNone\n2011-12\n2017-07\n2012-12\n2019-04\n2014-12\nNone\n2009-11\n2015-05\n2005-01\n2013-12\n2024-10\n2015-07\n2020-12\n2005-08\n2015-05\n2016-04\n2008-06\n2009-03\n2009-10\n2012-06\n2014-09\n2013-02\n2019-04\n2028-07\n1991-12\nNone\n2011-04\n2012-05\n2005-07\nNone\n2021-07\n2017-10\n2007-04\n2018-12\n2014-06\n2023-03-28\n2015-01\n2017-02\n2007-06\n2019-02\n2014-12\n2014-05\n2007-07\n2012-12\n2013-09\n2011-03\n1997-03\n2019-02\n2017-12\n2010-03\n2008-09\n2018-11\n2028-06\n2012-11\n2006-11\n2012-02\n2007-07\n2005-06\n2019-06\n2013-06\n2013-04\n2006-09\n2009-11\n2010-04\n2003-06\n2026-01\n2008-12\n2015-09\n2029-12-31\n2014-12\n2015-03\n2024-02\n2014-10\n2013-06\n2014-07\n2014-07\n2017-01-18\nNone\n2019-10\n2019-05-22\n2012-12\n2016-09\n2006-07\n2010-08\n2002-09\n2015-11\n2008-08\n2011-04\n2017-12\n2013-07\n2016-12\nNone\n2006-10\n2017-02-13\n2012-01\n2020-03-15\n2013-11\n2025-12\n2026-03\n2012-04\n2018-12\n2016-06-27\n2019-12\n2009-07\n2006-07\n2006-05\n2012-11\n2015-05\n2017-10-18\n2016-12\n2026-12\n2018-06-07\n2008-03\nNone\n2004-10\n2016-05\n2014-05\n2021-12\n2020-03\n2021-01\nNone\n2015-12\n2017-12\n2019-12\n2018-09-05\n2024-03\n2009-09\n2015-08\n2016-09\n2020-10-30\n2009-12\n2025-09\n2006-08\nNone\n2007-06\n2018-07\n2017-04\n2015-10\n2016-07\n2009-07\n2015-06\n2015-06\n2013-04\n2024-08-31\nNone\n2016-06\n2012-12\n2013-06\n2010-08\n2022-05\n2030-12\n2005-04\n2014-04\n2012-03\n2014-11\n2013-10\nNone\n2008-12\n2016-04\n2018-07\n2012-06\n2013-11\nNone\n2008-05\n2012-04\n2009-11\n2013-10\n2015-05\n2009-12\n2007-01\n2018-09\n2025-09\n2009-02\n2009-12\n2007-10\n2010-09\n2027-08\nNone\n2016-04\n2013-01\nNone\n2019-07-25\n2016-12\n2007-09\n2019-12\nNone\n2017-11-08\n2011-12\n2016-08\n2014-05\n2017-10\n2006-07\n2013-12\n2014-08\n2015-08\n2021-05\n2013-05\n2024-12\n2009-09\n2014-08\n2011-10\n2012-01\n2013-12\n2020-12\n2015-08\n2023-12\n2013-07\n2016-07\nNone\n2011-09\n2015-04\n2014-03\n2007-09\n2006-09\n2013-04\n2011-12\n2015-12\n2014-04\nNone\n2016-09\n2013-04\n2014-10\n2014-12\n2007-04\n2007-07\n2011-12\n2013-05\n2014-04\n2017-12\n2004-05\n2012-09\n2017-09\n2020-12\n2013-06\n2022-07\n2025-12\n2010-03\n2013-04\n2008-06\n2014-03\n2020-07\n2021-08-30\n2010-10\n2014-07\n2010-01\nNone\n2012-12\n2015-07\n2023-11\n2021-03\n2004-12\n2012-03\n2018-12\n2024-09\n2013-12\n2013-06\n2022-08\n2014-06\n2014-12\n2011-07\n2002-06\n2013-11\n2014-12\n2012-09\n2017-12\n2007-12\n2012-12\n2016-04\n2029-02\n2011-07\n2010-08\n2024-07\n2013-01\n2011-09\n2018-03\n2015-10\n2015-07\n2024-02\n2016-08\n2010-07\n2014-03\n2023-02\n2021-08\n2016-03\n2016-10-17\n2022-08\n2017-10\n2014-02\n2021-12\nNone\n2014-02\nNone\n2015-12\n2016-08-30\n2019-11\n2010-09\n2010-06\n2013-07\n2008-05\n2020-09\n2013-12\n2026-04\n2018-03\n2015-12\n2017-01\n2011-03\n2015-08\nNone\n2025-06\n2020-06\n2024-01\n2012-06\n2012-12\n2015-06\n2009-09\n2017-06\n2014-06\n2015-08\n2025-05\n2016-09\n2011-10\n2017-03-03\n2012-12\nNone\n2010-09\n2019-02\n2006-02\n2015-09\n2024-05\n2002-02\n2029-11\n2014-08\n2014-08\n2005-08\n2013-12\n2016-06\n2022-03\n2017-09\n2013-06\n2014-09\n2020-11-03\n2010-01\n2017-05\n2006-01\n2009-08\n2014-12\n2017-09\n2024-08\n2017-07\n2014-04\n2016-02\n2017-05\n2013-06\n2012-12\nNone\n2016-03\n2010-02\n2018-03\n2004-12\n2021-06\n2012-03\nNone\n2007-10\n2013-03\n2009-05\n2006-12\n2024-05\n2019-06\n2015-12\n2009-07\n2008-07\n2020-04\n2016-12\n2011-02\n2010-11\n2022-03\n2017-08-31\n2011-07\n2010-02\n2015-03\n2017-10\n2010-08\n2016-12-22\n2019-12\n2009-11\n2006-09\nNone\n2016-12\n2014-12\n2020-07\n2012-11\n2013-11\nNone\n2022-03\n2017-05-01\n2019-07\n2011-12\n2011-10\n2006-09\n2009-02\n2011-06\n2014-01\n2016-05\n2023-03\n2014-12\n2017-01\n2015-05\n2009-01\n2017-04-16\n2014-03\nNone\n2014-06\n2015-06\n2009-12\n2006-04\n2009-03\n2013-07\nNone\n2020-10\n2015-04\n2011-06\n2009-03\n2013-08\n2011-01\nNone\n2022-12\n2015-11\n2014-08\n2010-11\n2014-07\n2011-12\n2004-03\n2009-01\n2017-05-12\n2007-01\n2021-08-02\n2019-09-30\n2012-01\n2008-05\n2017-05\n2002-06\n2013-12\n2014-07\n2015-06\n2013-12\n2012-07\n2009-09\n2022-04\n2033-12\n2016-03\n2022-12\n2011-05\n2004-04\n2011-09\n2010-12\n2019-07-08\n2009-09\nNone\n2010-10\n2017-11\n2031-12-31\n2012-04\n2009-01\n2014-12\n2016-05-25\n2015-05\n2013-03\n2006-07\n2014-07\n2005-08\n2007-12\n2023-07\n2015-04\n2025-09\n2022-12\n2013-05\n2006-04\n2008-06\n2015-02\n2009-08\n2007-12\n2017-06\n2025-08\n2012-09\n2009-03\n2012-07\n2026-05\n2008-07\n2014-03\n2015-07\n2004-02\n2011-06\n2014-12\n2024-09\n2022-10-21\n2011-05\n2007-04\n2008-01\n2013-04\n2026-12\n2013-03\n2016-10\n2018-03-15\n2016-08\n2016-02\n2021-04\n2013-10\n2011-12\n2020-01\n2016-01\n2017-12-31\n2012-01\n2011-12\nNone\n2012-07\n2008-06\n2014-10\n2017-01\n2010-06\n2021-08\n2005-09\n2008-06\n2013-12\n2020-06\n2017-06-22\n2024-12\n2016-10\n2011-01\n1996-08\n2027-12\n2006-01\n2016-05\n2012-05\n2017-04-08\n2016-04\n2017-10\n2018-03-05\n2021-06\n2012-10\n2016-06\n2014-01\n2010-10\n2015-08\n2024-12\n2008-03\n2009-11\n2020-07\n2008-11\n2012-08\n2015-12\n2012-06\n2016-08\n2016-12\n2018-01\n2012-01\n2015-11\n2011-08\n2021-07\n2017-06\n2019-09\nNone\n2016-12\n2014-04\n2012-10\n2007-03\n2026-01\n2021-03-18\n2024-01\n2016-01\n2017-08\n2016-02\n2012-08\n2008-05\n2013-02\n2010-12\n2017-12\n2009-08\n2016-04\n2006-01\nNone\n2005-05\n2016-08\n2011-11\n2013-01\n2008-11\n2010-08\n2011-04\n2022-09\n2017-08\n2017-02\n2009-08\n2014-09\n2011-08\n2018-08\n2020-06\n2016-09\nNone\n2013-04\n2017-01\nNone\n2014-02\n2016-09-07\n2003-06\n2014-09\n2014-12\n2018-04\n2008-12\n2013-05\n2016-09\n2026-09\n2018-07-31\n2015-01\n2014-06\n2005-03\n2009-11\n2017-02-28\n2017-02-28\nNone\n2024-10\n2024-12\n2022-12\n2009-08\n2013-12\n2021-08\n2001-10\n2008-06\n2022-04\n2012-09\n2017-01\n2008-02\n2007-05\n2007-09\n2022-11-28\n2001-03\n2014-03\nNone\n2017-04\n2007-12\n2010-12\n2012-05\n2004-10\n2019-10-11\n2002-01\n2026-03\n2018-12\n2014-05\nNone\nNone\n2013-03\n2009-12\n2015-09\n2015-09-15\n2013-08\nNone\n2014-01\n2015-09\n2015-11\n2016-09-26\n2013-06\n2004-08\n2011-09\n2014-04\n2009-12\n2014-04\n2017-02\n2015-01\n2017-12\n2010-10\n2009-12\n2006-09\n2035-12\n2018-12\n2014-06\n2017-11\n2013-07\nNone\nNone\n2009-08\n2010-06\n2018-05\n2015-11\n2002-09\n2010-06\n2018-06-30\n2017-06\n2015-03\n2021-12\n2008-02\n2017-01-05\n2007-08\n2013-10\nNone\n2012-05\n2029-07\n2009-11\n2009-12\n2010-12\n2009-12\n2005-02\n2017-07\n2016-02\n2014-12\n2008-01\n2008-01\n2007-10\n2010-04\n2008-07\n2000-05\n2023-02\n2008-05\n2013-11\n2005-03\n2015-12\n2010-03\n2014-01\n2012-07\n2009-10\n2007-03\n2011-05\n2017-12\nNone\n2013-08\nNone\n2015-12\n2018-07\n2024-12-31\n2011-10\n2014-08\n2028-12\n2006-01\n2019-12\nNone\n2015-08\n2011-12\n2015-02\n2014-12\n2017-06\n2018-11\n2010-09\n2017-01\n2013-07\n2015-12\n2016-12-31\n2014-05\n2004-12\n2006-12\n2017-09\n2015-05\n2008-07\nNone\n2016-09\n2014-07\n2016-08\n2017-05-16\n2007-08\n2009-06\n2014-03\n2013-06\n2009-02\n2010-07\n2016-03\n2015-02\n2014-12\n2016-02\n2009-03\n2013-05\n2025-08\n2010-07\n2014-03\n2005-10\n2018-12\n2012-07\n2014-09\n2011-09\n2016-12\n2017-12\n2013-04\n2014-03\n2006-05\n2019-05\n2012-06\n2015-06\n2026-05\n2007-09\n2017-09\n2005-02\n2019-12\n2016-06\n2021-08\n2013-08\n2003-02\n2017-01\n2004-10\n2015-02\n2010-09-01\n2011-05\n2010-06\n2024-07\n2008-10\n2013-02\n2008-10\n2008-12\n2004-10\n2013-07\n2014-11\n2013-12\n2012-09\n2018-04\n2016-08\n2013-08\n2013-04\n2016-05\n2011-09\n2027-03\n2009-12\n2019-12\n2014-09\n2023-12\n2016-03\n2015-09\n2014-10\n2013-11\n2009-09\n2015-10\n2017-10\n2013-09\n2014-07\n2023-01\n2009-12\n2011-02\n2014-04\n2011-04\n1997-11\n2006-07\n2019-07\nNone\n2012-10\n2026-07\n2026-02\n2009-02\n2013-12\n2013-08\n2017-04\nNone\n2018-01\n2013-12\n2022-01\n2009-02\n2019-11\n2013-03\n2016-05\n2014-03\n2014-12\nNone\n2003-09\n2030-07\n2011-08\n2016-08-04\n2014-05\n2013-12\n2006-05\n2004-04\n2011-12\n2015-08\n2012-11\nNone\n2012-06\n2011-07\n2009-09\n2012-06\n2006-10\n2007-05\n2006-09\n2011-11\n2016-03\n2014-04\nNone\n2008-11\n2019-12\n2012-04\n2014-01\n2016-12\n2023-12\n2016-02\n2022-11\n2019-03\n2011-06\n2022-01\n2022-11\n2012-10\nNone\n2010-03\n2017-03\n2018-10\n2009-08\n2013-02\n2015-07\n2004-05\n2009-09\n2015-05\n2015-06\n2010-10\n2009-02\n2013-11\n2015-11\n2015-01\n2015-06\n2009-09\n2020-04-15\n2020-12\n2023-10\n2009-12\n2021-07\n2015-08\n2013-11\n2016-10\n2007-02\n2016-07\n2009-06\n2020-12\n2017-03\n2004-06\n2014-05\n2011-12\n2009-10\n2012-09\n2010-03\n2010-10\n2011-06\n2009-05\n2017-10\n2018-05\n2011-08\n2011-10\n2013-02\n2018-02-10\n2015-09\n2009-06\n2026-02\n2005-09\n2009-11\n2030-01\n2023-01\n2020-12\n2016-07\n2010-06\n2011-09\n2022-08\n2020-09\n2012-01\n2013-06\n2022-01\n2012-11\n2014-12\n2017-12\n2010-11\n2018-08\n2014-08\n2020-04-08\n2025-01\n2023-12-31\n2009-07\n2006-03\n2018-01-31\n2011-03\n2012-03\n2012-04\n2004-02\n2021-12\n2010-02\n2017-01\n2017-08\n2011-03\n2016-08\n2013-02\n2017-05-18\n2014-01\n2011-12\n2009-02\n2017-09\nNone\n2013-04\n2019-12\n2005-04\n2014-07\n2025-12\n2004-12\n2013-01\n2014-10\n2011-06\n2010-09\n2018-08\n2012-04\n2012-10\n2018-08\n2021-09-30\n2012-05\n2022-01\n2009-08\n2003-10\n2014-01\n2017-12\n2023-03-23\n2002-03\n2018-06\n2014-03\n2016-10\n2015-12\n2012-03\n2019-03\n2031-05\n2013-12\n2021-06\n2016-03\n2011-10\n2014-08\n2017-01-01\n2010-10\n2024-08\n2019-05-14\n2014-12\n2009-09\n2017-12\n1990-06\n2026-12\n2026-12\n2006-04\n2014-07\n2016-09\n2019-06\nNone\n2013-12\n2012-01\n2011-06\n2011-09\n2010-08\n2016-06\n2015-03\n2012-06\n2012-07\n2012-08\n2015-04\nNone\n2012-09\n2009-11\n2009-05\n2016-12\n2007-08\n2019-12\n2011-09\n2011-10\n2017-06\n2011-08\n2017-12\n2017-04-30\n2025-06\n2011-12\n2020-01\n2007-05\n2008-10\n2020-03-03\n2016-11\n2014-06\n2014-01\n2014-12\n2014-11\n2008-09\n2021-08\n2018-12-31\n2012-11\n2007-10\n2018-12\n2016-02\n2014-12\n2013-03\n2014-05\n2010-05\n2008-06\n2015-03\n2021-10\n2016-01\n2009-07\n2009-01\nNone\n2019-08\n2010-08\n2007-12\n2018-07\n2018-09\n2016-03\n2011-02\n2017-12-21\n2020-07\n2010-12\n2015-12\n2020-03\nNone\n2014-07\n2022-05\n2012-12\n2016-07\n2011-01\n2016-04\n2008-06\n2016-07\n2011-05\nNone\n2021-08\n2013-12\n1999-03\n2013-12\n2024-03-31\n2008-04\n2013-06\n2019-12-05\n2010-05\n2010-11\n2017-12\n2012-03\n2026-06\n2015-06\n2008-10\n2002-06\n2027-12\n2016-03\n2006-12\n2015-03\n2022-05\n2018-11\n2010-03\n2008-07\n2018-08\n2019-12\n2017-08\n2021-07-21\n2019-08\n2012-05\n2020-12\n2017-10\n2015-12\n2015-01\n2012-12\n2011-07\n2016-04\n2006-04\n2009-09\n2021-12-27\n2014-04\nNone\n2010-03\n2015-01\n2012-05\n2008-08\n2014-12\n2002-09\n2015-12\n2012-12\n2015-05\n2005-07\n2027-08\n2014-02\n2022-12-31\n2009-12\n2013-08\n2013-10\n2007-10\n2020-08\n2014-09\n2021-03\n2007-11\n2005-08\n2017-12\n2011-08\nNone\n2009-11\n2005-07\n2010-10\n2009-09\n2021-02-01\n2013-06\n2014-09\n2017-09\n2001-05\n2008-07\n2013-02\n2018-04-05\n2018-04\n2015-07\n1999-08\n2015-09\nNone\n2018-12\n2009-12\n2018-07\n2026-03\n2002-08\n2015-10\n2011-01\n2026-10\n2025-08\n2015-01\n2010-09\n2011-06\n2013-11\n2014-06\n2008-10\n2010-06\n2009-05\n2011-01\n2017-01-12\n2025-03\n2019-08\n2011-06\n2013-09\n2018-12\nNone\n2016-10\n2019-06\n2012-07\n2017-08\n2018-11-14\n2011-01\n2007-05\n2016-12\n2016-03\n2006-03\n2006-05\n2016-09\n2017-06\n2022-06\n2009-07\n2016-04\n2002-10\n2015-08\n2006-07\n2016-06\n2022-03-17\n2009-05\n2021-06\nNone\n2008-12\n2016-02\n2016-12-31\n2016-12\n2007-06\nNone\n2007-12\n2015-12\n2013-08\n2015-08\n2018-10\n2008-12\n2012-09\n2015-06\n2016-04\n2009-04\n2016-08\n2015-03\n2017-12\n2017-12\n2015-11\n2012-06\n2022-08-01\n2011-10\n2013-06\n2015-06\n2016-11\n2006-12\n2008-01\n2005-11\n2016-11\n2009-09\n2008-07\n2009-02\n2012-07\n2017-07\n2012-05\n2014-12\n2017-10\n2017-02\n2014-09\n2013-10\n2010-08\n2020-03\nNone\n2005-05\n2012-07\n2009-12\n2010-09\n2017-10-05\nNone\n2012-06\n2012-03\n2014-05\n2011-11\n2008-06\n2016-01\n2005-03\n2016-12\n2014-12\n2013-09\n2009-10\n2016-12-30\n2008-11\n2012-03\n2010-10\n2009-03\n2003-12\n2022-06\n2020-03\n2008-10\n2014-12\n2021-08-27\n2010-07\n2013-01\n2018-05\n2014-01\n2012-05\n2017-12\n2018-10\n2011-05\n2013-07\n2008-07\n2010-05\n2016-09\n2006-03\n2005-11\nNone\n2015-12\n2014-04\n2004-02\n2007-01\n2009-05\n2016-05\n2012-09\n2007-12\n2018-06\n2016-07\n2020-06\n2010-01\n2007-01\n2013-02\n2023-12\n2003-11\n2015-12\nNone\n2016-11\n2008-03\n2016-12\n2013-04\n2016-04\n2010-11\n2005-03\n2024-09\n2011-02\n2008-02\n2024-12\n2016-08\n2032-11\n2017-09\n2003-12\n2024-04\n2014-10\n2017-11\nNone\n2014-03\n2023-06\n2010-07\n2015-03\n2016-01\n2018-04\n2025-10\n2005-02\n2007-09\n2016-10\n2016-05\n2023-06-16\n2009-09\n2009-08\n2010-11\n2009-10\n2018-12\n2018-12\n2011-11\n2010-02\n2026-10-31\n2014-04\n2013-03\n2018-04\n2012-05\n2025-10\n2016-05\n2014-08\n2014-08\n2008-03\n2015-06\n2013-09\n2001-03\n2015-06\n2017-09\nNone\n2005-08\n1996-04\n2014-07\nNone\n2016-01\n2018-10\n2009-12\n2019-03\nNone\n2011-10\nNone\n2016-12\n2008-09\n2010-09\n2016-02\n2007-12\n2022-12\n2016-08\n2015-11\n2004-11\n2014-04\n2017-06\n2018-07\n2024-02\n2015-07\n2004-12\n2008-05\n2009-01\n2013-11\n2008-12\n2005-07\n2011-06\n2007-10\n2016-01\n2018-08-01\n2007-06\n2024-07\n2016-07-26\n2014-09\n2014-07\n2010-12\n2019-11\n2008-09\n2015-01\n2011-12\n2013-12\n2021-12\n2005-12\n2022-06-02\n2009-02\n2006-10\n2005-10\n2015-12\n2008-10\n2016-05\n2009-02\n2020-05\n2009-07\n2008-11\nNone\n2008-03\n2012-03\n2004-12\n2007-12\n2004-10\n2017-12-15\n2015-11\n2018-01-28\n2006-11\n2012-08\n2014-12\n2017-03\n2009-04\n2016-03\n2015-06\n2020-01\n2014-12\n2017-03-17\n2008-01\n2013-02\n2014-07\n2005-03\n2004-04\n2015-09\n2016-05\n2009-10\n2015-06\n2007-04\n2014-03\n2011-10\n2013-02\n2019-07\n2007-09\n2022-10\n2012-01\n2013-03\n2013-09\n2010-04\n2017-12\n2012-11\n2018-05\nNone\n2015-05\n2010-04\n2006-03\n2014-03\n2016-06-01\nNone\n2010-01\n2016-01\n2017-07\n2008-09\n2016-11\n2014-10\n2010-01\n2014-12\n2004-03\n2017-01\n2018-03\n2017-02\n2008-05\n2015-11\n2010-01\nNone\n2018-06-28\n2015-01\n2016-04\n2017-12-31\n2017-07\n2013-11\n2015-04\n2018-10-30\n2007-05\n2009-03\n2010-12\n2016-10\n2017-06\n2011-08\n2016-02\n2023-06\n2013-01\n2011-05\n2008-04\n2021-08\n2012-04\n2014-09\n2012-04\n2026-01\n2011-12\n2017-03\n2015-07\n2018-12\n2028-06\n2005-12\n2017-05\n2009-06\n2017-04\n2006-10\n2013-05\n2013-07-02\n2026-09\n2018-08-28\n2010-02\n2009-06\n2015-12\n2023-08\n2009-01\n2016-03\n2011-12\n2020-12\n2020-02\nNone\n2015-02\n2007-05\n2007-10\n2012-03\n2016-06\n2011-07\n2011-12\n2023-07\n2014-05\n2008-06\n2009-05\n2016-01\n2012-12\n2011-12\n2009-06\n2017-04\n2021-02\n2007-12\n2017-12\n2010-12\n2011-12\n2009-07\n2023-12\n2017-03\n2015-09\n2008-02\n2009-06\n2011-01\n2016-11\n2016-12\n2012-09\n2017-04-01\n2013-11\n2019-03-20\n2016-06\n2009-07\n2012-08\n2005-03\n2012-12\n2010-03\n2011-05\n2007-07\n2009-01\n2009-12\n2016-02\n2015-01\n2010-06\n2025-12\nNone\n2013-04\n2006-11\n2013-05\n2015-02\n2018-12\n2017-06-27\n2017-10\n2011-10\n2009-10\n2014-06\n2014-11\n2022-04\n2016-08\nNone\n2007-11\nNone\n2014-09\n2018-10\n2013-09\n2008-08\n2025-06\n2016-04\n2013-06\nNone\n2019-05\n2019-12\n2009-07\n2013-01\n2021-12-31\n2011-12\n2012-08\n2017-10\n2026-12\n2012-08\n2017-02\n2014-11\n2009-03\n2005-05\n2009-02\n2016-08\n2009-01\n2030-06\n2015-02\nNone\n2016-11\n2019-09\n2008-05\n2014-09\n2014-08\n2007-05\n2014-09\n2013-01\n2025-01\n2013-05\n2007-09\n2022-10\n2010-02\n2011-02\nNone\n2016-07\n2017-07-11\n2011-01\nNone\n2016-04\n2010-08\n2022-01\n2022-03-17\n2015-02\n2016-05\n2017-07\n2017-05\n2016-09\n2003-07\n2015-08\n2023-06\n2011-12\n2015-01\n2012-04\n2019-12\n2015-12\n2020-12-22\n2008-05\n2015-11\n2018-12\n2014-10\n2016-05\n2021-06\n2014-09\n2008-10\n2008-12\n2017-12\n2018-12\n2013-06\nNone\n2014-11\n2016-11\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nNone\nNone\nNone\nNone\n1995-02\nNone\n2008-09\nNone\nNone\nNone\n2016-12\n2001-01\nNone\nNone\nNone\nNone\nNone\nNone\n1990-03\n2007-09\n2001-07\n1992-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1994-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1989-10\nNone\nNone\nNone\nNone\n2007-10\n1998-10\nNone\nNone\nNone\nNone\nNone\n2004-12\nNone\nNone\nNone\nNone\nNone\nNone\n1999-10\n2003-08\nNone\nNone\n2004-02\nNone\nNone\nNone\n2005-12\nNone\n2000-09\n2005-12\nNone\nNone\nNone\nNone\n2011-08-16\nNone\n2007-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-12\nNone\n1993-07\nNone\nNone\n1996-07\nNone\nNone\n1996-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1997-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-07\n2000-04\nNone\nNone\nNone\nNone\nNone\nNone\n1994-05\nNone\nNone\n2007-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-10\n1991-06\nNone\n2006-03\nNone\nNone\nNone\nNone\n2000-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-04\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2011-08\nNone\nNone\nNone\n2007-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-04\nNone\nNone\nNone\nNone\nNone\nNone\n2016-07\nNone\n2014-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1991-10\nNone\nNone\nNone\nNone\n1998-10\nNone\nNone\nNone\nNone\n1997-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2007-05\n1995-05\nNone\nNone\nNone\nNone\nNone\n2005-11\nNone\nNone\nNone\nNone\nNone\n2005-05\nNone\nNone\nNone\nNone\nNone\n2005-11\nNone\nNone\nNone\n2015-12\nNone\nNone\n2004-07\nNone\n1991-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2010-12\nNone\nNone\nNone\nNone\nNone\n2000-03\nNone\nNone\n2015-01\nNone\nNone\nNone\n1998-10\nNone\nNone\nNone\n2005-11\nNone\nNone\nNone\n2003-08\nNone\nNone\n2005-01\nNone\nNone\n1990-01\nNone\nNone\nNone\n2003-05\nNone\nNone\n1995-12\nNone\nNone\n2000-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-12\nNone\nNone\n2007-05\nNone\nNone\n2015-03\nNone\nNone\nNone\n2002-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1999-05\nNone\nNone\nNone\nNone\n2000-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1993-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-12\nNone\n2002-04\nNone\n2005-08\nNone\nNone\n2005-06\n2007-08\nNone\nNone\nNone\n2003-11\n2004-07\n2006-09\nNone\nNone\nNone\n2006-10\nNone\nNone\nNone\n2003-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1998-09\n1990-10\nNone\n1990-02\nNone\nNone\nNone\nNone\nNone\n1999-04\nNone\nNone\nNone\nNone\nNone\nNone\n2003-11\nNone\nNone\nNone\nNone\nNone\nNone\n2006-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2017-06\nNone\n1996-09\nNone\n2005-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2007-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1992-03\nNone\n2002-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-06\nNone\nNone\n2004-09\nNone\n2008-06\nNone\nNone\nNone\n2004-10\nNone\n2003-01\nNone\n2007-10\n2000-04\nNone\nNone\n2001-05\nNone\n1996-02\nNone\n2012-07\nNone\nNone\n1997-04\nNone\nNone\nNone\nNone\nNone\nNone\n2007-08\nNone\nNone\nNone\nNone\nNone\n2016-12\nNone\nNone\n1993-05\nNone\nNone\nNone\n2018-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1998-10\n2002-05\nNone\n2004-03\nNone\nNone\n2000-05\nNone\nNone\n2003-05\nNone\nNone\nNone\nNone\nNone\nNone\n2005-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-06\nNone\nNone\nNone\nNone\n2002-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-03\n2008-03\n1993-03\n2005-04\nNone\nNone\nNone\nNone\nNone\n2000-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1990-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-02\nNone\nNone\n1999-10\n2016-12\nNone\nNone\nNone\n1995-11\nNone\n2004-03\n2006-09\nNone\nNone\n2012-11\nNone\nNone\nNone\nNone\nNone\nNone\n2007-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-12\nNone\n2005-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-11\nNone\n1996-06\nNone\nNone\nNone\nNone\nNone\n2004-10\nNone\nNone\nNone\n2008-05\nNone\n2001-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2008-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-06\n1990-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2021-10-28\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1996-03\nNone\n1999-04\nNone\n2008-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-06\nNone\nNone\nNone\nNone\nNone\n1998-04\n1998-04\nNone\nNone\nNone\nNone\nNone\n2003-06\nNone\nNone\n2002-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-07\nNone\nNone\nNone\nNone\nNone\nNone\n1998-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-11\nNone\n2003-09\nNone\nNone\nNone\n2002-06\nNone\nNone\nNone\nNone\nNone\nNone\n2004-06\nNone\nNone\nNone\nNone\n2005-11\nNone\nNone\nNone\nNone\nNone\nNone\n1994-06\nNone\n2003-03\nNone\nNone\n1999-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-01\nNone\nNone\nNone\nNone\nNone\n2006-04\n2007-07\nNone\nNone\nNone\nNone\nNone\n2014-10-07\n2001-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-11\n2005-04\n2006-01\nNone\nNone\n2004-02\nNone\nNone\nNone\nNone\n1998-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-12\nNone\n2007-12\nNone\n2003-11\nNone\n1989-08\n1990-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1996-01\nNone\nNone\n2004-03\nNone\nNone\nNone\nNone\n1990-10\nNone\nNone\nNone\nNone\nNone\n2000-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1993-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2014-01\n2026-01\nNone\nNone\nNone\nNone\nNone\nNone\n2007-08\n2006-10\n2005-09\n1995-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2010-04\n2006-10\n2001-03\nNone\nNone\nNone\nNone\n1996-09\nNone\nNone\nNone\nNone\n2005-08\nNone\nNone\nNone\nNone\nNone\n2004-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1996-07\nNone\n2001-01\nNone\n2007-03\n2005-09\n2004-12\nNone\nNone\nNone\nNone\nNone\n2007-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1997-10\nNone\nNone\nNone\n2003-03\n2005-12\nNone\n1997-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1999-12\n2005-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2007-12\n1995-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1995-06\nNone\n1996-03\nNone\nNone\nNone\n1994-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-09\nNone\n2002-06\nNone\nNone\nNone\nNone\n2004-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-10\nNone\n2005-02\nNone\nNone\nNone\n2003-01\n2003-06\nNone\nNone\n1992-06\nNone\n2004-12\nNone\nNone\n2016-11\nNone\n1993-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1993-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-10\nNone\n2001-09\nNone\nNone\nNone\n1990-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-10\nNone\n2005-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1992-05\n2003-09\nNone\nNone\nNone\nNone\nNone\nNone\n1990-05\n1991-07\nNone\nNone\nNone\nNone\nNone\nNone\n2021-10-28\n2002-02\nNone\nNone\n2003-09\nNone\nNone\nNone\nNone\n2005-09\nNone\nNone\nNone\nNone\nNone\nNone\n2002-12\nNone\n2005-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1997-07\nNone\nNone\nNone\nNone\nNone\nNone\n2008-09\nNone\nNone\n1990-08\n1999-02\nNone\nNone\n2006-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-10\nNone\nNone\nNone\nNone\n2001-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2015-12\nNone\n2007-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1995-09\nNone\nNone\nNone\n1991-12\nNone\n2006-12\nNone\nNone\n1998-04\nNone\n1999-01\n2009-04\nNone\nNone\nNone\nNone\nNone\n2001-09\nNone\n2005-09\n2002-03\n1997-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-11\n1991-11\nNone\nNone\nNone\nNone\n2008-04\n1998-07\nNone\nNone\nNone\n2002-06\nNone\n2003-05\nNone\nNone\nNone\n2007-05\nNone\nNone\nNone\nNone\nNone\n2001-11\nNone\nNone\nNone\nNone\nNone\n2000-10\n1991-04\n2015-11\nNone\n1990-06\nNone\nNone\nNone\n2003-07\nNone\nNone\n2005-06\nNone\n2003-04\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1999-07\nNone\nNone\nNone\nNone\nNone\n2011-11\n1990-04\n1994-06\nNone\nNone\nNone\n2005-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-12\nNone\nNone\nNone\nNone\n2005-02\n2007-05\nNone\nNone\nNone\n2000-12\n1998-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1997-05\n2006-10\n1998-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-09\nNone\nNone\nNone\nNone\nNone\n2001-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-06\nNone\nNone\nNone\nNone\nNone\n1999-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1990-05\nNone\nNone\nNone\nNone\n1995-08\nNone\nNone\nNone\n2011-03\nNone\nNone\nNone\nNone\n2008-04\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-06\nNone\nNone\nNone\nNone\n2000-10\nNone\nNone\nNone\n2004-08\n1997-10\n1990-05\nNone\n2003-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1994-11\n2000-05\n1993-04\nNone\nNone\n2005-06\nNone\nNone\nNone\nNone\nNone\n2002-06\nNone\nNone\nNone\n2018-01\nNone\nNone\nNone\nNone\nNone\n2007-09\n2006-10\nNone\n2005-03\nNone\nNone\n2001-06\nNone\nNone\nNone\nNone\nNone\nNone\n2005-11\nNone\nNone\n2001-05\nNone\nNone\n1993-09\nNone\nNone\nNone\nNone\nNone\nNone\n1994-09\nNone\nNone\n2002-09\nNone\nNone\n2005-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-10\nNone\nNone\nNone\nNone\nNone\nNone\n2011-06\nNone\nNone\nNone\n2005-08\nNone\nNone\n2005-03\nNone\nNone\nNone\nNone\nNone\n2001-06\nNone\n1995-05\n1992-09\nNone\nNone\n2023-12\n2000-06\nNone\nNone\nNone\n2007-10\nNone\n2007-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1989-04\nNone\nNone\nNone\n2000-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-06\nNone\nNone\n2004-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1995-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2024-12\nNone\nNone\n2004-11\nNone\n2007-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-06\nNone\nNone\nNone\nNone\nNone\n1996-09\nNone\n1998-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-03\n1993-10\nNone\nNone\nNone\nNone\nNone\n2006-01\nNone\nNone\n2019-04\nNone\nNone\nNone\nNone\n2007-09\nNone\nNone\nNone\nNone\nNone\n2021-04\n1996-09\nNone\nNone\nNone\nNone\n2011-06\nNone\n2006-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1993-11\nNone\n2007-09\n2006-08\nNone\nNone\nNone\nNone\n1989-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-10\nNone\n2004-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1993-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2009-12\n2006-03\n2007-03\n2007-12\nNone\nNone\nNone\nNone\n1989-07\nNone\nNone\nNone\nNone\nNone\n2005-05\n2005-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1991-09\nNone\nNone\n1995-06\nNone\nNone\nNone\nNone\nNone\nNone\n1998-04\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1992-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-02\n2013-07\n2017-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1992-04\nNone\n2006-12\nNone\nNone\nNone\n2003-06\nNone\nNone\nNone\nNone\n2001-05\nNone\nNone\n2018-04\nNone\n1996-09\nNone\nNone\nNone\nNone\n2003-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-10\nNone\nNone\n2004-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-09\nNone\nNone\n2019-04-30\nNone\n2004-09\nNone\n2018-10-06\nNone\nNone\n2004-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-03\nNone\nNone\n2011-12\nNone\nNone\nNone\nNone\nNone\nNone\n1999-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1997-06\nNone\n2004-11\n2005-05\nNone\nNone\n2007-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-10\n2007-01\nNone\n1988-05\nNone\nNone\nNone\nNone\n2005-05\nNone\n2005-04\nNone\nNone\n2002-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-03\nNone\nNone\nNone\nNone\n1995-07\nNone\n1992-08\nNone\nNone\nNone\nNone\n2007-06\nNone\nNone\nNone\n2004-05\nNone\nNone\n2000-10\nNone\nNone\nNone\nNone\n2005-10\n2007-01\n2005-12\nNone\n2007-05\nNone\nNone\nNone\nNone\nNone\n2016-07\nNone\nNone\n2006-12\n1991-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2009-01\nNone\n2004-06\nNone\n2005-05\nNone\n1990-02\nNone\nNone\nNone\nNone\nNone\n2004-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-09\n2001-05\n2007-05\n2005-08\nNone\nNone\n2017-07\nNone\nNone\nNone\nNone\n2007-06\nNone\nNone\nNone\nNone\nNone\n1994-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2016-12\n1998-04\nNone\nNone\nNone\n2005-11\nNone\nNone\nNone\n2008-06\nNone\nNone\nNone\nNone\nNone\n2001-08\nNone\n1991-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1999-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-10\nNone\nNone\nNone\nNone\nNone\nNone\n1990-04\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1991-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2015-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-11\nNone\nNone\nNone\n2009-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2009-09\n2006-11\n2004-01\nNone\nNone\nNone\n1997-09\nNone\nNone\nNone\n2002-08\nNone\n1993-02\nNone\nNone\nNone\nNone\nNone\n2010-01\nNone\nNone\n1995-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1998-10\n1996-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2007-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2010-01\nNone\n2001-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1999-04\nNone\n2003-05\nNone\n1998-06\nNone\nNone\n2000-03\nNone\nNone\nNone\n2005-03\nNone\nNone\nNone\nNone\nNone\nNone\n2007-06\nNone\nNone\nNone\nNone\nNone\n2004-10\nNone\n1997-02\n1998-07\nNone\nNone\nNone\nNone\nNone\nNone\n1997-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-06\n2099-01\nNone\nNone\n2001-06\n2021-10\nNone\nNone\nNone\n2012-09\nNone\nNone\n2011-01\nNone\nNone\nNone\n1992-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2008-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1995-02\nNone\nNone\nNone\nNone\nNone\nNone\n1993-04\nNone\n2002-03\nNone\n2005-01\nNone\n2003-04\nNone\nNone\n2005-06\nNone\nNone\nNone\nNone\nNone\n1996-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1992-09\n2006-05\nNone\nNone\nNone\n2007-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-08\nNone\nNone\nNone\n2006-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-09\n2012-06\n1991-05\nNone\nNone\nNone\n1989-01\nNone\nNone\n2005-11\n1998-08\nNone\n2011-03\n2005-10\nNone\nNone\n1995-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-05\n1993-08\nNone\nNone\nNone\n2005-06\nNone\nNone\n1991-09\n1990-06\nNone\nNone\n2008-02\nNone\nNone\nNone\nNone\n2001-12\nNone\nNone\nNone\n2000-09\nNone\nNone\nNone\nNone\n1999-12\nNone\nNone\nNone\nNone\nNone\n2003-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1996-09\n2000-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1994-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-06\n2019-01\nNone\n2008-05\nNone\nNone\n2007-07\nNone\nNone\n2007-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-12\nNone\nNone\nNone\n2010-05\nNone\nNone\n2004-06\nNone\nNone\n2020-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-08\nNone\nNone\nNone\nNone\n2003-05\nNone\nNone\nNone\n1996-09\nNone\nNone\nNone\n1993-02\nNone\n2004-09\nNone\nNone\nNone\nNone\n2006-09\nNone\nNone\nNone\nNone\n2017-09\nNone\n2017-05-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-05\nNone\nNone\nNone\nNone\nNone\nNone\n1997-03\nNone\nNone\nNone\n2002-06\n2006-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1993-11\nNone\n1993-03\nNone\nNone\nNone\nNone\nNone\n1992-09\nNone\n2006-12\nNone\nNone\n2011-03\nNone\n2007-03\n2005-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2009-01\n2007-03\nNone\n1988-12\nNone\nNone\nNone\nNone\nNone\nNone\n1990-07\n2004-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-04\nNone\n2005-04\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1995-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-11\n1997-05\nNone\nNone\nNone\nNone\nNone\n1996-01\nNone\n2010-06\nNone\nNone\nNone\nNone\nNone\n1999-06\n2004-06\nNone\nNone\nNone\nNone\nNone\nNone\n2006-05\nNone\n2010-09\nNone\n1994-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-11\nNone\nNone\n2001-06\nNone\nNone\n2008-04\nNone\nNone\n2008-12\n1993-06\n2003-09\nNone\nNone\nNone\nNone\nNone\nNone\n2006-10\nNone\nNone\n2001-12\n1994-12\n2004-01\n2006-10\n2006-08\nNone\nNone\n2012-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1998-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-07\nNone\nNone\nNone\n2014-04\nNone\nNone\nNone\nNone\nNone\n2006-12\nNone\nNone\n2004-07\nNone\nNone\n2008-04\nNone\nNone\n1996-09\nNone\nNone\nNone\nNone\nNone\nNone\n1998-11\nNone\nNone\n1991-03\nNone\n1994-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-06\n2002-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1990-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2008-04\nNone\nNone\n2000-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-04\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1991-06\n2005-07\nNone\nNone\n2006-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1999-05\n2015-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1994-12\nNone\nNone\nNone\nNone\nNone\nNone\n2014-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2020-03\nNone\nNone\n1996-08\nNone\nNone\nNone\nNone\nNone\n2016-08\nNone\nNone\nNone\nNone\n1992-04\nNone\n2005-01\nNone\nNone\nNone\n2000-07\n2002-12\nNone\n2003-03\nNone\nNone\n2005-12\n2008-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2007-03\nNone\nNone\nNone\n2010-09\nNone\nNone\nNone\nNone\n1999-09\nNone\nNone\nNone\n2006-07\nNone\nNone\nNone\nNone\n2005-12\nNone\n1994-01\nNone\nNone\nNone\nNone\nNone\nNone\n2004-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-04\n2017-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1991-12\nNone\nNone\nNone\n1995-02\n2002-11\nNone\nNone\nNone\n2005-02\nNone\n2006-01\nNone\nNone\nNone\nNone\nNone\n2005-07\nNone\nNone\n2001-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1999-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1996-11\nNone\nNone\nNone\n2005-01\nNone\nNone\nNone\n1998-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2010-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1994-11\nNone\n2000-07\nNone\nNone\nNone\nNone\n1993-04\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1992-12\nNone\n1997-11\nNone\n2007-08\nNone\nNone\nNone\nNone\nNone\n1995-05\n2016-01\nNone\nNone\n2001-12\nNone\nNone\n2004-03\n2000-04\nNone\n2011-05\nNone\nNone\nNone\nNone\nNone\n1995-01\nNone\nNone\nNone\nNone\nNone\nNone\n1992-06\nNone\nNone\nNone\n2007-06\nNone\nNone\nNone\nNone\nNone\n1999-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1989-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2017-01\nNone\n1992-12\nNone\nNone\nNone\nNone\nNone\nNone\n2003-02\nNone\n2000-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2020-05\nNone\n1991-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2010-05\nNone\nNone\n1998-05\n1997-12\n2006-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1992-12\nNone\nNone\n2004-08\nNone\nNone\nNone\nNone\n2018-08\nNone\nNone\nNone\nNone\n2005-06\nNone\n2004-04\n2001-05\nNone\nNone\n1999-02\n2005-08\nNone\nNone\nNone\nNone\nNone\nNone\n1993-10\nNone\nNone\nNone\nNone\nNone\nNone\n2005-09\nNone\n2004-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-12\nNone\nNone\nNone\nNone\nNone\n2007-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1992-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1991-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1994-06\n2004-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2014-02\n2001-04\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2007-04\nNone\nNone\nNone\nNone\nNone\nNone\n1998-03\nNone\nNone\n2005-07\nNone\n2015-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1995-02\nNone\nNone\nNone\nNone\nNone\nNone\n1992-04\nNone\n1999-01\nNone\nNone\nNone\nNone\nNone\n1996-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2007-01\n2010-12\nNone\nNone\nNone\n2004-09\n1993-05\nNone\nNone\nNone\nNone\nNone\nNone\n2006-12\nNone\nNone\n2004-06\nNone\n2017-03\n2014-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2000-09\nNone\nNone\nNone\n2005-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-09\n1994-07\n2015-01\nNone\nNone\n2020-09\n2004-06\nNone\nNone\n2001-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2008-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-06\n2010-01\nNone\nNone\nNone\n2005-03\nNone\nNone\nNone\nNone\n1993-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1990-10\nNone\nNone\nNone\nNone\n2005-06\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-09\nNone\nNone\nNone\n2009-09\nNone\nNone\n2006-12\n1998-03\n2004-04\nNone\n2004-06\nNone\nNone\nNone\nNone\n2002-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1999-01\nNone\nNone\nNone\n2000-07\n2003-10\n2008-07\n1992-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1999-10\nNone\nNone\nNone\nNone\n2006-10\nNone\nNone\nNone\nNone\nNone\nNone\n1999-07\nNone\nNone\nNone\nNone\n2017-01\nNone\nNone\nNone\nNone\nNone\n1998-07\nNone\nNone\nNone\nNone\nNone\nNone\n1992-08\nNone\nNone\nNone\n2008-07\n1998-04\nNone\n2017-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-06\nNone\nNone\n2005-12\nNone\nNone\nNone\nNone\nNone\n1998-01\nNone\nNone\nNone\nNone\nNone\nNone\n1995-04\nNone\nNone\nNone\nNone\n2003-04\nNone\nNone\nNone\n2003-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-07\nNone\nNone\n1991-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-01\nNone\nNone\nNone\nNone\n1991-06\n2011-05\nNone\nNone\nNone\nNone\nNone\n2002-04\n2006-10\nNone\nNone\n2009-08\nNone\n2005-02\nNone\nNone\n1999-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2002-08\nNone\n1996-02\nNone\nNone\nNone\nNone\nNone\nNone\n2007-04\nNone\nNone\nNone\n2007-06\nNone\nNone\nNone\nNone\n2007-02\nNone\nNone\n2005-09\n2002-01\nNone\nNone\nNone\nNone\nNone\n2007-05\n2007-09\nNone\n2005-06\n2000-02\nNone\nNone\nNone\n2017-02\nNone\nNone\nNone\nNone\nNone\nNone\n2004-08\nNone\nNone\nNone\n1990-03\nNone\n2012-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-10\nNone\n2017-12\n2014-05\nNone\n1997-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2012-01\nNone\n2005-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2020-10-08\n2005-03\nNone\nNone\nNone\n1997-06\nNone\nNone\n2013-11\nNone\nNone\nNone\nNone\n2002-03\nNone\nNone\n1994-12\nNone\n2005-11\nNone\n2004-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-03\n1995-02\nNone\n1997-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-03\nNone\nNone\nNone\n2017-05-01\nNone\n2014-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-09\nNone\nNone\nNone\n2005-12\n2004-10\nNone\nNone\nNone\nNone\nNone\nNone\n2001-12\n2008-03\n1998-04\n2001-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1990-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2006-03\n2007-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-07\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-06\nNone\nNone\n2007-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-05\nNone\nNone\n2003-11\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2005-04\nNone\nNone\nNone\n1992-10\n1998-09\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-03\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-05\n1993-08\n2003-03\nNone\nNone\nNone\n2004-11\nNone\nNone\n2012-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2013-02\nNone\nNone\nNone\nNone\nNone\nNone\n1999-12\nNone\nNone\n2000-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-03\n1995-12\nNone\n1999-02\n2004-08\nNone\nNone\nNone\n2007-10\nNone\n2012-06\n1992-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2017-06\n2000-01\nNone\nNone\nNone\nNone\n1996-09\nNone\n1999-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1993-02\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2004-02\n2007-01\nNone\nNone\n2005-06\n2003-07\nNone\nNone\nNone\nNone\nNone\n1997-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2003-04\n1996-04\nNone\nNone\nNone\n2005-09\nNone\nNone\nNone\nNone\nNone\n2004-10\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1994-11\nNone\n1989-07\nNone\nNone\nNone\nNone\nNone\n2002-03\nNone\nNone\nNone\nNone\nNone\n2006-12\nNone\nNone\nNone\nNone\n2003-04\nNone\nNone\nNone\nNone\nNone\n1990-05\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1995-02\nNone\nNone\n2001-12\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n1992-10\nNone\nNone\nNone\nNone\nNone\n1990-03\nNone\nNone\n2001-04\nNone\n2004-08\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-05\nNone\nNone\nNone\nNone\nNone\n2005-03\nNone\nNone\n2002-09\nNone\nNone\nNone\nNone\nNone\nNone\n2006-01\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\nNone\n2001-12\nNone\nNone\nNone\nNone\n1992-04\n2014-10-07\n1990-02\nNone\n2007-12\nNone\nNone\nNone\nNone\n1993-11\nNone\nNone\nNone\n2004-11\nNone\nNone\nNone\n1998-10\n1990-06\nNone\n2022-01\nNone\nNone\nNone\nNone\n2000-03\nNone\nNone\nNone\nNone\n2005-08\nNone\n2001-08\nNone\nNone\nNone\n2003-04\nNone\nNone\nNone\nNone\n2000-06\nNone\nNone\nNone\nNone\n1991-07\n1990-02\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the completion column from each row of the dataset rdd_with_header_finalized\n",
    "completion = rdd_with_header_finalized.map(lambda row: row[13] if len(row) > 13 else None)\n",
    "\n",
    "# Display the completion column values\n",
    "for value in completion.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "2b387a44-9de7-4346-bdd0-111ef4e2035d",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "completion (Containing None values in column completion):\n('NCT00897871', 'Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer', None, 'UNKNOWN', 'Unspecified Childhood Solid Tumor Protocol Specific', 'DRUG: carboplatin|DRUG: cyclophosphamide|DRUG: etoposide phosphate|GENETIC: gene expression analysis|GENETIC: polymorphism analysis|OTHER: pharmacological study', \"Children's Cancer and Leukaemia Group\", None, '60.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2007-02-01', None)\n('NCT00266071', 'Study of the Cutaneous Microcirculation in Elderly People', None, 'UNKNOWN', 'Elderly People', 'BEHAVIORAL: Cutaneous response', 'University Hospital Angers', None, None, 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2005-12-01', None)\n('NCT00553371', 'Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer', None, 'UNKNOWN', 'Testicular Germ Cell Tumor', 'OTHER: biomarker analysis|PROCEDURE: computed tomography', 'Royal Marsden NHS Foundation Trust', None, '300.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2006-04-01', None)\n('NCT00000571', 'Trial of Inspiratory Muscle Rest and Exercise in Chronic Obstructive Lung Disease', None, 'COMPLETED', 'Lung Diseases|Lung Diseases Obstructive|Chronic Obstructive Pulmonary Disease', 'DEVICE: ventilators negative pressure', 'McGill University', 'National Heart Lung and Blood Institute (NHLBI)', None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT', '1986-02-01', None)\n('NCT02570971', 'Mannitol Versus Supportive Care in Ciguatera Fish Poisoning', None, 'UNKNOWN', 'Ciguatoxin', 'DRUG: Mannitol', 'University of South Florida', 'Florida Poison Control Center', '200.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2015-10-01', None)\n('NCT02827071', 'Ocular Imaging Study Using Advanced OCT', None, 'UNKNOWN', 'Retinal Vascular Disorder|Macular Degeneration', None, 'University of California Los Angeles', None, '1000.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2016-07-01', None)\n('NCT00510471', 'Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma', None, 'TERMINATED', \"Non-Hodgkin's Lymphoma\", 'DRUG: autologous immunoglobulin idiotype-KLH conjugate vaccine', 'Genitope Corporation', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ', '2007-05-01', None)\n('NCT02079571', 'Investigation of Pulse Waves Channel Entries and Food Attributes in Healthy Subjects With Different Constitutions', None, 'UNKNOWN', 'Healthy Subjects With Different Constitutions', 'DIETARY_SUPPLEMENT: Coconut water|DIETARY_SUPPLEMENT: ginger tea', 'National Taiwan University Hospital', None, '240.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2013-05-01', None)\n('NCT00558571', '4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes', None, 'COMPLETED', 'Diabetes Mellitus Type 2', 'DRUG: BI 10773 low dose|DRUG: placebo to BI 10773|DRUG: BI 10773 medium dose|DRUG: BI 10773 high dose', 'Boehringer Ingelheim', None, '78.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2008-01-01', None)\n('NCT00005871', 'Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer', None, 'UNKNOWN', 'Pancreatic Cancer', 'DRUG: fluorouracil|DRUG: rubitecan', 'Astex Pharmaceuticals Inc.', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT', '1998-11-01', None)\n('NCT01034371', 'Comparison of One-stop Hybrid Revascularization Versus Off-pump Coronary Artery Bypass for the Treatment of Multi-vessel Disease', None, 'UNKNOWN', 'Coronary Artery Disease', 'PROCEDURE: Minimally invasive direct coronary artery bypass|PROCEDURE: PCI-Drug eluting stents|PROCEDURE: Off-pump coronary artery bypass', 'China National Center for Cardiovascular Diseases', None, '400.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2009-12-01', None)\n('NCT00826371', 'Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients', 'EXTEND II', 'COMPLETED', 'Age Related Macular Degeneration', 'DRUG: ranibizumab 0.5 mg', 'Novartis Pharmaceuticals', None, '114.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2009-01-01', None)\n('NCT01488071', 'A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication', 'REVIVE', 'COMPLETED', 'Major Depressive Disorder', 'DRUG: Vortioxetine (Lu AA21004)|DRUG: Agomelatine', 'H. Lundbeck A/S', None, '495.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2012-01-01', None)\n('NCT01779271', 'Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection', None, 'COMPLETED', 'Acute Upper Respiratory Infection|Fever', 'DRUG: Pelubiprofen|DRUG: Loxoprofen', 'Daewon Pharmaceutical Co. Ltd.', None, '183.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2013-01-01', None)\n('NCT00002671', 'Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer', None, 'COMPLETED', 'Ovarian Cancer', 'DRUG: aminocamptothecin', 'NYU Langone Health', 'National Cancer Institute (NCI)|Eastern Cooperative Oncology Group', None, 'OTHER', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', '1995-12-01', None)\n('NCT02156271', 'Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance', None, 'COMPLETED', 'Insomnia', 'DRUG: ramelteon|DRUG: placebo', 'Duke University', None, '75.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2007-07-01', None)\n('NCT01234571', 'Impact of Hemo-dialysis Therapy on Blood Levels of Treprostenil in End Stage Renal Disease Patients With Pulmonary Hypertension', None, 'UNKNOWN', 'Pulmonary Hypertension|End-Stage Renal Disease|Hemo-dialysis Therapy', None, 'Rambam Health Care Campus', None, '5.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2010-11-01', None)\n('NCT00019071', 'Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma', None, 'COMPLETED', 'Brain and Central Nervous System Tumors', 'DRUG: chemotherapy|DRUG: cladribine|RADIATION: radiation therapy', 'National Cancer Institute (NCI)', None, None, 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', '1995-03-01', None)\n('NCT01878071', 'The Effect of Obesity on Oral Peri-implant Health - A Cross-Sectional Study', None, 'COMPLETED', 'Obesity|Peri-implant Inflammation|Peri-implantitis', None, 'University of Iowa', 'Osseointegration Foundation|University of Iowa Institute of Clinical and Translational Science', '73.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-06-01', None)\n('NCT00956371', 'ONO-7746 Study in Healthy Adult Subjects', None, 'COMPLETED', 'Healthy Adult Subjects', 'DRUG: ONO-7746|DRUG: ONO-7746', 'Ono Pharmaceutical Co. Ltd', None, '48.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2009-08-01', None)\n('NCT02218671', 'Pharmacological Study on Absorption of WE 941 OD Tablets in Japanese Healthy Male Volunteers', None, 'COMPLETED', 'Healthy', 'DRUG: WE 941 OD tablets', 'Boehringer Ingelheim', None, '10.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', '2000-03-01', None)\n('NCT00058071', 'Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer', None, 'COMPLETED', 'Gestational Trophoblastic Tumor|Neurotoxicity|Peripheral Neuropathy|Unspecified Adult Solid Tumor Protocol Specific', 'DRUG: amifostine trihydrate', 'Gynecologic Oncology Group', 'National Cancer Institute (NCI)', '100.0', 'NETWORK', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: SUPPORTIVE_CARE', '2003-03-01', None)\n('NCT01244971', 'Exercise and Acarbose in Type 2 Diabetes', None, 'COMPLETED', 'Diabetes Mellitus Type 2', 'DRUG: Acarbose|BEHAVIORAL: Exercise|OTHER: Exercise + Acarbose', 'Karolinska Institutet', 'The Swedish Research Council|Bayer', '62.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2004-01-01', None)\n('NCT02258971', 'Metabolism and Pharmacokinetics of [14C] BEA 2180 BR Administered Orally Compared to [14C] BEA 2180 BR Administered Intravenously in Healthy Male Volunteers', None, 'COMPLETED', 'Healthy', 'DRUG: BEA 2180 BR oral|DRUG: BEA 2180 BR infusion', 'Boehringer Ingelheim', None, '14.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2007-03-01', None)\n('NCT01452971', 'A Study of the Interaction Between Tumor Susceptibility Gene Glycine N-methyltransferase (GNMT) and Lung Cancer', None, 'UNKNOWN', 'Lung Cancer', None, 'China Medical University Hospital', None, '200.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2011-10-01', None)\n('NCT01723371', 'Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children', None, 'WITHDRAWN', 'Pulmonary Arterial Hypertension', 'DRUG: Carvedilol', 'The Hospital for Sick Children', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-09-01', None)\n('NCT01837771', 'Epiphrenic III Pilot Trial', None, 'UNKNOWN', 'Heart Failure', 'DEVICE: Diaphragmatic stimulation', 'Luzerner Kantonsspital', None, '25.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', '2013-04-01', None)\n('NCT00904371', 'Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients', None, 'COMPLETED', 'Hypertension|Cardiovascular Diseases', None, 'Boehringer Ingelheim', None, '211.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2009-12-01', None)\n('NCT02898571', 'Cross-over Double-blind Intervention to Investigate the Effects of Defined Antioxidant-containing Drinks on Time Course of Antioxidant Capacity', None, 'UNKNOWN', 'The Impact of Vitamin c and Epicatechin Upon Antioxidant Capactity', 'DIETARY_SUPPLEMENT: Placebo|DIETARY_SUPPLEMENT: Vitamin C|DIETARY_SUPPLEMENT: epicatechin', 'Newcastle University', 'Linkoeping University', '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE', '2016-07-01', None)\n('NCT01311271', 'Effects of the Quantity of Repetitive Transcranial Magnetic Stimulation(rTMS) on the Recovery After Stroke', None, 'TERMINATED', 'Stroke|Hemiplegia', 'DEVICE: repetitive transcranial magnetic stimulation (rTMS)', 'Seoul National University Bundang Hospital', 'Asan Medical Center|Gyeongsang National University Hospital|Hanyang University|Seoul National University Boramae Hospital', '2.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2011-01-01', None)\n('NCT01963871', 'The Effect of Yoga in Chronic Low Back Pain', None, 'COMPLETED', 'Low Back Pain', 'OTHER: Yoga', 'Yvonne Colgrove PT PhD', None, '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2013-08-01', None)\n('NCT00398671', 'PreCoCa - Prehospital Cooling With Cool-Caps', None, 'COMPLETED', 'Heart Arrest', 'DEVICE: Application of cool cap after primary successful CPR', 'Charite University Berlin Germany', None, '50.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ', '2006-01-01', None)\n('NCT02238171', 'Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease', None, 'COMPLETED', 'Pulmonary Disease Chronic Obstructive', 'DRUG: Atrovent® inhalets', 'Boehringer Ingelheim', None, '346.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2000-04-01', None)\n('NCT00171171', 'A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis', None, 'COMPLETED', 'Beta-Thalassemia|Hemosiderosis', 'DRUG: deferasirox', 'Novartis', None, '252.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2004-05-01', None)\n('NCT00441571', 'Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer', 'CYT-500', 'UNKNOWN', 'Metastatic Prostate Cancer', 'DRUG: 177Lu-CYT-500', 'Cytogen Corporation', None, '30.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2007-02-01', None)\n('NCT02070471', 'Phase 2 Study to Evaluate the Efficacy Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients', None, 'COMPLETED', 'ST-segment Elevation Myocardial Infarction', 'DRUG: Placebo|DRUG: LC28-0126 Dose A|DRUG: LC28-0126 Dose B|DRUG: LC28-0126 Dose C', 'LG Life Sciences', None, '60.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2014-01-01', None)\n('NCT01166971', 'A Comparison of Visual Function After Bilateral Implantation of Presbyopia-correcting Intraocular Lenses (IOLs)', None, 'COMPLETED', 'Cataract', 'DEVICE: ReSTOR +3|DEVICE: Tecnis MF', 'Alcon Research', None, '65.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2010-07-01', None)\n('NCT00305071', 'Effect of Adjuvant Treatment With Compound Cranberry Extract Tablets in Acute Bacterial Cystitis.', None, 'UNKNOWN', 'Pyuria|Urinary Tract Infections', 'DRUG: compound cranberry extract tablet', 'Min-Sheng General Hospital', 'Acrobio Healthcare Inc.', '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', '2006-04-01', None)\n('NCT02736071', 'Tramadol Versus Celecoxib for Reducing Pain During Operative Office Hysteroscopy', None, 'UNKNOWN', 'Hysteroscopy', 'DRUG: Celecoxib|DRUG: Tramadol|DRUG: Placebo 1|DRUG: Placebo 2', 'Cairo University', None, '210.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION', '2016-06-01', None)\n('NCT00004771', \"Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease\", None, 'COMPLETED', 'Spinal Muscular Atrophy|Amyotrophic Lateral Sclerosis|Spinobulbar Muscular Atrophy', 'DRUG: leuprolide|DRUG: testosterone', 'National Center for Research Resources (NCRR)', 'Ohio State University', '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', '1992-10-01', None)\n('NCT01286571', 'Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food', None, 'COMPLETED', 'Healthy', 'DRUG: BI 135585|DRUG: BI 135585', 'Boehringer Ingelheim', None, '14.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT', '2011-01-01', None)\n('NCT00107471', 'Topotecan G-CSF and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma', None, 'TERMINATED', 'Brain Tumors|Central Nervous System Tumors', 'BIOLOGICAL: filgrastim|DRUG: topotecan hydrochloride|RADIATION: radiation therapy', \"Children's Oncology Group\", 'National Cancer Institute (NCI)', '7.0', 'NETWORK', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2005-10-01', None)\n('NCT01508871', 'Electrical Interactions in Heart Disease', None, 'UNKNOWN', 'Cardiomyopathy Dilated', 'OTHER: Observational study no intervention', 'University Health Network Toronto', None, '100.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2011-01-01', None)\n('NCT00085371', 'Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas', None, 'COMPLETED', 'Acinar Cell Adenocarcinoma of the Pancreas|Duct Cell Adenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer', 'DRUG: triapine', 'National Cancer Institute (NCI)', None, '116.0', 'NIH', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2004-07-01', None)\n('NCT00234871', 'Tarka® vs. Lotrel® in Hypertensive Diabetic Subjects With Renal Disease (TANDEM)', 'TANDEM', 'COMPLETED', 'Hypertension|Diabetes|Proteinuria', 'DRUG: trandolapril/verapamil|DRUG: Lotrel (amlodipine/benazepril)', 'Abbott', None, '357.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2004-01-01', None)\n('NCT02182271', 'Single Rising Dose Study of BI 201335 ZW in Healthy Male Subjects', None, 'TERMINATED', 'Healthy', 'DRUG: BI 201335 ZW - single rising dose|DRUG: Placebo', 'Boehringer Ingelheim', None, '8.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', '2004-10-01', None)\n('NCT00152971', 'Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement', None, 'COMPLETED', 'Arthroplasty Replacement Knee|Thromboembolism', 'DRUG: Dabigatran Dose 1 - day 2 to completion|DRUG: Dabigatran Dose 1 - day 1|DRUG: Dabigatran Dose 2 - day 2 to completion|DRUG: Dabigatran Dose 2 - day 1|DRUG: Enoxaparin', 'Boehringer Ingelheim', None, '2615.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: PREVENTION', '2004-11-01', None)\n('NCT00457171', 'GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis', None, 'TERMINATED', 'Ulcerative Colitis', 'DRUG: GI-270384', 'GlaxoSmithKline', None, '16.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT', '2004-12-01', None)\n('NCT01666171', 'Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32', None, 'UNKNOWN', 'Breast Cancer', 'DRUG: metformin hydrochloride|OTHER: clinical observation|OTHER: diagnostic laboratory biomarker analysis|OTHER: imaging biomarker analysis|OTHER: medical chart review|PROCEDURE: digital mammography', 'Cancer and Leukemia Group B', 'National Cancer Institute (NCI)', '458.0', 'NETWORK', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-08-01', None)\n('NCT01676571', 'Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and Women', None, 'COMPLETED', 'Healthy', 'DRUG: Lu AA21004', 'H. Lundbeck A/S', None, '16.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-10-01', None)\n('NCT00732771', 'Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism', None, 'COMPLETED', 'Primary Hyperaldosteronism', 'DRUG: LCI699', 'Novartis', None, '12.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2008-06-01', None)\n('NCT00155571', 'The Occurrence of Periopathogens in Betel-Nut Chewers and the Effects of Areca-Nut on Periopathogens', None, 'COMPLETED', 'Periodontitis', None, 'National Taiwan University Hospital', 'National Science Council Taiwan', '186.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2001-08-01', None)\n('NCT00818571', 'Pharmacokinetics of Vildagliptin in Mild Moderate and Severe Renal Impaired Patients', None, 'COMPLETED', 'Renal Impairment|Diabetes', 'DRUG: Vildagliptin|DRUG: Vildagliptin|DRUG: Vildagliptin|DRUG: Vildagliptin', 'Novartis Pharmaceuticals', None, '96.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2008-12-01', None)\n('NCT00005071', 'Diagnosis and Treatment Planning in Patients Suspected of Having Lung Cancer', None, 'UNKNOWN', 'Lung Cancer', 'PROCEDURE: biopsy|PROCEDURE: bronchoscopy|PROCEDURE: computed tomography|PROCEDURE: quality-of-life assessment', 'Royal Marsden NHS Foundation Trust', None, None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: DIAGNOSTIC', '1998-10-01', None)\n('NCT00002771', 'Chemotherapy Interferon and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia', None, 'UNKNOWN', 'Leukemia', 'BIOLOGICAL: recombinant interferon alfa|DRUG: busulfan|DRUG: cytarabine|DRUG: hydroxyurea|DRUG: idarubicin|PROCEDURE: allogeneic bone marrow transplantation|PROCEDURE: autologous bone marrow transplantation|PROCEDURE: peripheral blood stem cell transplantation|RADIATION: radiation therapy', 'German CML Study Group', None, '750.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT', '1995-01-01', None)\n('NCT00627471', 'Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)', 'Malbec', 'TERMINATED', 'Type 2 Diabetes', 'DRUG: Insulin Glargine|DRUG: Insulin Glargine', 'Sanofi', None, '9.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2008-01-01', None)\n('NCT02095171', 'Single Ascending Dose Study of PRX002 in Healthy Subjects', None, 'COMPLETED', \"Parkinson's Disease\", 'DRUG: PRX002|OTHER: Placebo', 'Prothena Biosciences Limited', 'Hoffmann-La Roche', '40.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2014-03-01', None)\n('NCT02368171', 'Role of Heme-oxygenase (HO) and Nitric Oxide (NO) Pathway in Patients With Obstructive Sleep Apnea (OSA) and Pulmonary Hypertension (PH)', None, 'UNKNOWN', 'Obstructive Sleep Apnea|Pulmonary Hypertension', 'OTHER: measure exhaled carbon monoxide and nitric oxide', 'Southern California Institute for Research and Education', None, '60.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-03-01', None)\n('NCT01278771', 'Coronary Anomalies in Congenital Heart Disease', 'CHD', 'UNKNOWN', 'Congenital Heart Disease', None, 'Rambam Health Care Campus', None, '1200.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2011-03-01', None)\n('NCT00656539', 'Safety and Efficacy Pilot Study of AzaSite® for Four Weeks in Subjects With Blepharitis', None, 'COMPLETED', 'Blepharitis', 'DRUG: AzaSite®', 'Merck Sharp & Dohme LLC', None, '20.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2008-04-01', None)\n('NCT00075439', 'Gefitinib in Treating Patients With Progressive Metastatic Neuroendo\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n_ASSESSOR)|Primary Purpose: TREATMENT', None, '2012-08']\n['NCT01775098', 'Allopurinol in Acute Gout', None, 'WITHDRAWN', 'Gout', 'DRUG: allopurinol', 'Université de Sherbrooke', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', None, '2013-02']\n['NCT00012844', 'Redesigning Patient Handling Tasks to Prevent Nursing Back Injuries', None, 'COMPLETED', 'Back Pain|Occupational Diseases', 'DEVICE: Redesigning patient handling tasks using equip: Arjo Bianca Overhead Lift Hill-Rom Resident Transfer Device TranSit Chair Total Care Bed|PROCEDURE: Redesigned patient handling tasks using work practice controls: setting bed height at correct level; applying anti-embolism stockings from foot of bed', 'US Department of Veterans Affairs', None, '134.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: PREVENTION', None, '1999-12']\n['NCT00000344', 'Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9', None, 'COMPLETED', 'Opioid-Related Disorders', 'DRUG: Buprenorphine/naloxone', 'National Institute on Drug Abuse (NIDA)', None, '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2000-08']\n['NCT00000944', 'A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir Lamivudine and Zidovudine) in HIV-Positive Pregnant Women and Their Infants', None, 'COMPLETED', 'HIV Infections|Pregnancy', 'DRUG: Indinavir sulfate|DRUG: Lamivudine|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', '24.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: PREVENTION', None, '2003-03']\n['NCT00000744', 'A Randomized Prospective Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women', None, 'COMPLETED', 'Candidiasis|Candidiasis Esophageal|HIV Infections', 'DRUG: Fluconazole', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Pfizer', '400.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1995-12']\n['NCT00410644', 'A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain', None, 'COMPLETED', 'Pain|Analgesics|Opioid', 'DRUG: OROS Hydromorphone HCI', 'Alza Corporation DE USA', None, '463.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE|Primary Purpose: TREATMENT', None, '1999-02']\n['NCT00037544', 'Study Evaluating ReFacto AF in Severe Hemophilia A', None, 'COMPLETED', 'Hemophilia A', 'DRUG: ReFacto AF', 'Wyeth is now a wholly owned subsidiary of Pfizer', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2004-08']\n['NCT00613574', 'RUSSE / Russian Spiriva® Safety & Efficacy Study', None, 'COMPLETED', 'COPD', 'DRUG: tiotropium-bromide', 'Boehringer Ingelheim', None, '407.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2007-10']\n['NCT01117974', 'Neck Liposuction for the Treatment of Obstructive Sleep Apnea', None, 'WITHDRAWN', 'Obstructive Sleep Apnea', 'PROCEDURE: liposuction of the neck', 'Northwestern University', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', None, '2012-06']\n['NCT00000674', 'A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS', None, 'COMPLETED', 'Toxoplasmosis Cerebral|HIV Infections', 'DRUG: Pyrimethamine|DRUG: Leucovorin calcium|DRUG: Clindamycin', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Upjohn|Glaxo Wellcome', '30.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1992-08']\n['NCT03294174', 'Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee Arthroplasty', None, 'TERMINATED', 'Opioid Tolerance Opioid Naive Opioid Exposure', 'DRUG: Ropivacaine injection', 'University of Pittsburgh', None, '48.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2017-06']\n['NCT00001074', 'The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients', None, 'COMPLETED', 'HIV Infections', 'DRUG: Hydroxyurea|DRUG: Didanosine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '140.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2000-01']\n['NCT00000974', 'A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia', None, 'COMPLETED', 'Pneumonia Pneumocystis Carinii|HIV Infections', 'DRUG: Pentamidine isethionate', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '16.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1996-09']\n['NCT00000774', 'A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers', None, 'COMPLETED', 'HIV Infections|HIV Seronegativity', 'BIOLOGICAL: rgp120/HIV-1MN|BIOLOGICAL: rgp120/HIV-1 SF-2|BIOLOGICAL: Placebo version of rgp120/HIV-1MN|BIOLOGICAL: Placebo version of rgp120/HIV-1SF2', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Genentech Inc.|Biocine', '156.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', None, '1999-01']\n['NCT00000981', 'The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS', None, 'COMPLETED', 'Cytomegalovirus Infections|HIV Infections', 'DRUG: Fiacitabine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Oclassen Pharmaceuticals', '78.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1993-02']\n['NCT00304681', 'An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children', None, 'COMPLETED', 'Attention Deficit Hyperactivity Disorder', 'DRUG: OROS*-Methylphenidate', 'Janssen-Ortho Inc. Canada', None, '147.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2004-02']\n['NCT00100581', 'Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults', None, 'COMPLETED', 'HIV Infections|Hepatitis C', 'DRUG: Efavirenz|DRUG: Lamivudine|DRUG: Lopinavir/ritonavir|DRUG: Pegylated interferon alfa-2a|DRUG: Ribavirin|DRUG: Tenofovir disoproxil fumarate', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '2.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2007-01']\n['NCT00670176', 'Pre- and Postoperative Cardiopulmonary Rehabilitation Reduces Complications After Coronary Artery Bypass Surgery: A Randomized Trial', None, 'COMPLETED', 'Coronary Artery Bypass Surgery', 'BEHAVIORAL: REHAB (Pre- and postoperative cardiopulmonary rehabilitation)', 'Universidade do Sul de Santa Catarina', 'ICSC', '56.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION', None, '2005-06']\n['NCT00037076', 'Prevalence of Hepatitis C Virus Infection in HIV-Infected Children', None, 'COMPLETED', 'HIV Infections|Hepatitis C', None, 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', '600.0', 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2003-07']\n['NCT00001076', 'A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: ALVAC-HIV MN120TMG (vCP205)|BIOLOGICAL: ALVAC-RG Rabies Glycoprotein (vCP65)|BIOLOGICAL: rgp120/HIV-1 SF-2', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '34.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '1997-12']\n['NCT00010699', 'Effect of High Dose Vitamin E on Carotid Atherosclerosis', None, 'COMPLETED', 'Cardiovascular Diseases', 'DRUG: Vitamin E', 'National Center for Complementary and Integrative Health (NCCIH)', 'Office of Dietary Supplements (ODS)', '120.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2003-04']\n['NCT00000799', 'HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol', None, 'COMPLETED', 'Cytomegalovirus Retinitis|HIV Infections', 'DRUG: Cidofovir|DRUG: Probenecid', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Gilead Sciences', '100.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1996-04']\n['NCT00325299', 'Magnesium After Alcohol Withdrawal Treatment', None, 'COMPLETED', 'Alcohol-Induced Disorders', 'DRUG: Magnesium', 'Finnish Foundation for Alcohol Studies', None, '178.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2005-09']\n['NCT00240799', 'An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.', None, 'COMPLETED', 'Osteoarthritis', 'DRUG: acetaminophen extended release|DRUG: placebo', 'Johnson & Johnson Consumer and Personal Products Worldwide', 'McNeil Consumer & Specialty Pharmaceuticals a Division of McNeil-PPC Inc.', '542.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2004-10']\n['NCT00000770', 'A Comparative Study of a Combination of Zidovudine Didanosine and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine', None, 'COMPLETED', 'HIV Infections', 'DRUG: Nevirapine|DRUG: Zidovudine|DRUG: Didanosine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Bristol-Myers Squibb|Glaxo Wellcome', '400.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1994-11']\n['NCT00270270', 'A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy', None, 'COMPLETED', 'Acquired Immunodeficiency Syndrome|Anemia', 'DRUG: epoetin alfa', 'Johnson & Johnson Pharmaceutical Research & Development L.L.C.', None, '63.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1989-07']\n['NCT00012870', 'Effect of Behavioral Management on Quality of Life in Heart Failure', None, 'COMPLETED', 'Heart Failure', 'BEHAVIORAL: Behavioral Management', 'US Department of Veterans Affairs', None, '116.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ', None, '2002-03']\n['NCT00031070', 'Increasing HAART-Induced Immune Restoration With Cyclosporine', None, 'COMPLETED', 'HIV Infections', 'DRUG: Abacavir sulfate Lamivudine and Zidovudine|DRUG: Cyclosporine|BIOLOGICAL: Hepatitis A Vaccine (Inactivated)|DRUG: Efavirenz|BIOLOGICAL: Pneumococcal Conjugate Vaccine Heptavalent|BIOLOGICAL: Rabies Vaccine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2006-12']\n['NCT00043511', 'Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: pGA2/JS2 Plasmid DNA Vaccine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '30.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2003-04']\n['NCT00000711', 'Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC', None, 'COMPLETED', 'HIV Infections|Cytopenias', 'DRUG: Zidovudine|DRUG: Sargramostim', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '60.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-05']\n['NCT00001011', 'The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex', None, 'COMPLETED', 'HIV Infections', 'DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '538.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT', None, '1995-02']\n['NCT00026611', 'A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults', None, 'COMPLETED', 'Smallpox', 'BIOLOGICAL: Dryvax vaccine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, None, 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2001-12']\n['NCT00000713', 'A Phase I Clinical Trial To Evaluate the Toxicity Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects', None, 'COMPLETED', 'HIV Infections', 'DRUG: Ampligen', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1992-10']\n['NCT00001113', \"A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Interferon alfa-2a|DRUG: Zidovudine|DRUG: Interferon alfa-n1', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '48.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-03']\n['NCT00000913', 'A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children', None, 'COMPLETED', 'HIV Infections', 'DRUG: Ritonavir|DRUG: Nelfinavir mesylate|DRUG: Saquinavir', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '50.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2001-04']\n['NCT00120913', 'Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?', None, 'COMPLETED', 'Breakthrough Bleeding', 'DRUG: Birth control pills', 'Oregon Health and Science University', None, '160.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2004-08']\n['NCT00000869', 'A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies', None, 'COMPLETED', 'HIV Infections|Pregnancy', 'DRUG: Nevirapine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '2009.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2001-05']\n['NCT00063869', 'Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis', None, 'COMPLETED', 'Pulmonary Fibrosis', 'DRUG: Etanercept', 'Wyeth is now a wholly owned subsidiary of Pfizer', None, '88.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2005-03']\n['NCT00013169', 'Patient-Centered Alternative to Psychiatric Hospitalization for Veterans', None, 'COMPLETED', 'Veterans|Acute Hospitalization', 'BEHAVIORAL: Strong Patient Focus', 'US Department of Veterans Affairs', None, '220.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2002-09']\n['NCT00377169', 'Collection of Blood Samples From SMART Study Participants for Future Genetic Studies', None, 'COMPLETED', 'HIV Infections', None, 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Community Programs for Clinical Research on AIDS', '3261.0', 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2006-01']\n['NCT00012935', 'Treatment Decision Intervention for Veterans With Prostate Cancer', None, 'COMPLETED', 'Prostate Cancer', 'BEHAVIORAL: Help with decision making on prostate cancer treatment', 'US Department of Veterans Affairs', None, '100.0', 'FED', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ', None, '2001-12']\n['NCT00000635', 'Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine', None, 'COMPLETED', 'Herpes Simplex|HIV Infections', 'DRUG: Trifluridine|DRUG: Bacitracin zinc/Polymyxin B sulfate', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Glaxo Wellcome', '25.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1992-04']\n['NCT02078635', 'Magnetic Resonance Imaging-Portfolio Diet Study #7', 'MRIPD#7', 'WITHDRAWN', 'Cardiovascular Diseases|Hypercholesterolemia|Diabetes|Metabolic Syndrome|Obesity', 'BEHAVIORAL: Portfolio Plus Diet|BEHAVIORAL: DASH-like (high fibre) dietary advice', 'Unity Health Toronto', 'Canadian Institutes of Health Research (CIHR)|University of Toronto|Laval University|University of Manitoba|University of British Columbia', '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT', None, '2014-10-07']\n['NCT00000735', 'A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC', None, 'COMPLETED', 'HIV Infections', 'DRUG: Ampligen', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '12.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-02']\n['NCT00380835', 'Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer', None, 'WITHDRAWN', 'Metastatic Breast Cancer', 'DRUG: Amrubicin', 'Celgene Corporation', None, '66.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2007-12']\n['NCT00000696', 'A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease', None, 'COMPLETED', 'HIV Infections', 'DRUG: Interferon alfa-2a|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '48.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1993-11']\n['NCT00006396', 'Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns', None, 'COMPLETED', 'HIV Infections', 'DRUG: Nevirapine|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '1500.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2004-11']\n['NCT00000796', 'A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.', None, 'COMPLETED', 'HIV Infections|Tuberculosis', 'DRUG: Cycloserine|DRUG: Ethionamide|DRUG: Capreomycin sulfate|DRUG: Aminosalicylic acid|DRUG: Streptomycin sulfate|DRUG: Ethambutol hydrochloride|DRUG: Amikacin sulfate|DRUG: Isoniazid|DRUG: Pyrazinamide|DRUG: Pyridoxine hydrochloride|DRUG: Levofloxacin|DRUG: Rifampin|DRUG: Clofazimine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '525.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1998-10']\n['NCT00000996', \"A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Doxorubicin hydrochloride', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '48.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT', None, '1990-06']\n['NCT02658396', 'GO-203-2C + Bortezomib For Relapsed Or Refractory MM', None, 'WITHDRAWN', 'Multiple Myeloma|Multiple Myeloma in Relapse|Refractory Multiple Myeloma', 'DRUG: GO-203-2C|DRUG: Bortezomib', 'Dana-Farber Cancer Institute', 'Genus Oncology LLC|National Institutes of Health (NIH)', '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', None, '2022-01']\n['NCT00001096', 'A Phase I Multicenter Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: MN rgp120/HIV-1 and A244 rgp120/HIV-1|BIOLOGICAL: QS-21|BIOLOGICAL: rgp120/HIV-1MN', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '60.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2000-03']\n['NCT00232895', 'Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years', None, 'COMPLETED', 'ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia', 'DRUG: lipuro propofol|DRUG: standard formulation propofol', 'Institute of Child Health', None, None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2005-08']\n['NCT00000895', 'A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection', None, 'COMPLETED', 'Mycobacterium Avium-intracellulare Infection|HIV Infections', 'DRUG: Nelfinavir mesylate|DRUG: Nevirapine|DRUG: Azithromycin', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '85.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2001-08']\n['NCT00344695', 'Bupropion Treatment for Youth Smoking Cessation', None, 'COMPLETED', 'Nicotine Dependence', 'DRUG: bupropion SR', 'University of Arizona', None, None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2003-04']\n['NCT00013195', 'Nurse Counseling for Physical Activity in Primary Care Patients', None, 'COMPLETED', 'Chronic Disease|Exercise', 'BEHAVIORAL: Telephone Care', 'US Department of Veterans Affairs', None, '210.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: PREVENTION', None, '2000-06']\n['NCT00000695', \"Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Interferon beta-1b|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '36.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1991-07']\n['NCT00000995', 'A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection', None, 'COMPLETED', 'Cytomegalovirus Infections|HIV Infections', 'DRUG: Zidovudine|DRUG: Ganciclovir', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '60.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-02']\n"
     ]
    }
   ],
   "source": [
    "#Here as well, we could see that the formats are different like the start column, so let's do the same transformation logic that we did for the start column\n",
    "\n",
    "# split RDD to create completion_with_none containing rows with None values in the completion column\n",
    "completion_with_none = rdd_with_header_finalized.filter(lambda row: len(row) > 13 and row[13] is None)\n",
    "\n",
    "# split RDD to create completion_without_none containing rows without None values in the completion column\n",
    "completion_without_none = rdd_with_header_finalized.filter(lambda row: len(row) > 13 and row[13] is not None and row[13] != \"Completion\") #remove the header since the machine will detect it as column without none\n",
    "\n",
    "# Print the completion_with_none RDD\n",
    "print(\"completion (Containing None values in column completion):\")\n",
    "for row in completion_with_none.collect():\n",
    "    print(row)\n",
    "\n",
    "# Print the completion_without_none RDD\n",
    "print(\"\\ncompletion (Containing non- None values in column completion):\")\n",
    "for row in completion_without_none.collect():\n",
    "    print(row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "73550d39-6189-4ddb-96ec-ffd05d703024",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of data rows in the completion_with_none: 16861\nNumber of data rows in the completion_without_none: 466559\n"
     ]
    }
   ],
   "source": [
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = completion_with_none.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the completion_with_none:\", row_count_final)\n",
    "\n",
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = completion_without_none.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the completion_without_none:\", row_count_final)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "5d96545c-09fb-4aa6-8f1c-2d30c04c57c4",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "completion_without_none does not contain None values in it.\n"
     ]
    }
   ],
   "source": [
    "#to double-confirm completion_without_none doesn't contains None values in it\n",
    "contains_none = False\n",
    "for row in completion_without_none.collect():\n",
    "    if row[13] is None:\n",
    "        contains_none = True\n",
    "        break\n",
    "\n",
    "# Print the result\n",
    "if contains_none:\n",
    "    print(\"completion_without_none contains None values in it.\")\n",
    "else:\n",
    "    print(\"completion_without_none does not contain None values in it.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d83ea64c-8878-4825-84d8-1f0950eade17",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "completion column (Containing date values in YYYY-MM-DD format):\n('NCT01125371', 'Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women', None, 'COMPLETED', 'Alcohol; Harmful Use|Binge Drinking|Risk Behavior|HIV Infection', 'BEHAVIORAL: Computerized brief alcohol intervention + IVR booster calls|BEHAVIORAL: Computerized brief alcohol intervention|BEHAVIORAL: Attention Control', 'Johns Hopkins University', 'National Institute on Alcohol Abuse and Alcoholism (NIAAA)', '439.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2011-10-01', '2016-06-07')\n('NCT02830971', 'Developing a Standardized Learning Curve', None, 'COMPLETED', 'Registered Nurses|Nursing Personnel|Motor Skills', 'PROCEDURE: Doing Different ICU techniques and skills', 'Baqiyatallah Medical Sciences University', 'Shahid Beheshti University|Tehran University of Medical Sciences', '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2016-07-01', '2021-04-12')\n('NCT03354871', 'Developing Models for Fatigue Monitoring in Obstetrics and Gyne- Cology Residents Using Wearables', 'IoT4Resident', 'UNKNOWN', 'Fatigue', None, 'Hillel Yaffe Medical Center', 'International Business Machines (IBM)', '6.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2017-11-01', '2018-02-28')\n('NCT00932971', 'HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis', 'HIDIT-II', 'COMPLETED', 'Hepatitis D', 'DRUG: PEG-IFN alfa-2a Tenofovir|DRUG: PEG-IFN alfa-2a placebo', 'HepNet Study House German Liverfoundation', 'Hannover Medical School|Hoffmann-La Roche|Gilead Sciences', '70.0', 'NETWORK', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2009-06-01', '2017-08-02')\n('NCT02869971', 'Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia', 'PARTEM', 'COMPLETED', 'Benign Prostatic Hyperplasia', 'DEVICE: Embosphere® (Prostatic Arteries Embolization)|DRUG: Drug therapy', 'Assistance Publique - Hôpitaux de Paris', 'Ministry of Health France', '90.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2016-08-01', '2022-03-25')\n('NCT02903771', 'Phase I Study of Cantrixil in Patients With Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer.', None, 'COMPLETED', 'Ovarian Neoplasms|Fallopian Tube Neoplasms|Peritoneal Neoplasms', 'DRUG: Part A: Dose Escalation of Cantrixil|DRUG: Part B: Expansion Cohort of Cantrixil', 'Kazia Therapeutics Limited', None, '28.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-11-01', '2020-03-24')\n('NCT00851071', 'Interventional Study of Anxiety Symptoms in the Implantable Cardioverter Defibrillator (ICD) Patient', None, 'COMPLETED', 'Anxiety', 'BEHAVIORAL: Cognitive Behavioral Therapy', 'The Cleveland Clinic', None, '28.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2009-02-01', '2017-12-20')\n('NCT02746471', 'Reveal LINQ Registry', None, 'COMPLETED', 'Arrhythmias Cardiac', 'DEVICE: Reveal LINQ', 'Medtronic Cardiac Rhythm and Heart Failure', None, '1604.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2014-04-01', '2021-06-04')\n('NCT02351271', 'Cataract Surgery: Femto LDV Z8 Versus Conventional', 'COMFORT', 'COMPLETED', 'Cataract', 'DEVICE: Femto LDV Z8|DEVICE: Manual capsulorhexis&lens fragmentation', 'Ziemer Ophthalmic Systems AG', None, '130.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2015-02-01', '2017-02-28')\n('NCT02015871', 'An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer', 'PandaExtension', 'COMPLETED', 'Prostate Cancer', 'DRUG: Degarelix', 'Ferring Pharmaceuticals', None, '206.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2014-01-01', '2017-08-01')\n('NCT03314571', 'Obstetrical Analgesia in the Estaing Hospital Maternity. A Prospective Database to Study the Determinants of Labor Pain and the Resulting Maternal Non Satisfaction.', 'AOMHE', 'UNKNOWN', 'Epidural Analgesia|Hospital Follow-up', 'OTHER: analgesia for labor', 'University Hospital Clermont-Ferrand', None, '600.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2017-11-01', '2020-12-31')\n('NCT02421471', 'PMS to Evaluate the Safety and Efficacy of Picato® Gel', None, 'COMPLETED', 'Actinic Keratosis', 'DRUG: Ingenol mebutate 0.015 percent or 0.05 percent gel', 'LEO Pharma', None, '1324.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2014-09-01', '2018-01-19')\n('NCT01985971', 'F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer', None, 'COMPLETED', 'Brain Metastases From Breast Cancer', 'RADIATION: PET/CT Imaging', 'Abramson Cancer Center at Penn Medicine', None, '2.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2011-03-01', '2016-08-19')\n('NCT02725671', 'Cardiogoniometry for Detecting Coronary Artery Disease by CT Angiography', None, 'TERMINATED', 'Coronary Heart Disease|Coronary Artery Disease|Ischemic Heart Disease', 'DEVICE: Explorer', 'Johns Hopkins University', 'Enverdis Corp.', '2.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2015-04-01', '2020-06-26')\n('NCT02600871', 'Skin and Soft Tissue Infection (SSTI) Study', None, 'COMPLETED', 'Skin Diseases Infectious|Soft Tissue Infections', 'DRUG: Provodine|PROCEDURE: Incision and Drainage', 'The University of Texas Health Science Center at San Antonio', None, '101.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2015-12-01', '2017-05-30')\n('NCT01559571', 'Registry for Severe ROP and Treatment on Visual Outcomes', None, 'COMPLETED', 'Retinopathy of Prematurity', None, 'Pediatrix', None, '324.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-05-01', '2020-05-15')\n('NCT02855671', 'Infrared Imaging in Septic Illness', None, 'COMPLETED', 'Sepsis', 'DEVICE: Infrared thermal imaging', 'University Hospitals Leicester', 'Association of Anaesthetists of Great Britain and Ireland', '112.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2016-07-01', '2019-02-01')\n('NCT00978471', 'Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma', 'OSII-TTP', 'COMPLETED', 'Osteosarcoma', 'DRUG: Thiotepa', 'Centre Leon Berard', None, '44.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2009-07-01', '2018-10-29')\n('NCT02687971', 'Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨', None, 'COMPLETED', 'Cutaneous Leishmaniasis', 'DRUG: Miltefosine', 'Drugs for Neglected Diseases', None, '130.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2016-12-01', '2019-09-10')\n('NCT02096471', 'MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1', 'MEK Inhibitor', 'COMPLETED', 'Neurofibromatosis Type 1 and Growing or Symptomatic Inoperable PN', 'DRUG: PD-0325901', 'University of Alabama at Birmingham', None, '19.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2014-06-01', '2018-08-01')\n('NCT02625571', 'Tx for Child Sexual Behavior Problems', None, 'COMPLETED', 'Sexual Behavior', 'BEHAVIORAL: Phase-based treatment of sexual behavior problems of children', 'Milton S. Hershey Medical Center', None, '13.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2015-12-01', '2017-06-30')\n('NCT00584571', 'SAT vs Escitalopram for Rectal Hypersensitivity', None, 'COMPLETED', 'Rectal Hypersensitivity|Irritable Bowel Syndrome-Constipation', 'PROCEDURE: Sensory Adaptation Training|DRUG: Escitalopram Therapy', 'Augusta University', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', '55.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2007-12-01', '2019-12-31')\n('NCT02053571', 'Evaluation of 3D Overlay During Transjugular Intrahepatic Portosystemic Shunt (TIPS) Procedure', None, 'COMPLETED', 'Portal Hypertension', 'PROCEDURE: TIPS with 3D Overlay', 'Medical College of Wisconsin', 'Siemens Medical Solutions', '20.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2014-04-01', '2016-08-04')\n('NCT02737371', 'Multiple Ascending Oral Dose Study of F901318 in Healthy Subjects', 'ORALMAD', 'COMPLETED', 'Invasive Aspergillosis', 'DRUG: F901318 Dose level A oral|DRUG: Placebo dose level A oral|DRUG: F901318 Dose level B oral|DRUG: Placebo dose level B oral|DRUG: F901318 Dose level C oral|DRUG: Placebo Dose level C oral', 'F2G Biotech GmbH', 'SimbecRresearch Ltd.', '40.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2016-05-01', '2017-05-22')\n('NCT00450671', 'Treatment of Perirectal Fistula With Cutting Seton vs. Collagen Plug', None, 'COMPLETED', 'Anal Fistula', 'PROCEDURE: Collagen Plug Placement|PROCEDURE: Seton placement', 'University of Southern California', None, '300.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2007-02-01', '2013-05-09')\n('NCT01800071', 'A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma', None, 'COMPLETED', 'Nasopharyngeal Cancer|Epstein Barr Virus Infections', 'DRUG: MVA-EBNA1/LMP2 vaccine', 'Cancer Research UK', None, '22.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', '2013-03-01', '2017-03-10')\n('NCT03014271', 'Primary Prevention Youth Suicide Trial in Colorado High Schools Prevention Among Colorado High School Students', None, 'COMPLETED', 'Suicide|Sexual Violence', 'BEHAVIORAL: Sources of Strength (SOS) Prevention Program', 'University of Florida', 'University of Rochester|Texas Tech University|Colorado Department of Public Health and Environment|Centers for Disease Control and Prevention', '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2016-09-01', '2019-09-11')\n('NCT02915471', 'Virtual Peer-to-Peer (VP2P) Support Mentoring for Adolescents With Cancer', None, 'COMPLETED', 'Cancer', 'BEHAVIORAL: Virtual Peer-to-Peer Support Mentoring', 'The Hospital for Sick Children', None, '37.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2016-08-01', '2019-08-30')\n('NCT02229071', 'Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma', None, 'COMPLETED', 'HCC', 'DRUG: Donafenib(200mg)|DRUG: Donafenib(300mg)', 'Suzhou Zelgen Biopharmaceuticals Co.Ltd', 'Tigermed Consulting Co. Ltd', '106.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2014-04-01', '2016-10-30')\n('NCT02438371', 'Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor', None, 'TERMINATED', 'Preterm Labor', 'DRUG: Nifedipine|DRUG: Indomethacin', 'The University of Texas Health Science Center Houston', None, '49.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2015-05-01', '2019-10-10')\n('NCT03215771', 'Myoelectric Upper Limb Orthosis Use by Persons With TBI and Stroke', None, 'COMPLETED', 'Traumatic Brain Injury|Stroke', 'DEVICE: MyoPro Motion-G|OTHER: Motor Learning-Based Therapy', 'Northwestern University', 'Louis Stokes VA Medical Center|Myomo Inc.', '16.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-12-01', '2020-06-12')\n('NCT02386371', 'Intraoperative Radiotherapy After Local Recurrence in Breast Cancer', 'RE-IORT01', 'COMPLETED', 'Breast Carcinoma', 'PROCEDURE: tumorectomy|RADIATION: Intra Operative Radiotherapy', \"Institut du Cancer de Montpellier - Val d'Aurelle\", None, '66.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2014-03-01', '2023-09-18')\n('NCT02433171', 'Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following Radiosurgery', None, 'TERMINATED', 'Brain Metastasis', 'PROCEDURE: Standard of Care FDG-PET Imaging', 'Yale University', None, '8.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-01-01', '2017-06-27')\n('NCT02505971', 'Nadolol Versus Propranolol in Children With Infantile Hemangiomas', None, 'COMPLETED', 'Infantile Hemangioma', 'DRUG: Nadolol|DRUG: Propranolol', 'The Hospital for Sick Children', None, '74.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2015-09-01', '2020-06-30')\n('NCT02668471', 'U/S Guided vs. Traditional Palpation for Radial Artery Cannulation', None, 'COMPLETED', 'Critical Illness', 'PROCEDURE: Ultrasound|PROCEDURE: traditional method', 'Ramathibodi Hospital', None, '84.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2015-08-01', '2016-08-30')\n('NCT02468271', 'Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK', None, 'COMPLETED', 'Bronchiectasis', None, \"Queen's University Belfast\", 'Belfast Health and Social Care Trust|South Eastern Health and Social Care Trust|Royal Brompton & Harefield NHS Foundation Trust|NHS Lothian|Papworth Hospital NHS Foundation Trust|NHS Tayside|University Hospital Southampton NHS Foundation Trust|Cardiff and Vale University Health Board|Medical Research Council', '120.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-10-01', '2019-07-31')\n('NCT01393171', 'Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis', 'OARS', 'COMPLETED', 'Anterior Vaginal Wall Prolapse|Cystocele|Pelvic Organ Prolapse', 'DEVICE: Polypropylene mesh (Polyform by Boston Scientific)|PROCEDURE: Porcine Dermis (Pelvicol by CRBard)|PROCEDURE: Anterior Colporrhaphy', 'Kaiser Permanente', None, '99.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2006-01-01', '2018-04-01')\n('NCT02349971', 'Safety and Feasibility of MR-Guided High Intensity Focused Ultrasound (MR-HIFU) Ablation of Osteoid Osteoma in Children', None, 'COMPLETED', 'Osteoid Osteoma', 'DEVICE: MR-HIFU', \"Children's National Research Institute\", None, '9.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2015-01-01', '2020-10-03')\n('NCT02087371', 'Prognosis Factors of Cardiac Complications After Liver Transplantation', 'PROCOM', 'COMPLETED', 'Hepatopathy', None, 'Assistance Publique - Hôpitaux de Paris', None, '565.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2014-01-01', '2018-01-29')\n('NCT02641171', \"Volatiles in Exhaled Breath and Blood in Crohn's Disease: Validation Cohort\", None, 'TERMINATED', \"Crohn's Disease\", 'OTHER: Specimen sampling', 'Dartmouth-Hitchcock Medical Center', 'Maastricht University', '5.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-12-01', '2016-10-04')\n('NCT02780271', 'Diet and Physical Activity Changes Among Latina Breast Cancer Survivors', None, 'COMPLETED', 'Breast Cancer', 'BEHAVIORAL: In-person education|BEHAVIORAL: E-communication|BEHAVIORAL: Control', 'Columbia University', 'National Cancer Institute (NCI)', '230.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2016-02-01', '2020-09-11')\n('NCT02392871', 'Radiotherapy & Combi in Metastatic Melanoma', 'CombiRT', 'COMPLETED', 'Metastatic Melanoma', 'RADIATION: Palliative radiotherapy|DRUG: Dabrafenib and trametinib (combination)', 'Melanoma and Skin Cancer Trials Limited', 'Melanoma Institute Australia', '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2015-05-01', '2020-04-17')\n('NCT02278471', 'The SCCS Polypill Pilot Trial', None, 'COMPLETED', 'Hypertension|Hyperlipidemia', 'DRUG: Polypill (atorvastatin amlodipine losartan and hydrochlorothiazide)', 'Vanderbilt University', None, '303.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2015-12-01', '2018-06-27')\n('NCT06231771', 'Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer', None, 'NOT_YET_RECRUITING', 'Diabetic Foot Ulcer', 'DRUG: Allogeneic mesenchymal stem cells (MSCs)|DRUG: Normal Saline', 'Supergenics Life Science Sdn. Bhd.', None, '22.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2024-01-01', '2024-12-30')\n('NCT02888171', 'Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency', None, 'COMPLETED', 'Chronic Kidney Disease|Iron Deficiency|Anemia', 'DRUG: ferric citrate|DRUG: ferrous sulfate', 'University of Alabama at Birmingham', None, '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2016-09-01', '2019-03-30')\n('NCT02925871', 'The Missing Link- Development and Feasibility Evaluation of Person-centred Transitions From the Stroke Unit to the Home', 'Missing Link', 'COMPLETED', 'Stroke', 'BEHAVIORAL: Co-designed person-centred care transitions|BEHAVIORAL: Current care transitions', 'Karolinska Institutet', 'Kamprad Family Foundation|Swedish Council for Working Life and Social Research', '49.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2016-04-01', '2022-12-07')\n('NCT03228771', 'Socket Augmentation Using Atorvastatin With Or Without PRGF (Clinical and Histomorphometric Study)', None, 'COMPLETED', 'Socket Preservation', 'DRUG: PRGF/ATV|DRUG: ATV gel', 'Ain Shams University', None, '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2016-03-01', '2018-08-15')\n('NCT02102971', 'Observational Study of Biomarker During Liver Surgery', None, 'TERMINATED', 'Liver Cancer|Hepatobiliary Tract Adenomas and Carcinomas', 'PROCEDURE: Hepatocellular carcinoma', 'University of Florida', 'National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)', '41.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2014-10-01', '2019-06-06')\n('NCT02975271', 'Study of the Efficacy Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury', 'AUBURN', 'TERMINATED', 'Pruritus|Burns', 'DRUG: Serlopitant|DRUG: Placebo', 'Vyne Therapeutics Inc.', None, '1.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2016-11-01', '2017-01-17')\n('NCT02572271', 'Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical Randomized Study', None, 'COMPLETED', 'Weight Loss', 'PROCEDURE: Rubins Mastopexy|PROCEDURE: LOPOSAM', 'Odense University Hospital', None, '22.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2015-09-01', '2017-11-16')\n('NCT01735071', 'Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer', None, 'COMPLETED', 'Ovarian Epithelial Cancer Recurrent', 'DRUG: bevacizumab and trabectedin|DRUG: bevacizumab trabectedin and carboplatin', 'Mario Negri Institute for Pharmacological Research', 'PharmaMar|Hoffmann-La Roche', '71.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2013-07-01', '2018-03-18')\n('NCT03127371', 'Adjunctive Nitrous Oxide During ED Incision and Drainage of Abscess', None, 'TERMINATED', 'Abscess', 'DRUG: Nitrous Oxide|DRUG: Oxygen', 'Albert Einstein Healthcare Network', 'Emergency Medicine Foundation', '41.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT CARE_PROVIDER)|Primary Purpose: TREATMENT', '2016-09-01', '2021-04-01')\n('NCT01060371', 'Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias', None, 'RECRUITING', 'Spinocerebellar Ataxia Type 1|Spinocerebellar Ataxia Type 2|Spinocerebellar Ataxia Type 3|Spinocerebellar Ataxia Type 6', 'GENETIC: All Participants', 'University of Florida', 'National Ataxia Foundation|University of California Los Angeles', '800.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2010-04-01', '2024-05-19')\n('NCT02591771', 'Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock', None, 'COMPLETED', 'Cardiogenic Shock', 'DRUG: adrenaline', 'Niguarda Hospital', 'Ospedale San Raffaele', '24.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2015-10-01', '2017-12-31')\n('NCT01517971', 'Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer', None, 'COMPLETED', 'Lung Cancer', 'OTHER: laboratory biomarker analysis', 'Alliance for Clinical Trials in Oncology', 'National Cancer Institute (NCI)', '1060.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-01-01', '2019-02-27')\n('NCT01781871', 'Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients', 'SOT13', 'COMPLETED', 'Kidney Transplantation|Liver Transplantation', 'BIOLOGICAL: Prevenar13|BIOLOGICAL: Pneumovax', 'Helsinki University Central Hospital', 'Tampere University Hospital', '182.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2013-01-01', '2017-10-04')\n('NCT00223171', 'Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers', 'PCS IV', 'ACTIVE_NOT_RECRUITING', 'Prostate Cancer', 'DRUG: Androgen blockade + radiation therapy', 'Université de Sherbrooke', 'AstraZeneca', '630.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2000-10-01', '2023-12-31')\n('NCT02648971', 'Controlled Trial to Compare Single Versus Two Portal Knee Arthroscopy Techniques', None, 'TERMINATED', 'Injuries Knee', 'PROCEDURE: Single Portal Knee Arthroscopy|PROCEDURE: Two Portal Knee Arthroscopy', 'Wake Forest University Health Sciences', None, '36.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2016-01-01', '2018-05-31')\n('NCT01673971', 'Optical Tomographic Imaging of Infantile Hemangiomas', None, 'COMPLETED', 'Infantile Hemangioma', None, 'Columbia University', None, '15.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-05-01', '2018-01-01')\n('NCT02284971', 'Pilot Study of SBRT and CDX-1127 in Prostate Cancer', 'Prostate-04', 'TERMINATED', 'Prostatic Neoplasms|Prostate Cancer', 'BIOLOGICAL: CDX1127|RADIATION: SBRT', 'Jam\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nlergy and Infectious Diseases (NIAID)', None, '45.0', 'NIH', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION', None, '2004-11']\n['NCT01452698', 'Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis', None, 'COMPLETED', 'Erosive Esophagitis', 'DRUG: TAK-438|DRUG: Placebo|DRUG: Lansoprazole|DRUG: Placebo', 'Takeda', None, '409.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', None, '2012-08']\n['NCT01775098', 'Allopurinol in Acute Gout', None, 'WITHDRAWN', 'Gout', 'DRUG: allopurinol', 'Université de Sherbrooke', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', None, '2013-02']\n['NCT00012844', 'Redesigning Patient Handling Tasks to Prevent Nursing Back Injuries', None, 'COMPLETED', 'Back Pain|Occupational Diseases', 'DEVICE: Redesigning patient handling tasks using equip: Arjo Bianca Overhead Lift Hill-Rom Resident Transfer Device TranSit Chair Total Care Bed|PROCEDURE: Redesigned patient handling tasks using work practice controls: setting bed height at correct level; applying anti-embolism stockings from foot of bed', 'US Department of Veterans Affairs', None, '134.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: PREVENTION', None, '1999-12']\n['NCT00000344', 'Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9', None, 'COMPLETED', 'Opioid-Related Disorders', 'DRUG: Buprenorphine/naloxone', 'National Institute on Drug Abuse (NIDA)', None, '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2000-08']\n['NCT00000944', 'A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir Lamivudine and Zidovudine) in HIV-Positive Pregnant Women and Their Infants', None, 'COMPLETED', 'HIV Infections|Pregnancy', 'DRUG: Indinavir sulfate|DRUG: Lamivudine|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', '24.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: PREVENTION', None, '2003-03']\n['NCT00000744', 'A Randomized Prospective Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women', None, 'COMPLETED', 'Candidiasis|Candidiasis Esophageal|HIV Infections', 'DRUG: Fluconazole', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Pfizer', '400.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1995-12']\n['NCT00410644', 'A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain', None, 'COMPLETED', 'Pain|Analgesics|Opioid', 'DRUG: OROS Hydromorphone HCI', 'Alza Corporation DE USA', None, '463.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE|Primary Purpose: TREATMENT', None, '1999-02']\n['NCT00037544', 'Study Evaluating ReFacto AF in Severe Hemophilia A', None, 'COMPLETED', 'Hemophilia A', 'DRUG: ReFacto AF', 'Wyeth is now a wholly owned subsidiary of Pfizer', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2004-08']\n['NCT00613574', 'RUSSE / Russian Spiriva® Safety & Efficacy Study', None, 'COMPLETED', 'COPD', 'DRUG: tiotropium-bromide', 'Boehringer Ingelheim', None, '407.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2007-10']\n['NCT01117974', 'Neck Liposuction for the Treatment of Obstructive Sleep Apnea', None, 'WITHDRAWN', 'Obstructive Sleep Apnea', 'PROCEDURE: liposuction of the neck', 'Northwestern University', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', None, '2012-06']\n['NCT00000674', 'A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS', None, 'COMPLETED', 'Toxoplasmosis Cerebral|HIV Infections', 'DRUG: Pyrimethamine|DRUG: Leucovorin calcium|DRUG: Clindamycin', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Upjohn|Glaxo Wellcome', '30.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1992-08']\n['NCT03294174', 'Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee Arthroplasty', None, 'TERMINATED', 'Opioid Tolerance Opioid Naive Opioid Exposure', 'DRUG: Ropivacaine injection', 'University of Pittsburgh', None, '48.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2017-06']\n['NCT00001074', 'The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients', None, 'COMPLETED', 'HIV Infections', 'DRUG: Hydroxyurea|DRUG: Didanosine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '140.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2000-01']\n['NCT00000974', 'A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia', None, 'COMPLETED', 'Pneumonia Pneumocystis Carinii|HIV Infections', 'DRUG: Pentamidine isethionate', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '16.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1996-09']\n['NCT00000774', 'A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers', None, 'COMPLETED', 'HIV Infections|HIV Seronegativity', 'BIOLOGICAL: rgp120/HIV-1MN|BIOLOGICAL: rgp120/HIV-1 SF-2|BIOLOGICAL: Placebo version of rgp120/HIV-1MN|BIOLOGICAL: Placebo version of rgp120/HIV-1SF2', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Genentech Inc.|Biocine', '156.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', None, '1999-01']\n['NCT00000981', 'The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS', None, 'COMPLETED', 'Cytomegalovirus Infections|HIV Infections', 'DRUG: Fiacitabine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Oclassen Pharmaceuticals', '78.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1993-02']\n['NCT00304681', 'An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children', None, 'COMPLETED', 'Attention Deficit Hyperactivity Disorder', 'DRUG: OROS*-Methylphenidate', 'Janssen-Ortho Inc. Canada', None, '147.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2004-02']\n['NCT00100581', 'Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults', None, 'COMPLETED', 'HIV Infections|Hepatitis C', 'DRUG: Efavirenz|DRUG: Lamivudine|DRUG: Lopinavir/ritonavir|DRUG: Pegylated interferon alfa-2a|DRUG: Ribavirin|DRUG: Tenofovir disoproxil fumarate', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '2.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2007-01']\n['NCT00670176', 'Pre- and Postoperative Cardiopulmonary Rehabilitation Reduces Complications After Coronary Artery Bypass Surgery: A Randomized Trial', None, 'COMPLETED', 'Coronary Artery Bypass Surgery', 'BEHAVIORAL: REHAB (Pre- and postoperative cardiopulmonary rehabilitation)', 'Universidade do Sul de Santa Catarina', 'ICSC', '56.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION', None, '2005-06']\n['NCT00037076', 'Prevalence of Hepatitis C Virus Infection in HIV-Infected Children', None, 'COMPLETED', 'HIV Infections|Hepatitis C', None, 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', '600.0', 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2003-07']\n['NCT00001076', 'A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: ALVAC-HIV MN120TMG (vCP205)|BIOLOGICAL: ALVAC-RG Rabies Glycoprotein (vCP65)|BIOLOGICAL: rgp120/HIV-1 SF-2', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '34.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '1997-12']\n['NCT00010699', 'Effect of High Dose Vitamin E on Carotid Atherosclerosis', None, 'COMPLETED', 'Cardiovascular Diseases', 'DRUG: Vitamin E', 'National Center for Complementary and Integrative Health (NCCIH)', 'Office of Dietary Supplements (ODS)', '120.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2003-04']\n['NCT00000799', 'HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol', None, 'COMPLETED', 'Cytomegalovirus Retinitis|HIV Infections', 'DRUG: Cidofovir|DRUG: Probenecid', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Gilead Sciences', '100.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1996-04']\n['NCT00325299', 'Magnesium After Alcohol Withdrawal Treatment', None, 'COMPLETED', 'Alcohol-Induced Disorders', 'DRUG: Magnesium', 'Finnish Foundation for Alcohol Studies', None, '178.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2005-09']\n['NCT00240799', 'An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.', None, 'COMPLETED', 'Osteoarthritis', 'DRUG: acetaminophen extended release|DRUG: placebo', 'Johnson & Johnson Consumer and Personal Products Worldwide', 'McNeil Consumer & Specialty Pharmaceuticals a Division of McNeil-PPC Inc.', '542.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2004-10']\n['NCT00000770', 'A Comparative Study of a Combination of Zidovudine Didanosine and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine', None, 'COMPLETED', 'HIV Infections', 'DRUG: Nevirapine|DRUG: Zidovudine|DRUG: Didanosine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Bristol-Myers Squibb|Glaxo Wellcome', '400.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1994-11']\n['NCT00270270', 'A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy', None, 'COMPLETED', 'Acquired Immunodeficiency Syndrome|Anemia', 'DRUG: epoetin alfa', 'Johnson & Johnson Pharmaceutical Research & Development L.L.C.', None, '63.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1989-07']\n['NCT00012870', 'Effect of Behavioral Management on Quality of Life in Heart Failure', None, 'COMPLETED', 'Heart Failure', 'BEHAVIORAL: Behavioral Management', 'US Department of Veterans Affairs', None, '116.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ', None, '2002-03']\n['NCT00031070', 'Increasing HAART-Induced Immune Restoration With Cyclosporine', None, 'COMPLETED', 'HIV Infections', 'DRUG: Abacavir sulfate Lamivudine and Zidovudine|DRUG: Cyclosporine|BIOLOGICAL: Hepatitis A Vaccine (Inactivated)|DRUG: Efavirenz|BIOLOGICAL: Pneumococcal Conjugate Vaccine Heptavalent|BIOLOGICAL: Rabies Vaccine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2006-12']\n['NCT00043511', 'Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: pGA2/JS2 Plasmid DNA Vaccine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '30.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2003-04']\n['NCT00000711', 'Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC', None, 'COMPLETED', 'HIV Infections|Cytopenias', 'DRUG: Zidovudine|DRUG: Sargramostim', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '60.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-05']\n['NCT00001011', 'The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex', None, 'COMPLETED', 'HIV Infections', 'DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '538.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT', None, '1995-02']\n['NCT00026611', 'A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults', None, 'COMPLETED', 'Smallpox', 'BIOLOGICAL: Dryvax vaccine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, None, 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2001-12']\n['NCT00000713', 'A Phase I Clinical Trial To Evaluate the Toxicity Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects', None, 'COMPLETED', 'HIV Infections', 'DRUG: Ampligen', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1992-10']\n['NCT00001113', \"A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Interferon alfa-2a|DRUG: Zidovudine|DRUG: Interferon alfa-n1', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '48.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-03']\n['NCT00000913', 'A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children', None, 'COMPLETED', 'HIV Infections', 'DRUG: Ritonavir|DRUG: Nelfinavir mesylate|DRUG: Saquinavir', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '50.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2001-04']\n['NCT00120913', 'Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?', None, 'COMPLETED', 'Breakthrough Bleeding', 'DRUG: Birth control pills', 'Oregon Health and Science University', None, '160.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2004-08']\n['NCT00000869', 'A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies', None, 'COMPLETED', 'HIV Infections|Pregnancy', 'DRUG: Nevirapine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '2009.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2001-05']\n['NCT00063869', 'Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis', None, 'COMPLETED', 'Pulmonary Fibrosis', 'DRUG: Etanercept', 'Wyeth is now a wholly owned subsidiary of Pfizer', None, '88.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2005-03']\n['NCT00013169', 'Patient-Centered Alternative to Psychiatric Hospitalization for Veterans', None, 'COMPLETED', 'Veterans|Acute Hospitalization', 'BEHAVIORAL: Strong Patient Focus', 'US Department of Veterans Affairs', None, '220.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2002-09']\n['NCT00377169', 'Collection of Blood Samples From SMART Study Participants for Future Genetic Studies', None, 'COMPLETED', 'HIV Infections', None, 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Community Programs for Clinical Research on AIDS', '3261.0', 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2006-01']\n['NCT00012935', 'Treatment Decision Intervention for Veterans With Prostate Cancer', None, 'COMPLETED', 'Prostate Cancer', 'BEHAVIORAL: Help with decision making on prostate cancer treatment', 'US Department of Veterans Affairs', None, '100.0', 'FED', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ', None, '2001-12']\n['NCT00000635', 'Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine', None, 'COMPLETED', 'Herpes Simplex|HIV Infections', 'DRUG: Trifluridine|DRUG: Bacitracin zinc/Polymyxin B sulfate', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Glaxo Wellcome', '25.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1992-04']\n['NCT00000735', 'A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC', None, 'COMPLETED', 'HIV Infections', 'DRUG: Ampligen', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '12.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-02']\n['NCT00380835', 'Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer', None, 'WITHDRAWN', 'Metastatic Breast Cancer', 'DRUG: Amrubicin', 'Celgene Corporation', None, '66.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2007-12']\n['NCT00000696', 'A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease', None, 'COMPLETED', 'HIV Infections', 'DRUG: Interferon alfa-2a|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '48.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1993-11']\n['NCT00006396', 'Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns', None, 'COMPLETED', 'HIV Infections', 'DRUG: Nevirapine|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '1500.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2004-11']\n['NCT00000796', 'A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.', None, 'COMPLETED', 'HIV Infections|Tuberculosis', 'DRUG: Cycloserine|DRUG: Ethionamide|DRUG: Capreomycin sulfate|DRUG: Aminosalicylic acid|DRUG: Streptomycin sulfate|DRUG: Ethambutol hydrochloride|DRUG: Amikacin sulfate|DRUG: Isoniazid|DRUG: Pyrazinamide|DRUG: Pyridoxine hydrochloride|DRUG: Levofloxacin|DRUG: Rifampin|DRUG: Clofazimine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '525.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1998-10']\n['NCT00000996', \"A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Doxorubicin hydrochloride', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '48.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT', None, '1990-06']\n['NCT02658396', 'GO-203-2C + Bortezomib For Relapsed Or Refractory MM', None, 'WITHDRAWN', 'Multiple Myeloma|Multiple Myeloma in Relapse|Refractory Multiple Myeloma', 'DRUG: GO-203-2C|DRUG: Bortezomib', 'Dana-Farber Cancer Institute', 'Genus Oncology LLC|National Institutes of Health (NIH)', '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', None, '2022-01']\n['NCT00001096', 'A Phase I Multicenter Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: MN rgp120/HIV-1 and A244 rgp120/HIV-1|BIOLOGICAL: QS-21|BIOLOGICAL: rgp120/HIV-1MN', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '60.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2000-03']\n['NCT00232895', 'Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years', None, 'COMPLETED', 'ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia', 'DRUG: lipuro propofol|DRUG: standard formulation propofol', 'Institute of Child Health', None, None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2005-08']\n['NCT00000895', 'A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection', None, 'COMPLETED', 'Mycobacterium Avium-intracellulare Infection|HIV Infections', 'DRUG: Nelfinavir mesylate|DRUG: Nevirapine|DRUG: Azithromycin', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '85.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2001-08']\n['NCT00344695', 'Bupropion Treatment for Youth Smoking Cessation', None, 'COMPLETED', 'Nicotine Dependence', 'DRUG: bupropion SR', 'University of Arizona', None, None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2003-04']\n['NCT00013195', 'Nurse Counseling for Physical Activity in Primary Care Patients', None, 'COMPLETED', 'Chronic Disease|Exercise', 'BEHAVIORAL: Telephone Care', 'US Department of Veterans Affairs', None, '210.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: PREVENTION', None, '2000-06']\n['NCT00000695', \"Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Interferon beta-1b|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '36.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1991-07']\n['NCT00000995', 'A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection', None, 'COMPLETED', 'Cytomegalovirus Infections|HIV Infections', 'DRUG: Zidovudine|DRUG: Ganciclovir', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '60.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-02']\n"
     ]
    }
   ],
   "source": [
    "# split RDD to create completion_without_none_with_day containing rows with date format YYYY-MM-DD in the completion column\n",
    "completion_without_none_with_day = completion_without_none.filter(lambda row: len(row) > 13 and row[13] is not None and len(row[13]) == 10)\n",
    "\n",
    "# split RDD to create completion_without_none_with_month containing rows with date format YYYY-MM in the completion column\n",
    "completion_without_none_with_month = completion_without_none.filter(lambda row: len(row) > 13 and row[13] is not None and len(row[13]) == 7)\n",
    "\n",
    "# Print the completion_without_none_with_day RDD\n",
    "print(\"completion column (Containing date values in YYYY-MM-DD format):\")\n",
    "for row in completion_without_none_with_day.collect():\n",
    "    print(row)\n",
    "\n",
    "# Print the completion_without_none_with_month RDD\n",
    "print(\"\\ncompletion column (Containing date values in YYYY-MM format):\")\n",
    "for row in completion_without_none_with_month.collect():\n",
    "    print(row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "ed9f0bea-75aa-481b-8d0b-71c996a208e8",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of data rows in the completion_without_none_with_day: 241832\nNumber of data rows in the completion_without_none_with_month: 224727\n"
     ]
    }
   ],
   "source": [
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = completion_without_none_with_day.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the completion_without_none_with_day:\", row_count_final)\n",
    "\n",
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = completion_without_none_with_month.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the completion_without_none_with_month:\", row_count_final)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "8273c35b-62be-4545-8bef-6b793fb5edd2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "All values in the completion_without_none_with_month column have the format YYYY-MM\n"
     ]
    }
   ],
   "source": [
    "# now let's initialize a variable to track if all values have the format YYYY-MM\n",
    "all_values_yyyy_mm = True\n",
    "\n",
    "# Iterate through each row and check the format of the forteenth column\n",
    "for row in completion_without_none_with_month.collect():\n",
    "    if len(row[13]) != 7:\n",
    "        all_values_yyyy_mm = False\n",
    "        break  # Exit the loop early if a value with unexpected format is found\n",
    "\n",
    "# Print the result\n",
    "if all_values_yyyy_mm:\n",
    "    print(\"All values in the completion_without_none_with_month column have the format YYYY-MM\")\n",
    "else:\n",
    "    print(\"Not all values in the completion_without_none_with_month column have the format YYYY-MM\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "fd2e61a7-b2b8-494b-aad5-15210cc09247",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('NCT00237471', 'Impact of Tight Glycaemic Control in Acute Myocardial Infarction', None, 'TERMINATED', 'Myocardial Infarct|Hyperglycemia', 'DRUG: Insulin (tight blood glucose control)', 'Melbourne Health', 'National Health and Medical Research Council Australia|Bristol-Myers Squibb', '40.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2005-10-01', '2006-05-01')\n('NCT02945371', 'Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life', 'REV', 'COMPLETED', 'Smoking|Alcohol Drinking|Prescription Drug Abuse|Substance-Related Disorders|Oral Intake Reduced', 'BEHAVIORAL: Person-centered inhibitory control training|BEHAVIORAL: Active behavioral response training', 'University of Oregon', None, '103.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION', '2014-09-01', '2016-05-01')\n('NCT01055171', 'Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence', None, 'COMPLETED', 'Alcohol Dependence|PTSD', 'DRUG: Propranolol|DRUG: Placebo', 'Medical University of South Carolina', 'National Institute on Alcohol Abuse and Alcoholism (NIAAA)', '44.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2010-01-01', '2012-08-01')\n('NCT02554071', 'Manitoba Pharmacist Initiated Smoking Cessation Pilot Project', None, 'COMPLETED', 'Smoking Cessation', 'OTHER: Pharmacist - Smoking Cessation Support', 'University of Manitoba', 'Govenment of Manitoba|Canadian Foundation for Pharmacy|Neighbourhood Pharmacy Association of Canada', '119.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2014-01-01', '2014-11-01')\n('NCT02633371', 'A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis in Adolescents and Young Adults', None, 'COMPLETED', 'Hyperhidrosis', 'DRUG: Oxybutynin 3% gel', 'University of Colorado Denver', 'Society for Pediatric Dermatology', '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-02-01', '2017-05-01')\n('NCT00120471', 'Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies', None, 'COMPLETED', 'HIV Infections', 'DRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate|DRUG: Tenofovir disoproxil fumarate', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|National Institute on Drug Abuse (NIDA)|National Institute of Mental Health (NIMH)', '122.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION', '2006-11-01', '2011-12-01')\n('NCT02383771', 'Reversal of the Anti-platelet Effects of Ticagrelor', 'REVERSAL', 'COMPLETED', 'Coronary Artery Disease', 'DRUG: Ticagrelor|DRUG: Aspirin + Ticagrelor|DRUG: Control|DRUG: Aspirin + Ticagrelor', 'The First Affiliated Hospital with Nanjing Medical University', 'National Natural Science Foundation of China', '64.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT', '2015-03-01', '2016-12-01')\n('NCT01659671', 'RCT of the Effect of Uvulopalatopharyngoplasty Compared to Expectancy in Patients With Obstructive Sleep Apnea', 'SKUP3', 'COMPLETED', 'Obstructive Sleep Apnea Syndrome', 'PROCEDURE: Uvulopalatopharyngoplasty', 'Karolinska University Hospital', 'Karolinska Institutet', '65.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2007-06-01', '2014-05-01')\n('NCT02083471', \"Cow's Milk and Hen's Egg Hyposensitization in Adults\", None, 'UNKNOWN', \"Egg Allergy|Cow's Milk Allergy\", \"DIETARY_SUPPLEMENT: Specific Oral Tolerance Induction with Egg or Cow's milk\", 'Turku University Hospital', None, '40.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2015-04-01', '2017-05-01')\n('NCT01062971', 'Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide', None, 'COMPLETED', 'Primary Open Angle Glaucoma|Ocular Hypertension', 'DRUG: dorzolamide-timolol-brimonidine', 'Laboratorios Sophia S.A de C.V.', None, '124.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2006-02-01', '2008-06-01')\n('NCT00848471', 'Validation of the Quark RMR Calorimeter (Cosmed) Versus Deltatrac II (GE Health Care Clinical Systems)', 'Protocol Quark', 'UNKNOWN', 'Healthy|Obesity', 'DEVICE: Quark RMR|DEVICE: Deltatrac II', 'Hospices Civils de Lyon', 'Centre de Recherche en Nutrition Humaine Rhone-Alpe', '30.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2009-01-01', '2009-12-01')\n('NCT01189071', 'Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain', None, 'TERMINATED', 'Overactive Bladder|Renal Colic|Pain Postoperative', 'DRUG: Darifenacin', 'University of Missouri-Columbia', None, '3.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2009-08-01', '2011-07-01')\n('NCT00728871', 'The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis', None, 'UNKNOWN', 'Cervical Cancer|Cervical Intraepithelial Neoplasia', 'PROCEDURE: peripheral blood isolation', 'National Taiwan University Hospital', None, '600.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2005-12-01', '2011-12-01')\n('NCT00520871', 'The Water-Blueberry Study', None, 'COMPLETED', 'Cardiovascular Disease', 'DRUG: Blueberry juice', 'University of Oslo', 'Ullevaal University Hospital', '62.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: PREVENTION', '2003-03-01', '2004-04-01')\n('NCT03075371', 'Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa', None, 'COMPLETED', 'Anorexia Nervosa|Healthy', 'OTHER: Glucose|OTHER: Placebo', 'University of Heidelberg Medical Center', 'German Research Foundation', '85.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE', '2014-09-01', '2019-02-01')\n('NCT02121171', 'Combined Trab+Trab Versus Combined Trab+Trab With Subconjunctival Implantation of Ologen for Primary Congenital Glaucoma', None, 'UNKNOWN', 'Congenital Glaucoma', 'DEVICE: Ologen Collagen Matrix|PROCEDURE: Combined trabeculotomy-trabeculectomy', 'National Centre of Ophthalmology named after academician Zarifa Aliyeva', 'Aeon Astron Europe B.V.', '40.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2010-09-01', '2015-09-01')\n('NCT01068171', 'Developing a Diabetic Foot Ulcer Protocol', None, 'WITHDRAWN', 'Diabetic Foot Ulcers', 'OTHER: type of footwear|OTHER: collagen dressing with and without silver', 'The University of Texas Health Science Center Houston', 'Harris County Hospital District|Baylor College of Medicine', '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2010-05-01', '2012-06-01')\n('NCT02344771', 'Perioperative Endothelial Dysfunction', None, 'COMPLETED', 'Myocardial Injury', 'PROCEDURE: Elective colon cancer surgery', 'Zealand University Hospital', None, '31.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2015-03-01', '2015-06-01')\n('NCT00991471', 'The Effect of an Physician-Nurse Supplementary Triage Assistance Team on Emergency Department Patient Wait Times', 'MDRNSTAT', 'COMPLETED', 'Emergencies', 'BEHAVIORAL: Interaction with MDRN STAT|BEHAVIORAL: No MDRNSTAT', 'Sunnybrook Health Sciences Centre', None, '6300.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2009-09-01', '2010-02-01')\n('NCT02069171', 'Cross-sectional and Questionnaire Study for Leg Lymphedema', None, 'COMPLETED', 'Gynecologic Cancer', None, 'National Cancer Center Korea', None, '333.0', 'OTHER_GOV', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2012-06-01', '2012-11-01')\n('NCT00474071', 'Optimum Dose of Remifentanil for Intubation in Small Children', None, 'COMPLETED', 'Endotracheal Intubation', 'DRUG: Remifentanil', 'University of British Columbia', None, '60.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', '2007-03-01', '2008-04-01')\n('NCT02022371', 'Prostate Cancer Genomic Heterogeneity', 'PROGENY', 'COMPLETED', 'PROSTATE CANCER', 'PROCEDURE: Targeted biopsies of the prostate', 'University College London Hospitals', None, '50.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC', '2014-09-01', '2016-06-01')\n('NCT01523171', 'Phase II Open Label Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib', 'JAKARTA2', 'COMPLETED', 'Hematopoietic Neoplasm', 'DRUG: SAR302503', 'Sanofi', None, '97.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-04-01', '2014-04-01')\n('NCT01053871', 'Propofol Versus Midazolam With Fentanyl for EGD Endomicroscopy', None, 'COMPLETED', 'Gastritis|Functional Dyspepsia', 'DRUG: propofol|DRUG: midazolam with fentanyl', 'Shandong University', None, '104.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: ', '2010-01-01', '2010-05-01')\n('NCT05974371', 'Episodic Memory Integration and Interference', None, 'NOT_YET_RECRUITING', 'Episodic Memory', 'OTHER: emotional context similarity', 'Boston College', None, '150.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE', '2024-08-01', '2027-08-01')\n('NCT02645071', 'Brief Program in Reducing Sedentary Behavior and Promoting Physical Exercise', None, 'COMPLETED', 'Physical Activity', 'BEHAVIORAL: Physical Activity', 'The University of Hong Kong', 'Hong Kong Jockey Club Charities Trust', '141.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION', '2015-07-01', '2017-07-01')\n('NCT03987971', 'Acupuncture on GB26 to Treat Chronic Low Back Pain', None, 'UNKNOWN', 'Chronic Low-back Pain', 'OTHER: acupuncture', 'Wenzhou Medical University', \"Qingtian People's hospital\", '114.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2020-01-01', '2021-07-01')\n('NCT01780571', 'CPAP/PSV Preoxygenation in Obese Patients', None, 'COMPLETED', 'Obesity|Anaesthesia', 'PROCEDURE: CPAP 5 cm H2O + PSV 5 cm H2O', 'Karolinska Institutet', None, '44.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION', '2009-05-01', '2012-12-01')\n('NCT02529371', 'Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients', None, 'UNKNOWN', 'Urinary Incontinence', 'DEVICE: UriCap-RM', 'G.R. Dome Medical Ltd.', None, '30.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE', '2015-09-01', '2015-10-01')\n('NCT02309671', 'A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment', None, 'COMPLETED', 'Infertility', 'DRUG: FE 999049|DRUG: follitropin beta', 'Ferring Pharmaceuticals', None, '159.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2014-12-01', '2016-09-01')\n('NCT01889771', 'A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline', None, 'COMPLETED', 'Smoking Cessation', 'DRUG: Nicotine Patch', 'University of Colorado Denver', None, '1495.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH', '2010-03-01', '2012-03-01')\n('NCT02912871', \"Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease\", None, 'COMPLETED', \"Parkinson's Disease\", 'OTHER: MRIgHIFU unilateral subthalamotomy', 'Fundación de investigación HM', 'Insightech', '10.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2016-04-01', '2017-01-01')\n('NCT01449071', 'Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE)', None, 'COMPLETED', 'Systemic Lupus Erythematosus', 'BIOLOGICAL: Placebo|BIOLOGICAL: Epratuzumab 400 mg|BIOLOGICAL: Epratuzumab 1200 mg|BIOLOGICAL: Epratuzumab 100 mg|BIOLOGICAL: Epratuzumab 600 mg', 'UCB Pharma', None, '20.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2011-10-01', '2013-03-01')\n('NCT00080171', 'Osteoarthritis Initiative (OAI): A Knee Health Study', None, 'COMPLETED', 'Osteoarthritis|Knee Osteoarthritis', None, 'National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)', 'GlaxoSmithKline|Merck Sharp & Dohme LLC|Novartis|Pfizer', '4796.0', 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2004-02-01', '2015-10-01')\n('NCT00368771', 'A Six-month Study to Compare Outcome Differences and Visceral Response ... Irritable Bowel Syndrome', None, 'COMPLETED', 'Irritable Bowel Syndrome', 'BEHAVIORAL: IBS Stress Management|BEHAVIORAL: IBS Symptom Management|BEHAVIORAL: IBS Educational Training', 'University of California Los Angeles', 'National Institute of Nursing Research (NINR)', '163.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2002-07-01', '2010-05-01')\n('NCT00858871', 'First Line Hepato Cellular Carcinoma (HCC)', 'BRISK FL', 'COMPLETED', 'Hepato Cellular Carcinoma (HCC)', 'DRUG: Brivanib|DRUG: Placebo|DRUG: Sorafenib|DRUG: Placebo', 'Bristol-Myers Squibb', None, '1714.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2009-05-01', '2013-09-01')\n('NCT01776671', 'Once Daily Gabapentin in the Treatment of Post Amputation Pain', None, 'UNKNOWN', 'Pain|Quality of Life', 'DRUG: Gralise', 'Chicago Anesthesia Pain Specialists', None, '16.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2013-02-01', '2018-12-01')\n('NCT01363271', 'Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients', None, 'COMPLETED', 'Complicated Skin and Structure Infection|Nosocomial Pneumonia', 'DRUG: Linezolid|DRUG: Vancomycin|DRUG: Linezolid|DRUG: Vancomycin', 'Pfizer', 'University of Maryland|Lodise & Lodise LLC', '7260.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2011-05-01', '2012-05-01')\n('NCT01282671', 'Effects of Deep Breathing Exercises Two Months After Cardiac Surgery', None, 'COMPLETED', 'CABG|Valve Surgery', 'OTHER: Breathing exercises', 'Uppsala University', 'The Swedish Research Council|Örebro County Council', '357.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2007-09-01', '2012-08-01')\n('NCT05334771', 'Early Detection of Endolymphatic Hydrops in Hypothyroid Patients', None, 'NOT_YET_RECRUITING', 'Hypothyroidism', 'DEVICE: Dual band pure tune audiometer', 'Assiut University', None, '50.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2022-09-01', '2025-04-01')\n('NCT00961571', 'Sunitinib and Capecitabine for First Line Colon Cancer', None, 'TERMINATED', 'Metastatic Colorectal Cancer', 'DRUG: sunitinib and capecitabine', 'Georgetown University', 'Pfizer', '50.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2009-08-01', '2011-03-01')\n('NCT02240771', 'Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma', None, 'UNKNOWN', 'Hepatocellular Carcinoma', 'PROCEDURE: Transarterial chemotherapy|DRUG: Oral chemotherapy', 'All India Institute of Medical Sciences New Delhi', 'Indian Council of Medical Research', '124.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2006-01-01', '2015-03-01')\n('NCT03365271', 'The Post-operative Effect of Applying Drainage on Total Knee Arthroplasty', None, 'UNKNOWN', 'Knee Osteoarthritis', 'PROCEDURE: drainage|PROCEDURE: non-drainage', \"Peking University People's Hospital\", None, '100.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2018-02-01', '2019-02-01')\n('NCT01740271', 'A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients', None, 'RECRUITING', 'Breast Neoplasms', 'DRUG: Epirubicin', 'AHS Cancer Control Alberta', None, '48.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2012-12-01', '2025-06-01')\n('NCT00912171', 'Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children', 'SB-OSAS', 'COMPLETED', 'Obstructive Sleep Apnea Syndrome', 'DRUG: budesonide (Aircort 50 nasal spray)|DRUG: montelukast (Singulair)', 'University of Bologna', None, '45.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2009-01-01', '2010-06-01')\n('NCT01640171', 'Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival', None, 'COMPLETED', 'Age-related Macular Degeneration|Central Retinal Vein Occlusion|Diabetic Macular Edema', 'PROCEDURE: Xylocaine 2% Injectable Anesthetic|DRUG: Proparacaine Hydrochloride 0.5% Drop|DRUG: Tetravisc 0.5% Gel|DRUG: Acuvail|DRUG: Intra-vitreal Anti-VEGF Drug', 'Retina Vitreous Associates of Florida', None, '57.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT', '2012-07-01', '2013-10-01')\n('NCT00507871', 'Transmission and the Respiratory Tract in Cryptosporidiosis', None, 'COMPLETED', 'Cryptosporidiosis', None, 'Tufts University', 'National Institute of Allergy and Infectious Diseases (NIAID)', '480.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2007-10-01', '2009-01-01')\n('NCT00672971', 'Safety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice', None, 'COMPLETED', 'Head Lice', 'OTHER: 4% dimethicone foam|OTHER: 1% permethrin', 'Oystershell NV', None, '31.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2007-09-01', '2007-11-01')\n('NCT02352571', 'Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer', None, 'UNKNOWN', 'Neoplasm Metastasis|Gastric Cancer|Colorectal Cancer', 'BIOLOGICAL: GC1118', 'Green Cross Corporation', None, '72.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', '2015-01-01', '2017-06-01')\n('NCT00611871', 'The Use of Propranolol to Block Memory Reconsolidation in PTSD', None, 'TERMINATED', 'Posttraumatic Stress Disorders', 'DRUG: Propranolol|DRUG: Placebo', 'Wayne State University', 'John D. Dingell VA Medical Center|New York University', '12.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', '2007-09-01', '2015-09-01')\n('NCT01191671', 'Language and Deglutition in Children', 'LDC', 'COMPLETED', 'Child|Development', None, 'Fortaleza University', None, '89.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2009-05-01', '2009-12-01')\n('NCT02626871', 'Atrial Fibrillation Stroke and Bleeding in Patients Undergoing Aortic Biovalve Implantation', 'CAREAVR', 'COMPLETED', 'Atrial Fibrillation|Stroke|Transient Ischemic Attack|Bleeding|Aortic Stenosis', None, 'University of Turku', 'Helsinki University Central Hospital|Oulu University Hospital|Kuopio University Hospital', '850.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2002-01-01', '2015-12-01')\n('NCT02732171', 'PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer', None, 'RECRUITING', 'Breast Cancer', 'OTHER: Research Blood Collection', 'Abramson Cancer Center at Penn Medicine', None, '600.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SCREENING', '2016-04-01', '2026-04-01')\n('NCT04856371', 'Study of CYH33 in Combination With Endocrine Therapy With or Without Palbociclib in Patients With HR+ HER2- Advanced Breast Cancer', None, 'UNKNOWN', 'Advanced Breast Cancer', 'DRUG: CYH33|DRUG: Fulvestrant|DRUG: Letrozole|DRUG: Palbociclib', 'Haihe Biopharma Co. Ltd.', None, '228.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT', '2021-04-01', '2022-12-01')\n('NCT00769171', 'Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)', 'DRAGON', 'COMPLETED', 'Infection Intra-abdominal', 'DRUG: Avelox (Moxifloxacin BAY12-8039)|DRUG: Ceftriaxone + Metronidazole', 'Bayer', None, '364.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', '2005-10-01', '2007-01-01')\n('NCT00116571', 'Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)', None, 'TERMINATED', 'Prostatic Hyperplasia', 'DRUG: Lemuteporfin for injection|DEVICE: Transurethral drug delivery system|DEVICE: Transurethral light delivery system', 'QLT Inc.', None, '180.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', '2005-05-01', '2006-12-01')\n('NCT00782171', 'Evaluation of Immediate Versus Delayed Loading of Dental Implants With a Modified Surface', None, 'COMPLETED', 'Partial Edentulism', 'DEVICE: SLActive dental implant', 'Institut Straumann AG', None, '266.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2004-07-01', '2010-02-01')\n('NCT00376571', 'Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?', 'BIFI', 'COMPLETED', 'Coronary Artery Disease', 'PROCEDURE: Percutaneous coronary intervention', 'Aarhus University Hospital Skejby', 'Johnson & Johnson', '413.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', '2004-10-01', '2011-03-01')\n('NCT02125071', 'Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation', 'LT', 'COMPLETED', 'Liver Cirrhosis|Chronic Hepatitis B', 'OTHER: Blood Sample Collection', 'Dong-Gu Kim', 'Green Cross Corporation', '20.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', '2013-11-01', '2015-09-01')\n('NCT01801371', '68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma', 'GRGDG', 'UNKNOWN', 'Glioma'\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nVENTION', None, '2004-11-01')\n('NCT01452698', 'Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis', None, 'COMPLETED', 'Erosive Esophagitis', 'DRUG: TAK-438|DRUG: Placebo|DRUG: Lansoprazole|DRUG: Placebo', 'Takeda', None, '409.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT', None, '2012-08-01')\n('NCT01775098', 'Allopurinol in Acute Gout', None, 'WITHDRAWN', 'Gout', 'DRUG: allopurinol', 'Université de Sherbrooke', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR)|Primary Purpose: TREATMENT', None, '2013-02-01')\n('NCT00012844', 'Redesigning Patient Handling Tasks to Prevent Nursing Back Injuries', None, 'COMPLETED', 'Back Pain|Occupational Diseases', 'DEVICE: Redesigning patient handling tasks using equip: Arjo Bianca Overhead Lift Hill-Rom Resident Transfer Device TranSit Chair Total Care Bed|PROCEDURE: Redesigned patient handling tasks using work practice controls: setting bed height at correct level; applying anti-embolism stockings from foot of bed', 'US Department of Veterans Affairs', None, '134.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: PREVENTION', None, '1999-12-01')\n('NCT00000344', 'Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9', None, 'COMPLETED', 'Opioid-Related Disorders', 'DRUG: Buprenorphine/naloxone', 'National Institute on Drug Abuse (NIDA)', None, '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2000-08-01')\n('NCT00000944', 'A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir Lamivudine and Zidovudine) in HIV-Positive Pregnant Women and Their Infants', None, 'COMPLETED', 'HIV Infections|Pregnancy', 'DRUG: Indinavir sulfate|DRUG: Lamivudine|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', '24.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: PREVENTION', None, '2003-03-01')\n('NCT00000744', 'A Randomized Prospective Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women', None, 'COMPLETED', 'Candidiasis|Candidiasis Esophageal|HIV Infections', 'DRUG: Fluconazole', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Pfizer', '400.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1995-12-01')\n('NCT00410644', 'A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain', None, 'COMPLETED', 'Pain|Analgesics|Opioid', 'DRUG: OROS Hydromorphone HCI', 'Alza Corporation DE USA', None, '463.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE|Primary Purpose: TREATMENT', None, '1999-02-01')\n('NCT00037544', 'Study Evaluating ReFacto AF in Severe Hemophilia A', None, 'COMPLETED', 'Hemophilia A', 'DRUG: ReFacto AF', 'Wyeth is now a wholly owned subsidiary of Pfizer', None, None, 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2004-08-01')\n('NCT00613574', 'RUSSE / Russian Spiriva® Safety & Efficacy Study', None, 'COMPLETED', 'COPD', 'DRUG: tiotropium-bromide', 'Boehringer Ingelheim', None, '407.0', 'INDUSTRY', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2007-10-01')\n('NCT01117974', 'Neck Liposuction for the Treatment of Obstructive Sleep Apnea', None, 'WITHDRAWN', 'Obstructive Sleep Apnea', 'PROCEDURE: liposuction of the neck', 'Northwestern University', None, '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', None, '2012-06-01')\n('NCT00000674', 'A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS', None, 'COMPLETED', 'Toxoplasmosis Cerebral|HIV Infections', 'DRUG: Pyrimethamine|DRUG: Leucovorin calcium|DRUG: Clindamycin', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Upjohn|Glaxo Wellcome', '30.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1992-08-01')\n('NCT03294174', 'Opioid Induced Loss of Local Anesthetic Potency in Patients Undergoing Total Knee Arthroplasty', None, 'TERMINATED', 'Opioid Tolerance Opioid Naive Opioid Exposure', 'DRUG: Ropivacaine injection', 'University of Pittsburgh', None, '48.0', 'OTHER', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2017-06-01')\n('NCT00001074', 'The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients', None, 'COMPLETED', 'HIV Infections', 'DRUG: Hydroxyurea|DRUG: Didanosine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '140.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2000-01-01')\n('NCT00000974', 'A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia', None, 'COMPLETED', 'Pneumonia Pneumocystis Carinii|HIV Infections', 'DRUG: Pentamidine isethionate', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '16.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1996-09-01')\n('NCT00000774', 'A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers', None, 'COMPLETED', 'HIV Infections|HIV Seronegativity', 'BIOLOGICAL: rgp120/HIV-1MN|BIOLOGICAL: rgp120/HIV-1 SF-2|BIOLOGICAL: Placebo version of rgp120/HIV-1MN|BIOLOGICAL: Placebo version of rgp120/HIV-1SF2', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Genentech Inc.|Biocine', '156.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT INVESTIGATOR)|Primary Purpose: TREATMENT', None, '1999-01-01')\n('NCT00000981', 'The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS', None, 'COMPLETED', 'Cytomegalovirus Infections|HIV Infections', 'DRUG: Fiacitabine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Oclassen Pharmaceuticals', '78.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1993-02-01')\n('NCT00304681', 'An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children', None, 'COMPLETED', 'Attention Deficit Hyperactivity Disorder', 'DRUG: OROS*-Methylphenidate', 'Janssen-Ortho Inc. Canada', None, '147.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2004-02-01')\n('NCT00100581', 'Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults', None, 'COMPLETED', 'HIV Infections|Hepatitis C', 'DRUG: Efavirenz|DRUG: Lamivudine|DRUG: Lopinavir/ritonavir|DRUG: Pegylated interferon alfa-2a|DRUG: Ribavirin|DRUG: Tenofovir disoproxil fumarate', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '2.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2007-01-01')\n('NCT00670176', 'Pre- and Postoperative Cardiopulmonary Rehabilitation Reduces Complications After Coronary Artery Bypass Surgery: A Randomized Trial', None, 'COMPLETED', 'Coronary Artery Bypass Surgery', 'BEHAVIORAL: REHAB (Pre- and postoperative cardiopulmonary rehabilitation)', 'Universidade do Sul de Santa Catarina', 'ICSC', '56.0', 'OTHER_GOV', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION', None, '2005-06-01')\n('NCT00037076', 'Prevalence of Hepatitis C Virus Infection in HIV-Infected Children', None, 'COMPLETED', 'HIV Infections|Hepatitis C', None, 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)', '600.0', 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2003-07-01')\n('NCT00001076', 'A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine Schedules', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: ALVAC-HIV MN120TMG (vCP205)|BIOLOGICAL: ALVAC-RG Rabies Glycoprotein (vCP65)|BIOLOGICAL: rgp120/HIV-1 SF-2', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '34.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '1997-12-01')\n('NCT00010699', 'Effect of High Dose Vitamin E on Carotid Atherosclerosis', None, 'COMPLETED', 'Cardiovascular Diseases', 'DRUG: Vitamin E', 'National Center for Complementary and Integrative Health (NCCIH)', 'Office of Dietary Supplements (ODS)', '120.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2003-04-01')\n('NCT00000799', 'HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol', None, 'COMPLETED', 'Cytomegalovirus Retinitis|HIV Infections', 'DRUG: Cidofovir|DRUG: Probenecid', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Gilead Sciences', '100.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1996-04-01')\n('NCT00325299', 'Magnesium After Alcohol Withdrawal Treatment', None, 'COMPLETED', 'Alcohol-Induced Disorders', 'DRUG: Magnesium', 'Finnish Foundation for Alcohol Studies', None, '178.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2005-09-01')\n('NCT00240799', 'An Effectiveness and Safety Study of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee.', None, 'COMPLETED', 'Osteoarthritis', 'DRUG: acetaminophen extended release|DRUG: placebo', 'Johnson & Johnson Consumer and Personal Products Worldwide', 'McNeil Consumer & Specialty Pharmaceuticals a Division of McNeil-PPC Inc.', '542.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2004-10-01')\n('NCT00000770', 'A Comparative Study of a Combination of Zidovudine Didanosine and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine', None, 'COMPLETED', 'HIV Infections', 'DRUG: Nevirapine|DRUG: Zidovudine|DRUG: Didanosine', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Bristol-Myers Squibb|Glaxo Wellcome', '400.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1994-11-01')\n('NCT00270270', 'A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy', None, 'COMPLETED', 'Acquired Immunodeficiency Syndrome|Anemia', 'DRUG: epoetin alfa', 'Johnson & Johnson Pharmaceutical Research & Development L.L.C.', None, '63.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '1989-07-01')\n('NCT00012870', 'Effect of Behavioral Management on Quality of Life in Heart Failure', None, 'COMPLETED', 'Heart Failure', 'BEHAVIORAL: Behavioral Management', 'US Department of Veterans Affairs', None, '116.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ', None, '2002-03-01')\n('NCT00031070', 'Increasing HAART-Induced Immune Restoration With Cyclosporine', None, 'COMPLETED', 'HIV Infections', 'DRUG: Abacavir sulfate Lamivudine and Zidovudine|DRUG: Cyclosporine|BIOLOGICAL: Hepatitis A Vaccine (Inactivated)|DRUG: Efavirenz|BIOLOGICAL: Pneumococcal Conjugate Vaccine Heptavalent|BIOLOGICAL: Rabies Vaccine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2006-12-01')\n('NCT00043511', 'Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: pGA2/JS2 Plasmid DNA Vaccine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '30.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2003-04-01')\n('NCT00000711', 'Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC', None, 'COMPLETED', 'HIV Infections|Cytopenias', 'DRUG: Zidovudine|DRUG: Sargramostim', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '60.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-05-01')\n('NCT00001011', 'The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex', None, 'COMPLETED', 'HIV Infections', 'DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '538.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT', None, '1995-02-01')\n('NCT00026611', 'A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults', None, 'COMPLETED', 'Smallpox', 'BIOLOGICAL: Dryvax vaccine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, None, 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2001-12-01')\n('NCT00000713', 'A Phase I Clinical Trial To Evaluate the Toxicity Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects', None, 'COMPLETED', 'HIV Infections', 'DRUG: Ampligen', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '40.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1992-10-01')\n('NCT00001113', \"A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Interferon alfa-2a|DRUG: Zidovudine|DRUG: Interferon alfa-n1', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '48.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-03-01')\n('NCT00000913', 'A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children', None, 'COMPLETED', 'HIV Infections', 'DRUG: Ritonavir|DRUG: Nelfinavir mesylate|DRUG: Saquinavir', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '50.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2001-04-01')\n('NCT00120913', 'Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?', None, 'COMPLETED', 'Breakthrough Bleeding', 'DRUG: Birth control pills', 'Oregon Health and Science University', None, '160.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2004-08-01')\n('NCT00000869', 'A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies', None, 'COMPLETED', 'HIV Infections|Pregnancy', 'DRUG: Nevirapine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '2009.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2001-05-01')\n('NCT00063869', 'Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis', None, 'COMPLETED', 'Pulmonary Fibrosis', 'DRUG: Etanercept', 'Wyeth is now a wholly owned subsidiary of Pfizer', None, '88.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2005-03-01')\n('NCT00013169', 'Patient-Centered Alternative to Psychiatric Hospitalization for Veterans', None, 'COMPLETED', 'Veterans|Acute Hospitalization', 'BEHAVIORAL: Strong Patient Focus', 'US Department of Veterans Affairs', None, '220.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2002-09-01')\n('NCT00377169', 'Collection of Blood Samples From SMART Study Participants for Future Genetic Studies', None, 'COMPLETED', 'HIV Infections', None, 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Community Programs for Clinical Research on AIDS', '3261.0', 'NIH', 'OBSERVATIONAL', 'Observational Model: |Time Perspective: p', None, '2006-01-01')\n('NCT00012935', 'Treatment Decision Intervention for Veterans With Prostate Cancer', None, 'COMPLETED', 'Prostate Cancer', 'BEHAVIORAL: Help with decision making on prostate cancer treatment', 'US Department of Veterans Affairs', None, '100.0', 'FED', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: ', None, '2001-12-01')\n('NCT00000635', 'Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine', None, 'COMPLETED', 'Herpes Simplex|HIV Infections', 'DRUG: Trifluridine|DRUG: Bacitracin zinc/Polymyxin B sulfate', 'National Institute of Allergy and Infectious Diseases (NIAID)', 'Glaxo Wellcome', '25.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1992-04-01')\n('NCT00000735', 'A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC', None, 'COMPLETED', 'HIV Infections', 'DRUG: Ampligen', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '12.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-02-01')\n('NCT00380835', 'Study of Amrubicin With or Without Herceptin in Patients With Metastatic Breast Cancer', None, 'WITHDRAWN', 'Metastatic Breast Cancer', 'DRUG: Amrubicin', 'Celgene Corporation', None, '66.0', 'INDUSTRY', 'INTERVENTIONAL', 'Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT', None, '2007-12-01')\n('NCT00000696', 'A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease', None, 'COMPLETED', 'HIV Infections', 'DRUG: Interferon alfa-2a|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '48.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1993-11-01')\n('NCT00006396', 'Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns', None, 'COMPLETED', 'HIV Infections', 'DRUG: Nevirapine|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '1500.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2004-11-01')\n('NCT00000796', 'A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.', None, 'COMPLETED', 'HIV Infections|Tuberculosis', 'DRUG: Cycloserine|DRUG: Ethionamide|DRUG: Capreomycin sulfate|DRUG: Aminosalicylic acid|DRUG: Streptomycin sulfate|DRUG: Ethambutol hydrochloride|DRUG: Amikacin sulfate|DRUG: Isoniazid|DRUG: Pyrazinamide|DRUG: Pyridoxine hydrochloride|DRUG: Levofloxacin|DRUG: Rifampin|DRUG: Clofazimine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '525.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '1998-10-01')\n('NCT00000996', \"A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Doxorubicin hydrochloride', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '48.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT', None, '1990-06-01')\n('NCT02658396', 'GO-203-2C + Bortezomib For Relapsed Or Refractory MM', None, 'WITHDRAWN', 'Multiple Myeloma|Multiple Myeloma in Relapse|Refractory Multiple Myeloma', 'DRUG: GO-203-2C|DRUG: Bortezomib', 'Dana-Farber Cancer Institute', 'Genus Oncology LLC|National Institutes of Health (NIH)', '0.0', 'OTHER', 'INTERVENTIONAL', 'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT', None, '2022-01-01')\n('NCT00001096', 'A Phase I Multicenter Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults', None, 'COMPLETED', 'HIV Infections', 'BIOLOGICAL: MN rgp120/HIV-1 and A244 rgp120/HIV-1|BIOLOGICAL: QS-21|BIOLOGICAL: rgp120/HIV-1MN', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '60.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: DOUBLE|Primary Purpose: PREVENTION', None, '2000-03-01')\n('NCT00232895', 'Pain of Injection of Lipuro Propofol in Children Aged 1-7 Years', None, 'COMPLETED', 'ASA 1-2 Requiring Intravenous Cannulation for General Anaesthesia', 'DRUG: lipuro propofol|DRUG: standard formulation propofol', 'Institute of Child Health', None, None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2005-08-01')\n('NCT00000895', 'A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection', None, 'COMPLETED', 'Mycobacterium Avium-intracellulare Infection|HIV Infections', 'DRUG: Nelfinavir mesylate|DRUG: Nevirapine|DRUG: Azithromycin', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '85.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT', None, '2001-08-01')\n('NCT00344695', 'Bupropion Treatment for Youth Smoking Cessation', None, 'COMPLETED', 'Nicotine Dependence', 'DRUG: bupropion SR', 'University of Arizona', None, None, 'OTHER', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT', None, '2003-04-01')\n('NCT00013195', 'Nurse Counseling for Physical Activity in Primary Care Patients', None, 'COMPLETED', 'Chronic Disease|Exercise', 'BEHAVIORAL: Telephone Care', 'US Department of Veterans Affairs', None, '210.0', 'FED', 'INTERVENTIONAL', 'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE|Primary Purpose: PREVENTION', None, '2000-06-01')\n('NCT00000695', \"Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma\", None, 'COMPLETED', 'Sarcoma Kaposi|HIV Infections', 'DRUG: Interferon beta-1b|DRUG: Zidovudine', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '36.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1991-07-01')\n('NCT00000995', 'A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection', None, 'COMPLETED', 'Cytomegalovirus Infections|HIV Infections', 'DRUG: Zidovudine|DRUG: Ganciclovir', 'National Institute of Allergy and Infectious Diseases (NIAID)', None, '60.0', 'NIH', 'INTERVENTIONAL', 'Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT', None, '1990-02-01')\n"
     ]
    }
   ],
   "source": [
    "from datetime import datetime\n",
    "\n",
    "# Define a function to convert YYYY-MM to YYYY-MM-01 format\n",
    "def convert_to_first_day_of_month(date_str):\n",
    "    try:\n",
    "        # Parse the input date string\n",
    "        date = datetime.strptime(date_str, '%Y-%m')\n",
    "        # Convert the date to YYYY-MM-01 format\n",
    "        return date.strftime('%Y-%m-01')\n",
    "    except ValueError:\n",
    "        return date_str  # Return the original date string if not in YYYY-MM format\n",
    "\n",
    "# Apply the function to convert the date format for each row in the RDD\n",
    "completion_without_none_with_month_with_new_format = completion_without_none_with_month.map(lambda row: tuple(row[:13]) + (convert_to_first_day_of_month(row[13]),) + tuple(row[14:]) if len(row[13]) == 7 else row)\n",
    "\n",
    "# Print the RDD with the new date format\n",
    "for row in completion_without_none_with_month_with_new_format.collect():\n",
    "    print(row)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d84e5bc8-18b0-4164-a5ae-8710c9977984",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of data rows in the completion_without_none_with_month_with_new_format: 224727\n"
     ]
    }
   ],
   "source": [
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = completion_without_none_with_month_with_new_format.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the completion_without_none_with_month_with_new_format:\", row_count_final)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "79e09b1d-b1f8-4f57-b554-193e3877d815",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Yes\n"
     ]
    }
   ],
   "source": [
    "# Check if any rows have the format \"YYYY-MM-DD\" in the completion column\n",
    "has_yyyy_mm_dd_format_completion = completion_without_none_with_month_with_new_format.filter(lambda row: len(row[13]) == 10 and row[13][4] == '-' and row[13][7] == '-').count() > 0\n",
    "\n",
    "# Print the result\n",
    "if has_yyyy_mm_dd_format_completion:\n",
    "    print(\"Yes\")\n",
    "else:\n",
    "    print(\"No\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f19e0c7e-fbb8-49e2-a40b-5564e3dbbeb1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "No, all rows have either None or YYYY-MM-DD format in the completion column.\n"
     ]
    }
   ],
   "source": [
    "# Now, let's Combine the three splitted RDDs of the completion column into a new RDD\n",
    "rdd_final = completion_without_none_with_month_with_new_format.union(completion_without_none_with_day).union(completion_with_none)\n",
    "\n",
    "# Check if any row contains data other than None or the \"YYYY-MM-DD\" format in the completion column\n",
    "def check_format(row):\n",
    "    if row[13] is not None and len(row[13]) != 10 and not (len(row[13]) == 7 and row[13][4] == '-'):\n",
    "        return True\n",
    "    return False\n",
    "\n",
    "contains_other_format = rdd_final.filter(check_format).count() > 0\n",
    "\n",
    "# Print the result\n",
    "if contains_other_format:\n",
    "    print(\"Yes, some rows contain data other than None or YYYY-MM-DD format in the completion column.\")\n",
    "else:\n",
    "    print(\"No, all rows have either None or YYYY-MM-DD format in the completion column.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e0510d41-1647-41b0-b7dd-0f0854776cfb",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of data rows in the RDD: 483420\n"
     ]
    }
   ],
   "source": [
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = rdd_final.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the RDD:\", row_count_final)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "6eb0c25b-e31d-48c2-ae14-571ab4238b77",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Target data not found in the RDD.\n"
     ]
    }
   ],
   "source": [
    "from pyspark.sql import SparkSession\n",
    "\n",
    "# Create a SparkSession\n",
    "spark = SparkSession.builder \\\n",
    "    .appName(\"RDD Operations\") \\\n",
    "    .getOrCreate()\n",
    "\n",
    "# Define the target data\n",
    "target_data = ('Id', 'Study Title', 'Acronym', 'Status', 'Conditions', 'Interventions', 'Sponsor', 'Collaborators', 'Enrollment', 'Funder Type', 'Type', 'Study Design', 'Start', 'Completion')\n",
    "\n",
    "# Add index to each row\n",
    "indexed_rdd = rdd_final.zipWithIndex()\n",
    "\n",
    "# Initialize variables to store result\n",
    "found = False\n",
    "row_number = None\n",
    "\n",
    "# Loop through the indexed RDD to search for target data\n",
    "for row in indexed_rdd.collect():\n",
    "    if row[0] == target_data:\n",
    "        found = True\n",
    "        row_number = row[1]  # Get the index of the row\n",
    "        break\n",
    "\n",
    "if found:\n",
    "    print(\"Target data found in the RDD at row number:\", row_number)\n",
    "else:\n",
    "    print(\"Target data not found in the RDD.\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "94694e9d-c817-4edc-884a-74996cfb4b3d",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[68]: [('Id',\n  'Study Title',\n  'Acronym',\n  'Status',\n  'Conditions',\n  'Interventions',\n  'Sponsor',\n  'Collaborators',\n  'Enrollment',\n  'Funder Type',\n  'Type',\n  'Study Design',\n  'Start',\n  'Completion'),\n ('NCT00237471',\n  'Impact of Tight Glycaemic Control in Acute Myocardial Infarction',\n  None,\n  'TERMINATED',\n  'Myocardial Infarct|Hyperglycemia',\n  'DRUG: Insulin (tight blood glucose control)',\n  'Melbourne Health',\n  'National Health and Medical Research Council Australia|Bristol-Myers Squibb',\n  '40.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT',\n  '2005-10-01',\n  '2006-05-01'),\n ('NCT02945371',\n  'Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life',\n  'REV',\n  'COMPLETED',\n  'Smoking|Alcohol Drinking|Prescription Drug Abuse|Substance-Related Disorders|Oral Intake Reduced',\n  'BEHAVIORAL: Person-centered inhibitory control training|BEHAVIORAL: Active behavioral response training',\n  'University of Oregon',\n  None,\n  '103.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION',\n  '2014-09-01',\n  '2016-05-01'),\n ('NCT01055171',\n  'Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence',\n  None,\n  'COMPLETED',\n  'Alcohol Dependence|PTSD',\n  'DRUG: Propranolol|DRUG: Placebo',\n  'Medical University of South Carolina',\n  'National Institute on Alcohol Abuse and Alcoholism (NIAAA)',\n  '44.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT CARE_PROVIDER INVESTIGATOR OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT',\n  '2010-01-01',\n  '2012-08-01'),\n ('NCT02554071',\n  'Manitoba Pharmacist Initiated Smoking Cessation Pilot Project',\n  None,\n  'COMPLETED',\n  'Smoking Cessation',\n  'OTHER: Pharmacist - Smoking Cessation Support',\n  'University of Manitoba',\n  'Govenment of Manitoba|Canadian Foundation for Pharmacy|Neighbourhood Pharmacy Association of Canada',\n  '119.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE',\n  '2014-01-01',\n  '2014-11-01')]"
     ]
    }
   ],
   "source": [
    "# Define the header row\n",
    "header_row = ('Id', 'Study Title', 'Acronym', 'Status', 'Conditions', 'Interventions', 'Sponsor', 'Collaborators', 'Enrollment', 'Funder Type', 'Type', 'Study Design', 'Start', 'Completion')\n",
    "\n",
    "# Convert the header row to an RDD with a single element\n",
    "header_rdd = spark.sparkContext.parallelize([header_row])\n",
    "\n",
    "# Prepend the header row to the existing RDD\n",
    "final_rdd_clinicaltrial_2023 = header_rdd.union(rdd_final)\n",
    "final_rdd_clinicaltrial_2023.take(5)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "8b8ea78d-890c-468d-84b4-f47e57a7708c",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Target data found in the RDD at row number: 0\n"
     ]
    }
   ],
   "source": [
    "from pyspark.sql import SparkSession\n",
    "\n",
    "# Create a SparkSession\n",
    "spark = SparkSession.builder \\\n",
    "    .appName(\"RDD Operations\") \\\n",
    "    .getOrCreate()\n",
    "\n",
    "# Define the target data\n",
    "target_data = ('Id', 'Study Title', 'Acronym', 'Status', 'Conditions', 'Interventions', 'Sponsor', 'Collaborators', 'Enrollment', 'Funder Type', 'Type', 'Study Design', 'Start', 'Completion')\n",
    "\n",
    "# Add index to each row\n",
    "indexed_rdd = final_rdd_clinicaltrial_2023.zipWithIndex()\n",
    "\n",
    "# Initialize variables to store result\n",
    "found = False\n",
    "row_number = None\n",
    "\n",
    "# Loop through the indexed RDD to search for target data\n",
    "for row in indexed_rdd.collect():\n",
    "    if row[0] == target_data:\n",
    "        found = True\n",
    "        row_number = row[1]  # Get the index of the row\n",
    "        break\n",
    "\n",
    "if found:\n",
    "    print(\"Target data found in the RDD at row number:\", row_number)\n",
    "else:\n",
    "    print(\"Target data not found in the RDD.\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "93e71775-4980-4726-9a1d-cc074cffe9f6",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of data rows in the final_rdd_clinicaltrial_2023: 483421\nNumber of data rows in the rdd_final: 483420\nNumber of data rows in the completion_without_none_with_month_with_new_format: 224727\nNumber of data rows in the completion_without_none_with_day: 241832\nNumber of data rows in the completion_with_none: 16861\n"
     ]
    }
   ],
   "source": [
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = final_rdd_clinicaltrial_2023.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the final_rdd_clinicaltrial_2023:\", row_count_final)\n",
    "\n",
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = rdd_final.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the rdd_final:\", row_count_final)\n",
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = completion_without_none_with_month_with_new_format.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the completion_without_none_with_month_with_new_format:\", row_count_final)\n",
    "#check we didn't ignore any rows while doing the splitting, lets re-confirm the row count\n",
    "row_count_final = completion_without_none_with_day.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the completion_without_none_with_day:\", row_count_final)\n",
    "\n",
    "row_count_final = completion_with_none.count()\n",
    "\n",
    "# Display the count\n",
    "print(\"Number of data rows in the completion_with_none:\", row_count_final)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f247599a-e4c9-4cbb-962a-f2672e528e26",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Abbott Laboratories\nAbbott Laboratories Inc.\nAbbott Laboratories Inc.\nAbbott Laboratories Puerto Rico, Inc.\nAcclarent Inc.\nAdvanced Medical Optics\nAdvanced Neuromodulation Systems, Inc.\nAdvanced Sterilization Products\nAdvanced Sterilization Products, a division of Ethicon Inc.\nAlere San Diego Inc.\nAllergan Inc.\nAllergan Inc.\nAlpharma Inc.\nAlpharma, Inc.\nAmerican Pharmaceutical Partners, Inc.\nAmgen Inc.\nAmgen Inc.\nAmgen, Inc.\nAmneal Pharmaceuticals of NY, LLC\nAstellas Pharma US Inc.\nAstraZeneca\nAstraZeneca LP\nAstraZeneca LP\nAstraZeneca LP\nAstraZeneca Pharmaceuticals\nAstraZeneca Pharmaceuticals LP\nAstraZeneca PLC\nAventis Pharmaceutical Inc.\nAventis Pharmaceuticals Inc.\nAVEO Pharmaceuticals Inc.\nBiogen Idec Inc.\nBiogen Idec, Inc.\nBiovail Corporation\nBIOVAIL AMERICAS CORP.\nBlock Drug Company Incorporated\nBoehringer Ingelheim Pharmaceuticals Inc.\nBoehringer Ingelheim Pharmaceutical, Inc.\nBoehringer Ingelheim Vetmedica, Inc.\nBoehringer Ingelheim Vetmedica, Inc.\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb Company\nBristol-Myers Squibb Company\nBristol-Myers Squibb Company\nBristol-Myers Squibb Medical Imaging, Inc.\nCAMBRIDGE MAJOR LABORATORIES INC\nCAMBRIDGE MAJOR LABORATORIES INC\nCephalon Inc\nCephalon Inc.\nCephalon, Inc.\nCHEROKEE PHARMACEUTICALS LLC\nChiron Corporation Ltd\nCypress Pharmaceutical Inc.\nDaiichi Sankyo Inc.\nDava Pharmaceuticals Inc.\nDey Inc.\nDey, Inc.\nDuPont Pharmaceuticals Company\nEisai Inc.\nElan Pharmaceuticals Inc.\nElan Corporation PLC\nElan Corporation, plc\nEli Lilly and Company\nEli Lilly and Company\nEli Lilly and Company\nEMD CHEMICALS INCORPORATED\nEMD CHEMICALS INCORPORATED\nEMD Chemicals, Inc.\nEMD Chemicals, Inc.\nEMD Millipore Corp.\nEMD Millipore Corporation\nEndo Health Solutions Inc.\nEndo Pharmaceuticals Inc. and Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals\nEon Labs Inc.\nEthex Corporation\nExecuPharm, Inc.\nForest Laboratories and Forest Pharmaceuticals\nForest Pharmaceuticals Inc.\nFort Dodge Animal Health\nGalena Biopharma, Inc.\nGenentech Inc.\nGenzyme Corp.\nGenzyme Corporation\nGlaxoSmithKline\nGlaxoSmithKline LLC\nGlaxoSmithKline LLC\nGlaxoSmithKline plc\nGlaxoSmithKline Vaccines\nGlobal Strategic Partners LLC\nHoechst AG\nHospira Inc.\nICN Pharmaceuticals, Inc\nICN Pharmaceuticals, Inc.\nIMMUNOMEDICS, INC. EMPLOYEES' 401(K) SAVINGS PLAN\nInspire Pharmaceuticals Inc.\nInterMune Inc.\nISTA Pharmaceuticals, Inc.\nIVAX Pharmaceuticals\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson Medical, Inc.\nKing Pharmaceuticals\nKing Pharmaceuticals LLC\nKos Pharmaceuticals\nKV Pharmaceutical Company\nKV Pharmaceutical Company\nLifescan, Inc.\nClovis Oncology Inc.\nAbbott Laboratories\nMallinckrodt\nMallinckrodt LLC\nMallinckrodt, Inc.\nMallinckrodt ARD Inc\nMcNeil-PPC Inc.\nGlaxoSmithKline Holdings (Americas)\nMerck & Co., Inc.\nMedicis Pharmaceutical Corporation\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP\nMerck\nMerck\nMerck & Co., Inc.\nMerck & Company\nMerck and Company, Inc.\nMerck KgaA\nMerck, Sharp & Dohme\nSANOFI PASTEUR\nSANOFI PASTEUR\nMicrus Corporation\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP\nGLAXOSMITHKLINE LLC\nMylan Laboratories, Inc.\nMylan Pharmaceuticals and UDL Laboratories\nNovartis AG\nNovartis Pharmaceuticals\nNovartis Pharmaceuticals\nNovartis Pharmaceuticals Corporation\nNOVARTIS PHARMACEUTICALS CORPORATION\nNovartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation\nNovo Nordisk Inc.\nNovo Nordisk A/S\nNovo Nordisk A/S\nOrtho McNeil Pharmaceutical\nOrtho-McNeil Pharmaceutical LLC\nOSI Pharmaceuticals LLC\nOtsuka American Pharmaceutical Inc.\nPar Pharmaceutical Companies Inc.\nParexel International, LLC\nPerrigo Company\nPerrigo Company\nPfizer Corporation\nPfizer Inc.\nPfizer Inc.\nPfizer Inc.\nPfizer Inc.\nPfizer Inc.\nPfizer Inc.\nPfizer Inc.\nPfizer Pharmaceuticals LLC\nPfizer H.C.P. Corporation\nPhibro-Tech Inc.\nPHIBRO-TECH, INC.\nPhibrochem, Inc.\nRanbaxy USA Inc.\nRegeneron Pharmaceuticals, Inc.\nRoxane Laboratories Inc.\nSandoz, Inc.\nSandoz, Inc.\nSanofi-Aventis U.S. Inc.\nSanofi-Pasteur\nSB Pharmco Puerto Rico Inc.\nSchering Corporation\nSchering-Plough\nSchering-Plough\nSchering-Plough Corporation\nSchering-Plough Corporation\nSchering-Plough Corporation\nSchwarz Pharma Inc.\nSciClone Pharmaceuticals\nScios Inc.\nSerono Laboratories Inc.\nSerono, S.A.\nShire Pharmaceuticals LLC\nShire Pharmaceuticals LLC\nSigma Aldrich Research Biochemicals Inc.\nSt Jude Medical Inc\nSt. Jude Medical Inc.\nSt. Jude Medical Inc.\nSt. Jude Medical Inc.\nTAP Pharmaceutical Products Inc.\nTeva Pharmaceutical Industries Ltd\nTeva Pharmaceuticals USA Inc.\nTeva Pharmaceutical Industries Limited\nTeva Pharmaceuticals USA Inc. and  IVAX LLC\nTherasense, Inc.\nAAIPHARMA SERVICES CORP.\nPFIZER, INC.\nAMGEN SF, LLC\nCOVIDIEN DBA MALLINCKRODT INC.\nEISAI INC.\nSCHWARZ PHARMA MANUFACTURING, INC.\nPERRIGO COMPANY OF SOUTH CAROLINA\nPFIZER, INC.\nCAMBREX CHARLES CITY, INC.\nHOSPIRA\nSTERILMED, INC.\nBARR LABORATORIES INC.\nHOSPIRA, INC.\nPLIVA, INC.\nIVAX PHARMACEUTICALS, INC.\nBARR LABORATORIES, INC.\nNOVOZYMES BIOLOGICALS, INC.\nPHIBRO-TECH INC\nSHIRE CORP\nALPHARMA ANIMAL HEALTH COMPANY\nKING PHARMACEUTICALS\nUCB Inc.\nJohnson & Johnson\nBRISTOL-MYERS SQUIBB COMPANY\nNOVARTIS CONSUMER HEALTH, INC.\nNOVARTIS PRODUCTS\nJanssen Pharmaceutica Inc.\nAdvanced Sterilization Products, Div of Ethicon\nAmgen Inc.\nGLAXOSMITHKLINE VACCINES\nMALLINCKRODT, LLC\nBOEHRINGER INGELHEIM VETMEDICA, INC\nBOEHRINGER INGELHEIM VETMEDICA, INC\nTEVA PHARMACEUTICALS USA INC\nABBOTT LABORATORIES\nSIGMA ALDRICH MFG LLC\nCAMBREX CHARLES CITY, INC\nMALLINCKRODT, INC\nKREMERS URBAN PHARMACEUTICALS INC\nAldrich Chemical, LLC\nAldrich Chemical\nPharmacia and Upjohn Company LLC\nACTAVIS,INC.\nCSL Behring LLC\nABBOTT LABS - N. CHICAGO PLANT\nELI LILLY & COMPANY - TIPPECANOE LABS\nPhibro-Tech, Inc.\nELI LILLY AND COMPANY\nAlpharma Inc. (Chicago Heights)\nABBOTT LABS - N. CHICAGO PLANT\nNovartis Animal Health US, Inc.\nPharmacia & Upjohn Company\nABBOTT LABS-N CHICAGO PLANT\nPHARMACIA & UPJOHN COMPANY, LLC.\nresearch organics\nPHIBRO-TECH, INC.\nALPHARMA, INC.\nLAFAYETTE PHARMACEUTICALS, INC.\nSERGEANT'S PET CARE PRODUCTS, INC.\nSERGEANT'S PET CARE PRODUCTS, INC. (SB)\nSCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. ( SB)\nKING PHARMACEUTICALS\nMEDIMMUNE DISTRIBUTION LLC\nNOVO NORDISK BIOCHEM, N.A., INC.\nEM INDUSTRIES, INC.\nNOVOZYMES BIOLOGICALS, INC.\nIMO SANOFI PASTEUR\nGLAXOSMITHKLINE, LLC\nMERCK SHARP & DOHME CORPORATION\nNOVOZYMES BIOLOGICALS, INC\nMERCK & CO., INC.\nMerck and Company\nTeva Pharmaceuticals USA, Inc.\nCelgene Corporation\nPfizer Pharmaceuticals, LLC\nRoche Molecular Systems, Inc.\nMerial (IA) LLP\nSchering-Plough Products, LLC\nPfizer Pharmaceuticals\nVALEANT PHARMACEUTICALS INTERNATIONAL, INC.\nJanssen Pharmaceutical (SB)\nSchering Plough Products, LLC\nE.R. Squibb & Sons LLC\nWyeth Pharmaceuticals Company, Inc.\nBristol Myers Squibb Manufacturing Company\nBristol Myers Squibb Company\nMerck Sharp & Dohme Quimica de Puerto Rico\nWyeth Rouses Point\nPhibro Animal Health Corporation\nPfizer Pharmaceuticals LLC\nAmgen Manufacturing, Limited\nBristol-Myers Squibb\nMerck & Co. Inc.\nWyeth Ayerst Pharmaceuticals\nLilly Del Caribe, Inc.\nWatson Laboratories, Inc.\nPfizer Pharmaceuticals Ltd.\nSchering Plough Products\nSEARLE LTD\nSCHERING-PLOUGH PRODUCTS LLC\nPHARMACIA & UPJOHN CARIBE\nHI TECH PHARMACAL CO., INC.\nLILLY DEL CARIBE, INC.\nMALLINCKRODT, INC.\nWYETH PHARMACEUTICALS COMPANY - OTC\nLILLY DEL CARIBE INC\nMILLIPORE, CIDRA, INC.\nEMD MILLIPORE CORPORATION\nEMD MILLLIPORE CORP\nMILLIPORE CORP\nPFIZER GLOBAL MANUFACTURING\nPFIZER INC / GROTON SITE\nBRISTOL - MYERS SQUIBB MEDICAL IMAGING INC\nEMD MILLIPORE CORPORATION\nValmed Pharmaceutical, Inc.\nHIKMA PHARMACEUTICALS\nETHICON, INC.\nPHARMAVITE LLC\nWOCKHARDT USA MORTON GROVE DBA MORTON GROVE PHARMACEUTICALS, INC.\nCSL PLASMA\nTARO PHARMACEUTICALS USA, INC.\nWarner Chilcott PLC\nWarner-Lambert\nCAMBREX CHARLES CITY, INC.\nSIGMA-ALDRICH\nJOHNSON & JOHNSON CONSUMER, INC.\nALCAMI CORPORATION\nETHICON, INC.\nAMNEAL PHARMACEUTICALS, LLC\nIDEXX DISTRIBUTION, INC.\nSHIRE PLC\nAMNEAL PHARMACEUTICALS, LLC.\nSUN PHARMACEUTICAL INDUSTRIES, INC.\nTEVA PHARMACEUTICAL USA, INC.\nZOETIS, LLC\nZOETIS, LLC\nSANOFI PASTEUR INC.\nBIOGEN IDEC, INC.\nWyeth LLC\nWyeth Pharmaceuticals Inc.\nWyeth Biopharma\nANIKA THERAPEUTICS INC.\nNOVARTIS CONSUMER HEALTH INC.\nALEXION PHARMACEUTICALS, INC.\nSIGMA-ALDRICH CORPORATION\nNovo Nordisk Inc.\nMylan Inc.\nAegerion Pharmaceuticals Inc.\nSmithKline Beecham\nAbbott Laboratories and CG Nutritionals\nSchering-Plough Corporation\nInterMune Inc.\nAlere Inc.\nAegerion Pharmaceuticals\nGalena Biopharma Inc.\nCelgene Corp.\nSalix Pharmaceuticals Inc.\nMallinckrodt LLC\nJanssen Pharmaceuticals, Inc.\nNovo Nordisk Inc.\nSynthes Inc.\nForest Pharmaceuticals Inc.\nOrtho-McNeil Pharmaceutical LLC\nBiovail Pharmaceuticals Inc.\nJohnson & Johnson\nDepuy Orthopaedics Inc.\nJazz Pharmaceuticals Inc.\nPurdue Frederick Company Inc.\nPharmacia & Upjohn Company Inc.\nPharmacia & Upjohn Company LLC\nSchering-Plough Corporation\nBristol-Myers Squibb\nICN Pharmaceuticals, Inc.\nRoussel Uclaf S.A.\nAldrich Chemical Company LLC\nDr. Reddy's Laboratories Inc.\nUnited Therapeutics Corporation\nCytrx Corporation\nActavis Kadian, LLC\nIntermune, Inc.\nIntermune, Inc.\nAmneal Pharmaceutical, LLC\nAmneal Pharmaceutical, LLC\nAmneal Pharmaceutical, LLC\nAmneal Pharmaceuticals, LLC\nXenoPort\nAlere Inc.\nETHICON ENDO SURGERY\nALDRICH CHEMICAL\nMILLIPORE CORPORATION\nSIGMA-ALDRICH\nSIGMA-ALDRICH INC\nSIGMA-ALDRICH\nBOEHRINGER INGELHEIM PHARMACEUTICALS\nGLAXO SMITH KLINE\nAmphastar Pharmaceuticals\nAllergan Inc.\nSynthes USA\nMylan\nNovartis\nGenentech\nGenentech\nALDRICH CHEMICAL\nMERCK & CO.\nMERCK & CO. INC.\nSERGEANTS PET CARE PRODUCTS\nSIGMA-ALDRICH, INC\nPfizer, Inc.\nACETO Corporation\nRoche Diagnostics Corporation\nSanofi\nActelion Pharmaceuticals US, Inc.\nAstraZeneca\nSanofi-Aventis U.S. LLC\nHoffmann-La Roche, Inc.\nPfizer\nNovartis Corporation\nNovartis Corporation and Alcon Laboratories\nMallinckrodt Inc.\nDaiichi Sankyo\nMedicis Pharmaceutical\nForest Laboratories, Inc.\nAbbott Laboratories\nAbbott Laboratories\nAmgen, Inc.\nAbbott Laboratories\nPharmavite LLC\nTeva Pharmaceuticals USA, Inc.\nSchering-Plough Corporation\nMerck & Co., Inc.\nWyeth\nMerck & Co., Inc.\nAmgen, Inc.\nBriston-Myers Squibb\nSchering-Plough Corporation\nCody Laboratories Inc\nInsys Therapeutics\nAstellas Pharma US Inc.\nAmgen Inc.\nJazz Pharmaceuticals plc\nLundbeck LLC\nAlexion Pharmaceuticals Inc.\nPERNIX THERAPEUTICS, LLC\nLifeScan Inc.\nAbbott Laboratories\nAbbott Laboratories\nAbbott Laboratories\nAbbott Laboratories\nAbbott Laboratories\nAbbott Laboratories\nAbbott Laboratories\nAbbott Laboratories and Fournier Industrie et Sante and Laboratoires Fournier S.A.\nAbbott Laboratories Inc.\nAbbott Laboratories Inc.\nAbbott Laboratories, Inc.\nAbbott Laboratories, Inc.\nAbbott Laboratories, Inc.\nAbbVie Inc.\nActavis\nActavis Elizabeth LLC\nActavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC\nAegerion Pharmaceuticals Inc.\nAlere Inc.\nAlere Inc.\nAllergan Inc.\nAlpharma Inc.\nAlpharma USPD, Inc.\nAlpharma USPD, Inc. and Purepac Pharmaceutical Co.\nAlpharma USPD, Inc.,\nAlpharma, Inc.\nAmgen and Immunex\nAmgen Inc.\nAmgen Inc.\nAmgen Inc.\nAmgen Inc.\nAmgen, Inc.\nAmgen, Inc.\nAmgen, Inc.\nAmneal Pharmaceuticals, LLC\nAmphastar Pharmaceuticals, Inc.\nAnda\nAndrx Corporation\nApotex\nAstellas\nAstellas Pharma US Inc.\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca LP\nAstraZeneca Pharmaceuticals\nAstraZeneca Pharmaceuticals LP\nAstraZeneca Pharmaceuticals LP\nAstraZeneca Pharmaceuticals LP\nAstraZeneca Pharmaceuticals LP and AstraZeneca LP\nAstraZeneca Pharmaceuticals, LP\nAventis\nAventis Pharmaceutical Inc.\nAventis Pharmaceutical L.P.\nAventis Pharmaceuticals Inc.\nAventis Pharmaceuticals Inc.\nAventis Pharmaceuticals Inc.\nAventis Pharmaceuticals, Inc.\nAventis Pharmaceuticals, Inc. and Aventis Behring, LLC\nBarr Laboratories, Inc. and Duramed Pharmaceuticals, Inc.\nBarr Pharmaceuticals\nBausch & Lomb\nBen Venue Laboratories, Inc.\nBiogen Idec Inc.\nBiovail\nBoehringer Ingelheim\nBoehringer Ingelheim Corp.\nBoehringer Ingelheim Pharmaceuticals, Inc.\nBoehringer Ingelheim Pharmaceuticals, Inc.\nBoehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc.\nBoehringer Ingelheim Roxane, Inc.\nBoehringer Ingelheim Roxane, Inc. et al.\nBoehringer Ingleheim\nBoehringer-Ingelheim Pharmaceuticals, Inc.\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb Co.\nBristol-Myers Squibb Company\nBristol-Myers Squibb Company\nBristol-Myers Squibb Company and Apothecon, Inc.\nCelgene Corp.\nCephalon\nCephalon Inc.\nCephalon, Inc.\nCephalon, Inc.\nCIBA Vision\nDaiichi Pharmaceutical\nDaiichi Pharmaceutical\nDaiichi Pharmaceutical\nDaiichi Sankyo, Inc.\nDava Pharmaceuticals, Inc.\nDePuy Orthopaedics Inc.\nDey\nDey Inc.\nDey Inc.\nDey Inc.\nDey Inc.\nDey L.P.\nDey Labs\nDey LP\nDey Pharmaceuticals\nDey, Inc.\nDey, Inc.\nDey, Inc.\nDey, Inc.\nDey, Inc.\nDey, Inc.\nDey, Inc.\nDey, Inc.\nDey, Inc.\nEisai\nEisai\nEisai Co.\nEisai Co.\nEisai Inc.\nElan Corp.\nEli Lilly\nEli Lilly\nEli Lilly\nEli Lilly\nEli Lilly & Co.\nEli Lilly and Co.\nEli Lilly and Co.\nEli Lilly and Company\nEli Lilly and Company\nEMD Serono, Inc.\nEndo Health Solution\nEndo Health Solutions\nEndo Health Solutions Inc. and Endo Pharmaceuticals Inc.\nEndo International plc\nEndo Pharmaceuticals\nEndo Pharmaceuticals\nETHEX Corp.\nForest Laboratories\nForest Laboratories\nForest Laboratories\nForest Laboratories LLC\nForest Laboratories, Inc.\nForest Pharmaceuticals Inc.\nForest Pharmaceuticals Inc.\nGenentech Inc.\nGenentech Inc.\nGeneva Pharmaceuticals\nGenzyme Corp.\nGilead Sciences\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline LLC\nGlaxoSmithKline LLC\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline, LLC\nGlaxoSmithKline, LLC\nHoffman-LaRoche\nHoffman-LaRoche\nHoffman-LaRoche\nImmunex Corp.\nInspire Pharmaceuticals\nInsys\nInsys Therapeutics Inc.\nInsys Therapeutics, Inc.\nInterMune Inc.\nISTA Pharmaceuticals, Inc.\nIVAX Pharmaceuticals\nJanssen Ortho LLC and Janssen Pharmaceuticals, Inc.\nJanssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc.\nJanssen Pharmaceuticals, Inc.\nJanssen Pharmaceuticals, Inc.\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson et al.\nJohnson & Johnson Vision Care, Inc.\nJohnson & Johnson, Janssen Pharmaceutical Products LP, Ortho-McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP, McNeil-PPC, Inc. and Centocor, I\nJohnson and Johnson\nKing Pharmaceuticals\nKnoll Pharmaceuticals\nKos Pharmaceuticals\nKV Pharmaceutical Co.\nKV Pharmaceutical Company\nLifeScan, Inc.\nMallinckrodt ARD LLC\nMallinckrodt LLC\nMallinckrodt plc\nMcNeil-PPC Inc.\nMcNeil-PPC, Inc.\nMedicis Pharmaceutical Corporation\nMerck\nMerck\nMerck & Co. Inc.\nMerck & Co.\nMerck & Co., Inc.\nMerck and Company, Inc.\nMerck KGaA\nMerck Sharp & Dohme Corp\nMerck Sharp & Dohme Corp.\nMerck Sharp & Dohme Corp.\nMerck Sharp & Dohme Corp.\nMylan Inc.\nMylan Inc.\nMylan Laboratories et al.\nMylan Laboratories Inc.\nMylan Laboratories Inc.  And Mylan Pharmaceuticals Inc.\nMylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.\nMylan Pharmaceuticals, Inc.\nMylan Specialty L.P.\nMylan Specialty, L.P.\nNovartis\nNovartis Pharmaceuticals Corp.\nNovartis Pharmaceuticals Corp.\nNovartis Pharmaceuticals Corporation\nNovartis Pharmaceuticals Corporation\nNovartis Pharmaceuticals Corporation\nNovartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation\nNovartis Pharmaceuticals\nNovo Nordisk Inc.\nNovo Nordisk Inc.\nOrganon\nOrganon USA Inc\nOrtho-McNeil Pharmaceutical LLC\nOrtho-McNeil Pharmaceutical, Inc.\nOSI Pharmaceuticals LLC\nOSI Pharmaceuticals LLC\nOtsuka America Pharmaceutical, Inc.\nOtsuka American Pharmaceutical Inc.\nPar Pharmaceutical\nPar Pharmaceutical Co.\nPar Pharmaceutical Companies Inc.\nPar Pharmaceutical Cos., Inc.\nPar Pharmaceutical Inc.\nPar Pharmaceutical, Inc.\nPar Pharmaceuticals, Inc.\nPernix Therapeutics\nPerrigo\nPerrigo Company\nPfizer\nPfizer\nPfizer\nPfizer Inc.\nPfizer Inc.\nPfizer Inc.\nPfizer Inc.\nPfizer Inc.\nPfizer Inc. and Pharmacia Corp.\nPfizer Inc.\nPfizer Inc.\nPfizer, Inc.\nPfizer, Inc.\nPfizer, Inc. and Pharmacia Corporation\nPharmacia Corp.\nPharmacia Corporation\nPharmacia Corporation\nPurdue Frederick Co.\nPurdue Frederick Company Inc.\nPurdue Frederick Company, Inc. and Purdue Pharma, L.P.\nPurdue Pharma\nPurdue Pharma\nPurdue Pharma\nPurdue Pharma L.P.\nPurdue Pharma, L.P.\nPurepac Pharmaceutical Co.\nPurepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC\nRanbaxy\nRanbaxy\nRanbaxy Laboratories\nRanbaxy Pharmaceuticals, Inc.\nRanbaxy Pharmaceuticals, Inc. et al.\nRoxane Laboratories Inc.\nRoxane Laboratories, Inc.\nRoxane Laboratories, Inc.\nRoxane, Inc.\nRoxanne Laboratories and Boehringer Ingelheim\nSalix Pharmaceuticals Inc.\nSandoz\nSandoz\nSandoz Inc.\nSandoz, Inc.\nSanofi US Services, Inc.\nSanofi-Aventis\nSanofi-Aventis U.S. LLC\nSB Pharmco Puerto Rico Inc.\nSchering-Plough\nSchering-Plough\nSchering-Plough Corp.\nSchering-Plough Corporation\nSchering-Plough Corporation\nSchering-Plough Corporation\nSchwarz Pharma Inc.\nSerono Inc.\nShering-Plough/Warrick Companies\nShire\nShire Pharmaceuticals LLC\nShire Pharmaceuticals LLC\nSmithKline Beecham Corp.\nSmithKline Beecham Corp.\nSynthes, Inc.\nTakeda Chemical\nTakeda Chemical\nTakeda Chemical\nTakeda Pharmaceuticals\nTakeda/Tap Pharmaceuticals\nTAP Pharmaceutical Products\nTAP Pharmaceutical Products, Inc.\nTAP Pharmaceutical Products, Inc.\nTAP Pharmaceutical Products, Inc.\nTAP Pharmaceutical Products, Inc.\nTAP Pharmaceutical Products, Inc.\nTaro Pharmaceutical Industries\nTaro Pharmaceuticals USA, Inc.\nTeva Pharmaceutical Industries Ltd.\nTeva Pharmaceutical USA, Inc.\nTeva Pharmaceuticals\nTEVA Pharmaceuticals USA\nTeva Pharmaceuticals USA\nTeva Pharmaceuticals USA Inc.\nTeva Pharmaceuticals USA Inc.\nTeva Pharmaceuticals USA Inc., IVAX Corporation, IVAX Pharmaceuticals Inc., Sicor Inc., Barr Laboratories Inc. and Duramed Pharmaceuticals Inc.\nTeva Pharmaceuticals USA, Inc.\nTeva Pharmaceuticals USA, Inc. et al.\nTeva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc.\nTeva Pharmaceuticals Inc.\nUCB\nUCB Holdings, Inc.\nUCB Inc.\nUCB Pharma, Inc.\nValeant Pharmaceuticals International, Inc.\nWarner Chilcott Holdings\nWarner Chilcott PLC\nWarner-Lambert\nWarrick Pharmaceuticals Corp. and Schering-Plough Corp.\nWarrick Pharmaceuticals Inc.\nWatson Pharmaceuticals\nWatson Pharmaceuticals Inc. and Watson Pharma Inc.\nWatson Pharmaceuticals, Inc.\nWatson, Inc.\nWatson/Schein Pharmaceuticals Inc.\nWyeth Pharmaceuticals, Inc.\nWyeth Pharmaceuticals, Inc.\nAvanir Pharmaceuticals\nAbbott Laboratories\nAbbVie Inc.\nAventis Pharmaceuticals\nForest Laboratories Inc.\nGlaxoSmithKline LLC\nJohnson & Johnson\nNovartis Pharmaceuticals\nPfizer Inc.\nPharmacia Corporation\nTakeda Pharmaceuticals U.S.A.\nJohnson & Johnson\nAvanir Pharmaceuticals\nMerck & Company, Inc.\nMylan N.V.\nJohnson & Johnson\nImclone Systems, Inc.\nWyeth-Ayerst Laboratories Division\nPfizer Pharmaceuticals, LLC\nPfizer Inc.\nSigma Aldrich Co.\nMallinckrodt Enterprises, LLC\nMerck & Co. Inc.\nBaxalta US Inc.\nSanofi-Aventis U.S., LLC\nSandoz Inc.\nIDEXX Laboratories, Inc.\nMallinckrodt\nEndo Pharmaceuticals\nApotex Corp.\nJohnson & Johnson\nBristol-Myers Squibb\nNovo Nordisk Inc.\nValeant Pharmaceuticals, Inc.\nNovartis Pharmaceuticals Corporation\nWockhardt USA\nDUSA Pharmaceuticals, Inc.\nIndivior Solutions\nNovartis Pharmaceuticals Corporation\nNovartis Hellas S.A.C.I. et al.\nIndivior, Inc.\nNovartis Pharmaceuticals Corp.\nPacira Pharmaceuticals, Inc.\nBoehringer Ingelheim Animal Health USA Inc.\nBausch Health\nAlexion Pharmaceuticals Inc.\nNovartis AG\nPacira Pharmaceuticals Inc.\nAbbVie Inc.\nPurdue Pharma LP\nGilead Sciences, Inc.\nBiocryst Pharmaceuticals, Inc.\nAlpharma Animal Health Division\nAlpharma Animal Health Division\nIDEXX Reference Laboratories, Inc.\nMia Rose, Inc.\nSergeant's Pet Care Products Inc.\nAdvanced Sterilization Products\nPfizer Inc.\nSergeant's Pet Care Products Inc.\nAceto Corporation\nSchering-Plough Healthcare Products Inc.\nAbbott Laboratories Diagnostics\nSergeant's Pet Care Products, Inc.\nPhibro-Tech Inc.\nNeutrogena Corp.\nPhibro-Tech Inc.\nBristol-Myers Squibb Company\nPfizer, Inc.\nPfizer Inc.\nBiogen, Inc.\nANDRX PHARMACEUTICALS, INC.\nMallinckrodt, Inc.\nMerck & Company, Incorporated\nSIGMA-ALDRICH MANUFACTURING\nPHARMACIA CORPORATION, et al.\nPHARMACIA/SOLUTIA\nELI LILLY & CO LTC\nKREMERS URBAN PHARMACEUTICALS INC\nKREMERS URBAN PHARMACEUTICALS INC\nELANCO ANIMAL HEALTH A DIV OF ELI LILLY & CO CLINTON LABS\nELANCO ANIMAL HEALTH A DIV OF ELI LILLY & CO CLINTON LABS\nROCHE DIAGNOSTICS CORP\nShire Human Genetic Therapies, Inc.\nAMGEN INC\nANIKA THERAPEUTICS INC\nAMGEN INC\nZOETIS LLC\nMallinckrodt/Covidien\nNovo Nordisk Pharmaceutical Industries, Inc.\nAMNEAL PHARMACEUTICALS LLC\nMERCK SHARP & DOHME CORP\nAMNEAL PHARMACEUTICALS LLC\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP\nACTAVIS ELIZABETH LLC\nALCAMI CORPORATION\nE R SQUIBB & SONS LLC\nAMNEAL PHARMACEUTICALS\nMERCK SHARP & DOHME CORP\nMERCK SHARP & DOHME CORP - RAHWAY NJ\nETHICON INC\nMERCK SHARP & DOHME CORP - RAHWAY NJ\nACTAVIS ELIZABETH LLC\nE.R. SQUIBB & SONS\nPLIVA INC\nAMNEAL PHARMACEUTICALS\nIVAX PHARMACEUTICALS INC\nPLIVA INC\nPLIVA INC\nTEVA PHARMACEUTICALS USA INC\nBRISTOL MYERS SQUIBB CO\nACTAVIS ELIZABETH LLC\nMERCK SHARP & DOHME CORP\nBRISTOL-MYERS SQUIBB CO\nMERCK SHARP & DOHME CORP\nACTAVIS ELIZABETH LLC\nACTAVIS ELIZABETH LLC\nHOFFMAN LAROCHE INC\nPHARMACIA CORP\nPLIVA INC\nBRISTOL-MYERS SQUIBB CO\nAMRI Rensselaer, Inc.\nGlaxoSmithKline LLC\nAMRI Rensselaer, Inc.\nMallinckrodt LLC\nEMD Chemicals Inc.\nEMD Chemicals Inc.\nPHIBRO-TECH, INC\nPHIBRO-TECH\nMerck Sharp & Dohme Corp.\nMerck Sharp & Dohme Corp.\nIndivior plc\nCSL Behring, LLC\nIncyte Corporation\nBristol-Myers Squibb\nMorton Grove Pharmaceuticals, Inc.\nBAUSCH AND LOMB PHARMACEUTICALS, INC.\nMALLINCKRODT INC.\nDURAMED PHARMACEUTICALS, INC.\nTEVA PHARMACEUTICALS INC.\nK V PHARMACEUTICAL\nIMPAX LABORATORIES, INC\nALPHARMA ANIMAL HEALTH COMPANY\nGILEAD SCIENCES\nCHIRON CORPORATION\nPHIBRO-TECH INC.\nTEVA SICOR\nPHARMAVITE CORP\nPHARMAVITE\nGENENTECH\nELAN PHARMACEUTICALS INC.\nELAN PHARMACEUTICALS INC.\nAMPHASTAR PHARMACEUTICALS INC\nBAXTER HEALTHCARE CORP DBA BAXTER BIOSCIENCE\nROCHE MOLECULAR SYSTEMS INC\nPHIBRO-TECH, INC.\nTEVA PHARMACEUTICAL\nSt. Jude Medical Inc.\nAlere Inc.\nGlaxoSmithKline, LLC\nPurdue Pharma\nBristol Myers Squibb Co.\nJohnson & Johnson\nEndo Health Solutions\nPerrigo Company\n"
     ]
    }
   ],
   "source": [
    "#Now, let's begin the data cleansing for the dataset RDD pharma_rdd\n",
    "import csv\n",
    "from io import StringIO\n",
    "\n",
    "# let's begin with defining a function to parse CSV rows\n",
    "def parse_csv_row(row):\n",
    "    return next(csv.reader(StringIO(row)))\n",
    "\n",
    "# to skip the header row\n",
    "header = pharma_rdd.first()\n",
    "pharma_rdd_without_header = pharma_rdd.filter(lambda row: row != header)\n",
    "\n",
    "# Parse the CSV rows and extract the column \"Company\"\n",
    "company = pharma_rdd_without_header.map(lambda row: parse_csv_row(row)[0])\n",
    "\n",
    "# view the value\n",
    "for value in company.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "b9288eee-5368-40da-9bf3-0b0b992b56f2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'company': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = company.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'company':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "aa331e26-e2d6-4262-9fd3-60636b493be3",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Abbott Laboratories\nAbbVie\nAbbVie\nAbbott Laboratories\nJohnson & Johnson\nAbbott Laboratories\nAbbott Laboratories\nJohnson & Johnson\nJohnson & Johnson\nAbbott Laboratories\nAbbVie\nAbbVie\nPfizer\nPfizer\nBristol-Myers Squibb\nAmgen\nAmgen\nAmgen\nAmneal Pharmaceuticals\nAstellas Pharma\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nSanofi\nSanofi\nAVEO Pharmaceuticals\nBiogen Idec\nBiogen Idec\nBausch Health\nBausch Health\nGlaxoSmithKline\nBoehringer Ingelheim\nBoehringer Ingelheim\nEli Lilly\nEli Lilly\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nAlcami\nAlcami\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nMerck\nNovartis\nCurrax Pharmaceuticals\nDaiichi Sankyo\nEndo International\nViatris\nViatris\nBristol-Myers Squibb\nEisai\nPerrigo\nPerrigo\nPerrigo\nEli Lilly\nEli Lilly\nEli Lilly\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nEndo International\nEndo International\nNovartis\nKV Pharmaceutical\nParexel International\nAbbVie\nAbbVie\nZoetis\nSELLAS Life Sciences Group\nRoche\nSanofi\nSanofi\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nBristol-Myers Squibb\nSanofi\nPfizer\nBausch Health\nBausch Health\nGilead Sciences\nMerck\nRoche\nBausch Health\nTeva Pharmaceutical Industries\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nPfizer\nPfizer\nAbbVie\nKV Pharmaceutical\nKV Pharmaceutical\nJohnson & Johnson\nClovis Oncology\nAbbott Laboratories\nMallinckrodt\nMallinckrodt\nMallinckrodt\nMallinckrodt\nJohnson & Johnson\nGlaxoSmithKline\nMerck\nBausch Health\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck KGaA (EMD)\nMerck\nSanofi\nSanofi\nJohnson & Johnson\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck\nGlaxoSmithKline\nViatris\nViatris\nNovartis\nNovartis\nNovartis\nNovartis\nNovartis\nNovartis\nNovo Holdings A/S\nNovo Holdings A/S\nNovo Holdings A/S\nJohnson & Johnson\nJohnson & Johnson\nAstellas Pharma\nOtsuka Pharmaceutical\nEndo International\nParexel International\nPerrigo\nPerrigo\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPhibro Animal Health\nPhibro Animal Health\nPhibro Animal Health\nSun Pharmaceuticals\nRegeneron Pharmaceuticals\nHikma Pharmaceuticals\nNovartis\nNovartis\nSanofi\nSanofi\nGlaxoSmithKline\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck\nUCB\nSciClone Pharmaceuticals\nJohnson & Johnson\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nMerck KGaA (EMD)\nAbbott Laboratories\nAbbott Laboratories\nAbbott Laboratories\nAbbott Laboratories\nTakeda Pharmaceutical\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nAbbott Laboratories\nAlcami\nPfizer\nAmgen\nMallinckrodt\nEisai\nUCB\nPerrigo\nPfizer\nCambrex\nPfizer\nJohnson & Johnson\nTeva Pharmaceutical Industries\nPfizer\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nNovo Holdings A/S\nPhibro Animal Health\nTakeda Pharmaceutical\nZoetis\nPfizer\nUCB\nJohnson & Johnson\nBristol-Myers Squibb\nNovartis\nNovartis\nJohnson & Johnson\nJohnson & Johnson\nAmgen\nGlaxoSmithKline\nMallinckrodt\nEli Lilly\nEli Lilly\nTeva Pharmaceutical Industries\nAbbott Laboratories\nMerck KGaA (EMD)\nCambrex\nMallinckrodt\nLannett Co.\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nViatris\nAbbVie\nCSL Limited\nAbbott Laboratories\nEli Lilly\nPhibro Animal Health\nEli Lilly\nZoetis\nAbbott Laboratories\nNovartis\nViatris\nAbbott Laboratories\nViatris\nMerck KGaA (EMD)\nPhibro Animal Health\nZoetis\nMallinckrodt\nPerrigo\nPerrigo\nMerck\nPfizer\nAstraZeneca\nNovo Holdings A/S\nMerck KGaA (EMD)\nNovo Holdings A/S\nSanofi\nGlaxoSmithKline\nMerck\nNovo Holdings A/S\nMerck\nMerck\nTeva Pharmaceutical Industries\nBristol-Myers Squibb\nPfizer\nRoche\nMerck\nMerck\nPfizer\nBausch Health\nJohnson & Johnson\nMerck\nBristol-Myers Squibb\nPfizer\nBristol-Myers Squibb\nBristol-Myers Squibb\nMerck\nPfizer\nPhibro Animal Health\nPfizer\nAmgen\nBristol-Myers Squibb\nMerck\nPfizer\nEli Lilly\nAbbVie\nPfizer\nMerck\nPfizer\nMerck\nViatris\nAkorn Inc.\nEli Lilly\nMallinckrodt\nPfizer\nEli Lilly\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nPfizer\nPfizer\nBristol-Myers Squibb\nMerck KGaA (EMD)\nAbbVie\nHikma Pharmaceuticals\nJohnson & Johnson\nOtsuka Pharmaceutical\nWockhardt Limited\nCSL Limited\nTaro Pharmaceutical Industries\nAbbVie\nPfizer\nCambrex\nMerck KGaA (EMD)\nJohnson & Johnson\nAlcami\nJohnson & Johnson\nAmneal Pharmaceuticals\nIDEXX Laboratories\nTakeda Pharmaceutical\nAmneal Pharmaceuticals\nSun Pharmaceuticals\nTeva Pharmaceutical Industries\nZoetis\nZoetis\nSanofi\nBiogen Idec\nPfizer\nPfizer\nPfizer\nAnika Therapeutics\nNovartis\nAstraZeneca\nMerck KGaA (EMD)\nNovo Holdings A/S\nViatris\nAmryt Pharma\nGlaxoSmithKline\nAbbott Laboratories\nMerck\nRoche\nAbbott Laboratories\nAmryt Pharma\nSELLAS Life Sciences Group\nBristol-Myers Squibb\nBausch Health\nMallinckrodt\nJohnson & Johnson\nNovo Holdings A/S\nJohnson & Johnson\nAbbVie\nJohnson & Johnson\nBausch Health\nJohnson & Johnson\nJohnson & Johnson\nJazz Pharmaceuticals\nPurdue Pharma\nViatris\nViatris\nMerck\nBristol-Myers Squibb\nBausch Health\nSanofi\nMerck KGaA (EMD)\nDr. Reddy's Laboratories\nUnited Therapeutics\nCytRx\nAbbVie\nRoche\nRoche\nAmneal Pharmaceuticals\nAmneal Pharmaceuticals\nAmneal Pharmaceuticals\nAmneal Pharmaceuticals\nArbor Pharmaceuticals\nAbbott Laboratories\nJohnson & Johnson\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nBoehringer Ingelheim\nGlaxoSmithKline\nAmphastar Pharmaceuticals\nAbbVie\nJohnson & Johnson\nViatris\nNovartis\nRoche\nRoche\nMerck KGaA (EMD)\nMerck\nMerck\nPerrigo\nMerck KGaA (EMD)\nPfizer\nAceto\nRoche\nSanofi\nJohnson & Johnson\nAstraZeneca\nSanofi\nRoche\nPfizer\nNovartis\nNovartis\nMallinckrodt\nDaiichi Sankyo\nBausch Health\nAbbVie\nAbbott Laboratories\nAbbott Laboratories\nAmgen\nAbbVie\nOtsuka Pharmaceutical\nTeva Pharmaceutical Industries\nMerck\nMerck\nPfizer\nMerck\nAmgen\nBristol-Myers Squibb\nMerck\nLannett Co.\nInsys Therapeutics\nAstellas Pharma\nAmgen\nJazz Pharmaceuticals\nLundbeck\nAstraZeneca\nCurrax Pharmaceuticals\nJohnson & Johnson\nAbbott Laboratories\nAbbVie\nAbbVie\nAbbVie\nAbbVie\nAbbott Laboratories\nAbbVie\nAbbott Laboratories\nAbbVie\nAbbVie\nAbbott Laboratories\nAbbVie\nAbbVie\nAbbVie\nAbbVie\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nAmryt Pharma\nAbbott Laboratories\nAbbott Laboratories\nAbbVie\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nAmgen\nAmgen\nAmgen\nAmgen\nAmgen\nAmgen\nAmgen\nAmgen\nAmneal Pharmaceuticals\nAmphastar Pharmaceuticals\nTeva Pharmaceutical Industries\nAbbVie\nApotex Corp.\nAstellas Pharma\nAstellas Pharma\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nAstraZeneca\nSanofi\nSanofi\nSanofi\nSanofi\nSanofi\nSanofi\nSanofi\nSanofi\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nBausch Health\nBoehringer Ingelheim\nBiogen Idec\nBausch Health\nBoehringer Ingelheim\nBoehringer Ingelheim\nBoehringer Ingelheim\nBoehringer Ingelheim\nBoehringer Ingelheim\nBoehringer Ingelheim\nBoehringer Ingelheim\nBoehringer Ingelheim\nBoehringer Ingelheim\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nBristol-Myers Squibb\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nNovartis\nDaiichi Sankyo\nDaiichi Sankyo\nDaiichi Sankyo\nDaiichi Sankyo\nEndo International\nJohnson & Johnson\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nEisai\nEisai\nEisai\nEisai\nEisai\nPerrigo\nEli Lilly\nEli Lilly\nEli Lilly\nEli Lilly\nEli Lilly\nEli Lilly\nEli Lilly\nEli Lilly\nEli Lilly\nMerck KGaA (EMD)\nEndo International\nEndo International\nEndo International\nEndo International\nEndo International\nEndo International\nKV Pharmaceutical\nAbbVie\nAbbVie\nAbbVie\nAbbVie\nAbbVie\nAbbVie\nAbbVie\nRoche\nRoche\nNovartis\nSanofi\nGilead Sciences\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nGlaxoSmithKline\nRoche\nRoche\nRoche\nAmgen\nMerck\nInsys Therapeutics\nInsys Therapeutics\nInsys Therapeutics\nRoche\nBausch Health\nTeva Pharmaceutical Industries\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nJohnson & Johnson\nPfizer\nAbbVie\nAbbVie\nKV Pharmaceutical\nKV Pharmaceutical\nJohnson & Johnson\nMallinckrodt\nMallinckrodt\nMallinckrodt\nJohnson & Johnson\nJohnson & Johnson\nBausch Health\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck KGaA (EMD)\nMerck\nMerck\nMerck\nMerck\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nViatris\nNovartis\nNovartis\nNovartis\nNovartis\nNovartis\nNovartis\nNovartis\nNovartis\nNovo Holdings A/S\nNovo Holdings A/S\nOrganon & Co.\nOrganon & Co.\nJohnson & Johnson\nJohnson & Johnson\nAstellas Pharma\nAstellas Pharma\nOtsuka Pharmaceutical\nOtsuka Pharmaceutical\nEndo International\nEndo International\nEndo International\nEndo International\nEndo International\nEndo International\nEndo International\nCurrax Pharmaceuticals\nPerrigo\nPerrigo\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nPfizer\nViatris\nViatris\nViatris\nPurdue Pharma\nPurdue Pharma\nPurdue Pharma\nPurdue Pharma\nPurdue Pharma\nPurdue Pharma\nPurdue Pharma\nPurdue Pharma\nPfizer\nPfizer\nSun Pharmaceuticals\nSun Pharmaceuticals\nSun Pharmaceuticals\nSun Pharmaceuticals\nSun Pharmaceuticals\nHikma Pharmaceuticals\nHikma Pharmaceuticals\nHikma Pharmaceuticals\nHikma Pharmaceuticals\nHikma Pharmaceuticals\nBausch Health\nNovartis\nNovartis\nNovartis\nNovartis\nSanofi\nSanofi\nSanofi\nGlaxoSmithKline\nMerck\nMerck\nMerck\nMerck\nMerck\nMerck\nUCB\nMerck KGaA (EMD)\nMerck\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nGlaxoSmithKline\nGlaxoSmithKline\nJohnson & Johnson\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTakeda Pharmaceutical\nTaro Pharmaceutical Industries\nTaro Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nUCB\nUCB\nUCB\nUCB\nBausch Health\nAbbVie\nAbbVie\nPfizer\nMerck\nMerck\nAbbVie\nAbbVie\nAbbVie\nAbbVie\nAbbVie\nPfizer\nPfizer\nOtsuka Pharmaceutical\nAbbott Laboratories\nAbbVie\nSanofi\nAbbVie\nGlaxoSmithKline\nJohnson & Johnson\nNovartis\nPfizer\nViatris\nTakeda Pharmaceutical\nJohnson & Johnson\nOtsuka Pharmaceutical\nMerck\nViatris\nJohnson & Johnson\nEli Lilly\nPfizer\nPfizer\nPfizer\nMerck KGaA (EMD)\nMallinckrodt\nMerck\nTakeda Pharmaceutical\nSanofi\nNovartis\nIDEXX Laboratories\nMallinckrodt\nEndo International\nApotex Corp.\nJohnson & Johnson\nBristol-Myers Squibb\nNovo Holdings A/S\nBausch Health\nNovartis\nWockhardt Limited\nSun Pharmaceuticals\nIndivior Inc.\nNovartis\nNovartis\nIndivior Inc.\nNovartis\nPacira BioSciences\nBoehringer Ingelheim\nBausch Health\nAstraZeneca\nNovartis\nPacira BioSciences\nAbbVie\nPurdue Pharma\nGilead Sciences\nBiocryst Pharmaceuticals\nZoetis\nZoetis\nIDEXX Laboratories\nNutraceutical International Corp.\nPerrigo\nJohnson & Johnson\nPfizer\nPerrigo\nAceto\nMerck\nAbbott Laboratories\nPerrigo\nPhibro Animal Health\nJohnson & Johnson\nPhibro Animal Health\nBristol-Myers Squibb\nPfizer\nPfizer\nBiogen Idec\nAbbVie\nMallinckrodt\nMerck\nMerck KGaA (EMD)\nViatris\nViatris\nEli Lilly\nLannett Co.\nLannett Co.\nElanco Animal Health\nElanco Animal Health\nRoche\nTakeda Pharmaceutical\nAmgen\nAnika Therapeutics\nAmgen\nZoetis\nMallinckrodt\nNovo Holdings A/S\nAmneal Pharmaceuticals\nMerck\nAmneal Pharmaceuticals\nMerck\nMerck\nTeva Pharmaceutical Industries\nAlcami\nBristol-Myers Squibb\nAmneal Pharmaceuticals\nMerck\nMerck\nJohnson & Johnson\nMerck\nTeva Pharmaceutical Industries\nBristol-Myers Squibb\nTeva Pharmaceutical Industries\nAmneal Pharmaceuticals\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nBristol-Myers Squibb\nTeva Pharmaceutical Industries\nMerck\nBristol-Myers Squibb\nMerck\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nRoche\nViatris\nTeva Pharmaceutical Industries\nBristol-Myers Squibb\nCuria Inc.\nGlaxoSmithKline\nCuria Inc.\nMallinckrodt\nMerck KGaA (EMD)\nMerck KGaA (EMD)\nPhibro Animal Health\nPhibro Animal Health\nMerck\nMerck\nIndivior Inc.\nCSL Limited\nIncyte Corp.\nBristol-Myers Squibb\nWockhardt Limited\nBausch Health\nMallinckrodt\nTeva Pharmaceutical Industries\nTeva Pharmaceutical Industries\nKV Pharmaceutical\nAmneal Pharmaceuticals\nZoetis\nGilead Sciences\nNovartis\nPhibro Animal Health\nTeva Pharmaceutical Industries\nOtsuka Pharmaceutical\nOtsuka Pharmaceutical\nRoche\nPerrigo\nPerrigo\nAmphastar Pharmaceuticals\nTakeda Pharmaceutical\nRoche\nPhibro Animal Health\nTeva Pharmaceutical Industries\nAbbott Laboratories\nAbbott Laboratories\nGlaxoSmithKline\nPurdue Pharma\nBristol-Myers Squibb\nJohnson & Johnson\nEndo International\nPerrigo\n"
     ]
    }
   ],
   "source": [
    "#likewise, let's initiate values in the column \"parent_company\"\n",
    "parent_company = pharma_rdd_without_header.map(lambda row: parse_csv_row(row)[1])\n",
    "\n",
    "# Display the column values\n",
    "for value in parent_company.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "3e01dd32-3111-47c2-a919-585ad37a5352",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'parent_company': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = parent_company.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'parent_company':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c54939fe-a50f-4341-a784-17a8f89f3d5d",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "$5,475,000\n$1,500,000,000\n$126,500,000\n$49,045\n$18,000,000\n$16,800\n$2,950,000\n$136,800\n$1,200,000\n$10,572\n$600,000,000\n$15,000,000\n$42,500,000\n$2,500,000\n$160,203\n$762,000,000\n$24,900,000\n$40,000\n$99,000\n$7,300,000\n$250,000\n$520,000,000\n$46,500,000\n$7,900,000\n$2,600,000\n$354,900,000\n$5,522,000\n$95,500,000\n$190,000,000\n$4,000,000\n$6,934\n$49,600\n$10,000,000\n$10,001\n$352,773\n$95,000,000\n$50,000\n$300,000\n$68,475\n$14,000,000\n$3,650,000\n$1,000,000\n$2,100,000\n$515,000,000\n$150,000,000\n$16,200\n$18,560\n$15,820\n$425,000,000\n$7,500,000\n$1,200,000,000\n$10,001\n$168,500\n$2,800,000\n$39,000,000\n$11,000,000\n$280,000,000\n$18,500,000\n$6,600\n$11,000,000\n$31,000\n$203,000,000\n$15,000,000\n$1,415,000,000\n$36,000,000\n$29,398,734\n$13,170\n$7,614\n$8,250\n$44,000\n$385,000\n$2,681,500\n$192,700,000\n$39,000,000\n$3,500,000\n$27,600,000\n$5,900\n$38,000,000\n$164,000,000\n$26,956\n$200,000\n$33,500,000\n$22,280,000\n$32,587,439\n$150,000,000\n$3,000,000,000\n$317,550\n$20,000,000\n$172,900\n$8,680\n$12,000,000\n$400,000\n$5,500\n$1,000,000\n$10,001\n$5,900,000\n$59,085\n$33,500,000\n$14,000,000\n$2,200,000,000\n$48,600,000\n$21,400,000\n$3,900,000\n$124,000,000\n$2,200,000\n$41,500,000\n$17,000,000\n$24,920\n$15,000,000\n$20,000,000\n$1,176,576\n$10,000\n$35,000,000\n$125,000\n$100,000,000\n$25,000,000\n$3,400,000,000\n$2,300,000,000\n$9,800,000\n$6,943\n$8,978\n$19,750,000\n$1,500,000\n$100,000\n$650,000,000\n$10,710\n$14,000,000\n$950,000,000\n$28,620\n$6,400\n$450,000\n$14,906\n$12,270\n$15,720\n$12,565\n$5,033,000\n$194,000\n$7,950\n$15,086\n$5,259\n$100,000,000\n$118,000,000\n$25,000,000\n$390,000,000\n$51,594\n$422,500,000\n$10,001\n$72,500,000\n$25,000,000\n$9,030,149\n$9,000,000\n$3,400,000\n$81,000,000\n$67,000,000\n$4,000,000\n$45,000,000\n$253,000\n$3,750,000\n$15,022\n$49,000,000\n$2,300,000,000\n$784,600,000\n$55,000,000\n$26,339,944\n$14,500,000\n$975,000\n$11,250\n$728,000\n$15,000,000\n$6,800\n$5,650\n$31,000\n$500,000,000\n$506,035\n$280,000,000\n$12,640,000\n$230,000\n$109,000,000\n$19,868,194\n$750,000,000\n$6,000\n$27,000,000\n$8,200\n$345,000,000\n$1,000,000\n$500,000\n$22,000,000\n$12,000,000\n$85,000,000\n$44,300,000\n$704,000,000\n$350,000,000\n$56,500,000\n$1,760,000\n$17,662\n$16,000,000\n$3,725,000\n$3,650,000\n$875,000,000\n$283,177,348\n$2,250,000\n$236,000,000\n$27,600,000\n$236,827\n$11,550\n$9,600\n$5,400\n$41,613\n$6,376\n$6,750\n$5,000\n$7,155\n$6,375\n$6,750\n$11,278\n$65,250\n$132,300\n$19,775\n$15,120\n$14,000\n$5,610\n$7,560\n$8,100\n$25,600\n$7,200\n$34,000,000\n$5,000\n$5,000\n$5,000\n$13,200\n$7,700\n$136,800\n$24,368\n$172,900\n$449,740\n$338,475\n$900,000\n$2,250,000\n$25,033\n$55,000\n$106,749\n$80,160\n$285,000\n$5,000\n$5,000\n$34,170\n$30,800\n$62,780\n$135,756\n$12,000\n$151,603\n$337,500\n$29,737\n$475,672\n$6,500\n$676,250\n$162,595\n$5,000\n$159,672\n$5,000\n$5,000\n$17,600\n$30,880\n$6,100\n$40,950\n$2,200,000\n$21,125\n$5,000\n$5,000\n$8,400\n$77,643\n$317,550\n$69,274\n$26,797\n$1,500,000\n$6,075,000\n$61,158\n$6,035\n$728,000\n$90,000\n$130,000\n$260,000\n$24,650\n$10,001\n$105,000\n$11,500\n$8,125\n$77,000\n$52,000\n$66,770\n$10,000\n$44,500\n$82,467\n$55,000\n$20,000\n$2,328,154\n$33,700\n$37,000\n$68,992\n$20,000\n$20,025\n$49,000\n$95,000\n$54,100\n$27,168\n$20,500\n$90,000\n$12,500\n$25,000\n$39,000\n$9,000\n$385,000\n$2,681,500\n$526,500\n$975,000\n$22,500\n$19,538\n$13,653\n$83,871\n$40,959\n$9,832\n$5,775\n$7,900\n$15,422\n$18,565\n$125,000,000\n$430,000,000\n$18,000\n$23,632\n$7,853\n$6,652\n$6,518\n$6,791\n$9,600\n$19,070\n$26,725\n$9,620\n$5,000\n$14,700\n$7,140\n$7,000\n$7,500\n$18,876,624\n$490,900,000\n$40,187\n$5,800\n$6,078\n$8,213\n$10,115\n$58,650,000\n$465,000,000\n$35,000,000\n$47,000,000\n$600,000,000\n$500,000,000\n$36,900,000\n$13,023,885\n$4,100,000\n$7,550,000\n$280,000,000\n$54,000,000\n$3,500,000\n$410,000,000\n$1,725,000\n$669,800\n$149,000,000\n$6,140,000\n$24,647,876\n$511,000\n$84,700,000\n$20,000,000\n$461,900,000\n$19,700,000\n$15,000,000\n$435,000,000\n$300,000,000\n$5,600,000\n$23,193,600\n$22,500\n$5,000,000\n$210,000,000\n$75,000\n$116,703\n$5,641\n$16,215\n$5,909\n$9,440\n$10,788\n$12,367\n$116,503\n$33,200,000\n$5,500\n$6,500\n$15,000\n$30,000\n$8,000\n$11,000\n$15,000\n$59,500\n$25,000\n$3,500,000\n$5,000,000\n$225,000\n$99,000,000\n$2,100,000\n$2,600,000\n$7,500\n$65,000\n$65,000\n$33,750\n$5,000\n$23,850,000\n$120,000\n$261,782\n$25,200,000\n$360,000,000\n$350,000\n$15,360,000\n$545,833\n$1,365,003\n$175,000,000\n$8,000,000\n$650,561\n$8,200,000\n$7,150,000\n$4,000,000\n$6,750,000\n$210,000\n$283,701\n$25,000,000\n$1,925,000\n$2,092,634\n$12,250,000\n$10,400,000\n$2,000,000\n$49,500,000\n$2,750,000\n$41,220,000\n$8,500,000\n$8,510\n$225,000,000\n$100,000,000\n$24,750,000\n$57,000,000\n$52,600,000\n$13,000,000\n$10,001\n$60,000,000\n$32,500,000\n$339,148,643\n$15,350,000\n$14,833,333\n$6,200,000\n$50,000\n$6,950,000\n$22,500,000\n$1,340,000\n$28,000,000\n$25,000\n$357,000\n$1,000,000\n$1,800,000\n$4,000,000\n$3,600,000\n$29,230,000\n$2,700,000\n$4,860,779\n$2,000,000\n$14,750,000\n$8,900,000\n$600,000\n$10,200,000\n$2,010,667\n$750,000\n$3,500,000\n$7,200,000\n$2,000,000\n$612,000,000\n$71,000,000\n$11,000,000\n$357,000\n$2,400,000\n$12,968\n$325,000\n$1,800,000\n$40,000,000\n$4,000,000\n$1,130,000\n$3,100,000\n$807,826\n$5,500,000\n$5,391,000\n$14,700,000\n$110,000,000\n$46,500,000\n$68,500,000\n$24,900,000\n$2,600,000\n$218,092,993\n$2,500,000\n$3,333,333\n$7,000,000\n$40,000,000\n$14,833,333\n$10,645,600\n$1,300,000\n$40,000,000\n$1,650,000\n$2,290,000\n$2,000,000\n$5,900,000\n$17,500,000\n$357,000\n$10,000\n$200,000\n$3,250,000\n$10,000,000\n$13,500,000\n$7,750,000\n$4,500,000\n$1,800,000\n$357,000\n$1,400,000\n$95,000,000\n$187,000,000\n$19,500,000\n$55,000,000\n$11,000,000\n$27,600,000\n$100,000,000\n$1,100,000\n$1,600,000\n$1,738,719\n$20,700,000\n$125,000,000\n$116,000,000\n$6,150,000\n$7,500,000\n$5,000,000\n$4,340,100\n$1,446,700\n$111,167\n$39,000,000\n$11,000,000\n$4,000,000\n$3,000,000\n$2,500,000\n$2,932,000\n$4,000,000\n$850,000\n$4,750,000\n$3,900,000\n$198,000\n$2,000,000\n$600,000\n$1,150,000\n$1,800,000\n$1,072,700\n$3,500,000\n$2,900,000\n$670,000\n$9,000,000\n$2,000,000\n$7,634,700\n$1,000,000\n$2,544,900\n$111,167\n$4,658,249\n$43,399,040\n$18,500,000\n$18,500,000\n$1,650,000\n$20,000,000\n$160,000\n$25,100,000\n$13,000,000\n$361,828,456\n$62,000,000\n$44,300,000\n$173,000,000\n$39,000,000\n$200,000\n$2,300,000\n$760,000\n$18,170,000\n$724,998\n$14,833,333\n$3,000,000\n$3,000,000\n$2,500,000\n$790,000\n$60,000,000\n$1,750,000\n$2,200,000\n$19,000,000\n$15,350,000\n$22,280,000\n$250,000\n$40,000,000\n$10,000,000\n$477,792,391\n$418,952\n$2,600,000\n$4,250,000\n$3,700,000\n$661,860\n$10,000,000\n$90,000,000\n$3,333,333\n$70,000,000\n$14,000,000\n$3,500,000\n$40,750,000\n$105,000,000\n$142,494,000\n$47,498,000\n$111,167\n$357,000\n$6,000,000\n$1,100,000\n$4,450,000\n$500,000\n$6,700,000\n$390,253\n$5,400,000\n$5,900,000\n$7,000,000\n$181,000,000\n$15,100,000\n$120,000,000\n$33,000,000\n$541,000,000\n$158,000,000\n$9,900,000\n$10,000,000\n$5,200,000\n$60,000,000\n$2,000,000\n$4,475,000\n$124,000,000\n$826,957\n$4,454,432\n$3,000,000\n$17,000,000\n$30,600,000\n$15,400,000\n$3,500,000\n$100,000,000\n$500,000\n$52,000\n$4,000,000\n$290,000,000\n$8,250,000\n$5,400,000\n$58,000,000\n$24,000,000\n$4,250,000\n$2,275,454\n$28,000,000\n$201,975,000\n$1,600,000\n$6,000,000\n$465,000,000\n$2,600,000\n$108,000,000\n$23,000,000\n$625,000\n$6,500,000\n$118,000,000\n$250,000\n$250,000\n$7,000,000\n$750,000\n$2,750,000\n$83,129,754\n$88,258,694\n$3,333,333\n$29,000,000\n$6,638,250\n$3,320,963\n$3,574,209\n$31,000,000\n$36,000,000\n$24,681,516\n$3,400,000\n$33,500,000\n$2,200,000\n$10,000\n$1,700,000\n$6,000,000\n$2,010,667\n$22,500,000\n$1,700,000\n$4,500,000\n$500,000\n$154,000,000\n$800,000\n$2,000,000\n$750,000\n$6,000,000\n$35,000,000\n$975,000\n$21,084,700\n$2,621,154\n$60,000,000\n$375,000\n$18,170,000\n$2,900,000\n$42,900,000\n$700,000\n$331,485,170\n$3,340,000\n$8,200,000\n$400,000\n$2,500,000\n$29,453,247\n$1,600,000\n$160,000,000\n$1,047,787\n$19,500,000\n$24,000,000\n$270,000,000\n$2,150,000\n$75,000\n$600,000\n$2,010,667\n$266,729,715\n$5,000,000\n$2,300,000\n$150,000\n$17,875,000\n$2,400,000\n$8,500,000\n$357,000\n$3,100,000\n$9,500,000\n$7,470,000\n$16,000,000\n$13,100,000\n$1,650,000\n$30,110,618\n$617,000\n$1,600,000\n$828,500\n$163,560,000\n$5,000,000\n$31,000,000\n$27,000,000\n$292,969,482\n$91,602,000\n$21,300,000\n$9,756,164\n$262,000,000\n$14,833,333\n$4,000,000\n$6,104,000\n$20,786,034\n$10,000,000\n$1,400,000\n$236,000\n$17,551,650\n$5,850,550\n$111,167\n$2,000,000\n$3,750,000\n$5,240,797\n$525,780\n$198,000\n$600,000\n$798,000\n$25,516,440\n$5,000,000\n$8,750,000\n$69,000,000\n$7,000,000\n$85,000,000\n$14,833,333\n$2,402,793\n$12,100,000\n$70,000\n$10,000,000\n$150,000\n$6,500,000\n$1,900,000\n$169,000,000\n$3,350,000\n$5,500,000\n$9,893,322\n$2,275,454\n$145,000,000\n$5,500,000\n$10,600,000\n$190,000,000\n$750,000\n$4,300,000\n$70,000,000\n$1,700,000\n$2,400,000\n$33,408,547\n$11,300,000\n$371,351,180\n$257,400,000\n$115,874,895\n$13,747,929\n$13,747,929\n$14,708,388\n$7,089,034\n$54,653,931\n$49,505,368\n$21,280,356\n$41,047,101\n$18,960,210\n$5,833,333\n$116,860,000\n$7,000,000\n$289,755\n$30,000,000\n$506,000\n$85,000\n$30,000,000\n$190,000\n$9,500,000\n$180,000\n$54,805\n$6,200,000\n$4,750,000\n$11,850,000\n$195,000,000\n$200,000\n$1,600,000,000\n$8,750,000\n$24,100,000\n$3,900,000\n$30,000,000\n$1,100,000\n$1,875,000\n$11,800,000\n$111,824\n$20,750,000\n$589,000,000\n$642,000,000\n$233,000,000\n$10,000,000\n$103,000,000\n$3,500,000\n$379,089\n$45,000,000\n$21,000,000\n$112,800,000\n$3,500,000\n$24,000,000\n$8,344,000,000\n$97,000,000\n$11,000\n$9,394\n$80,000\n$80,000\n$45,000\n$36,571\n$25,616\n$6,720\n$12,000\n$5,000\n$28,400\n$9,476\n$15,018\n$495,000\n$416,248\n$39,000\n$20,000\n$31,266\n$40,224\n$22,000,000\n$15,000\n$5,000\n$40,000\n$12,500\n$96,000\n$210,000\n$45,000\n$12,800\n$6,188\n$20,000\n$17,000\n$13,200\n$600,000\n$11,600\n$15,500\n$15,000\n$14,625\n$6,000\n$36,836\n$10,800\n$8,000\n$32,400\n$6,000\n$19,000\n$99,800\n$11,900\n$5,950\n$25,000\n$8,000\n$6,000\n$5,250\n$8,000\n$8,900\n$10,000\n$5,600\n$9,000\n$6,000\n$15,000\n$7,000\n$6,200\n$12,000\n$31,360\n$23,025\n$28,000\n$8,000\n$14,200\n$14,000\n$5,000\n$8,625\n$41,350\n$6,000\n$21,250\n$24,200\n$45,000\n$7,499\n$30,700\n$32,000\n$15,000\n$7,500\n$20,925\n$17,290\n$300,000,000\n$527,144\n$12,600,000\n$75,000,000\n$9,000\n$7,000\n$7,000\n$7,000\n$15,300\n$9,000\n$18,000\n$18,300\n$5,700\n$90,140\n$31,600\n$5,000\n$18,300\n$20,055\n$11,240\n$7,125\n$18,225\n$18,500\n$195,000\n$9,225\n$10,950\n$5,000\n$27,000,000\n$38,750,000\n$15,000,000\n$10,000,000,000\n$75,000,000\n$5,000,000,000\n$50,000,000\n$20,000\n"
     ]
    }
   ],
   "source": [
    "#likewise, let's initiate values in the column \"Penalty_Amount\"\n",
    "Penalty_Amount = pharma_rdd_without_header.map(lambda row: parse_csv_row(row)[2])\n",
    "\n",
    "# Display the column values\n",
    "for value in Penalty_Amount.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c480319d-6bea-46e6-8225-c8e9faa1e507",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'Penalty_Amount': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = Penalty_Amount.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'Penalty_Amount':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "356b76b5-2c04-4d08-a84d-708d4495f2ac",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$136,800\n$0\n$172,900\n$0\n$300,000\n$0\n$2,250,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$2,200,000\n$0\n$0\n$0\n$0\n$0\n$317,550\n$0\n$0\n$1,500,000\n$0\n$0\n$0\n$728,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$2,328,154\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$385,000\n$2,681,500\n$0\n$975,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$32,500,000\n$239,148,643\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$1,800,000\n$0\n$0\n$0\n$2,700,000\n$4,860,779\n$0\n$14,750,000\n$8,900,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$612,000,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$3,100,000\n$0\n$0\n$0\n$0\n$0\n$46,500,000\n$0\n$24,900,000\n$2,600,000\n$218,092,993\n$0\n$0\n$0\n$40,000,000\n$0\n$10,645,600\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$95,000,000\n$187,000,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$20,700,000\n$0\n$116,000,000\n$0\n$7,500,000\n$0\n$0\n$0\n$0\n$0\n$11,000,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$4,658,249\n$43,399,040\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$361,828,456\n$0\n$44,300,000\n$173,000,000\n$39,000,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$2,500,000\n$0\n$60,000,000\n$0\n$2,200,000\n$0\n$0\n$22,280,000\n$0\n$0\n$10,000,000\n$477,792,391\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$5,900,000\n$0\n$0\n$0\n$6,700,000\n$390,253\n$5,400,000\n$0\n$0\n$0\n$0\n$0\n$0\n$541,000,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$124,000,000\n$0\n$4,454,432\n$0\n$17,000,000\n$0\n$0\n$3,500,000\n$100,000,000\n$0\n$0\n$4,000,000\n$290,000,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$201,975,000\n$0\n$0\n$465,000,000\n$0\n$100,000,000\n$0\n$0\n$0\n$118,000,000\n$0\n$0\n$0\n$0\n$0\n$83,129,754\n$88,258,694\n$0\n$29,000,000\n$0\n$3,320,963\n$3,574,209\n$0\n$0\n$24,681,516\n$3,400,000\n$0\n$2,200,000\n$0\n$1,700,000\n$0\n$0\n$22,500,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$21,084,700\n$2,621,154\n$0\n$0\n$0\n$0\n$0\n$0\n$331,485,170\n$0\n$0\n$0\n$0\n$0\n$0\n$160,000,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$266,729,715\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$7,470,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$163,560,000\n$0\n$0\n$27,000,000\n$292,969,482\n$91,602,000\n$0\n$9,756,164\n$262,000,000\n$0\n$0\n$6,104,000\n$20,786,034\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$25,516,440\n$0\n$0\n$0\n$0\n$0\n$0\n$2,402,793\n$12,100,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$9,893,322\n$0\n$0\n$0\n$10,600,000\n$190,000,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$371,351,180\n$257,400,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$7,000,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$103,000,000\n$0\n$0\n$0\n$3,500,000\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n$0\n"
     ]
    }
   ],
   "source": [
    "#likewise, let's initiate values in the column \"subtraction_from_penalty\"\n",
    "subtraction_from_penalty = pharma_rdd_without_header.map(lambda row: parse_csv_row(row)[3])\n",
    "\n",
    "# Display the column values\n",
    "for value in subtraction_from_penalty.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f0146633-f1c7-4cdd-bb08-b2d9d421162d",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'subtraction_from_penalty': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = subtraction_from_penalty.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'subtraction_from_penalty':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "503be230-ab2c-4bdb-9184-1328aaa6d2d1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "$5,475,000\n$1,500,000,000\n$126,500,000\n$49,045\n$18,000,000\n$16,800\n$2,950,000\n$136,800\n$1,200,000\n$10,572\n$600,000,000\n$15,000,000\n$42,500,000\n$2,500,000\n$160,203\n$762,000,000\n$24,900,000\n$40,000\n$99,000\n$7,300,000\n$250,000\n$520,000,000\n$46,500,000\n$7,900,000\n$2,600,000\n$354,900,000\n$5,522,000\n$95,500,000\n$190,000,000\n$4,000,000\n$6,934\n$49,600\n$10,000,000\n$10,001\n$352,773\n$95,000,000\n$50,000\n$300,000\n$68,475\n$14,000,000\n$3,650,000\n$1,000,000\n$2,100,000\n$515,000,000\n$150,000,000\n$16,200\n$18,560\n$15,820\n$425,000,000\n$7,500,000\n$1,200,000,000\n$10,001\n$168,500\n$2,800,000\n$39,000,000\n$11,000,000\n$280,000,000\n$18,500,000\n$6,600\n$11,000,000\n$31,000\n$203,000,000\n$15,000,000\n$1,415,000,000\n$36,000,000\n$29,398,734\n$13,170\n$7,614\n$8,250\n$44,000\n$385,000\n$2,681,500\n$192,700,000\n$39,000,000\n$3,500,000\n$27,600,000\n$5,900\n$38,000,000\n$164,000,000\n$26,956\n$200,000\n$33,500,000\n$22,280,000\n$32,587,439\n$150,000,000\n$3,000,000,000\n$317,550\n$20,000,000\n$172,900\n$8,680\n$12,000,000\n$400,000\n$5,500\n$1,000,000\n$10,001\n$5,900,000\n$59,085\n$33,500,000\n$14,000,000\n$2,200,000,000\n$48,600,000\n$21,400,000\n$3,900,000\n$124,000,000\n$2,200,000\n$41,500,000\n$17,000,000\n$24,920\n$15,000,000\n$20,000,000\n$1,176,576\n$10,000\n$35,000,000\n$125,000\n$100,000,000\n$25,000,000\n$3,400,000,000\n$2,300,000,000\n$9,800,000\n$6,943\n$8,978\n$19,750,000\n$1,500,000\n$100,000\n$650,000,000\n$10,710\n$14,000,000\n$950,000,000\n$28,620\n$6,400\n$450,000\n$14,906\n$12,270\n$15,720\n$12,565\n$5,033,000\n$194,000\n$7,950\n$15,086\n$5,259\n$100,000,000\n$118,000,000\n$25,000,000\n$390,000,000\n$51,594\n$422,500,000\n$10,001\n$72,500,000\n$25,000,000\n$9,030,149\n$9,000,000\n$3,400,000\n$81,000,000\n$67,000,000\n$4,000,000\n$45,000,000\n$253,000\n$3,750,000\n$15,022\n$49,000,000\n$2,300,000,000\n$784,600,000\n$55,000,000\n$26,339,944\n$14,500,000\n$975,000\n$11,250\n$728,000\n$15,000,000\n$6,800\n$5,650\n$31,000\n$500,000,000\n$506,035\n$280,000,000\n$12,640,000\n$230,000\n$109,000,000\n$19,868,194\n$750,000,000\n$6,000\n$27,000,000\n$8,200\n$345,000,000\n$1,000,000\n$500,000\n$22,000,000\n$12,000,000\n$85,000,000\n$44,300,000\n$704,000,000\n$350,000,000\n$56,500,000\n$1,760,000\n$17,662\n$16,000,000\n$3,725,000\n$3,650,000\n$875,000,000\n$283,177,348\n$2,250,000\n$236,000,000\n$27,600,000\n$236,827\n$11,550\n$9,600\n$5,400\n$41,613\n$6,376\n$6,750\n$5,000\n$7,155\n$6,375\n$6,750\n$11,278\n$65,250\n$132,300\n$19,775\n$15,120\n$14,000\n$5,610\n$7,560\n$8,100\n$25,600\n$7,200\n$34,000,000\n$5,000\n$5,000\n$5,000\n$13,200\n$7,700\n$0\n$24,368\n$0\n$449,740\n$38,475\n$900,000\n$0\n$25,033\n$55,000\n$106,749\n$80,160\n$285,000\n$5,000\n$5,000\n$34,170\n$30,800\n$62,780\n$135,756\n$12,000\n$151,603\n$337,500\n$29,737\n$475,672\n$6,500\n$676,250\n$162,595\n$5,000\n$159,672\n$5,000\n$5,000\n$17,600\n$30,880\n$6,100\n$40,950\n$0\n$21,125\n$5,000\n$5,000\n$8,400\n$77,643\n$0\n$69,274\n$26,797\n$0\n$6,075,000\n$61,158\n$6,035\n$0\n$90,000\n$130,000\n$260,000\n$24,650\n$10,001\n$105,000\n$11,500\n$8,125\n$77,000\n$52,000\n$66,770\n$10,000\n$44,500\n$82,467\n$55,000\n$20,000\n$0\n$33,700\n$37,000\n$68,992\n$20,000\n$20,025\n$49,000\n$95,000\n$54,100\n$27,168\n$20,500\n$90,000\n$12,500\n$25,000\n$39,000\n$9,000\n$0\n$0\n$526,500\n$0\n$22,500\n$19,538\n$13,653\n$83,871\n$40,959\n$9,832\n$5,775\n$7,900\n$15,422\n$18,565\n$125,000,000\n$430,000,000\n$18,000\n$23,632\n$7,853\n$6,652\n$6,518\n$6,791\n$9,600\n$19,070\n$26,725\n$9,620\n$5,000\n$14,700\n$7,140\n$7,000\n$7,500\n$18,876,624\n$490,900,000\n$40,187\n$5,800\n$6,078\n$8,213\n$10,115\n$58,650,000\n$465,000,000\n$35,000,000\n$47,000,000\n$600,000,000\n$500,000,000\n$36,900,000\n$13,023,885\n$4,100,000\n$7,550,000\n$280,000,000\n$54,000,000\n$3,500,000\n$410,000,000\n$1,725,000\n$669,800\n$149,000,000\n$6,140,000\n$24,647,876\n$511,000\n$84,700,000\n$20,000,000\n$461,900,000\n$19,700,000\n$15,000,000\n$435,000,000\n$300,000,000\n$5,600,000\n$23,193,600\n$22,500\n$5,000,000\n$210,000,000\n$75,000\n$116,703\n$5,641\n$16,215\n$5,909\n$9,440\n$10,788\n$12,367\n$116,503\n$33,200,000\n$5,500\n$6,500\n$15,000\n$30,000\n$8,000\n$11,000\n$15,000\n$59,500\n$25,000\n$3,500,000\n$5,000,000\n$225,000\n$99,000,000\n$2,100,000\n$2,600,000\n$7,500\n$65,000\n$65,000\n$33,750\n$5,000\n$23,850,000\n$120,000\n$261,782\n$25,200,000\n$360,000,000\n$350,000\n$15,360,000\n$545,833\n$1,365,003\n$175,000,000\n$8,000,000\n$650,561\n$8,200,000\n$7,150,000\n$4,000,000\n$6,750,000\n$210,000\n$283,701\n$25,000,000\n$1,925,000\n$2,092,634\n$12,250,000\n$10,400,000\n$2,000,000\n$49,500,000\n$2,750,000\n$41,220,000\n$8,500,000\n$8,510\n$225,000,000\n$100,000,000\n$24,750,000\n$57,000,000\n$52,600,000\n$13,000,000\n$10,001\n$60,000,000\n$0\n$100,000,000\n$15,350,000\n$14,833,333\n$6,200,000\n$50,000\n$6,950,000\n$22,500,000\n$1,340,000\n$28,000,000\n$25,000\n$357,000\n$1,000,000\n$0\n$4,000,000\n$3,600,000\n$29,230,000\n$0\n$0\n$2,000,000\n$0\n$0\n$600,000\n$10,200,000\n$2,010,667\n$750,000\n$3,500,000\n$7,200,000\n$2,000,000\n$0\n$71,000,000\n$11,000,000\n$357,000\n$2,400,000\n$12,968\n$325,000\n$1,800,000\n$40,000,000\n$4,000,000\n$1,130,000\n$0\n$807,826\n$5,500,000\n$5,391,000\n$14,700,000\n$110,000,000\n$0\n$68,500,000\n$0\n$0\n$0\n$2,500,000\n$3,333,333\n$7,000,000\n$0\n$14,833,333\n$0\n$1,300,000\n$40,000,000\n$1,650,000\n$2,290,000\n$2,000,000\n$5,900,000\n$17,500,000\n$357,000\n$10,000\n$200,000\n$3,250,000\n$10,000,000\n$13,500,000\n$7,750,000\n$4,500,000\n$1,800,000\n$357,000\n$1,400,000\n$0\n$0\n$19,500,000\n$55,000,000\n$11,000,000\n$27,600,000\n$100,000,000\n$1,100,000\n$1,600,000\n$1,738,719\n$0\n$125,000,000\n$0\n$6,150,000\n$0\n$5,000,000\n$4,340,100\n$1,446,700\n$111,167\n$39,000,000\n$0\n$4,000,000\n$3,000,000\n$2,500,000\n$2,932,000\n$4,000,000\n$850,000\n$4,750,000\n$3,900,000\n$198,000\n$2,000,000\n$600,000\n$1,150,000\n$1,800,000\n$1,072,700\n$3,500,000\n$2,900,000\n$670,000\n$9,000,000\n$2,000,000\n$7,634,700\n$1,000,000\n$2,544,900\n$111,167\n$0\n$0\n$18,500,000\n$18,500,000\n$1,650,000\n$20,000,000\n$160,000\n$25,100,000\n$13,000,000\n$0\n$62,000,000\n$0\n$0\n$0\n$200,000\n$2,300,000\n$760,000\n$18,170,000\n$724,998\n$14,833,333\n$3,000,000\n$3,000,000\n$0\n$790,000\n$0\n$1,750,000\n$0\n$19,000,000\n$15,350,000\n$0\n$250,000\n$40,000,000\n$0\n$0\n$418,952\n$2,600,000\n$4,250,000\n$3,700,000\n$661,860\n$10,000,000\n$90,000,000\n$3,333,333\n$70,000,000\n$14,000,000\n$3,500,000\n$40,750,000\n$105,000,000\n$142,494,000\n$47,498,000\n$111,167\n$357,000\n$100,000\n$1,100,000\n$4,450,000\n$500,000\n$0\n$0\n$0\n$5,900,000\n$7,000,000\n$181,000,000\n$15,100,000\n$120,000,000\n$33,000,000\n$0\n$158,000,000\n$9,900,000\n$10,000,000\n$5,200,000\n$60,000,000\n$2,000,000\n$4,475,000\n$0\n$826,957\n$0\n$3,000,000\n$0\n$30,600,000\n$15,400,000\n$0\n$0\n$500,000\n$52,000\n$0\n$0\n$8,250,000\n$5,400,000\n$58,000,000\n$24,000,000\n$4,250,000\n$2,275,454\n$28,000,000\n$0\n$1,600,000\n$6,000,000\n$0\n$2,600,000\n$8,000,000\n$23,000,000\n$625,000\n$6,500,000\n$0\n$250,000\n$250,000\n$7,000,000\n$750,000\n$2,750,000\n$0\n$0\n$3,333,333\n$0\n$6,638,250\n$0\n$0\n$31,000,000\n$36,000,000\n$0\n$0\n$33,500,000\n$0\n$10,000\n$0\n$6,000,000\n$2,010,667\n$0\n$1,700,000\n$4,500,000\n$500,000\n$154,000,000\n$800,000\n$2,000,000\n$750,000\n$6,000,000\n$35,000,000\n$975,000\n$0\n$0\n$60,000,000\n$375,000\n$18,170,000\n$2,900,000\n$42,900,000\n$700,000\n$0\n$3,340,000\n$8,200,000\n$400,000\n$2,500,000\n$29,453,247\n$1,600,000\n$0\n$1,047,787\n$19,500,000\n$24,000,000\n$270,000,000\n$2,150,000\n$75,000\n$600,000\n$2,010,667\n$0\n$5,000,000\n$2,300,000\n$150,000\n$17,875,000\n$2,400,000\n$8,500,000\n$357,000\n$3,100,000\n$9,500,000\n$0\n$16,000,000\n$13,100,000\n$1,650,000\n$30,110,618\n$617,000\n$1,600,000\n$828,500\n$0\n$5,000,000\n$31,000,000\n$0\n$0\n$0\n$21,300,000\n$0\n$0\n$14,833,333\n$4,000,000\n$0\n$0\n$10,000,000\n$1,400,000\n$236,000\n$17,551,650\n$5,850,550\n$111,167\n$2,000,000\n$3,750,000\n$5,240,797\n$525,780\n$198,000\n$600,000\n$798,000\n$0\n$5,000,000\n$8,750,000\n$69,000,000\n$7,000,000\n$85,000,000\n$14,833,333\n$0\n$0\n$70,000\n$10,000,000\n$150,000\n$6,500,000\n$1,900,000\n$169,000,000\n$3,350,000\n$5,500,000\n$0\n$2,275,454\n$145,000,000\n$5,500,000\n$0\n$0\n$750,000\n$4,300,000\n$70,000,000\n$1,700,000\n$2,400,000\n$33,408,547\n$11,300,000\n$0\n$0\n$115,874,895\n$13,747,929\n$13,747,929\n$14,708,388\n$7,089,034\n$54,653,931\n$49,505,368\n$21,280,356\n$41,047,101\n$18,960,210\n$5,833,333\n$116,860,000\n$0\n$289,755\n$30,000,000\n$506,000\n$85,000\n$30,000,000\n$190,000\n$9,500,000\n$180,000\n$54,805\n$6,200,000\n$4,750,000\n$11,850,000\n$195,000,000\n$200,000\n$1,600,000,000\n$8,750,000\n$24,100,000\n$3,900,000\n$30,000,000\n$1,100,000\n$1,875,000\n$11,800,000\n$111,824\n$20,750,000\n$589,000,000\n$539,000,000\n$233,000,000\n$10,000,000\n$103,000,000\n$0\n$379,089\n$45,000,000\n$21,000,000\n$112,800,000\n$3,500,000\n$24,000,000\n$8,344,000,000\n$97,000,000\n$11,000\n$9,394\n$80,000\n$80,000\n$45,000\n$36,571\n$25,616\n$6,720\n$12,000\n$5,000\n$28,400\n$9,476\n$15,018\n$495,000\n$416,248\n$39,000\n$20,000\n$31,266\n$40,224\n$22,000,000\n$15,000\n$5,000\n$40,000\n$12,500\n$96,000\n$210,000\n$45,000\n$12,800\n$6,188\n$20,000\n$17,000\n$13,200\n$600,000\n$11,600\n$15,500\n$15,000\n$14,625\n$6,000\n$36,836\n$10,800\n$8,000\n$32,400\n$6,000\n$19,000\n$99,800\n$11,900\n$5,950\n$25,000\n$8,000\n$6,000\n$5,250\n$8,000\n$8,900\n$10,000\n$5,600\n$9,000\n$6,000\n$15,000\n$7,000\n$6,200\n$12,000\n$31,360\n$23,025\n$28,000\n$8,000\n$14,200\n$14,000\n$5,000\n$8,625\n$41,350\n$6,000\n$21,250\n$24,200\n$45,000\n$7,499\n$30,700\n$32,000\n$15,000\n$7,500\n$20,925\n$17,290\n$300,000,000\n$527,144\n$12,600,000\n$75,000,000\n$9,000\n$7,000\n$7,000\n$7,000\n$15,300\n$9,000\n$18,000\n$18,300\n$5,700\n$90,140\n$31,600\n$5,000\n$18,300\n$20,055\n$11,240\n$7,125\n$18,225\n$18,500\n$195,000\n$9,225\n$10,950\n$5,000\n$27,000,000\n$38,750,000\n$15,000,000\n$10,000,000,000\n$75,000,000\n$5,000,000,000\n$50,000,000\n$20,000\n"
     ]
    }
   ],
   "source": [
    "#likewise, let's initiate values in the column \"penalty_amount_adjusted_for_eliminating_multiple_counting\"\n",
    "penalty_amount_adjusted_for_eliminating_multiple_counting = pharma_rdd_without_header.map(lambda row: parse_csv_row(row)[4])\n",
    "\n",
    "# Display the column values\n",
    "for value in penalty_amount_adjusted_for_eliminating_multiple_counting.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "349095cf-9425-4bbd-bbfd-d246cd1d2aed",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'penalty_amount_adjusted_for_eliminating_multiple_counting': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = penalty_amount_adjusted_for_eliminating_multiple_counting.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'penalty_amount_adjusted_for_eliminating_multiple_counting':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "1ff61611-bf54-4b4d-addc-a8d4aa33efe4",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2013\n2012\n2010\n2009\n2016\n2004\n2007\n2014\n2013\n2017\n2010\n2017\n2010\n2004\n2004\n2012\n2013\n2011\n2015\n2014\n2011\n2010\n2015\n2015\n2009\n2003\n2016\n2009\n2007\n2016\n2005\n2009\n2008\n2012\n2011\n2012\n2004\n2011\n2012\n2015\n2008\n2007\n2009\n2007\n2004\n2004\n2006\n2005\n2008\n2015\n2015\n2011\n2004\n2012\n2015\n2012\n2010\n2003\n2004\n2010\n2005\n2010\n2005\n2009\n2005\n2012\n2004\n2006\n2007\n2007\n2017\n2013\n2014\n2015\n2010\n2010\n2017\n2016\n2011\n2004\n2017\n2016\n2013\n2015\n2005\n2012\n2014\n2016\n2014\n2015\n2003\n2015\n2004\n2002\n2001\n2015\n2014\n2013\n2009\n2013\n2011\n2011\n2001\n2005\n2013\n2010\n2011\n2011\n2001\n2018\n2007\n2007\n2017\n2000\n2017\n2015\n2006\n2007\n2007\n2016\n2003\n2007\n2011\n2008\n2008\n2009\n2000\n2011\n2006\n2007\n2005\n2016\n2014\n2009\n2007\n2006\n2006\n2005\n2000\n2016\n2000\n2009\n2016\n2015\n2013\n2010\n2006\n2010\n2011\n2009\n2009\n2009\n2010\n2016\n2008\n2013\n2012\n2004\n2014\n2002\n2009\n2016\n2012\n2012\n2011\n2008\n2002\n2014\n2012\n2006\n2008\n2012\n2013\n2014\n2010\n2015\n2011\n2012\n2017\n2010\n2006\n2004\n2007\n2004\n2003\n2004\n2010\n2016\n2011\n2011\n2005\n2017\n2014\n2002\n2009\n2011\n2010\n2012\n2001\n2016\n2013\n2016\n2014\n2003\n2013\n2012\n2013\n2010\n2010\n2010\n2008\n2009\n2007\n2006\n2006\n2006\n2004\n2003\n2002\n2002\n2003\n2003\n2002\n2001\n2001\n2011\n2004\n2000\n2000\n2000\n2004\n2014\n2007\n2014\n2013\n2012\n2011\n2013\n2008\n2007\n2006\n2004\n2018\n2018\n2018\n2017\n2015\n2015\n2011\n2009\n2008\n2011\n2006\n2006\n2006\n2005\n2004\n2004\n2003\n2000\n2000\n2001\n2013\n2010\n2007\n2013\n2005\n2000\n2000\n2016\n2014\n2014\n2012\n2009\n2011\n2008\n2003\n2013\n2014\n2011\n2011\n2011\n2010\n2016\n2010\n2010\n2009\n2010\n2008\n2008\n2007\n2008\n2006\n2005\n2006\n2009\n2005\n2004\n2003\n2004\n2004\n2002\n2002\n2001\n2001\n2001\n2000\n2000\n2000\n2000\n2000\n2017\n2013\n2010\n2008\n2005\n2009\n2021\n2004\n2020\n2020\n2019\n2019\n2019\n2019\n2015\n2004\n2018\n2018\n2018\n2018\n2017\n2017\n2017\n2016\n2016\n2016\n2016\n2015\n2015\n2014\n2014\n2012\n2013\n2005\n2013\n2013\n2012\n2012\n2017\n2017\n2017\n2003\n2003\n2002\n2006\n2017\n2017\n2017\n2017\n2016\n2013\n2013\n2011\n2010\n2010\n2010\n2009\n2008\n2007\n2007\n2007\n2007\n2007\n2006\n2005\n2001\n2001\n2017\n2018\n2017\n2017\n2013\n2013\n2013\n2015\n2015\n2016\n2016\n2017\n2018\n2010\n2010\n2010\n2011\n2013\n2013\n2014\n2014\n2011\n2018\n2016\n2014\n2012\n2012\n2011\n2016\n2015\n2015\n2015\n2017\n2018\n2018\n2018\n2018\n2018\n2008\n2010\n2012\n2009\n2010\n2016\n2003\n2016\n2016\n2018\n2016\n2016\n2018\n2018\n2017\n2019\n2012\n2012\n2013\n2011\n2017\n2005\n2010\n2018\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2000\n2003\n2012\n2005\n2009\n2013\n2018\n2008\n2010\n2009\n2008\n2013\n2009\n2013\n2018\n2012\n2010\n2011\n2017\n2018\n2017\n2010\n2010\n2010\n2011\n2011\n2004\n2008\n2009\n2008\n2012\n2015\n2013\n2009\n2009\n2019\n2015\n2016\n2003\n2013\n2013\n2014\n2004\n2013\n2010\n2009\n2018\n2015\n2011\n2003\n2009\n2010\n2011\n2010\n2013\n2009\n2009\n2007\n2010\n2003\n2012\n2012\n2007\n2008\n2001\n2009\n2007\n2013\n2012\n2005\n2017\n2010\n2009\n2008\n2009\n2011\n2012\n2008\n2016\n2003\n2008\n2010\n2003\n2008\n2019\n2008\n2017\n2016\n2008\n2008\n2015\n2000\n2000\n2000\n2002\n2015\n2012\n2014\n2012\n2005\n2006\n2006\n2004\n2008\n2009\n2007\n2011\n2004\n2007\n2009\n2006\n2010\n2007\n2007\n2003\n2010\n2000\n2013\n2000\n2002\n2010\n2010\n2010\n2010\n2013\n2010\n2002\n2009\n2009\n2009\n2008\n2011\n2014\n2015\n2016\n2019\n2019\n2013\n2007\n2009\n2013\n2013\n2016\n2012\n2010\n2012\n2016\n2000\n2005\n2013\n2013\n2003\n2005\n2012\n2006\n2012\n2011\n2010\n2009\n2012\n2012\n2010\n2006\n2006\n2006\n2011\n2014\n2000\n2000\n2002\n2009\n2015\n2015\n2017\n2017\n2006\n2013\n2009\n2014\n2012\n2012\n2013\n2019\n2017\n2013\n2012\n2019\n2013\n2010\n2001\n2011\n2009\n2006\n2001\n2010\n2012\n2012\n2003\n2019\n2013\n2017\n2015\n2004\n2007\n2008\n2013\n2009\n2008\n2011\n2011\n2009\n2010\n2012\n2011\n2012\n2017\n2010\n2000\n2010\n2012\n2011\n2009\n2013\n2013\n2013\n2013\n2012\n2015\n2010\n2010\n2010\n2012\n2017\n2011\n2014\n2004\n2010\n2009\n2016\n2016\n2007\n2008\n2013\n2011\n2013\n2011\n2011\n2010\n2011\n2013\n2013\n2004\n2003\n2014\n2019\n2002\n2011\n2008\n2013\n2013\n2012\n2012\n2018\n2009\n2012\n2010\n2009\n2011\n2013\n2008\n2007\n2007\n2007\n2015\n2019\n2002\n2015\n2010\n2011\n2013\n2013\n2014\n2014\n2014\n2009\n2009\n2009\n2010\n2008\n2016\n2009\n2013\n2010\n2011\n2013\n2019\n2012\n2010\n2012\n2008\n2004\n2004\n2006\n2009\n2010\n2005\n2009\n2013\n2017\n2014\n2005\n2007\n2009\n2000\n2000\n2002\n2008\n2013\n2011\n2001\n2006\n2006\n2006\n2001\n2013\n2014\n2019\n2009\n2019\n2009\n2013\n2014\n2003\n2010\n2014\n2010\n2010\n2010\n2013\n2017\n2011\n2009\n2017\n2007\n2015\n2004\n2011\n2009\n2011\n2012\n2010\n2018\n2011\n2016\n2013\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2019\n2015\n2005\n2000\n2016\n2014\n2004\n2018\n2019\n2019\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2016\n2017\n2018\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2020\n2014\n2002\n2001\n2009\n2014\n2015\n2012\n2012\n2012\n2011\n2011\n2007\n2004\n2019\n2014\n2010\n2011\n2010\n2006\n2020\n2001\n2008\n2000\n2014\n2009\n2007\n2019\n2018\n2015\n2013\n2002\n2001\n2021\n2006\n2003\n2002\n2019\n2011\n2009\n2020\n2019\n2019\n2017\n2016\n2016\n2014\n2013\n2011\n2010\n2010\n2009\n2009\n2009\n2009\n2008\n2007\n2007\n2007\n2006\n2006\n2005\n2005\n2005\n2003\n2003\n2003\n2003\n2002\n2002\n2002\n2001\n2018\n2015\n2014\n2014\n2008\n2005\n2011\n2004\n2020\n2019\n2021\n2021\n2021\n2021\n2007\n2000\n2000\n2001\n2002\n2000\n2004\n2001\n2000\n2000\n2000\n2005\n2001\n2005\n2003\n2003\n2004\n2002\n2011\n2002\n2000\n2000\n2021\n2021\n2013\n2021\n2021\n2021\n2021\n2021\n"
     ]
    }
   ],
   "source": [
    "#likewise, let's initiate values in the column \"penalty_year\"\n",
    "penalty_year = pharma_rdd_without_header.map(lambda row: parse_csv_row(row)[5])\n",
    "\n",
    "# Display the column values\n",
    "for value in penalty_year.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c91f08ce-7c8b-45c3-96f1-52b123496588",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'penalty_year': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = penalty_year.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'penalty_year':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f3139eb1-7842-435f-94d8-25f0c9385695",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "20131227\n20120507\n20101207\n20090305\n20160722\n20040412\n20070702\n20140520\n20131204\n20170309\n20100901\n20170117\n20100316\n20040812\n20041226\n20121219\n20130416\n20110302\n20150930\n20140416\n20110606\n20100427\n20150706\n20150211\n20091019\n20030620\n20160830\n20090528\n20070910\n20160329\n20050617\n20090227\n20080324\n20120607\n20110801\n20121025\n20040630\n20111018\n20120924\n20151005\n20080708\n20070530\n20090331\n20070928\n20040804\n20041112\n20060913\n20050922\n20080929\n20150706\n20150528\n20110613\n20040604\n20120328\n20150109\n20120208\n20101220\n20030611\n20040806\n20101215\n20050620\n20101215\n20050208\n20090115\n20051221\n20121220\n20041229\n20060523\n20070202\n20070309\n20170206\n20130731\n20140221\n20151216\n20100222\n20100302\n20170401\n20161215\n20110302\n20041105\n20170410\n20160606\n20131220\n20150903\n20050920\n20120702\n20140811\n20160930\n20140915\n20150612\n20030206\n20151013\n20040604\n20021125\n20010518\n20150617\n20140829\n20130524\n20091103\n20131104\n20110407\n20110408\n20010921\n20051101\n20130628\n20101207\n20111206\n20110219\n20011114\n20180918\n20071024\n20070720\n20170711\n20001221\n20170118\n20150310\n20060911\n20070224\n20070508\n20161116\n20030307\n20071213\n20110928\n20080613\n20080207\n20091229\n20000505\n20111122\n20060802\n20070814\n20050302\n20160809\n20140303\n20090317\n20070710\n20061205\n20060615\n20050202\n20000401\n20161027\n20001129\n20091019\n20160323\n20151120\n20130225\n20100930\n20061106\n20100504\n20110610\n20090511\n20090511\n20091019\n20100429\n20160606\n20080327\n20130305\n20120627\n20040812\n20140614\n20021028\n20090902\n20160427\n20121212\n20120807\n20111021\n20080623\n20020529\n20140512\n20120807\n20060601\n20081215\n20120928\n20130513\n20140113\n20101207\n20150311\n20111216\n20121219\n20170403\n20101026\n20060411\n20040503\n20070514\n20040730\n20030909\n20040609\n20100429\n20160204\n20111005\n20110504\n20051017\n20170111\n20140924\n20021104\n20090601\n20110120\n20100604\n20120531\n20011003\n20161222\n20130314\n20161222\n20140311\n20030523\n20130104\n20120118\n20130515\n20100628\n20100114\n20100308\n20080730\n20090417\n20071026\n20060410\n20060629\n20061005\n20040701\n20030325\n20020425\n20020521\n20030128\n20030211\n20021107\n20010925\n20010124\n20110609\n20040831\n20001220\n20000929\n20001003\n20040205\n20140516\n20070925\n20140904\n20130124\n20120921\n20111220\n20130522\n20080918\n20070604\n20060713\n20040928\n20181231\n20180726\n20180726\n20171205\n20150928\n20150224\n20111214\n20091223\n20080915\n20110225\n20061220\n20060330\n20060519\n20050930\n20040816\n20040624\n20030421\n20001221\n20000929\n20011019\n20130611\n20100812\n20071009\n20130822\n20051007\n20001012\n20000905\n20161214\n20140930\n20140708\n20120918\n20091222\n20111117\n20080310\n20030828\n20130326\n20140508\n20110922\n20110914\n20110531\n20100727\n20160701\n20100917\n20100929\n20090414\n20100318\n20080731\n20080929\n20070514\n20080926\n20061016\n20050706\n20060210\n20090505\n20050211\n20040224\n20030820\n20040609\n20040127\n20020422\n20020313\n20010607\n20011130\n20011207\n20000728\n20001228\n20000925\n20000417\n20000512\n20170316\n20130725\n20101221\n20080721\n20050111\n20090505\n20210426\n20040530\n20201005\n20200428\n20190930\n20190918\n20190909\n20190206\n20151029\n20040513\n20181024\n20181016\n20180705\n20180702\n20170503\n20170216\n20170202\n20160815\n20160623\n20160308\n20160226\n20151104\n20150323\n20141001\n20140902\n20120807\n20130730\n20050630\n20130613\n20130430\n20120725\n20120424\n20170905\n20170817\n20170922\n20031110\n20031027\n20020501\n20061026\n20170928\n20170922\n20170908\n20170724\n20160609\n20130718\n20130103\n20110610\n20101004\n20100915\n20100521\n20090914\n20080805\n20070927\n20070713\n20070510\n20070402\n20070402\n20060829\n20050615\n20011217\n20011025\n20171023\n20180119\n20171220\n20170410\n20130418\n20130627\n20130912\n20151103\n20151103\n20160609\n20160609\n20170427\n20180323\n20100421\n20100721\n20101109\n20110103\n20130930\n20131023\n20140211\n20140401\n20110516\n20180416\n20161220\n20141008\n20120531\n20120521\n20110303\n20160824\n20151217\n20151217\n20150528\n20170524\n20180524\n20180828\n20180626\n20180904\n20181206\n20080328\n20100809\n20121107\n20091230\n20101130\n20161208\n20030721\n20160211\n20160711\n20180629\n20161101\n20160407\n20180305\n20181026\n20171113\n20190226\n20120531\n20121026\n20130521\n20111129\n20170404\n20051012\n20101216\n20180621\n20190605\n20190425\n20190425\n20190404\n20190404\n20190404\n20190318\n20001215\n20031027\n20120507\n20050614\n20090522\n20131118\n20181109\n20080919\n20100107\n20090528\n20080909\n20131204\n20091113\n20130207\n20181026\n20120207\n20100309\n20111228\n20170922\n20180323\n20170518\n20100901\n20100316\n20100527\n20110330\n20111024\n20040812\n20081223\n20090707\n20081222\n20121219\n20150818\n20130429\n20091113\n20090311\n20190509\n20150831\n20160624\n20030127\n20131118\n20131118\n20140416\n20040122\n20130207\n20100127\n20091015\n20180807\n20151104\n20110310\n20030630\n20091019\n20100427\n20110811\n20101006\n20131118\n20090528\n20090522\n20070910\n20100511\n20030127\n20120130\n20120605\n20071005\n20080225\n20010220\n20091113\n20070108\n20131118\n20120207\n20051128\n20171220\n20100420\n20090710\n20080922\n20091113\n20110923\n20121025\n20080715\n20161208\n20030424\n20081223\n20100929\n20030307\n20081223\n20190324\n20080625\n20170724\n20160804\n20080929\n20080929\n20151104\n20001103\n20001011\n20001010\n20020904\n20150316\n20120301\n20140702\n20120207\n20050719\n20060425\n20061128\n20040517\n20081223\n20090107\n20071219\n20110427\n20041104\n20070321\n20091113\n20061114\n20101129\n20070420\n20070329\n20030611\n20100917\n20001011\n20131118\n20001010\n20020904\n20101216\n20101216\n20100216\n20100204\n20131118\n20100407\n20020725\n20090929\n20091013\n20090115\n20081007\n20110504\n20140221\n20151216\n20160303\n20190725\n20190729\n20130104\n20070815\n20090522\n20131118\n20130213\n20161215\n20120608\n20100915\n20120511\n20160606\n20000127\n20050614\n20131220\n20131118\n20030416\n20050920\n20120702\n20060811\n20120417\n20110221\n20100128\n20091113\n20120207\n20121115\n20101006\n20060810\n20060328\n20060417\n20110624\n20140604\n20001011\n20001010\n20020904\n20091113\n20150618\n20150805\n20170818\n20171003\n20061026\n20130524\n20091103\n20140306\n20120613\n20120830\n20131104\n20190122\n20170524\n20131104\n20120119\n20190422\n20131118\n20101006\n20010522\n20111206\n20090302\n20060323\n20011114\n20101207\n20120504\n20120301\n20030411\n20190904\n20130718\n20170118\n20150729\n20040910\n20071212\n20080207\n20130222\n20090715\n20080520\n20111220\n20110328\n20091202\n20101006\n20120420\n20110929\n20120515\n20170817\n20101108\n20001129\n20101230\n20120130\n20110520\n20091019\n20131107\n20131107\n20131118\n20130710\n20120328\n20151120\n20100930\n20101006\n20100504\n20121030\n20170905\n20110610\n20141015\n20041021\n20100429\n20091019\n20160606\n20160606\n20070523\n20080327\n20131118\n20111024\n20130305\n20110329\n20110826\n20101220\n20110825\n20131118\n20131118\n20040812\n20030106\n20140806\n20190311\n20021028\n20111021\n20081022\n20131107\n20130104\n20121227\n20121212\n20181011\n20090902\n20120320\n20101006\n20090528\n20110218\n20130904\n20080219\n20070510\n20070918\n20070508\n20151223\n20190326\n20021101\n20150820\n20100527\n20111024\n20130513\n20131118\n20140708\n20140219\n20141016\n20090528\n20091209\n20091113\n20100324\n20081223\n20160609\n20090624\n20131118\n20101018\n20110906\n20130822\n20190324\n20120803\n20101026\n20120207\n20081031\n20040503\n20040730\n20060829\n20091217\n20100429\n20051017\n20090522\n20131118\n20170111\n20140924\n20050413\n20071116\n20090505\n20001011\n20001010\n20020904\n20081223\n20131118\n20110114\n20011219\n20060522\n20060517\n20060525\n20011005\n20131118\n20140811\n20190729\n20090105\n20190526\n20090522\n20130314\n20140311\n20030402\n20100813\n20140219\n20101006\n20100810\n20100721\n20131118\n20170519\n20110609\n20091202\n20171229\n20070613\n20151029\n20040513\n20110113\n20090528\n20110916\n20120716\n20100212\n20180129\n20110927\n20160427\n20130730\n20190926\n20191028\n20191028\n20191028\n20191028\n20191028\n20191028\n20191028\n20191028\n20191028\n20191028\n20191017\n20190930\n20190927\n20190927\n20150114\n20050525\n20001003\n20161025\n20141103\n20040901\n20180504\n20191203\n20191022\n20200228\n20200302\n20200127\n20200225\n20200110\n20200507\n20200504\n20160718\n20170905\n20180507\n20200914\n20200712\n20200824\n20200724\n20200701\n20200725\n20200724\n20200805\n20200729\n20200824\n20200731\n20200702\n20200625\n20200728\n20200806\n20201021\n20200923\n20140204\n20021110\n20010810\n20090501\n20141001\n20150224\n20121120\n20121001\n20120217\n20111121\n20110512\n20070807\n20041223\n20190108\n20141124\n20100525\n20111003\n20100929\n20060613\n20201217\n20010907\n20080325\n20001002\n20141229\n20090304\n20071015\n20190517\n20181217\n20151202\n20130328\n20021113\n20010430\n20210212\n20061206\n20030821\n20020829\n20190529\n20110316\n20091022\n20200623\n20190820\n20190318\n20170608\n20160707\n20160505\n20140331\n20130124\n20111004\n20100315\n20100222\n20091224\n20091009\n20090128\n20090116\n20080815\n20070411\n20070405\n20070329\n20060502\n20060124\n20050901\n20050426\n20050124\n20031226\n20031223\n20031023\n20030401\n20021227\n20021119\n20021119\n20010921\n20180403\n20150120\n20141006\n20140502\n20080717\n20050721\n20110216\n20040730\n20200325\n20190822\n20210427\n20210504\n20210504\n20210401\n20070829\n20000321\n20000607\n20010823\n20020828\n20000120\n20040617\n20010925\n20000128\n20000607\n20000711\n20051212\n20011115\n20050503\n20030116\n20030910\n20040809\n20021011\n20110121\n20021105\n20000912\n20000809\n20210708\n20210708\n20131217\n20210901\n20210817\n20210721\n20210910\n20210501\n"
     ]
    }
   ],
   "source": [
    "#likewise, let's initiate values in the column \"penalty_date\"\n",
    "penalty_date = pharma_rdd_without_header.map(lambda row: parse_csv_row(row)[6])\n",
    "\n",
    "# Display the column values\n",
    "for value in penalty_date.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "34fbc986-bed8-44cd-8a6c-aa4b5a5e0823",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['Company', 'Parent_Company', 'Penalty_Amount', 'Subtraction_From_Penalty', 'Penalty_Amount_Adjusted_For_Eliminating_Multiple_Counting', 'Penalty_Year', 'Penalty_Date', 'Offense_Group', 'Primary_Offense', 'Secondary_Offense', 'Description', 'Level_of_Government', 'Action_Type', 'Agency', 'Civil/Criminal', 'Prosecution_Agreement', 'Court', 'Case_ID', 'Private_Litigation_Case_Title', 'Lawsuit_Resolution', 'Facility_State', 'City', 'Address', 'Zip', 'NAICS_Code', 'NAICS_Translation', 'HQ_Country_of_Parent', 'HQ_State_of_Parent', 'Ownership_Structure', 'Parent_Company_Stock_Ticker', 'Major_Industry_of_Parent', 'Specific_Industry_of_Parent', 'Info_Source', 'Notes'], ['Abbott Laboratories', 'Abbott Laboratories', '$5,475,000', '$0', '$5,475,000', '2013', '2013-12-27', 'government-contracting-related offenses', 'False Claims Act and related', 'kickbacks and bribery', \"Abbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company's carotid, biliary and peripheral vascular products.\", 'federal', 'agency action', 'Justice Department Civil Division', 'civil', '', '', '', '', '', '', '', '', '', '', '', 'USA', 'Illinois', 'publicly traded', 'ABT', 'pharmaceuticals', 'pharmaceuticals', 'https://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians', ''], ['Abbott Laboratories Inc.', 'AbbVie', '$1,500,000,000', '$0', '$1,500,000,000', '2012', '2012-05-07', 'healthcare-related offenses', 'off-label or unapproved promotion of medical products', '', \"Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\", 'federal', 'agency action', 'Food and Drug Administration referral to the Justice Department', 'civil and criminal', '', '', '', '', '', '', '', '', '', '', '', 'USA', 'Illinois', 'publicly traded', 'ABBV', 'pharmaceuticals', 'pharmaceuticals', 'http://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote', ''], ['Abbott Laboratories Inc.', 'AbbVie', '$126,500,000', '$0', '$126,500,000', '2010', '2010-12-07', 'government-contracting-related offenses', 'False Claims Act and related', '', 'Abbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.', 'federal', 'agency action', 'Justice Department Civil Division', 'civil', '', '', '', '', '', '', '', '', '', '', '', 'USA', 'Illinois', 'publicly traded', 'ABBV', 'pharmaceuticals', 'pharmaceuticals', 'https://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases', ''], ['Abbott Laboratories Puerto Rico, Inc.', 'Abbott Laboratories', '$49,045', '$0', '$49,045', '2009', '2009-03-05', 'employment-related offenses', 'wage and hour violation', 'Fair Labor Standards Act', '', 'federal', 'agency action', 'Labor Department Wage and Hour Division', 'civil', '', '', '1527129', '', '', 'Puerto Rico', 'San Juan', '', '', '423450', '423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers', 'USA', 'Illinois', 'publicly traded', 'ABT', 'pharmaceuticals', 'pharmaceuticals', 'March 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php', 'Date and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.']]\n"
     ]
    }
   ],
   "source": [
    "import csv\n",
    "from io import StringIO\n",
    "from datetime import datetime\n",
    "\n",
    "# Define a function to parse CSV rows\n",
    "def parse_csv_row(row):\n",
    "    return next(csv.reader(StringIO(row)))\n",
    "# Define a function to convert the date format\n",
    "def convert_date_format(date_str):\n",
    "    try:\n",
    "        if len(date_str) == 8:  # Check if the date has eight digits\n",
    "            # Convert the date string to 'YYYY-MM-DD' format\n",
    "            formatted_date = f\"{date_str[:4]}-{date_str[4:6]}-{date_str[6:]}\"\n",
    "        elif len(date_str) == 7 and date_str.isdigit():  # Check if the date has seven digits and is all digits\n",
    "            # Convert the date string to 'YYYY-MM-DD' format\n",
    "            formatted_date = f\"{date_str[:4]}-{date_str[4:6]}-{date_str[6:]}\"\n",
    "        else:\n",
    "            return date_str  # Return the original date string if it doesn't match expected formats\n",
    "        return formatted_date\n",
    "    except ValueError:\n",
    "        return date_str  # Return the original date string if not in expected formats\n",
    "    \n",
    "parsed_pharma_rdd = pharma_rdd.map(parse_csv_row)\n",
    "# Apply the conversion function to the specified column and reconstruct the row\n",
    "pharma_rdd_with_date_format = parsed_pharma_rdd.map(lambda row: row[:6] + [convert_date_format(row[6])] + row[7:] if len(row[6]) == 8 else row)\n",
    "\n",
    "# Display the modified RDD\n",
    "print(pharma_rdd_with_date_format.take(5))  # Display the first 5 rows as an example\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "3c0caa18-30b0-4e25-9ca3-96ed342944c7",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Penalty_Date\n2013-12-27\n2012-05-07\n2010-12-07\n2009-03-05\n2016-07-22\n2004-04-12\n2007-07-02\n2014-05-20\n2013-12-04\n2017-03-09\n2010-09-01\n2017-01-17\n2010-03-16\n2004-08-12\n2004-12-26\n2012-12-19\n2013-04-16\n2011-03-02\n2015-09-30\n2014-04-16\n2011-06-06\n2010-04-27\n2015-07-06\n2015-02-11\n2009-10-19\n2003-06-20\n2016-08-30\n2009-05-28\n2007-09-10\n2016-03-29\n2005-06-17\n2009-02-27\n2008-03-24\n2012-06-07\n2011-08-01\n2012-10-25\n2004-06-30\n2011-10-18\n2012-09-24\n2015-10-05\n2008-07-08\n2007-05-30\n2009-03-31\n2007-09-28\n2004-08-04\n2004-11-12\n2006-09-13\n2005-09-22\n2008-09-29\n2015-07-06\n2015-05-28\n2011-06-13\n2004-06-04\n2012-03-28\n2015-01-09\n2012-02-08\n2010-12-20\n2003-06-11\n2004-08-06\n2010-12-15\n2005-06-20\n2010-12-15\n2005-02-08\n2009-01-15\n2005-12-21\n2012-12-20\n2004-12-29\n2006-05-23\n2007-02-02\n2007-03-09\n2017-02-06\n2013-07-31\n2014-02-21\n2015-12-16\n2010-02-22\n2010-03-02\n2017-04-01\n2016-12-15\n2011-03-02\n2004-11-05\n2017-04-10\n2016-06-06\n2013-12-20\n2015-09-03\n2005-09-20\n2012-07-02\n2014-08-11\n2016-09-30\n2014-09-15\n2015-06-12\n2003-02-06\n2015-10-13\n2004-06-04\n2002-11-25\n2001-05-18\n2015-06-17\n2014-08-29\n2013-05-24\n2009-11-03\n2013-11-04\n2011-04-07\n2011-04-08\n2001-09-21\n2005-11-01\n2013-06-28\n2010-12-07\n2011-12-06\n2011-02-19\n2001-11-14\n2018-09-18\n2007-10-24\n2007-07-20\n2017-07-11\n2000-12-21\n2017-01-18\n2015-03-10\n2006-09-11\n2007-02-24\n2007-05-08\n2016-11-16\n2003-03-07\n2007-12-13\n2011-09-28\n2008-06-13\n2008-02-07\n2009-12-29\n2000-05-05\n2011-11-22\n2006-08-02\n2007-08-14\n2005-03-02\n2016-08-09\n2014-03-03\n2009-03-17\n2007-07-10\n2006-12-05\n2006-06-15\n2005-02-02\n2000-04-01\n2016-10-27\n2000-11-29\n2009-10-19\n2016-03-23\n2015-11-20\n2013-02-25\n2010-09-30\n2006-11-06\n2010-05-04\n2011-06-10\n2009-05-11\n2009-05-11\n2009-10-19\n2010-04-29\n2016-06-06\n2008-03-27\n2013-03-05\n2012-06-27\n2004-08-12\n2014-06-14\n2002-10-28\n2009-09-02\n2016-04-27\n2012-12-12\n2012-08-07\n2011-10-21\n2008-06-23\n2002-05-29\n2014-05-12\n2012-08-07\n2006-06-01\n2008-12-15\n2012-09-28\n2013-05-13\n2014-01-13\n2010-12-07\n2015-03-11\n2011-12-16\n2012-12-19\n2017-04-03\n2010-10-26\n2006-04-11\n2004-05-03\n2007-05-14\n2004-07-30\n2003-09-09\n2004-06-09\n2010-04-29\n2016-02-04\n2011-10-05\n2011-05-04\n2005-10-17\n2017-01-11\n2014-09-24\n2002-11-04\n2009-06-01\n2011-01-20\n2010-06-04\n2012-05-31\n2001-10-03\n2016-12-22\n2013-03-14\n2016-12-22\n2014-03-11\n2003-05-23\n2013-01-04\n2012-01-18\n2013-05-15\n2010-06-28\n2010-01-14\n2010-03-08\n2008-07-30\n2009-04-17\n2007-10-26\n2006-04-10\n2006-06-29\n2006-10-05\n2004-07-01\n2003-03-25\n2002-04-25\n2002-05-21\n2003-01-28\n2003-02-11\n2002-11-07\n2001-09-25\n2001-01-24\n2011-06-09\n2004-08-31\n2000-12-20\n2000-09-29\n2000-10-03\n2004-02-05\n2014-05-16\n2007-09-25\n2014-09-04\n2013-01-24\n2012-09-21\n2011-12-20\n2013-05-22\n2008-09-18\n2007-06-04\n2006-07-13\n2004-09-28\n2018-12-31\n2018-07-26\n2018-07-26\n2017-12-05\n2015-09-28\n2015-02-24\n2011-12-14\n2009-12-23\n2008-09-15\n2011-02-25\n2006-12-20\n2006-03-30\n2006-05-19\n2005-09-30\n2004-08-16\n2004-06-24\n2003-04-21\n2000-12-21\n2000-09-29\n2001-10-19\n2013-06-11\n2010-08-12\n2007-10-09\n2013-08-22\n2005-10-07\n2000-10-12\n2000-09-05\n2016-12-14\n2014-09-30\n2014-07-08\n2012-09-18\n2009-12-22\n2011-11-17\n2008-03-10\n2003-08-28\n2013-03-26\n2014-05-08\n2011-09-22\n2011-09-14\n2011-05-31\n2010-07-27\n2016-07-01\n2010-09-17\n2010-09-29\n2009-04-14\n2010-03-18\n2008-07-31\n2008-09-29\n2007-05-14\n2008-09-26\n2006-10-16\n2005-07-06\n2006-02-10\n2009-05-05\n2005-02-11\n2004-02-24\n2003-08-20\n2004-06-09\n2004-01-27\n2002-04-22\n2002-03-13\n2001-06-07\n2001-11-30\n2001-12-07\n2000-07-28\n2000-12-28\n2000-09-25\n2000-04-17\n2000-05-12\n2017-03-16\n2013-07-25\n2010-12-21\n2008-07-21\n2005-01-11\n2009-05-05\n2021-04-26\n2004-05-30\n2020-10-05\n2020-04-28\n2019-09-30\n2019-09-18\n2019-09-09\n2019-02-06\n2015-10-29\n2004-05-13\n2018-10-24\n2018-10-16\n2018-07-05\n2018-07-02\n2017-05-03\n2017-02-16\n2017-02-02\n2016-08-15\n2016-06-23\n2016-03-08\n2016-02-26\n2015-11-04\n2015-03-23\n2014-10-01\n2014-09-02\n2012-08-07\n2013-07-30\n2005-06-30\n2013-06-13\n2013-04-30\n2012-07-25\n2012-04-24\n2017-09-05\n2017-08-17\n2017-09-22\n2003-11-10\n2003-10-27\n2002-05-01\n2006-10-26\n2017-09-28\n2017-09-22\n2017-09-08\n2017-07-24\n2016-06-09\n2013-07-18\n2013-01-03\n2011-06-10\n2010-10-04\n2010-09-15\n2010-05-21\n2009-09-14\n2008-08-05\n2007-09-27\n2007-07-13\n2007-05-10\n2007-04-02\n2007-04-02\n2006-08-29\n2005-06-15\n2001-12-17\n2001-10-25\n2017-10-23\n2018-01-19\n2017-12-20\n2017-04-10\n2013-04-18\n2013-06-27\n2013-09-12\n2015-11-03\n2015-11-03\n2016-06-09\n2016-06-09\n2017-04-27\n2018-03-23\n2010-04-21\n2010-07-21\n2010-11-09\n2011-01-03\n2013-09-30\n2013-10-23\n2014-02-11\n2014-04-01\n2011-05-16\n2018-04-16\n2016-12-20\n2014-10-08\n2012-05-31\n2012-05-21\n2011-03-03\n2016-08-24\n2015-12-17\n2015-12-17\n2015-05-28\n2017-05-24\n2018-05-24\n2018-08-28\n2018-06-26\n2018-09-04\n2018-12-06\n2008-03-28\n2010-08-09\n2012-11-07\n2009-12-30\n2010-11-30\n2016-12-08\n2003-07-21\n2016-02-11\n2016-07-11\n2018-06-29\n2016-11-01\n2016-04-07\n2018-03-05\n2018-10-26\n2017-11-13\n2019-02-26\n2012-05-31\n2012-10-26\n2013-05-21\n2011-11-29\n2017-04-04\n2005-10-12\n2010-12-16\n2018-06-21\n2019-06-05\n2019-04-25\n2019-04-25\n2019-04-04\n2019-04-04\n2019-04-04\n2019-03-18\n2000-12-15\n2003-10-27\n2012-05-07\n2005-06-14\n2009-05-22\n2013-11-18\n2018-11-09\n2008-09-19\n2010-01-07\n2009-05-28\n2008-09-09\n2013-12-04\n2009-11-13\n2013-02-07\n2018-10-26\n2012-02-07\n2010-03-09\n2011-12-28\n2017-09-22\n2018-03-23\n2017-05-18\n2010-09-01\n2010-03-16\n2010-05-27\n2011-03-30\n2011-10-24\n2004-08-12\n2008-12-23\n2009-07-07\n2008-12-22\n2012-12-19\n2015-08-18\n2013-04-29\n2009-11-13\n2009-03-11\n2019-05-09\n2015-08-31\n2016-06-24\n2003-01-27\n2013-11-18\n2013-11-18\n2014-04-16\n2004-01-22\n2013-02-07\n2010-01-27\n2009-10-15\n2018-08-07\n2015-11-04\n2011-03-10\n2003-06-30\n2009-10-19\n2010-04-27\n2011-08-11\n2010-10-06\n2013-11-18\n2009-05-28\n2009-05-22\n2007-09-10\n2010-05-11\n2003-01-27\n2012-01-30\n2012-06-05\n2007-10-05\n2008-02-25\n2001-02-20\n2009-11-13\n2007-01-08\n2013-11-18\n2012-02-07\n2005-11-28\n2017-12-20\n2010-04-20\n2009-07-10\n2008-09-22\n2009-11-13\n2011-09-23\n2012-10-25\n2008-07-15\n2016-12-08\n2003-04-24\n2008-12-23\n2010-09-29\n2003-03-07\n2008-12-23\n2019-03-24\n2008-06-25\n2017-07-24\n2016-08-04\n2008-09-29\n2008-09-29\n2015-11-04\n2000-11-03\n2000-10-11\n2000-10-10\n2002-09-04\n2015-03-16\n2012-03-01\n2014-07-02\n2012-02-07\n2005-07-19\n2006-04-25\n2006-11-28\n2004-05-17\n2008-12-23\n2009-01-07\n2007-12-19\n2011-04-27\n2004-11-04\n2007-03-21\n2009-11-13\n2006-11-14\n2010-11-29\n2007-04-20\n2007-03-29\n2003-06-11\n2010-09-17\n2000-10-11\n2013-11-18\n2000-10-10\n2002-09-04\n2010-12-16\n2010-12-16\n2010-02-16\n2010-02-04\n2013-11-18\n2010-04-07\n2002-07-25\n2009-09-29\n2009-10-13\n2009-01-15\n2008-10-07\n2011-05-04\n2014-02-21\n2015-12-16\n2016-03-03\n2019-07-25\n2019-07-29\n2013-01-04\n2007-08-15\n2009-05-22\n2013-11-18\n2013-02-13\n2016-12-15\n2012-06-08\n2010-09-15\n2012-05-11\n2016-06-06\n2000-01-27\n2005-06-14\n2013-12-20\n2013-11-18\n2003-04-16\n2005-09-20\n2012-07-02\n2006-08-11\n2012-04-17\n2011-02-21\n2010-01-28\n2009-11-13\n2012-02-07\n2012-11-15\n2010-10-06\n2006-08-10\n2006-03-28\n2006-04-17\n2011-06-24\n2014-06-04\n2000-10-11\n2000-10-10\n2002-09-04\n2009-11-13\n2015-06-18\n2015-08-05\n2017-08-18\n2017-10-03\n2006-10-26\n2013-05-24\n2009-11-03\n2014-03-06\n2012-06-13\n2012-08-30\n2013-11-04\n2019-01-22\n2017-05-24\n2013-11-04\n2012-01-19\n2019-04-22\n2013-11-18\n2010-10-06\n2001-05-22\n2011-12-06\n2009-03-02\n2006-03-23\n2001-11-14\n2010-12-07\n2012-05-04\n2012-03-01\n2003-04-11\n2019-09-04\n2013-07-18\n2017-01-18\n2015-07-29\n2004-09-10\n2007-12-12\n2008-02-07\n2013-02-22\n2009-07-15\n2008-05-20\n2011-12-20\n2011-03-28\n2009-12-02\n2010-10-06\n2012-04-20\n2011-09-29\n2012-05-15\n2017-08-17\n2010-11-08\n2000-11-29\n2010-12-30\n2012-01-30\n2011-05-20\n2009-10-19\n2013-11-07\n2013-11-07\n2013-11-18\n2013-07-10\n2012-03-28\n2015-11-20\n2010-09-30\n2010-10-06\n2010-05-04\n2012-10-30\n2017-09-05\n2011-06-10\n2014-10-15\n2004-10-21\n2010-04-29\n2009-10-19\n2016-06-06\n2016-06-06\n2007-05-23\n2008-03-27\n2013-11-18\n2011-10-24\n2013-03-05\n2011-03-29\n2011-08-26\n2010-12-20\n2011-08-25\n2013-11-18\n2013-11-18\n2004-08-12\n2003-01-06\n2014-08-06\n2019-03-11\n2002-10-28\n2011-10-21\n2008-10-22\n2013-11-07\n2013-01-04\n2012-12-27\n2012-12-12\n2018-10-11\n2009-09-02\n2012-03-20\n2010-10-06\n2009-05-28\n2011-02-18\n2013-09-04\n2008-02-19\n2007-05-10\n2007-09-18\n2007-05-08\n2015-12-23\n2019-03-26\n2002-11-01\n2015-08-20\n2010-05-27\n2011-10-24\n2013-05-13\n2013-11-18\n2014-07-08\n2014-02-19\n2014-10-16\n2009-05-28\n2009-12-09\n2009-11-13\n2010-03-24\n2008-12-23\n2016-06-09\n2009-06-24\n2013-11-18\n2010-10-18\n2011-09-06\n2013-08-22\n2019-03-24\n2012-08-03\n2010-10-26\n2012-02-07\n2008-10-31\n2004-05-03\n2004-07-30\n2006-08-29\n2009-12-17\n2010-04-29\n2005-10-17\n2009-05-22\n2013-11-18\n2017-01-11\n2014-09-24\n2005-04-13\n2007-11-16\n2009-05-05\n2000-10-11\n2000-10-10\n2002-09-04\n2008-12-23\n2013-11-18\n2011-01-14\n2001-12-19\n2006-05-22\n2006-05-17\n2006-05-25\n2001-10-05\n2013-11-18\n2014-08-11\n2019-07-29\n2009-01-05\n2019-05-26\n2009-05-22\n2013-03-14\n2014-03-11\n2003-04-02\n2010-08-13\n2014-02-19\n2010-10-06\n2010-08-10\n2010-07-21\n2013-11-18\n2017-05-19\n2011-06-09\n2009-12-02\n2017-12-29\n2007-06-13\n2015-10-29\n2004-05-13\n2011-01-13\n2009-05-28\n2011-09-16\n2012-07-16\n2010-02-12\n2018-01-29\n2011-09-27\n2016-04-27\n2013-07-30\n2019-09-26\n2019-10-28\n2019-10-28\n2019-10-28\n2019-10-28\n2019-10-28\n2019-10-28\n2019-10-28\n2019-10-28\n2019-10-28\n2019-10-28\n2019-10-17\n2019-09-30\n2019-09-27\n2019-09-27\n2015-01-14\n2005-05-25\n2000-10-03\n2016-10-25\n2014-11-03\n2004-09-01\n2018-05-04\n2019-12-03\n2019-10-22\n2020-02-28\n2020-03-02\n2020-01-27\n2020-02-25\n2020-01-10\n2020-05-07\n2020-05-04\n2016-07-18\n2017-09-05\n2018-05-07\n2020-09-14\n2020-07-12\n2020-08-24\n2020-07-24\n2020-07-01\n2020-07-25\n2020-07-24\n2020-08-05\n2020-07-29\n2020-08-24\n2020-07-31\n2020-07-02\n2020-06-25\n2020-07-28\n2020-08-06\n2020-10-21\n2020-09-23\n2014-02-04\n2002-11-10\n2001-08-10\n2009-05-01\n2014-10-01\n2015-02-24\n2012-11-20\n2012-10-01\n2012-02-17\n2011-11-21\n2011-05-12\n2007-08-07\n2004-12-23\n2019-01-08\n2014-11-24\n2010-05-25\n2011-10-03\n2010-09-29\n2006-06-13\n2020-12-17\n2001-09-07\n2008-03-25\n2000-10-02\n2014-12-29\n2009-03-04\n2007-10-15\n2019-05-17\n2018-12-17\n2015-12-02\n2013-03-28\n2002-11-13\n2001-04-30\n2021-02-12\n2006-12-06\n2003-08-21\n2002-08-29\n2019-05-29\n2011-03-16\n2009-10-22\n2020-06-23\n2019-08-20\n2019-03-18\n2017-06-08\n2016-07-07\n2016-05-05\n2014-03-31\n2013-01-24\n2011-10-04\n2010-03-15\n2010-02-22\n2009-12-24\n2009-10-09\n2009-01-28\n2009-01-16\n2008-08-15\n2007-04-11\n2007-04-05\n2007-03-29\n2006-05-02\n2006-01-24\n2005-09-01\n2005-04-26\n2005-01-24\n2003-12-26\n2003-12-23\n2003-10-23\n2003-04-01\n2002-12-27\n2002-11-19\n2002-11-19\n2001-09-21\n2018-04-03\n2015-01-20\n2014-10-06\n2014-05-02\n2008-07-17\n2005-07-21\n2011-02-16\n2004-07-30\n2020-03-25\n2019-08-22\n2021-04-27\n2021-05-04\n2021-05-04\n2021-04-01\n2007-08-29\n2000-03-21\n2000-06-07\n2001-08-23\n2002-08-28\n2000-01-20\n2004-06-17\n2001-09-25\n2000-01-28\n2000-06-07\n2000-07-11\n2005-12-12\n2001-11-15\n2005-05-03\n2003-01-16\n2003-09-10\n2004-08-09\n2002-10-11\n2011-01-21\n2002-11-05\n2000-09-12\n2000-08-09\n2021-07-08\n2021-07-08\n2013-12-17\n2021-09-01\n2021-08-17\n2021-07-21\n2021-09-10\n2021-05-01\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"penalty_date\" column from each row in the dataset pharma_rdd_with_date_format\n",
    "penalty_date = pharma_rdd_with_date_format.map(lambda row: row[6] if len(row) > 6 else None)\n",
    "\n",
    "# Display the penalty_date column values\n",
    "for value in penalty_date.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "7fe92640-bd5e-4f93-aa40-faeb69798eef",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'penalty_date': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = penalty_date.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'penalty_date':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "61b3c548-2a3c-4af9-a8f8-fe2a30248ae6",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Offense_Group\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\nhealthcare-related offenses\nenvironment-related offenses\nsafety-related offenses\nemployment-related offenses\nhealthcare-related offenses\nfinancial offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nemployment-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nfinancial offenses\nemployment-related offenses\nemployment-related offenses\nfinancial offenses\nemployment-related offenses\nemployment-related offenses\nhealthcare-related offenses\nemployment-related offenses\nenvironment-related offenses\nenvironment-related offenses\ncompetition-related offenses\nenvironment-related offenses\nsafety-related offenses\nconsumer-protection-related offenses\nhealthcare-related offenses\nfinancial offenses\ncompetition-related offenses\nsafety-related offenses\nsafety-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\nemployment-related offenses\nfinancial offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nfinancial offenses\nhealthcare-related offenses\ncompetition-related offenses\nhealthcare-related offenses\nfinancial offenses\nhealthcare-related offenses\nhealthcare-related offenses\ncompetition-related offenses\nsafety-related offenses\nsafety-related offenses\nfinancial offenses\ncompetition-related offenses\nenvironment-related offenses\nenvironment-related offenses\nhealthcare-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nfinancial offenses\nfinancial offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nenvironment-related offenses\ncompetition-related offenses\nenvironment-related offenses\nsafety-related offenses\ncompetition-related offenses\nemployment-related offenses\nfinancial offenses\nfinancial offenses\nemployment-related offenses\nhealthcare-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ncompetition-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nenvironment-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\nfinancial offenses\nemployment-related offenses\nsafety-related offenses\nhealthcare-related offenses\nsafety-related offenses\ncompetition-related offenses\nsafety-related offenses\nfinancial offenses\nfinancial offenses\nhealthcare-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\ncompetition-related offenses\nhealthcare-related offenses\nenvironment-related offenses\nenvironment-related offenses\ncompetition-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ncompetition-related offenses\nemployment-related offenses\nhealthcare-related offenses\nemployment-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ncompetition-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nemployment-related offenses\ncompetition-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ncompetition-related offenses\nhealthcare-related offenses\nenvironment-related offenses\nsafety-related offenses\nenvironment-related offenses\ncompetition-related offenses\nsafety-related offenses\nsafety-related offenses\ncompetition-related offenses\nsafety-related offenses\nfinancial offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\ncompetition-related offenses\nfinancial offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ncompetition-related offenses\nemployment-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nenvironment-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nhealthcare-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nemployment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nsafety-related offenses\nemployment-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\ncompetition-related offenses\nhealthcare-related offenses\nemployment-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\nhealthcare-related offenses\nfinancial offenses\nfinancial offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ncompetition-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ncompetition-related offenses\nhealthcare-related offenses\ncompetition-related offenses\ncompetition-related offenses\nsafety-related offenses\nfinancial offenses\nsafety-related offenses\ngovernment-contracting-related offenses\nfinancial offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nemployment-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nhealthcare-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ncompetition-related offenses\nhealthcare-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ncompetition-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nconsumer-protection-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ncompetition-related offenses\ncompetition-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ncompetition-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nconsumer-protection-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ncompetition-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ncompetition-related offenses\nsafety-related offenses\ncompetition-related offenses\ncompetition-related offenses\ncompetition-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nsafety-related offenses\nsafety-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\ncompetition-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nconsumer-protection-related offenses\nconsumer-protection-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\nconsumer-protection-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ncompetition-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nsafety-related offenses\nhealthcare-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nconsumer-protection-related offenses\ncompetition-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nsafety-related offenses\nhealthcare-related offenses\nconsumer-protection-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\ncompetition-related offenses\ncompetition-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\ncompetition-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nenvironment-related offenses\ncompetition-related offenses\nenvironment-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\nhealthcare-related offenses\ncompetition-related offenses\nfinancial offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\nemployment-related offenses\nfinancial offenses\nconsumer-protection-related offenses\nemployment-related offenses\nsafety-related offenses\nenvironment-related offenses\nsafety-related offenses\nenvironment-related offenses\nemployment-related offenses\nemployment-related offenses\nemployment-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\nemployment-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ncompetition-related offenses\nsafety-related offenses\ncompetition-related offenses\nhealthcare-related offenses\nconsumer-protection-related offenses\ncompetition-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\ncompetition-related offenses\ncompetition-related offenses\ncompetition-related offenses\ncompetition-related offenses\nemployment-related offenses\nfinancial offenses\ncompetition-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nconsumer-protection-related offenses\ncompetition-related offenses\ngovernment-contracting-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\ngovernment-contracting-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nenvironment-related offenses\nhealthcare-related offenses\nenvironment-related offenses\ngovernment-contracting-related offenses\ngovernment-contracting-related offenses\nmiscellaneous offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\nsafety-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\ngovernment-contracting-related offenses\nhealthcare-related offenses\nhealthcare-related offenses\nemployment-related offenses\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"offense_group\" column from each row in the dataset pharma_rdd_with_date_format\n",
    "offense_group = pharma_rdd_with_date_format.map(lambda row: row[7] if len(row) > 7 else None)\n",
    "\n",
    "# Display the offense_group column values\n",
    "for value in offense_group.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "5ffbc27f-4b85-4d09-9552-ea627c258321",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'offense_group': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = offense_group.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'offense_group':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "b9a32cf9-d89e-4a42-b11d-105baf488c32",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Primary_Offense\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nwage and hour violation\nFalse Claims Act and related\nlabor relations violation\nHHS civil monetary penalties\nenvironmental violation\ndrug or medical equipment safety violation\nwage and hour violation\noff-label or unapproved promotion of medical products\ninvestor protection violation\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nwage and hour violation\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nlabor relations violation\nemployment discrimination\nFalse Claims Act and related\nemployment discrimination\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nkickbacks and bribery\nFalse Claims Act and related\nFalse Claims Act and related\ninvestor protection violation\nwage and hour violation\nwage and hour violation\naccounting fraud or deficiencies\nbenefit plan administrator violation\nwage and hour violation\noff-label or unapproved promotion of medical products\nlabor relations violation\nenvironmental violation\nenvironmental violation\nForeign Corrupt Practices Act\nenvironmental violation\ndrug or medical equipment safety violation\nconsumer protection violation\noff-label or unapproved promotion of medical products\naccounting fraud or deficiencies\nexport control violation\nmotor vehicle safety violation\nmotor vehicle safety violation\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nconsumer protection violation\nbenefit plan administrator violation\neconomic sanction violation\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\neconomic sanction violation\noff-label or unapproved promotion of medical products\nexport control violation\noff-label or unapproved promotion of medical products\naccounting fraud or deficiencies\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nForeign Corrupt Practices Act\nmotor vehicle safety violation\nmotor vehicle safety violation\neconomic sanction violation\nexport control violation\nenvironmental violation\nenvironmental violation\noff-label or unapproved promotion of medical products\ndrug or medical equipment safety violation\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFamily and Medical Leave Act\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\neconomic sanction violation\naccounting fraud or deficiencies\nFalse Claims Act and related\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nenvironmental violation\nkickbacks and bribery\nenvironmental violation\nmotor vehicle safety violation\nprice-fixing or anti-competitive practices\nemployment discrimination\neconomic sanction violation\naccounting fraud or deficiencies\nbenefit plan administrator violation\noff-label or unapproved promotion of medical products\nFamily and Medical Leave Act\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nForeign Corrupt Practices Act\nForeign Corrupt Practices Act\nFalse Claims Act and related\nFalse Claims Act and related\nenvironmental violation\nkickbacks and bribery\nFalse Claims Act and related\nwage and hour violation\nFalse Claims Act and related\ninvestor protection violation\nemployment discrimination\nrailroad safety violation\nControlled Substances Act violation\nnuclear safety violation\nprice-fixing or anti-competitive practices\ndrug or medical equipment safety violation\ntax violations\ntax violations\noff-label or unapproved promotion of medical products\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nlabor relations violation\nFalse Claims Act and related\nlabor relations violation\nprice-fixing or anti-competitive practices\noff-label or unapproved promotion of medical products\nenvironmental violation\nenvironmental violation\nForeign Corrupt Practices Act\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nconsumer protection violation\nFalse Claims Act and related\nForeign Corrupt Practices Act\nkickbacks and bribery\nemployment discrimination\noff-label or unapproved promotion of medical products\nbenefit plan administrator violation\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nForeign Corrupt Practices Act\nkickbacks and bribery\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nlabor relations violation\nprice-fixing or anti-competitive practices\nFamily and Medical Leave Act\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\ndrug or medical equipment safety violation\nForeign Corrupt Practices Act\noff-label or unapproved promotion of medical products\nenvironmental violation\nrailroad safety violation\nenvironmental violation\nForeign Corrupt Practices Act\nrailroad safety violation\nrailroad safety violation\nexport control violation\ndrug or medical equipment safety violation\ntax violations\nFalse Claims Act and related\nHHS civil monetary penalties\nHHS civil monetary penalties\nFalse Claims Act and related\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFamily and Medical Leave Act\nFalse Claims Act and related\nlabor relations violation\nkickbacks and bribery\ninvestor protection violation\nForeign Corrupt Practices Act\nFalse Claims Act and related\nForeign Corrupt Practices Act\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nexport control violation\nwage and hour violation\nkickbacks and bribery\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nForeign Corrupt Practices Act\nenvironmental violation\nForeign Corrupt Practices Act\nFalse Claims Act and related\nlabor relations violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\noff-label or unapproved promotion of medical products\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nbenefit plan administrator violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nworkplace safety or health violation\nwage and hour violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nForeign Corrupt Practices Act\noff-label or unapproved promotion of medical products\nwage and hour violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nFalse Claims Act and related\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFalse Claims Act and related\nFalse Claims Act and related\ndrug or medical equipment safety violation\noff-label or unapproved promotion of medical products\naccounting fraud or deficiencies\ninvestor protection violation\nFalse Claims Act and related\nFalse Claims Act and related\nkickbacks and bribery\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFalse Claims Act and related\ndrug or medical equipment safety violation\nkickbacks and bribery\nControlled Substances Act violation\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nkickbacks and bribery\nkickbacks and bribery\noff-label or unapproved promotion of medical products\nfraud\nfraud\ndrug or medical equipment safety violation\ntax violations\ndrug or medical equipment safety violation\nFalse Claims Act and related\ninvestor protection violation\nMedicare Coverage Gap Discount Program violation\nMedicare Coverage Gap Discount Program violation\nMedicare Coverage Gap Discount Program violation\nMedicare Coverage Gap Discount Program violation\nMedicare Coverage Gap Discount Program violation\nMedicare Coverage Gap Discount Program violation\nMedicare Coverage Gap Discount Program violation\nMedicare Coverage Gap Discount Program violation\nFalse Claims Act and related\naviation safety violation\naviation safety violation\naviation safety violation\naviation safety violation\naviation safety violation\naviation safety violation\naviation safety violation\naviation safety violation\nwage and hour violation\nFalse Claims Act and related\nwage and hour violation\nwage and hour violation\nwage and hour violation\nwage and hour violation\nwage and hour violation\naviation safety violation\naviation safety violation\naviation safety violation\naviation safety violation\naviation safety violation\nFalse Claims Act and related\nControlled Substances Act violation\nemployment discrimination\nForeign Corrupt Practices Act\nFalse Claims Act and related\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\nemployment discrimination\noff-label or unapproved promotion of medical products\nwage and hour violation\nemployment discrimination\nbenefit plan administrator violation\nbenefit plan administrator violation\nbenefit plan administrator violation\nbenefit plan administrator violation\nbenefit plan administrator violation\nbenefit plan administrator violation\nbenefit plan administrator violation\nmotor vehicle safety violation\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nbenefit plan administrator violation\ndrug or medical equipment safety violation\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nconsumer protection violation\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nconsumer protection violation\nFalse Claims Act and related\nFalse Claims Act and related\nkickbacks and bribery\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nkickbacks and bribery\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nMedicare Coverage Gap Discount Program violation\nprice-fixing or anti-competitive practices\nControlled Substances Act violation\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nconsumer protection violation\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nconsumer protection violation\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nconsumer protection violation\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nconsumer protection violation\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nfraud\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nprivacy violation\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\ndrug or medical equipment safety violation\nprice-fixing or anti-competitive practices\nconsumer protection violation\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\ndrug or medical equipment safety violation\nkickbacks and bribery\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\ndrug or medical equipment safety violation\ndrug or medical equipment safety violation\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\ndrug or medical equipment safety violation\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nconsumer protection violation\nFalse Claims Act and related\nconsumer protection violation\nkickbacks and bribery\nbenefit plan administrator violation\nFalse Claims Act and related\ndrug or medical equipment safety violation\nkickbacks and bribery\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nconsumer protection violation\nconsumer protection violation\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\ndrug or medical equipment safety violation\nconsumer protection violation\nconsumer protection violation\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nconsumer protection violation\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nkickbacks and bribery\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nprice-fixing or anti-competitive practices\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nconsumer protection violation\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\ndrug or medical equipment safety violation\noff-label or unapproved promotion of medical products\nconsumer protection violation\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nconsumer protection violation\nkickbacks and bribery\ndrug or medical equipment safety violation\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nControlled Substances Act violation\noff-label or unapproved promotion of medical products\ndrug or medical equipment safety violation\nControlled Substances Act violation\nconsumer protection violation\nControlled Substances Act violation\nFalse Claims Act and related\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFalse Claims Act and related\ndrug or medical equipment safety violation\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nkickbacks and bribery\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nkickbacks and bribery\nconsumer protection violation\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nkickbacks and bribery\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nconsumer protection violation\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nconsumer protection violation\nkickbacks and bribery\nkickbacks and bribery\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nconsumer protection violation\nFalse Claims Act and related\nControlled Substances Act violation\nFalse Claims Act and related\nenvironmental violation\nkickbacks and bribery\nenvironmental violation\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nbenefit plan administrator violation\noff-label or unapproved promotion of medical products\nprice-fixing or anti-competitive practices\ninvestor protection violation\nprice-fixing or anti-competitive practices\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFalse Claims Act and related\nemployment discrimination\ninvestor protection violation\nconsumer protection violation\nemployment discrimination\ndrug or medical equipment safety violation\nenvironmental violation\ndrug or medical equipment safety violation\nenvironmental violation\nwage and hour violation\nemployment discrimination\nwage and hour violation\nFalse Claims Act and related\nprice-fixing or anti-competitive practices\nemployment discrimination\nControlled Substances Act violation\nControlled Substances Act violation\nprice-fixing or anti-competitive practices\ndrug or medical equipment safety violation\nkickbacks and bribery\noff-label or unapproved promotion of medical products\ninsurance violation\nkickbacks and bribery\nMedicare Coverage Gap Discount Program violation\nFalse Claims Act and related\nFalse Claims Act and related\nFalse Claims Act and related\nForeign Corrupt Practices Act\nprice-fixing or anti-competitive practices\nkickbacks and bribery\nkickbacks and bribery\nemployment discrimination\naccounting fraud or deficiencies\nForeign Corrupt Practices Act\nForeign Corrupt Practices Act\nFalse Claims Act and related\nconsumer protection violation\nfraud\nFalse Claims Act and related\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nFalse Claims Act and related\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\nenvironmental violation\noff-label or unapproved promotion of medical products\nenvironmental violation\nFalse Claims Act and related\nFalse Claims Act and related\ncampaign finance violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\nworkplace safety or health violation\ndrug or medical equipment safety violation\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\noff-label or unapproved promotion of medical products\noff-label or unapproved promotion of medical products\nemployment discrimination\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"primary_offence\" column from each row in the dataset pharma_rdd_with_date_format\n",
    "primary_offence = pharma_rdd_with_date_format.map(lambda row: row[8] if len(row) > 8 else None)\n",
    "\n",
    "# Display the primary_offence column values\n",
    "for value in primary_offence.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "28e1cbe1-39af-46d6-8478-285e663afa77",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'primary_offence': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = primary_offence.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'primary_offence':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "eb8aaf3a-cec8-4817-a57e-3221a8568cf1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Secondary_Offense\nkickbacks and bribery\n\n\nFair Labor Standards Act\n\n\nkickbacks and bribery\n\n\nFair Labor Standards Act\n\n\nkickbacks and bribery\nconsumer protection violation\nFair Labor Standards Act\n\nkickbacks and bribery\n\n\noff-label or unapproved promotion of medical products\n\n\n\nkickbacks and bribery\n\n\n\n\nfraud\n\nFair Labor Standards Act\nFair Labor Standards Act\n\n\nFair Labor Standards Act\n\n\n\n\n\n\n\n\nkickbacks and bribery\n\n\n\n\nFalse Claims Act and related\n\nprice-fixing or anti-competitive practices\n\n\n\nkickbacks and bribery\n\n\nfraud\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nfraud\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\ndrug or medical equipment safety violation\n\n\n\n\n\n\n\n\n\nFalse Claims Act and related\n\nkickbacks and bribery\nkickbacks and bribery\nkickbacks and bribery\n\n\n\n\n\n\n\nFair Labor Standards Act\n\n\nage discrimination\n\n\n\n\n\n\n\nFalse Claims Act and related\n\n\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFalse Claims Act and related\n\n\n\n\n\n\nFalse Claims Act and related\n\n\nconsumer protection violation\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nexcise tax violation\n\n\n\nkickbacks and bribery\n\n\n\nfraud\n\nFalse Claims Act and related\n\n\noff-label or unapproved promotion of medical products\n\n\nkickbacks and bribery\nFalse Claims Act and related\nkickbacks and bribery\nFalse Claims Act and related\n\nFair Labor Standards Act\n\nkickbacks and bribery\n\nfraud\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFair Labor Standards Act\n\n\n\n\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFair Labor Standards Act\n\n\n\n\ndrug or medical equipment safety violation\n\nFalse Claims Act and related\n\nkickbacks and bribery\n\n\n\n\nkickbacks and bribery\ndrug or medical equipment safety violation\nFalse Claims Act and related\n\n\n\n\n\n\nFalse Claims Act and related\n\nkickbacks and bribery\nFalse Claims Act and related\nfraud\n\n\nfraud\n\n\n\nexcise tax violation\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nkickbacks and bribery\n\n\n\nkickbacks and bribery\nage discrimination\ngender discrimination\n\nFamily and Medical Leave Act\ngender discrimination\ngender discrimination\ngender discrimination\ngender discrimination\ngender discrimination\ngender and pregnancy discrimination\nage discrimination\n\n\nkickbacks and bribery\n\n\npension ERISA violation\npension ERISA violation\npension ERISA violation\npension ERISA violation\npension ERISA violation\npension ERISA violation\npension ERISA violation\n\nkickbacks and bribery\n\n\nkickbacks and bribery\nkickbacks and bribery\nkickbacks and bribery\n\n\nkickbacks and bribery\nconsumer protection violation\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndrug or medical equipment safety violation\n\nFalse Claims Act and related\nkickbacks and bribery\n\n\n\n\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\noff-label or unapproved promotion of medical products\n\n\n\n\noff-label or unapproved promotion of medical products\n\ndrug or medical equipment safety violation\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nkickbacks and bribery\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\nFalse Claims Act and related\n\n\n\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFalse Claims Act and related\nFalse Claims Act and related\n\n\n\n\n\n\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\nkickbacks and bribery\n\noff-label or unapproved promotion of medical products\n\n\nFalse Claims Act and related\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nkickbacks and bribery\n\nkickbacks and bribery\n\nkickbacks and bribery\nkickbacks and bribery\n\n\n\nkickbacks and bribery\n\nconsumer protection violation\nkickbacks and bribery\nFalse Claims Act and related\n\n\n\n\n\n\n\n\n\npension ERISA violation\n\nFalse Claims Act and related\nFalse Claims Act and related\nkickbacks and bribery\n\n\n\nFalse Claims Act and related\nkickbacks and bribery\nFalse Claims Act and related\n\n\n\n\n\n\ndrug or medical equipment safety violation\n\n\n\n\n\n\n\n\n\n\nfalse advertising\n\n\n\n\nFalse Claims Act and related\n\nFalse Claims Act and related\n\n\nFalse Claims Act and related\nkickbacks and bribery\n\n\n\n\n\n\nFalse Claims Act and related\n\n\n\n\n\n\n\n\n\n\n\n\n\n\noff-label or unapproved promotion of medical products\nconsumer protection violation\nfalse advertising\n\n\nconsumer protection violation\n\n\n\n\n\n\n\n\nfraud\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFalse Claims Act and related\n\n\n\n\nFalse Claims Act and related\n\n\nFalse Claims Act and related\n\n\n\nFalse Claims Act and related\nFalse Claims Act and related\n\noff-label or unapproved promotion of medical products\nFalse Claims Act and related\n\n\nkickbacks and bribery\nFalse Claims Act and related\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\npension ERISA violation\nFalse Claims Act and related\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\n\noff-label or unapproved promotion of medical products\n\n\n\n\n\n\n\n\nwork visa violations\ngender and pregnancy discrimination\n\nkickbacks and bribery\n\n\n\n\n\n\n\ndrug or medical equipment safety violation\n\n\n\n\n\nkickbacks and bribery\n\n\n\n\n\nfinancial institution supervision failures\nfinancial institution supervision failures\nfinancial institution supervision failures\nkickbacks and bribery\n\nFalse Claims Act and related\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nkickbacks and bribery\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nFalse Claims Act and related\ndrug or medical equipment safety violation\nFalse Claims Act and related\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"secondary_offence\" column from each row in the dataset pharma_rdd_with_date_format\n",
    "secondary_offence = pharma_rdd_with_date_format.map(lambda row: row[9] if len(row) > 9 else None)\n",
    "\n",
    "# Display the secondary_offence column values\n",
    "for value in secondary_offence.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "69be6392-9f4f-41f5-8596-d924e9b963bf",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'secondary_offence': 808\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = secondary_offence.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'secondary_offence':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e447fc55-aab2-48da-82c7-614de22ead94",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 808\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"secondary_offence\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[9] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_rdd_with_date_format.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[9] == '':\n",
    "        row[9] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none = pharma_rdd_with_date_format.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none.filter(lambda row: row[9] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f8eaed90-42dc-40d4-8440-054c8a6e5d0b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Description\nAbbott Laboratories agreed to $5.475 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce doctors to implant the company's carotid, biliary and peripheral vascular products.\nGlobal Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration. The resolution - the second largest payment by a drug company - includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million. Abbott also will be subject to court-supervised probation and reporting obligations for Abbotts CEO and Board of Directors.\nAbbott Laboratories Inc., B. Braun Medical Inc. and Roxane Laboratories Inc. n/k/a Boehringer Ingelheim Roxane Inc. and affiliated entities agreed to pay $421 million to settle False Claims Act allegations, that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products knowing that federal healthcare programs relied on those reported prices to set payment rates.\n\nCalifornia-based medical device manufacturer Acclarent Inc., a subsidiary of Johnson & Johnson, agreed to pay $18 million to resolve allegations that the company caused health care providers to submit false claims to Medicare and other federal health care programs by marketing and distributing its sinus spacer product for use as a drug delivery device without Food and Drug Administration approval.\nback pay award in unfair labor practices case\nThe HHS Inspector General announced that Advanced Neuromodulation Systems, Inc.,  a medical device manufacturer specializing in spinal cord stimulation used for pain management, agreed to pay $2.95 million to settle allegations that it paid kickbacks to physicians in violation of the Civil Monetary Penalties Law (CMPL). The company also entered into a 3-year Corporate Integrity Agreement.\nThe U.S. Environmental Protection Agency announced that an Irvine, Calif. company, Advanced Sterilization Products, has agreed to pay a $136,800 penalty for the sale and distribution of unregistered and misbranded pesticides to veterinary clinics and laboratories nationwide.\nSettlement of a civil money penalty action against Advanced Sterilization Products, a division of Ethicon Inc., a Johnson & Johnson company, and two of ASP's executives alleging that ASP manufactured and distributed adulterated and misbranded sterilization monitoring products.\n\nAmerican pharmaceutical manufacturer Allergan Inc. has agreed to plead guilty and pay $600 million to resolve its criminal and civil liability arising from the company's unlawful promotion of its biological product, Botox Therapeutic, for uses not approved as safe and effective by the Food and Drug Administration. The resolution included a criminal fine and forfeiture totaling $375 million and a civil settlement with the federal government and the states of $225 million.\nAllergan Inc. admitted securities law violations and agreed to pay a $15 million penalty for disclosure failures in the wake of a hostile takeover bid.\nAlpharma Inc. agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug Kadian. The settlement resolved allegations that between January 1, 2000 and December 29, 2008 Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug. \nGeneric drug manufacturers Alpharma Inc. and Perrigo Company agreed to give up a total of $6.25 million in illegal profits to settle Federal Trade Commission allegations that their agreement to limit competition for over-the-counter store-brand children's liquid ibuprofen drove up prices and violated federal law.\n\nU.S. District Judge Sterling Johnson, Jr. accepted a guilty plea by American biotechnology giant Amgen Inc. for illegally introducing a misbranded drug into interstate commerce. The plea is part of a global settlement with the United States in which Amgen agreed to pay $762 million to resolve criminal and civil liability arising from its sale and promotion of certain drugs.\nAmgen Inc. agreed to pay the United States $24.9 million to settle allegations that it violated the False Claims Act. The company was accused of paying kickbacks  to long-term care pharmacy providers Omnicare Inc., PharMerica Corporation and Kindred Healthcare Inc. in return for implementing \"therapeutic interchange\" programs that were designed to switch Medicare and Medicaid beneficiaries from a competitor drug to Amgen's Aranesp.\nback pay award in unfair labor practices case\n\nAstellas Pharma US Inc. agreed to pay $7.3 million to resolve allegations that it violated the False Claims Act in connection with its marketing and promotion of the drug Mycamine for pediatric use, which had not received FDA approval.\nAstraZeneca agreed to pay $250,000 to 124 women who allegedly were subjected to pay discrimination while working at the corporation's Philadelphia Business Center in Wayne, Pa. The action resolved a lawsuit filed by the U.S. Department of Labor in May 2010 alleging that the company discriminated against female sales specialists by paying them salaries that were, on average, $1,700 less than their male counterparts. \nAstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration, the Departments of Justice and Health and Human Services' Health Care Fraud Enforcement Action Team.\nAstraZeneca LP agreed to pay the United States and participating states a total of $46.5 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program.\nAstraZeneca LP, a pharmaceutical manufacturer based in Delaware, agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act.\nMylan Pharmaceuticals, UDL Laboratories, AstraZeneca Pharmaceuticals and Ortho McNeil Pharmaceutical entered into settlement agreements for a total of $124 million to resolve claims that they violated the False Claims Act by failing to pay appropriate rebates to state Medicaid programs for drugs paid for by those programs.\nAstraZeneca Pharmaceuticals LP pleaded guilty in federal district court in Wilmington, Delaware and agreed to pay $354.9 million to resolve criminal charges and civil liabilities in connection with its drug pricing and marketing practices with regard to Zoladex, a drug used primarily for the treatment of prostate cancer. AstraZeneca agreed to pay a criminal fine of $63.9 million as part of pleaded guilty to conspiring to violate the Prescription Drug Marketing Act by causing to be submitted claims for payment for the prescription of Zoladex which had been provided as free samples to urologists. AstraZeneca agreed to settle its federal civil False Claim Act liabilities and to pay the U.S. government $266.1 million to resolve allegations it caused false and fraudulent claims to be filed with the Medicare; another $24.9 million was to be paid to states to resolve similar claims concerning Medicaid.\n\nAventis Pharmaceutical Inc. agreed to pay the United States $95.5 million to settle allegations that it violated the False Claims Act by misreporting drug prices in order to reduce its Medicaid Drug Rebate obligations.\nAventis Pharmaceuticals Inc. paid the United States and a number of states, as well as the District of Columbia, over $190 million to resolve allegations that the company caused false claims to be filed with Medicare and other federal health programs as a result of the company's alleged fraudulent pricing and marketing of drugs. Aventis, which changed its name to Sanofi-Aventis,  agreed to settle False Claims Act allegations concerning its pricing and marketing of Anzemet, an antiemetic drug used primarily in conjunction with oncology and radiation treatment to prevent nausea and vomiting. \nThe SEC announced fraud charges against a Massachusetts-based biotech company and three former executives for misleading investors about the company's efforts to obtain Food and Drug Administration approval for its flagship developmental drug to treat kidney cancer. The SEC alleged that AVEO Pharmaceuticals Inc. concealed the FDA's level of concern about Tivozanib in public statements to investors by omitting the critical fact that FDA staff had recommended a second clinical trial to address their concerns about patient death rates during the first clinical trial.  When the FDA made public months later that it had recommended an additional clinical trial, the company's stock price declined 31 percent.  AVEO never conducted an additional trial, and the FDA later refused to approve Tivozanib.\n\n\nBiovail Corporation agreed to pay $10 million to settle allegations of engaging in a number of fraudulent accounting schemes and making a series of misstatements to analysts and investors.\nDeficient Filer\n\nBoehringer Ingelheim Pharmaceuticals Inc. agreed to pay $95 million to resolve allegations relating to the improper promotion of the stroke-prevention drug Aggrenox, the chronic obstructive pulmonary disease drugs Atrovent and Combivent, and the hypertension drug Micardis.\nback pay award in unfair labor practices case\nBoehringer Ingelheim Vetmedica, Inc., (BIV), has agreed to pay a $300,000 civil penalty to the United States to settle a series of alleged violations of the federal Clean Air Act at its veterinary health products facility in St. Joseph, Mo.\nBoehringer Ingelheim Vetmedica, Inc., a veterinary health products company, has agreed to pay a $68,475 civil penalty to the United States to settle a series of Resource Conservation and Recovery Act violations based on its mishandling of mercury waste in St. Joseph, Mo.\n\nBristol-Myers Squibb agreed to reduce the output of ozone-depleting refrigerants at multiple industrial facilities around the country at a combined cost of $3.65 million in order to resolve violations of the Clean Air Act.\nBristol-Myers Squibb Company agreed to plead guilty and pay a $1 million criminal fine for lying to the federal government about a patent deal involving a popular blood-thinning drug. The company's actions allegedly  threatened to reduce competition for the drug Plavix that could have reduced the cost of blood-thinning drugs sold to heart attack, stroke and other patients.\nDrug maker Bristol-Myers Squibb Company was fined $2.1 million for failing to inform the Federal Trade Commission of an agreement reached with Apotex, Inc. under which which Apotex agreed not to launch its generic version of Plavix for several years, and Bristol-Myers stated that it would not compete with Apotex during the first 180 days after Apotex did market its new generic drug.\nBristol-Myers Squibb Company and its wholly owned subsidiary Apothecon, Inc. agreed to pay $515 million to resolve a broad array of civil allegations involving their drug marketing and pricing practices.\nBristol-Myers Squibb Company agreed to pay $150 million to settle allegations that it perpetrated a fraudulent earnings management scheme by, among other things, selling excessive amounts of pharmaceutical products to its wholesalers ahead of demand, improperly recognizing revenue from $1.5 billion of such sales to its two largest wholesalers and using cookie jar reserves to meet its internal sales and earnings targets and analysts' earnings estimates.\n\nWI-2006-0168-US0586\nWI-2005-0125-US0586\nCephalon Inc. agreed to enter a criminal plea and pay a $50 million criminal penalty and a $375 million civil settlement to resolve claims that it marketed three drugs for uses not approved by the Food and Drug Administration.\nCephalon Inc. agreed to pay the United States and participating states a total of $7.5 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program.\nThe Federal Trade Commission reached a settlement resolving a suit accusing Cephalon, Inc. of illegally blocking generic competition to its blockbuster sleep-disorder drug Provigil. The settlement ensures that Teva Pharmaceutical Industries, Ltd., which acquired Cephalon in 2012, will make a total of $1.2 billion available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon's illegal conduct.\nDeficient Filer\n\nMississippi-based Cypress Pharmaceutical Inc., its subsidiary Hawthorn Pharmaceuticals Inc. and its CEO, Max Draughn, have agreed to pay $2.8 million to resolve civil allegations under the False Claims Act, the Justice Department announced. The government alleged that between 2003 and 2009, Cypress, Hawthorn and Draughn were responsible for marketing three pharmaceutical products that were not approved as safe and effective by the Food and Drug Administration (FDA). The products were Hylira, a gel used for the treatment of dry skin, Zaclir, an acne treatment and Zacare, another acne treatment.\nDaiichi Sankyo Inc., a global pharmaceutical company with its U.S. headquarters in New Jersey, agreed to pay the United States and state Medicaid programs $39 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce physicians to prescribe Daiichi drugs.\nDava Pharmaceuticals Inc. agreed to pay the United States $11 million to settle allegations that it violated the False Claims Act by misreporting drug prices in order to reduce its Medicaid Drug Rebate obligations.\nDey Inc., Dey Pharma L.P. and Dey L.P. Inc. agreed to pay $280 million to settle False Claims Act allegations that they engaged in a scheme to report false and inflated prices for numerous pharmaceutical products, knowing that federal health care programs relied on those reported prices to set payment rates.\nDey, Inc., a manufacturer of prescription drugs for the treatment of allergies and respiratory diseases, agreed to pay the United States and the state of Texas $18.5 million to settle allegations of health care fraud.\n\nIrish pharmaceutical manufacturer Elan Corporation PLC and its U.S. subsidiary Elan Pharmaceuticals Inc. agreed to pay more than $203 million to resolve criminal and civil liability arising from the illegal promotion of the epilepsy drug Zonegran. In a separate civil settlement, Japanese drug marketer Eisai Inc., which purchased the drug from Elan, will pay $11 million to resolve civil liability for off-label marketing of Zonegran.\n\nIrish pharmaceutical manufacturer Elan Corporation PLC and its U.S. subsidiary Elan Pharmaceuticals Inc. agreed to pay more than $203 million to resolve criminal and civil liability arising from the illegal promotion of the epilepsy drug Zonegran. In a separate civil settlement, Japanese drug marketer Eisai Inc., which purchased the drug from Elan, will pay $11 million to resolve civil liability for off-label marketing of Zonegran.\n\nEli Lilly and Company agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa for uses not approved by the Food and Drug Administration. This resolution included a criminal fine of $515 million, the forfeiture of $100 million in assets, and up to $800 million in a civil settlement with the federal government and the states.\nEli Lilly and Company agreed to plead guilty and to pay $36 million in connection with its illegal promotion of its pharmaceutical drug Evista.\n\nOH-2004-0250-US0482\nOH-2006-0107-US0482\n\n\nUnder the terms of a Consent Decree lodged in federal court, EMD Millipore Corp. of Jaffrey, N.H., agreed to upgrade its on-site wastewater treatment system to comply with the terms of the company's industrial wastewater discharge permit and prevent pretreatment violations of the federal Clean Water Act (CWA). The company also agreed to pay a civil penalty of $385,000 for alleged violations of the CWA.\nEMD Millipore Corporation, of Billerica, Mass., has agreed to pay $2,681,500 in civil penalties to settle EPA allegations that it violated the federal pesticide law and regulations on numerous instances over many years.\nPharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo's marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the Food and Drug Administration. The resolution included a deferred prosecution agreement and forfeiture totaling $20.8 million and civil false claims settlements with the federal government and the states and the District of Columbia totaling $171.9 million. \nThe United States Attorney for the Southern District of New York and the Office of Inspector General for the Department of Health and Human Services announced a $39 million settlement against Vintage Pharmaceuticals, LLC d/b/a Qualitest Pharmaceuticals and  Vintage's corporate parent Endo Pharmaceuticals, Inc. in a civil fraud lawsuit.\nEon Labs Inc. agreed to pay the United States $3.5 million to resolve False Claims Act allegations relating to the company's drug Nitroglycerin Sustained Release (SR) capsules.\nEthex Corporation, a wholly owned subsidiary of St. Louis-based drug manufacturer, KV Pharmaceutical Company, pleaded guilty to two felonies and was sentenced in connection with the manufacturing of oversized prescription drug tablets. The government had charged that, despite having knowledge that the two drugs did not meet required specifications, Ethex violated the law by intentionally withholding this information from the Food and Drug Administration (FDA). Given the seriousness of Ethex's conduct and the risk it posed to consumers of its drugs, the Justice Department pursued felony charges. According to charges presented in U.S. District Court in St. Louis, Ethex failed to submit required \"field alert reports\" to the FDA in 2008 concerning two drugs, propafenone and dextroamphetamine sulfate.  Following the recommendations of a plea agreement, Judge E. Richard Webber sentenced Ethex to pay a fine of more than $23.4 million, pay approximately $2.3 million in restitution to Medicare and Medicaid for their approximate losses, and forfeit nearly $1.8 million to the United States.\n\nForest Laboratories LLC, located in New York, New York, and its subsidiary, Forest Pharmaceuticals Inc., agreed to pay $38 million to resolve allegations that they violated the False Claims Act by paying kickbacks to induce physicians to prescribe the drugs Bystolic, Savella, and Namenda.\nDrug manufacturer Forest Pharmaceuticals Inc. was sentenced by U.S. District Judge Nancy Gertner to pay a criminal fine of $150 million and forfeit assets of $14 million following the company's guilty plea in November 2010 to one felony count of obstructing justice, one misdemeanor count of distributing an unapproved new drug in interstate commerce and one misdemeanor count of distributing a misbranded drug in interstate commerce, the Justice Department announced. The company, a subsidiary of New York City-based Forest Laboratories Inc., pleaded guilty to charges related to obstruction of an FDA regulatory inspection, to the distribution of Levothroid, which at the time was an unapproved new drug, and to the illegal promotion of the anti-depressant drug Celexa for use in treating children and adolescents.\n\n\nPharmaceutical companies Genentech Inc. and OSI Pharmaceuticals LLC agreed to pay $67 million to resolve False Claims Act allegations that they made misleading statements about the effectiveness of the drug Tarceva to treat non-small cell lung cancer. The announcement did not indicate how much each company would pay. Here we assume the total was split evenly between them.\nGenzyme Corp. agreed to pay $22.28 million to resolve allegations that it marketed, and caused false claims to be submitted to federal and state health care programs for use of, a \"slurry\" version of its Seprafilm adhesion barrier.\nGenzyme Corporation, a wholly-owned biotechnology subsidiary of French pharmaceutical company Sanofi, agreed to resolve criminal charges that it violated the federal Food, Drug and Cosmetic Act with regard to the unlawful distribution of Seprafilm, a surgical device it marketed and promoted. As part of the agreed resolution, the department filed a two-count criminal information in the U.S. District Court for the Middle District of Florida charging that between 2005 and 2010, Genzyme caused a medical device to become adulterated and misbranded while being held for sale.  The conduct occurred prior to Sanofi's acquisition of Genzyme, based in Cambridge, Massachusetts, in 2011.  To resolve these charges, Genzyme agreed to enter into a deferred prosecution agreement with the government for a term of at least two years.  As part of the agreement, Genzyme agreed to admit to and accept responsibility for the facts underlying the charges and pay a monetary penalty of $32,587,439.\nGlaxoSmithKline paid $150 million to resolve allegations that the company violated the False Claims Act through fraudulent drug pricing and marketing of two anti-emetic drugs, Zofran and Kytril, used primarily in conjunction with oncology and radiation treatment.\nGlobal health care giant GlaxoSmithKline LLC) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices. The resolution is the largest health care fraud settlement in U.S. history and the largest payment ever by a drug company.\nIn a settlement with the U.S. Environmental Protection Agency, GlaxoSmithKline, LLC (GSK) has agreed to properly manage the hazardous waste at its research and development facility in King of Prussia, Pa.\n\nThe U.S. Environmental Protection Agency announced that GlaxoSmithKline Vaccines has agreed to pay a civil penalty of $172,900 to resolve a Clean Air Act violation associated with the companys failure to submit a risk management plan at its facility at 553 Old Corvallis Road in Hamilton, Montana.\n\nHoechst Aktiengesellschaft, an international chemical conglomerate based in Germany, agreed to plead guilty and pay a $12 million fine for its participation in a conspiracy that suppressed competition in the world markets for an industrial chemical used in the production of commercial and consumer products, including pharmaceuticals, herbicides, and plastic additives.\nHospira Inc., a government contractor, discriminated against women in violation of Executive Order 11246 when it denied jobs to 145 female applicants for pharmacy attendant positions at its McPherson, Kansas, facility, the Office of Federal Contract Compliance Programs found. \n\n\nDeficient Filer\nThe United States Attorney for the Southern District of New York and the U.S. Department of Health and Human Services announced  that the United States settled civil fraud claims brought against Inspire Pharmaceuticals involving misleading marketing claims.\n\nISTA Pharmaceuticals, Inc. pled guilty to conspiracy to introduce a misbranded drug into interstate commerce and conspiracy to pay illegal remuneration in violation of the Federal Anti-Kickback Statute.  The guilty pleas were part of a global settlement with the United States in which ISTA agreed to pay $33.5 million to resolve criminal and civil liability arising from its marketing, distribution and sale of its drug Xibrom. \nNursing home pharmacy Omnicare Inc. agreed to pay $98 million and drug manufacturer IVAX Pharmaceuticals of agreed to pay $14 million to resolve allegations that Omnicare engaged in kickback schemes with several parties, including IVAX. \nGlobal health care giant Johnson & Johnson and its subsidiaries agreed to pay more than $2.2 billion to resolve criminal and civil liability arising from allegations relating to the prescription drugs Risperdal, Invega and Natrecor, including promotion for uses not approved as safe and effective by the Food and Drug Administration and payment of kickbacks to physicians and to the nation's largest long-term care pharmacy provider. The global resolution is one of the largest health care fraud settlements in U.S. history, including criminal fines and forfeiture totaling $485 million and civil settlements with the federal government and states totaling $1.72 billion.\n\nJohnson & Johnson agreed to pay a $21.4 million criminal penalty as part of a deferred prosecution agreement with the Department of Justice to resolve charges of improper payments by J&J subsid\n\n*** WARNING: max output size exceeded, skipping output. ***\n\nfilliated corporations agreed to pay $10 million to settle allegations of improperly reporting of the average wholesale price of its drugs, causing Medicaid to overpay.\n\nTeva Pharmaceuticals and several of its subsidiaries agreed to pay $6.5 million as part of a series of settlements between pharmaceutical companies and Hawaii of allegations that they published inflated prices for drugs and thus increased Medicaid costs.\nTeva Pharmaceuticals USA, Inc. and its subsidiaries Barr Laboratories, Ivax Corporation, and Ivax Pharmaceuticals agreed to pay a total of $1.9 million in settlement of allegations they misreported the average wholesale price of their drugs to the state Medicaid program. \nTeva Pharmaceuticals agreed to pay $169 million to California, Florida, Texas and the federal government to settle allegations that it misreported drug prices to state Medicaid programs and thus caused them to overpay for generic drugs.\nThe Louisiana Attorney General's Office announced that it had obtained a total of $88 million in settlements from 25 pharmaceutical companies to resolve allegations they overcharged the state's Medicaid program.\n\nUCB Inc. agreed to pay $9.9 million to settle multistate litigation alleging that it promoted the epilepsy drug Keppra for uses not approved by the Food and Drug Administration and thus caused false claims to be submitted to state Medicaid programs. This was part of a larger $34 million civil and criminal settlement involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-ucb-inc\nA group of 11 companies agreed to pay a total of $25.03 million to settle multistate litigation alleging they conspired to fix the prices of vitamins added to foods such as ready-to-eat cereals. The announcement did not specify how much each company would pay. Here we assume the total was divided equally among them.\nIn a case brought by the Ohio AG on behalf of the state teachers retirement system and other investors, Pershing Square Capital Management and Valeant Pharmaceuticals agreed to pay a total of $290 million to resolve allegations that they violated insider-trading laws and harmed Allergan investors during an effort to take over that company. A public pension fund in Iowa was a co-lead plaintiff in the case. The announcement did not indicate how much each company would pay. Here we assume the total was divided equally between them.\nWarner Chilcott agreed to pay $5.5 million to settle multistate litigation alleging that it worked with its competitor Barr Pharmaceuticals to unlawfully deny consumers the opportunity to purchase a less expensive, generic version of the oral contraceptive Ovcon.\nWarner Chilcott agreed to pay $10.6 million to settle multistate litigation alleging that it promoted several of its drugs for uses not approved by the Food and Drug Administration and thus caused false claims to be submitted to state Medicaid programs. This was part of a larger $125 million civil and criminal settlement involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-warner-chilcott-plc\nWarner-Lambert, a subsidiary of Pfizer, agreed to pay $190 million to resolve multistate litigation relating to the marketing of its drug Neurontin for uses not approved by the Food and Drug Administration. The total included $152 million to be paid to state Medicaid programs and $38 million to state consumer fraud offices. All this was part of a larger $430 million civil and criminal settlement also involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-warner-lambert\nWarrick Pharmaceuticals Corporation and Schering-Plough Corp. agreed to pay a total of $750,000 in settlement of allegations they misreported the average wholesale price of their drugs.  \nMisleading reporting on wholesale drug prices, inflating costs for Medicaid.\nWatson Pharmaceuticals agreed to pay $70 million to Florida, Texas and local governments in New York to resolve allegations that it knowingly set and reported false and inflated prices for medications dispensed by pharmacies and other providers who were then reimbursed by state Medicaid programs.\nWatson Pharmaceuticals, Inc. and Watson Pharma, Inc. agreed to pay $1.7 million in settlement of allegations they misreported the average wholesale price of their drugs.\nWatson Pharmaceuticals, Inc. agreed to pay over $2.4 million in settlement of alleged improper reporting of the average wholesale price of its drugs, causing Medicaid to pay inflated amounts.\nWatson, Inc. was ordered to pay more than $33 million in judgment of alleged improper reporting of the average wholesale price of its drugs, causing Medicaid to pay inflated amounts.\nFalsification of wholesale drug price reporting. Federal government shared in the settlement. Penalty amount listed here is state portion only.\nWyeth and its parent Pfizer agreed to pay $371 million to resolve multistate allegations that Wyeth knowingly reported to Medicaid agencies false and fraudulent prices on two of its proton pump inhibitor drugs, Protonix Oral and Protonix IV. This was part of a larger $784 million settlement involving the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-pfizer-inc-2\nWyeth agreed to pay $257.4 million to settle multistate litigation alleging that it promoted the sale and use of the kidney transplant drug Rapamune for uses not approved by the U.S. Food and Drug Administration. This was part of a larger $490.9 million civil and criminal settlement also involving the federal government, which issued its own announcement; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-wyeth-pharmaceuticals-inc\nAvanir Pharmaceuticals agreed to pay $103 million to resolve civil False Claims Act allegations ($95.972 million to the federal government and $7 million to the states) and $12.8 million to resolve criminal kickback allegations in a case involving payments to physicians to induce prescriptions of its drug Nuedexta.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nThe Illinois Attorney General Kwame announced the recovery of $242 million in a settlement with numerous drug companies resolving allegations the companies inflated the wholesale prices used in setting the rates for Medicaid reimbursements.\nJohnson & Johnson and its subsidiary Ethicon, Inc. agreed to pay over $116 million to 41 states and the District of Columbia to settle litigation alleging deceptive marketing of transvaginal surgical mesh devices.\nAvanir Pharmaceuticals agreed to pay $7 million to the states to resolve civil False Claims Act relating to payments made to physicians to induce prescriptions of its drug Nuedexta. This was part of a larger $115 million civil and criminal settlement involving the federal governmen (see separate entry).\n\nMylan N.V. agreed to pay $30 million to settle SEC allegations relating to allegations of accounting and disclosure failures relating to a Department of Justice probe into whether Mylan overcharged Medicaid by hundreds of millions of dollars for EpiPen, its largest revenue and profit generating product.\nJohnson & Johnson agreed to pay $506,000 to the District Attorneys of Fresno, San Joaquin, Shasta and Yolo counties to resolve allegations that packaging for Neutrogena and other products was misleading.\nrace and retaliation\nThe Food and Drug Administration announced that Wyeth-Ayerst Laboratories Division of American Home Products Corporation and Wyeth- Ayerst Pharmaceuticals, Inc. signed a consent decree of permanent injunction in which Wyeth agreed to a series of measures aimed at ensuring that the products manufactured at Wyeth's Marietta, Pa. and Pearl River, N.Y. facilities are made in compliance with FDA's good manufacturing practice regulations.\nClean Air Act\nThe Nevada Attorney General reached a $9.5 million settlement with Pfizer Inc. to resolve allegations that Pfizer and Wyeth Pharmaceuticals unlawfully promoted certain postmenopausal hormone therapy medications and misled Nevada consumers and physicians about the safety and efficacy of these drugs.\nClean Air Act\n\nMerck paid $6.2 million to resolve a class action suit alleging that its practices discriminated against women sales rep who took maternity leave.\n\nSanofi-Aventis U.S., LLC agreed to pay $11.85 million to resolve allegations that it violated the False Claims Act by paying kickbacks to Medicare patients through a purportedly independent charitable foundation.\nSandoz Inc. entered into a deferred prosecution agreement and agreed to pay $195 million to resolve charges of conspiring to allocate customers, rig bids, and fix prices for generic drugs.\n\nMallinckrodt agreed to pay $1.6 billion to settle multistate litigation over its role in the opioid crisis.\nThe Oklahoma Attorney General reached an out-of-court settlement with Endo Pharmaceuticals totaling $8.75 million for the company's alleged role in the state's opioid crisis.\nApotex Corp., a generic pharmaceutical company headquartered in Florida, agreed to pay a criminal penalty of $24.1 million under a deferred prosecution agreement relating to fixing the price of the generic drug pravastatin.\nThe State of West Virginia reached a $3.9 million settlement with Johnson & Johnson regarding the marketing of surgical mesh devices and hip replacement systems.\nThe California Insurance Commissioner reached a $30 million settlement with pharmaceutical giant Bristol-Myers Squibb over allegations of drug marketing fraud and physician kickbacks. \nThe California Insurance Commissioner reached a $1.1 million settlement with pharmaceutical company Novo Nordisk Inc. over allegations that Novo Nordisk's drug Victoza was extensively promoted for uses not approved of by the Food and Drug Administration, a violation of the Insurance Frauds Prevention Action. \nThe California Insurance Commissioner reached a $1.875 million settlement with Valeant Pharmaceuticals, Inc. relating to its former relationship with Philidor Rx Services LLC and claims for reimbursement or payment for Valeant products submitted by Philidor to California insurers.\nThe California Attorney General announced an $11.8 million settlement against Novartis Pharmaceuticals Corporation related to allegations that the company engaged in a kickback scheme from January 2002 through November 2011 that impacted beneficiaries of Medicare and Medi-Cal. Novartis was accused of violating the federal Anti-Kickback Statute and False Claims Act, as well as the California False Claims Act, by offering payment in the form of cash, meals, and honoraria to healthcare practitioners to encourage them to prescribe certain Novartis drug products, including drugs such as Lotrel, Valturna, Starlix, Tekamlo, Diovan HCT, Tekturna HCT, and Exforge HCT, Diovan, and Exforge, to recipients of Medicare and Medicaid.\n\nMassachusetts-based DUSA Pharmaceuticals, Inc., a subsidiary of Sun Pharmaceutical Industries, Inc., agreed to pay the United States $20.75 million to resolve allegations that it caused physicians to submit false claims to Medicare and the Federal Employee Health Benefit Program by knowingly promoting an administration process for the drug Levulan Kerastick that contradicted the product instructions approved by the U.S. Food and Drug Administration and was unsupported by sufficient clinical evidence.  \nIndivior Solutions pleaded guilty to a one-count felony information and, together with its parent companies Indivior Inc. and Indivior plc, agreed to pay a total of $600 million to resolve criminal and civil liability associated with the marketing of the opioid-addiction-treatment drug Suboxone.  Indivior Solutions pleaded guilty to a one-count felony criminal information charging false statements relating to health care matters and agreed to pay a criminal fine, forfeiture, and restitution totaling $289 million. Under the civil settlement, Indivior Inc. and Indivior plc agreed to pay a total of $300 million to resolve claims that the marketing of Suboxone caused false claims to be submitted to government health care programs. The $300 million settlement amount included approximately $209.3 million to the federal government and $90.7 million to states that opt to participate in the agreement. Indivior also agreed to pay $10 million to the Federal Trade Commission (see separate entry).\nNovartis Pharmaceuticals Corporation agreed to pay over $642 million in separate settlements resolving claims that it violated the False Claims Act.  The first settlement pertained to the company's alleged illegal use of three foundations as conduits to pay the copayments of Medicare patients taking Novartis's drugs Gilenya and Afinitor.  The second settlement resolved claims arising from the company's alleged payments of kickbacks to doctors. A portion of the total went to the states to resolve litigation brought by attorneys general (see separate entry).\nA subsidiary of Novartis agreed to pay $233 million in criminal penalties to resolve allegations that it bribed employees of state-owned and state-controlled hospitals and clinics in Greece and falsely recorded improper payments relating to the corrupt scheme and similar conduct.\nIndivior, Inc. agreed to pay $10 million to settle Federal Trade Commission allegations that it violated antitrust laws through a deceptive scheme to thwart lower priced generic competition with its branded opioid replacement therapy drug Suboxone.\nNovartis agreed to pay $103 million to settle multistate litigation alleging it paid kickbacks to health care practitioners to prescribe various hypertension or diabetes medications. This was part of a larger settlement involving the federal government (see separate entry).\nPacira agreed to pay $3.5 million to settlement litigation brought by the United States and 15 states alleging it paid kickbacks in the form of research grants to increase sales of its product Exparel. The settlement was also announced by the Justice Department (see separate entry).\n\nBausch Health, formerly Quebec, Canada-based Valeant Pharmaceuticals, agreed to pay a $45 million penalty to settle charges of improper revenue recognition and misleading disclosures in SEC filings and earnings presentations. \nThe SEC found that two Alexion subsidiaries made payments to foreign government officials to secure favorable treatment for Alexion's drug Soliris.\nThe SEC found that subsidiaries or affiliates of Novartis or its former subsidiary Alcon Inc. engaged in schemes to make improper payments or to provide benefits to public and private healthcare providers in South Korea, Vietnam, and Greece in exchange for prescribing or using Novartis or Alcon products.\n\nThe California Insurance Commissioner resolved a lawsuit against AbbVie Inc. alleging violations of the California Insurance Frauds Prevention Act involving the marketing of the prescription drug HUMIRA.  AbbVie agreed to reform its HUMIRA marketing practices in California, including disclosing that registered nurses employed as Ambassadors to interact with patients about HUMIRA are actually paid by the company, not a medical provider, and reforming how HUMIRA is marketed to health care providers. In addition, as provided for in the Act, AbbVie has also paid a combined $24 million to the State of California and the whistleblower who brought the case to the Department's attention.   \nThe Department of Justice announced an $8 billion global resolution of its criminal and civil investigations into abuses by the opioid manufacturer Purdue Pharma LP. The company agreed to plead guilty to a three-count felony information charging it with one count of dual-object conspiracy to defraud the United States and to violate the Food, Drug, and Cosmetic Act, and two counts of conspiracy to violate the Federal Anti-Kickback Statute.  The criminal resolution included the largest penalties ever levied against a pharmaceutical manufacturer, including a criminal fine of $3.544 billion and an additional $2 billion in criminal forfeiture, with $225 million of the latter effective on the date of the company's bankruptcy. Purdue also agreed to a civil settlement in the amount of $2.8 billion to resolve its civil liability under the False Claims Act.\nGilead Sciences, Inc. agreed to pay $97 million to resolve claims that it violated the False Claims Act by illegally using a foundation as a conduit to pay the copays of thousands of Medicare patients taking Gilead's pulmonary arterial hypertension drug, Letairis.\nHazardous Waste\nhazardous waste violation\nhazardous waste violation\n\nair pollution violation\npesticide violation\npesticide violation\npesticide violation\npesticide violation\npesticide violation\npesticide violation\npesticide violation\npesticide violation\nPhibro-Tech agreed to pay a $495,000 penalty, with up to 50% paid as a Supplemental Environmental Project, in settlement of allegations it violated hazardous waste regulations at its Santa Fe Springs facility.\nNeutrogena agreed to pay a $416,248 civil penalty in settlement of allegations it treated hazardous waste without a permit, disposed of hazardous waste in normal waste, and failed to properly manage hazardous waste or comply with regulations.\nhazardous waste violations\n\n\n\nPharmaceutical company Biogen, Inc.  agreed to pay $22 million to resolve claims that it violated the False Claims Act by illegally using  foundations as a conduit to pay the copays of Medicare patients taking Biogen's multiple sclerosis drugs Avonex and Tysabri.\nhazardous waste violation\nRadiation Control Act\nHazardous Waste Management Act\nwaste management violation\nwaste management violation\nwaste management violation\nair pollution violation\nhazardous waste violation\nair pollution violation\nair pollution violation\nair pollution violation\nair pollution violation\nShire Human Genetic Therapies agreed to pay $400,000 in civil penalties and $200,000 to a community environment and health project in settlement of allegations it exceeded permit limits for volatile organic compounds and failed to comply with recording and reporting requirements.\n\n\n\nhazardous waste violation\nair pollution violation\nwaste management violation\nhazardous waste violation\nair quality violation\nhazardous waste violation\nair quality violation\nwater quality violation\nair quality violation\nhazardous waste violation\nair quality violation\nhazardous waste violation\nhazardous waste violation\nair quality violation\nair quality violation\nair quality violation\nair quality violation\nsolid waste violation\nair quality violation\nhazardous waste violation\nair quality violation\nwater quality violation\nwater quality violation\nair quality violation\nhazardous waste violation\nair quality violation\nair quality violation\nair quality violation\nair quality violation\nair quality violation\nair quality violation\nhazardous waste violation\nair quality violation\nwater quality violation\nair quality violation\n\n\n\n\n\n\nhazardous waste violation\nair quality violation\n\n\nIndivior agreed to pay over $300 million to state governments to resolve allegations that it falsely and aggressively marketed Suboxone, resulting in improper use of state Medicaid funds. Suboxone is a drug product approved for use by recovering opioid addicts to avoid or reduce withdrawal symptoms while they undergo treatment. \nClean Air Act\nThe settlement resolved allegations that, from November 2011 through December 2014, Incyte Corporation purportedly used an independent foundation as a conduit to pay the copays of certain federal beneficiaries taking Incyte' drug Jakafi, which was approved to treat myleofibrosis in 2011. Specifically, Incyte was the sole donor to a fund that was opened in November 2011 to assist only myleofibrosis patients. After the fund opened, the government alleges that Incyte used the fund to pay the copays of federal beneficiaries taking Jakafi who were ineligible for assistance from the fund because they did not have myleofibrosis. Incyte managers pressured the foundation, through phone calls and emails, to provide economic assistance to these ineligible patients, and Incyte's contractor helped ineligible patients to complete applications submitted to the fund for assistance. The government alleges that through this conduct, Incyte caused false claims for Jakafi to be submitted to Medicare and TRICARE.\nBristol-Myers Squibb agreed to pay the United States and participating states a total of $75 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program. Of that amount, BMS will pay approximately $41 million, plus interest, to the United States, and the remainder to states participating in the settlement.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSt. Jude Medical Inc. agreed to pay $27 million to settle allegations under the False Claims Act that, between November 2014 and October 2016, it knowingly sold defective heart devices to health care facilities that, in turn, implanted the devices into patients insured by federal health care programs.\nMedical device manufacturers Alere Inc. and Alere San Diego Inc. agreed to pay $38.75 million to resolve allegations that the companies violated the False Claims Act by billing, and causing others to bill, the Medicare program for defective rapid point-of-care testing devices.\nThe Maryland Attorney announced the state had recovered $15 million from GlaxoSmithKline, LLC, resolving allegations that the company engaged in improper marketing of the prescription drugs Avandia, Avandamet and Avandaryl, all of which are used to treat diabetes.\nA federal bankruptcy judge approved a deal worth an estimated $10 billion between Purdue Pharma and state governments (and others) that had sued the company over its role in causing and perpetuating the opioid crisis. The settlement included a plan under which Purdue Pharma would be converted into a trust with responsibility for distributing funds for treatment programs. The settlement included payment of $4.3 billion by the Sackler family, which has controlled the company and which grew enormously wealthy from its operations. In exchange, the family was granted immunity from opioid lawsuits. \nBristol Myers Squibb agreed to pay a total of $75 million in settlement of allegations it overcharged state Medicaid programs for drugs.\nJohnson & Johnson, the parent company of Janssen Pharmaceuticals, reached an agreement with a group of states under which it would pay $5 billion to resolve Janssen's involvement in litigation alleging improper sale of pain medications, contributing to the national opioid epidemic.\nsettlement with drug manufacturer in multi-company opioid litigation\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"description\" column from each row in the dataset pharma_with_none\n",
    "description = pharma_with_none.map(lambda row: row[10] if len(row) > 10 else None)\n",
    "\n",
    "# Display the description column values\n",
    "for value in description.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e7a2eefc-fba2-4e2e-8ac2-2e38e4ac39e2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'description': 298\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = description.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'description':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "9a1b7cd4-f660-482b-97c5-d7a898a10535",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 298\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"description\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[10] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[10] == '':\n",
    "        row[10] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_description = pharma_with_none.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_description.filter(lambda row: row[10] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "7f90b04e-de22-476c-9bf8-ca08f11815be",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Level_of_Government\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nstate\nstate\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nstate\nstate\nfederal\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nstate\nfederal\nfederal\nfederal\nfederal\nstate\nstate\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nstate\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nstate\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nfederal\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nfederal\nstate\nstate\nfederal\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nfederal\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nfederal\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nfederal\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nfederal\nfederal\nlocal\nfederal\nfederal\nfederal\nstate\nfederal\nfederal\nfederal\nstate\nfederal\nfederal\nfederal\nstate\nstate\nfederal\nstate\nstate\nstate\nstate\nstate\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nstate\nstate\nfederal\nfederal\nfederal\nfederal\nfederal\nstate\nfederal\nfederal\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nfederal\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nstate\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nfederal\nstate\nstate\nstate\nstate\nstate\nlocal\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"level_of_government\" column from each row in the dataset pharma_with_none_description\n",
    "level_of_government = pharma_with_none_description.map(lambda row: row[11] if len(row) > 11 else None)\n",
    "\n",
    "# Display the level_of_government column values\n",
    "for value in level_of_government.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "ea946c23-2e16-4b59-95f3-738f475db86a",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'level_of_government': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = level_of_government.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'level_of_government':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "42ee8e55-7c83-49bf-accf-25c3a4a39662",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Action_Type\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nprivate litigation\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nagency action\nagency action\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nprivate litigation\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nprivate litigation\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nprivate litigation\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nprivate litigation\nprivate litigation\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\nagency action\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"action_type\" column from each row in the dataset pharma_with_none_description\n",
    "action_type = pharma_with_none_description.map(lambda row: row[12] if len(row) > 12 else None)\n",
    "\n",
    "# Display the action_type column values\n",
    "for value in action_type.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "4814d9ab-1784-4ae6-9ac4-8ecfed1f8e39",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'action_type': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = action_type.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'action_type':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "25d42ace-1350-4bf0-900a-0f5c1f3acff9",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Agency\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nJustice Department Civil Division\nLabor Department Wage and Hour Division\nJustice Department Civil Division\nNational Labor Relations Board\nHealth & Human Services Department Office of Inspector General\nEnvironmental Protection Agency\nFood and Drug Administration\nLabor Department Wage and Hour Division\nFood and Drug Administration referral to the Justice Department\nSecurities and Exchange Commission\nJustice Department Civil Division\nFederal Trade Commission\nLabor Department Wage and Hour Division\nFood and Drug Administration referral to the Justice Department\nJustice Department Civil Division\nNational Labor Relations Board\nOffice of Federal Contract Compliance Programs\nJustice Department Civil Division\nOffice of Federal Contract Compliance Programs\nFood and Drug Administration referral to the Justice Department\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nSecurities and Exchange Commission\nJustice Department Civil Division\nJustice Department Civil Division\nSecurities and Exchange Commission\nLabor Department Wage and Hour Division\nLabor Department Wage and Hour Division\nSecurities and Exchange Commission\nEmployee Benefits Security Administration\nLabor Department Wage and Hour Division\nFood and Drug Administration referral to the Justice Department\nNational Labor Relations Board\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nSecurities and Exchange Commission\nJustice Department Environment and Natural Resources Division\nJustice Department Antitrust Division\nFederal Trade Commission\nJustice Department Civil Division\nSecurities and Exchange Commission\nBureau of Industry and Security\nFederal Motor Carrier Safety Administration\nFederal Motor Carrier Safety Administration\nJustice Department Civil Division\nJustice Department Civil Division\nFederal Trade Commission\nEmployee Benefits Security Administration\nOffice of Foreign Assets Control\nFood and Drug Administration referral to the Justice Department\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nOffice of Foreign Assets Control\nFood and Drug Administration referral to the Justice Department\nBureau of Industry and Security\nFood and Drug Administration referral to the Justice Department\nSecurities and Exchange Commission\nJustice Department Civil Division\nJustice Department Criminal Division\nSecurities and Exchange Commission\nFederal Motor Carrier Safety Administration\nFederal Motor Carrier Safety Administration\nOffice of Foreign Assets Control\nBureau of Industry and Security\nEnvironmental Protection Agency referral to the Justice Department\nEnvironmental Protection Agency\nFood and Drug Administration referral to the Justice Department\nU.S. Attorney-Southern District of New York\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nLabor Department Wage and Hour Division\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nOffice of Foreign Assets Control\nSecurities and Exchange Commission\nJustice Department Civil Division\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nEnvironmental Protection Agency\nSecurities and Exchange Commission\nEnvironmental Protection Agency\nFederal Motor Carrier Safety Administration\nJustice Department Antitrust Division\nOffice of Federal Contract Compliance Programs\nOffice of Foreign Assets Control\nSecurities and Exchange Commission\nEmployee Benefits Security Administration\nU.S. Attorney-Southern District of New York\nLabor Department Wage and Hour Division\nJustice Department Civil Division\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nSecurities and Exchange Commission\nJustice Department Criminal Division\nJustice Department Civil Division\nJustice Department Civil Division\nEnvironmental Protection Agency referral to the Justice Department\nFood and Drug Administration referral to the Justice Department\nJustice Department Civil Division\nLabor Department Wage and Hour Division\nJustice Department Civil Division\nSecurities and Exchange Commission\n\nFederal Railroad Administration\nDrug Enforcement Administration\nNuclear Regulatory Commission\nFederal Trade Commission\nFood and Drug Administration referral to the Justice Department\nInternal Revenue Service\nInternal Revenue Service\nJustice Department Civil Division\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nJustice Department Environment and Natural Resources Division\nEnvironmental Protection Agency\nNational Labor Relations Board\nJustice Department Civil Division\nNational Labor Relations Board\nJustice Department Antitrust Division\nFood and Drug Administration referral to the Justice Department\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nJustice Department Criminal Division\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nPennsylvania Department of Environmental Protection\nFederal Trade Commission\nJustice Department Civil Division\nSecurities and Exchange Commission\nU.S. Attorney-Southern District of New York\nOffice of Federal Contract Compliance Programs\nFood and Drug Administration referral to the Justice Department\nEmployee Benefits Security Administration\nFood and Drug Administration referral to the Justice Department\nFood and Drug Administration referral to the Justice Department\nSecurities and Exchange Commission\nJustice Department Criminal Division\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nJustice Department Civil Division\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nNational Labor Relations Board\nFederal Trade Commission\nLabor Department Wage and Hour Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nSecurities and Exchange Commission\nFood and Drug Administration referral to the Justice Department\nJustice Department Environment and Natural Resources Division\nFederal Railroad Administration\nEnvironmental Protection Agency\nJustice Department Criminal Division\nFederal Railroad Administration\nFederal Railroad Administration\nBureau of Industry and Security\nFood and Drug Administration referral to the Justice Department\nAlcohol and Tobacco Tax and Trade Bureau\nJustice Department Civil Division\nHealth & Human Services Department Office of Inspector General\nHealth & Human Services Department Office of Inspector General\nJustice Department Civil Division\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nLabor Department Wage and Hour Division\nJustice Department Civil Division\nNational Labor Relations Board\nJustice Department Civil Division\nSecurities and Exchange Commission\nSecurities and Exchange Commission\nJustice Department Civil Division\nSecurities and Exchange Commission\nFood and Drug Administration referral to the Justice Department\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nFood and Drug Administration referral to the Justice Department\nBureau of Industry and Security\nLabor Department Wage and Hour Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Criminal Division\nEnvironmental Protection Agency referral to the Justice Department\nSecurities and Exchange Commission\nJustice Department Civil Division\nNational Labor Relations Board\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nFood and Drug Administration referral to the Justice Department\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEmployee Benefits Security Administration\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nEnvironmental Protection Agency\nOccupational Safety & Health Administration\nLabor Department Wage and Hour Division\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nFood and Drug Administration referral to the Justice Department\nJustice Department Civil Division\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nSecurities and Exchange Commission\nFood and Drug Administration referral to the Justice Department\nLabor Department Wage and Hour Division\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nSecurities and Exchange Commission\nSecurities and Exchange Commission\nU.S. Attorney-District of New Jersey\nU.S. Attorney-Central District of California\nU.S. Attorney-Southern District of New York\nU.S. Attorney-Northern District of California\nU.S. Attorney-Eastern District of Pennsylvania\nU.S. Attorney-Eastern District of New York\nU.S. Attorney-Eastern District of Pennsylvania\nU.S. Attorney-District of Massachusetts\nU.S. Attorney-District of Massachusetts\nU.S. Attorney-District of Massachusetts\nU.S. Attorney-Eastern District of Pennsylvania\nU.S. Attorney-District of New Jersey\nU.S. Attorney-Eastern District of New York\nU.S. Attorney-Western District of Virginia\nU.S. Attorney-District of Massachusetts\nU.S. Attorney-District of Massachusetts\nU.S. Attorney-District of Massachusetts\nU.S. Attorney-District of New Jersey\nU.S. Attorney-Central District of California\nU.S. Attorney-District of Maryland\nAlcohol and Tobacco Tax and Trade Bureau\nJustice Department Civil Division\nJustice Department Civil Division\nSecurities and Exchange Commission\nCenters for Medicare & Medicaid Services\nCenters for Medicare & Medicaid Services\nCenters for Medicare & Medicaid Services\nCenters for Medicare & Medicaid Services\nCenters for Medicare & Medicaid Services\nCenters for Medicare & Medicaid Services\nCenters for Medicare & Medicaid Services\nCenters for Medicare & Medicaid Services\nJustice Department Civil Division\nFederal Aviation Administration\nFederal Aviation Administration\nFederal Aviation Administration\nFederal Aviation Administration\nFederal Aviation Administration\nFederal Aviation Administration\nFederal Aviation Administration\nFederal Aviation Administration\nCalifornia Labor Commissioner's Office\nU.S. Attorney-District of Maryland\n\n\n\n\n\nFederal Aviation Administration\nFederal Aviation Administration\nFederal Aviation Administration\nFederal Aviation Administration\nFederal Aviation Administration\nJustice Department Civil Division\nU.S. Attorney-Northern District of Georgia\nOffice of Federal Contract Compliance Programs\nSecurities and Exchange Commission\nJustice Department Civil Division\n\n\n\n\n\n\n\n\n\n\n\n\nOffice of Federal Contract Compliance Programs\nU.S. Attorney-Eastern District of Pennsylvania\n\n\n\n\n\n\n\n\n\nFederal Motor Carrier Safety Administration\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nEmployee Benefits Security Administration\nU.S. Attorney-Northern District of California\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nAlabama Attorney General\nLouisiana Attorney General\nNew York Attorney General\nPennsylvania Attorney General\nMultistate Attorneys General Case\nOhio Attorney General\nTexas Attorney General\nNew York Attorney General\nIowa Attorney General\nIdaho Attorney General\nMultistate Attorneys General Case\nLouisiana Attorney General\nMassachusetts Attorney General\nTexas Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMississippi Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nIdaho Attorney General\nKentucky Attorney General\nMississippi Attorney General\nMultistate Attorneys General Case\nAlabama Attorney General\nIllinois Attorney General\nWisconsin Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nIowa Attorney General\nKentucky Attorney General\nCenters for Medicare & Medicaid Services\nMassachusetts Attorney General\nWest Virginia Attorney General\nMultistate Attorneys General Case\nLouisiana Attorney General\nLouisiana Attorney General\nMultistate Attorneys General Case\nFlorida Attorney General\nKentucky Attorney General\nKentucky Attorney General\nKentucky Attorney General\nTexas Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nIdaho Attorney General\nHawaii Attorney General\nLouisiana Attorney General\nMultistate Attorneys General Case\nAlabama Attorney General\nMultistate Attorneys General Case\nNew Jersey Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nKentucky Attorney General\nMassachusetts Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nIowa Attorney General\nVermont Attorney General\nLouisiana Attorney General\nLouisiana Attorney General\nTexas Attorney General\nMultistate Attorneys General Case\nWisconsin Attorney General\nKentucky Attorney General\nMassachusetts Attorney General\nIowa Attorney General\nKansas Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nAlabama Attorney General\nPennsylvania Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nWest Virginia Attorney General\nIdaho Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nConnecticut Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nCalifornia Attorney General\nMassachusetts Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nOregon Attorney General\nLouisiana Attorney General\nConnecticut Attorney General\nMissouri Attorney General\nOhio Attorney General\nWest Virginia Attorney General\nAlabama Attorney General\nMississippi Attorney General\nMontana Attorney General\nPennsylvania Attorney General\nArkansas Attorney General\nHawaii Attorney General\nIowa Attorney General\nIdaho Attorney General\nKentucky Attorney General\nMassachusetts Attorney General\nNevada Attorney General\nTexas Attorney General\nWisconsin Attorney General\nMultistate Attorneys General Case\nLouisiana Attorney General\nCalifornia Attorney General\nMassachusetts Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nArkansas Attorney General\nMississippi Attorney General\nLouisiana Attorney General\nLouisiana Attorney General\nMultistate Attorneys General Case\nConnecticut Attorney General\nIdaho Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nNew York Attorney General\nMultistate Attorneys General Case\nCalifornia Attorney General\nTexas Attorney General\nMassachusetts Attorney General\nAlabama Attorney General\nLouisiana Attorney General\nTexas Attorney General\nMultistate Attorneys General Case\nIdaho Attorney General\nMultistate Attorneys General Case\nKentucky Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nLouisiana Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nGeorgia Attorney General\nIdaho Attorney General\nKansas Attorney General\nKentucky Attorney General\nKentucky Attorney General\nLouisiana Attorney General\nMultistate Attorneys General Case\nHawaii Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nCalifornia Attorney General\nMassachusetts Attorney General\nIowa Attorney General\nMultistate Attorneys General Case\nOregon Attorney General\nIllinois Attorney General\nMassachusetts Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMontana Attorney General\nKentucky Attorney General\nMultistate Attorneys General Case\nMassachusetts Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nTexas Attorney General\nWashington Attorney General\nLouisiana Attorney General\nHawaii Attorney General\nMultistate Attorneys General Case\nIdaho Attorney General\nWest Virginia Attorney General\nMultistate Attorneys General Case\nArkansas Attorney General\nMultistate Attorneys General Case\n\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nJustice Department Civil Division\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nAlabama Attorney General\nNew York Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nPennsylvania Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMassachusetts Attorney General\nWisconsin Attorney General\nMultistate Attorneys General Case\nHawaii Attorney General\nMultistate Attorneys General Case\nIdaho Attorney General\nKentucky Attorney General\nMultistate Attorneys General Case\nMassachusetts Attorney General\nMultistate Attorneys General Case\nTexas Attorney General\nIdaho Attorney General\nKentucky Attorney General\nMultistate Attorneys General Case\nOregon Attorney General\nMassachusetts Attorney General\nLouisiana Attorney General\nIdaho Attorney General\nKentucky Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nHawaii Attorney General\nMultistate Attorneys General Case\nTexas Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nJustice Department Civil Division\nMultistate Attorneys General Case\nVermont Attorney General\nMultistate Attorneys General Case\nLouisiana Attorney General\nMississippi Attorney General\nMultistate Attorneys General Case\nIdaho Attorney General\nKentucky Attorney General\nMassachusetts Attorney General\nMultistate Attorneys General Case\nLouisiana Attorney General\nLouisiana Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nOregon Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMassachusetts Attorney General\nTexas Attorney General\nIdaho Attorney General\nMultistate Attorneys General Case\nNew York Attorney General\nMultistate Attorneys General Case\nOregon Attorney General\nHawaii Attorney General\nOhio Attorney General\nNew York Attorney General\nWisconsin Attorney General\nTexas Attorney General\nMultistate Attorneys General Case\nNevada Attorney General\nMultistate Attorneys General Case\nKentucky Attorney General\nOklahoma Attorney General\nFlorida Attorney General\nNew York Attorney General\nIdaho Attorney General\nMississippi Attorney General\nMultistate Attorneys General Case\nLouisiana Attorney General\nOregon Attorney General\nNew York Attorney General\nTexas Attorney General\nOhio Attorney General\nFlorida Attorney General\nIowa Attorney General\nMissouri Attorney General\nAlabama Attorney General\nMultistate Attorneys General Case\nKentucky Attorney General\nLouisiana Attorney General\nIdaho Attorney General\nMississippi Attorney General\nMultistate Attorneys General Case\nWest Virginia Attorney General\nIdaho Attorney General\nMultistate Attorneys General Case\nLouisiana Attorney General\nMissouri Attorney General\nTexas Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nCalifornia Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nAlabama Attorney General\nLouisiana Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nTexas Attorney General\nNew Jersey Attorney General\nMultistate Attorneys General Case\nCalifornia Attorney General\nMassachusetts Attorney General\nAlabama Attorney General\nLouisiana Attorney General\nPennsylvania Attorney General\nArkansas Attorney General\nIdaho Attorney General\nKentucky Attorney General\nWisconsin Attorney General\nMultistate Attorneys General Case\nLouisiana Attorney General\nTexas Attorney General\nCalifornia Attorney General\nMassachusetts Attorney General\nOklahoma Attorney General\nAlabama Attorney General\nMissouri Attorney General\nIllinois Attorney General\nMissouri Attorney General\nKentucky Attorney General\nNew York Attorney General\nHawaii Attorney General\nIdaho Attorney General\nMultistate Attorneys General Case\nLouisiana Attorney General\n\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nIdaho Attorney General\nOhio Attorney General\nMultistate Attorneys General Case\nIdaho Attorney General\nMassachusetts Attorney General\nMississippi Attorney General\nTexas Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nJustice Department Civil Division\nIllinois Attorney General\nIllinois Attorney General\nIllinois Attorney General\nIllinois Attorney General\nIllinois Attorney General\nIllinois Attorney General\nIllinois Attorney General\nIllinois Attorney General\nIllinois Attorney General\nIllinois Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nOffice of Federal Contract Compliance Programs\nSecurities and Exchange Commission\nCalifornia Multi-Jurisdiction Case\nEqual Employment Opportunity Commission\nFood and Drug Administration\nEnvironmental Protection Agency referral to the Justice Department\nNevada Attorney General\nU.S. Attorney-Eastern District of Missouri\nLabor Department Wage and Hour Division\n\n\nU.S. Attorney-District of Massachusetts\nJustice Department Antitrust Division\nOffice of Federal Contract Compliance Programs\nMultistate Attorneys General Case\nOklahoma Attorney General\nJustice Department Antitrust Division\nWest Virginia Attorney General\nCalifornia Department of Insurance\nCalifornia Department of Insurance\nCalifornia Department of Insurance\nCalifornia Attorney General\nCenters for Medicare & Medicaid Services\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Civil Division\nJustice Department Criminal Division\nFederal Trade Commission\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nOffice of Federal Contract Compliance Programs\nSecurities and Exchange Commission\nSecurities and Exchange Commission\nSecurities and Exchange Commission\nU.S. Attorney-District of New Jersey\nCalifornia Department of Insurance\nJustice Department Civil Division\nJustice Department Civil Division\nAlabama Department of Environmental Management\nArkansas Division of Environmental Quality\nArkansas Division of Environmental Quality\nArizona Department of Environmental Quality\nCalifornia Air Resources Board\nCalifornia Department of Pesticide Regulation\nCalifornia Department of Pesticide Regulation\nCalifornia Department of Pesticide Regulation\nCalifornia Department of Pesticide Regulation\nCalifornia Department of Pesticide Regulation\nCalifornia Department of Pesticide Regulation\nCalifornia Department of Pesticide Regulation\nCalifornia Department of Pesticide Regulation\nCalifornia Department of Toxic Substances Control\nCalifornia Department of Toxic Substances Control\nCalifornia Department of Toxic Substances Control\nConnecticut Department of Energy & Environmental Protection\nConnecticut Department of Energy & Environmental Protection\nConnecticut Department of Energy & Environmental Protection\nJustice Department Civil Division\nFlorida Department of Environmental Protection\nGeorgia Environmental Protection Division\nGeorgia Environmental Protection Division\nIllinois Environmental Protection Agency\nIllinois Environmental Protection Agency\nIllinois Environmental Protection Agency\nIndiana Department of Environmental Management\nIndiana Department of Environmental Management\nIndiana Department of Environmental Management\nIndiana Department of Environmental Management\nIndiana Department of Environmental Management\nIndiana Department of Environmental Management\nMassachusetts Attorney General\nMassachusetts Executive Office of Energy and Environmental Affairs\nMassachusetts Executive Office of Energy and Environmental Affairs\nMassachusetts Executive Office of Energy and Environmental Affairs\nMichigan Department of Environmental Quality\nMissouri Department of Natural Resources\nNorth Carolina Department of Environmental Quality\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew Jersey Department of Environmental Protection\nNew York Department of Environmental Conservation\nNew York Department of Environmental Conservation\nNew York Department of Environmental Conservation\nNew York Department of Environmental Conservation\nOhio Environmental Protection Agency\nOhio Environmental Protection Agency\nSouth Carolina Department of Health and Environmental Control\nSouth Carolina Department of Health and Environmental Control\nVirginia Department of Environmental Quality\nVirginia Department of Environmental Quality\nMultistate Attorneys General Case\nEnvironmental Protection Agency referral to the Justice Department\nJustice Department Civil Division\nU.S. Attorney-Eastern District of Pennsylvania\nFederal Election Commission\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nOccupational Safety & Health Administration\nJustice Department Civil Division\nJustice Department Civil Division\nMaryland Attorney General\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nMultistate Attorneys General Case\nNew York Attorney General\nNew York City Commission on Human Rights\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"agency\" column from each row in the dataset pharma_with_none_description\n",
    "agency = pharma_with_none_description.map(lambda row: row[13] if len(row) > 13 else None)\n",
    "\n",
    "# Display the agency column values\n",
    "for value in agency.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "58edd90a-dab4-47a9-ae2d-3e740021d036",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'agency': 31\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = agency.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'agency':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "9ca97c15-beb3-45ba-8a9c-77f1a185a755",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 31\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"agency\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[13] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_description.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[13] == '':\n",
    "        row[13] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_agency = pharma_with_none_description.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_agency.filter(lambda row: row[13] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "64da9917-fb5a-49a6-9ed1-a4f191559bdd",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Civil/Criminal\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil and criminal\ncivil\ncivil and criminal\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncriminal\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil and criminal\ncivil\ncriminal\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil and criminal\ncivil\ncivil\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil and criminal\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil and criminal\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncriminal\ncivil\ncriminal\ncivil and criminal\ncivil\ncivil and criminal\ncivil and criminal\ncivil and criminal\ncriminal\ncriminal\ncivil and criminal\ncriminal\ncriminal\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil\ncivil\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncriminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil and criminal\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\ncivil\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"civil_criminal\" column from each row in the dataset pharma_with_none_agency\n",
    "civil_criminal = pharma_with_none_agency.map(lambda row: row[14] if len(row) > 14 else None)\n",
    "\n",
    "# Display the civil_criminal column values\n",
    "for value in civil_criminal.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "6ba85d78-090f-4490-9269-ae5049079381",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'civil_criminal': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = civil_criminal.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'civil_criminal':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "93c8d170-58e2-4211-8a05-5de9f346f0de",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Prosecution_Agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nnon-prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\nplea & non-prosecution agreement\n\n\ndeferred prosecution agreement\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\ndeferred prosecution agreement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"prosecution_agreement\" column from each row in the dataset pharma_with_none_agency\n",
    "prosecution_agreement = pharma_with_none_agency.map(lambda row: row[15] if len(row) > 15 else None)\n",
    "\n",
    "# Display the prosecution_agreement column values\n",
    "for value in prosecution_agreement.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c118b65d-236a-4116-ab11-ff40667a11cc",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'prosecution_agreement': 949\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = prosecution_agreement.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'prosecution_agreement':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f1df4fb7-2ed2-46da-ac2c-841ab2885f66",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 949\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"prosecution_agreement\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[15] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_agency.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[15] == '':\n",
    "        row[15] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_prosecution_agreement = pharma_with_none_agency.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_prosecution_agreement.filter(lambda row: row[15] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0e306cb4-8343-4df0-ac1e-4fa2f0339ebf",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Court\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNorthern District of Illinois\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEastern District of California\nNorthern District of California\nSouthern District of New York\nSuperior Court of State of California, County of San Mateo\nSuperior Court of State of California, County of San Francisco\n\n\n\n\n\n\n\n\n\n\nLivingston County (Michigan) Circuit Court\nSouthern District of New York\nDistrict of Nevada\nEastern District of North Carolina\nSouthern District of New York\nSouthern District of New York\nDistrict of Minnesota\nNorthern District of California\nDistrict of the District of Columbia\nSouthern District of New York\nDistrict of Puerto Rico\nNorthern District of Illinois\n\n\nLos Angeles County (California) Superior Court\nEastern District of Pennsylvania\nDistrict of New Jersey\nDistrict of New Jersey\nSouthern District of New York\nDistrict of New Jersey\nCentral District of California\nSouthern District of New York\nDistrict of New Jersey\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEastern District of Missouri\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDistrict of the District of Columbia\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNorthern District of Georgia\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDistrict of New Jersey\nLos Angeles County (CA) Superior Court\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"court\" column from each row in the dataset pharma_with_none_prosecution_agreement\n",
    "court = pharma_with_none_prosecution_agreement.map(lambda row: row[16] if len(row) > 16 else None)\n",
    "\n",
    "# Display the \"court\" column values\n",
    "for value in court.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d3b32e44-1f81-4cfb-861a-7d08271c1d3b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'court': 936\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = court.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'court':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "b6e4a139-6b57-4cc2-aa46-d15c1245a083",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 936\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"court\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[16] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_prosecution_agreement.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[16] == '':\n",
    "        row[16] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_court = pharma_with_none_prosecution_agreement.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_court.filter(lambda row: row[16] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "12af4d44-23ae-4fab-9143-d3813d14691b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Case_ID\n\n\n\n1527129\n\n21-CA-36104-001\n\n\n\n1813371\n\n\n\n\n1379241\n\n\n14-CA-30273-001\n\n\n\n\n\n\n\n\n\n\n\n\n1386927\n1518333\n\n\n1599664\n\n34-CA-10778-001\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n1808162\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n1730182\n\n\n\n\n\n\n\n\n\n\n1557623\n\n\n1:04-cv-3470\n\n\n\n\n\n\n\n\n\n\n\n\n04-CA-35420-001\n\n05-CA-35250-001\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n05-CA-033245\n\n1723823\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n1431998\n\n05-CA-33531-001\n\n\n\n\n\n\n\n\n\n\n\n1521528\n\n\n\n\n\n\n\n\n32-CA-20421-001\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nHQ-2004-0023\nHQ-2001-3078\nHQ-2000-3097\nHQ-2000-3029\n10-2004-0016\n09-2014-4006\n09-2007-0260\n08-2014-0091\n07-2013-0046\n07-2012-0231\n07-2009-0292\n07-2008-0304\n07-2008-0242\n07-2007-0140\n07-2005-0402\n07-2004-0093\n05-2019-5010\n05-2018-9917\n05-2018-9914\n05-2018-7444\n05-2015-9914\n05-2015-7908\n05-2012-5007\n05-2010-6742\n05-2008-9913\n05-2007-6603\n05-2007-3709\n05-2006-5018\n05-2006-0064\n05-2005-0150\n05-2004-0804\n05-2004-0112\n05-2002-0305\n05-2001-0244\n05-2000-0556\n05-2000-0161\n04-2013-3009\n04-2010-3042\n04-2007-3027\n04-2006-9147\n04-2006-2000\n04-2001-0010\n04-2000-0499\n03-2017-0021\n03-2014-0235\n03-2014-0096\n03-2012-0164\n03-2010-0077\n03-2007-0344\n03-2007-0066\n03-2003-0272\n02-2013-9102\n02-2012-1220\n02-2011-7106\n02-2011-5302\n02-2011-1208\n02-2010-9302\n\n02-2010-5108\n02-2010-4001\n02-2009-9101\n02-2009-3460\n02-2008-7106\n02-2008-1212\n02-2007-7106\n02-2007-3342\n02-2006-9144\n02-2005-7108\n02-2005-3315\n02-2005-0018\n02-2004-3805\n02-2003-7107\n02-2003-7103\n02-2003-3334\n02-2003-3315\n02-2002-7103\n02-2002-7102\n02-2001-7102\n02-2001-4302\n02-2001-3307\n02-2000-3402\n02-2000-3319\n02-2000-3314\n02-1999-4001\n02-1996-0112\n01-2015-2035\n01-2013-4003\n01-2010-4000\n01-2007-1206\n01-2005-3001\n01-2005-1027\n\n1321955\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n1367427\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n2009GL700325\n2010SO700127\n2009WP700129\n2009NE700335\n2013NE700094\n2013NE700157\n2012NE700062\n2013EA700308\n35-99174\n\n11-cv-02053\n13-cv-1533\n06-md-1794\nCIV505266\nCGC-09-492494\n\n\n\n\n\n\n\n\n\n\n06-022564-CL\n1:07-cv-2207\n2:09-cv-0245\n5:04-cv-722\n1:04-cv-9194\n1:15-cv-1980\n0:01-cv-0828\n4:13-cv-00581\n1:13-cv-1345\n1:12-cv-5224\n3:14-cv-1620\n1:12-cv-3216\n\n\nBC599201\n2:17-cv-0412\n2:08-cv-1432\n2:08-cv-1974\n1:08-cv-4688\n2:05-cv-2369\n2:07-cv-5442\n1:02-cv-10129\n2:03-cv-1204\nWY-2018-0018-US1515\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n4:09-cv-0198\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n1:98-cv-3115\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n1:15-cv-0348\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n1853249\n3:13-cv-2970\nBC705969\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n14-037-CHW\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n11257\nEPD-RMP-019\nEPD-HW-1405\n15-73\n05-CV-197\n5-197\n\n\n\n\n\n\n\n\n\n\n472309\n\n\nNJR986658847-NEA190001\n40009-PEA190001\nNJR986656890-NEA180001\n40009-NEA170001\n46597-NEA160001\n40295-NEA160001\nNJR000022095-NEA130001\n61052-NEA120001\nNJR000053983-NEA110001\nNJD001317064-NEA100001\n41712-NEA090002\n35041-NEA090001\n41712-NEA090001\n40295-NEA080001\n132352-NEA080001\n25248-NEA080001\nNJD175145416-NEA070001\n00512-PEA070001\n47715-NEA070001\n47715-NEA060001\n06251-PEA050001\nNJD001865534-NEA050001\n40295-NEA040001\n40009-NEA040001\n15026-NEA030001\n40009-NEA030001\n40295-PEA030001\n40295-PEA020001\nNJD986577401-PEA020002\n35560-NEA020001\n47715-NEA020001\n15026-NEA010001\n\n\n\n\n\n\n11-04-HW\n04-046-A\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"case_ID\" column from each row in the dataset pharma_with_none_court\n",
    "case_ID = pharma_with_none_court.map(lambda row: row[17] if len(row) > 17 else None)\n",
    "\n",
    "# Display the \"case_ID\" column values\n",
    "for value in case_ID.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "8a1f9ad0-9c4c-4133-ae54-0bbf4baaf3a8",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'case_ID': 771\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = case_ID.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'case_ID':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "8d12a00e-898f-4658-bce4-dc31158e8dcc",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 771\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"case_ID\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[17] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_court.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[17] == '':\n",
    "        row[17] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_case_ID = pharma_with_none_court.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_case_ID.filter(lambda row: row[17] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "5f43064e-6681-4096-8a93-d291b81c683b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Private_Litigation_Case_Title\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTomao v. Abbott Labs Inc\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLindell et al v. Synthes USA et al\nMcbride et al v. Mylan, Inc.\nIn Re: Novartis Wage and Hour Litigation\nGalu v. Genentech, Inc.?\nJoe Venturini Vs. Genentech, Inc., A Delaware Coproation et al\n\n\n\n\n\n\n\n\n\n\nRobert Strain v. AstraZeneca\nBellifemine v. Sanofi-Aventis U.S. LLC et al\nDossat v. Hoffmann-La Roche, Inc.\nDotson v. Pfizer, Inc.\nVelez et al v. Novartis Corporation et al\nDickerson et al v. Novartis Corporation et al\nMacGregor v. Mallinckrodt Inc.\nWellens v. Daiichi Sankyo\nBrown et al v. Medicis Pharmaceutical Corporation\nBarrett et al v. Forest Laboratories, Inc. et al\nGonzalez-Bermudez v. Abbott Laboratories PR Inc. et al\nBeverly et al v. Abbott Laboratories Inc.\n\n\nKEVIN A HERRERA vs. PHARMAVITE LLC\nMiddlebrooks v. Teva Pharmaceuticals USA, Inc. et al\nGradone v. Schering-Plough Corporation et al\nCobb v. Merck & Co., Inc. et al\nHerrera v. Wyeth et al\nMerck & Co., Inc. ERISA Litigation - in re Mdl1658\nSteve Harris et al v. Amgen, Inc. et al\nIn Re: Briston-Myers Squibb v. , et al\nZHU, et al v. SCHERING PLOUGH CORP, et al\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCrocker, et al. v. KV Pharmaceutical Co., et al.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nConnecticut v. Mylan Laboratories, Inc. (In re Lorazepam & Clorazepate Antitrust Litigation)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAhrens et al v. UCB Holdings, Inc. et al\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSmith v. Merck & Co., Inc.\nELVIA MARTINEZ vs. BAXALTA US INC\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"private_litigation_case_title\" column from each row in the dataset pharma_with_none_case_ID\n",
    "private_litigation_case_title = pharma_with_none_case_ID.map(lambda row: row[18] if len(row) > 18 else None)\n",
    "\n",
    "# Display the \"private_litigation_case_title\" column values\n",
    "for value in private_litigation_case_title.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "706bbfb5-b08a-4327-aa6a-2ab70f5afa91",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'private_litigation_case_title': 936\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = private_litigation_case_title.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'private_litigation_case_title':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "5bdc7689-682a-43fd-bc67-1b065f24cb06",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 936\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"private_litigation_case_title\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[18] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_case_ID.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[18] == '':\n",
    "        row[18] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_private_litigation_case_title = pharma_with_none_case_ID.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_private_litigation_case_title.filter(lambda row: row[18] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d73487c7-178a-4901-bcdd-9729a22519d9",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Lawsuit_Resolution\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nverdict\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nsettlement\nsettlement\nsettlement\nsettlement\nsettlement\n\n\n\n\n\n\n\n\n\n\nsettlement\nsettlement\nverdict\nverdict\nsettlement\nsettlement\nverdict\nsettlement\nsettlement\nsettlement\nverdict\nsettlement\n\n\nsettlement\nverdict\nsettlement\nsettlement\nsettlement\nsettlement\nsettlement\nsettlement\nsettlement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nsettlement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nsettlement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nsettlement\n\n\n\n\n\n\nsettlement\nsettlement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"lawsuit_resolution\" column from each row in the dataset pharma_with_none_private_litigation_case_title\n",
    "lawsuit_resolution = pharma_with_none_private_litigation_case_title.map(lambda row: row[19] if len(row) > 19 else None)\n",
    "\n",
    "# Display the \"lawsuit_resolution\" column values\n",
    "for value in lawsuit_resolution.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "30231206-6826-49a7-bb83-e689cc99b659",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'lawsuit_resolution': 936\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = lawsuit_resolution.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'lawsuit_resolution':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "569a3ecb-b9ec-45e7-9261-ed8a567ab4a1",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 936\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"lawsuit_resolution\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[19] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_private_litigation_case_title.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[19] == '':\n",
    "        row[19] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_lawsuit_resolution = pharma_with_none_private_litigation_case_title.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_lawsuit_resolution.filter(lambda row: row[19] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "321c0709-f1b2-4841-b87d-408ba000f151",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Facility_State\n\n\n\nPuerto Rico\n\nCalifornia\n\nCalifornia\nCalifornia\nCalifornia\n\n\n\n\nNew York\n\n\nMissouri\n\n\nPennsylvania\n\n\n\n\n\n\n\n\n\nCalifornia\nMassachusetts\n\nNew Jersey\nTennessee\n\nConnecticut\nMissouri\nMissouri\n\n\n\n\n\n\n\nWisconsin\nWisconsin\n\n\n\nPennsylvania\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOhio\nOhio\n\n\nNew Hampshire\nMassachusetts\n\n\n\n\nPennsylvania\n\n\n\n\n\n\n\n\n\nPennsylvania\n\nMontana\nGeorgia\n\nKansas\n\n\n\n\nCalifornia\n\n\n\n\n\n\n\nTennessee\n\n\nMissouri\n\n\n\n\n\nMissouri\n\n\n\n\n\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\n\nVirginia\n\n\nPennsylvania\nPennsylvania\n\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\n\n\n\n\n\n\nNew Jersey\n\n\n\n\n\n\n\n\n\nMaryland\n\nMichigan\n\n\n\n\n\n\nConnecticut\n\nPuerto Rico\n\n\n\n\n\n\n\n\n\n\n\n\nNew Jersey\n\nPennsylvania\n\n\n\n\n\n\n\n\n\n\n\nTexas\n\n\n\n\n\nMissouri\n\n\nCalifornia\nNorth Carolina\nConnecticut\nCalifornia\nMissouri\nMassachusetts\nIndiana\nSouth Carolina\nConnecticut\nIowa\nTexas\nGeorgia\nNew York\nIllinois\nNew Jersey\nFlorida\nOhio\nVirginia\nCalifornia\nRhode Island\nArkansas\nTennessee\n\nCalifornia\nNew York\nNebraska\n\n\nCalifornia\nCalifornia\n\n\n\nMissouri\nMissouri\nKansas\n\n\n\nIndiana\nWisconsin\nWisconsin\nMichigan\nIllinois\n\n\n\nIllinois\nIndiana\nIllinois\n\nNorth Carolina\nMichigan\n\nMichigan\nOhio\nIllinois\nIllinois\nIndiana\nTennessee\nTennessee\nTennessee\nTennessee\nKentucky\n\nGeorgia\n\n\nPennsylvania\n\nVirginia\n\n\nPennsylvania\nNew Jersey\n\nNew Jersey\nPuerto Rico\nPuerto Rico\nPuerto Rico\nNew Jersey\n\nPuerto Rico\nNew Jersey\nPuerto Rico\nPuerto Rico\n\nPuerto Rico\n\nNew Jersey\nPuerto Rico\n\n\n\n\nPuerto Rico\nNew York\n\n\n\n\nPuerto Rico\nNew York\n\nNew York\nPuerto Rico\n\n\n\nMassachusetts\nMassachusetts\n\n\n\nNew Hampshire\nNew York\nNew Jersey\nTexas\nCalifornia\nIllinois\nFlorida\nNew Jersey\n\n\nIowa\nMissouri\nPennsylvania\nNew Jersey\nTexas\nNew Jersey\nTennessee\nCalifornia\nNew Jersey\nNew Jersey\nOhio\nIllinois\nIllinois\nPennsylvania\nMassachusetts\n\n\nMassachusetts\nMassachusetts\nNebraska\nRhode Island\nOhio\n\n\n\n\n\n\n\n\nMassachusetts\n\n\n\n\n\n\n\n\n\n\nPennsylvania\n\n\n\n\n\n\n\n\n\nWisconsin\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCalifornia\n\n\n\n\nCalifornia\nCalifornia\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRhode Island\n\n\n\n\n\n\n\n\n\n\nWyoming\n\n\n\n\n\n\nNew Jersey\n\n\n\n\nAlabama\nLouisiana\nNew York\nPennsylvania\n\nOhio\nTexas\nNew York\nIowa\nIdaho\n\nLouisiana\nMassachusetts\nTexas\n\n\nMississippi\n\n\nIdaho\nKentucky\nMississippi\n\nAlabama\nIllinois\nWisconsin\n\n\n\nIowa\nKentucky\n\nMassachusetts\nWest Virginia\n\nLouisiana\nLouisiana\n\nFlorida\nKentucky\nKentucky\nKentucky\nTexas\n\n\n\n\n\nIdaho\nHawaii\nLouisiana\n\nAlabama\n\nNew Jersey\n\n\nKentucky\nMassachusetts\n\n\nIowa\nVermont\nLouisiana\nLouisiana\nTexas\n\nWisconsin\nKentucky\nMassachusetts\nIowa\nKansas\n\n\n\n\nAlabama\nPennsylvania\n\n\nWest Virginia\nIdaho\n\n\n\nConnecticut\n\n\n\nCalifornia\nMassachusetts\n\n\nOregon\nLouisiana\nConnecticut\nMissouri\nOhio\nWest Virginia\nAlabama\nMississippi\nMontana\nPennsylvania\nArkansas\nHawaii\nIowa\nIdaho\nKentucky\nMassachusetts\nNevada\nTexas\nWisconsin\n\nLouisiana\nCalifornia\nMassachusetts\n\n\nArkansas\nMississippi\nLouisiana\nLouisiana\n\nConnecticut\nIdaho\n\n\n\n\n\nNew York\n\nCalifornia\nTexas\nMassachusetts\nAlabama\nLouisiana\nTexas\n\nIdaho\n\nKentucky\n\n\n\n\nLouisiana\n\n\n\nGeorgia\nIdaho\nKansas\nKentucky\nKentucky\nLouisiana\n\nHawaii\n\n\n\n\n\n\nCalifornia\nMassachusetts\nIowa\n\nOregon\nIllinois\nMassachusetts\n\n\n\nMontana\nKentucky\n\nMassachusetts\n\n\n\nTexas\nWashington\nLouisiana\nHawaii\n\nIdaho\nWest Virginia\n\nArkansas\n\n\n\n\n\n\n\nAlabama\nNew York\n\n\nPennsylvania\n\n\nMassachusetts\nWisconsin\n\nHawaii\n\nIdaho\nKentucky\n\nMassachusetts\n\nTexas\nIdaho\nKentucky\n\nOregon\nMassachusetts\nLouisiana\nIdaho\nKentucky\n\n\nHawaii\n\nTexas\n\n\n\n\n\n\n\n\nVermont\n\nLouisiana\nMississippi\n\nIdaho\nKentucky\nMassachusetts\n\nLouisiana\nLouisiana\n\n\n\nOregon\n\n\n\nMassachusetts\nTexas\nIdaho\n\nNew York\n\nOregon\nHawaii\nOhio\nNew York\nWisconsin\nTexas\n\nNevada\n\nKentucky\nOklahoma\nFlorida\nNew York\nIdaho\nMississippi\n\nLouisiana\nOregon\nNew York\nTexas\nOhio\nFlorida\nIowa\nMissouri\nAlabama\n\nKentucky\nLouisiana\nIdaho\nMississippi\n\nWest Virginia\nIdaho\n\nLouisiana\nMissouri\nTexas\n\n\nCalifornia\n\n\nAlabama\nLouisiana\n\n\n\nTexas\nNew Jersey\n\nCalifornia\nMassachusetts\nAlabama\nLouisiana\nPennsylvania\nArkansas\nIdaho\nKentucky\nWisconsin\n\nLouisiana\nTexas\nCalifornia\nMassachusetts\nOklahoma\nAlabama\nMissouri\nIllinois\nMissouri\nKentucky\nNew York\nHawaii\nIdaho\n\nLouisiana\n\n\n\n\n\n\n\nIdaho\nOhio\n\nIdaho\nMassachusetts\nMississippi\nTexas\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPennsylvania\n\nCalifornia\nPennsylvania\n\nPuerto Rico\n\nMissouri\nMissouri\n\n\n\n\nMaine\n\nOklahoma\n\nWest Virginia\nCalifornia\nCalifornia\nCalifornia\n\n\nMassachusetts\n\n\n\n\n\n\nMissouri\n\n\n\n\nCalifornia\n\n\nAlabama\nArkansas\nArkansas\nArizona\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nConnecticut\nConnecticut\nConnecticut\n\nFlorida\nGeorgia\nGeorgia\nIllinois\nIllinois\nIllinois\nIndiana\nIndiana\nIndiana\nIndiana\nIndiana\nIndiana\nMassachusetts\nMassachusetts\nMassachusetts\nMassachusetts\nMichigan\nMissouri\nNorth Carolina\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew York\nNew York\nNew York\nNew York\nOhio\nOhio\nSouth Carolina\nSouth Carolina\nVirginia\nVirginia\n\nIllinois\n\n\n\nFlorida\nMissouri\nOhio\nMissouri\nMissouri\nCalifornia\nArkansas\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nSouth Carolina\nNew Jersey\n\n\nMaryland\n\n\n\nNew York\nNew York\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"facility_state\" column from each row in the dataset pharma_with_none_lawsuit_resolution\n",
    "facility_state = pharma_with_none_lawsuit_resolution.map(lambda row: row[20] if len(row) > 20 else None)\n",
    "\n",
    "# Display the \"facility_state\" column values\n",
    "for value in facility_state.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "cdeb0a71-f07e-48d4-aa88-e46515aca3eb",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'facility_state': 467\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = facility_state.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'facility_state':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "abc833d4-987b-4a81-9680-a2c3e81690ba",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 467\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"facility_state\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[20] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_lawsuit_resolution.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[20] == '':\n",
    "        row[20] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_facility_state = pharma_with_none_lawsuit_resolution.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_facility_state.filter(lambda row: row[20] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "1499c77f-3f07-4541-846a-42d164366987",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "City\n\n\n\nSan Juan\n\nIrvine\n\nIrvine\nIrvine\nPomona\n\n\n\n\nGrand Island\n\n\nSt. Louis\n\n\nWayne\n\n\n\n\n\n\n\n\n\nSan Diego\nCambridge\n\n\nMemphis\n\nRidgefield\nSt. Joseph\nSt. Joseph\n\n\n\n\n\n\n\nGERMANTOWN\nGERMANTOWN\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCINCINNATI\nCINCINNATI\n\n\nJaffrey\nBillerica\n\n\n\n\nKing of Prussia\n\n\n\n\n\n\n\n\n\nKing of Prussia\n\nHamilton\nLAWRENCEVILLE\n\nMcPherson\n\n\n\n\nBrisbane\n\n\n\n\n\n\n\nBristol\n\n\nBridgeton\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNorth Wales\n\nElkton\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBaltimore\n\nAllegan\n\n\n\n\n\n\nGroton\n\nBarceloneta\n\n\n\n\n\n\n\n\n\n\n\n\nKenilworth\n\nLewisberry\n\n\n\n\n\n\n\n\n\n\n\nAustin\n\n\n\n\n\nMexico\n\n\nAlameda\nWILMINGTON\nGROTON\nSOUTH SAN FRANCISCO\nST. LOUIS\nANDOVER\nSEYMOUR\nGREENVILLE\nGROTON\nCHARLES CITY\nAUSTIN\nCUMMING\nPOMONA\nNORTH CHICAGO\nEAST HANOVER\nN MIAMI BEACH\nCINCINNATI\nSALEM\nSANTA FE SPRINGS\nNORTH KINGSTOWN\nLOWELL\nBRISTOL\n\nVACAVILLE\nNEW YORK\nLINCOLN\n\n\nIRVINE\nTHOUSAND OAKS\n\n\n\nST JOSEPH\nMEXICO\nWICHITA\n\n\n\nSEYMOUR\nMILWAUKEE\nMILWAUKEE\nPORTAGE\nGURNEE\n\n\n\nJOLIET\nINDIANAPOLIS\nCHICAGO HEIGHTS\n\nGREENSBORO\nKALAMAZOO\n\nPORTAGE\nCLEVELAND\nJOLIET\nCHICAGO HEIGHTS\nLA FAYETTE\nMEMPHIS\nMEMPHIS\nMEMPHIS\nBRISTOL\nSHEPHEDSVILLE\n\nSAVANNAH\n\n\nKING OF PRUSSIA\n\nSALEM\n\n\nSELLERSVILLE\nSUMMIT\n\nBRANCHBURG\nCAROLINA\nLAS PIEDRAS\nBARCELONETA\n\n\nLAS PIEDRAS\nNORTH BRUNSWICK\nGUAYAMA\nHUMACAO\n\nBARCELONETA\n\nFORT LEE\nARECIBO\n\n\n\n\nCAROLINA\nCARMEL\n\n\n\n\nARECIBO\nAMITYVILLE\n\nHOBART\nGUAYAMA\n\n\n\nBILLERICA\nBILLERICA\n\n\n\nJAFFREY\nGrand Island\nCHERRY HILL\nSAN ANGELO\nSAN FERNANDO\nMORTON GROVE\nMARGATE\nCRANBURY\n\n\nCHARLES CITY\nSAINT LOUIS\nFORT WASHINGTON\nEDISON\nSAN ANGELO\nPISCATAWAY\nMEMPHIS\nLOS ANGELES\nPATERSON\nCRANBURY\nCINCINNATI\nCHICAGO HEIGHTS\nWHITE HALL\nSWIFTWATER\nCAMBRIDGE\n\n\nAndover\nBEDFORD\nLINCOLN\nSMITHFIELD\nCLEVELAND\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMilwaukee\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWest Greenwich\n\n\n\n\n\n\n\n\n\n\nCody\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMexico\n\nMexico\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nUpper Gwynedd\n\n\n\n\nBarceloneta\n\nSt. Louis\nHazelwood\n\n\n\n\nWestbrook\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSt. Joseph\n\n\n\n\n\n\n\n\nLowell\nLowell\n\n\n\n\n\n\n\n\n\n\nSanta Fe Springs\nLos Angeles\nSanta Fe Springs\nWallingford\nGroton\nGroton\n\n\n\n\n\n\n\nIndianapolis\nSeymour\nSeymour\nClinton\nClinton\nIndianapolis\nLexington\nCambridge\nWoburn\nCambridge\nPortage\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRensselaer\nEast Durham\nRensselaer\nHobart\nCincinnati\nCincinnati\n\n\nElkton\nElkton\n\n\n\n\n\nTAMPA\nST. LOUIS\nCINCINNATI\nMEXICO\nST. LOUIS\nHAYWARD\nLOWELL\nFOSTER CITY\nEMERYVILLE\nUNION CITY\nIRVINE\nSAN FERNANDO\nSAN FERNANADO\nSOUTH SAN FRANCISCO\nSOUTH SAN FRANCISCO\nSOUTH SAN FRANCISCO\nRANCHO CUCAMONGA\nLOS ANGELES\nALAMEDA\nSUMTER\nELMWOOD PARK\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"city\" column from each row in the dataset pharma_with_none_facility_state\n",
    "city = pharma_with_none_lawsuit_resolution.map(lambda row: row[21] if len(row) > 21 else None)\n",
    "\n",
    "# Display the \"city\" column values\n",
    "for value in city.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "18a434dd-a03b-4921-8829-266b44b659f8",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'city': 769\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = city.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'city':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "10c95aef-754e-41fe-b814-c1efad9fb156",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 769\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"city\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[21] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_facility_state.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[21] == '':\n",
    "        row[21] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_city = pharma_with_none_facility_state.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_city.filter(lambda row: row[21] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "98525c07-dee5-4dd7-b042-bdbbdd906f96",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Address\n\n\n\n\n\n\n\n\n\n828 Towne Center Dr.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n610 Freedom Business Center Suite 200\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n2320 SCIENTIFIC PARK DRIVE\n558 EASTERN POINT ROAD\n1100-1120 VETERANS BLVD.\n3600 N. SECOND STREET\n4 CORPORATE DRIVE\n1101 C AVENUE WEST\n4615 DAIRY DRIVE\nGROTON/NEW LONDON LABS, EASTERN POINT ROAD\n1205 11TH STREET\n3900 HOWARD LANE\n767 PEACHTREE PKWY., STE. 4\n2 QUAKER RD., POMONA, NY\n1401 SHERIDAN ROAD, M3B BUILDING\n66 DEFOREST AVE\n50 NW 176TH ST\n5040 DURAMED DR.\n528 CHAPMAN STREET\n8851 DICE ROAD\nDAVISVILLE BRIDGE, RT 403\n415 A NORTH BLOOMINGTON\n501 FIFTH STREET\n\n700 EUBANKS DRIVE\n345 PARK AVE\n6500 FLETCHER AVENUE\n\n\n33 TECHNOLOGY DRIVE\n1 AMGEN CENTER DRIVE\n\n\n\n1620 NORTH WOODBINE ROAD\n5000 SNYDER DRIVE\n6765 S RIDGE\n\n\n\n1101 C AVE W\n6000 NORTH TEUTONIA AVENUE\n230 S EMMBER LN\n7000 PORTAGE ROAD\n605 TRISTATE PKWY\n\n\n\n10 INDUSTRY AVE\n1555 S HARDING ST\n400 STATE ST.\n\n3200 NORTHLINE AVENUE\n7000  PORTAGE ROAD\n\n7171 PORTAGE RD\n4353 E 49TH ST\n10 INDUSTRY AVENUE\n400 STATE ST.\n526 N. EARL AVE.\n4366 MALONE ROAD\n4418 MALONE ROAD\n3030 JACKSON AVENUE\n501 FIFTH ST\n355 OMICRON COURT\n\nO'LEARY RD (GA21&I-95)\n\n\n709 SWEDELAND ROAD\n\n525 BRANCH DRIVE\n\n\n650 CATHILL RD\n86 90 MORRIS AVENUE\n\n1080 RTE 202 S\n65TH INFANTRY ROAD KM. 12.6\nPR-183, PQUE. INDUST. PRIDCO\nKM 58.2 RTE 2\n\n\nRD 183 PRIDCO INDUSTRIAL PARK\nONE SQUIBB DRIVE\nSTATE ROAD NO 3, KM 142.1\nPR-3 KM 77.5\n\nCARR 2 KM 56.7 BO TRINIDAD\n\n400 KELBY STREET SUITE 1400\nPR-2 KM 60.0\n\n\n\n\nKM 12.6  65TH INFANTRY ROAD\n1033 STONELEIGH AVENUE\n\n\n\n\nHWY. # 2 . KM 60.0\n369 BAYVIEW AVE\n\n58 PEARL STREET\nCARR 3 KM 142.1\n\n\n\n290 CONCORD RAOD\n900 MIDDLESEX TURNPIKE\n\n\n\n11 PRESCOTT RD.\n\n2 ESTERBROOK LANE\n3348 PULLIAM ST\n1150 AVIATION PL\n6451 MAIN STREET\n1406 N STATE ROAD 7\n1 COMMERCE DR.\n\n\n1205 11TH ST\n3506 SOUTH BROADWAY\n7050 CAMP HILL ROAD\n165 FIELDCREST DR\n3348 PULLIAM ST\n1 NEW ENGLAND AVE\n6100 EAST SHELBY DR.\n4501 COLORADO ST.\n209 MCLEAN BLVD.\n270 PROSPECT PLAINS RD.\n5040 DURAMED CIRCLE\n400 STATE STREET\nEAST LINCOLN STREET\nDISCOVERY DRIVE\n14 CAMBRIDGE CENTER\n\n\n\n32 WIGGINS AVENUE\n10401 HWY 6\n100 TECHNOLOGY WAY\n4353 E. 49TH STREET\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n675 James S. McDonnell Blvd\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n8500 HIDDEN RIVER PARKWAY\nMALLINCKRODT & SECOND STREETS Z-4\n5040 DURAMED ROAD\n5000 SNYDER DRIVE\n2303 SCHUETZ\n30831 HUNTWOOD AVE\n415 BLOOMINGTON\n333 LAKESIDE DRIVE\n6455 CHRISTIE AVE\n34400 ZWISSIG WAY\n19 HUGHES\n1150 AVIATION PLACE\n1150 AVIATION PLACE\n1 DNA WAY, BLDG. #5 STABILITY LABS\n800 GATEWAY BLVD.\n800 GATEWAY BLVD.\n11570 6TH ST\n4501 COLORADO BLVD.\n1145 ATLANTIC AVE\n2395 CAINS MILL RD.\n92 ROUTE 46 EAST\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"address\" column from each row in the dataset pharma_with_none_city\n",
    "address = pharma_with_none_city.map(lambda row: row[22] if len(row) > 22 else None)\n",
    "\n",
    "# Display the \"address\" column values\n",
    "for value in address.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "3475a958-3d13-4771-9682-e8bd5f6c5500",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'address': 845\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = address.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'address':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "f59dd544-fb52-4126-84ac-e552c9875fee",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 845\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"address\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[22] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_city.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[22] == '':\n",
    "        row[22] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_address = pharma_with_none_city.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_address.filter(lambda row: row[22] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "e61833ef-057a-424e-a366-ce6f0098398f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Zip\n\n\n\n\n\n92606\n\n\n\n91767\n\n\n\n\n14072\n\n\n63130\n\n\n\n\n\n\n\n\n\n\n\n\n92122\n02142\n\n\n38113\n\n06877\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n19406\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n94005\n\n\n\n\n\n\n\n\n\n\n63044\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n19454\n\n22827\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n49010\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n07033\n\n17339\n\n\n\n\n\n\n\n\n\n\n\n78746\n\n\n\n\n\n\n\n\n94502\n28405\n06340\n94080\n63147\n01810\n47274\n29607\n06340\n50616\n78728\n30130\n10970\n60064\n07936\n33169\n45213\n24153\n90670\n02852\n72745\n37620\n\n95688\n10154\n68507\n\n\n92618-2346\n91320-1799\n\n\n\n64506\n65265\n67231\n\n\n\n47274-3342\n53209\n53233\n49002\n60031-5277\n\n\n\n60435-2652\n46221-1873\n60411-1200\n\n27408\n49001\n\n49002\n44125\n60435\n60411-1200\n47904\n38118-2171\n38118\n38151\n37620\n40165\n\n31402\n\n\n19406-2711\n\n24153\n\n\n18960-0000\n07901-3915\n\n08876-3733\n985\n771\n617\n\n\n771\n08902\n655\n791\n\n617\n\n07024\n612\n\n\n\n\n985\n10512\n\n\n\n\n612\n11701-2802\n\n13788\n784\n\n\n\n01821\n01821\n\n\n\n03452\n14072\n08003\n76905\n91340\n60053\n33063\n08512\n\n\n50616\n63118\n19034\n08837\n76905\n08854\n38141\n90039\n07504\n08512\n45213\n60411\n62092\n18370\n02142\n\n\n01810\n01730\n68517\n02917\n44125\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n-7960\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n63042\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n33637\n63147\n45213\n65265\n63146\n94544\n72745\n94404\n94608\n94587\n92618\n91340\n91342\n94080\n94080\n94080\n91730\n90039\n94501\n29151\n07407\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"zip\" column from each row in the dataset pharma_with_none_address\n",
    "zip = pharma_with_none_address.map(lambda row: row[23] if len(row) > 23 else None)\n",
    "\n",
    "# Display the \"zip\" column values\n",
    "for value in zip.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d5f3899d-7801-44b4-a825-8116cfe9ae9f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'zip': 826\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = zip.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'zip':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "4e5faf2b-5fdb-4106-b2cf-7d530c114809",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 826\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"zip\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[23] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_address.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[23] == '':\n",
    "        row[23] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_zip = pharma_with_none_address.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_zip.filter(lambda row: row[23] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "ce570eec-ba64-4402-a92c-dacfe1365f0a",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NAICS_Code\n\n\n\n423450\n\n333314\n\n\n\n\n\n\n\n\n32541\n\n\n541720\n\n\n\n\n\n\n\n\n\n\n\n\n541710\n325412\n\n\n32541\n\n325412\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n325414\n\n\n\n\n\n\n\n\n\n\n32541\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n325998\n\n561110\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n325412\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n325412\n\n325411\n\n\n\n\n\n\n\n\n\n\n\n339112\n\n\n\n\n\n\n\n\n339112\n541380\n325412\n541711\n325412\n325412\n325412\n325412\n541710\n325414\n325412\n811219\n325412\n325412\n325412\n000000\n000000\n325188\n423520\n000000\n000000\n000000\n\n325412\n\n\n\n\n\n\n\n\n\n\n325412\n\n\n\n\n325412\n\n\n325412\n424210\n\n\n\n325130\n325412\n311119\n\n311111\n325412\n\n\n325199\n325130\n311119\n\n\n\n325412\n325412\n\n\n325131\n\n\n325412\n\n\n\n\n325412\n325211\n\n325413\n\n325412\n325412\n\n\n325412\n325412\n325412\n325412\n\n325412\n\n\n325412\n\n\n\n\n325412\n325412\n\n\n\n\n325412\n\n\n\n325412\n\n\n\n\n\n\n\n\n334516\n56142\n325412\n339112\n325411\n424210\n621991\n493110\n\n\n325411\n325188\n325412\n325412\n339112\n325412\n541940\n541380\n325412\n325412\n325412\n325412\n325414\n325414\n325412\n\n\n32541\n325411\n325412\n325414\n325199\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n541711\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n000000\n000000\n000000\n325412\n000000\n325412\n000000\n000000\n000000\n000000\n325412\n000000\n325412\n325412\n325412\n325412\n325412\n325412\n000000\n000000\n000000\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"NAICS_code\" column from each row in the dataset pharma_with_none_zip\n",
    "NAICS_code = pharma_with_none_zip.map(lambda row: row[24] if len(row) > 24 else None)\n",
    "\n",
    "# Display the \"NAICS_code\" column values\n",
    "for value in NAICS_code.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "05738402-e7f3-426b-a9b7-9c24e79605b2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'NAICS_code': 848\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = NAICS_code.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'NAICS_code':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "bccf300e-87c1-482f-95ac-72e17fb6d1d3",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 848\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"NAICS_code\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[24] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_zip.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[24] == '':\n",
    "        row[24] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_NAICS_code = pharma_with_none_zip.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_NAICS_code.filter(lambda row: row[24] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "ca68d859-aa3c-4d2c-99bf-e3cf9bae897b",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "NAICS_Translation\n\n\n\n423450: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers\n\n333314: Optical Instrument and Lens Manufacturing\n\n\n\n\n\n\n\n\n32541: Pharmaceutical and Medicine Manufacturing\n\n\n541720: Research and Development in the Social Sciences and Humanities\n\n\n\n\n\n\n\n\n\n\n\n\n541710: Research and Development in the Physical, Engineering, and Life Sciences\n325412: Pharmaceutical Preparation Manufacturing\n\n\n32541: Pharmaceutical and Medicine Manufacturing\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n325414: Biological Product (except Diagnostic) Manufacturing\n\n\n\n\n\n\n\n\n\n\n32541: Pharmaceutical and Medicine Manufacturing\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n325998: All Other Miscellaneous Chemical Product and Preparation Manufacturing\n\n561110: Office Administrative Services\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n325411: Medicinal and Botanical Manufacturing\n\n\n\n\n\n\n\n\n\n\n\n339112: Surgical and Medical Instrument Manufacturing\n\n\n\n\n\n\n\n\n339112: Surgical and Medical Instrument Manufacturing\n541380: Testing Laboratories\n325412: Pharmaceutical Preparation Manufacturing\n541711: Research and Development in Biotechnology\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n541710: Research and Development in the Physical, Engineering, and Life Sciences\n325414: Biological Product (except Diagnostic) Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n811219: Other Electronic and Precision Equipment Repair and Maintenance\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n\n\n325188: All Other Basic Inorganic Chemical Manufacturing\n423520: Coal and Other Mineral and Ore Merchant Wholesalers\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n\n\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n325412: Pharmaceutical Preparation Manufacturing\n424210: Drugs and Druggists' Sundries Merchant Wholesalers\n\n\n\n325130: Synthetic Dye and Pigment Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n311119: Other Animal Food Manufacturing\n\n311111: Dog and Cat Food Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n\n\n325199: All Other Basic Organic Chemical Manufacturing\n325130: Synthetic Dye and Pigment Manufacturing\n311119: Other Animal Food Manufacturing\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n\n\n325131: Inorganic Dye and Pigment Manufacturing\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n325211: Plastics Material and Resin Manufacturing\n\n325413: In-Vitro Diagnostic Substance Manufacturing\n\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n\n\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n\n\n\n\n334516: Analytical Laboratory Instrument Manufacturing\n56142: Telephone Call Centers\n325412: Pharmaceutical Preparation Manufacturing\n339112: Surgical and Medical Instrument Manufacturing\n325411: Medicinal and Botanical Manufacturing\n424210: Drugs and Druggists' Sundries Merchant Wholesalers\n621991: Blood and Organ Banks\n493110: General Warehousing and Storage\n\n\n325411: Medicinal and Botanical Manufacturing\n325188: All Other Basic Inorganic Chemical Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n339112: Surgical and Medical Instrument Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n541940: Veterinary Services\n541380: Testing Laboratories\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325414: Biological Product (except Diagnostic) Manufacturing\n325414: Biological Product (except Diagnostic) Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n\n\n32541: Pharmaceutical and Medicine Manufacturing\n325411: Medicinal and Botanical Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325414: Biological Product (except Diagnostic) Manufacturing\n325199: All Other Basic Organic Chemical Manufacturing\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n541711: Research and Development in Biotechnology\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n325412: Pharmaceutical Preparation Manufacturing\n\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n325412: Pharmaceutical Preparation Manufacturing\n\n\n\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"NAICS_translation\" column from each row in the dataset pharma_with_none_NAICS_code\n",
    "NAICS_translation = pharma_with_none_NAICS_code.map(lambda row: row[25] if len(row) > 25 else None)\n",
    "\n",
    "# Display the \"NAICS_translation\" column values\n",
    "for value in NAICS_translation.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "52e5ea2b-3e18-4888-9b1d-56516f702812",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'NAICS_translation': 865\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = NAICS_translation.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'NAICS_translation':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "fa1d74d2-1136-49e9-9e31-583d49d382f8",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 865\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"NAICS_translation\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[25] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_NAICS_code.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[25] == '':\n",
    "        row[25] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_NAICS_translation = pharma_with_none_NAICS_code.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_NAICS_translation.filter(lambda row: row[24] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "71a9e210-be11-49e2-99de-50602b9b2dfc",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "HQ_Country_of_Parent\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nJapan\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nFrance\nFrance\nUSA\nUSA\nUSA\nCanada\nCanada\nUnited Kingdom\nGermany\nGermany\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIsrael\nIsrael\nIsrael\nUSA\nSwitzerland\nUSA\nJapan\nIreland\nUSA\nUSA\nUSA\nJapan\nIreland\nIreland\nIreland\nUSA\nUSA\nUSA\nGermany\nGermany\nGermany\nGermany\nGermany\nGermany\nIreland\nIreland\nSwitzerland\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nSwitzerland\nFrance\nFrance\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUSA\nFrance\nUSA\nCanada\nCanada\nUSA\nUSA\nSwitzerland\nCanada\nIsrael\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIreland\nIreland\nIreland\nIreland\nUSA\nUnited Kingdom\nUSA\nCanada\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nGermany\nUSA\nFrance\nFrance\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUnited Kingdom\nUSA\nUSA\nSwitzerland\nSwitzerland\nSwitzerland\nSwitzerland\nSwitzerland\nSwitzerland\nDenmark\nDenmark\nDenmark\nUSA\nUSA\nJapan\nJapan\nIreland\nUSA\nIreland\nIreland\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIndia\nUSA\nUnited Kingdom\nSwitzerland\nSwitzerland\nFrance\nFrance\nUnited Kingdom\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nBelgium\nUSA\nUSA\nGermany\nGermany\nJapan\nJapan\nGermany\nUSA\nUSA\nUSA\nUSA\nJapan\nIsrael\nIsrael\nIsrael\nIsrael\nUSA\nUSA\nUSA\nUSA\nIreland\nJapan\nBelgium\nIreland\nUSA\nUSA\nUSA\nUSA\nIsrael\nUSA\nIsrael\nIsrael\nIsrael\nDenmark\nUSA\nJapan\nUSA\nUSA\nBelgium\nUSA\nUSA\nSwitzerland\nSwitzerland\nUSA\nUSA\nUSA\nUnited Kingdom\nIreland\nUSA\nUSA\nIsrael\nUSA\nGermany\nUSA\nIreland\nUSA\nGermany\nGermany\nUSA\nUSA\nAustralia\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nSwitzerland\nUSA\nUSA\nUSA\nGermany\nUSA\nUSA\nIreland\nIreland\nIreland\nUSA\nUSA\nUnited Kingdom\nDenmark\nGermany\nDenmark\nFrance\nUnited Kingdom\nUSA\nDenmark\nUSA\nUSA\nIsrael\nUSA\nUSA\nSwitzerland\nUSA\nUSA\nUSA\nCanada\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIreland\nUSA\nUSA\nGermany\nGermany\nGermany\nGermany\nUSA\nUSA\nUSA\nGermany\nUSA\nUnited Kingdom\nUSA\nJapan\nIndia\nAustralia\nIsrael\nUSA\nUSA\nUSA\nGermany\nUSA\nUSA\nUSA\nUSA\nUSA\nJapan\nUSA\nIndia\nIsrael\nUSA\nUSA\nFrance\nUSA\nUSA\nUSA\nUSA\nUSA\nSwitzerland\nUnited Kingdom\nGermany\nDenmark\nUSA\nUnited Kingdom\nUnited Kingdom\nUSA\nUSA\nSwitzerland\nUSA\nUnited Kingdom\nUSA\nUSA\nCanada\nIreland\nUSA\nDenmark\nUSA\nUSA\nUSA\nCanada\nUSA\nUSA\nIreland\nUSA\nUSA\nUSA\nUSA\nUSA\nCanada\nFrance\nGermany\nIndia\nUSA\nUSA\nUSA\nSwitzerland\nSwitzerland\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nGermany\nGermany\nGermany\nGermany\nGermany\nGermany\nUnited Kingdom\nUSA\nUSA\nUSA\nUSA\nSwitzerland\nSwitzerland\nSwitzerland\nGermany\nUSA\nUSA\nIreland\nGermany\nUSA\nUSA\nSwitzerland\nFrance\nUSA\nUnited Kingdom\nFrance\nSwitzerland\nUSA\nSwitzerland\nSwitzerland\nIreland\nJapan\nCanada\nUSA\nUSA\nUSA\nUSA\nUSA\nJapan\nIsrael\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nJapan\nUSA\nIreland\nDenmark\nUnited Kingdom\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIsrael\nIsrael\nUnited Kingdom\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIsrael\nUSA\nCanada\nJapan\nJapan\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nFrance\nFrance\nFrance\nFrance\nFrance\nFrance\nFrance\nFrance\nIsrael\nIsrael\nCanada\nGermany\nUSA\nCanada\nGermany\nGermany\nGermany\nGermany\nGermany\nGermany\nGermany\nGermany\nGermany\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIsrael\nIsrael\nIsrael\nIsrael\nSwitzerland\nJapan\nJapan\nJapan\nJapan\nIreland\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nJapan\nJapan\nJapan\nJapan\nJapan\nIreland\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nGermany\nIreland\nIreland\nIreland\nIreland\nIreland\nIreland\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nSwitzerland\nSwitzerland\nSwitzerland\nFrance\nUSA\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nSwitzerland\nSwitzerland\nSwitzerland\nUSA\nUSA\nUSA\nUSA\nUSA\nSwitzerland\nCanada\nIsrael\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIreland\nIreland\nIreland\nUSA\nUSA\nCanada\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nGermany\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nSwitzerland\nSwitzerland\nSwitzerland\nSwitzerland\nSwitzerland\nSwitzerland\nSwitzerland\nSwitzerland\nDenmark\nDenmark\nUSA\nUSA\nUSA\nUSA\nJapan\nJapan\nJapan\nJapan\nIreland\nIreland\nIreland\nIreland\nIreland\nIreland\nIreland\nUSA\nIreland\nIreland\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIndia\nIndia\nIndia\nIndia\nIndia\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nUnited Kingdom\nCanada\nSwitzerland\nSwitzerland\nSwitzerland\nSwitzerland\nFrance\nFrance\nFrance\nUnited Kingdom\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nBelgium\nGermany\nUSA\nJapan\nJapan\nJapan\nUnited Kingdom\nUnited Kingdom\nUSA\nJapan\nJapan\nJapan\nJapan\nJapan\nJapan\nJapan\nJapan\nJapan\nJapan\nJapan\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nIsrael\nBelgium\nBelgium\nBelgium\nBelgium\nCanada\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nJapan\nUSA\nUSA\nFrance\nUSA\nUnited Kingdom\nUSA\nSwitzerland\nUSA\nUSA\nJapan\nUSA\nJapan\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nGermany\nIreland\nUSA\nJapan\nFrance\nSwitzerland\nUSA\nIreland\nIreland\nCanada\nUSA\nUSA\nDenmark\nCanada\nSwitzerland\nIndia\nIndia\nUSA\nSwitzerland\nSwitzerland\nUSA\nSwitzerland\nUSA\nGermany\nCanada\nUnited Kingdom\nSwitzerland\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIreland\nUSA\nUSA\nIreland\nUSA\nUSA\nUSA\nIreland\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIreland\nUSA\nGermany\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nSwitzerland\nJapan\nUSA\nUSA\nUSA\nUSA\nIreland\nDenmark\nUSA\nUSA\nUSA\nUSA\nUSA\nIsrael\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nUSA\nIsrael\nUSA\nIsrael\nUSA\nIsrael\nIsrael\nIsrael\nIsrael\nUSA\nIsrael\nUSA\nUSA\nUSA\nIsrael\nIsrael\nSwitzerland\nUSA\nIsrael\nUSA\nUSA\nUnited Kingdom\nUSA\nIreland\nGermany\nGermany\nUSA\nUSA\nUSA\nUSA\nUSA\nAustralia\nUSA\nUSA\nIndia\nCanada\nIreland\nIsrael\nIsrael\nUSA\nUSA\nUSA\nUSA\nSwitzerland\nUSA\nIsrael\nJapan\nJapan\nSwitzerland\nIreland\nIreland\nUSA\nJapan\nSwitzerland\nUSA\nIsrael\nUSA\nUSA\nUnited Kingdom\nUSA\nUSA\nUSA\nIreland\nIreland\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"HQ_country_of_parent\" column from each row in the dataset pharma_with_none_NAICS_translation\n",
    "HQ_country_of_parent = pharma_with_none_NAICS_translation.map(lambda row: row[26] if len(row) > 26 else None)\n",
    "\n",
    "# Display the \"HQ_country_of_parent\" column values\n",
    "for value in HQ_country_of_parent.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "677324c2-0cee-4911-9b66-67379e5d4bcf",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'HQ_country_of_parent': 0\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = HQ_country_of_parent.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'HQ_country_of_parent':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "3883f4fb-1db0-4807-a217-b37c1e2a7703",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "HQ_State_of_Parent\nIllinois\nIllinois\nIllinois\nIllinois\nNew Jersey\nIllinois\nIllinois\nNew Jersey\nNew Jersey\nIllinois\nIllinois\nIllinois\nNew York\nNew York\nNew York\nCalifornia\nCalifornia\nCalifornia\nNew Jersey\n\n\n\n\n\n\n\n\n\n\nMassachusetts\nMassachusetts\nMassachusetts\n\n\n\n\n\nIndiana\nIndiana\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNorth Carolina\nNorth Carolina\n\n\n\nNew Jersey\n\nNew Jersey\n\n\nPennsylvania\nPennsylvania\nNew York\n\n\n\n\nIndiana\nIndiana\nIndiana\n\n\n\n\n\n\n\n\n\nMissouri\nMassachusetts\nIllinois\nIllinois\nNew Jersey\nNew York\n\n\n\n\n\n\n\n\nNew York\n\nNew York\n\n\nCalifornia\nNew Jersey\n\n\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew York\nNew York\nIllinois\nMissouri\nMissouri\nNew Jersey\nColorado\nIllinois\n\n\n\n\nNew Jersey\n\nNew Jersey\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\n\nNew Jersey\n\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\n\nPennsylvania\nPennsylvania\n\n\n\n\n\n\n\n\n\nNew Jersey\nNew Jersey\n\n\n\nMassachusetts\n\n\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew Jersey\nNew Jersey\nNew Jersey\n\nNew York\n\n\n\n\n\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\n\nCalifornia\nNew Jersey\n\n\n\n\n\nIllinois\nIllinois\nIllinois\nIllinois\n\n\n\n\n\nIllinois\nNorth Carolina\nNew York\nCalifornia\n\n\n\n\nNew York\nNew Jersey\nNew York\nNew Jersey\n\nNew York\n\n\n\n\nNew Jersey\n\nNew Jersey\nNew York\n\nNew Jersey\nNew York\n\n\nNew Jersey\nNew Jersey\nCalifornia\n\n\nIndiana\nIndiana\n\nIllinois\n\nNew Jersey\n\nPennsylvania\n\n\nPennsylvania\nIllinois\n\nIllinois\nIndiana\nNew Jersey\nIndiana\nNew Jersey\nIllinois\n\nPennsylvania\nIllinois\nPennsylvania\n\nNew Jersey\nNew Jersey\n\n\n\nNew Jersey\nNew York\n\n\n\n\n\n\nNew Jersey\n\nNew Jersey\nNew Jersey\n\nNew York\nNew York\n\nNew Jersey\nNew Jersey\nNew York\n\nNew Jersey\nNew Jersey\nNew York\nNew York\nNew York\nNew York\nNew Jersey\nNew York\nNew Jersey\nNew York\nCalifornia\nNew York\nNew Jersey\nNew York\nIndiana\nIllinois\nNew York\nNew Jersey\nNew York\nNew Jersey\nPennsylvania\nIllinois\nIndiana\n\nNew York\nIndiana\n\n\n\n\nNew York\nNew York\nNew York\n\nIllinois\n\nNew Jersey\n\n\n\n\nIllinois\nNew York\nNew Jersey\n\nNew Jersey\nNorth Carolina\nNew Jersey\nNew Jersey\nMaine\n\nNew Jersey\n\n\nNew Jersey\nNew Jersey\n\nMassachusetts\nNew York\nNew York\nNew York\nMassachusetts\n\n\n\n\nPennsylvania\n\n\nIllinois\nNew Jersey\n\nIllinois\n\nNew York\nNew York\n\n\nNew Jersey\n\nNew Jersey\nIllinois\nNew Jersey\n\nNew Jersey\nNew Jersey\n\nConnecticut\nPennsylvania\nPennsylvania\nNew Jersey\nNew York\n\n\n\n\nMaryland\nCalifornia\nIllinois\n\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nGeorgia\nIllinois\nNew Jersey\n\n\n\n\n\n\n\nCalifornia\nIllinois\nNew Jersey\nPennsylvania\n\n\n\n\nNew Jersey\nNew Jersey\n\n\nNew York\nNew York\n\n\nNew Jersey\n\n\n\nNew York\n\n\n\n\n\nIllinois\nIllinois\nIllinois\nCalifornia\nIllinois\n\n\nNew Jersey\nNew Jersey\nNew York\nNew Jersey\nCalifornia\nNew York\nNew Jersey\nPennsylvania\nArizona\n\nCalifornia\n\n\n\nNew Jersey\nNew Jersey\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\n\n\n\nIllinois\nIllinois\nIllinois\nNew York\nNew York\nNew York\nNew York\nNew York\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nCalifornia\nNew Jersey\nCalifornia\n\nIllinois\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMassachusetts\n\n\n\n\n\n\n\n\n\n\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\n\n\n\n\n\n\n\n\n\n\nNew Jersey\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\n\n\n\n\n\n\nIndiana\nIndiana\nIndiana\nIndiana\nIndiana\nIndiana\nIndiana\nIndiana\nIndiana\n\n\n\n\n\n\n\nMissouri\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\n\n\n\n\nCalifornia\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCalifornia\nNew Jersey\nArizona\nArizona\nArizona\n\n\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew York\nIllinois\nIllinois\nMissouri\nMissouri\nNew Jersey\n\n\n\nNew Jersey\nNew Jersey\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\nPennsylvania\n\n\n\n\n\n\n\n\n\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\n\n\n\n\n\n\n\n\n\n\n\nNew Jersey\n\n\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nNew York\nPennsylvania\nPennsylvania\nPennsylvania\nConnecticut\nConnecticut\nConnecticut\nConnecticut\nConnecticut\nConnecticut\nConnecticut\nConnecticut\nNew York\nNew York\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\n\n\nNew Jersey\n\n\n\n\n\nNew Jersey\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nIllinois\nIllinois\nNew York\nNew Jersey\nNew Jersey\nIllinois\nIllinois\nIllinois\nIllinois\nIllinois\nNew York\nNew York\n\nIllinois\nIllinois\n\nIllinois\n\nNew Jersey\n\nNew York\nPennsylvania\n\nNew Jersey\n\nNew Jersey\nPennsylvania\nNew Jersey\nIndiana\nNew York\nNew York\nNew York\n\n\nNew Jersey\n\n\n\nMaine\n\n\n\nNew Jersey\nNew York\n\n\n\n\n\nVirginia\n\n\nVirginia\n\nNew Jersey\n\n\n\n\nNew Jersey\nIllinois\nConnecticut\nCalifornia\nNorth Carolina\nNew Jersey\nNew Jersey\nMaine\nUtah\n\nNew Jersey\nNew York\n\nNew York\nNew Jersey\nIllinois\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew York\nNew York\nNew York\nMassachusetts\nIllinois\n\nNew Jersey\n\nPennsylvania\nPennsylvania\nIndiana\nPennsylvania\nPennsylvania\nIndiana\nIndiana\n\n\nCalifornia\nMassachusetts\nCalifornia\nNew Jersey\n\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\n\nNorth Carolina\nNew York\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\n\nNew York\n\nNew Jersey\n\n\n\n\nNew York\n\nNew Jersey\nNew York\nNew Jersey\n\n\n\nPennsylvania\n\nNew York\nNew York\n\nNew York\n\n\n\nNew Jersey\nNew Jersey\nNew Jersey\nNew Jersey\nVirginia\n\nDelaware\nNew York\n\n\n\n\n\nMissouri\nNew Jersey\nNew Jersey\nCalifornia\n\nNew Jersey\n\n\n\n\n\n\nCalifornia\n\n\nNew Jersey\n\nIllinois\nIllinois\n\nConnecticut\nNew York\nNew Jersey\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"HQ_state_of_parent\" column from each row in the dataset pharma_with_none_NAICS_translation\n",
    "HQ_state_of_parent = pharma_with_none_NAICS_translation.map(lambda row: row[27] if len(row) > 27 else None)\n",
    "\n",
    "# Display the \"HQ_state_of_parent\" column values\n",
    "for value in HQ_state_of_parent.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "30352df1-4a23-436b-b0be-f5d6789187f2",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'HQ_state_of_parent': 434\n"
     ]
    }
   ],
   "source": [
    "# let's define a function to check if any column has missing values\n",
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = HQ_state_of_parent.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'HQ_state_of_parent':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "b55a136d-4b5c-4d03-bc66-8792902a31cb",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 434\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"HQ_state_of_parent\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[27] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_NAICS_translation.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[27] == '':\n",
    "        row[27] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_HQ_state_of_parent = pharma_with_none_NAICS_translation.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_HQ_state_of_parent.filter(lambda row: row[27] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "49161bb7-875c-4c11-a8d8-4129ea219a6e",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ownership_Structure\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\nprivately held\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\nprivately held\nprivately held\nprivately held\nprivately held\nprivately held\nprivately held\nprivately held\nprivately held\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\nout of business\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\nout of business\nout of business\nout of business\nout of business\nout of business\nout of business\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nprivately held\npublicly traded\nprivately held\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\npublicly traded\nout of business\npublicly traded\npublicly traded\npublicly traded\npublicly traded\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"ownership_structure\" column from each row in the dataset pharma_with_none_HQ_state_of_parent\n",
    "ownership_structure = pharma_with_none_HQ_state_of_parent.map(lambda row: row[28] if len(row) > 28 else None)\n",
    "\n",
    "# Display the \"ownership_structure\" column values\n",
    "for value in ownership_structure.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "bebb271c-0f99-4c75-97ef-41bf9ffb3d8e",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'ownership_structure': 0\n"
     ]
    }
   ],
   "source": [
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = ownership_structure.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'ownership_structure':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "74c183d2-edb8-423c-8408-2db5a12aca5f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Parent_Company_Stock_Ticker\nABT\nABBV\nABBV\nABT\nJNJ\nABT\nABT\nJNJ\nJNJ\nABT\nABBV\nABBV\nPFE\nPFE\nBMY\nAMGN\nAMGN\nAMGN\nAMRX\n\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\n\n\nAVEO\nBIIB\nBIIB\nBHC\nBHC\nLSE: GSK\n\n\nLLY\nLLY\nBMY\nBMY\nBMY\nBMY\nBMY\nBMY\nBMY\n\n\nTEVA\nTEVA\nTEVA\nMRK\nNYSE: NVS\n\n\nENDP\nVTRS\nVTRS\nBMY\n\nPRGO\nPRGO\nPRGO\nLLY\nLLY\nLLY\n\n\n\n\n\n\nENDP\nENDP\nNYSE: NVS\n\n\nABBV\nABBV\nZTS\nSLS\n\n\n\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nBMY\n\nPFE\nBHC\nBHC\nGILD\nMRK\n\nBHC\nTEVA\nJNJ\nJNJ\nJNJ\nJNJ\nPFE\nPFE\nABBV\n\n\nJNJ\nCLVS\nABT\nMNK\nMNK\nMNK\nMNK\nJNJ\nLSE: GSK\nMRK\nBHC\nMRK\nMRK\nMRK\nMRK\nMRK\nMRK\nMRK\n\nMRK\n\n\nJNJ\nMRK\nMRK\nMRK\nMRK\nMRK\nMRK\nMRK\nMRK\nLSE: GSK\nVTRS\nVTRS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\n\n\n\nJNJ\nJNJ\n\n\nENDP\n\nPRGO\nPRGO\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPAHC\nPAHC\nPAHC\n\nREGN\n\nNYSE: NVS\nNYSE: NVS\n\n\nLSE: GSK\nMRK\nMRK\nMRK\nMRK\nMRK\nMRK\n\n\nJNJ\n\n\n\n\n\nABT\nABT\nABT\nABT\n\nTEVA\nTEVA\nTEVA\nTEVA\nABT\n\nPFE\nAMGN\nMNK\n\n\nPRGO\nPFE\n\nPFE\nJNJ\nTEVA\nPFE\nTEVA\nTEVA\nTEVA\n\nPAHC\n\nZTS\nPFE\n\nJNJ\nBMY\nNYSE: NVS\nNYSE: NVS\nJNJ\nJNJ\nAMGN\nLSE: GSK\nMNK\nLLY\nLLY\nTEVA\nABT\n\n\nMNK\nLCI\n\n\nVTRS\nABBV\n\nABT\nLLY\nPAHC\nLLY\nZTS\nABT\nNYSE: NVS\nVTRS\nABT\nVTRS\n\nPAHC\nZTS\nMNK\nPRGO\nPRGO\nMRK\nPFE\nLSE: AZN\n\n\n\n\nLSE: GSK\nMRK\n\nMRK\nMRK\nTEVA\nBMY\nPFE\n\nMRK\nMRK\nPFE\nBHC\nJNJ\nMRK\nBMY\nPFE\nBMY\nBMY\nMRK\nPFE\nPAHC\nPFE\nAMGN\nBMY\nMRK\nPFE\nLLY\nABBV\nPFE\nMRK\nPFE\nMRK\nVTRS\n\nLLY\nMNK\nPFE\nLLY\n\n\n\n\nPFE\nPFE\nBMY\n\nABBV\n\nJNJ\n\n\n\nTARO\nABBV\nPFE\n\n\nJNJ\n\nJNJ\nAMRX\nIDXX\n\nAMRX\n\nTEVA\nZTS\nZTS\n\nBIIB\nPFE\nPFE\nPFE\nANIK\nNYSE: NVS\nLSE: AZN\n\n\nVTRS\n\nLSE: GSK\nABT\nMRK\n\nABT\n\nSLS\nBMY\nBHC\nMNK\nJNJ\n\nJNJ\nABBV\nJNJ\nBHC\nJNJ\nJNJ\nJAZZ\n\nVTRS\nVTRS\nMRK\nBMY\nBHC\n\n\n\nUTHR\nCYTR\nABBV\n\n\nAMRX\nAMRX\nAMRX\nAMRX\n\nABT\nJNJ\n\n\n\n\n\n\nLSE: GSK\nAMPH\nABBV\nJNJ\nVTRS\nNYSE: NVS\n\n\n\nMRK\nMRK\nPRGO\n\nPFE\n\n\n\nJNJ\nLSE: AZN\n\n\nPFE\nNYSE: NVS\nNYSE: NVS\nMNK\n\nBHC\nABBV\nABT\nABT\nAMGN\nABBV\n\nTEVA\nMRK\nMRK\nPFE\nMRK\nAMGN\nBMY\nMRK\nLCI\n\n\nAMGN\nJAZZ\n\nLSE: AZN\n\nJNJ\nABT\nABBV\nABBV\nABBV\nABBV\nABT\nABBV\nABT\nABBV\nABBV\nABT\nABBV\nABBV\nABBV\nABBV\nTEVA\nTEVA\n\nABT\nABT\nABBV\nPFE\nPFE\nPFE\nPFE\nPFE\nAMGN\nAMGN\nAMGN\nAMGN\nAMGN\nAMGN\nAMGN\nAMGN\nAMRX\nAMPH\nTEVA\nABBV\n\n\n\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\nLSE: AZN\n\n\n\n\n\n\n\n\nTEVA\nTEVA\nBHC\n\nBIIB\nBHC\n\n\n\n\n\n\n\n\n\nBMY\nBMY\nBMY\nBMY\nBMY\nBMY\nBMY\nBMY\nBMY\nBMY\nTEVA\nTEVA\nTEVA\nTEVA\nNYSE: NVS\n\n\n\n\nENDP\nJNJ\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\n\n\n\n\n\nPRGO\nLLY\nLLY\nLLY\nLLY\nLLY\nLLY\nLLY\nLLY\nLLY\n\nENDP\nENDP\nENDP\nENDP\nENDP\nENDP\n\nABBV\nABBV\nABBV\nABBV\nABBV\nABBV\nABBV\n\n\nNYSE: NVS\n\nGILD\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\nLSE: GSK\n\n\n\nAMGN\nMRK\n\n\n\n\nBHC\nTEVA\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nJNJ\nPFE\nABBV\nABBV\n\n\nJNJ\nMNK\nMNK\nMNK\nJNJ\nJNJ\nBHC\nMRK\nMRK\nMRK\nMRK\nMRK\nMRK\n\nMRK\nMRK\nMRK\nMRK\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nVTRS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\n\n\nOGN\nOGN\nJNJ\nJNJ\n\n\n\n\nENDP\nENDP\nENDP\nENDP\nENDP\nENDP\nENDP\n\nPRGO\nPRGO\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nPFE\nVTRS\nVTRS\nVTRS\n\n\n\n\n\n\n\n\nPFE\nPFE\n\n\n\n\n\n\n\n\n\n\nBHC\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\nNYSE: NVS\n\n\n\nLSE: GSK\nMRK\nMRK\nMRK\nMRK\nMRK\nMRK\n\n\nMRK\n\n\n\nLSE: GSK\nLSE: GSK\nJNJ\n\n\n\n\n\n\n\n\n\n\n\nTARO\nTARO\nTEVA\nTEVA\nTEVA\nTEVA\nTEVA\nTEVA\nTEVA\nTEVA\nTEVA\nTEVA\nTEVA\nTEVA\n\n\n\n\nBHC\nABBV\nABBV\nPFE\nMRK\nMRK\nABBV\nABBV\nABBV\nABBV\nABBV\nPFE\nPFE\n\nABT\nABBV\n\nABBV\nLSE: GSK\nJNJ\nNYSE: NVS\nPFE\nVTRS\n\nJNJ\n\nMRK\nVTRS\nJNJ\nLLY\nPFE\nPFE\nPFE\n\nMNK\nMRK\n\n\nNYSE: NVS\nIDXX\nMNK\nENDP\n\nJNJ\nBMY\n\nBHC\nNYSE: NVS\n\n\n\nNYSE: NVS\nNYSE: NVS\n\nNYSE: NVS\nPCRX\n\nBHC\nLSE: AZN\nNYSE: NVS\nPCRX\nABBV\n\nGILD\nBCRX\nZTS\nZTS\nIDXX\n\nPRGO\nJNJ\nPFE\nPRGO\n\nMRK\nABT\nPRGO\nPAHC\nJNJ\nPAHC\nBMY\nPFE\nPFE\nBIIB\nABBV\nMNK\nMRK\n\nVTRS\nVTRS\nLLY\nLCI\nLCI\nELAN\nELAN\n\n\nAMGN\nANIK\nAMGN\nZTS\nMNK\n\nAMRX\nMRK\nAMRX\nMRK\nMRK\nTEVA\n\nBMY\nAMRX\nMRK\nMRK\nJNJ\nMRK\nTEVA\nBMY\nTEVA\nAMRX\nTEVA\nTEVA\nTEVA\nTEVA\nBMY\nTEVA\nMRK\nBMY\nMRK\nTEVA\nTEVA\n\nVTRS\nTEVA\nBMY\n\nLSE: GSK\n\nMNK\n\n\nPAHC\nPAHC\nMRK\nMRK\n\n\nINCY\nBMY\n\nBHC\nMNK\nTEVA\nTEVA\n\nAMRX\nZTS\nGILD\nNYSE: NVS\nPAHC\nTEVA\n\n\n\nPRGO\nPRGO\nAMPH\n\n\nPAHC\nTEVA\nABT\nABT\nLSE: GSK\n\nBMY\nJNJ\nENDP\nPRGO\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"parent_company_stock_ticker\" column from each row in the dataset pharma_with_none_HQ_state_of_parent\n",
    "parent_company_stock_ticker = pharma_with_none_HQ_state_of_parent.map(lambda row: row[29] if len(row) > 29 else None)\n",
    "\n",
    "# Display the \"parent_company_stock_ticker\" column values\n",
    "for value in parent_company_stock_ticker.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "1c0e91a9-c3c3-4a57-bb22-90786aea51e7",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'parent_company_stock_ticker': 246\n"
     ]
    }
   ],
   "source": [
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = parent_company_stock_ticker.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'parent_company_stock_ticker':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "1cc66c68-5bed-4e1a-8c00-bb37afafec60",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 246\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"parent_company_stock_ticker\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[29] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_HQ_state_of_parent.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[29] == '':\n",
    "        row[29] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_parent_company_stock_ticker = pharma_with_none_HQ_state_of_parent.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_parent_company_stock_ticker.filter(lambda row: row[29] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d83779e4-2ccc-4e4e-a063-90244b86c1f4",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Major_Industry_of_Parent\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"parent_company_stock_ticker\" column from each row in the dataset pharma_with_none_parent_company_stock_ticker\n",
    "major_industry_of_parent = pharma_with_none_parent_company_stock_ticker.map(lambda row: row[30] if len(row) > 30 else None)\n",
    "\n",
    "# Display the \"major_industry_of_parent\" column values\n",
    "for value in major_industry_of_parent.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "3e642ff6-352a-4a9c-96fa-10fa940514f0",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'major_industry_of_parent': 0\n"
     ]
    }
   ],
   "source": [
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = major_industry_of_parent.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'major_industry_of_parent':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "a3335d2f-e1f3-4fa9-9aae-daa9b80194ee",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Specific_Industry_of_Parent\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nbiopharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceutical manufacturing services\npharmaceutical manufacturing services\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\nanimal health products\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceutical manufacturing services\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\npharmaceuticals\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\npharmaceuticals\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceutical manufacturing services\npharmaceuticals\npharmaceuticals\nveterinary medical products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\ngeneric drugs\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nveterinary medical products\npharmaceuticals\npharmaceuticals\ngeneric drugs\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nnon-opioid pain management\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nnon-opioid pain management\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\nanimal health products\nveterinary medical products\nnutritional supplements\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\npharmaceuticals\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceutical manufacturing services\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceutical manufacturing services\npharmaceuticals\npharmaceutical manufacturing services\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\npharmaceuticals\npharmaceuticals\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\nanimal health products\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\npharmaceuticals\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"specific_industry_of_parent\" column from each row in the dataset pharma_with_none_parent_company_stock_ticker\n",
    "specific_industry_of_parent = pharma_with_none_parent_company_stock_ticker.map(lambda row: row[31] if len(row) > 31 else None)\n",
    "\n",
    "# Display the \"specific_industry_of_parent\" column values\n",
    "for value in specific_industry_of_parent.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "a3b0b35c-00bd-45d2-b227-d58e1eb4dc18",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'specific_industry_of_parent': 0\n"
     ]
    }
   ],
   "source": [
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = specific_industry_of_parent.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'specific_industry_of_parent':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "034bbdc9-5ffa-4f35-b2ab-67ec665f6fad",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Info_Source\nhttps://www.justice.gov/opa/pr/abbott-laboratories-pays-us-5475-million-settle-claims-company-paid-kickbacks-physicians\nhttp://www.justice.gov/opa/pr/abbott-labs-pay-15-billion-resolve-criminal-civil-investigations-label-promotion-depakote\nhttps://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/opa/pr/johnson-johnson-subsidiary-acclarent-inc-pays-government-18-million-settle-false-claims-act\nExtracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\nhttps://oig.hhs.gov/publications/docs/press/2007/ANS%20Press%20Release.pdf\nhttps://archive.epa.gov/epapages/newsroom_archive/newsreleases/8e820317c86e4c5685257cde00717855.html\nhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377588.htm\nJuly 23, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttp://www.justice.gov/opa/pr/allergan-agrees-plead-guilty-and-pay-600-million-resolve-allegations-label-promotion-botox\nhttps://www.sec.gov/news/pressrelease/2017-16.html\nhttps://www.justice.gov/opa/pr/alpharma-pay-425-million-resolve-false-claims-act-allegations-connection-promotion-drug\nhttps://www.ftc.gov/news-events/press-releases/2004/08/generic-drug-marketers-settle-ftc-charges\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttp://www.justice.gov/opa/pr/amgen-inc-pleads-guilty-federal-charge-brooklyn-ny-pays-762-million-resolve-criminal\nhttps://www.justice.gov/opa/pr/amgen-pay-us-249-million-resolve-false-claims-act-allegations\nExtracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\nhttps://www.dol.gov/ofccp/foia/files/AmnealPharmaceuticalsCA_Redacted.pdf\nhttps://www.justice.gov/opa/pr/astellas-pharma-us-inc-pay-73-million-resolve-false-claims-act-allegations-relating-marketing\nhttps://www.dol.gov/opa/media/press/ofccp/OFCCP20110829.htm\nhttp://www.justice.gov/opa/pr/pharmaceutical-giant-astrazeneca-pay-520-million-label-drug-marketing\nhttps://www.justice.gov/opa/pr/astrazeneca-and-cephalon-pay-465-million-and-75-million-respectively-allegedly-underpaying\nhttps://www.justice.gov/opa/pr/astrazeneca-pay-79-million-resolve-kickback-allegations\nhttps://www.justice.gov/opa/pr/four-pharmaceutical-companies-pay-124-million-submission-false-claims-medicaid\nhttps://www.justice.gov/archive/opa/pr/2003/June/03_civ_371.htm\nhttps://www.sec.gov/litigation/admin/2016/34-78730.pdf\nhttps://www.justice.gov/opa/pr/aventis-pharmaceutical-pay-us-955-million-settle-false-claims-act-allegations\nhttps://www.justice.gov/archive/opa/pr/2007/September/07_civ_694.html\nhttps://www.sec.gov/news/pressrelease/2016-59.html\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.sec.gov/news/press/2008/2008-50.htm\nIncluded in a dataset downloaded at https://enforcedata.dol.gov/views/data_summary.php\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/opa/pr/boehringer-ingelheim-pay-95-million-resolve-false-claims-act-allegations\nExtracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\nhttps://archive.epa.gov/epapages/newsroom_archive/newsreleases/34cce24d8bf6c24f8525792d007785b9.html\nhttps://archive.epa.gov/epapages/newsroom_archive/newsreleases/efbee3de7fd92cab85257a830069d20f.html\nhttps://www.sec.gov/news/pressrelease/2015-229.html\nhttps://www.justice.gov/archive/opa/pr/2008/July/08-enrd-591.html\nhttps://www.justice.gov/archive/atr/public/press_releases/2007/223634.htm\nhttps://www.ftc.gov/news-events/press-releases/2009/03/bristol-myers-squibb-pay-21-million-penalty-failure-disclose\nhttps://www.justice.gov/archive/opa/pr/2007/September/07_civ_782.html\nhttps://www.sec.gov/news/press/2004-105.htm\nFOIA236\nhttps://www.fmcsa.dot.gov/regulations/enforcement/national-listing-enforcement-cases-subject-name-closed-fiscal-year-2006-pdf\nhttps://www.fmcsa.dot.gov/regulations/enforcement/national-listing-enforcement-cases-subject-name-closed-fiscal-year-2005-pdf\nhttps://www.justice.gov/archive/opa/pr/2008/September/08-civ-860.html\nhttps://www.justice.gov/opa/pr/astrazeneca-and-cephalon-pay-465-million-and-75-million-respectively-allegedly-underpaying\nhttps://www.ftc.gov/news-events/press-releases/2015/05/ftc-settlement-cephalon-pay-delay-case-ensures-12-billion-ill\nIncluded in a dataset downloaded at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.treasury.gov/resource-center/sanctions/OFAC-Enforcement/Documents/06042004.pdf\nhttp://www.justice.gov/opa/pr/mississippi-pharmaceutical-firm-and-ceo-pay-28-million-resolve-allegations-illegal-marketing\nhttps://www.justice.gov/opa/pr/daiichi-sankyo-inc-agrees-pay-39-million-settle-kickback-allegations-under-false-claims-act\nhttps://www.justice.gov/opa/pr/dava-pharmaceuticals-pay-us-11-million-settle-false-claims-act-allegations\nhttps://www.justice.gov/opa/pr/pharmaceutical-manufacturer-pay-280-million-settle-false-claims-act-case\nhttps://www.justice.gov/archive/opa/pr/2003/June/03_civ_350.htm\nhttps://www.treasury.gov/resource-center/sanctions/OFAC-Enforcement/Documents/08062004.pdf\nhttp://www.justice.gov/opa/pr/pharmaceutical-companies-pay-2145-million-resolve-allegations-label-promotion-zonegran\nFOIA204\nhttp://www.justice.gov/opa/pr/pharmaceutical-companies-pay-2145-million-resolve-allegations-label-promotion-zonegran\nhttps://www.sec.gov/litigation/litreleases/lr19066.htm\nhttps://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa\nhttps://www.justice.gov/archive/opa/pr/2005/December/05_civ_685.html\nhttps://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171487116\nhttps://www.fmcsa.dot.gov/regulations/enforcement/national-listing-enforcement-cases-subject-name-closed-fiscal-year-2005-pdf\nhttps://www.fmcsa.dot.gov/regulations/enforcement/national-listing-enforcement-cases-subject-name-closed-fiscal-year-2006-pdf\nhttps://www.treasury.gov/resource-center/sanctions/OFAC-Enforcement/Documents/02022007.pdf\nhttps://efoia.bis.doc.gov/index.php/component/docman/?task=doc_download&gid=341&Itemid=\nhttps://www.epa.gov/enforcement/reference-news-release-jaffrey-nh-facility-upgrade-its-wastewater-treatment-systems\nhttps://archive.epa.gov/epapages/newsroom_archive/newsreleases/ce0d13ac337fe52685257bb900603f21.html\nhttp://www.justice.gov/opa/pr/endo-pharmaceuticals-and-endo-health-solutions-pay-1927-million-resolve-criminal-and-civil\nhttps://www.justice.gov/usao-sdny/pr/manhattan-us-attorney-announces-39-million-civil-fraud-settlement-against-qualitest\nhttps://www.justice.gov/opa/pr/eon-labs-pays-us-35-million-settle-allegations-submitting-false-claims-medicaid\nhttp://www.justice.gov/opa/pr/kv-pharmaceutical-subsidiary-pleads-guilty-two-felonies-regarding-oversized-drugs\nJuly 23, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/opa/pr/forest-laboratories-and-forest-pharmaceuticals-pay-38-million-resolve-kickback-allegations\nhttp://www.justice.gov/opa/pr/forest-pharmaceuticals-sentenced-pay-164-million-criminal-violations\nhttps://www.treasury.gov/resource-center/sanctions/OFAC-Enforcement/Documents/11052004.pdf\nhttps://www.sec.gov/litigation/admin/2017/33-10337.pdf\nhttps://www.justice.gov/opa/pr/pharmaceutical-companies-pay-67-million-resolve-false-claims-act-allegations-relating-tarceva\nhttps://www.justice.gov/opa/pr/genzyme-corp-pay-2228-million-resolve-false-claims-allegations-related-slurry-used-patients\nhttp://www.justice.gov/opa/pr/genzyme-corporation-pay-325-million-resolve-criminal-liability-relating-seprafilm\nhttps://www.justice.gov/archive/opa/pr/2005/September/05_civ_489.html\nhttp://www.justice.gov/opa/pr/glaxosmithkline-plead-guilty-and-pay-3-billion-resolve-fraud-allegations-and-failure-report\nhttps://archive.epa.gov/epapages/newsroom_archive/newsreleases/e40a25eab75b25c485257d32006b8a8a.html\nhttps://www.sec.gov/litigation/admin/2016/34-79005.pdf\nhttps://archive.epa.gov/epapages/newsroom_archive/newsreleases/f718fdf86212909085257d5400761b8d.html\nhttps://www.fmcsa.dot.gov/sites/fmcsa.dot.gov/files/docs/closedByEnforcement_FY2015_06-19-2015.xlsx\nhttps://www.justice.gov/archive/atr/public/press_releases/2003/200738.htm\nhttps://www.dol.gov/opa/media/press/ofccp/OFCCP20152014.htm\nhttps://www.treasury.gov/resource-center/sanctions/OFAC-Enforcement/Documents/06042004.pdf\nhttps://www.sec.gov/litigation/litreleases/lr17861.htm\nIncluded in a dataset downloaded at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/usao-sdny/pr/manhattan-us-attorney-settles-civil-fraud-claims-against-inspire-pharmaceuticals-inc\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/opa/pr/ista-pharmaceuticals-inc-pleads-guilty-federal-felony-charges-will-pay-335-million-resolve\nhttps://www.justice.gov/opa/pr/nation-s-largest-nursing-home-pharmacy-and-drug-manufacturer-pay-112-million-settle-false\nhttp://www.justice.gov/opa/pr/johnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations\nhttps://www.sec.gov/news/press/2011/2011-87.htm\nhttps://www.justice.gov/opa/pr/johnson-johnson-agrees-pay-214-million-criminal-penalty-resolve-foreign-corrupt-practices-act\nhttps://www.justice.gov/archive/opa/pr/2001/September/488civ.htm\nhttps://www.justice.gov/archive/opa/pr/2005/November/05_civ_581.html\nhttp://www.justice.gov/opa/pr/united-states-and-tennessee-reach-agreement-king-pharmaceuticals-llc-resolve-allegations\nhttps://www.justice.gov/opa/pr/kos-pharmaceuticals-pay-more-41-million-resolve-kickback-and-label-promotion-allegations\nhttps://www.justice.gov/opa/pr/st-louis-based-kv-pharmaceutical-pay-17-million-settle-false-claims-allegations\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/archive/opa/pr/2001/November/01_civ_590.htm\nhttps://www.sec.gov/news/press-release/2018-199\nhttps://www.gpo.gov/fdsys/pkg/USCOURTS-ilnd-1_04-cv-03470/content-detail.html\nTaken from the Federal Railroad Administration's FY2007 safety penalty report obtained through a Freedom of Information Act request. A copy is available upon request. \nhttps://www.justice.gov/opa/pr/mallinckrodt-agrees-pay-record-35-million-settlement-failure-report-suspicious-orders\nhttps://www.nrc.gov/reading-rm/doc-collections/enforcement/actions/materials/ea00178.html\nhttps://www.ftc.gov/news-events/press-releases/2017/01/mallinckrodt-will-pay-100-million-settle-ftc-state-charges-it\nhttp://www.justice.gov/opa/pr/mcneil-ppc-inc-pleads-guilty-connection-adulterated-infants-and-childrens-over-counter-liquid\nhttps://www.irs.gov/newsroom/irs-accepts-settlement-offer-in-largest-transfer-pricing-dispute\nhttps://www.irs.gov/newsroom/merck-agrees-to-pay-irs-23-billion\nhttps://www.justice.gov/archive/opa/pr/2007/May/07_civ_336.html\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nhttps://www.justice.gov/archive/opa/pr/2007/December/07_enrd_1000.html\nhttp://www2.epa.gov/enforcement/merck-co-inc-settlement\nExtracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\nhttps://www.justice.gov/archive/opa/pr/2008/February/08_civ_094.html\nExtracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\nhttps://www.justice.gov/archive/atr/public/press_releases/2000/4684.htm\nhttp://www.justice.gov/opa/pr/us-pharmaceutical-company-merck-sharp-dohme-pay-nearly-one-billion-dollars-over-promotion\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nhttps://www.justice.gov/archive/opa/pr/2005/March/05_crm_090.htm\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nContained in data received from the agency on February 25, 2021 in response to an open records request. The data -- which in some cases merged penalty amounts from multiple violations --was a spreadsheet version of information contained in individual case documents that can be retrieved at https://www.ahs.dep.pa.gov/eFACTSWeb/default.aspx\nhttps://www.ftc.gov/news-events/press-releases/2000/11/ftc-reaches-record-financial-settlement-settle-charges-price\nhttps://www.justice.gov/opa/pr/four-pharmaceutical-companies-pay-124-million-submission-false-claims-medicaid\nhttps://www.sec.gov/litigation/admin/2016/34-77431-s.pdf\nhttps://www.justice.gov/usao-sdny/pr/manhattan-us-attorney-announces-370-million-civil-fraud-settlement-against-novartis\nhttps://www.dol.gov/ofccp/foia/files/Novartis_CA_Redacted.pdf\nhttp://www.justice.gov/opa/pr/novartis-pharmaceuticals-corp-pay-more-420-million-resolve-label-promotion-and-kickback\nIncluded in a dataset downloaded at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/opa/pr/novartis-vaccines-diagnostics-pay-more-72-million-resolve-false-claims-act-allegations\nhttp://www.justice.gov/opa/pr/danish-pharmaceutical-novo-nordisk-pay-25-million-resolve-allegations-label-promotion\nhttps://www.sec.gov/litigation/litreleases/2009/lr21033.htm\nhttps://www.justice.gov/opa/pr/novo-nordisk-agrees-pay-9-million-fine-connection-payment-14-million-kickbacks-through-united\nhttps://www.justice.gov/opa/pr/four-pharmaceutical-companies-pay-124-million-submission-false-claims-medicaid\nhttp://www.justice.gov/opa/pr/two-johnson-johnson-subsidiaries-pay-over-81-million-resolve-allegations-label-promotion\nhttps://www.justice.gov/opa/pr/pharmaceutical-companies-pay-67-million-resolve-false-claims-act-allegations-relating-tarceva\nhttps://www.justice.gov/archive/opa/pr/2008/March/08_civ_244.html\nhttp://www.justice.gov/opa/pr/par-pharmaceuticals-pleads-guilty-and-agrees-pay-45-million-resolve-civil-and-criminal\nExtracted from a spreadsheet obtained from the NLRB through a Freedom of Information Act request fulfilled on 5/16/2017.\nhttps://www.ftc.gov/news-events/press-releases/2004/08/generic-drug-marketers-settle-ftc-charges\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/archive/opa/pr/2002/October/02_civ_622.htm\nhttps://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history\nhttps://www.justice.gov/opa/pr/wyeth-and-pfizer-agree-pay-7846-million-resolve-lawsuit-alleging-wyeth-underpaid-drug-rebates\nhttp://www.justice.gov/opa/pr/pfizer-agrees-pay-55-million-illegally-promoting-protonix-label-use\nhttps://www.sec.gov/News/PressRelease/Detail/PressRelease/1365171483696\nhttp://www.justice.gov/opa/pr/pfizer-pay-145-million-illegal-marketing-drug-detrol\nhttps://www.justice.gov/archive/opa/pr/2008/June/08-enrd-555.html\nTaken from the Federal Railroad Administration's FY2002 safety penalty report obtained through a Freedom of Information Act request. A copy is available upon request. \nhttps://archive.epa.gov/epapages/newsroom_archive/newsreleases/e39379c592136f4085257cd60061d087.html\nhttps://www.justice.gov/opa/pr/pfizer-hcp-corp-agrees-pay-15-million-penalty-resolve-foreign-bribery-investigation\nTaken from the Federal Railroad Administration's FY2006 safety penalty report obtained through a Freedom of Information Act request. A copy is available upon request. \nhttps://railroads.dot.gov/sites/fra.dot.gov/files/fra_net/282/Annual_Enforcement_Report_2009.pdf\nhttp://efoia.bis.doc.gov/index.php/component/docman/doc_view/808-e2287?Itemid=\nhttp://www.justice.gov/opa/pr/generic-drug-manufacturer-ranbaxy-pleads-guilty-and-agrees-pay-500-million-resolve-false\nhttps://www.ttb.gov/images/pdfs/fo-compromise/2014/signed-as-regeneron-pharmaceuticals-Redacted.pdf\nhttps://www.justice.gov/opa/pr/pharmaceutical-manufacturers-pay-4212-million-settle-false-claims-act-cases\nhttps://oig.hhs.gov/newsroom/news-releases/2015/sandoz.asp\nhttps://oig.hhs.gov/fraud/enforcement/cmp/cmp-ae.asp\nhttps://www.justice.gov/opa/pr/sanofi-us-agrees-pay-109-million-resolve-false-claims-act-allegations-free-product-kickbacks\nhttps://www.justice.gov/opa/pr/sanofi-pasteur-agrees-pay-198-million-resolve-drug-overcharges-department-veterans-affairs\nhttp://www.justice.gov/opa/pr/glaxosmithkline-plead-guilty-pay-750-million-resolve-criminal-and-civil-liability-regarding\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/archive/opa/pr/2004/May/04_civ_292.htm\nExtracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\nhttps://www.justice.gov/archive/opa/pr/2004/July/04_civ_523.htm\nhttps://www.sec.gov/news/press/2003-109.htm\nhttps://www.sec.gov/litigation/litreleases/lr18740.htm\nhttps://www.justice.gov/opa/pr/schwarz-pharma-pays-22-million-settle-false-claims-allegations-concerning-reimbursement\nhttps://www.sec.gov/litigation/admin/2016/34-77058-s.pdf\nhttp://www.justice.gov/opa/pr/johnson-johnson-subsidiary-scios-pleads-guilty-misbranding-heart-failure-drug-natrecor\nhttps://www.justice.gov/opa/pr/pharmaceutical-giant-serono-agrees-pay-443-million-settle-false-claims-act-case\nhttps://www.justice.gov/archive/opa/pr/2005/October/05_civ_545.html\nhttps://www.justice.gov/opa/pr/shire-plc-subsidiaries-pay-350-million-settle-false-claims-act-allegations\nhttps://www.justice.gov/opa/pr/shire-pharmaceuticals-llc-pay-565-million-resolve-false-claims-act-allegations-relating-drug\nFOIA139\nMarch 7, 2017 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.justice.gov/opa/pr/minnesota-based-st-jude-medical-pays-us-16-million-settle-claims-company-paid-kickbacks\nhttps://www.justice.gov/opa/pr/heart-device-manufacturer-minnesota-and-hospitals-ohio-kentucky-pay-nearly-4-million-resolve\nhttps://www.justice.gov/opa/pr/minnesota-based-st-jude-medical-pays-us-365-million-settle-claims-it-overcharged-implantable\nhttps://www.justice.gov/archive/opa/pr/2001/October/513civ.htm\nhttps://www.justice.gov/opa/pr/teva-pharmaceutical-industries-ltd-agrees-pay-more-283-million-resolve-foreign-corrupt\nhttp://www.justice.gov/opa/pr/teva-pharmaceuticals-usa-pay-225-million-civil-penalty-air-water-and-hazardous-waste\nhttps://www.sec.gov/news/pressrelease/2016-277.html\nhttps://www.justice.gov/opa/pr/pharmaceutical-company-pay-276-million-settle-allegations-involving-false-billings-federal\nExtracted from an NLRB dataset covering 1999-2011 downloaded at https://catalog.data.gov/dataset/nlrb-cats-final-c-case-data-bulk-19990101-20110930-in-xml\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/\n\n*** WARNING: max output size exceeded, skipping output. ***\n\n://ago.mo.gov/home/news-archives/2013-news-archives/ag-koster-reaches-2.25m-settlement-with-pharmaceutical-company\nhttps://web.archive.org/web/20140802133939/http://illinoisattorneygeneral.gov/pressroom/2014_03/20140311.html\nhttps://web.archive.org/web/20031013025400/http://www.ago.state.mo.us/newsrls/2003/040203.htm\nhttps://web.archive.org/web/20101218023920/http://migration.kentucky.gov/Newsroom/ag/tevaawpsettlement.htm\nhttps://web.archive.org/web/20190827225126/https://ag.ny.gov/press-release/ag-schneiderman-announces-settlement-generic-pharmaceutical-companies-entering\nhttp://ag.hawaii.gov/wp-content/uploads/2012/12/2010-21.pdf\nhttps://web.archive.org/web/20110306105203/http://www.ag.idaho.gov/media/newsReleases/2010/nr_08102010.html\nAttorney General Abbott Recovers $51 Million for Texas; Medicaid Fraud Exposed, US Fed News, July 21, 2010 (via Nexis).\nhttps://web.archive.org/web/20131206104321/http://www.ag.state.la.us/Article.aspx?articleID=788&catID=2\n\nhttps://www.justice.gov/opa/pr/us-subsidiary-belgian-pharmaceutical-manufacturer-pleads-guilty-label-promotion-company-pay\nhttp://www.illinoisattorneygeneral.gov/pressroom/2009_12/20091202.html\nhttps://www.ohioattorneygeneral.gov/Media/News-Releases/December-2017/Lawsuit-Settlement-on-Insider-Trading-Case\nhttp://www.marylandattorneygeneral.gov/press/2007/061307.pdf\nhttps://www.justice.gov/opa/pr/warner-chilcott-agrees-plead-guilty-felony-health-care-fraud-scheme-and-pay-125-million\nhttps://web.archive.org/web/20100214194003/http://www.ag.ny.gov/media_center/2004/may/may13b_04.html\nhttps://web.archive.org/web/20120513203722/http://www.ag.idaho.gov/media/newsReleases/2011/nr_01132011.html\nhttps://web.archive.org/web/20101227185039/http://www.ohioattorneygeneral.gov/Briefing-Room/News-Releases/May-2009/Attorney-General-Cordray-Announces-$8-44-Million-S\nAttorney General Bondi's Office Recovers $20.2 Million for Florida from Pharmaceutical Company in Medicaid Fraud Settlement, States News Service, September 16, 2011 (via Nexis).\nhttps://web.archive.org/web/20121124050430/http://www.ag.idaho.gov/media/newsReleases/2012/nr_07162012.html\nhttps://web.archive.org/web/20100321213517/http://www.mass.gov/?pageID=cagopressrelease&L=1&L0=Home&sid=Cago&b=pressrelease&f=2010_02_12_watson_settlement&csid=Cago\nhttps://web.archive.org/web/20180222161200/http://www.ago.state.ms.us/releases/ag-announces-33-million-judgement-amid-legislative-attempt-to-strip-prosecutorial-rights/\nAttorney General Abbott Recovers $11.3 Million for Texas Medicaid Program, Targeted News Service, September 27, 2011 (via Nexis).\nhttps://www.justice.gov/opa/pr/wyeth-and-pfizer-agree-pay-7846-million-resolve-lawsuit-alleging-wyeth-underpaid-drug-rebates\nhttps://web.archive.org/web/20150906094937/http://www.ag.ny.gov/press-release/pharmaceutical-giant-pay-nearly-500-million-resolve-allegations-label-marketing-kidney\nhttps://www.justice.gov/opa/pr/pharmaceutical-company-targeting-elderly-victims-admits-paying-kickbacks-resolves-related\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.illinoisattorneygeneral.gov/pressroom/2019_10/20191028.html\nhttp://www.law.state.ak.us/press/releases/2019/101719-JohnsonJohnson.html\nhttps://www.ohioattorneygeneral.gov/Media/News-Releases/September-2019/AG-Yost-Announces-$103-Million-Multistate-Settleme\nhttps://www.dol.gov/ofccp/foia/files/20190927MerckERCAMAPRedacted.pdf\nhttps://www.sec.gov/news/press-release/2019-194\nDA offices settle product packaging case, The Davis Enterprise, January 14, 2015 (via Nexis).\nhttps://web.archive.org/web/20090813022743/http://eeoc.gov/litigation/settlements/settlement05-05.html\nhttps://web.archive.org/web/20001219083500/http://www.fda.gov/bbs/topics/ANSWERS/ANS01041.html\nhttps://19january2017snapshot.epa.gov/newsreleases/epa-fines-pfizer-puerto-rico-not-disclosing-chemical-information_.html\nhttp://ag.nv.gov/News/PR/2014/Consumer_Protection/Attorney_General_Masto_Announces_an_$8_Million_Charitable_Contribution_as_Part_of_a_Settlement_with_Pfizer/\nSIGMA ALDRICH COMPANY AGREES TO SETTLEMENT WITH U.S. RESOLVING ALLEGATIONS OF ENVIRONMENTAL CLEAN AIR ACT VIOLATIONS AT TWO FACILITIES IN ST. LOUIS, US Fed News, Sepember 1, 2004 (via Nexis).\nFeburary 7, 2020 download of a dataset posted by the Wage and Hour Division at https://enforcedata.dol.gov/views/data_summary.php\nhttps://www.lexology.com/library/detail.aspx?g=e6852ca9-49cc-476c-a416-c0ae750e8f2d\nhttps://www.law360.com/articles/1212192/takeda-unit-s-workers-get-ok-on-4-8m-deal-in-wage-suit\nhttps://www.justice.gov/usao-ma/pr/sanofi-agrees-pay-1185-million-resolve-allegations-it-paid-kickbacks-through-co-pay\nhttps://www.justice.gov/opa/pr/major-generic-pharmaceutical-company-admits-antitrust-crimes\nhttps://www.dol.gov/ofccp/foia/files/20200127IDEXXLaboratories-CA-NE_Redacted.pdf\nhttps://www.oag.ca.gov/news/press-releases/attorney-general-becerra-16-billion-global-settlement-opioid-manufacturer\nhttp://www.oag.ok.gov/attorney-general-hunter\nhttps://www.justice.gov/opa/pr/generic-pharmaceutical-company-admits-fixing-price-widely-used-cholesterol-medication\nhttps://www.wvgazettemail.com/news/legal_affairs/wv-settles-pelvic-mesh-hip-device-lawsuit-with-johnson-johnson-for-3-9m/article_7e769d78-2ac0-5923-bbbe-0f965798b2db.html\nhttps://web.archive.org/web/20171219182404/http://www.insurance.ca.gov/0400-news/0100-press-releases/2016/release082-16.cfm\nhttps://web.archive.org/web/20180118190234/http://www.insurance.ca.gov/0400-news/0100-press-releases/2017/release088-17.cfm\nhttp://www.insurance.ca.gov/0400-news/0100-press-releases/2018/release050-18.cfm\nhttps://www.oag.ca.gov/news/press-releases/attorney-general-becerra-announces-118-million-settlement-against-novartis\nhttps://www.cms.gov/medicarecompliance-and-auditspart-c-and-part-d-compliance-and/wockhardtusacmp2019q4p1292\nhttps://www.justice.gov/opa/pr/dusa-pharmaceuticals-pay-us-2075-million-settle-false-claims-act-allegations-relating\nhttps://www.justice.gov/opa/pr/indivior-solutions-pleads-guilty-felony-charge-and-indivior-entities-agree-pay-600-million\nhttps://www.justice.gov/opa/pr/novartis-pays-over-642-million-settle-allegations-improper-payments-patients-and-physicians\nhttps://www.justice.gov/opa/pr/novartis-hellas-saci-and-alcon-pte-ltd-agree-pay-over-233-million-combined-resolve-criminal\nhttps://www.ftc.gov/news-events/press-releases/2020/07/indivior-inc-pay-10-million-consumers-settling-ftc-charges\nhttps://www.marylandattorneygeneral.gov/press/2020/080520.pdf\nhttps://ncdoj.gov/attorney-general-josh-stein-reaches-settlement-over-pharma-company-kickback-allegations/\nhttps://www.dol.gov/sites/dolgov/files/ofccp/foia/files/2020-08-14BoehringerIngelheimVetmedicaCA-Redacted3.pdf\nhttps://www.sec.gov/news/press-release/2020-169\nhttps://www.sec.gov/news/press-release/2020-149\nhttps://www.sec.gov/news/press-release/2020-144\nhttps://www.justice.gov/usao-nj/pr/pharmaceutical-company-agrees-pay-35-million-resolve-allegations-violating-false-claims\nhttp://www.insurance.ca.gov/0400-news/0100-press-releases/2020/release071-2020.cfm\nhttps://www.justice.gov/opa/pr/justice-department-announces-global-resolution-criminal-and-civil-investigations-opioid\nhttps://www.justice.gov/opa/pr/gilead-agrees-pay-97-million-resolve-alleged-false-claims-act-liability-paying-kickbacks\nhttp://adem.alabama.gov/compInfo/2014orders.pdf\nhttps://www.adeq.state.ar.us/downloads/Communications/Enforcement_Actions/2002-11-10_Notice_of_Enforcement_Actions.pdf\nhttps://www.adeq.state.ar.us/downloads/Communications/Enforcement_Actions/2001-08-10_Notice_of_Enforcement_Actions.pdf\nContained in data received from the agency on November 10, 2020 in response to an open records request.\nhttps://ww2.arb.ca.gov/mia-rose-inc-settlement\nhttps://www.cdpr.ca.gov/docs/mill/actions/fines.htm\nContained in data obtained from the agency on October 6, 2020 in response to an open records request. \nContained in data obtained from the agency on October 6, 2020 in response to an open records request. \nContained in data obtained from the agency on October 6, 2020 in response to an open records request. \nContained in data obtained from the agency on October 6, 2020 in response to an open records request. \nContained in data obtained from the agency on October 6, 2020 in response to an open records request. \nContained in data obtained from the agency on October 6, 2020 in response to an open records request. \nContained in data obtained from the agency on October 6, 2020 in response to an open records request. \nhttps://www.envirostor.dtsc.ca.gov/public/eerppublicdocs/8166623771/PTI%5FCEI2015%5FFinalJudg%5F010819%2Epdf\nhttps://dtsc.ca.gov/2014/12/18/neutrogena-fined-for-hazardous-waste/\nhttps://www.envirostor.dtsc.ca.gov/public/eerppublicdocs/1803558170/Phibro%5FTech%5FConsentOrder%5F2010%2Epdf\nhttps://www.ct.gov/deep/lib/deep/enforcement/consentorder/COWRIN11003.pdf\nhttps://www.ct.gov/deep/lib/deep/enforcement/consentorder/COAR2151.pdf\nhttps://www.depdata.ct.gov/enforcement/createrpt.asp?Programopt=Air&Townopt=Andover&select=all&B1=Submit\nhttps://www.justice.gov/opa/pr/biogen-agrees-pay-22-million-resolve-alleged-false-claims-act-liability-paying-kickbacks\nContained in a spreadsheet received from the agency on October 2, 2020 in response to an open records request. The spreadsheet included data from  the agency's Oculus database, which can be searched at https://prodenv.dep.state.fl.us/DepNexus/public/searchPortal\nContained in a spreadsheet obtained from the agency on October 7, 2020 in response to an open records request. The spreadsheet contains cases from the enforcement database accessible at https://enfo.gaepd.org/Orders/Search\nContained in a spreadsheet obtained from the agency on October 7, 2020 in response to an open records request. The spreadsheet contains cases from the enforcement database accessible at https://enfo.gaepd.org/Orders/Search\nContained in data received from the agency on October 15, 2020 in response to an open records request. The data is a spreadsheet version of the entries contained in the search engine at http://www.epa.state.il.us/cgi-bin/en/orders/orders.pl\nContained in data received from the agency on October 15, 2020 in response to an open records request. The data is a spreadsheet version of the entries contained in the search engine at http://www.epa.state.il.us/cgi-bin/en/orders/orders.pl\nContained in data received from the agency on October 15, 2020 in response to an open records request. The data is a spreadsheet version of the entries contained in the search engine at http://www.epa.state.il.us/cgi-bin/en/orders/orders.pl\nhttp://www.in.gov/idem/oe/cause/AO/25216-A.htm\nhttp://www.in.gov/idem/oe/cause/AO/25477-H.htm\nhttp://www.in.gov/idem/oe/cause/AO/23215-A.htm\nhttp://www.in.gov/idem/oe/cause/AO/21384-A.htm\nhttp://www.in.gov/idem/oe/cause/AO/10783-A.htm\nhttp://www.in.gov/idem/oe/cause/AO/10141-A.htm\nhttps://www.mass.gov/news/biopharmaceutical-company-to-pay-600000-to-settle-allegations-of-clean-air-act-violations-at\nhttps://eeaonline.eea.state.ma.us/Portal/#!/search/enforcements/results?FacilityName=AMGEN INC\nhttps://eeaonline.eea.state.ma.us/Portal/#!/search/enforcements/results?FacilityName=ANIKA THERAPEUTICS INC\nhttps://eeaonline.eea.state.ma.us/Portal/#!/search/enforcements/results?FacilityName=AMGEN INC\nContained in data received from the agency on January 28, 2021 in response to an open records request.\nContained in data received from the agency on October 20, 2020 in response to an open records request.\nhttps://files.nc.gov/ncdeq/Waste%20Management/DWM/HW/Programs%20Branch/penalties/2009.pdf\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on January 28, 2021 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nContained in data received from the agency on October 26, 2020 in response to an open records request. The data was a spreadsheet version of information contained in the records in the DEP DataMiner at https://www13.state.nj.us/DataMiner\nhttps://web.archive.org/web/20201124071506/https://www.dec.ny.gov/docs/regions_pdf/amriorder(2).pdf\nhttps://web.archive.org/web/20201128054706/https://www.dec.ny.gov/docs/regions_pdf/glaxosmithkline.pdf\nhttps://web.archive.org/web/20201124010632/https://www.dec.ny.gov/docs/regions_pdf/amriorder.pdf\nhttps://web.archive.org/web/20201128041726/https://www.dec.ny.gov/docs/regions_pdf/mallinckrodt.pdf\nhttp://edocpub.epa.ohio.gov/publicportal/ViewDocument.aspx?docid=52149\nhttp://edocpub.epa.ohio.gov/publicportal/ViewDocument.aspx?docid=295488\nContained in data received from the agency on October 22, 2020 in response to an open records request.\nContained in data received from the agency on October 22, 2020 in response to an open records request.\nhttps://www.deq.virginia.gov/permits-regulations/enforcement/final-orders\nhttps://www.deq.virginia.gov/permits-regulations/enforcement/final-orders\nhttps://www.oag.ca.gov/news/press-releases/attorney-general-bonta-announces-300-million-settlement-against-indivior\nhttps://www.epa.gov/newsreleases/epa-reaches-settlement-csl-behring-illinois-improve-risk-management-program\nhttps://www.justice.gov/opa/pr/incyte-corporation-pay-126-million-resolve-false-claims-act-allegations-paying-kickbacks\nhttps://www.justice.gov/usao-edpa/pr/bristol-myers-squibb-pay-75-million-resolve-false-claims-act-allegations-underpayment\nhttps://www.fec.gov/data/legal/matter-under-review/5784/\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nExtracted from a download of OSHA's Enforcment Data downloaded on 9/16/2021, available at https://enforcedata.dol.gov/views/data_catalogs.php\nhttps://www.justice.gov/opa/pr/st-jude-agrees-pay-27-million-allegedly-selling-defective-heart-devices\nhttps://www.justice.gov/opa/pr/medical-device-companies-alere-inc-and-alere-san-diego-inc-agree-pay-3875-million-settle\nhttps://www.marylandattorneygeneral.gov/press/2013/121713a.pdf\nhttps://www.washingtonpost.com/business/2021/09/01/purdue-pharma-bankruptcy-judge-ruling/\nhttps://portal.ct.gov/AG/Press-Releases/2021-Press-Releases/AG-Tong-Announces-75-Million-Settlement-with-Bristol-Myers-Squibb-over-Medicaid-Charges\nhttps://ncdoj.gov/attorney-general-josh-stein-announces-26-billion-agreement-with-opioid-distributors-manufacturer/\nhttps://ag.ny.gov/press-release/2021/attorney-general-james-secures-50-million-opioid-abatement-drug-manufacturer-endo\nhttps://www1.nyc.gov/site/cchr/enforcement/2021-settlements.page\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"info_source\" column from each row in the dataset pharma_with_none_parent_company_stock_ticker\n",
    "info_source = pharma_with_none_parent_company_stock_ticker.map(lambda row: row[32] if len(row) > 32 else None)\n",
    "\n",
    "# Display the \"info_source\" column values\n",
    "for value in info_source.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "c5349b2c-4a05-4f83-b000-d9ca73e530a0",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'info_source': 3\n"
     ]
    }
   ],
   "source": [
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = info_source.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'info_source':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "d7eaa4b9-b8cc-4e70-abc0-40b3462ee5be",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 3\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"infor_source\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[32] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_parent_company_stock_ticker.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[32] == '':\n",
    "        row[32] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_info_source = pharma_with_none_parent_company_stock_ticker.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_info_source.filter(lambda row: row[32] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "604c1cc7-a9b6-41d9-89c0-a4d58ea399b4",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Notes\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\nCompany is plan administrator. Penalty amount reported in range of $10,001 to $50,000. \nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\nSource document obtained through a Freedom of Information Act request to the agency.\nYear is fiscal year. Date is closing date.\nYear is fiscal year. Date is closing date.\n\n\n\nCompany is plan administrator. Penalty amount reported in range of $10,001 to $50,000. \n\n\n\n\n\n\n\n\nSource document obtained through a Freedom of Information Act request to the agency.\n\n\n\n\n\n\nYear is fiscal year. Date is closing date.\n\n\n\n\n\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCompany is plan administrator. Penalty amount reported in range of $10,001 to $50,000. \n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCompany is plan administrator. Penalty amount reported in range of $10,001 to $50,000. \n\n\n\n\n\n\n\n\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\n\n\nSource document obtained through a Freedom of Information Act request to the agency.\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\n\n\n\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\n\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\n\n\n\nCompany is plan administrator. Penalty amount reported in range of $10,001 to $50,000. \n\n\n\n\n\n\n\n\n\n\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\nNote: This penalty is a duplicate of an amount shown in another record (either because it applies to a multi-location settlement or because Violation Tracker contains an agency record and a settlement announcement for the same case).\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe company originally agreed to pay up to $4.5 million but the amount was later revised to $2.6 million.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCompany is plan administrator. Penalty amount reported in range of $10,001 to $50,000. \n\n\n\n\n\n\n\n\n\n\n\n\nAbbott Laboratories, Inc.; Amgen, Inc.; Baxter International, Inc. (and associated companies); Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. (and associated companies); Immunex Corp.; and Roxane Laboratories, Inc. collectively agreed to pay $2.5 million in settlement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbbott Laboratories, Inc.; Amgen, Inc.; Baxter International, Inc. (and associated companies); Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. (and associated companies); Immunex Corp.; and Roxane Laboratories, Inc. collectively agreed to pay $2.5 million in settlement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbbott Laboratories, Inc.; Amgen, Inc.; Baxter International, Inc. (and associated companies); Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. (and associated companies); Immunex Corp.; and Roxane Laboratories, Inc. collectively agreed to pay $2.5 million in settlement\n\n\n\n\n\n\n\n\nAbbott Laboratories, Inc.; Amgen, Inc.; Baxter International, Inc. (and associated companies); Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. (and associated companies); Immunex Corp.; and Roxane Laboratories, Inc. collectively agreed to pay $2.5 million in settlement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLater press release gives settlement as $1,180,600.00\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAttorney General press release: \"The settlement, in conjunction with an earlier Federal Settlement, resulted in $418,951.52 being repaid to Georgia's Medicaid program\" \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbbott Laboratories, Inc.; Amgen, Inc.; Baxter International, Inc. (and associated companies); Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. (and associated companies); Immunex Corp.; and Roxane Laboratories, Inc. collectively agreed to pay $2.5 million in settlement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThis was a settlement over post-verdict motions to withdraw an appeal and end the litigation.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nAbbott Laboratories, Inc.; Amgen, Inc.; Baxter International, Inc. (and associated companies); Ben Venue Laboratories, Inc.; Boehringer Ingelheim Roxane, Inc. (and associated companies); Immunex Corp.; and Roxane Laboratories, Inc. collectively agreed to pay $2.5 million in settlement\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLater press release gives settlement as $252,027.44\n\n\n\n\n\n\n\n\n\nSettlement was jointly lodged with the EPA, press release did not note if a portion of settlement payment went to the United States.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDate and year are the Findings End Date in the dataset posted by the Wage and Hour Division, which does not provide case opening or closing dates. The company name is the Legal Name provided by the dataset unless that field is blank, in which case the Trade Name is used. The dataset provides only one address and does not indicate whether it is the company headquarters address or the establishment address. The penalty amount is the total of civil monetary penalties and mandated back wages. The original dataset provides a breakdown.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCaptured from summaries produced by DEP; may not include full details of penalties.\nCaptured from summaries produced by DEP; may not include full details of penalties.\nCaptured from summaries produced by DEP; may not include full details of penalties.\n\nCase number is the designation given by the DEP's Office of General Counsel.\n\n\n\n\n\n\n\n\n\n\n\n\nCaptured from records in EEA database with basic enforcement information; may not include full details of penalties.\nCaptured from records in EEA database with basic enforcement information; may not include full details of penalties.\nCaptured from records in EEA database with basic enforcement information; may not include full details of penalties.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPenalty listed includes a $6,140 Supplemental Environmental Project.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n"
     ]
    }
   ],
   "source": [
    "# To get the values of the \"notes\" column from each row in the dataset pharma_with_none_info_source\n",
    "notes = pharma_with_none_info_source.map(lambda row: row[33] if len(row) > 33 else None)\n",
    "\n",
    "# Display the \"notes\" column values\n",
    "for value in notes.collect():\n",
    "    print(value)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "7c019051-d3e9-47f3-909e-faf47b1d9aaa",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values in column 'notes': 909\n"
     ]
    }
   ],
   "source": [
    "def is_missing(value):\n",
    "    return value == ''\n",
    "\n",
    "# Filter out missing values\n",
    "missing_values = notes.filter(is_missing)\n",
    "\n",
    "# Count the missing values\n",
    "num_missing_values = missing_values.count()\n",
    "\n",
    "# Display the count of missing values\n",
    "print(\"Number of missing values in column 'notes':\", num_missing_values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "783abbd1-d3b4-49ab-b40c-afacaa332b70",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of missing values before replacement: 909\nNumber of missing values after replacement: 0\n"
     ]
    }
   ],
   "source": [
    "# Since there is missing values in the column \"notes\", in order to replace it with none, let's first define a function to count missing values in the required column\n",
    "def count_missing_values(row):\n",
    "    # Check if the value is empty\n",
    "    return 1 if row[33] == '' else 0\n",
    "\n",
    "# To count the number of missing values\n",
    "num_missing_values_before_transformation = pharma_with_none_info_source.filter(count_missing_values).count()\n",
    "\n",
    "# Now, to replace the missing value columns with 'none', define another function: \n",
    "def replace_missing_with_none(row):\n",
    "    # Check if the value is empty\n",
    "    if row[33] == '':\n",
    "        row[33] = 'None'  # Replace the empty value with 'None'\n",
    "    return row\n",
    "\n",
    "# since there are missing Replace missing values with 'None' in the parsed RDD\n",
    "pharma_with_none_notes = pharma_with_none_info_source.map(replace_missing_with_none)\n",
    "\n",
    "# Count the number of missing values after replacement\n",
    "num_missing_values_after_transformation = pharma_with_none_notes.filter(lambda row: row[33] == '').count()\n",
    "\n",
    "# Display the number of missing values before and after transformation\n",
    "print(\"Number of missing values before replacement:\", num_missing_values_before_transformation)\n",
    "print(\"Number of missing values after replacement:\", num_missing_values_after_transformation)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "74dfebd4-e1bd-4f9b-b7b9-d658cfdc8452",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Row count of pharma_with_none_notes RDD: 969\n"
     ]
    }
   ],
   "source": [
    "#Now, after the replacement of the missing values for the complete columns in the dataset pharma_with_none_notes, lets review the first frw rows and the row count of it\n",
    "\n",
    "pharma_with_none_notes.take(5)\n",
    "\n",
    "# Assuming pharma_with_none_notes is your RDD\n",
    "row_count = pharma_with_none_notes.count()\n",
    "\n",
    "print(\"Row count of pharma_with_none_notes RDD:\", row_count)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "82f5b3ea-59dc-401b-bae9-70483eeea261",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Row number: ('Id', 'Study Title', 'Acronym', 'Status', 'Conditions', 'Interventions', 'Sponsor', 'Collaborators', 'Enrollment', 'Funder Type', 'Type', 'Study Design', 'Start', 'Completion')\nRow content: 0\n"
     ]
    }
   ],
   "source": [
    "#Now, let's begin doing the actual tasks given\n",
    "# Completing the tasks using Resilient Distributed Dataset using pyspark\n",
    "# Task 1: The number of studies in the dataset. You must ensure that you explicitly checkdistinct studies.\n",
    "#since this is only depending upon the first dataset clinicaltrial_2023, lets consider that in order to do this task\n",
    "#just to double confirm that only required rows are coming in the dataset \n",
    "# Add index to each row\n",
    "rows_with_index = final_rdd_clinicaltrial_2023.zipWithIndex()\n",
    "\n",
    "# Filter rows where 'Id' column contains 'Id' and is not None\n",
    "rows_with_valid_type = rows_with_index.filter(lambda row_index: row_index[0][0] and 'Id' in row_index[0][0])\n",
    "\n",
    "# Print the row number and rows\n",
    "for row_index, row in rows_with_valid_type.collect():\n",
    "    print(\"Row number:\", row_index)\n",
    "    print(\"Row content:\", row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "92d1ca19-d084-47fd-bd47-8a6ebded3093",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of unique studies in the dataset: 483420\n"
     ]
    }
   ],
   "source": [
    "\n",
    "# Now, you can proceed with the rest of your operations using final_rdd_clinicaltrial_2023\n",
    "# Count the number of distinct studies\n",
    "num_unique_studies = (\n",
    "    final_rdd_clinicaltrial_2023  # Assuming verified_rdd contains the prepared dataset\n",
    "    .zipWithIndex()  # Pair each element with its index\n",
    "    .filter(lambda row_index: row_index[1] != 0)  # Ignore the first row by filtering out the index 0\n",
    "    .map(lambda row_index: row_index[0][0])  # Select the study ID (assuming it's in the second position of each row)\n",
    "    .distinct()  # Get distinct study IDs\n",
    "    .count()  # Count the distinct study IDs\n",
    ")\n",
    "\n",
    "# Print the number of studies\n",
    "print(\"Number of unique studies in the dataset:\", num_unique_studies)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "eb4d0194-010e-4693-a182-625f9c387e16",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('INTERVENTIONAL', 371381)\n('OBSERVATIONAL', 110221)\n('EXPANDED_ACCESS', 928)\n(None, 889)\n"
     ]
    }
   ],
   "source": [
    "# Now, let's consider our second task: You should list all the types (as contained in the Type column) of studies in thedataset along with the frequencies of each type. These should be ordered frommost frequent to least frequent.\n",
    "\n",
    "# mapping each study to a tuple\n",
    "type_counts = (\n",
    "    final_rdd_clinicaltrial_2023\n",
    "    .zipWithIndex()  # Add index to each row\n",
    "    .filter(lambda row_index: row_index[1] != 0)  # Ignore the first row by filtering out the index 0\n",
    "    .filter(lambda row_index: row_index[1] != 224728) #couldn't find a logic to remove the row, the logic is failing so. removed the row from the rdd in this one only.\n",
    "    .map(lambda x: (x[0][10], 1)) \n",
    "    .reduceByKey(lambda x, y: x + y)  # Reduce by key to count occurrences\n",
    ")\n",
    "\n",
    "# Sort the type counts by frequency in descending order\n",
    "sorted_type_counts = type_counts.sortBy(lambda x: x[1], ascending=False)\n",
    "\n",
    "# Collect the result\n",
    "result = sorted_type_counts.collect()\n",
    "\n",
    "# Print the result\n",
    "for row in result:\n",
    "    print(row)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "fafa4ae4-b5cf-41c3-84b9-0c95580dff5f",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Condition: Healthy, Frequency: 7997\nCondition: Breast Cancer, Frequency: 4556\nCondition: Prostate Cancer, Frequency: 2650\nCondition: Asthma, Frequency: 2309\nCondition: Obesity, Frequency: 2284\n"
     ]
    }
   ],
   "source": [
    "# Now, let's consider our third task: The top 5 conditions (from Conditions) with their frequencies.\n",
    "\n",
    "# First of all, let's define a function to parse each row of the RDD in order to avoid the parsing error while doing the task\n",
    "def parse_row(row):\n",
    "    #the row index of the column \"conditions\" is 4, hence\n",
    "    conditions = row[4]\n",
    "    if conditions is not None:\n",
    "        # Split the conditions by comma and remove in between whitespaces\n",
    "        parsed_conditions = [condition.strip() for condition in conditions.split(',')]\n",
    "        return parsed_conditions\n",
    "    else:\n",
    "        return []\n",
    "\n",
    "# Apply the parsing function to each row of the RDD clinicaltrial_2023_filtered\n",
    "parsed_rdd = final_rdd_clinicaltrial_2023.map(parse_row)\n",
    "\n",
    "# only take out rows with None values in the Conditions column\n",
    "filtered_rdd_with_conditions = parsed_rdd.filter(lambda row: row != [])\n",
    "\n",
    "# Mapping each condition to a tuple of (condition, 1), then reduce by key to count occurrences\n",
    "condition_counts = (\n",
    "    filtered_rdd_with_conditions\n",
    "    .flatMap(lambda row: [(condition, 1) for condition in row])  \n",
    "    .reduceByKey(lambda x, y: x + y) \n",
    ")\n",
    "\n",
    "# Sort the condition counts by frequency in descending order so as to get the most highest count as first one and most lowest count as last\n",
    "sorted_condition_counts = condition_counts.sortBy(lambda x: x[1], ascending=False)\n",
    "\n",
    "# Collect the top 5 conditions since our requirement is only to get the top five!\n",
    "top_5_conditions = sorted_condition_counts.take(5)\n",
    "\n",
    "# Print the top 5 conditions with their frequencies alongwith\n",
    "for condition, frequency in top_5_conditions:\n",
    "    print(f\"Condition: {condition}, Frequency: {frequency}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "5fe8e746-a087-439a-b364-e2b2cf0a80ce",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Abbott Laboratories\nAbbVie\nAmneal Pharmaceuticals\nAstraZeneca\nSanofi\nAVEO Pharmaceuticals\nBausch Health\nGlaxoSmithKline\nTeva Pharmaceutical Industries\nMerck\nNovartis\nDaiichi Sankyo\nEisai\nKV Pharmaceutical\nParexel International\nNovo Holdings A/S\nSun Pharmaceuticals\nRegeneron Pharmaceuticals\nTakeda Pharmaceutical\nCambrex\nLannett Co.\nCSL Limited\nAkorn Inc.\nWockhardt Limited\nAnika Therapeutics\nPurdue Pharma\nArbor Pharmaceuticals\nAceto\nApotex Corp.\nBiocryst Pharmaceuticals\nElanco Animal Health\nCuria Inc.\nParent_Company\nJohnson & Johnson\nPfizer\nBristol-Myers Squibb\nAmgen\nAstellas Pharma\nBiogen Idec\nBoehringer Ingelheim\nEli Lilly\nAlcami\nCurrax Pharmaceuticals\nEndo International\nViatris\nPerrigo\nMerck KGaA (EMD)\nZoetis\nSELLAS Life Sciences Group\nRoche\nGilead Sciences\nClovis Oncology\nMallinckrodt\nOtsuka Pharmaceutical\nPhibro Animal Health\nHikma Pharmaceuticals\nUCB\nSciClone Pharmaceuticals\nTaro Pharmaceutical Industries\nIDEXX Laboratories\nAmryt Pharma\nJazz Pharmaceuticals\nDr. Reddy's Laboratories\nUnited Therapeutics\nCytRx\nAmphastar Pharmaceuticals\nInsys Therapeutics\nLundbeck\nOrganon & Co.\nIndivior Inc.\nPacira BioSciences\nNutraceutical International Corp.\nIncyte Corp.\n"
     ]
    }
   ],
   "source": [
    "# considert our Task 4: Find the 10 most common sponsors that are not pharmaceutical companies, alongwith the number of clinical trials they have sponsored. Hint: For a basicimplementation, you can assume that the Parent Company column contains allpossible pharmaceutical companies.\n",
    "\n",
    "#first we have to get all the possible pharmaceutical companies from the parent_company table of the dataset pharma_with_none_notes\n",
    "\n",
    "# Filter out None values and empty strings in the parent_company column\n",
    "filtered_parent_company_rdd = pharma_with_none_notes.filter(lambda row: row[1] is not None and row[1].strip() != '')\n",
    "\n",
    "# Get distinct parent company names\n",
    "distinct_parent_companies_rdd = filtered_parent_company_rdd.map(lambda row: row[1]).distinct()\n",
    "\n",
    "# Collect the distinct parent company names into a list\n",
    "all_pharmaceutical_companies = distinct_parent_companies_rdd.collect()\n",
    "\n",
    "# Print the list of all pharmaceutical companies\n",
    "for company in all_pharmaceutical_companies:\n",
    "    print(company)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "59ed4763-66a0-41a9-986e-68ad5aca902e",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sponsor: National Cancer Institute (NCI), Number of Clinical Trials: 3410\nSponsor: Assiut University, Number of Clinical Trials: 3335\nSponsor: Cairo University, Number of Clinical Trials: 3023\nSponsor: Assistance Publique - Hôpitaux de Paris, Number of Clinical Trials: 2951\nSponsor: Mayo Clinic, Number of Clinical Trials: 2766\nSponsor: M.D. Anderson Cancer Center, Number of Clinical Trials: 2702\nSponsor: Novartis Pharmaceuticals, Number of Clinical Trials: 2393\nSponsor: National Institute of Allergy and Infectious Diseases (NIAID), Number of Clinical Trials: 2340\nSponsor: Massachusetts General Hospital, Number of Clinical Trials: 2263\nSponsor: National Taiwan University Hospital, Number of Clinical Trials: 2181\n"
     ]
    }
   ],
   "source": [
    "#now, assuming that these are the all possible pharmaceutical companies that we need to omit from considering the sponsers. \n",
    "# Get the list of pharmaceutical companies\n",
    "pharmaceutical_companies_set = set(all_pharmaceutical_companies)\n",
    "\n",
    "# Extracting sponsors from the dataset\n",
    "sponsors_rdd = final_rdd_clinicaltrial_2023.map(lambda row: row[6])\n",
    "\n",
    "# Filtering out pharmaceutical companies from the list of sponsors\n",
    "non_pharma_sponsors_rdd = sponsors_rdd.filter(lambda sponsor: sponsor not in pharmaceutical_companies_set)\n",
    "\n",
    "# Count the occurrences of each sponsor\n",
    "sponsor_counts = non_pharma_sponsors_rdd.map(lambda sponsor: (sponsor, 1)).reduceByKey(lambda x, y: x + y)\n",
    "\n",
    "# Sort the sponsors by the number of clinical trials they have sponsored\n",
    "sorted_sponsors = sponsor_counts.sortBy(lambda x: x[1], ascending=False)\n",
    "\n",
    "# Take the top 10 sponsors since we only need that according to the question\n",
    "top_10_sponsors = sorted_sponsors.take(10)\n",
    "\n",
    "# Print the top 10 sponsors along with the number of clinical trials they have sponsored\n",
    "for sponsor, count in top_10_sponsors:\n",
    "    print(f\"Sponsor: {sponsor}, Number of Clinical Trials: {count}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "99a0f94a-99cf-4bae-9c1c-822bd7c0c067",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "display_data",
     "data": {
      "image/png": "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\n"
     },
     "metadata": {
      "application/vnd.databricks.v1+output": {
       "addedWidgets": {},
       "arguments": {},
       "data": "data:image/png;base64,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\n",
       "datasetInfos": [],
       "metadata": {},
       "removedWidgets": [],
       "type": "image"
      }
     },
     "output_type": "display_data"
    },
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Table of Completed Studies for Each Month in 2023:\nMonth\t\tCompleted Studies\n2023-01\t\t2567\n2023-02\t\t2112\n2023-03\t\t2947\n2023-04\t\t2402\n2023-05\t\t2627\n2023-06\t\t3634\n2023-07\t\t2752\n2023-08\t\t2696\n2023-09\t\t2878\n2023-10\t\t2616\n2023-11\t\t2313\n2023-12\t\t9283\n"
     ]
    }
   ],
   "source": [
    "#Now, consider the fifth task: Plot number of completed studies for each month in 2023. You need to include yourvisualization as well as a table of all the values you have plotted for each month\n",
    "\n",
    "#importing the required library: matplotlib.pyplot --> commonly used for creating plots and visualizations in Python.  \n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "# Extract completion dates from final_rdd_clinicaltrial_2023 in order to do the task\n",
    "completion_dates = final_rdd_clinicaltrial_2023.map(lambda row: row[13])\n",
    "\n",
    "# Filtering completion dates for 2023 by removing the None values\n",
    "completion_dates_2023 = completion_dates.filter(lambda date: date is not None and date.startswith('2023'))\n",
    "\n",
    "# Map each completion date to month and count occurrences so as to plot it\n",
    "completed_studies_per_month = completion_dates_2023 \\\n",
    "    .map(lambda date: date[:7]) \\\n",
    "    .map(lambda month: (month, 1)) \\\n",
    "    .reduceByKey(lambda x, y: x + y) \\\n",
    "    .collect()\n",
    "\n",
    "# Sort by month in order to get a client-friednly view\n",
    "completed_studies_per_month.sort(key=lambda x: x[0])\n",
    "\n",
    "# Extract month labels and counts\n",
    "months = [entry[0] for entry in completed_studies_per_month]\n",
    "counts = [entry[1] for entry in completed_studies_per_month]\n",
    "\n",
    "# Plotting the data into a pyplot visualization\n",
    "plt.figure(figsize=(10, 6))\n",
    "plt.bar(months, counts, color='skyblue')\n",
    "plt.title('Number of Completed Studies for Each Month in 2023')\n",
    "plt.xlabel('Month')\n",
    "plt.ylabel('Number of Completed Studies')\n",
    "plt.xticks(rotation=45)\n",
    "plt.grid(axis='y', linestyle='--', alpha=0.7)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# Table of values containing the completed study details\n",
    "print(\"Table of Completed Studies for Each Month in 2023:\")\n",
    "print(\"Month\\t\\tCompleted Studies\")\n",
    "for month, count in completed_studies_per_month:\n",
    "    print(f\"{month}\\t\\t{count}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 0,
   "metadata": {
    "application/vnd.databricks.v1+cell": {
     "cellMetadata": {
      "byteLimit": 2048000,
      "rowLimit": 10000
     },
     "inputWidgets": {},
     "nuid": "0aad47ea-bac6-4b9b-8d9d-18c8bddc4fbf",
     "showTitle": false,
     "title": ""
    }
   },
   "outputs": [
    {
     "output_type": "stream",
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Out[167]: [('Id',\n  'Study Title',\n  'Acronym',\n  'Status',\n  'Conditions',\n  'Interventions',\n  'Sponsor',\n  'Collaborators',\n  'Enrollment',\n  'Funder Type',\n  'Type',\n  'Study Design',\n  'Start',\n  'Completion'),\n ('NCT00237471',\n  'Impact of Tight Glycaemic Control in Acute Myocardial Infarction',\n  None,\n  'TERMINATED',\n  'Myocardial Infarct|Hyperglycemia',\n  'DRUG: Insulin (tight blood glucose control)',\n  'Melbourne Health',\n  'National Health and Medical Research Council Australia|Bristol-Myers Squibb',\n  '40.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT',\n  '2005-10-01',\n  '2006-05-01'),\n ('NCT02945371',\n  'Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life',\n  'REV',\n  'COMPLETED',\n  'Smoking|Alcohol Drinking|Prescription Drug Abuse|Substance-Related Disorders|Oral Intake Reduced',\n  'BEHAVIORAL: Person-centered inhibitory control training|BEHAVIORAL: Active behavioral response training',\n  'University of Oregon',\n  None,\n  '103.0',\n  'OTHER',\n  'INTERVENTIONAL',\n  'Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION',\n  '2014-09-01',\n  '2016-05-01')]"
     ]
    }
   ],
   "source": [
    "final_rdd_clinicaltrial_2023.take(3)"
   ]
  }
 ],
 "metadata": {
  "application/vnd.databricks.v1+notebook": {
   "dashboards": [],
   "language": "python",
   "notebookMetadata": {
    "mostRecentlyExecutedCommandWithImplicitDF": {
     "commandId": 2309071625620769,
     "dataframes": [
      "_sqldf"
     ]
    },
    "pythonIndentUnit": 4
   },
   "notebookName": "Sunena_Salam_rdd",
   "widgets": {}
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
